concept_id	concept_synonym_name	language_concept_id
40638341	Densovirus of Aedes (organism)	4180186
40638344	Epigastric hernia with obstruction but no gangrene (disorder)	4180186
40638350	Verdoglobin (substance)	4180186
40638360	Penicillium rubrum (organism)	4180186
40638370	Temporary bladder catheter	4180186
40638370	Temporary urinary catheter (physical device) (physical object)	4180186
40638395	Brussels griffon dog (organism)	4180186
40638399	Salmonella 47;b;e,n,x,z15	4180186
40638399	Salmonella II 47:b:e,n,x,z15	4180186
40638399	Salmonella II khami (organism)	4180186
40638399	Salmonella khami	4180186
40638434	Retired procedure (procedure)	4180186
40638478	Retired procedure (procedure)	4180186
40638481	Blood group antigen Doughty (substance)	4180186
40638495	Steroid 11-beta-monooxygenase deficiency (disorder)	4180186
40638499	Aspiration curettage of uterus after delivery (procedure)	4180186
40638534	Retired procedure (procedure)	4180186
40638584	Neurocytoma (morphologic abnormality)	4180186
40638604	Retired procedure (procedure)	4180186
40638606	Salmonella 45;a;z10	4180186
40638606	Salmonella ejeda	4180186
40638606	Salmonella II 45:a:z10	4180186
40638606	Salmonella II ejeda (organism)	4180186
40638628	Retired procedure (procedure)	4180186
40638634	Retired procedure (procedure)	4180186
40638682	Salmonella, Subgenus IV (organism)	4180186
40638705	Gyrate atrophy of the choroid AND/OR retina (disorder)	4180186
40638706	Red-billed tickbird (organism)	4180186
40638710	Retired procedure (procedure)	4180186
40638714	Reovirus (living organism) (organism)	4180186
40638727	Duration of uterine contraction, function (observable entity)	4180186
40638737	Retired procedure (procedure)	4180186
40638739	CDC group M-4f	4180186
40638739	Flavobacterium odoratum (organism)	4180186
40638741	Poisoning by papaverine (disorder)	4180186
40638784	Retired procedure (procedure)	4180186
40638790	Densovirus of Bombyx (organism)	4180186
40638803	Retired procedure (procedure)	4180186
40638817	AIDS with Burkitt's tumor (disorder)	4180186
40638817	AIDS with Burkitt's tumour	4180186
40638838	Ehrlichia equi (organism)	4180186
40638872	Lice	4180186
40638872	Family: Pediculidae	4180186
40638872	Louse (organism)	4180186
40638872	Pediculidae	4180186
40638936	Retired procedure (procedure)	4180186
40638945	Retired procedure (procedure)	4180186
40638958	Retired procedure (procedure)	4180186
40638969	Nicobar pigeon (organism)	4180186
40639019	Retired procedure (procedure)	4180186
40639037	Thick (modifier) (qualifier value)	4180186
40639041	Menage a trois	4180186
40639041	M+nage E trois (social status) (finding)	4180186
40639077	Pericardiocentesis (procedure)	4180186
40639108	Excision of lactiferous duct fistula of breast (procedure)	4180186
40639111	Retired procedure (procedure)	4180186
40639153	Retired procedure (procedure)	4180186
40639182	Retired procedure (procedure)	4180186
40639185	Retired procedure (procedure)	4180186
40639201	Isopropyl alcohol (substance)	4180186
40639215	Mosquito iridescent virus (organism)	4180186
40639239	Retired procedure (procedure)	4180186
40639242	Fourth degree perineal laceration (disorder)	4180186
40639242	Fourth degree perineal tear	4180186
40639242	Fourth degree perineal tear during delivery	4180186
40639242	CPT - Complete perineal tear	4180186
40639242	Obstetrical laceration, fourth degree	4180186
40639279	Retired procedure (procedure)	4180186
40639282	Malignant lymphoma, lymphocytic, poorly differentiated, nodular (morphologic abnormality)	4180186
40639313	Perognathus (organism)	4180186
40639313	Pocket mouse	4180186
40639338	Subtotal recent retinal detachment (disorder)	4180186
40639378	Map source (foundation metadata concept)	4180186
40639378	Map source	4180186
40639378	Map source concept (foundation metadata concept)	4180186
40639379	Map group (foundation metadata concept)	4180186
40639383	Map target (foundation metadata concept)	4180186
40639384	Language type reference set	4180186
40639384	Language type reference set (foundation metadata concept)	4180186
40639385	English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)	4180186
40639385	English [International Organization for Standardization 639-1 code en] language reference set	4180186
40639387	United States of America English language reference set (foundation metadata concept)	4180186
40639387	United States of America English language reference set	4180186
40639388	Description in dialect (foundation metadata concept)	4180186
40639389	Acceptability (foundation metadata concept)	4180186
40639390	Query specification type reference set (foundation metadata concept)	4180186
40639390	Query specification type reference set	4180186
40639391	Simple query specification reference set	4180186
40639391	Simple query specification reference set (foundation metadata concept)	4180186
40639397	Annotation (foundation metadata concept)	4180186
40639398	Image (foundation metadata concept)	4180186
40639403	MOVED FROM association reference set (foundation metadata concept)	4180186
40639406	WAS A association reference set (foundation metadata concept)	4180186
40639409	REFERS TO concept association reference set (foundation metadata concept)	4180186
40639410	Association source component (foundation metadata concept)	4180186
40639412	Module dependency reference set (foundation metadata concept)	4180186
40639412	Module dependency reference set	4180186
40639413	Dependency target (foundation metadata concept)	4180186
40639414	Source effective time (foundation metadata concept)	4180186
40639415	Target effective time (foundation metadata concept)	4180186
40639416	Description format	4180186
40639416	Description format reference set (foundation metadata concept)	4180186
40639418	Plain text (foundation metadata concept)	4180186
40639419	Limited HyperText Markup Language	4180186
40639419	Limited HyperText Markup Language (foundation metadata concept)	4180186
40639423	Active value (foundation metadata concept)	4180186
40639425	Relationship inactivation indicator attribute value reference set (foundation metadata concept)	4180186
40639425	Relationship inactivation indicator attribute value reference set	4180186
40639432	Salmonella II, group S (organism)	4180186
40639435	Retired procedure (procedure)	4180186
40639438	Nocardiopsis coeruleofusca (organism)	4180186
40639456	Retired procedure (procedure)	4180186
40639486	Salmonella II 1,40:c:e,n,x,z15	4180186
40639486	Salmonella 1,40;c;e,n,x,z15	4180186
40639486	Salmonella II suarez (organism)	4180186
40639486	Salmonella suarez	4180186
40639492	Acquired stenosis of nasolacrimal duct (disorder)	4180186
40639512	Salmonella 1,13,23;z;1,5	4180186
40639512	Salmonella II 1,13,23:z:1,5	4180186
40639512	Salmonella II nachshonim (organism)	4180186
40639512	Salmonella nachshonim	4180186
40639538	Splendid pigeon (organism)	4180186
40639575	Retired procedure (procedure)	4180186
40639606	Retired procedure (procedure)	4180186
40639610	Pied-billed grebe (organism)	4180186
40639652	Retired procedure (procedure)	4180186
40639659	Retired procedure (procedure)	4180186
40639682	Total adrenalectomy (procedure)	4180186
40639688	Repair of pulmonary valve with tissue graft (procedure)	4180186
40639703	Disease due to Eimeria (disorder)	4180186
40639728	Anticoagulant coverage	4180186
40639728	Anticoagulant prophylaxis	4180186
40639728	Low dose heparin prophylaxis	4180186
40639728	Prescription of prophylactic anticoagulant (procedure)	4180186
40639728	Thrombosis prophylaxis	4180186
40639730	Angiotomy of aorta	4180186
40639730	Aortotomy	4180186
40639730	Arteriotomy of aorta	4180186
40639730	Exploration of aorta	4180186
40639730	Incision of aorta (procedure)	4180186
40639735	Retired procedure (procedure)	4180186
40639741	Retired procedure (procedure)	4180186
40639752	Retired procedure (procedure)	4180186
40639772	Protein C activation peptide (substance)	4180186
40639784	Inferior lumbar trigone	4180186
40639784	Lumbar trigone (body structure)	4180186
40639784	Petit's triangle	4180186
40639823	Retired procedure (procedure)	4180186
40639835	Salmonella 6,8:a:e,n,x (organism)	4180186
40639845	Emotional stability	4180186
40639845	Normal emotional state (finding)	4180186
40639856	Mourning dove (organism)	4180186
40639871	Furuncle of vulva (disorder)	4180186
40639882	HLA-B7 antigen (substance)	4180186
40639884	Retired procedure (procedure)	4180186
40639900	Retired procedure (procedure)	4180186
40639904	Retired procedure (procedure)	4180186
40639928	Knee arthrodesis with plate (procedure)	4180186
40639956	Paralysis of glottis (disorder)	4180186
40639957	Retired procedure (procedure)	4180186
40639975	Quinazoline diuretic (product)	4180186
40639980	Retired procedure (procedure)	4180186
40639991	Razor-billed auk (organism)	4180186
40639993	Blood group antigen Singleton (substance)	4180186
40640008	AIDS with histoplasmosis (disorder)	4180186
40640012	Tetanus immunisation	4180186
40640012	Tetanus immunization (procedure)	4180186
40640015	Retired procedure (procedure)	4180186
40640044	Lymphogranuloma venereum (disorder)	4180186
40640059	AIDS with encephalopathy (disorder)	4180186
40640075	Radioallergosorbent test, in vitro testing for allergen-specific IGE, IP type (procedure)	4180186
40640075	RAST test, I type	4180186
40640155	Chronic antritis (disorder)	4180186
40640180	Retired procedure (procedure)	4180186
40640210	Manipulation of neck or trunk (procedure)	4180186
40640212	Anti-hyaluronidase assay (procedure)	4180186
40640297	Retired procedure (procedure)	4180186
40640312	Body recently dead AND well preserved (observable entity)	4180186
40640321	Referred to	4180186
40640321	Referred (qualifier value)	4180186
40640330	Nephrectomy (procedure)	4180186
40640330	Nx - Nephrectomy	4180186
40640347	MIF	4180186
40640347	Migration inhibiting factor (substance)	4180186
40640381	Retired procedure (procedure)	4180186
40640384	Retired procedure (procedure)	4180186
40640388	Nerodia sipedon	4180186
40640388	Northern water snake (organism)	4180186
40640390	Salmonella 16;z4,z23;-	4180186
40640390	Salmonella IV 16:z4,z23:-	4180186
40640390	Salmonella IV ochsenzoll (organism)	4180186
40640390	Salmonella ochsenzoll	4180186
40640396	Haematoma of caesarean section AND/OR perineal wound	4180186
40640396	Hematoma of cesarean section AND/OR perineal wound (disorder)	4180186
40640457	Scapulohumeral fibrositis (disorder)	4180186
40640461	Retired procedure (procedure)	4180186
40640468	Generalised anaphylaxis	4180186
40640468	Generalized anaphylaxis (disorder)	4180186
40640471	Retired procedure (procedure)	4180186
40640494	Ryania (substance)	4180186
40640497	Aortic balloon pump operation	4180186
40640497	Cardioassist by aortic balloon pump (procedure)	4180186
40640497	IABC - Intra-aortic balloon catheter operation	4180186
40640497	IABP - Intra-aortic balloon pumping	4180186
40640497	Intra-aortic balloon counterpulsation operation	4180186
40640518	Cranial arteritis	4180186
40640518	GCA - Giant cell arteritis	4180186
40640518	Giant cell arteritis (disorder)	4180186
40640518	Horton's disease	4180186
40640518	Necrotising arteritis	4180186
40640518	Necrotizing arteritis	4180186
40640518	TA - Temporal arteritis	4180186
40640518	Temporal arteritis	4180186
40640518	Temporal giant cell arteritis	4180186
40640553	Buspirone hydrochlorine (product)	4180186
40640558	Dyspepsia (disorder)	4180186
40640561	Retired procedure (procedure)	4180186
40640563	Retired procedure (procedure)	4180186
40640572	Idiopathic crescentic glomerulonephritis, type II (disorder)	4180186
40640604	Closed fracture maxilla	4180186
40640604	Closed fracture of maxilla (disorder)	4180186
40640604	Closed fracture of superior maxilla	4180186
40640604	Closed fracture of upper jaw bone	4180186
40640611	Epidermal cyst	4180186
40640611	Epidermal inclusion cyst	4180186
40640611	Epidermoid cyst	4180186
40640611	Epithelial cyst	4180186
40640611	Epithelial inclusion cyst (morphologic abnormality)	4180186
40640611	Epithelium lined cyst	4180186
40640611	Horn cyst	4180186
40640611	Inclusion cyst	4180186
40640611	Keratin cyst	4180186
40640629	Other peripheral enthesopathy, NEC (disorder)	4180186
40640631	Retired procedure (procedure)	4180186
40640640	Retired procedure (procedure)	4180186
40640650	Retired procedure (procedure)	4180186
40640674	HIV infection with aseptic meningitis (disorder)	4180186
40640698	Amiloride hydrochloride (product)	4180186
40640704	Alkyl dimethyl benzyl ammonium chloride (substance)	4180186
40640752	Salmonella III arizonae 48:i:z35:(z57) (organism)	4180186
40640761	Drug preparation (product)	4180186
40640771	Intrinsic asthma (disorder)	4180186
40640792	Alcaligenes paradoxus (living organism) (organism)	4180186
40640815	Arthropathy (disorder)	4180186
40640815	Arthrosis	4180186
40640815	Disorder of joint	4180186
40640815	Joint derangement	4180186
40640815	Joint disease	4180186
40640815	Joint disorder	4180186
40640827	Salmonella III arizonae 48:l,v:1,5,(7) (organism)	4180186
40640831	Salmonella 21;c;e,n,x	4180186
40640831	Salmonella II 21:c:e,n,x	4180186
40640831	Salmonella rhone (organism)	4180186
40640875	Closure of abdominal fistula (procedure)	4180186
40640883	Cyesiophobia (finding)	4180186
40640883	Fear of pregnancy	4180186
40640902	Bamboo rat (organism)	4180186
40640905	Pediculus humanus humanus (organism)	4180186
40640910	Grafting of nerve (procedure)	4180186
40640917	Occupational eczema (disorder)	4180186
40640928	Retired procedure (procedure)	4180186
40640957	White sponge naevus	4180186
40640957	White sponge nevus of mucosa (disorder)	4180186
40640965	Retired procedure (procedure)	4180186
40640971	Bone of forelimb	4180186
40640971	Bone of upper extremity	4180186
40640971	Bone structure of upper limb (body structure)	4180186
40641007	Retired procedure (procedure)	4180186
40641009	Retired procedure (procedure)	4180186
40641017	Metazoa	4180186
40641017	Metazoan parasite (organism)	4180186
40641052	Chestnut-sided shrike-vireo (organism)	4180186
40641066	Retired procedure (procedure)	4180186
40641073	Anastomosis of lacrimal sac to conjunctival sac (procedure)	4180186
40641078	Contrast radiography of orbit (procedure)	4180186
40641097	Poisoning by Centruroides sculpturatus (disorder)	4180186
40641113	Acquired pharyngo-esophageal diverticulum	4180186
40641113	Acquired pharyngoesophageal diverticulum (disorder)	4180186
40641113	Acquired pharyngo-oesophageal diverticulum	4180186
40641113	Hypopharyngeal diverticulum	4180186
40641113	Zenker's diverticulum	4180186
40641113	Zenker's hypopharyngeal diverticulum	4180186
40641130	Retired procedure (procedure)	4180186
40641147	AIDS with Nocardia infection (disorder)	4180186
40641175	Chacma baboon	4180186
40641175	Papio ursinus (organism)	4180186
40641213	Retired procedure (procedure)	4180186
40641237	Salmonella 3,10:d:e,n,x (organism)	4180186
40641288	Fracture of clavicle as birth trauma (disorder)	4180186
40641294	Somesthesia	4180186
40641294	Ability to be consciously aware of the body	4180186
40641294	Somaesthesia	4180186
40641294	Somataesthesia	4180186
40641294	Somatesthesia	4180186
40641294	Somatic sensation, function (observable entity)	4180186
40641304	Retired procedure (procedure)	4180186
40641318	Acute lymphoblastic leukemia (morphologic abnormality)	4180186
40641320	Retired procedure (procedure)	4180186
40641326	External (modifier) (qualifier value)	4180186
40641359	Indian fruit bat (organism)	4180186
40641362	Retired procedure (procedure)	4180186
40641365	AIDS with organic dementia (disorder)	4180186
40641366	Black vulture (organism)	4180186
40641369	Retired procedure (procedure)	4180186
40641389	First (modifier) (qualifier value)	4180186
40641395	Erwinia stewartii (organism)	4180186
40641405	Felis veverrinus (organism)	4180186
40641405	Fishing cat	4180186
40641437	Retired procedure (procedure)	4180186
40641440	Patch (morphologic abnormality)	4180186
40641448	Incision of aortic arch (procedure)	4180186
40641455	Oral aphthae (disorder)	4180186
40641459	Pneumoconiosis due to silicates (disorder)	4180186
40641459	Silicatosis	4180186
40641469	Retired procedure (procedure)	4180186
40641477	Woodworking-machine setter-operator (general) (occupation)	4180186
40641482	Cardiovascular flow study imaging (procedure)	4180186
40641484	Retired procedure (procedure)	4180186
40641491	Excision of redundant mucosa from colostomy (procedure)	4180186
40641546	Operative procedure on spinal structures (procedure)	4180186
40641546	Operative procedure on spine	4180186
40641546	Operative procedure on vertebral column	4180186
40641546	Procedure on spine	4180186
40641546	Spinal operation	4180186
40641549	Pathological dislocation of forearm (disorder)	4180186
40641559	Recurrent acute pancreatitis (disorder)	4180186
40641567	Lactobacillus minor (organism)	4180186
40641587	Recurrent dislocation of lower leg (disorder)	4180186
40641591	Retired procedure (procedure)	4180186
40641599	Lumbosacral spinal cord posterior column	4180186
40641599	Lumbosacral spinal cord posterior column structure (body structure)	4180186
40641606	Retired procedure (procedure)	4180186
40641623	AV - Anaerobic vaginosis	4180186
40641623	Bacterial vaginitis	4180186
40641623	Bacterial vaginosis (disorder)	4180186
40641623	BV - Bacterial vaginosis	4180186
40641623	Gardnerella infection	4180186
40641623	Gardnerella vaginalis infection	4180186
40641623	Nonspecific vaginitis	4180186
40641623	NSV - Nonspecific vaginitis	4180186
40641623	Vaginitis due to Gardnerella vaginalis	4180186
40641638	Retired procedure (procedure)	4180186
40641641	Retired procedure (procedure)	4180186
40641660	Atony of bladder (disorder)	4180186
40641671	Salmonella 4,12;d,e,h;d,e,n,z15	4180186
40641671	Salmonella salinatis (organism)	4180186
40641714	Retired procedure (procedure)	4180186
40641722	Sinusotomy (procedure)	4180186
40641728	Toxic epidermal necrolysis, subcorneal type (disorder)	4180186
40641739	Retired procedure (procedure)	4180186
40641744	Retired procedure (procedure)	4180186
40641759	Anaesthesia procedure	4180186
40641759	Anesthesia procedure (procedure)	4180186
40641759	Procedure related to anaesthesia and sedation	4180186
40641759	Procedure related to anesthesia and sedation	4180186
40641774	Dicephalus (disorder)	4180186
40641808	Retired procedure (procedure)	4180186
40641835	Retired procedure (procedure)	4180186
40641850	Buphthalmos with congenital keratoglobus (disorder)	4180186
40641854	Retired procedure (procedure)	4180186
40641875	Monitoring of cardiac output by other technique (regime/therapy)	4180186
40641883	Excision of accessory breast (procedure)	4180186
40641905	Retired procedure (procedure)	4180186
40641912	AIDS with malaise (disorder)	4180186
40641913	Ability to identify odor	4180186
40641913	Ability to identify odour	4180186
40641913	Odor identification sense, function (observable entity)	4180186
40641913	Odour identification sense	4180186
40641916	Retired procedure (procedure)	4180186
40641917	Coronary artery disease (disorder)	4180186
40641917	Disease of the coronary arteries	4180186
40641946	Right ventricular hypertrophy by EKG (finding)	4180186
40641946	RVH by EKG	4180186
40642058	Glucose measurement by monitoring device (procedure)	4180186
40642062	Other acute rheumatic heart disease, NEC (disorder)	4180186
40642070	Antibody variable region (substance)	4180186
40642080	Open fracture of foot (disorder)	4180186
40642105	Infection-associated arthritis	4180186
40642105	Infectious arthropathy	4180186
40642105	Infective arthritis (disorder)	4180186
40642108	17-Hydroxycorticosteroid (substance)	4180186
40642117	Idiopathic hypertrophic subaortic stenosis (disorder)	4180186
40642120	Pseudomonas mephitica (organism)	4180186
40642121	AIDS with respiratory abnormality (disorder)	4180186
40642127	Biopsy of conjunctiva (procedure)	4180186
40642142	Paralytic flail joint (disorder)	4180186
40642144	Congenital imperfect closure	4180186
40642144	Congenital incomplete closure (morphologic abnormality)	4180186
40642144	Congenital septal defect	4180186
40642144	Patent embryonic structure	4180186
40642151	Toxic effect of bite of venomous snake (disorder)	4180186
40642168	18-Hydroxycorticosterone dehydrogenase deficiency (disorder)	4180186
40642169	Retired procedure (procedure)	4180186
40642205	Other specified adrenal disorder, NEC (disorder)	4180186
40642212	Negative (modifier) (qualifier value)	4180186
40642216	Ventral hernia without obstruction AND without gangrene (disorder)	4180186
40642233	Osseous portion of auditory canal	4180186
40642233	Structure of osseous portion of auditory canal (body structure)	4180186
40642240	Body system (body structure)	4180186
40642263	Salmonella III arizonae 51:l,v:z (organism)	4180186
40642284	Retired procedure (procedure)	4180186
40642304	Meconium aspiration syndrome (finding)	4180186
40642305	Systemic chondromalacia (disorder)	4180186
40642337	Retired procedure (procedure)	4180186
40642350	Abdominopelvic amputation (procedure)	4180186
40642359	Hereditary sensory and autonomic neuropathy, type I (disorder)	4180186
40642380	Measles live virus vaccine (product)	4180186
40642380	Rubeola virus vaccine	4180186
40642409	Retired procedure (procedure)	4180186
40642421	Acute haemorrhagic enterocolitis	4180186
40642421	Acute hemorrhagic enterocolitis (disorder)	4180186
40642433	Retired procedure (procedure)	4180186
40642435	Poor labor contractions (disorder)	4180186
40642435	Poor labour contractions	4180186
40642459	Retired procedure (procedure)	4180186
40642460	Sorbitol agent (substance)	4180186
40642471	Candidal intertrigo (disorder)	4180186
40642499	Pseudomonas huttiensis (organism)	4180186
40642508	Strict vegetarian diet (substance)	4180186
40642516	VEE	4180186
40642516	VEE - Venezuelan equine encephalitis	4180186
40642516	Venezuelan equine encephalitis (disorder)	4180186
40642516	Venezuelan equine encephalomyelitis	4180186
40642516	Venezuelan equine fever	4180186
40642517	Retired procedure (procedure)	4180186
40642524	Nontraumatic rupture of tendon (disorder)	4180186
40642527	SNOMED CT universally unique identifier (core metadata concept)	4180186
40642527	SNOMED CT universally unique identifier	4180186
40642529	Defining relationship (core metadata concept)	4180186
40642534	Synonym (core metadata concept)	4180186
40642535	Entire term case sensitive (core metadata concept)	4180186
40642535	Entire term case sensitive	4180186
40642536	Only initial character case insensitive	4180186
40642536	Only initial character case insensitive (core metadata concept)	4180186
40642539	SNOMED CT core module (core metadata concept)	4180186
40642539	SNOMED CT core module	4180186
40642541	Mandatory refinability (foundation metadata concept)	4180186
40642542	Qualifying relationship (core metadata concept)	4180186
40642543	Refinability value (foundation metadata concept)	4180186
40642544	Additional relationship (core metadata concept)	4180186
40642545	SNOMED CT integer identifier (core metadata concept)	4180186
40642545	SNOMED CT integer identifier	4180186
40642546	SNOMED CT Model Component (metadata)	4180186
40642547	Core metadata concept (core metadata concept)	4180186
40642548	Module (core metadata concept)	4180186
40642549	Definition status (core metadata concept)	4180186
40642550	International Health Terminology Standards Development Organisation maintained module (core metadata concept)	4180186
40642550	International Health Terminology Standards Development Organisation maintained module	4180186
40642552	Case significance (core metadata concept)	4180186
40642554	Characteristic type (core metadata concept)	4180186
40642561	Reference set descriptor reference set	4180186
40642561	Reference set descriptor reference set (foundation metadata concept)	4180186
40642563	Attribute description (foundation metadata concept)	4180186
40642564	Attribute type (foundation metadata concept)	4180186
40642565	Component type (foundation metadata concept)	4180186
40642566	Concept type component (foundation metadata concept)	4180186
40642568	Relationship type component (foundation metadata concept)	4180186
40642570	String (foundation metadata concept)	4180186
40642573	Text less than 256 bytes	4180186
40642573	Text less than 256 bytes (foundation metadata concept)	4180186
40642577	Joint Photographic Experts Group format reference (foundation metadata concept)	4180186
40642577	Joint Photographic Experts Group format reference	4180186
40642578	Graphics Interchange Format reference	4180186
40642578	Graphics Interchange Format reference (foundation metadata concept)	4180186
40642579	Universally Unique Identifier	4180186
40642579	Universally Unique Identifier (foundation metadata concept)	4180186
40642582	Signed integer (foundation metadata concept)	4180186
40642583	Unsigned integer (foundation metadata concept)	4180186
40642584	Attribute order (foundation metadata concept)	4180186
40642587	Duplicate component	4180186
40642587	Duplicate component (foundation metadata concept)	4180186
40642588	Outdated component	4180186
40642588	Outdated component (foundation metadata concept)	4180186
40642589	Ambiguous component (foundation metadata concept)	4180186
40642589	Ambiguous component	4180186
40642590	Erroneous component	4180186
40642590	Erroneous component (foundation metadata concept)	4180186
40642591	Limited component (foundation metadata concept)	4180186
40642591	Limited component	4180186
40642594	Concept inactivation indicator attribute value reference set	4180186
40642594	Concept inactivation indicator attribute value reference set (foundation metadata concept)	4180186
40642595	Description inactivation indicator attribute value reference set (foundation metadata concept)	4180186
40642595	Description inactivation indicator attribute value reference set	4180186
40642597	Pending move (foundation metadata concept)	4180186
40642599	Inappropriate component (foundation metadata concept)	4180186
40642599	Inappropriate component	4180186
40642600	Concept non-current (foundation metadata concept)	4180186
40642601	Simple map from SNOMED CT	4180186
40642601	Simple map from SNOMED CT type reference set (foundation metadata concept)	4180186
40642601	Simple map from SNOMED CT type reference set	4180186
40642601	Simple map type reference set	4180186
40642601	Simple map type reference set (foundation metadata concept)	4180186
40642602	CTV3 to SNOMED CT simple map	4180186
40642602	CTV3 to SNOMED CT simple map reference set	4180186
40642602	CTV3 to SNOMED CT simple map reference set (foundation metadata concept)	4180186
40642602	CTV3 simple map reference set (foundation metadata concept)	4180186
40642602	CTV3 simple map reference set	4180186
40642652	Sprain of metatarsophalangeal joint (disorder)	4180186
40642660	Retired procedure (procedure)	4180186
40642667	Pseudomonas flava (organism)	4180186
40642751	Salmonella III arizonae 21:l,v:z57 (organism)	4180186
40642760	Pasteurella anatis (organism)	4180186
40642762	Medical procedure on endocrine system (procedure)	4180186
40642789	Ancylostomiasis	4180186
40642789	Ancylostomiasis due to Ancylostoma duodenale	4180186
40642789	Ancylostomosis	4180186
40642789	Hookworm infection	4180186
40642789	Infection by Uncinaria (disorder)	4180186
40642789	Uncinariasis	4180186
40642789	Uncinariosis	4180186
40642792	Salmonella balboa	4180186
40642792	Salmonella V 48:z41:-	4180186
40642792	Salmonella V balboa (organism)	4180186
40642792	Salmonella 48;z41;-	4180186
40642797	Bilateral parotid duct diversion (procedure)	4180186
40642797	Wilke type procedure, parotid duct diversion	4180186
40642845	Retired procedure (procedure)	4180186
40642867	Sprain of leg (disorder)	4180186
40642872	Salmonella II, group H (organism)	4180186
40642878	Tannin (substance)	4180186
40642895	Methyl p-hydroxybenzoate (substance)	4180186
40642908	Retired procedure (procedure)	4180186
40642910	Retired procedure (procedure)	4180186
40642911	Retired procedure (procedure)	4180186
40642912	Incision of cervix to assist delivery (procedure)	4180186
40642922	Retired procedure (procedure)	4180186
40642940	Congenital cranial osteoporosis (disorder)	4180186
40642940	Craniotabes	4180186
40642948	Carbamate insecticide causing toxic effect	4180186
40642948	Carbamate insecticide toxicity	4180186
40642948	Organophosphate toxicity	4180186
40642948	Toxic effect of organophosphate AND/OR carbamate pesticide (disorder)	4180186
40642965	Retired procedure (procedure)	4180186
40642976	Retired procedure (procedure)	4180186
40642982	Epauleted fruit bat	4180186
40642982	Epomophorus (organism)	4180186
40643007	Retired procedure (procedure)	4180186
40643029	Parietal pleurectomy (procedure)	4180186
40643033	Deep third degree burn of scapular region with loss of body part (disorder)	4180186
40643034	Nonallopathic lesion, NEC (finding)	4180186
40643036	Retired procedure (procedure)	4180186
40643052	Branick's rat	4180186
40643052	Dinomys (organism)	4180186
40643052	Pacarana	4180186
40643096	Atrophy of papillary muscle (disorder)	4180186
40643096	Papillary muscle atrophy	4180186
40643098	Retired procedure (procedure)	4180186
40643104	Antifungal antibiotic (substance)	4180186
40643109	Retired procedure (procedure)	4180186
40643110	Manipulation of tissue of chest wall (procedure)	4180186
40643133	Retired procedure (procedure)	4180186
40643156	Retired procedure (procedure)	4180186
40643178	Arcobacter nitrofigilis	4180186
40643178	Campylobacter nitrofigilis (organism)	4180186
40643211	Retired procedure (procedure)	4180186
40643219	Retired procedure (procedure)	4180186
40643237	Complication of internal intestinal anastomosis and bypass, NEC (disorder)	4180186
40643265	Salmonella IV, group K (organism)	4180186
40643270	Retired procedure (procedure)	4180186
40643277	Micrococcus halobius (organism)	4180186
40643292	Retired procedure (procedure)	4180186
40643293	Nervous system complication from surgically implanted device	4180186
40643293	Nervous system complications from surgical implanted device (disorder)	4180186
40643298	Ventriculoatrial shunt with valve (procedure)	4180186
40643305	Retired procedure (procedure)	4180186
40643314	VA - Visual acuity	4180186
40643314	Visual acuity, function (observable entity)	4180186
40643317	Chemical measurement	4180186
40643317	Chemical procedure (procedure)	4180186
40643317	Chemical test	4180186
40643319	Instrument of aggression, device (physical object)	4180186
40643323	Retired procedure (procedure)	4180186
40643336	Full thickness skin transplantation (procedure)	4180186
40643347	Retired procedure (procedure)	4180186
40643360	Retired procedure (procedure)	4180186
40643363	Retired procedure (procedure)	4180186
40643427	Posttraumatic amnesia (finding)	4180186
40643428	Biopsy of extraocular muscle (procedure)	4180186
40643431	Nocardiopsis longispora (organism)	4180186
40643469	Retired procedure (procedure)	4180186
40643475	Q fever (disorder)	4180186
40643479	Salmonella 1,13,23;g,t;1,5	4180186
40643479	Salmonella gojenberg	4180186
40643479	Salmonella II 1,13,23:g,t:1,5	4180186
40643479	Salmonella II gojenberg (organism)	4180186
40643509	Excision of lesion of skin of hindlimb	4180186
40643509	Excision of lesion of skin of lower extremity (procedure)	4180186
40643536	Retired procedure (procedure)	4180186
40643559	TBG	4180186
40643559	Thyrotropin binding globulin (substance)	4180186
40643559	Thyroxin-binding prealbumin	4180186
40643559	Thyroxine binding globulin	4180186
40643571	Retired procedure (procedure)	4180186
40643577	Acremonium kiliense (living organism) (organism)	4180186
40643582	Sprain of other specified site of elbow and forearm (disorder)	4180186
40643584	Malignant lymphoma, lymphocytic, intermediate differentiation, nodular (morphologic abnormality)	4180186
40643586	Retired procedure (procedure)	4180186
40643588	Hypnotic AND/OR sedative drug (product)	4180186
40643607	Retired procedure (procedure)	4180186
40643624	Retired procedure (procedure)	4180186
40643637	Retired procedure (procedure)	4180186
40643640	Rhodococcus rubropertinctus (organism)	4180186
40643655	Cervical spinal cord ventral column	4180186
40643655	Structure of cervical spinal cord ventral column (body structure)	4180186
40643675	Poisoning by pentamethonium bromide (disorder)	4180186
40643704	Retired procedure (procedure)	4180186
40643720	Atrial septostomy (procedure)	4180186
40643722	Retired procedure (procedure)	4180186
40643787	Salmonella 57;z39;e,n,x,z15	4180186
40643787	Salmonella II 57:z39:e,n,x,z15	4180186
40643787	Salmonella II manombo (organism)	4180186
40643787	Salmonella manombo	4180186
40643789	Dental scaling and polishing (procedure)	4180186
40643800	Kangaroo rat (organism)	4180186
40643807	Retired procedure (procedure)	4180186
40643816	Lateral lemniscus of pons (body structure)	4180186
40643824	Retired procedure (procedure)	4180186
40643844	Retired procedure (procedure)	4180186
40643855	Change in stool consistency (finding)	4180186
40643890	Retired procedure (procedure)	4180186
40643903	Retired procedure (procedure)	4180186
40643928	Retired procedure (procedure)	4180186
40643935	Retired procedure (procedure)	4180186
40643938	Retired procedure (procedure)	4180186
40643954	Retired procedure (procedure)	4180186
40643958	Retired procedure (procedure)	4180186
40643972	Retired procedure (procedure)	4180186
40643997	Haematoside	4180186
40643997	Hematoside (substance)	4180186
40644002	Civil engineering technician (general) (occupation)	4180186
40644004	Onychotomy (procedure)	4180186
40644043	Incomplete remission (qualifier value)	4180186
40644072	Retired procedure (procedure)	4180186
40644085	Gastroenteritis due to radiation (disorder)	4180186
40644114	Bacteroides corporis (organism)	4180186
40644118	Retired procedure (procedure)	4180186
40644145	Colour of urine	4180186
40644145	Finding of urine color (observable entity)	4180186
40644145	Finding of urine colour	4180186
40644145	Observation of urine color	4180186
40644145	Observation of urine colour	4180186
40644145	Color of urine	4180186
40644173	Lactoflavin preparation	4180186
40644173	Riboflavin preparation (product)	4180186
40644173	Vitamin B>2< preparation	4180186
40644173	Vitamin G preparation	4180186
40644196	Noonan-Ehmke syndrome	4180186
40644196	Noonan syndrome (disorder)	4180186
40644196	Turner-like syndrome	4180186
40644196	Ullrich-Turner syndrome	4180186
40644225	Open fine needle biopsy of liver (procedure)	4180186
40644230	Retired procedure (procedure)	4180186
40644236	Retired procedure (procedure)	4180186
40644251	Retired procedure (procedure)	4180186
40644257	Animal inoculation with autopsy, smear and culture (procedure)	4180186
40644264	Retired procedure (procedure)	4180186
40644285	Total recent retinal detachment (disorder)	4180186
40644313	Malignant lymphoma, lymphoblastic (morphologic abnormality)	4180186
40644324	Fixation of vision, function (observable entity)	4180186
40644330	Retired procedure (procedure)	4180186
40644338	Neonatal calf diarrhea coronavirus (organism)	4180186
40644338	Neonatal calf diarrhoea coronavirus	4180186
40644351	Menopause (finding)	4180186
40644352	Retired procedure (procedure)	4180186
40644358	Other specified complication of labor and delivery affecting fetus or newborn, NEC (disorder)	4180186
40644358	Other specified complication of labour and delivery affecting foetus or newborn, NEC	4180186
40644369	Full thickness burn of multiple sites of lower limb (disorder)	4180186
40644369	Third degree burn of multiple sites of lower limb	4180186
40644384	Salmonella arizonae 1,13,23:z4,z24:-- (organism)	4180186
40644405	Hospital-based outpatient immunology clinic (site of care) (environment)	4180186
40644449	Retired procedure (procedure)	4180186
40644461	Malignant lymphoma, small cell, noncleaved, diffuse (morphologic abnormality)	4180186
40644464	Retired procedure (procedure)	4180186
40644474	AIDS with thrombocytopenia (disorder)	4180186
40644479	Retired procedure (procedure)	4180186
40644493	Urticaria pigmentosa, solitary cutaneous nodule (disorder)	4180186
40644494	Nontraumatic rupture of bladder (disorder)	4180186
40644509	Bat - animal	4180186
40644509	Bat (organism)	4180186
40644509	Chiroptera speies	4180186
40644509	Order chiroptera - bat	4180186
40644516	AIDS with acute myocarditis (disorder)	4180186
40644525	Retired procedure (procedure)	4180186
40644543	Retired procedure (procedure)	4180186
40644549	Retired procedure (procedure)	4180186
40644552	Acute osteomyelitis of ankle AND/OR foot (disorder)	4180186
40644567	Retired procedure (procedure)	4180186
40644569	Salmonella III arizonae 57:i:z (organism)	4180186
40644577	Coitus interruptus (finding)	4180186
40644601	Retired procedure (procedure)	4180186
40644621	Open dislocation of acromioclavicular joint (disorder)	4180186
40644628	Simmonds' test	4180186
40644628	Squeeze test	4180186
40644628	Thompson's squeeze test	4180186
40644628	Thompson's test (procedure)	4180186
40644661	Arthroplasty of knee, tibial plateaus (procedure)	4180186
40644662	Chronic osteomyelitis of pelvic region (disorder)	4180186
40644678	Retired procedure (procedure)	4180186
40644704	Repair of epididymis and vas deferens	4180186
40644704	Anastomosis of epididymis to vas deferens	4180186
40644704	Anastomosis of epididymis to vas deferens (procedure)	4180186
40644704	Repair of vas deferens by anastomosis to epididymis	4180186
40644719	Retired procedure (procedure)	4180186
40644732	Retired procedure (procedure)	4180186
40644755	Drug granules (product)	4180186
40644795	Retired procedure (procedure)	4180186
40644812	Salmonella III arizonae 42:l,v:z (organism)	4180186
40644824	Lymphocyte blastogenic factor	4180186
40644824	Lymphocyte mitogenic factor (substance)	4180186
40644829	Retired procedure (procedure)	4180186
40644841	Retired procedure (procedure)	4180186
40644848	Retired procedure (procedure)	4180186
40644866	Retired procedure (procedure)	4180186
40644911	Clostridium difficile enterotoxin	4180186
40644911	Clostridium difficile toxin A (substance)	4180186
40644913	Salmonella III arizonae 53:z4,z23,z32:-- (organism)	4180186
40644924	Bacillus polymyxa (organism)	4180186
40644968	Replacement of heart valve poppet, prosthetic (procedure)	4180186
40645068	Bilateral hilar adenopathy syndrome (disorder)	4180186
40645114	Acromesomelic dysplasia syndrome (disorder)	4180186
40645120	Ankylosis of joint of upper arm (disorder)	4180186
40645176	Salmonella 1,13,22;g,m,t;1,5	4180186
40645176	Salmonella II limbe (organism)	4180186
40645186	Organic phosphorus insecticide (substance)	4180186
40645186	Organophosphorus insecticide	4180186
40645198	Obstetrical laceration of cervix (disorder)	4180186
40645206	Retired procedure (procedure)	4180186
40645209	Lifelong obesity (disorder)	4180186
40645225	One stage prothrombin time	4180186
40645225	Prothrombin time (procedure)	4180186
40645225	Protime	4180186
40645225	PT assay	4180186
40645225	PT - Prothrombin time	4180186
40645225	PTT - Prothrombin time	4180186
40645225	Quick one stage prothrombin time	4180186
40645293	Carcinoma in situ of skin of arm (disorder)	4180186
40645341	Carcinoma in situ of splenic flexure of colon (disorder)	4180186
40645369	Retired procedure (procedure)	4180186
40645408	Haitian solenodon	4180186
40645408	Hispaniolan solenodon (organism)	4180186
40645478	Metastatic malignant neoplasm to lacrimal duct	4180186
40645478	Secondary malignant neoplasm of lacrimal duct (disorder)	4180186
40645611	Copper supplement (product)	4180186
40645707	Retired procedure (procedure)	4180186
40645719	Salmonella III arizonae 21:k:e,n,x,z15 (organism)	4180186
40645761	Current tear of medial cartilage AND/OR meniscus of knee (disorder)	4180186
40645769	ERC	4180186
40645769	Diagnostic endoscopic retrograde examination of bile duct	4180186
40645769	Endoscopic retrograde cholangiography (procedure)	4180186
40645769	ERC - Endoscopic retrograde cholangiography	4180186
40645780	Retired procedure (procedure)	4180186
40645781	Excision of malignant lesion of cervical esophagus with laryngectomy and radical neck dissection (procedure)	4180186
40645781	Excision of malignant lesion of cervical oesophagus with laryngectomy and radical neck dissection	4180186
40645788	Leuconostoc oenos (organism)	4180186
40645790	Retired procedure (procedure)	4180186
40645801	Patellar luxation (disorder)	4180186
40645838	Incision of uvula (procedure)	4180186
40645847	Chronic erythremia (disorder)	4180186
40645847	Chronic erythraemia	4180186
40645853	Chronic monocytic leukaemia in remission	4180186
40645853	Chronic monocytic leukemia in remission (disorder)	4180186
40645854	Chronic monocytic leukaemia	4180186
40645854	Chronic monocytic leukemia (morphologic abnormality)	4180186
40645862	Articular crepitus of temporomandibular joint (disorder)	4180186
40646090	Gonadorelin hydrochloride (product)	4180186
40646095	Retired procedure (procedure)	4180186
40646120	Caseating tuberculoid granuloma (disorder)	4180186
40646123	Retired procedure (procedure)	4180186
40646128	Period disorder	4180186
40646128	Menstrual disorder	4180186
40646128	Menstruation disorder	4180186
40646128	Paramenia	4180186
40646128	Abnormal menstruation (finding)	4180186
40646128	Menoxenia	4180186
40646128	Problem of menstruation	4180186
40646173	Intestinal infection due to Enterobacter aerogenes (disorder)	4180186
40646200	Cycrin Tablets (product)	4180186
40646201	Retired procedure (procedure)	4180186
40646240	Disease due to Linguatula serrata (disorder)	4180186
40646272	Retired procedure (procedure)	4180186
40646320	Hydra (organism)	4180186
40646334	Retired procedure (procedure)	4180186
40646377	Tenrec (organism)	4180186
40646464	Congenital absence of oviduct (disorder)	4180186
40646464	Congenital absence of oviduct	4180186
40646495	Other joint derangement, NEC (disorder)	4180186
40646528	Great blue heron (organism)	4180186
40646695	Koate-HS Antihaemophilic Factor (Human)	4180186
40646695	Koate-HS Antihemophilic Factor (Human) (substance)	4180186
40646698	Lacrisert Sterile Ophthalmic Insert (product)	4180186
40646702	Internal cardioversion (procedure)	4180186
40646703	Medical ophthalmologist	4180186
40646703	Ophthalmologist (occupation)	4180186
40646741	Acquired disease (navigational concept)	4180186
40646743	Retired procedure (procedure)	4180186
40646758	Closure of ureterovisceral fistula (procedure)	4180186
40646765	OptiPranolol Sterile Ophthalmic Solution (product)	4180186
40646771	Retired procedure (procedure)	4180186
40646779	Salmonella III arizonae 48:a:(z35) (organism)	4180186
40646793	Retired procedure (procedure)	4180186
40646798	Cervicoplasty	4180186
40646798	Reconstruction of cervix	4180186
40646798	Repair of cervix (procedure)	4180186
40646798	Tracheloplasty	4180186
40646798	Uterine cervix repair	4180186
40646798	Uterine stomatoplasty	4180186
40646824	Retired procedure (procedure)	4180186
40646869	Excision of cyst of vulva (procedure)	4180186
40646871	Retired procedure (procedure)	4180186
40646907	Biopsy of nerve ganglion (procedure)	4180186
40646926	Eye examination under anaesthesia, limited	4180186
40646926	Eye examination under anesthesia, limited (procedure)	4180186
40647003	Congenital hypertrophy of eye bulge (disorder)	4180186
40647005	cryotherapy of lesion of palate (procedure)	4180186
40647016	Retired procedure (procedure)	4180186
40647234	Open dislocations of multiple cervical vertebrae (disorder)	4180186
40647238	Retired procedure (procedure)	4180186
40647243	Adrenergic blocking agent	4180186
40647243	Antiadrenergic agent	4180186
40647243	Sympatholytic agent (product)	4180186
40647251	Retired procedure (procedure)	4180186
40647255	Dwarf antelope	4180186
40647255	Neotragus (organism)	4180186
40647257	Toradol IM Injection (product)	4180186
40647273	Uro-Mag (product)	4180186
40647285	Pseudomonas beijerinckii (organism)	4180186
40647290	Ib Ar 33853 virus (organism)	4180186
40647376	Hypersensitivity (finding)	4180186
40647380	Refashioning of tracheostomy	4180186
40647380	Repair of stoma of trachea	4180186
40647380	Revision of stoma of trachea	4180186
40647380	Revision of stoma of trachea (procedure)	4180186
40647387	Juxtacortical osteosarcoma (morphologic abnormality)	4180186
40647406	Retired procedure (procedure)	4180186
40647425	Complete (modifier) (qualifier value)	4180186
40647426	Antibody to tissue specific antigen measurement (procedure)	4180186
40647438	Living organism not assigned to a scientific category (organism)	4180186
40647455	Flexibacter columnaris (organism)	4180186
40647487	Red shank (organism)	4180186
40647489	Congenital stenosis of esophagus (disorder)	4180186
40647489	Congenital stenosis of oesophagus	4180186
40647503	Neonatal myasthenia (disorder)	4180186
40647531	Lymphoid leukaemia	4180186
40647531	Lymphoid leukemia, disease (disorder)	4180186
40647534	Lymphosarcoma of intrapelvic lymph nodes (disorder)	4180186
40647536	Lymphosarcoma of lymph nodes of axilla AND/OR upper limb (disorder)	4180186
40647538	Lymphosarcoma of lymph nodes of inguinal region AND/OR lower limb (disorder)	4180186
40647540	Lymphosarcoma of spleen (disorder)	4180186
40647541	Lymphosarcoma of extranodal AND/OR solid organ site (disorder)	4180186
40647588	Retired procedure (procedure)	4180186
40647625	Mixed cell type lymphosarcoma of lymph nodes of axilla AND/OR upper limb (disorder)	4180186
40647628	Mixed cell type lymphosarcoma of lymph nodes of inguinal region and lower limb (disorder)	4180186
40647629	Mixed cell type lymphosarcoma of lymph nodes of multiple sites (disorder)	4180186
40647644	Multiple myeloma (disorder)	4180186
40647653	Mycosis fungoides of lymph nodes of multiple sites (disorder)	4180186
40647736	Retired procedure (procedure)	4180186
40647739	Other combination of endocrine dysfunction, NEC (disorder)	4180186
40647771	Retired procedure (procedure)	4180186
40647794	Obstetrical trauma to urethra (disorder)	4180186
40647835	Retired procedure (procedure)	4180186
40647859	Retired procedure (procedure)	4180186
40647862	Retired procedure (procedure)	4180186
40648136	Retired procedure (procedure)	4180186
40648145	Sedative-induced organic mental disorder (disorder)	4180186
40648177	Salmonella III arizonae 50:z36:-- (organism)	4180186
40648191	Peripheral vascular disease (disorder)	4180186
40648191	PVD - Peripheral vascular disease	4180186
40648191	Peripheral angiopathy	4180186
40648191	Peripheral arterial disease	4180186
40648191	Peripheral arterial occlusive disease	4180186
40648191	PAOD - Peripheral arterial occlusive disease	4180186
40648249	Venous catheter insertion	4180186
40648249	Venous catheterisation	4180186
40648249	Venous catheterization	4180186
40648249	Venous line insertion	4180186
40648249	Venous cannulation	4180186
40648249	Catheterisation of vein	4180186
40648249	Catheterization of vein (procedure)	4180186
40648249	Establishes IV access	4180186
40648249	Insertion of catheter into vein	4180186
40648249	Intravenous cannulation	4180186
40648249	Introduction of catheter into vein	4180186
40648249	Needling	4180186
40648249	Vein catheter insertion	4180186
40648249	Venous cannula insertion	4180186
40648284	No living organism identified (organism)	4180186
40648284	No living organism present	4180186
40648329	Transplant of lymphatic structure (procedure)	4180186
40648380	Haemangioma of intra-abdominal structure	4180186
40648380	Hemangioma of intra-abdominal structure (disorder)	4180186
40648399	Hodgkin's disease, lymphocytic depletion of intra-abdominal lymph nodes (disorder)	4180186
40648401	Hodgkin's disease, lymphocytic depletion of intrathoracic lymph nodes (disorder)	4180186
40648448	Neoplasm of uncertain behavior of major salivary gland (disorder)	4180186
40648448	Neoplasm of uncertain behaviour of major salivary gland	4180186
40648452	Neoplasm of uncertain behavior of mastoid air cells (disorder)	4180186
40648452	Neoplasm of uncertain behaviour of mastoid air cells	4180186
40648467	Bot fly (organism)	4180186
40648467	Warble fly	4180186
40648565	Retired procedure (procedure)	4180186
40648697	Retired procedure (procedure)	4180186
40648701	Retired procedure (procedure)	4180186
40648752	Retired procedure (procedure)	4180186
40648758	Lymphocyte antigen CD55 (substance)	4180186
40648769	Salmonella III arizonae 43:z4,z23:-- (organism)	4180186
40648830	Organ subdivision (body structure)	4180186
40648851	Neurocranium	4180186
40648851	Neurocranium structure (body structure)	4180186
40648851	Vault of skull	4180186
40648858	Hodgkin's disease, lymphocytic depletion of lymph nodes of multiple sites (disorder)	4180186
40648875	Hodgkin's disease, mixed cellularity of intrathoracic lymph nodes (disorder)	4180186
40648879	Hodgkin's disease, mixed cellularity of lymph nodes of multiple sites (disorder)	4180186
40648884	Hodgkin's disease, nodular sclerosis of intrapelvic lymph nodes (disorder)	4180186
40648889	Hodgkin's disease, nodular sclerosis of lymph nodes of multiple sites (disorder)	4180186
40648914	Hodgkin's paragranuloma of intrathoracic lymph nodes (disorder)	4180186
40648919	Hodgkin's paragranuloma of lymph nodes of multiple sites (disorder)	4180186
40648929	Hodgkin's sarcoma of lymph nodes of multiple sites (disorder)	4180186
40648954	Neoplasm of uncertain behavior of paraganglion (disorder)	4180186
40648954	Neoplasm of uncertain behaviour of paraganglion	4180186
40648976	Intrahepatic cholestasis of pregnancy (disorder)	4180186
40649148	Gyrus (external anatomical feature) (body structure)	4180186
40649165	Corpus luteum of pregnancy (morphologic abnormality)	4180186
40649201	Incomplete ossification of ilium (disorder)	4180186
40649201	Reduced ossification of ilium	4180186
40649218	Articular cartilage disorder of forearm (disorder)	4180186
40649218	Articular cartilage disorder of the forearm	4180186
40649290	Malignant tumor of adrenal medulla	4180186
40649290	Malignant tumour of adrenal medulla	4180186
40649290	Primary malignant neoplasm of adrenal medulla (disorder)	4180186
40649292	Malignant tumor of ampulla of Vater	4180186
40649292	Malignant tumour of ampulla of Vater	4180186
40649292	Primary malignant neoplasm of ampulla of vater (disorder)	4180186
40649300	Primary malignant neoplasm of anterior wall of urinary bladder (disorder)	4180186
40649303	Malignant neoplasm of dome of urinary bladder	4180186
40649303	Primary malignant neoplasm of apex of urinary bladder (disorder)	4180186
40649325	Dexpanthenol agent (substance)	4180186
40649325	D-pantothenyl alcohol preparation	4180186
40649325	Panthenol preparation	4180186
40649325	Pantothenylol preparation	4180186
40649348	Peptostreptococcus (living organism) (organism)	4180186
40649352	Neoplasm of uncertain behavior of stomach (disorder)	4180186
40649352	Neoplasm of uncertain behaviour of stomach	4180186
40649352	Tumor-like lesion of stomach	4180186
40649352	Tumour-like lesion of stomach	4180186
40649355	Neoplasm of uncertain behavior of submaxillary gland (disorder)	4180186
40649355	Neoplasm of uncertain behaviour of submaxillary gland	4180186
40649553	Primary malignant neoplasm of axillary tail of female breast (disorder)	4180186
40649556	Malignant neoplasm of gallbladder and extrahepatic bile ducts	4180186
40649556	Malignant tumor of biliary tract	4180186
40649556	Malignant tumour of biliary tract	4180186
40649556	Primary malignant neoplasm of biliary tract (disorder)	4180186
40649560	Primary malignant neoplasm of blood vessel of arm (disorder)	4180186
40649573	Primary malignant neoplasm of blood vessel of leg (disorder)	4180186
40649590	Body of uterus Ca	4180186
40649590	CA - Cancer of uterus	4180186
40649590	Malignant neoplasm of corpus uteri	4180186
40649590	Malignant neoplasm of uterus	4180186
40649590	Malignant tumor of body of uterus	4180186
40649590	Malignant tumor of uterus	4180186
40649590	Malignant tumour of body of uterus	4180186
40649590	Malignant tumour of uterus	4180186
40649590	Primary malignant neoplasm of body of uterus (disorder)	4180186
40649609	Malignant tumour of buccal mucosa	4180186
40649609	Malignant tumour of cheek mucosa	4180186
40649609	CA - Cancer of buccal mucosa	4180186
40649609	CA - Cancer of cheek mucosa	4180186
40649609	Cancer of buccal mucosa	4180186
40649609	Cancer of cheek mucosa	4180186
40649609	Malignant neoplasm of cheek mucosa	4180186
40649609	Malignant tumor of buccal mucosa	4180186
40649609	Malignant tumor of cheek mucosa	4180186
40649609	Malignant tumor of internal cheek	4180186
40649609	Malignant tumour of internal cheek	4180186
40649609	Primary malignant neoplasm of buccal mucosa (disorder)	4180186
40649626	Malignant neoplasm of cervical esophagus	4180186
40649626	Malignant neoplasm of cervical oesophagus	4180186
40649626	Primary malignant neoplasm of cervical esophagus (disorder)	4180186
40649626	Primary malignant neoplasm of cervical oesophagus	4180186
40649639	Malignant tumor of commissure of lip	4180186
40649639	Malignant tumor of labial commissure	4180186
40649639	Malignant tumour of commissure of lip	4180186
40649639	Malignant tumour of labial commissure	4180186
40649639	Primary malignant neoplasm of commissure of lip (disorder)	4180186
40649658	Malignant tumor of endocrine gland	4180186
40649658	Malignant tumour of endocrine gland	4180186
40649658	Primary malignant neoplasm of endocrine gland (disorder)	4180186
40649725	Reticulosarcoma of lymph nodes of axilla and upper limb (disorder)	4180186
40649726	Reticulosarcoma of lymph nodes of head, face, and neck (disorder)	4180186
40649731	Reticulosarcoma of unspecified, extranodal or solid organ site (disorder)	4180186
40649759	Sézary's disease of intrathoracic lymph nodes (disorder)	4180186
40649774	Subacute leukaemia in remission	4180186
40649774	Subacute leukemia in remission (disorder)	4180186
40649775	Subacute leukaemia	4180186
40649775	Subacute leukemia (disorder)	4180186
40649779	Subacute monocytic leukaemia	4180186
40649779	Subacute monocytic leukemia (disorder)	4180186
40649780	Subacute myeloid leukaemia in remission	4180186
40649780	Subacute myeloid leukemia in remission (disorder)	4180186
40649781	Subacute myeloid leukaemia	4180186
40649781	Subacute myeloid leukemia (disorder)	4180186
40649816	Chronic osteomyelitis of other specific site, NEC (disorder)	4180186
40649869	Retired procedure (procedure)	4180186
40649893	Benign neoplasm of bone and articular cartilage (disorder)	4180186
40649902	Salicylate (product)	4180186
40649902	Salicylates	4180186
40649912	Drug of abuse screen on urine (procedure)	4180186
40649916	Benign neoplasm of carina (disorder)	4180186
40649927	Benign neoplasm of cerebrum (disorder)	4180186
40649935	Retired procedure (procedure)	4180186
40649985	CA - Cancer of esophagus	4180186
40649985	CA - Cancer of oesophagus	4180186
40649985	Cancer of esophagus	4180186
40649985	Cancer of oesophagus	4180186
40649985	Esophageal cancer	4180186
40649985	Malignant neoplasm of esophagus	4180186
40649985	Malignant neoplasm of oesophagus	4180186
40649985	Malignant tumor of esophagus	4180186
40649985	Malignant tumour of oesophagus	4180186
40649985	Oesophageal cancer	4180186
40649985	Primary malignant neoplasm of esophagus (disorder)	4180186
40649985	Primary malignant neoplasm of oesophagus	4180186
40649992	Malignant neoplasm of eye	4180186
40649992	Malignant tumor of eye	4180186
40649992	Malignant tumour of eye	4180186
40649992	Primary malignant neoplasm of eye, primary (disorder)	4180186
40649996	Malignant neoplasm of ventricular bands of larynx	4180186
40649996	Primary malignant neoplasm of false vocal cord (disorder)	4180186
40650008	Malignant neoplasm of foreskin	4180186
40650008	Primary malignant neoplasm of prepuce (disorder)	4180186
40650013	Carcinoma gallbladder	4180186
40650013	Malignant tumor of gallbladder	4180186
40650013	Malignant tumour of gallbladder	4180186
40650013	Primary malignant neoplasm of gallbladder (disorder)	4180186
40650017	Cancer of glans penis	4180186
40650017	Malignant tumor of glans penis	4180186
40650017	Malignant tumour of glans penis	4180186
40650017	Primary malignant neoplasm of glans penis (disorder)	4180186
40650036	Excision of broad ligament (procedure)	4180186
40650044	Cancer of bowel	4180186
40650044	CA - Cancer of bowel	4180186
40650044	CA - Cancer of intestine	4180186
40650044	Cancer of intestine	4180186
40650044	Intestinal cancer	4180186
40650044	Malignant neoplasm of intestine	4180186
40650044	Malignant tumor of intestine	4180186
40650044	Malignant tumour of intestine	4180186
40650044	Primary malignant neoplasm of intestinal tract (disorder)	4180186
40650054	Primary malignant neoplasm of junctional region of epiglottis (disorder)	4180186
40650060	Primary malignant neoplasm of lacrimal duct (disorder)	4180186
40650061	Malignant neoplasm of lacrimal gland	4180186
40650061	Malignant tumor of lacrimal gland	4180186
40650061	Malignant tumour of lacrimal gland	4180186
40650061	Primary malignant neoplasm of lacrimal gland (disorder)	4180186
40650064	Malignant neoplasm of laryngeal aspect of interarytenoid fold (disorder)	4180186
40650067	CA - Cancer of larynx	4180186
40650067	Cancer of larynx	4180186
40650067	Laryngeal cancer	4180186
40650067	Malignant tumor of larynx	4180186
40650067	Malignant tumour of larynx	4180186
40650067	Primary malignant neoplasm of larynx (disorder)	4180186
40650083	Malignant tumor of lower gingiva	4180186
40650083	Malignant tumor of lower gum	4180186
40650083	Malignant tumour of lower gingiva	4180186
40650083	Malignant tumour of lower gum	4180186
40650083	Primary malignant neoplasm of lower gum (disorder)	4180186
40650092	Malignant neoplasm of lymphoid AND/OR histiocytic tissue (disorder)	4180186
40650122	Unilateral agenesis of foot	4180186
40650122	Unilateral congenital absence of foot (disorder)	4180186
40650122	Unilateral hindpaw apodia	4180186
40650150	Lipodermatosclerosis (disorder)	4180186
40650150	Post-phlebitic liposclerosis	4180186
40650232	Cervical rib syndrome (disorder)	4180186
40650235	Villonodular synovitis (disorder)	4180186
40650288	Benign neoplasm of hypopharyngeal aspect of aryepiglottic fold (disorder)	4180186
40650299	Benign neoplasm of inner aspect of lower lip (disorder)	4180186
40650300	Benign neoplasm of inner aspect of upper lip (disorder)	4180186
40650312	Benign neoplasm of islets of Langerhans (disorder)	4180186
40650322	Benign neoplasm of lacrimal duct (disorder)	4180186
40650338	Benign neoplasm of leg (disorder)	4180186
40650343	Benign neoplasm of long bone of lower limb (disorder)	4180186
40650347	Retired procedure (procedure)	4180186
40650376	Benign neoplasm of metacarpal bone (disorder)	4180186
40650393	Malignant neoplasm of middle third of esophagus	4180186
40650393	Malignant neoplasm of middle third of oesophagus	4180186
40650393	Primary malignant neoplasm of middle third of esophagus (disorder)	4180186
40650393	Primary malignant neoplasm of middle third of oesophagus	4180186
40650400	Retired procedure (procedure)	4180186
40650420	Malignant neoplasm of nasopharynx (disorder)	4180186
40650441	CA - Cancer of pancreas	4180186
40650441	CA - Pancreatic cancer	4180186
40650441	Carcinoma of pancreas	4180186
40650441	Malignant tumor of pancreas	4180186
40650441	Malignant tumour of pancreas	4180186
40650441	Pancreatic cancer	4180186
40650441	Primary malignant neoplasm of pancreas (disorder)	4180186
40650459	Primary malignant neoplasm of penis (disorder)	4180186
40650459	CA - Cancer of penis	4180186
40650459	Cancer of penis	4180186
40650459	Malignant tumor of penis	4180186
40650459	Malignant tumour of penis	4180186
40650459	Penile Ca	4180186
40650477	Retired procedure (procedure)	4180186
40650479	Primary malignant neoplasm of posterior wall of urinary bladder (disorder)	4180186
40650550	Congenital cyst of kidney (disorder)	4180186
40650563	Congenital amblyopia (disorder)	4180186
40650593	Congenital absence of auricle (disorder)	4180186
40650604	Jaw pain	4180186
40650604	Pain of jaw (finding)	4180186
40650625	Diverticulum of duodenum (disorder)	4180186
40650627	Diverticulum of ileum (disorder)	4180186
40650728	Benign neoplasm of pisiform bone of hand (disorder)	4180186
40650734	Benign neoplasm of mouth (disorder)	4180186
40650734	Benign neoplasm of oral cavity	4180186
40650734	Benign tumor of oral cavity	4180186
40650734	Benign tumour of oral cavity	4180186
40650734	Oral benign tumor	4180186
40650734	Oral benign tumour	4180186
40650778	Benign neoplasm of second cuneiform bone of foot (disorder)	4180186
40650785	Infection by Toxoplasma gondii (disorder)	4180186
40650795	Scrotal Ca	4180186
40650795	CA - Cancer of scrotum	4180186
40650795	Cancer of scrotum	4180186
40650795	Malignant scrotal tumor	4180186
40650795	Malignant scrotal tumour	4180186
40650795	Malignant tumor of scrotum	4180186
40650795	Malignant tumour of scrotum	4180186
40650795	Primary malignant neoplasm of scrotum (disorder)	4180186
40650807	Primary malignant neoplasm of skin of arm (disorder)	4180186
40650809	Closed fracture of inferior maxilla	4180186
40650809	Closed fracture of lower jaw bone	4180186
40650809	Closed fracture of mandible (disorder)	4180186
40650853	Retired procedure (procedure)	4180186
40650874	CA - Cancer of spine	4180186
40650874	Cancer of spine	4180186
40650874	Malignant neoplasm of spine	4180186
40650874	Malignant tumor of vertebral column	4180186
40650874	Malignant tumour of vertebral column	4180186
40650874	Primary malignant neoplasm of vertebral column (disorder)	4180186
40650879	CA - Cancer of stomach	4180186
40650879	Cancer of stomach	4180186
40650879	Gastric cancer	4180186
40650879	Malignant tumor of stomach	4180186
40650879	Malignant tumour of stomach	4180186
40650879	Primary malignant neoplasm of stomach (disorder)	4180186
40650907	Ureterolithiasis	4180186
40650928	Prostatic lithiasis (disorder)	4180186
40650930	Irritation of penis (disorder)	4180186
40650930	Penile irritation	4180186
40650954	Neonatal gangrene (disorder)	4180186
40650987	Anoxia of brain (disorder)	4180186
40650987	Cerebral anoxia	4180186
40650987	Cerebral hypoxia	4180186
40650987	Hypoxia of brain	4180186
40650993	Arthrobacter duodecadis (organism)	4180186
40651015	Skin anti-inflammatory agent (product)	4180186
40651049	Epstein's pearl of mouth (disorder)	4180186
40651049	Gingival cysts of infant	4180186
40651087	Retired procedure (procedure)	4180186
40651095	Poor-will (organism)	4180186
40651119	Fallopian tube excision	4180186
40651119	Salpingectomy (procedure)	4180186
40651152	Grahamella peromysci (organism)	4180186
40651163	Retired procedure (procedure)	4180186
40651171	Staphylococcus aureus neutral proteinase (substance)	4180186
40651175	Injury of peritoneum with open wound into abdominal cavity (disorder)	4180186
40651187	Amanita phalloides poisoning (disorder)	4180186
40651235	Benign neoplasm of skin of leg (disorder)	4180186
40651272	Anal sphincterectomy (procedure)	4180186
40651279	Benign neoplasm of vertebral column (disorder)	4180186
40651307	Benign neoplasm of the omentum (disorder)	4180186
40651311	Benign neoplasm of third cuneiform bone of foot (disorder)	4180186
40651346	CA - Cancer of peritoneum	4180186
40651346	Cancer of peritoneum	4180186
40651346	Malignant tumor of peritoneum	4180186
40651346	Malignant tumour of peritoneum	4180186
40651346	Peritoneal cancer	4180186
40651346	Primary malignant neoplasm of the peritoneum (disorder)	4180186
40651350	Malignant neoplasm of thoracic esophagus	4180186
40651350	Malignant neoplasm of thoracic oesophagus	4180186
40651350	Primary malignant neoplasm of thoracic esophagus (disorder)	4180186
40651350	Primary malignant neoplasm of thoracic oesophagus	4180186
40651377	Malignant neoplasm of upper third of esophagus	4180186
40651377	Malignant neoplasm of upper third of oesophagus	4180186
40651377	Primary malignant neoplasm of upper third of esophagus (disorder)	4180186
40651377	Primary malignant neoplasm of upper third of oesophagus	4180186
40651386	Malignant neoplasm of uterus (disorder)	4180186
40651396	Malignant neoplasm of lower lip, lipstick area	4180186
40651396	Malignant neoplasm of lower lip, vermilion border	4180186
40651396	Malignant tumor of lipstick area of lower lip	4180186
40651396	Malignant tumor of vermilion border of lower lip	4180186
40651396	Malignant tumour of lipstick area of lower lip	4180186
40651396	Malignant tumour of vermilion border of lower lip	4180186
40651396	Primary malignant neoplasm of vermilion border of lower lip (disorder)	4180186
40651397	Malignant neoplasm of upper lip, vermilion border	4180186
40651397	Malignant tumor of lipstick area of upper lip	4180186
40651397	Malignant tumor of vermilion border of upper lip	4180186
40651397	Malignant tumour of lipstick area of upper lip	4180186
40651397	Malignant tumour of vermilion border of upper lip	4180186
40651397	Primary malignant neoplasm of vermilion border of upper lip (disorder)	4180186
40651410	Acute megakaryoblastic leukaemia, FAB M7	4180186
40651410	Acute megakaryoblastic leukemia, FAB M7 (disorder)	4180186
40651410	Megakaryocytic leukaemia	4180186
40651410	Megakaryocytic leukemia	4180186
40651453	Metastatic malignant neoplasm to blood vessel of arm	4180186
40651453	Secondary malignant neoplasm of blood vessel of arm (disorder)	4180186
40651483	Wedge-tailed fruit pigeon (organism)	4180186
40651562	Vitreous floater	4180186
40651562	Vitreous opacities (disorder)	4180186
40651562	Vitreous opacity	4180186
40651579	Disabling positional vertigo (finding)	4180186
40651579	Malignant positional vertigo	4180186
40651645	Retired procedure (procedure)	4180186
40651670	Removal of electrodes of brain with synchronous replacement (procedure)	4180186
40651684	Mongolian gerbil (organism)	4180186
40651687	Localised scleroderma	4180186
40651687	Localized scleroderma (disorder)	4180186
40651694	Aplastic anaemia secondary to drugs	4180186
40651694	Aplastic anemia secondary to drugs (disorder)	4180186
40651701	Skin of arm and elbow (body structure)	4180186
40651712	Retired procedure (procedure)	4180186
40651728	Repair of intestinouterine fistula (procedure)	4180186
40651729	Salmonella III arizonae 59:c:e,n,x,z55 (organism)	4180186
40651751	Dwarfism (disorder)	4180186
40651783	Benign neoplasm of vestibule of nose (disorder)	4180186
40651806	Bilateral acheiria (disorder)	4180186
40651806	Bilateral agenesis of hands	4180186
40651806	Bilateral congenital absence of hands	4180186
40651806	Bilateral forepaw apodia	4180186
40651828	Carcinoma in situ of abdominal esophagus (disorder)	4180186
40651828	Carcinoma in situ of abdominal oesophagus	4180186
40651871	Carcinoma in situ of carina (disorder)	4180186
40651896	Metastatic malignant neoplasm to blood vessel of leg	4180186
40651896	Secondary malignant neoplasm of blood vessel of leg (disorder)	4180186
40651916	Secondary malignant neoplasm of bone and articular cartilage (disorder)	4180186
40651998	Injury of neck including whiplash (disorder)	4180186
40652056	Retired procedure (procedure)	4180186
40652133	Order rodentia - rodent or gnawing animal	4180186
40652133	Rodent (organism)	4180186
40652170	Retired procedure (procedure)	4180186
40652186	Retired procedure (procedure)	4180186
40652192	Skin of arm and shoulder (disorder)	4180186
40652223	Finding of sensation (qualifier value)	4180186
40652251	Primary ciliary dyskinesia (disorder)	4180186
40652283	AIDS with agranulocytosis (disorder)	4180186
40652361	Carcinoma in situ of inner aspect of lower lip (disorder)	4180186
40652362	Carcinoma in situ of inner aspect of upper lib (disorder)	4180186
40652374	Carcinoma in situ of lacrimal duct (disorder)	4180186
40652390	Carcinoma in situ of lesser curvature of stomach (disorder)	4180186
40652420	This parent group contains individual groups of microbiology terms that have the same Component, Property, Time aspect, and any respiratory System (e.g., nasopharynx, sputum, bronchoalveolar lavage, respiratory.upper), regardless of the method.	4180186
40652426	This parent group contains individual groups for each Subject Matter Domain+Role combination in the Document Ontology, regardless of the Type of Service, Kind of Note, and Setting.	4180186
40652431	This parent group contains individual groups for terms that can be equivalenced based on converting mass concentration to molar concentration or vice versa. The Component, Time aspect, System and Method for all of the terms in a given group are the same.	4180186
40652432	This parent group contains individual groups for kidney imaging terms that have the same method (modality) and component, regardless of laterality.	4180186
40652435	This parent group contains separate groups at the genus level, for individual non-virus microorganisms that are considered reportable based on the Centers for Disease Control and Prevention (CDC) list for notifiable infectious diseases from October 2017.	4180186
40652439	This parent group contains a single group of LOINC terms related to smoking status and smoke exposure, regardless of whether the exposure is primary or secondary. This group is defined primarily by string matching for key words, since there is no single unifying aspect for all of the LOINC terms contained in the group. Feedback about missing concepts or terms that should not be included is welcome.	4180186
40652440	This parent group contains individual groups of microbiology terms that have the same Component, Property, Time aspect, and any genitourinary System (e.g., cervix, urethra), regardless of the Method. General, non-organism specific bacterial cultures (e.g., urine culture) are excluded, because the results have different clinical significance.	4180186
40652441	"This parent group contains a single group for LOINC radiology terms that have ""Breast"" as the region imaged, regardless of the imaging focus or method (modality)."	4180186
40652444	"This parent group contains a single group for LOINC radiology terms that have ""Abdomen"" as the region imaged. It allows users to find all radiology studies that image the abdomen, regardless of the imaging focus or method (modality). Note that terms with multiple regions imaged will be included in the individual group for each region."	4180186
40652447	This parent group contains a single group of LOINC terms that represent concepts related to physical activity. These terms span a broad range of concepts, from quantitative exercise frequency and duration to activity preferences and physical activity protocols. This group relies on manual tagging of concepts related to exercise within the LOINC database, since there is no single unifying aspect for all of the LOINC terms contained in the group. Feedback about missing concepts or terms that should not be included is welcome.	4180186
40652448	This parent group contains individual groups for radiology extremity terms that have the same method (modality), component and imaging focus, regardless of laterality. This parent group does not contain extremity terms that do not have an imaging focus.	4180186
40652449	This parent group contains individual groups for radiology extremity terms that have the same method (modality) and component, regardless of laterality. This parent group only contains extremity terms that do not have an imaging focus.	4180186
40652450	This parent group contains individual groups for each Setting in the Document Ontology, regardless of Type of Service, Kind of Document, Subject Matter Domain, or Role.	4180186
40652451	This parent group contains individual groups for antimicrobial susceptibility regardless of the Method, so for example, a single group for penicillin susceptibility contains terms that have the Component 'Penicilin' and Property 'Susc', and either no Method or any of the susceptibility testing Methods, such as MIC, gradient strip, and disk diffusion.	4180186
40652452	"This parent group contains individual groups for each vital sign, where each group contains terms that represent the more routine measurements for each vital sign. These groups do not take the Method into account, so, for example, terms for heart rate measured by palpation and intra-arterial line are grouped together. All of the terms have a timing of point in time and do not include a challenge (e.g., standing or post bronchodilation) for that particular vital sign. All of the vitals are defined as ""routine"" based on the following criteria: 1) all measurements are point in time (e.g., do not include min/max values for various time periods); 2) none of the terms include a challenge (e.g., standing or post bronchodilation); 3) blood pressure terms only include the ones where the System is 'Arterial system' or 'Brachial artery'; 4) respiratory rate terms only include those with a System of 'Respiratory system'; 5) temperature terms exclude those with a System of 'Finger', 'Toe' and..."	4180186
40652454	This parent group contains separate groups at the genus+species level, for individual non-virus microorganisms that are considered reportable based on the Centers for Disease Control and Prevention (CDC) list for notifiable infectious diseases from October 2017.	4180186
40652455	"This parent group contains a single group for LOINC radiology terms that have ""Pelvis"" as the region imaged. It allows users to find all radiology studies that image the pelvis, regardless of the imaging focus or method (modality). Note that terms with multiple regions imaged will be included in the individual group for each region."	4180186
40757162	Assessment; CARE; CARE Survey; Continuity Assessment Record and Evaluation (CARE) Pnl; Eval; H&P; History and physical; Pan; Panel; Panl; Pnl; Point in time; Random; Survey	4180186
40757163	CARE Survey; CCN; CMS certification #; Ident; Identifier; No; Nominal; Num; Point in time; Random; Survey	4180186
40757165	CARE Survey; Continuity Assessment Record and Evaluation (CARE) Pnl; Major Txs; Major Txs admitted/discharged with; Major Txs admitted/discharged with Pnl; Pan; Panl; Pnl; Point in time; Random; Survey; Transferred; Tx; Txs	4180186
40757167	CARE Survey; Finding; Findings; Nominal; Point in time; Random; React; Rxn; Survey	4180186
40757168	CARE Survey; Point in time; Random; Survey; Temporal Orientation/Mental Status	4180186
40757170	CARE Survey; Point in time; Random; Survey	4180186
40757176	2 days; 48 hours; CARE Survey; FCN; Func; Funct; Past; Survey	4180186
40757178	CARE Survey; Disch; Point in time; Random; Survey	4180186
40757179	CARE Survey; Point in time; Random; Survey	4180186
40757180	CARE Survey; Point in time; Random; Survey	4180186
40757181	CARE Survey; Disch; Point in time; Random; Survey	4180186
40757182	CARE Survey; Disch; Point in time; Random; Survey	4180186
40757183	CARE Survey; Point in time; Random; Survey	4180186
40757187	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
40757189	CARE Survey; Disch; Finding; Findings; Housing; Living Arrangement; Living Arrangements; Nominal; Point in time; Random; S prime; Survey	4180186
40757190	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Nominal; Othr; Point in time; Random; Survey	4180186
40757191	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Self-care; Survey	4180186
40757192	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757194	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757196	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Nominal; Point in time; Random; Survey; Ulcer	4180186
40757197	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Nominal; Othr; Point in time; Random; Survey	4180186
40757199	CARE Survey; Finding; Findings; Ordinal; Point in time; Primary language; Ql; Qual; Qualitative; Random; Screen; SDOH; Survey	4180186
40757201	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Translator	4180186
40757205	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757208	2 days; 48 hours; CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Memory/recall ability; Nominal; Survey	4180186
40757209	2 days; 48 hours; CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Memory/recall ability; Nominal; Survey	4180186
40757211	2 days; 48 hours; CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; Sx	4180186
40757214	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757216	CARE Survey; Continuity assessment record and evaluation; Disch; Discharge location; Discharge status; Nominal; Point in time; Random; Survey; Typ	4180186
40757218	CARE Survey; Continuity assessment record and evaluation; Disch; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757220	CARE Survey; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
40757222	Activities of Daily Living; CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
40757223	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
40757227	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
40757230	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
40757231	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Nominal; Point in time; Random; SNF; Survey	4180186
40757232	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Hosp; Nominal; Point in time; Random; Survey	4180186
40757233	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Hosp; LTC hospital considered appropriate; Nominal; Point in time; Random; Survey	4180186
40757234	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Hosp; Nominal; Point in time; Random; Survey	4180186
40757239	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; LTC nursing facility considered appropriate; Nominal; Point in time; Random; Survey	4180186
40757240	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Nominal; Othr; Point in time; Random; Survey	4180186
40757242	CARE Survey; Continuity assessment record and evaluation; Nominal; Point in time; Random; Survey; Typ	4180186
40757243	CARE Survey; Continuity assessment record and evaluation; Nominal; Othr; Point in time; Random; Survey; Typ	4180186
40757248	Admin; CARE Survey; Continuity assessment record and evaluation; Nominal; Point in time; Random; Survey; Transferred; Typ	4180186
40757250	CARE Survey; Continuity assessment record and evaluation; Dx; Identity or presence; Nominal; Point in time; Prev; Primary Dx code from previous setting; Random; Survey	4180186
40757251	2 months; 60 days; CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Medical services received in the last 2 months; Nominal; Past; Survey	4180186
40757253	CARE Survey; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey	4180186
40757254	3; Brief Interview for Mental Status; Cnt; Count; Number; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757255	Brief Interview for Mental Status; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757256	Brief Interview for Mental Status; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757260	Brief Interview for Mental Status; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757263	2 days; 48 hours; CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Levels; Levl; LV; LVL; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
40757264	2 days; 48 hours; CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
40757265	Assessment; CARE; CARE Survey; Continuity Assessment Record and Evaluation (CARE) Pnl; Eval; H&P; History and physical; Pan; Panel; Panl; Pnl; Point in time; Random; Survey	4180186
40757267	After; Assessment; CARE; CARE Survey; CARE tool - PAC discharge; Continuity Assessment Record and Evaluation (CARE) Pnl; Disch; Eval; H&P; History and physical; Pan; Panel; Panl; Pnl; Point in time; PST; Random; Survey	4180186
40757268	Assessment; CARE; CARE Survey; CARE Tool - Home Health Adm; Continuity Assessment Record and Evaluation (CARE) Pnl; Eval; H&P; History and physical; Pan; Panel; Panl; Pnl; Point in time; Random; Survey	4180186
40757271	CARE Survey; Continuity Assessment Record and Evaluation (CARE) Pnl; Major Txs; Major Txs discharged with; Major Txs discharged with panel; Pan; Panl; Pnl; Point in time; Random; Survey; Tx; Txs	4180186
40757273	Amplif; Amplification; Amplified; bDNA; Bdn-A; Branched Chain DNA; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; HC; HPA; Hybidization Protection Assay; Hybrid Capture; Hybrid Capture nucleic acid hybridization; ID; Infectious Disease; InfectiousDisease; Microbiology; Monilia; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; Probe amp; Probe with ampification; Probe with signal amplification; Probe+sig amp; Ql; Qual; Qualitative; Random; Screen; species; spp; Thrush; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
40757273	Candida DNA Vag Ql Probe+sig amp	4180186
40757273	假丝酵母属单个未知种 DNA:存在情况或阈值:时间点:阴道:序数型:探针法.基因扩增.信号	4182948
40757274	Amplif; Amplification; Amplified; bDNA; Bdn-A; Branched Chain DNA; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; G vaginalis; Genital vaginal; Gyn; Gynecology; HC; HPA; Hybidization Protection Assay; Hybrid Capture; Hybrid Capture nucleic acid hybridization; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; Probe amp; Probe with ampification; Probe with signal amplification; Probe+sig amp; Ql; Qual; Qualitative; Random; Screen; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
40757274	G vaginalis DNA Vag Ql Probe+sig amp	4180186
40757274	阴道加德纳菌 DNA:存在情况或阈值:时间点:阴道:序数型:探针法.基因扩增.信号	4182948
40757277	ABS; Aby; Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; M tb; M tuberculosis; MEIA; Microbiology; Mtb; Myco; Mycobact; Mycobacterium tuberculosum; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS; TB; Tuberculosis	4180186
40757277	M tb IgG Ser IA-aCnc	4180186
40757277	结核分枝杆菌 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40757280	ACIF; ANA; ANA Homogen; ANA Pat; ANF; Anticomplement Immunofluorescence; Antinuclear antibody; FA; FANA; Fluorescent antibody; Fluoresent; Homogen; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF	4180186
40757280	ANA Homogen Ser Ql IF	4180186
40757280	细胞核抗体模式.均质型:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40757281	Deprecated Centriole Ab Ser Ql IF	4180186
40757281	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CE; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; MSA CE; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF	4180186
40757282	Deprecated Centriole Ab Titr Ser IF	4180186
40757282	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CE; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; MSA CE; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40757283	NuMA Ab Ser Ql IF	4180186
40757283	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; FANA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; MSA NuMA; MSA-1; Nuc; NuMA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF	4180186
40757283	有丝分裂器 抗体:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40757286	细胞核抗体模式.细胞间桥型:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40757286	ANA intercell bridge Titr Ser IF	4180186
40757286	ACIF; ANA; ANA intercell bridge; ANA Pat; ANF; Anticomplement Immunofluorescence; Antinuclear antibody; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Midbody; NA; Nuc; Point in time; Random; Serology; Serum; SmQn; SR; Stem body; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40757287	RNAp I Ab Ser Ql IF	4180186
40757287	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Point in time; Pol I; PR; QL; Qual; Qualitative; Random; Ribonucleic acid; RNAp I; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF	4180186
40757287	RNA 聚合酶 I 抗体:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40757288	RNAp I Ab Titr Ser IF	4180186
40757288	RNA 聚合酶 I 抗体:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40757288	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Point in time; Pol I; Random; Ribonucleic acid; RNAp I; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40757291	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Ki/SL; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SL; SL-Ki; SR	4180186
40757291	Ki Ab Ser Ql	4180186
40757291	Ki 抗体:存在情况或阈值:时间点:血清:序数型	4182948
40757292	CA Pat PL-7+PL-12 Ser Ql IF	4180186
40757292	ACIF; Anticomplement Immunofluorescence; CA Pat; CA Pat PL-7+PL-12; Cytopl; Cytoplas; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; PL12; PL7; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF	4180186
40757292	细胞浆抗体模式.PL-7+PL-12:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40757296	TBP-1 Ser-aCnc	4180186
40757296	Arbitrary concentration; Bind; Chemistry; Fac; Fact; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Serum; SR; TBP1; TBP-1; TNF	4180186
40757296	肿瘤坏死因子结合蛋白:任意型浓度:时间点:血清:定量型	4182948
40757299	ANTIBIOTIC SUSCEPTIBILITIES; AST; Cefobid; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757299	Cefoperazone+Sulbac Islt KB	4180186
40757299	头孢哌酮+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40757300	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757300	Thiamphenicol Susc Islt	4180186
40757300	甲砜氯霉素:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
40757301	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Imipeneum; Imp; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Primaxin; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757301	Imipenem+EDTA Susc Islt	4180186
40757301	亚胺培南+EDTA:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
40757302	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Imipeneum; Imp; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Primaxin; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757302	Imipenem+EDTA Islt MIC	4180186
40757302	亚胺培南+EDTA:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
40757303	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Imipeneum; Imp; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Primaxin; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757303	Imipenem+EDTA Islt KB	4180186
40757303	亚胺培南+EDTA:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40757304	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; Habekacin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757304	Arbekacin Islt KB	4180186
40757304	黄花高:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40757305	ANTIBIOTIC SUSCEPTIBILITIES; AST; Bestcall; Cefmax; Cefmenoxim; Cemix; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tacef	4180186
40757305	Cefmenoxime Islt KB	4180186
40757305	头孢甲肟:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40757306	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757306	Caspofungin Islt KB	4180186
40757306	卡泊芬净:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40757307	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757307	Caspofungin Islt MIC	4180186
40757307	卡泊芬净:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
40757309	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; Ecostatin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Spectazole; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757309	Econazole Islt KB	4180186
40757309	益康唑:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40757310	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sporanax; Sporanox; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757310	Itraconaz Islt KB	4180186
40757310	伊曲康唑:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40757311	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Micostadin; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757311	Miconazole Islt KB	4180186
40757311	咪康唑:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40757312	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757312	Nitroxoline Islt KB	4180186
40757312	硝羟喹啉:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40757313	p-氨基水杨酸:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40757313	Aminosalicycic; Aminosalycilate; ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; Epusal; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; NA-PAS; Nemasol sodium; p-aminosalicyclic acid; Para aminosalicylic acid; PAS; Point in time; Random; Salf-pas; Sodico; Sodium PAS; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Therazid	4180186
40757313	PAS Islt KB	4180186
40757318	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Noxafil; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757318	Posaconazole Islt MIC	4180186
40757318	泊沙康唑:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
40757319	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Noxafil; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757319	Posaconazole Susc Islt	4180186
40757319	泊沙康唑:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
40757321	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Nagaban; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Temopen	4180186
40757321	Temocillin Islt Grad strip	4180186
40757321	替莫西林:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40757322	ANTIBIOTIC SUSCEPTIBILITIES; AST; Claforan; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757322	Cefotaxime+Sulbac Susc Islt	4180186
40757322	头孢噻肟+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
40757323	ANTIBIOTIC SUSCEPTIBILITIES; AST; Claforan; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757323	Cefotaxime+Sulbac Islt MIC	4180186
40757323	头孢噻肟+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
40757324	ANTIBIOTIC SUSCEPTIBILITIES; AST; Claforan; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757324	Cefotaxime+Sulbac Islt KB	4180186
40757324	头孢噻肟+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40757325	ANTIBIOTIC SUSCEPTIBILITIES; AST; Baypen; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Mezlin; Optocillin; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757325	Mezlocillin+Sulbac Susc Islt	4180186
40757325	美洛西林+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
40757330	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Piper; PIPJ; Pipracil; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757330	Piperacillin+Sulbac Islt KB	4180186
40757330	氧哌嗪青霉素+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40757332	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40757332	Griseofulvin Islt MIC	4180186
40757332	灰黄霉素:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
40757335	Amithiozone; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Thioacetazone	4180186
40757335	Thiacetazone Islt MIC	4180186
40757335	氨硫脲:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
40757336	L pneumo 7-14 Ab Titr Ser	4180186
40757336	嗜肺军团菌 7+8+9+10+11+12+13+14 型 抗体:滴定度:时间点:血清:定量型	4182948
40757336	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chicago 8; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; L pneumo; L pneumo 7-14; L pneumo 7-14 Ab; L pneumo7; L pneumonphila; Legion; Legionela; Legionella pneumophila serogroup 7; Microbiology; Pneu; pneum; Pneumophilia; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40757338	Activated partial thromboplastin time; aPTT; aPTT correction study; Clot; Clottable; Coag; Coagulation assay; Fac; Fact; Factor 5; FV; Hematology; Heme; imm FV DP; Immediatedly after 1:1 addition of; Little(A)PTT; Mixing studies; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube	4180186
40757338	aPTT imm FV DP PPP	4180186
40757338	表面诱导型凝血过程.因子替换^紧接着在添加因子V缺乏型血浆之后:时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
40757339	Activated partial thromboplastin time; aPTT; aPTT correction study; Clot; Clottable; Coag; Coagulation assay; Fac; Fact; Factor 5; FV; Hematology; Heme; imm FV DP; imm FV DP+APC; Immediatedly after 1:1 addition of; Little(A)PTT; Mixing studies; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube	4180186
40757339	aPTT imm FV DP+APC PPP	4180186
40757339	表面诱导型凝血过程.因子替换^紧接着在添加因子V缺乏型血浆+活化蛋白 C之后:时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
40757340	Hgb C-Harlem MFr Bld	4180186
40757340	Blood; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hemoglobin C - Harlam; Hgb; Hgb C; Hgb C-Harlem; Mass Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
40757340	血红蛋白 C-Harlem/血红蛋白.总计:质量分数:时间点:全血:定量型	4182948
40757341	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HBV; HBV BCP; HBV BCP Mut; Hep; Hep B; Hepatis; Hepatit; Hepatology; HepB; ID; Identity or presence; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Liver; Microbiology; Mut; Mutations; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Serum; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40757341	HBV BCP Mut Ser NAA+probe	4180186
40757341	乙型肝炎病毒基本核心启动子:存在与否或特征标识:时间点:血清:名义型:探针法.基因扩增.靶向	4182948
40757343	17-Hydroxycorticosterone; 3D p Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Decadron; Dexameth; Dexone; F; Hexadrol; hydrocortisone; Level; p Dex; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40757343	Cortis 3D p Dex SerPl-sCnc	4180186
40757343	皮质醇^在给予剂量地塞米松之后3天:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757344	Cortis 4D p Dex SerPl-sCnc	4180186
40757344	17-Hydroxycorticosterone; 4D p Dex; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Cortrosyn; F; hydrocortisone; Level; p ACTH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	4180186
40757344	皮质醇^在给予剂量促肾上腺皮质激素之后4天:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757346	17-Hydroxycorticosterone; 5h p Dex; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Cortrosyn; F; hydrocortisone; Level; p ACTH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	4180186
40757346	Cortis 5h p Dex SerPl-sCnc	4180186
40757346	皮质醇^在给予剂量促肾上腺皮质激素之后5小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757347	After; Before; Bind; CHEMISTRY.CHALLENGE TESTING; Fac; Fact; HUM; Humulin; i; IGF; IGF BP; IGF BP1; IGFBP; IGFBP1; IGFBP-1; IH7; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; PR; pre/p chal; Prot; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
40757347	IGF BP1 pre/p chal SerPl-mCnc	4180186
40757347	胰岛素样生长因子结合蛋白 1^在XXX刺激之前/之后:质量浓度:时间点:血清/血浆:定量型	4182948
40757348	CLIN; Identity or presence; Misc; Miscellaneous; Nominal; Other; PH notifiable condition; Point in time; Random; Spec; To be specified in another part of the message; Unspecified	4180186
40757348	PH notifiable condition	4180186
40757348	公共卫生法定上报疾病:存在与否或特征标识:时间点:XXX:名义型	4182948
40757352	CELL MARKERS; Hematology; Heme; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Narrative; Other; Point in time; Random; Report; Spec; To be specified in another part of the message; Unspecified	4180186
40757352	Lymphoma markers Spec-Imp	4180186
40757352	淋巴瘤标志物:印象:时间点:XXX:叙述型	4182948
40757353	CELL MARKERS; Hematology; Heme; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Narrative; Other; Point in time; Random; Report; Scn; Scr; Scrn; Spec; To be specified in another part of the message; Unspecified	4180186
40757353	Lymphoma - acute screen markers Spec-Imp	4180186
40757353	淋巴瘤 - 急性筛查标志物:印象:时间点:XXX:叙述型	4182948
40757358	CELL MARKERS; Dynamic; FC; Lymphoma - acute screen Pnl; Misc; Miscellaneous; Other; Pan; PANEL.CELLMARK; Panl; Pnl; Point in time; Random; Scn; Scr; Scrn; Spec; To be specified in another part of the message; UniversalLabOrders; Unspecified	4180186
40757358	Lymphoma - acute screen Pnl Spec FC	4180186
40757358	淋巴瘤 - 急性筛查组套:-:时间点:XXX:-:流式细胞测量术	4182948
40757359	CELL MARKERS; Chronic lymphocytic leukemia; Dynamic; FC; Lymphoma - CLL screen Pnl; Misc; Miscellaneous; Other; Pan; PANEL.CELLMARK; Panl; Pnl; Point in time; Random; Scn; Scr; Scrn; Spec; To be specified in another part of the message; UniversalLabOrders; Unspecified	4180186
40757359	Lymphoma - CLL screen Pnl Spec FC	4180186
40757359	淋巴瘤 - 慢性淋巴细胞白血病筛查组套:-:时间点:XXX:-:流式细胞测量术	4182948
40757360	CELL MARKERS; Dynamic; FC; Lymphoma - T-cell screen Pnl; Misc; Miscellaneous; Other; Pan; PANEL.CELLMARK; Panl; Pnl; Point in time; Random; Scn; Scr; Scrn; Spec; T cell; T prime; To be specified in another part of the message; UCHL-1; UniversalLabOrders; Unspecified	4180186
40757360	Lymphoma - T-cell screen Pnl Spec FC	4180186
40757360	淋巴瘤 - T-细胞筛查组套:-:时间点:XXX:-:流式细胞测量术	4182948
40757362	Ejaculate; FERTILITY TESTING; Genitourinary; GU; Pan; PANEL.FERTILITY; Panl; Pnl; Point in time; Random; Sem; Semen analysis fertility Pnl; Seminal fluid; Smn; SMPLS; UniversalLabOrders; URO; Urology	4180186
40757362	Semen analysis fertility Pnl	4180186
40757362	精液分析生育力组套:-:时间点:精液:-	4182948
40757365	Cell cnt & Diff Pnl with Glu & Prot Fld	4180186
40757365	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell cnt & Diff Pnl with Glu & Prot; Cell Cnt + Diff Pnl; Diff; Diff Pnl; Differl; Differn; Fl; Fld; FLU; Fluid; Glu; Gluc; Glucoseur; HEMATOLOGY/CELL COUNTS; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; PR; Prot; Random	4180186
40757365	带有葡萄糖和蛋白质测定项目的细胞计数与分类组套:-:时间点:体液:-	4182948
40757368	9 AM day 2; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rc206; Second; Spec; Tumor marker	4180186
40757368	ACTH 9 AM day 2 Plas-mCnc	4180186
40757368	促肾上腺皮质激素^第2天上午9点标本:质量浓度:时间点:血浆:定量型	4182948
40757372	Antigen; Antigens; FLUB; FLUBV; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; Islt; Isol; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
40757372	FLUBV Ag Islt Ql	4180186
40757372	流感病毒 B 型 抗原:存在情况或阈值:时间点:分离株:序数型	4182948
40757374	DNA NUCLEIC ACID PROBE; DNA probe; FLUV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Influ; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Ribonucleic acid; Spec; To be specified in another part of the message; Unspecified	4180186
40757374	FLUV RNA Spec Probe	4180186
40757374	流感病毒 RNA:存在与否或特征标识:时间点:XXX:名义型:DNA探针	4182948
40757377	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Glu; Gluc; Glucoseur; Level; Mass concentration; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; PR; Prot; Prot + Glucose Pnl; QNT; Quan; Quant; Quantitative; Random	4180186
40757377	Prot + Glucose Pnl Fld-mCnc	4180186
40757377	蛋白质与葡萄糖组套:质量浓度:时间点:体液:定量型	4182948
40757379	10M pre Gc; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HGF; Hyperglycemic factor; Level; Pl; Plasma; Plsm; Point in time; pre Gc; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40757379	Glucose 10M pre Gc SerPl-sCnc	4180186
40757379	葡萄糖^在给予剂量胰高血糖素之前10分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757380	15M p Gc; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HGF; Hyperglycemic factor; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40757380	Glucose 15M p Gc SerPl-sCnc	4180186
40757380	葡萄糖^在给予剂量胰高血糖素之后15分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757382	20M p Gc; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HGF; Hyperglycemic factor; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40757382	Glucose 20M p Gc SerPl-sCnc	4180186
40757382	葡萄糖^在给予剂量胰高血糖素之前20分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757383	2M p Gc; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HGF; Hyperglycemic factor; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40757383	Glucose 2M p Gc SerPl-sCnc	4180186
40757383	葡萄糖^在给予剂量胰高血糖素之前2分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757384	4M p Gc; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HGF; Hyperglycemic factor; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40757384	Glucose 4M p Gc SerPl-sCnc	4180186
40757384	葡萄糖^在给予剂量胰高血糖素之前4分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757385	5M pre Gc; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HGF; Hyperglycemic factor; Level; Pl; Plasma; Plsm; Point in time; pre Gc; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40757385	Glucose 5M pre Gc SerPl-sCnc	4180186
40757385	葡萄糖^在给予剂量胰高血糖素之前5分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757386	6M p Gc; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HGF; Hyperglycemic factor; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40757386	Glucose 6M p Gc SerPl-sCnc	4180186
40757386	葡萄糖^在给予剂量胰高血糖素之后6分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757387	8M p Gc; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HGF; Hyperglycemic factor; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40757387	Glucose 8M p Gc SerPl-sCnc	4180186
40757387	葡萄糖^在给予剂量胰高血糖素之后8分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757390	2.5h p Ins IV; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40757390	Glucose 2.5h p Ins IV SerPl-sCnc	4180186
40757390	葡萄糖^在静脉注射剂量胰岛素之后2.5小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757393	3h pre Ins IV; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; Pl; Plasma; Plsm; Point in time; pre Ins IV; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40757393	Glucose 3h pre Ins IV SerPl-sCnc	4180186
40757393	葡萄糖^在静脉注射剂量胰岛素之前3小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757395	45M p Ins IV; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40757395	Glucose 45M p Ins IV SerPl-sCnc	4180186
40757395	葡萄糖^在静脉注射剂量胰岛素之后45分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757396	1 hour; 1.0Hr; 1h p Ins IV; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40757396	Glucose 1h p Ins IV SerPl-sCnc	4180186
40757396	葡萄糖^在静脉注射剂量胰岛素之后1小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757399	2-ketoglutarate; 2-ketoglutaric acid; 2-oxoglutarate; 2-oxoglutaric acid; AKG; Alfa; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; OKG; Orn; Ornicetil; Pl; Plasma; Plsm; Point in time; pre OKG; pre Orn; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40757399	Glucose pre OKG SerPl-sCnc	4180186
40757399	葡萄糖^在给予剂量鸟氨酸 alpha-酮戊二酸之前:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757403	15M pre OKG; 15M pre Orn; 2-ketoglutarate; 2-ketoglutaric acid; 2-oxoglutarate; 2-oxoglutaric acid; AKG; Alfa; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; OKG; Orn; Ornicetil; Pl; Plasma; Plsm; Point in time; pre OKG; pre Orn; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40757403	Glucose 15M pre OKG SerPl-sCnc	4180186
40757403	葡萄糖^在给予剂量鸟氨酸 alpha-酮戊二酸之前15分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757406	2-ketoglutarate; 2-ketoglutaric acid; 2-oxoglutarate; 2-oxoglutaric acid; 45M p OKG; 45M p Orn; After; AKG; Alfa; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; OKG; Orn; Ornicetil; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40757406	Glucose 45M p OKG SerPl-sCnc	4180186
40757406	葡萄糖^在给予剂量鸟氨酸 alpha-酮戊二酸之后45分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757410	Glutarylcarn/Creat Ur-sRto	4180186
40757410	C5DC; C5-DC; Chemistry; CR; Crea; Creat; Dicarboxylic carnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40757410	戊二酰肉碱 (C5-DC)/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40757414	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40757414	Glycerol Fld-mCnc	4180186
40757414	甘油:质量浓度:时间点:体液:定量型	4182948
40757416	Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40757416	Glycerol Ur-sCnc	4180186
40757416	甘油:物质的量浓度:时间点:尿液:定量型	4182948
40757417	Glycolate CSF-sCnc	4180186
40757417	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Glycolic acid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
40757417	羟乙酸:物质的量浓度:时间点:脑脊液:定量型	4182948
40757423	Heptanoylcarn Amn-sCnc	4180186
40757423	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C7; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40757423	庚酰肉碱 (C7):物质的量浓度:时间点:羊水:定量型	4182948
40757425	VLCFA C26:0/Creat Ur-sRto	4180186
40757425	Acd; Acid; Aliphatic carboxylate; C26:0; Cerotiate; Cerotic acid; Chains; Chemistry; Chn; CR; Crea; Creat; Fatty acid; Hexacosanoate; Hexacosanoic acid; Lipid; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn; VLC; VLCF; VLCFA; VLCFA C26:0	4180186
40757425	脂肪酸类.极长链型.C26:0/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40757429	C6; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40757429	Hexanoylcarn Ur-sCnc	4180186
40757429	己酰肉碱 (C6):物质的量浓度:时间点:尿液:定量型	4182948
40757430	Homocitrulline Amn-sCnc	4180186
40757430	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chemistry; Hci; HOMCIT; Homocit; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40757430	同型瓜氨酸:物质的量浓度:时间点:羊水:定量型	4182948
40757431	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chemistry; Genetics; Gyn; Gynecology; HCY; Hcys; Hcyst; Heredity; Heritable; Homocyst(e)ine; Inherited; Level; Neuro; Neurology; OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40757431	Hcys Amn-sCnc	4180186
40757431	同型半胱氨酸:物质的量浓度:时间点:羊水:定量型	4182948
40757432	Blood; Cardio; Cardiology; Chemistry; DBS; Dried blood spot; Filter paper; FP; HCY; Hcys; Hcyst; Heart Disease; Homocyst(e)ine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
40757432	Hcys DBS-sCnc	4180186
40757432	同型半胱氨酸:物质的量浓度:时间点:全血.斑点:定量型	4182948
40757436	Isovaleryl+MeButyrylcarn CSF-sCnc	4180186
40757436	C5; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Isovaleryl+MeButyrylcarn; Isovaleryl-2-Methylbutyrylcarnitine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
40757436	异戊酰肉碱+甲基丁酰肉碱 (C5):物质的量浓度:时间点:脑脊液:定量型	4182948
40757437	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C5; Chemistry; Isovaleryl+MeButyrylcarn; Isovaleryl-2-Methylbutyrylcarnitine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40757437	Isovaleryl+MeButyrylcarn Amn-sCnc	4180186
40757437	异戊酰肉碱+甲基丁酰肉碱 (C5):物质的量浓度:时间点:羊水:定量型	4182948
40757439	Isovalerylgly CSF-sCnc	4180186
40757439	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
40757439	异戊酰甘氨酸:物质的量浓度:时间点:脑脊液:定量型	4182948
40757440	Lactate/Pyruvate CSF-sRto	4180186
40757440	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Lact; Lactic acid; L-lactate; Point in time; Pyruvic acid; QNT; Quan; Quant; Quantitative; Random; Scrto; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration ratio; Substance ratio	4180186
40757440	乳酸/丙酮酸:物质的量比率:时间点:脑脊液:定量型	4182948
40757442	Linoleoylcarn CSF-sCnc	4180186
40757442	C18:2; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; II; Level; Linoleylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
40757442	亚油酰肉碱 (C18:2):物质的量浓度:时间点:脑脊液:定量型	4182948
40757444	C18:2; Chemistry; II; Level; Linoleylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40757444	Linoleoylcarn Ur-sCnc	4180186
40757444	亚油酰肉碱 (C18:2):物质的量浓度:时间点:尿液:定量型	4182948
40757446	Methylmalonate CSF-sCnc	4180186
40757446	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Methylmalonic acid; Methylmalonic Acidemia; MMA; Point in time; Propionic acidemia; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
40757446	甲基丙二酸:物质的量浓度:时间点:脑脊液:定量型	4182948
40757452	C8; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
40757452	Octanoylcarn CSF-sCnc	4180186
40757452	辛酰肉碱 (C8):物质的量浓度:时间点:脑脊液:定量型	4182948
40757455	C16; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Hexadecanoylcarnitine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
40757455	Palmitoylcarn CSF-sCnc	4180186
40757455	棕榈酰肉碱 (C16):物质的量浓度:时间点:脑脊液:定量型	4182948
40757458	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Pipa; Pipecolic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
40757458	Pipecolate CSF-sCnc	4180186
40757458	哌啶酸:物质的量浓度:时间点:脑脊液:定量型	4182948
40757459	Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Level; Pipa; Pipecolic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
40757459	Pipecolate DBS-sCnc	4180186
40757459	哌啶酸:物质的量浓度:时间点:全血.斑点:定量型	4182948
40757460	C3; C3-carntitine; Chemistry; CR; Crea; Creat; Point in time; Propanoylcarnitine; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40757460	Propionylcarn/Creat Ur-sRto	4180186
40757460	丙酰肉碱 (C3)/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40757462	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C3; C3-carntitine; Chemistry; Level; Point in time; Propanoylcarnitine; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40757462	Propionylcarn Amn-sCnc	4180186
40757462	丙酰肉碱 (C3):物质的量浓度:时间点:羊水:定量型	4182948
40757463	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
40757463	Propionylgly CSF-sCnc	4180186
40757463	丙酰甘氨酸:物质的量浓度:时间点:脑脊液:定量型	4182948
40757464	Stearoylcarn/Creat Ur-sRto	4180186
40757464	C18; Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Steroylcarnitine; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40757464	硬脂酰肉碱 (C18)/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40757473	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
40757473	Tiglylgly CSF-sCnc	4180186
40757473	甲基巴豆酰甘氨酸:物质的量浓度:时间点:脑脊液:定量型	4182948
40757474	1 day; 24 hours; 24HR; 3Me-tyramine; Chemistry; CR; Crea; Creat; Dopamine metabolite; III; Mass concentration ratio; Mass ratio; MCRto; QNT; Quan; Quant; Quantitative; UA; UCr; UR; Urn	4180186
40757474	3Me-tyramine/Creat 24h Ur	4180186
40757474	3-甲氧酪氨酸/肌酐:质量比率:24小时:尿液:定量型	4182948
40757475	3Me-tyramine 24h Ur-mCnc	4180186
40757475	1 day; 24 hours; 24HR; 3Me-tyramine; Chemistry; Dopamine metabolite; III; Level; Mass concentration; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40757475	3-甲氧酪氨酸:质量浓度:24小时:尿液:定量型	4182948
40757477	Alb; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Hepatology; Kidney; Level; Liver; Mass Concentration; Nephrology; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Renal; Stl; Stool = Fecal	4180186
40757477	Albumin Stl-mCnc	4180186
40757477	白蛋白:质量浓度:时间点:大便:定量型	4182948
40757478	Alb; Chemistry; Hepatology; Kidney; Level; Liver; Nephrology; Pl; Plasma; Plsm; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Renal; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40757478	Albumin SerPl-sCnc	4180186
40757478	白蛋白:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757479	AFP BldCo-mCnc	4180186
40757479	A1; AFP; Alfa; Alpha fetoprotein; Alphafetoprotein; Blood - (umbilical) cord; Chemistry; Cord (umbilical) blood; Cord bld; Cord blood; Feto; i; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Tumor marker	4180186
40757479	Alpha-1-胎儿球蛋白:质量浓度:时间点:脐带全血:定量型	4182948
40757481	Vit C+DHA SerPl-sCnc	4180186
40757481	Ascorbic acid; c702; Chemistry; DHA; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Vit C; Vit C+DHA; Vitamin C	4180186
40757481	抗坏血酸+脱氢抗坏血酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757485	Beta2 Glob Ur Elph-mCnc	4180186
40757485	B; B2 globulin; Beta2 Glob; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; II; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40757485	Beta 2 球蛋白:质量浓度:时间点:尿液:定量型:电泳	4182948
40757487	1 day; 24 hours; 24HR; B; B2 Microglob; b2-M; Chemistry; Hematology; Heme; II; Level; Mass concentration; Microglob; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40757487	B2 Microglob 24h Ur-mCnc	4180186
40757487	Beta-2-微球蛋白:质量浓度:24小时:尿液:定量型	4182948
40757488	B; B2 globulin; Beta2 Glob; Beta2+Gamma Glob; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; II; Mass fraction; Percent; PEUR; Point in time; PR; Prot; Protein gamma globulin; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; TP; UA; UPEP; UR; Urn	4180186
40757488	Beta2+Gamma Glob MFr Ur Elph	4180186
40757488	Beta 2 球蛋白+Gamma 球蛋白/蛋白质.总计:质量分数:时间点:尿液:定量型:电泳	4182948
40757489	B-Globulin MFr Dial fld Elph	4180186
40757489	B; B-Globulin; Chemistry; Diaf; Dialysate; Dialysis fluid; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; Mass fraction; Percent; Point in time; PR; Prot; Protein beta globulin; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; TP	4180186
40757489	Beta 球蛋白/蛋白质.总计:质量分数:时间点:透析液:定量型:电泳	4182948
40757491	Ascites; Ascitic fluid; Ascitis; BIC; bicar; Bicarb; Chemistry; HCO3; Level; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40757491	HCO3 Prt-sCnc	4180186
40757491	碳酸氢盐:物质的量浓度:时间点:腹膜液:定量型	4182948
40757492	BIC; bicar; Bicarb; Chemistry; HCO3; Level; Lung; Pleural; Pleural fluid; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Substance Concentration; thoracentesis fluid	4180186
40757492	HCO3 Plr-sCnc	4180186
40757492	碳酸氢盐:物质的量浓度:时间点:胸膜液:定量型	4182948
40757494	Bili; Bilirubins; Billirubin; Blood; Chemistry; Hematology; Heme; Hepatology; Level; Liver; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; TBIL; WB; Whole blood	4180186
40757494	Bilirub Bld-sCnc	4180186
40757494	胆红素:物质的量浓度:时间点:全血:定量型	4182948
40757495	Ca; Cal; Chemistry; Fld.NB; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40757495	Calcium Fld.NB-sCnc	4180186
40757495	钙:物质的量浓度:时间点:液体.非生物性:定量型	4182948
40757500	Chloride p dialysis SerPl-sCnc	4180186
40757500	After; Chemistry; Cl; Cl-; Dialy; Level; p dialysis; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40757500	氯^在透析之后:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757503	HDLc Fld-mCnc	4180186
40757503	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Fl; Fld; FLU; Fluid; HDLc; HDL-C; High density lipoprotein cholesterols; Level; Lipid; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; TCHHDL	4180186
40757503	胆固醇.HDL 之中的:质量浓度:时间点:体液:定量型	4182948
40757504	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol free; Cholesterol total; Cholesterols; Esterif; F-CHO; Heart Disease; Level; Lipid; NE Cholest; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40757504	NE Cholest SerPl-sCnc	4180186
40757504	胆固醇.非酯化型:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757506	Chemistry; CR; Crea; Creat; Level; Lung; Pleural; Pleural fluid; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Substance Concentration; thoracentesis fluid	4180186
40757506	Creat Plr-sCnc	4180186
40757506	肌酐:物质的量浓度:时间点:胸膜液:定量型	4182948
40757509	C721; Cbl; Cobalamin; DRUG/TOXICOLOGY; Drugs; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn; Vit B12; Vitamin B12	4180186
40757509	Vit B12 Ur-sCnc	4180186
40757509	钴胺素类:物质的量浓度:时间点:尿液:定量型	4182948
40757510	Cystatin C/Creat Ur-Rto	4180186
40757510	Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; UA; UCr; UR; Urn	4180186
40757510	半胱氨酸蛋白酶抑制剂 C/肌酐:比率:时间点:尿液:定量型	4182948
40757512	Cystatin C 24h Ur-mRate	4180186
40757512	1 day; 24 hours; 24HR; Chemistry; Mass rate; mRate; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40757512	半胱氨酸蛋白酶抑制剂 C:质量速率:24小时:尿液:定量型	4182948
40757516	Ascorbic acid; c702; Chemistry; DHA; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance fraction; Vit C; Vitamin C	4180186
40757516	DHA/Vit C SFr SerPl	4180186
40757516	脱氢抗坏血酸/抗坏血酸:物质的量分数:时间点:血清/血浆:定量型	4182948
40757517	Chemistry; DHA; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40757517	DHA SerPl-sCnc	4180186
40757517	脱氢抗坏血酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757520	Dodecanoylcarn Ur-sCnc	4180186
40757520	C12; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40757520	十二烷酰肉碱 (C12):物质的量浓度:时间点:尿液:定量型	4182948
40757522	Chemistry; Diaf; Dialysate; Dialysis fluid; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; Kidney; Mass Fraction; Nephrology; Percent; Point in time; PR; Prot; Protein gamma globulin; QNT; Quan; Quant; Quantitative; Random; Renal; Tot; Totl; TP	4180186
40757522	Gamma glob MFr Dial fld Elph	4180186
40757522	Gamma 球蛋白/蛋白质.总计:质量分数:时间点:透析液:定量型:电泳	4182948
40757523	Acute specimen; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; First; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p chal; Pl; Plasma; Plsm; Point in time; Pre immunization; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp1; sp1 p chal; Spec; SR; Substance concentration	4180186
40757523	Glucose sp1 p chal SerPl-sCnc	4180186
40757523	葡萄糖^在XXX刺激之后的第1个标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757524	After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp10; sp10 p chal; Spec; SR; Substance concentration	4180186
40757524	Glucose sp10 p chal SerPl-sCnc	4180186
40757524	葡萄糖^在XXX刺激之后的第10个标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757526	After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp12; sp12 p chal; Spec; SR; Substance concentration	4180186
40757526	Glucose sp12 p chal SerPl-sCnc	4180186
40757526	葡萄糖^在XXX刺激之后的第12个标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757528	After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp3; sp3 p chal; Spec; SR; Substance concentration	4180186
40757528	Glucose sp3 p chal SerPl-sCnc	4180186
40757528	葡萄糖^在XXX刺激之后的第3个标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757530	After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp9; sp9 p chal; Spec; SR; Substance concentration	4180186
40757530	Glucose sp9 p chal SerPl-sCnc	4180186
40757530	葡萄糖^在XXX刺激之后的第9个标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757531	Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HGF; Hyperglycemic factor; Level; Pl; Plasma; Plsm; Point in time; pre Gc; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40757531	Glucose pre Gc SerPl-sCnc	4180186
40757531	葡萄糖^在给予剂量胰高血糖素之前:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757532	10M p Gc; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HGF; Hyperglycemic factor; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40757532	Glucose 10M p Gc SerPl-sCnc	4180186
40757532	葡萄糖^在给予剂量胰高血糖素之后10分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757534	Num units trans 5% PPF	4180186
40757534	5% PPF; BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Cnt; Count; Frac; Fract; Fractionation; Fractions; Num units trans 5% PPF; Number; Point in time; PPF; PR; Prot; QNT; Quan; Quant; Quantitative; Random	4180186
40757534	输注 5% 血浆蛋白质成分单位:数量(计数):时间点:^血液制品单位:定量型	4182948
40757540	Antiglob; Beta 1 C-globulin; BLOOD BANK; Comp; Complmt; DAGT; DAT; DAT C3+C4 Comp-Sp Reag; DCT; Dir; Direct Coomb; Direct coombs test; Erythrocytes; Hematology; Heme; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen; Spec	4180186
40757540	DAT C3+C4 Comp-Sp Reag RBC Ql	4180186
40757540	直接抗球蛋白试验.补体 C3+C4 特异性试剂:存在情况或阈值:时间点:红细胞:序数型	4182948
40757543	BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Cnt; Count; CP; Cryo; Cryo-poor; Cryoppt; Cryoprec; Gvn; Hematology; Heme; Number; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40757543	CP Gvn BPU	4180186
40757543	贫冷沉淀血浆单位 给予的:数量(计数):时间点:^血液制品单位:定量型	4182948
40757546	Num units trans LP platelets	4180186
40757546	BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Cnt; Count; Leuc; Leuk; Leukocytes; Leukodepleted; Leukoreduced; Lkcs; LP; Num units trans LP platelets; Number; Platelet; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrb; Thrombocyte; Thrombocytes; WBC; WBCs; White blood cell; White blood cells	4180186
40757546	输注贫白细胞血小板单位:数量(计数):时间点:^血液制品单位:定量型	4182948
40757548	ABO + Rh; ABO group and Rh type; ABO+Rh Gp; Blood; BLOOD BANK; D phenotyping; D typing; Fetal; Gyn; Gynecology; Hematology; Heme; Nominal; OB; ObGyn; Obstetrics; Point in time; Random; Rh phenotyping; Rh typing; Typ; WB; Whole blood	4180186
40757548	ABO + Rh Bld Fetus	4180186
40757548	ABO与Rh血型:类型:时间点:全血^胎儿:名义型	4182948
40757549	BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Cnt; Count; FFP; FFP ped; Froz; Frozn; Num ped units trans FFP; Number; PEDS; Point in time; QNT; Quan; Quant; Quantitative; Random; Trans FFP	4180186
40757549	Num ped units trans FFP	4180186
40757549	输注新鲜冰冻血浆儿科单位:数量(计数):时间点:^血液制品单位:定量型	4182948
40757550	Whole blood ped Gvn BPU	4180186
40757550	BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Cnt; Count; Gvn; Number; PEDS; Point in time; QNT; Quan; Quant; Quantitative; Random; Whole Bld	4180186
40757550	全血儿科单位 给予的:数量(计数):时间点:^血液制品单位:定量型	4182948
40757552	Num ped units trans frozen RBC	4180186
40757552	BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Cnt; Count; Discocytes; Erthrocyte; Erythrocyte; Froz; Frozen RBC; Frozen RBC ped; Frozn; Num ped units trans frozen RBC; Number; PEDS; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells	4180186
40757552	输注冰冻红细胞儿科单位:数量(计数):时间点:^血液制品单位:定量型	4182948
40757555	1/2 Platpheresis; BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Cnt; Count; Gvn; Number; pheresis; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40757555	1/2 Platpheresis Gvn BPU	4180186
40757555	采血小板半量单位 给予的:数量(计数):时间点:^血液制品单位:定量型	4182948
40757564	DOCUMENT.REF; FDA insert; Narrative; Report; SPL; Structured Product Labelling	4180186
40757564	FDA insert User safety warnings	4180186
40757564	用户安全警告小节:-:-:^FDA 包装说明书:叙述型	4182948
40757566	A fumigatus Ab Titr Ser	4180186
40757566	烟曲霉 抗体:滴定度:时间点:血清:定量型	4182948
40757566	A fumigatus; ABS; Aby; Antby; Anti; Antibodies; Antibody; Asperg; Aspergil; Aspergilis; Aspergilla; Aspergillin; Aspergillosis; Aspergils; Aspergilus; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); Farmers lung; Fum; ID; Infectious Disease; InfectiousDisease; m003; m3; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40757569	Calc; Calculi; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Gastro; Gastroenterology; GI; Kidney; Lipid; Mass fraction; Nephrology; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Stn; Stone; Stones; TC; Tot; Totl	4180186
40757569	Cholest MFr Stone	4180186
40757569	胆固醇/总计:质量分数:时间点:结石:定量型	4182948
40757576	VLCFA.C22:1n9 SerPl-mCnc	4180186
40757576	Acd; Acid; Aliphatic carboxylate; Chains; Chemistry; Chn; Erucate; Erucic acid; Fatty acid; Level; Lipid; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; VLC; VLCF; VLCFA; VLCFA.C22:1n9	4180186
40757576	脂肪酸类.极长链型.C22:1n9:质量浓度:时间点:血清/血浆:定量型	4182948
40757577	VLCFA C26:1 SerPl-mCnc	4180186
40757577	Acd; Acid; Aliphatic carboxylate; C26:1; Chains; Chemistry; Chn; Fatty acid; Hexacosenoate; Hexacosenoic acid; i; Level; Lipid; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; VLC; VLCF; VLCFA; VLCFA C26:1	4180186
40757577	脂肪酸类.极长链型.C26:1:质量浓度:时间点:血清/血浆:定量型	4182948
40757578	BM; BON; Bone marrow; CD135; Document; Finding; Findings; FL cytokine receptor precursor; FLK2; FLK-2; fms-like tyrosine kinase 3; fms-related tyrosine kinase 3; Genetics; Heredity; Heritable; Inherited; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; PCR; Point in time; Random; Stem cell tyrosine kinase 1; STK1; STK-1	4180186
40757578	FLT3 gene Mut Anl Mar	4180186
40757578	FLT3 基因 突变分析:发现:时间点:骨髓:文档型:分子遗传学类实验室方法	4182948
40757579	B23; Blood; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; NPM; Nucleolar phosphoprotein b23; nucleophosmin (nucleolar phosphoprotein B23, numatrin); Numatrin; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40757579	NPM1 gene Mut Anl Bld/T	4180186
40757579	NPM1 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40757580	BCD541; Blood; C-BCD541; Document; Finding; Findings; GEMIN1; Gemin-1; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; PCR; Point in time; Random; SMN; SMNC; SMNT; survival of motor neuron 2, centromeric; TDRD16B; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40757580	SMN2 gene Mut Anl Bld/T	4180186
40757580	SMN2 基因 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
40757581	CYP2C9 + VKORC1 Pnl Bld/T	4180186
40757581	Blood; CYP2C9 + VKORC1 Pnl; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Pan; Panel.molpath; Panel.molpath.pharmg; Panl; PCR; Pnl; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40757581	CYP2C9 与 VKORC1 组套:-:时间点:全血/组织:-:分子遗传学类实验室方法	4182948
40757582	Blood; Genetics; Heredity; Heritable; Impression; Impression/interpretation of study; Impressions; Inherited; Interp; Interpretation; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Narrative; PCR; Point in time; Random; Report; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40757582	CYP2C9 & VKORC1 Bld/T-Imp	4180186
40757582	CYP2C9 与 VKORC1:印象:时间点:全血/组织:叙述型:分子遗传学类实验室方法	4182948
40757584	Ejaculate; FERTILITY TESTING; Genitourinary; GU; Meth; Method of; Nominal; Point in time; Random; Sem; Seminal fluid; Smn; SMPLS; Test mthd; Typ; URO; Urology	4180186
40757584	Smn Analysis method	4180186
40757584	试验方法:类型:时间点:精液:名义型:*	4182948
40757589	G-CSF SerPl-mCnc	4180186
40757589	Chemistry; Colonies; CSF; Fac; Fact; G-CSF; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40757589	粒细胞集落刺激因子:质量浓度:时间点:血清/血浆:定量型	4182948
40757590	C16DC; C16-DC; Chemistry; CR; Crea; Creat; Hexadecanediolycarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; thapsoyl carnitine; UA; UCr; UR; Urn	4180186
40757590	Dicarboxypalmitoylcarn/Creat Ur-sRto	4180186
40757590	二羧基棕榈酰肉碱 (C16-DC)/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40757591	Malonylcarn CSF-sCnc	4180186
40757591	C3DC; C3-DC; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Dicarboxylic carnitine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
40757591	丙二酰肉碱 (C3-DC):物质的量浓度:时间点:脑脊液:定量型	4182948
40757592	Malonylcarn Amn-sCnc	4180186
40757592	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C3DC; C3-DC; Chemistry; Dicarboxylic carnitine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40757592	丙二酰肉碱 (C3-DC):物质的量浓度:时间点:羊水:定量型	4182948
40757596	Alpha1 Glob MFr Dial fld Elph	4180186
40757596	A1; Alfa; Alpha1 Glob; Chemistry; Diaf; Dialysate; Dialysis fluid; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; i; Mass fraction; Percent; Point in time; PR; Prot; Protein.alpha 1 globulin; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; TP	4180186
40757596	Alpha 1 球蛋白/蛋白质.总计:质量分数:时间点:透析液:定量型:电泳	4182948
40757597	Alpha2 Glob MFr Dial fld Elph	4180186
40757597	A2; Alfa; Alpha2 Glob; Chemistry; Diaf; Dialysate; Dialysis fluid; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; II; Mass fraction; Percent; Point in time; PR; Prot; Protein.alpha 2 globulin; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; TP	4180186
40757597	Alpha 2 球蛋白/蛋白质.总计:质量分数:时间点:透析液:定量型:电泳	4182948
40757598	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; HDLc; HDL-C; HDLc 2a; Heart Disease; High density lipoprotein cholesterols; Lipid; Mass fraction; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TCHHDL; Tot; Totl	4180186
40757598	HDLc 2a MFr SerPl Elph	4180186
40757598	胆固醇.HDL 2a 之中的/胆固醇.HDL 之中的.总计:质量分数:时间点:血清/血浆:定量型:电泳	4182948
40757600	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; HDLc; HDL-C; HDLc 3a; Heart Disease; High density lipoprotein cholesterols; Lipid; Mass fraction; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TCHHDL; Tot; Totl	4180186
40757600	HDLc 3a MFr SerPl Elph	4180186
40757600	胆固醇.HDL 3a 之中的/胆固醇.HDL 之中的.总计:质量分数:时间点:血清/血浆:定量型:电泳	4182948
40757601	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; HDLc; HDL-C; HDLc 3b; Heart Disease; High density lipoprotein cholesterols; Lipid; Mass fraction; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TCHHDL; Tot; Totl	4180186
40757601	HDLc 3b MFr SerPl Elph	4180186
40757601	胆固醇.HDL 3b 之中的/胆固醇.HDL 之中的.总计:质量分数:时间点:血清/血浆:定量型:电泳	4182948
40757602	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; HDLc; HDL-C; HDLc 3c; Heart Disease; High density lipoprotein cholesterols; Lipid; Mass fraction; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TCHHDL; Tot; Totl	4180186
40757602	HDLc 3c MFr SerPl Elph	4180186
40757602	胆固醇.HDL 3c 之中的/胆固醇.HDL 之中的.总计:质量分数:时间点:血清/血浆:定量型:电泳	4182948
40757603	Alpha amylase; Ams; Amyl; Amylase Macro; Catalytic Fraction; Chemistry; Diastase; Gastro; Gastroenterology; GI; k87; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl	4180186
40757603	Amylase Macro CFr SerPl	4180186
40757603	淀粉酶.大分子/淀粉酶.总计:催化分数:时间点:血清/血浆:定量型	4182948
40757604	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Dicarboxylic carnitine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
40757604	Pimeloylcarn CSF-sCnc	4180186
40757604	庚二酰肉碱 (C7-DC):物质的量浓度:时间点:脑脊液:定量型	4182948
40757605	Pimeloylcarn Amn-sCnc	4180186
40757605	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chemistry; Dicarboxylic carnitine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40757605	庚二酰肉碱 (C7-DC):物质的量浓度:时间点:羊水:定量型	4182948
40757609	Dicarboxypalmitoylcarn Amn-sCnc	4180186
40757609	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C16DC; C16-DC; Chemistry; Hexadecanediolycarnitine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; thapsoyl carnitine	4180186
40757609	二羧基棕榈酰肉碱 (C16-DC):物质的量浓度:时间点:羊水:定量型	4182948
40757610	Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
40757610	Deprecated Dicarboxypalmitoylcarn Bld.do	4180186
40757611	C16DC; C16-DC; Chemistry; Hexadecanediolycarnitine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; thapsoyl carnitine; UA; UR; Urn	4180186
40757611	Dicarboxypalmitoylcarn Ur-sCnc	4180186
40757611	二羧基棕榈酰肉碱 (C16-DC):物质的量浓度:时间点:尿液:定量型	4182948
40757613	C18DC; C18-DC; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Dicarboxy stearoyl carnitine; Dicarboxy stearoylcarnitine; Dicarboxylic carnitine; Level; octadecanedioyl carnitine; octadecanedioylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
40757613	Dicarboxystearoylcarn CSF-sCnc	4180186
40757613	二羧基硬脂酰肉碱 (C18-DC):物质的量浓度:时间点:脑脊液:定量型	4182948
40757616	Dicarboxystearoylcarn Ur-sCnc	4180186
40757616	C18DC; C18-DC; Chemistry; Dicarboxy stearoyl carnitine; Dicarboxy stearoylcarnitine; Dicarboxylic carnitine; Level; octadecanedioyl carnitine; octadecanedioylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40757616	二羧基硬脂酰肉碱 (C18-DC):物质的量浓度:时间点:尿液:定量型	4182948
40757617	Chemistry; Glu; Gluc; Glucoseur; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Wat	4180186
40757617	Glucose Wat-mCnc	4180186
40757617	葡萄糖:质量浓度:时间点:水:定量型	4182948
40757618	Glucose Wat-sCnc	4180186
40757618	Chemistry; Glu; Gluc; Glucoseur; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Wat	4180186
40757618	葡萄糖:物质的量浓度:时间点:水:定量型	4182948
40757621	Pipecolate Amn-sCnc	4180186
40757621	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chemistry; Level; Pipa; Pipecolic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40757621	哌啶酸:物质的量浓度:时间点:羊水:定量型	4182948
40757622	ALT Prt-cCnc	4180186
40757622	Ala; Alanine transaminase; ALAT; Alpha alanine; ALT; Ascites; Ascitic fluid; Ascitis; Catalytic Concentration; Chemistry; Glutamic-pyruvic transferase; L-alanine; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; SGPT	4180186
40757622	丙氨酸氨基转移酶:催化浓度:时间点:腹膜液:定量型	4182948
40757623	Ala; Alanine transaminase; ALAT; Alpha alanine; ALT; Catalytic Concentration; Chemistry; Glutamic-pyruvic transferase; Hepatology; L-alanine; Liver; Lung; Pleural; Pleural fluid; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SGPT; thoracentesis fluid	4180186
40757623	ALT Plr-cCnc	4180186
40757623	丙氨酸氨基转移酶:催化浓度:时间点:胸膜液:定量型	4182948
40757625	Chemistry; Cl; Cl-; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Wat	4180186
40757625	Chloride Wat-mCnc	4180186
40757625	氯:质量浓度:时间点:水:定量型	4182948
40757626	After; Chemistry; Dialy; Glu; Gluc; Glucoseur; Kidney; Level; Nephrology; p dialysis; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Renal; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40757626	Glucose p dialysis SerPl-sCnc	4180186
40757626	葡萄糖^在透析之后:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757627	After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp5; sp5 p chal; Spec; SR; Substance concentration	4180186
40757627	Glucose sp5 p chal SerPl-sCnc	4180186
40757627	葡萄糖^在XXX刺激之后的第5个标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757628	After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp6; sp6 p chal; Spec; SR; Substance concentration	4180186
40757628	Glucose sp6 p chal SerPl-sCnc	4180186
40757628	葡萄糖^在XXX刺激之后的第6个标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
40757631	AST Macro/AST.total CFr SerPl	4180186
40757631	Asp; Aspartate amino transferase; Aspartate transaminase; Aspartic acid; AST; AST Macro; AST.total; Catalytic Fraction; Chemistry; Glutamic oxaloacetic transaminase; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SGOT; SR; Tot; Totl	4180186
40757631	天冬氨酸氨基转移酶.大分子/天冬氨酸氨基转移酶.总计:催化分数:时间点:血清/血浆:定量型	4182948
40757632	Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757636	Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
40757637	Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
40757638	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
40757639	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
40757640	Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757641	Brief Interview for Mental Status; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey; Temporal orientation (orientation to year, month, and day) - MDSv3	4180186
40757644	Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS; Sx	4180186
40757649	Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757650	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
40757651	Activ; Actvty; Centers for Medicare and Medicaid Assessment; Movements; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
40757652	Activ; Actvty; Movements; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757654	Activities of Daily Living; ADL assistance; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Past; Pnl; Survey	4180186
40757655	Bal; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
40757656	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Rnge; Survey	4180186
40757658	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
40757660	Appls; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757661	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
40757662	Active Disease Dx; Dis; Diseases; Dx; Dz; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757663	Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757665	GI; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757667	Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757668	Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757669	Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757670	Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757671	Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757678	Add; Addl ICD Dx 2 in last 7D; Dx; Identity or presence; II; International Classification of Diseases; Nominal; Past; Survey; SURVEY.MDS	4180186
40757680	Add; Addl ICD Dx 4 in last 7D; Dx; Identity or presence; International Classification of Diseases; Nominal; Past; Survey; SURVEY.MDS	4180186
40757682	Add; Addl ICD Dx 6 in last 7D; Dx; Identity or presence; International Classification of Diseases; Nominal; Past; Survey; SURVEY.MDS	4180186
40757684	Add; Addl ICD Dx 8 in last 7D; Dx; Identity or presence; International Classification of Diseases; Nominal; Past; Survey; SURVEY.MDS	4180186
40757685	Add; Addl ICD Dx 9 in last 7D; Dx; Identity or presence; International Classification of Diseases; Nominal; Past; Survey; SURVEY.MDS	4180186
40757688	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
40757690	Centers for Medicare and Medicaid Assessment; FCN; Func; Funct; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
40757691	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
40757692	Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757693	Indicator; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757694	Othr; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757695	Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757697	Deglutition; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757698	Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS; Wt	4180186
40757701	Oral/dent status; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757702	Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757704	Pan; Panel; Panl; Pnl; Point in time; pressure injury; Pressure ulcer; Pressure Ulcers; Random; Survey; SURVEY.MDS; Ulcer	4180186
40757705	Point in time; pressure injury; Pressure ulcer; Pressure Ulcers; Random; Survey; SURVEY.MDS; Ulcer	4180186
40757706	No; Num; Pan; Panel; Panl; Pnl; Point in time; Pressure ulcer; Pressure Ulcers; Random; Survey; SURVEY.MDS	4180186
40757708	III; Pan; Panel; Panl; Pnl; Point in time; Pressure ulcer; Pressure Ulcers; Random; Survey; SURVEY.MDS	4180186
40757711	MDS; MDSv3; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40757714	Centers for Medicare and Medicaid Assessment; Nominal; Point in time; Random; Survey; Typ	4180186
40757716	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Othr; Point in time; Random; Survey	4180186
40757717	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757725	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757729	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey	4180186
40757732	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey	4180186
40757734	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey	4180186
40757739	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757741	MDS version 3; Point in time; Random; Survey; SURVEY.MDS	4180186
40757742	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757747	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
40757748	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
40757750	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757751	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757753	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757756	Finding; Findings; MDS version 3; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757758	MDS version 3; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS; Sx	4180186
40757759	Finding; Findings; Nominal; Past; Survey	4180186
40757760	Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey	4180186
40757761	Finding; Findings; Levels; Levl; LV; LVL; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey	4180186
40757762	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757763	Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey	4180186
40757765	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757770	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
40757773	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
40757774	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
40757775	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
40757780	14 days; 2 weeks; Arterial Stenosis; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
40757782	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Othr; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
40757783	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
40757785	Mental health; MentalHealth; Patient Health Questionnaire; PHQ9; Point in time; Psych; Psychiatry; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; Tot; Totl	4180186
40757787	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757788	Mental health; MentalHealth; Pan; Panel; PANEL.SURVEY.CMS; Panl; Patient Health Questionnaire; PHQ9; Pnl; Point in time; Psych; Psychiatry; Random; Survey	4180186
40757789	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
40757790	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
40757791	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
40757792	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
40757794	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey; Trouble falling or staying asleep, or sleeping too much.frequency	4180186
40757797	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
40757803	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Othr; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; S prime; Screen; Survey	4180186
40757804	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey; T prime	4180186
40757806	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; PHQ9; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
40757808	Mental health; MentalHealth; Patient Health Questionnaire; PHQ9; Point in time; Psych; Psychiatry; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; Tot; Totl	4180186
40757809	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757810	Finding; Findings; MDS version 3; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757812	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757815	Centers for Medicare and Medicaid Assessment; Count/time; nRate; Number rate; Number Rate = Count/Time; Ordinal; Othr; QL; Qual; Qualitative; Report period; Screen; Survey; Sx	4180186
40757817	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey; Ulcer	4180186
40757820	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey; Ulcer	4180186
40757821	Activ; Actvty; Centers for Medicare and Medicaid Assessment; Finding; Findings; Movements; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
40757823	Centers for Medicare and Medicaid Assessment; Count/time; nRate; Number rate; Number Rate = Count/Time; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey	4180186
40757825	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey	4180186
40757827	Centers for Medicare and Medicaid Assessment; Exchange; Finding; Findings; Ordinal; Othr; Past; QL; Qual; Qualitative; Replace; Screen; Survey; Sx	4180186
40757830	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757832	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757834	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757837	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757838	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757839	Arterial Stenosis; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757840	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757849	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757852	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757858	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757864	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757865	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757866	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757867	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757869	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757870	Finding; Findings; MDS version 3; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757873	Finding; Findings; MDS version 3; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757874	Finding; Findings; MDS version 3; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757875	bod; Bodies; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS; Up	4180186
40757878	Finding; Findings; Grooming/personal hygiene in last 7D; MDS version 3; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757882	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
40757887	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757888	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757891	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757892	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757894	Cath; EXT; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757896	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757897	Appls; Appls - none of the above used in last 7D; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757898	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757899	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757901	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey	4180186
40757903	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40757904	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
40757905	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757912	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757913	Dis; Diseases; Dz; Finding; Findings; MDS version 3; Ordinal; Past; Periph; PVD; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757914	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757922	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757924	Finding; Findings; MDS version 3; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757925	Finding; Findings; Hep; Hepatis; Hepatit; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757929	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757930	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757931	Arth; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757933	Finding; Findings; Lower extremity joint; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757937	Cereb; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757938	Cerebrovascular accident/transient ischemic attack/stroke in last 7D; CVA; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Stroke; Survey; SURVEY.MDS; TIA	4180186
40757939	Finding; Findings; MDS version 3; Non-Alzheimer's dementia last 7D; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.MDS	4180186
40757941	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757945	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757948	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757951	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; SCZ; Survey; SURVEY.MDS	4180186
40757952	After; Finding; Findings; MDS version 3; Ordinal; Past; PST; PTSD; PTSD in last 7D; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757953	Asthma/chronic obstructive lung disease or chronic lung disease in last 7D; COLD; COPD; Dis; Diseases; Dz; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757954	Cataracts/glaucoma or macular degeneration in last 7D; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757963	Centers for Medicare and Medicaid Assessment; Finding; Findings; LMTED; LTD; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
40757965	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
40757967	5 days; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757969	5 days; bod; Bodies; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757970	5 days; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757971	Finding; Findings; MDS version 3; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS; Ther	4180186
40757972	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757974	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757976	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
40757979	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40757980	Centers for Medicare and Medicaid Assessment; Fall Hx on admission; Hx; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
40757981	1 month; 1 month (30 days); 30 days; Centers for Medicare and Medicaid Assessment; Fall one or more times in the last month prior to admission; Finding; Findings; month; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey	4180186
40757982	Centers for Medicare and Medicaid Assessment; Fall one or more times in the last 2 to 6 months prior to admission; Finding; Findings; II; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey	4180186
40757983	Any fracture related to a fall in the 6 months prior to admission; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
40757984	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
40757988	# falls since admission or prior assessment; # falls since admission or prior assessment - major injury; Centers for Medicare and Medicaid Assessment; Cnt; Count; No; Num; Num of falls; Number; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey; Ulcer	4180186
40757991	Deglutition; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757992	Deglutition; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757993	Deglutition; Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS; Sx	4180186
40757995	Finding; Findings; MDS version 3; Ordinal; Parenteral/IV feeding in last 7D; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757996	Abd; Abdo; Abdomen; Finding; Findings; MDS version 3; Ordinal; Past; PEG; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40757998	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS; Ther	4180186
40757999	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758003	edentulous; Finding; Findings; Frag; Fragment; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758004	abn; abnorm; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758005	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758006	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758007	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758010	Finding; Findings; MDS version 3; Ordinal; Point in time; pressure injury; Pressure ulcer; Pressure Ulcers; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS; Ulcer	4180186
40758011	Finding; Findings; MDS version 3; Ordinal; Point in time; pressure injury; Pressure ulcer; Pressure Ulcers; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS; Ulcer	4180186
40758012	Finding; Findings; MDS version 3; Ordinal; Point in time; pressure injury; Pressure ulcer; Pressure Ulcers; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS; Ulcer	4180186
40758013	Finding; Findings; MDS version 3; Ordinal; Point in time; Pressure ulcer; Pressure Ulcers; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40758014	Date and time; Injury; MDS version 3; Point in time; Pressure injuries; pressure injury; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.MDS; Time stamp; Timestamp	4180186
40758015	Centers for Medicare and Medicaid Assessment; Cnt; Count; i; No; Num; Number; Point in time; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40758017	Centers for Medicare and Medicaid Assessment; Cnt; Count; II; No; Num; Number; Point in time; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40758018	Centers for Medicare and Medicaid Assessment; Cnt; Count; III; No; Num; Number; Point in time; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40758022	MDS version 3; Point in time; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.MDS	4180186
40758023	Date and time; MDS version 3; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.MDS; Time stamp; Timestamp	4180186
40758028	MDS version 3; Past; QNT; Quan; Quant; Quantitative; Survey; SURVEY.MDS; Tot; Totl	4180186
40758029	Dis; Diseases; Dz; MDS version 3; Othr; Pan; Panel; Panl; Past; Pnl; Survey; SURVEY.MDS	4180186
40758030	ADMIN; ADMIN.PATIENT; ADMIN.PT.DEMOG; Nominal; Point in time; Preferred language; Random; SDOH; Typ	4180186
40758030	语言.首选:类型:时间点:^患者:名义型	4182948
40758031	IgA Prt-mCnc	4180186
40758031	Ascites; Ascitic fluid; Ascitis; Chemistry; Immune globulin A; Immunoglobulin A; Level; Mass concentration; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random	4180186
40758031	IgA:质量浓度:时间点:腹膜液:定量型	4182948
40758033	Ascites; Ascitic fluid; Ascitis; Chemistry; Immune globulin M; Immunoglobulin M; Level; Mass concentration; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random	4180186
40758033	IgM Prt-mCnc	4180186
40758033	IgM:质量浓度:时间点:腹膜液:定量型	4182948
40758037	AF; Alk; Alk phos; Alkaline phos; Alkaline phosphatase.total; ALKP; ALP; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; AP; Catalytic Concentration; Chemistry; Gyn; Gynecology; OB; ObGyn; Obstetrics; Phos; Phosphtase; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40758037	ALP Amn-cCnc	4180186
40758037	碱性磷酸酶:催化浓度:时间点:羊水:定量型	4182948
40758041	Giant grouper IgE Qn	4180186
40758041	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Brindle bass; Brown spotted cod; Bumblebee grouper; Giant grouper; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Queensland groper; Random; Serum; SR	4180186
40758041	鞍带石斑鱼 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40758043	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Aminoglycosides; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; c213; Garamycin; Genirr; Genj; Gent; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40758043	Gentamicin IgE Qn	4180186
40758043	庆大霉素 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40758046	Angler IgE Qn	4180186
40758046	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Angler; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Fishing-frog; Frog-fish; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Sea-devil; Serum; SR	4180186
40758046	安康鱼 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40758049	Chemistry; Ejaculate; Genitourinary; GU; Level; MAG; Magnes; Mass concentration; Mg; Point in time; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; URO; Urology	4180186
40758049	Magnesium Smn-mCnc	4180186
40758049	镁:质量浓度:时间点:精液:定量型	4182948
40758052	Phosphate 12h Ur-mRate	4180186
40758052	12 hours; 12HR; Chemistry; i Phos; Inorganic phosphate; Mass rate; mRate; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40758052	磷酸盐:质量速率:12小时:尿液:定量型	4182948
40758056	#; ABL; ABS; absolute; absolutes; ALL; bcr/abl; BCR1; bcr-abl1; Blood; Breakpoint cluster region; Chronic myeloid leukemia; CML; Cnt; Count; Count/volume; CT; D22S11; D22S662; DNA; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; JTK7; major breakpoints; Mbr; Mcr; minor breakpoints; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; Number concentration; Number Concentration (count/vol); p150; PCR; Ph chromosome; Philadelphia chromosome; PHL; Point in time; QNT; Quan; Quant; Quantitative; Random; RNA; T prime; t(9,22)(ABL1,BCR) gene translocation; t(9,22)(ABL1,BCR) p230 gene translocation; t(9,22)(ABL1,BCR) Translocation; t(9,22)(q34,q11); t(9,22)(q34.1,q11); t(9;22)(ABL1,BCR); t(ABL1,BCR)e19a2; Tissue; Tissue, unspecified; translocation; v-abl Abelson murine leukemia viral oncogene homolog 1; WB; Whole blood; Whole blood or Tissue	4180186
40758056	t(ABL1,BCR)e19a2 # Bld/T	4180186
40758056	t(9;22)(q34.1;q11)(ABL1,BCR) e19a2 融合转录物:计数型浓度:时间点:全血/组织:定量型:分子遗传学类实验室方法	4182948
40758057	T urticae IgE Qn	4180186
40758057	2-spotted spider mite; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; T urticae; Tetranichus urticae	4180186
40758057	二点叶螨 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40758059	tTG Ab Titr Ser IF	4180186
40758059	组织谷氨酰胺转移酶 抗体:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40758059	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Celiac disease; Dilution factor; Dilution Factor (Titer); FA; Fibrin stabilizing factor; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Point in time; Protein-glutamine gamma glutamyltransferase; Random; Serology; Serum; SmQn; SR; TG2; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; tTG; Ttr	4180186
40758062	Abrin; CEH abrine+ricinine Pnl; Centers for Environmental Health; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; UA; UR; Urn	4180186
40758062	CEH abrine+ricinine Pnl Ur-mCnc	4180186
40758062	CEH 相思豆碱与蓖麻碱组套:质量浓度:时间点:尿液:-	4182948
40758065	1,2DCA; 1,2-DCA; 1,2-Ethylene dichloride; DCA; DRUG/TOXICOLOGY; Drugs; EDC; Glycol dichloride; i; II; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40758065	1,2DCA SerPl-mCnc	4180186
40758065	1,2-二氯乙烷:质量浓度:时间点:血清/血浆:定量型	4182948
40758067	DRUG/TOXICOLOGY; Drugs; Formyl trichloride; Level; Mass concentration; Methane trichloride; Methenyl chloride; Methenyl trichloride; Methyl trichloride; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Trichloromethane	4180186
40758067	Chloroform SerPl-mCnc	4180186
40758067	氯仿:质量浓度:时间点:血清/血浆:定量型	4182948
40758068	Cyclohexatriene; DRUG/TOXICOLOGY; Drugs; Ethylbenzene; Ethylbenzol; Level; Mass concentration; Phenylethane; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40758068	Ethyl Benzene SerPl-mCnc	4180186
40758068	乙苯:质量浓度:时间点:血清/血浆:定量型	4182948
40758069	3-methlhippurate; 4-methylhippurate; DRUG/TOXICOLOGY; Drugs; Level; m+p-Methylhippurate; Mass Concentration; Methylhippuric acid; m-methlhippurate; m-Methylhippurate; Para methylhippuric acid; Pl; Plasma; Plsm; p-methylhippurate; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Xylene metabolite	4180186
40758069	m+p-Methylhippurate SerPl-mCnc	4180186
40758069	间甲基马尿酸+对甲基马尿酸:质量浓度:时间点:血清/血浆:定量型	4182948
40758072	N-ethyldiethanolamine Ur-mCnc	4180186
40758072	DRUG/TOXICOLOGY; Drugs; EDEA; Ethyl diethanolamine; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40758072	N-乙基二乙醇胺:质量浓度:时间点:尿液:定量型	4182948
40758074	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Monofluoroacetic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40758074	Monofluoroacetate Ur-mCnc	4180186
40758074	氟乙酸:质量浓度:时间点:尿液:定量型	4182948
40758076	Centers for Medicare and Medicaid Assessment; Cnt; Count; No; Num; Number; Point in time; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40758078	Date and time; Date of onset of pressure ulcers onset in this facility - oldest or only unstageable due to coverage of wound bed by slough/eschar; MDS version 3; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.MDS; Time stamp; Timestamp	4180186
40758079	Date and time; Date of onset of pressure ulcers onset in this facility - newest unstageable due to coverage of wound bed by slough/eschar; MDS version 3; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.MDS; Time stamp; Timestamp	4180186
40758080	Centers for Medicare and Medicaid Assessment; Cnt; Count; No; Num; Number; Point in time; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey; Ulcer	4180186
40758081	Centers for Medicare and Medicaid Assessment; Cnt; Count; No; Num; Number; Point in time; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey; Ulcer	4180186
40758082	Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Past; Pnl; Point in time; pressure injury; Pressure ulcer; Pressure Ulcers; Random; Survey; Ulcer	4180186
40758083	Centers for Medicare and Medicaid Assessment; Cnt; Count; II; No; Num; Number; Point in time; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40758084	Centers for Medicare and Medicaid Assessment; Cnt; Count; III; No; Num; Number; Point in time; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40758085	Centers for Medicare and Medicaid Assessment; Cnt; Count; No; Num; Number; Point in time; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40758086	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Pressure ulcer; Pressure Ulcers; Random; Survey	4180186
40758087	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; Pressure ulcer; Pressure Ulcers; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40758089	Centers for Medicare and Medicaid Assessment; Cnt; Count; III; No; Num; Number; Point in time; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40758091	Integument; Othr; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40758092	Finding; Findings; MDS version 3; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40758093	Diabetic foot ulcer(s) in last 7D; Finding; Findings; Lower extremity; MDS version 3; Ordinal; Past; pressure injury; Pressure ulcer; Pressure Ulcers; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS; Ulcer	4180186
40758095	Finding; Findings; Low; Lower extremity; MDS version 3; Ordinal; Othr; Past; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40758096	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; Surg; Survey; SURVEY.MDS	4180186
40758098	2nd; 2nd or third degree burns; 3rd; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758106	Finding; Findings; MDS version 3; Ordinal; Past; pressure injury; Pressure ulcer; Pressure Ulcers; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS; Ulcer; Ulcer care provided in last 7D	4180186
40758114	Antipsychotic received in last 7D or since admission/reentry if less than 7D; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758115	Antianxiety received in last 7D or since admission/reentry if less than 7D; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758117	Finding; Findings; Hypnotic received in last 7D or since admission/reentry if less than 7D; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758119	Finding; Findings; MDS version 3; Medications received - none of the above were received in last 7D or since admission/reentry if less than 7D; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758121	Pan; Panel; Panl; Past; Pnl; Point in time; Random; Special Txs and programs in last 14D; Survey; SURVEY.MDS; Tx; Txs	4180186
40758122	Chemo; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758127	Finding; Findings; MDS version 3; O2; O2 therapy; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS; tO2	4180186
40758129	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758130	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758135	BIPAP/CPAP machine in last 14D - while a resident; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758137	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758139	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758141	Dialy; Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758142	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758143	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758145	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758146	Dis; Diseases; Dz; Finding; Findings; Isol; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758147	Dis; Diseases; Dz; Finding; Findings; Isol; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40758151	Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
40758152	Centers for Medicare and Medicaid Assessment; Finding; Findings; Immunizations; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Vaccine	4180186
40758153	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40758158	Centers for Medicare and Medicaid Assessment; OT; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40758159	Centers for Medicare and Medicaid Assessment; Point in time; PT; QNT; Quan; Quant; Quantitative; Random; Started; Survey	4180186
40758162	MDS version 3; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.MDS	4180186
40758166	# days with at least 15M of recreational and music therapy in last 7D; Centers for Medicare and Medicaid Assessment; Count/time; Dextro; No; nRate; Num; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
40758167	Date and time; MDS version 3; Point in time; QNT; Quan; Quant; Quantitative; Random; Started; Survey; SURVEY.MDS; Time stamp; Timestamp	4180186
40758169	Nursing rehabilitation/restorative care in last 7D; Pan; Panel; Panl; Past; Pnl; Survey; SURVEY.MDS	4180186
40758174	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40758175	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40758177	Finding; Findings; MDS version 3; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40758178	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40758179	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40758180	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40758181	Finding; Findings; MDS version 3; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40758182	Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40758184	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40758187	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
40758189	Point in time; Random; Survey; SURVEY.MDS	4180186
40758191	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40758195	Nominal; Point in time; Random; Survey; Typ	4180186
40758196	Nominal; Point in time; Random; Resource Utilization Groups; Survey; Typ	4180186
40758197	Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
40758199	Nominal; Point in time; Random; Resource Utilization Groups; Survey; Typ	4180186
40758200	Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
40758204	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40758207	Admin; Ident; Identifier; Intradermal; Nominal; Point in time; Random; Survey; SURVEY.MDS	4180186
40758209	Ident; Identifier; Nominal; Point in time; Random; Survey; SURVEY.MDS	4180186
40758211	Ident; Identifier; Nominal; Point in time; Random; Survey; SURVEY.MDS	4180186
40758219	Pan; Panel; Panl; Pnl; Point in time; Pressure ulcer; Pressure Ulcers; Random; Survey; SURVEY.MDS	4180186
40758221	ANTIBIOTIC SUSCEPTIBILITIES; AST; DRV; Genotype; Genotypic; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Ordinal; Point in time; Prezista; QL; Qual; Qualitative; Random; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TMC114	4180186
40758221	Darunavir Islt Genotyp	4180186
40758221	地瑞那韦:抗生素敏感性:时间点:分离株:序数型:基因分型	4182948
40758222	Arbitrary; Blood; CD140A; FIP1L1-PDGFRA; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; Ordinal; PCR; PDGFR2; PDGFR-2; platelet-derived growth factor receptor, alpha polypeptide; Point in time; QL; Qual; Qualitative; Random; Rearr; Rearrangement; RHEPDGFRA; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40758222	PDGFRA gene Rear Bld/T Ql	4180186
40758222	PDGFRA 基因重排:任意型:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40758223	Nominal; Point in time; Random; Survey; SURVEY.MDS	4180186
40758225	Adeno virus; C&S; Cult; Cultures; HAdV; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
40758225	HAdV Spec Ql Cult	4180186
40758225	腺病毒:存在情况或阈值:时间点:XXX:序数型:微生物特异性培养	4182948
40758226	ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Isolated; Microbiology; Nominal; Point in time; Random; species; spp	4180186
40758226	Nocardia Islt	4180186
40758226	奴卡菌属单个未知种 已鉴定的:存在与否或特征标识:时间点:分离株:名义型	4182948
40758228	C&S; Cult; Cultures; HPIV; HPIV2; Human rubulavirus 2; ID; II; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Para; Parainflu; Parainfluenza type 2; Parainfluenza type II; PI2; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
40758228	HPIV2 Spec Ql Cult	4180186
40758228	副流感病毒 2 型:存在情况或阈值:时间点:XXX:序数型:微生物特异性培养	4182948
40758232	Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H+P; H+P.SURGICAL PROCEDURES; Narrative; notes; Operative note; Operative note disposition; P prime; Point in time; Random; Report; Surg; Visit note	4180186
40758232	Operative note disposition	4180186
40758232	外科手术记录 处置:发现:时间点:^患者:叙述型	4182948
40758233	Bld loss; Blood output; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H+P; H+P.SURGICAL PROCEDURES; Narrative; notes; Operative note; Operative note estimated blood loss; P prime; Point in time; Random; Report; Surg; Visit note	4180186
40758233	Operative note estimated blood loss	4180186
40758233	外科手术记录 预计失血量:发现:时间点:^患者:叙述型	4182948
40758235	FDA label OTC - Purpose	4180186
40758235	DOCUMENT.REGULATORY; FDA label; Narrative; Over-the-counter; Report	4180186
40758235	OTC - 用途小节:-:-:^FDA 产品标签:叙述型	4182948
40758236	DOCUMENT.REGULATORY; FDA label; Narrative; Over-the-counter; Report	4180186
40758236	FDA label OTC - Active ingredient	4180186
40758236	OTC - 有效成份小节:-:-:^FDA 产品标签:叙述型	4182948
40758237	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
40758237	Addendum Doc	4180186
40758237	补遗:发现:时间点:^患者:文档型	4182948
40758238	Clinical presentation Doc	4180186
40758238	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
40758238	临床表现:发现:时间点:^患者:文档型	4182948
40758242	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
40758242	文档摘要:发现:时间点:^患者:文档型	4182948
40758243	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Rad; Radiology; Random	4180186
40758243	Key images Doc Radiology	4180186
40758243	关键图像:发现:时间点:^患者:文档型:放射医学	4182948
40758244	Prior imaging procedure descriptions Doc	4180186
40758244	Description; DOC.MISC; Document; MISC; Point in time; Random	4180186
40758244	既往成像操作描述:描述:时间点:^患者:文档型	4182948
40758246	CEH volatile organic cmpd Pnl; Centers for Environmental Health; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Volatiles	4180186
40758246	CEH volatile organic cmpd Pnl SerPl-mCnc	4180186
40758246	CEH 挥发性有机化合物组套:质量浓度:时间点:血清/血浆:-	4182948
40758247	CEH trace metals scn Pnl Ur-mCnc	4180186
40758247	CEH trace metals scn Pnl; Centers for Environmental Health; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Metal; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; Scn; Scr; Scrn; UA; UR; Urn	4180186
40758247	CEH 痕量金属元素筛查组套:质量浓度:时间点:尿液:-	4182948
40758250	CEH met toxin Pnl Ur-mCnc	4180186
40758250	CEH met toxin Pnl; Centers for Environmental Health; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; UA; UR; Urn	4180186
40758250	CEH 代谢毒素组套:质量浓度:时间点:尿液:-	4182948
40758251	Both serum and cerebrospinal fluid; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; MS; MS Pnl; Mult; Multi; Neuro; Neurology; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Serum; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SR	4180186
40758251	MS Pnl Ser+CSF	4180186
40758251	多发性硬化组套:-:时间点:血清+脑脊液:-	4182948
40758253	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40758255	Centers for Medicare and Medicaid Assessment; Cnt; Count; III; No; Num; Number; Point in time; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40758258	Disch; Discharge location; Discharge status; Nominal; Point in time; Random; Survey; Typ	4180186
40758261	# days of rehabilitative or restorative techniques; Dextro; No; Num; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40758263	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; complementary DNA; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV HA; FLUV; Fowl plague; HA; ID; Identity or presence; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40758263	FLUAV HA cDNA Islt NAA+probe	4180186
40758263	流感病毒 A 型血凝素 cDNA:存在与否或特征标识:时间点:分离株:名义型:探针法.基因扩增.靶向	4182948
40758267	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Islt.mening; Isol; Mening; Minimum inhibitory concentration; PCN; Pen; Penicillin Parenteral; Penicilloyl; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Wycillin	4180186
40758267	Penicillin Parenteral Islt.mening MIC	4180186
40758267	青霉素.胃肠外:抗生素敏感性:时间点:分离株.脑膜炎:定量型或序数型:最小抑菌浓度法	4182948
40758269	Blood; cardiac sodium channel alpha subunit; CDCD2; CMD1E; CMPD2; Document; Finding; Findings; Genetics; HB1; HB2; HBB; HBBD; Heredity; Heritable; HH1; ICCD; Inherited; IVF; LQT3; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; NAV1.5; PCR; PFHB1; Point in time; Random; Sodium channel protein cardiac muscle subunit alpha; Sodium channel protein type V subunit alpha; sodium channel, voltage gated, type V alpha subunit; SSS1; Tissue; Tissue, unspecified; VF1; Voltage-gated sodium channel subunit alpha Nav1.5; WB; Whole blood; Whole blood or Tissue	4180186
40758269	SCN5A gene Mut Anl Bld/T	4180186
40758269	SCN5A 基因 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
40758272	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; CVV; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Orthobunyaviruses; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40758272	CVV RNA Spec Ql NAA+probe	4180186
40758272	卡赤谷病病毒 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40758275	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Enc; Enceph; Encephalomyelitis; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; SLE virus; SLEV; Spec; St Louis; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40758275	SLEV RNA Spec Ql NAA+probe	4180186
40758275	圣路易型脑炎病毒 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40758277	ABL; ABL1; ABL1 transcript; ALL; bcr/abl; BCR1; bcr-abl1; Blood; Breakpoint cluster region; Chronic myeloid leukemia; CML; control gene; D22S11; D22S662; DNA; e13a2; e14a2; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; JTK7; major breakpoints; Mbr; Mcr; minor breakpoints; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; Number ratio; p150; p210; PCR; Ph chromosome; Philadelphia chromosome; PHL; Point in time; QNT; Quan; Quant; Quantitative; Random; RNA; T prime; t(9,22)(ABL1,BCR) gene translocation; t(9,22)(ABL1,BCR) p210 gene translocation; t(9,22)(ABL1,BCR) Translocation; t(9,22)(q34,q11); t(9,22)(q34.1,q11); t(9;22)(ABL1,BCR); t(ABL1,BCR)b2a2; t(ABL1,BCR)p210; Tissue; Tissue, unspecified; translocation; v-abl Abelson murine leukemia viral oncogene homolog 1; WB; Whole blood; Whole blood or Tissue	4180186
40758277	t(ABL1,BCR)p210/control Bld/T	4180186
40758277	t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 融合转录物/对照转录物:计数型比率:时间点:全血/组织:定量型:分子遗传学类实验室方法	4182948
40758279	ABL; ALL; BCR1; Blood; Breakpoint cluster region; Chronic myeloid leukemia; CML; D22S11; D22S662; Genetics; Hematology; Heme; Heredity; Heritable; Inherited; JTK7; Molecular genetics; Molecular pathology; MOLPATH; Ordinal; p150; PCR; PHL; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; v-abl Abelson murine leukemia viral oncogene homolog 1; WB; Whole blood; Whole blood or Tissue	4180186
40758279	e1a2 Bld/T Ql	4180186
40758279	BCR-ABL e1a2 融合蛋白:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40758282	Amiodarone + Deseth Pnl; Amiodarone metabolite; Amiodarone+Deseth; Cordarone; DEA; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Noramiodarone; Pacerone; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders	4180186
40758282	Amiodarone + Deseth Pnl SerPl-mCnc	4180186
40758282	胺碘酮与去乙基胺碘酮组套:质量浓度:时间点:血清/血浆:定量型	4182948
40758283	Biotinidase Pnl; Chemistry; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40758283	Biotinidase Pnl SerPl	4180186
40758283	生物素酶组套:-:时间点:血清/血浆:定量型	4182948
40758285	Flunitrazepam+7Amino Pnl Ur-mCnc	4180186
40758285	7-amino flunitrazepam; 7Aminoflunitrazepam; Darkene; DRUG/TOXICOLOGY; Drugs; Flunitrazepam metabolite; Flunitrazepam+7Amino Pnl; Hypnodorm; Hypnor; Level; Mass concentration; Narcozep; Noriel; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Rohipnol; Rohypnol; Roipnol; UA; UR; Urn; Valsera	4180186
40758285	氟硝安定与 7-氨基氟硝安定组套:质量浓度:时间点:尿液:定量型	4182948
40758286	AFB; Aknemin; ANTIBIOTIC SUSCEPTIBILITIES; AST; c128; Dentomycin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Klinomysin; Lederderm; Mestacine; Mino-50; Minocin; Minomycin; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Mynocine; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis	4180186
40758286	Minocycline Islt SlowMyco	4180186
40758286	二甲胺四环素:抗生素敏感性:时间点:分离株:定量型或序数型:针对慢长型分枝杆菌的方法	4182948
40758290	HAdV IgG+IgM Pnl Ser	4180186
40758290	Adeno virus; HAdV; HAdV IgG+IgM Pnl; ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders	4180186
40758290	腺病毒抗体.IgG 与 IgM 组套:-:时间点:血清:定量型	4182948
40758293	Enz; Enzymes; GAS; Group A Strep; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; QL; Qual; Qualitative; Random; S pyog enzyme Ab Pnl; S pyog.enz; S pyogenes; Screen; Serum; SR; Steptococcus Group A; Strep; Strept; Streptococci group A; Streptococcus group A; Streptozyme	4180186
40758293	S pyog enzyme Ab Pnl Ser	4180186
40758293	化脓性链球菌酶抗体组套:-:时间点:血清:序数型	4182948
40758294	Blood; CELL MARKERS; Pan; PANEL.CELLMARK; Panl; Paroxysmal nocturnal Pnl; PNH; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders; WB; Whole blood	4180186
40758294	Paroxysmal nocturnal Pnl Bld	4180186
40758294	阵发性睡眠性组套:-:时间点:全血:定量型	4182948
40758297	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; ID; Infectious Disease; InfectiousDisease; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; species; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; spp	4180186
40758297	Mycoplasma Ab CSF Ql	4180186
40758297	支原体属单个未知种 抗体:存在情况或阈值:时间点:脑脊液:序数型	4182948
40758298	DEEDS; DEEDS 1.1; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); EMERGENCY DEPARTMENT (DEEDS) PANEL; Pan; Panel; Panl; Pnl; Point in time; Random	4180186
40758298	DEEDS 1.1	4180186
40758298	急诊科系统数据元 发布版本 1.1:-:时间点:^患者:-	4182948
40758300	Cytoplasmic Ab Titr Ser IF	4180186
40758300	细胞浆 抗体:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40758300	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cytopl; Cytoplas; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40758301	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CA Pat; Cytopl; Cytoplas; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random; Serology; Serum; SR; Time Resolved Fluorescence; TRF	4180186
40758301	Cytoplasmic Ab pattern Ser IF-Imp	4180186
40758301	细胞浆 抗体模式:印象:时间点:血清:名义型:免疫荧光法	4182948
40758302	Data Elements for Emergency Department Systems; DEEDS; ED procedures & results; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); EMERGENCY DEPARTMENT (DEEDS) PANEL; Pan; Panel; Panl; Pnl; Point in time; Random	4180186
40758302	ED procedures & results DEEDS	4180186
40758302	急诊科操作与结果:-:时间点:^患者:集合型:DEEDS	4182948
40758304	Patient ID data DEEDS	4180186
40758304	Data Elements for Emergency Department Systems; DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); EMERGENCY DEPARTMENT (DEEDS) PANEL; Pan; Panel; Panl; Patient ID data; Pnl; Point in time; Random	4180186
40758304	患者身份标识数据:-:时间点:^患者:集合型:DEEDS	4182948
40758306	ED arrival and 1st assessment data DEEDS	4180186
40758306	1st; Data Elements for Emergency Department Systems; DEEDS; ED arrival & 1st assessment data; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); EMERGENCY DEPARTMENT (DEEDS) PANEL; Encounter; Pan; Panel; Panl; Pnl	4180186
40758306	急诊科到达与首次评估数据:-:就医过程持续时间^第一:^患者:集合型:DEEDS	4182948
40758307	ED H&P Exam Data DEEDS	4180186
40758307	Data Elements for Emergency Department Systems; DEEDS; ED H&P Exam Data; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); EMERGENCY DEPARTMENT (DEEDS) PANEL; Hx; Pan; Panel; Panl; PEA; Pnl; Point in time; Random	4180186
40758307	急诊科病史与体格检查数据:-:时间点:^患者:集合型:DEEDS	4182948
40758312	Document; Finding; Findings; Point in time; QRDA; QRDA incidence report; Random; Survey; SURVEY.QRDA	4180186
40758313	Document; Finding; Findings; Point in time; QRDA; QRDApatient list report; Random; Survey; SURVEY.QRDA	4180186
40758317	Document; Finding; Findings; Misc; Miscellaneous; Other; Point in time; Random; Spec; Survey; SURVEY.QRDA; To be specified in another part of the message; Unspecified	4180186
40758321	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chrom analy; Chrom analy interphase; Chromosom; Chromosomes; Cytogenetics; Fluorescent in situ hybridization; Genetics; Gyn; Gynecology; Heredity; Heritable; Impression; Impression/interpretation of study; Impressions; Inherited; Interp; Interpretation; Karyotype; Molecular pathology; MOLPATH; Narrative; OB; ObGyn; Obstetrics; Point in time; Random; Report	4180186
40758321	Chrom analy interphase Amn FISH-Imp	4180186
40758321	染色体分析.分裂间期:印象:时间点:羊水:叙述型:FISH	4182948
40758322	Chorionic villi; Chorionic villus sample; Chrom analy; Chrom analy interphase; Chromosom; Chromosomes; Cytogenetics; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Impression; Impression/interpretation of study; Impressions; Inherited; Interp; Interpretation; Karyotype; Molecular pathology; MOLPATH; Narrative; Point in time; Random; Report	4180186
40758322	Chrom analy interphase CVS FISH-Imp	4180186
40758322	染色体分析.分裂间期:印象:时间点:绒毛膜绒毛样本:叙述型:FISH	4182948
40758323	1 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; c250; c307; C81; Ciloxan; Cipro; Ciprofloxacn; Ciprofloxin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis	4180186
40758323	Ciprofloxacin 1 ug/mL Islt SlowMyco	4180186
40758323	环丙沙星 1.0 微克/毫升:抗生素敏感性:时间点:分离株:定量型或序数型:针对慢长型分枝杆菌的方法	4182948
40758324	7-dehydrocholesterol reductase; 7-DHC reductase; Blood; D7SR; delta-7-dehydrocholesterol reductase; Document; Finding; Findings; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; PCR; Point in time; Putative sterol reductase SR-2; Random; SLOS; Smith-Lemli-Opitz syndrome; Sterol Delta(7)-reductase; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40758324	DHCR7 gene Mut Anl Bld/T	4180186
40758324	DHCR7 基因 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
40758325	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758325	Terconazole Susc Islt	4180186
40758325	特康唑:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
40758330	Blood; CD117; c-KIT; Document; Finding; Findings; Genetics; Heredity; Heritable; Inherited; mast/stem cell growth factor receptor; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; PBT; PCR; piebald trait; Point in time; Proto-oncogene tyrosine-protein kinase Kit; Random; SCFR; soluble KIT variant; Tissue; Tissue, unspecified; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; WB; Whole blood; Whole blood or Tissue	4180186
40758330	KIT gene Mut Anl Bld/T	4180186
40758330	KIT 基因 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
40758331	5M p NP; Activated partial thromboplastin time; After; aPTT; aPTT correction study; Clot; Clottable; Coag; Coagulation assay; Control; Fac; Fact; Hematology; Heme; Little(A)PTT; Mixing studies; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; PST; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube	4180186
40758331	aPTT 5M p NP PPP	4180186
40758331	表面诱导型凝血过程.因子替换^在添加正常血浆后孵育之后5分钟:时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
40758333	Macroamylase Plr Ql	4180186
40758333	Chemistry; Macro amylase; Ordinal; Pleural; Pleural fluid; Point in time; PR; QL; Qual; Qualitative; Random; Screen; thoracentesis fluid	4180186
40758333	大分子淀粉酶:存在情况或阈值:时间点:胸膜液:序数型	4182948
40758334	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Intest; Intestine; Level; Mass concentration; Pept; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Vaso; Vasoactive intestinal polypeptide; VIP	4180186
40758334	VIP CSF-mCnc	4180186
40758334	血管活性肠肽:质量浓度:时间点:脑脊液:定量型	4182948
40758337	Blood; Deoxyribonucleic acid; DNA analysis discrete seq var Pnl; Genetic; Genetics; Genomic; Heredity; Heritable; HL7.GENETICS; Inherited; Molecular genetics; MOLPATH.GENERAL; Pan; PANEL.HL7.GENETICS; Panl; PCR; Pnl; Point in time; Positional Variant Panel; Random; Sequence Variant Panel; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40758337	DNA analysis discrete seq var Pnl	4180186
40758337	DNA 分析 离散序列变异组套:-:时间点:全血/组织:-:分子遗传学类实验室方法	4182948
40758339	Finding; Findings; Geotemporal hx; Hx; Nominal; Point in time; Public Health; PUBLICHEALTH; Random	4180186
40758339	Geotemporal hx	4180186
40758339	地理时间历史:发现:时间点:^患者:名义型	4182948
40758340	Finding; Findings; Nominal; Point in time; Public Health; PUBLICHEALTH; Random; Shared razor, toothbrushes or nail items	4180186
40758340	Shared razor, toothbrushes or nail items	4180186
40758340	共用剃须刀、牙刷或指甲保养工具:发现:时间点:^患者:名义型	4182948
40758341	bod; Bodies; Dir; Exp; Finding; Findings; Fld; Job; Nominal; Occ related direct Bdy fl expos freq; Point in time; Public Health; PUBLICHEALTH; Random; Work	4180186
40758341	Occ related direct Bdy fl expos freq	4180186
40758341	与职业相关的直接血液或体液暴露频率:发现:时间点:^患者:名义型	4182948
40758342	# M Sex Prtnrs 6M Bfr Symp nRate	4180186
40758342	# M Sex Prtnrs 6M Bfr Symp; Count/time; No; nRate; Num; Number rate; Number Rate = Count/Time; Point in time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random; Sx	4180186
40758342	症状发作之前6个月当中男性性伴侣的人数:计数型速率:时间点:^患者:定量型	4182948
40758343	# F Sex Prtnrs 6M Bfr Symp nRate	4180186
40758343	# F Sex Prtnrs 6M Bfr Symp; Count/time; No; nRate; Num; Number rate; Number Rate = Count/Time; Point in time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random; Sx	4180186
40758343	症状发作之前6个月当中女性性伴侣的人数:计数型速率:时间点:^患者:定量型	4182948
40758347	bod; Bodies; Date exposure to Bdy fl; Exp; Fld; Point in time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random	4180186
40758347	Date exposure to Bdy fl	4180186
40758347	血液和或体液实际暴露日期:日期:时间点:^患者:定量型	4182948
40758349	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; ASGPR; Autoantibodies; Autoantibody; Hepatology; Liver; Point in time; QNT; Quan; Quant; Quantitative; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; Serum; SR	4180186
40758349	ASGPR Ab Ser-aCnc	4180186
40758349	无唾液酸糖蛋白受体 抗体:任意型浓度:时间点:血清:定量型	4182948
40758354	Okoume IgE Qn	4180186
40758354	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Angouma; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Aucomumea klaineana; Autoantibodies; Autoantibody; Gaboon; Immune globulin E; Immunoglobulin E; Okoume; Okumen; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40758354	奥克榄 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40758355	Panc Polypept SerPl-sCnc	4180186
40758355	Chemistry; Level; Panc Polypept; Pancr; Pancreatc; Pl; Plasma; Plsm; Point in time; Polypeptides; PP; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758355	胰多肽:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758357	细胞遗传学检查:发现:时间点:^患者:文档型:细胞遗传学方法	4182948
40758357	Cytog; DOC.MISC; Document; Finding; Findings; Karyotype; MISC; Point in time; Random; Study report	4180186
40758358	免疫染色检查:发现:时间点:组织与涂片:文档型:免疫染色法	4182948
40758358	DOC.MISC; Document; Finding; Findings; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; MISC; Point in time; Random; St; Stains; Stn; Study report; Tissue; Tissue, unspecified	4180186
40758361	Blood; Genetic; Genetic analysis summary Pnl; Genetics; Genomic; Heredity; Heritable; HL7.GENETICS; Inherited; Molecular genetics; MOLPATH.GENERAL; Pan; PANEL.HL7.GENETICS; Panl; PCR; Pnl; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40758361	Genetic analysis summary Pnl	4180186
40758361	遗传分析摘要组套:-:时间点:全血/组织:-:分子遗传学类实验室方法	4182948
40758364	abn; abnorm; Abnormal hemoglobin Pnl; Blood; Haemoglobin; Hb; Hgb; Molecular genetics; Molecular pathology; MOLPATH; Pan; Panel.molpath; Panl; PCR; Pnl; Point in time; Random; WB; Whole blood	4180186
40758364	Abnormal hemoglobin Pnl Bld	4180186
40758364	异常血红蛋白基因组套:-:时间点:全血:-:分子遗传学类实验室方法	4182948
40758365	HBA2 alpha 4.2kb Del Bld Ql	4180186
40758365	Alfa; Alpha thal; Alpha thal 2; Alpha thal 2 (- alpha^4.2 deletion); Alpha thalassemia; alpha-2 globin; Arbitrary; Blood; Del; Deletions; HBA2 alpha 4.2kb; HBA2 gene alpha 4.2 deletion; HBA-T2; HBH; Hemoglobin, alpha 2; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.DELETIONS; Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
40758365	HBA2 基因 alpha 4.2kb 缺失:任意型:时间点:全血:序数型:分子遗传学类实验室方法	4182948
40758366	alpha-2 globin; Blood; Genetics; HB Constant Spring; HBA2 c.427T&gt;C; HBA-T2; HBH; Hemoglobin, alpha 2; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
40758366	HBA2 c.427T>C Bld Ql	4180186
40758366	HBA2 基因.c.427T>C:存在情况或阈值:时间点:全血:序数型:分子遗传学类实验室方法	4182948
40758367	A429T; alpha-2 globin; Blood; Genetics; HB Pakse; HB Paske; HBA2 c.429A&gt;T; HBA-T2; HBH; Hemoglobin, alpha 2; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; rs41412046; Screen; T prime; Ter143Tyr; WB; Whole blood	4180186
40758367	HBA2 c.429A>T Bld Ql	4180186
40758367	HBA2 基因.c.429A>T:存在情况或阈值:时间点:全血:序数型:分子遗传学类实验室方法	4182948
40758369	Beta globulin gene; Beta thalessemia; beta-globin; Blood; c.G251A; CD113t-C; Genetics; Gly84Val; HB Mizumani; HB Pyrgos; HBB c.251G&gt;A; Hemoglobin beta chain; Hemoglobin S gene; hemoglobin, beta; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; rs1803195; Screen; Sickle cell anemia; WB; Whole blood	4180186
40758369	HBB c.251G>A Bld Ql	4180186
40758369	HBB 基因.c.251G>A:存在情况或阈值:时间点:全血:序数型:分子遗传学类实验室方法	4182948
40758373	Arbitrary; Blood; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; Screen; ThaiGgama(Agammadeltabeta)0-Thal; WB; Whole blood	4180186
40758373	HPFH-6 gene Bld Ql	4180186
40758373	HPFH-6 基因:任意型:时间点:全血:序数型:分子遗传学类实验室方法	4182948
40758375	alpha-2 globin; Blood; G84C; Genetics; HB Hekinan; HBA2 c.84G&gt;C; HBA-T2; HBH; Hemoglobin, alpha 2; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
40758375	HBA2 c.84G>C Bld Ql	4180186
40758375	HBA2 基因.c.84G>C:存在情况或阈值:时间点:全血:序数型:分子遗传学类实验室方法	4182948
40758376	Alpha globulin of hemoglobin; Blood; G223C; Genetics; Hb Asabara; HB G-Taichung; HB Kurashiki-I; HB Mahidol; Hb Q-Thailand; HBA1 c.223G&gt;C; HBA-T3; HBH; Hemoglobin, alpha 1; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Thalassemia alpha; WB; Whole blood	4180186
40758376	HBA1 c.223G>C Bld Ql	4180186
40758376	HBA1 基因.c.223G>C:存在情况或阈值:时间点:全血:序数型:分子遗传学类实验室方法	4182948
40758380	HBA2 alpha 3.7kb Del Bld Ql	4180186
40758380	Alfa; Alpha thal; Alpha thal 2; Alpha thal 2 (-alpha^3.7 deletion type); Alpha thalassemia; alpha-2 globin; Arbitrary; Blood; Del; Deletions; HBA2 alpha 3.7kb; HBA-T2; HBH; Hemoglobin, alpha 2; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.DELETIONS; Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
40758380	HBA2 基因 alpha 3.7kb 缺失:任意型:时间点:全血:序数型:分子遗传学类实验室方法	4182948
40758382	DRUG DOSES; Gvn; Hep; Hepar; Heparin 10000 u/mL; Heparn; Point in time; QNT; Quan; Quant; Quantitative; Random; Volume	4180186
40758382	Heparin 10000 u/mL Gvn Vol	4180186
40758382	肝素 10000 单位/毫升 给予的:体积型属性:时间点:^患者:定量型	4182948
40758383	DRUG DOSES; Gvn; Hep; Hepar; Heparin 5000 U/mL; Heparn; Point in time; QNT; Quan; Quant; Quantitative; Random; Volume	4180186
40758383	Heparin 5000 U/mL Gvn Vol	4180186
40758383	肝素 5000 单位/毫升 给予的:体积型属性:时间点:^患者:定量型	4182948
40758384	PYD Pnl Ur	4180186
40758384	Chemistry; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; PYD; PYD Pnl; Pyr; Pyridinium collagen crosslinks; Random; UA; UR; Urn	4180186
40758384	吡啶啉组套:-:时间点:尿液:-	4182948
40758387	Finding; Findings; H+P; H+P.HX; Narrative; P prime; Point in time; Random; Report	4180186
40758387	Problem alleviating factors	4180186
40758387	问题缓解因素:发现:时间点:^患者:叙述型	4182948
40758390	H+P; H+P.HX; History; ID; Immunization status; Infectious Disease; InfectiousDisease; Lyssavirus; Nominal; P prime; Point in time; Rabies; RABV; RABV immunization status; Random; Vaccination; Vaccinations; Vaccine	4180186
40758390	RABV immunization status	4180186
40758390	狂犬病病毒疫苗接种状态:历史记录:时间点:^患者:名义型	4182948
40758392	B pert immunization status	4180186
40758392	B pert; B pert immunization status; B pertussis; H+P; H+P.HX; History; Immunization status; Nominal; P prime; Pertussis; Point in time; Random; Vaccination; Vaccinations; Vaccine; Whooping cough	4180186
40758392	百日咳博德特菌疫苗接种状态:历史记录:时间点:^患者:名义型	4182948
40758395	H flu; H influenza; H influenzae; H+P; H+P.HX; Haem influ; Haem influ B; Haemoph; HIB; HIB immunization status; History; Immunization status; Influ; Nominal; P prime; Point in time; Random; Vaccination; Vaccinations; Vaccine	4180186
40758395	HIB immunization status	4180186
40758395	流感嗜血杆菌 B 型疫苗接种状态:历史记录:时间点:^患者:名义型	4182948
40758396	HPV immunization status	4180186
40758396	Genital warts; H+P; H+P.HX; History; HPV; HPV immunization status; Human papillomavirus; Immunization status; Nominal; P prime; Point in time; Random; Vaccination; Vaccinations; Vaccine	4180186
40758396	人乳头瘤病毒疫苗接种状态:历史记录:时间点:^患者:名义型	4182948
40758397	H+P; H+P.HX; History; Immunization status; Nominal; P prime; Point in time; Random; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; RV immunization status; Vaccination; Vaccinations; Vaccine	4180186
40758397	RV immunization status	4180186
40758397	轮状病毒疫苗接种状态:历史记录:时间点:^患者:名义型	4182948
40758399	S pneum polyvalent immunization status	4180186
40758399	H+P; H+P.HX; History; Immunization status; Nominal; P prime; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Pneumovax; Pneuovax; Point in time; Random; S pneum polyvalent immunization status; S pneumo; S pneumoniae; Spn; Strep; Strept; Vaccination; Vaccinations; Vaccine	4180186
40758399	肺炎链球菌多价疫苗接种状态:历史记录:时间点:^患者:名义型	4182948
40758400	H+P; H+P.HX; History; Immunization status; Nominal; P prime; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Prevnar; Random; S pneum conjugated immunization status; S pneumo; S pneumoniae; Spn; Strep; Strept; Vaccination; Vaccinations; Vaccine	4180186
40758400	S pneum conjugated immunization status	4180186
40758400	肺炎链球菌结合疫苗接种状态:历史记录:时间点:^患者:名义型	4182948
40758401	C diphtheriae; C diphtheriae immunization status; Diphtheria; Diptheria; H+P; H+P.HX; History; Immunization status; Nominal; P prime; Point in time; Random; Vaccination; Vaccinations; Vaccine	4180186
40758401	C diphtheriae immunization status	4180186
40758401	白喉棒状杆菌疫苗接种状态:历史记录:时间点:^患者:名义型	4182948
40758405	H+P; H+P.HX; HCV; HCV status; Hep; Hep C; Hepatis; Hepatit; Hepatology; History; ID; Infectious Disease; InfectiousDisease; Liver; Nominal; P prime; Point in time; Random	4180186
40758405	HCV status	4180186
40758405	丙型肝炎病毒状态:历史记录:时间点:^患者:名义型	4182948
40758406	AIDS; H+P; H+P.HX; History; Human immunodeficiency virus; Nominal; P prime; Point in time; Random	4180186
40758406	HIV 状态:历史记录:时间点:^患者:名义型	4182948
40758407	Congenital rubella syndrome; German measles; H+P; H+P.HX; History; ID; Infectious Disease; InfectiousDisease; Nominal; P prime; Point in time; Random; RUBV; RUBV status	4180186
40758407	RUBV status	4180186
40758407	风疹病毒状态:历史记录:时间点:^患者:名义型	4182948
40758410	Cnt; Count; Fetal; Gyn; Gynecology; H+P; H+P.HX; Number; OB; ObGyn; Obstetrics; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40758410	# Fetuses	4180186
40758410	多个胎儿:数量(计数):时间点:^患者:定量型	4182948
40758412	Count/time; Fetal; Gyn; Gynecology; H+P; H+P.HX; Heart beat; nRate; Number rate; Number Rate = Count/Time; OB; ObGyn; Obstetrics; P prime; Point in time; Pulse; QNT; Quan; Quant; Quantitative; Random	4180186
40758412	Fet Heart rate	4180186
40758412	心率:计数型速率:时间点:^胎儿:定量型	4182948
40758413	BP sys/dias	4180186
40758413	Art sys; BLOOD PRESSURE MEASUREMENTS.ATOM; BP; BP sys/dias; Dias; Diast; Diastoli; Point in time; Random	4180186
40758413	收缩期与舒张期血压:-:时间点:动脉系统:-	4182948
40758417	ED medication data DEEDS	4180186
40758417	Data Elements for Emergency Department Systems; DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); EMERGENCY DEPARTMENT (DEEDS) PANEL; Pan; Panel; Panl; Pnl; Point in time; Random	4180186
40758417	急诊科药物治疗数据:-:时间点:^患者:集合型:DEEDS	4182948
40758418	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758418	Sulopenem Susc Islt	4180186
40758418	硫培南:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
40758419	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758419	Sulopenem Islt MIC	4180186
40758419	硫培南:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
40758420	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758420	Sulopenem Islt KB	4180186
40758420	硫培南:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40758421	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; NXL 103; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; XRP 2868	4180186
40758421	Linopristin+Flopristin Susc Islt	4180186
40758421	利诺普丁+氟洛普丁:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
40758424	Chemistry; Frac; Fract; Fraction; Fractionated; Fractionation; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; PR; Prot; Prot Elph + Immunoglobulins Pnl; Random; Serum; SR	4180186
40758424	Prot Elph + Immunoglobulins Pnl Ser	4180186
40758424	蛋白质类成分与免疫球蛋白组套:-:时间点:血清:-	4182948
40758425	Blood; CAV-3; Caveolin 3; Genetics; Heredity; Heritable; Inherited; LGMD1C; LQT9; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; VIP21; VIP-21; WB; Whole blood; Whole blood or Tissue	4180186
40758425	CAV3 gene Mut Anl Bld/T Ql	4180186
40758425	CAV3 基因 突变分析:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40758426	Arbitrary; Blood; CD140A; FIP1L1+PDGFRA rearrangements; FIP1L1-PDGFRA; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; Ordinal; PCR; PDGFR2; PDGFR-2; platelet-derived growth factor receptor, alpha polypeptide; Point in time; QL; Qual; Qualitative; Random; Rearr; Rearrangement; RHEPDGFRA; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40758426	Deprecated FIP1L1+PDGFRA gene Rear Bld/T	4180186
40758431	Deprecated Paraneoplastic pemphigus Ab Titr Ser	4180186
40758431	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; Titer; Titered; Titre; Ttr	4180186
40758432	Dermatologic; Epidermis; Fung; Fungal; Fungi; ID; Infectious Disease; InfectiousDisease; Integument; Microbiology; Ordinal; Point in time; Potassium hydroxide preparation; PR; Prep; QL; Qual; Qualitative; Random; Screen; Skn	4180186
40758432	Fungus Skin Ql KOH Prep	4180186
40758432	真菌:存在情况或阈值:时间点:皮肤:序数型:氢氧化钾制片法	4182948
40758434	Fung; Fungal; Fungi; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; Potassium hydroxide preparation; PR; Prep; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
40758434	Fungus Spec Ql KOH Prep	4180186
40758434	真菌:存在情况或阈值:时间点:XXX:序数型:氢氧化钾制片法	4182948
40758435	Fung; Fungal; Fungi; ID; Infectious Disease; InfectiousDisease; Microbiology; Nails; Ordinal; Point in time; Potassium hydroxide preparation; PR; Prep; QL; Qual; Qualitative; Random; Screen; Ungal nail	4180186
40758435	Fungus Nail Ql KOH Prep	4180186
40758435	真菌:存在情况或阈值:时间点:甲:序数型:氢氧化钾制片法	4182948
40758436	Fung; Fungal; Fungi; Genital vaginal; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Point in time; Potassium hydroxide preparation; PR; Prep; QL; Qual; Qualitative; Random; Screen; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
40758436	Fungus Vag Ql KOH Prep	4180186
40758436	真菌:存在情况或阈值:时间点:阴道:序数型:氢氧化钾制片法	4182948
40758439	ID; Infectious Disease; InfectiousDisease; Microbiology; Nails; Ordinal; Point in time; Potassium hydroxide preparation; PR; Prep; QL; Qual; Qualitative; Random; Screen; Ungal nail; Yeast pseudohyphae	4180186
40758439	Yeast pseudohyphae Nail Ql KOH Prep	4180186
40758439	酵母菌.假菌丝:存在情况或阈值:时间点:甲:序数型:氢氧化钾制片法	4182948
40758442	Genital vaginal; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Point in time; Potassium hydroxide preparation; PR; Prep; QL; Qual; Qualitative; Random; Screen; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
40758442	Yeast Vag Ql KOH Prep	4180186
40758442	酵母:存在情况或阈值:时间点:阴道:序数型:氢氧化钾制片法	4182948
40758443	ID; Infectious Disease; InfectiousDisease; Microbiology; Nails; Ordinal; Point in time; Potassium hydroxide preparation; PR; Prep; QL; Qual; Qualitative; Random; Screen; Ungal nail	4180186
40758443	Yeast Nail Ql KOH Prep	4180186
40758443	酵母:存在情况或阈值:时间点:甲:序数型:氢氧化钾制片法	4182948
40758450	C sup(w) Ab Titr SerPl	4180186
40758450	Cw 抗体:滴定度:时间点:血清/血浆:定量型	4182948
40758450	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; C sup(w); Cw; Dilution factor; Dilution Factor (Titer); Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40758451	Fy sup(b) Ab Titr SerPl	4180186
40758451	Fy^b 抗体:滴定度:时间点:血清/血浆:定量型	4182948
40758451	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Dilution factor; Dilution Factor (Titer); Duffy; Duffy Blood Group System; F (little y) (little b); Fy sup(b); Fy^b; Fyb; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40758452	Jk sup(a) Ab Titr SerPl	4180186
40758452	Jk^a 抗体:滴定度:时间点:血清/血浆:定量型	4182948
40758452	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Dilution factor; Dilution Factor (Titer); J (little k) (little a); Jk sup(a); Jk^a; k; Kell Blood Group System; Kidd Blood Group System; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40758454	Js sup(a) Ab Titr SerPl	4180186
40758454	Js^a 抗体:滴定度:时间点:血清/血浆:定量型	4182948
40758454	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Dilution factor; Dilution Factor (Titer); J (little s) (little a); Js sup(a); Js^a; Kell Blood Group System; Pl; Plasma; Plsm; Point in time; Random; s; S prime; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40758455	Kp sup(a) Ab Titr SerPl	4180186
40758455	Kp^a 抗体:滴定度:时间点:血清/血浆:定量型	4182948
40758455	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Dilution factor; Dilution Factor (Titer); K (little p) (little a); Kell Blood Group System; Kp sup(a); Kp^a; p; P prime; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40758456	Kp sup(b) Ab Titr SerPl	4180186
40758456	Kp^b 抗体:滴定度:时间点:血清/血浆:定量型	4182948
40758456	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Dilution factor; Dilution Factor (Titer); K (little p) (little b); Kell Blood Group System; Kp sup(b); Kp^b; p; P prime; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40758460	Lu sup(b) Ab Titr SerPl	4180186
40758460	Lu^b 抗体:滴定度:时间点:血清/血浆:定量型	4182948
40758460	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Dilution factor; Dilution Factor (Titer); L (little u) (little b); Left; Levo; Lu sup(b); Lu^b; Lutheran Blood Group System; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40758461	little c Ab Titr SerPl	4180186
40758461	c 抗体:滴定度:时间点:血清/血浆:定量型	4182948
40758461	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; c; Dilution factor; Dilution Factor (Titer); Pl; Plasma; Plsm; Point in time; Random; Rh Blood Group System; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40758462	little f Ab Titr SerPl	4180186
40758462	f 抗体:滴定度:时间点:血清/血浆:定量型	4182948
40758462	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Dilution factor; Dilution Factor (Titer); f; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40758466	P1 Ab Titr SerPl	4180186
40758466	P1 抗体:滴定度:时间点:血清/血浆:定量型	4182948
40758466	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Dilution factor; Dilution Factor (Titer); Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40758467	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Dextro; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; S prime; Screen; Sd sup(a); Sd^e; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40758467	Sd sup(a) Ab SerPl Ql	4180186
40758467	Sd^a 抗体:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40758469	V Ab Titr SerPl	4180186
40758469	V 抗体:滴定度:时间点:血清/血浆:定量型	4182948
40758469	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Dilution factor; Dilution Factor (Titer); Pl; Plasma; Plsm; Point in time; Random; Rh Blood Group System; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40758470	Xg sup(a) Ab Titr SerPl	4180186
40758470	Xg^a 抗体:滴定度:时间点:血清/血浆:定量型	4182948
40758470	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Dilution factor; Dilution Factor (Titer); Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr; X (little g) (little a); Xg sup(a); Xg^a	4180186
40758472	ANTIBIOTIC SUSCEPTIBILITIES; AST; Ecalta; Eraxis; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LY303366; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758472	Anidulafungin Islt MIC	4180186
40758472	阿尼芬净:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
40758476	Blood; Clot; Clottable; Coag; Coagulation assay; Ecarin clotting time; ECT; Hematology; Heme; Point in time; QNT; Quan; Quant; Quantitative; Random; Tilt tube; WB; Whole blood	4180186
40758476	ECT Bld	4180186
40758476	锯鳞蝰蛇毒诱导型凝血过程:时间:时间点:全血:定量型:凝血功能分析	4182948
40758477	Cortis 20M p chal SerPl-sCnc	4180186
40758477	17-Hydroxycorticosterone; 20M p chal; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758477	皮质醇^在XXX刺激之后20分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758483	After; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p 4h FFST; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40758483	Osmolality p 4h FFST Ur	4180186
40758483	渗透压^在液体型禁食之后4小时:渗透压:时间点:尿液:定量型	4182948
40758484	After; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p 7h FFST; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40758484	Osmolality p 7h FFST Ur	4180186
40758484	渗透压^在液体型禁食之后7小时:渗透压:时间点:尿液:定量型	4182948
40758487	Osmolality p 2h FFST Ur	4180186
40758487	120 min; 120 minutes; 120min; 2 hours; After; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p 2h FFST; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40758487	渗透压^在液体型禁食之后2小时:渗透压:时间点:尿液:定量型	4182948
40758488	Osmolality p 1h FFST Ur	4180186
40758488	1 hour; 1.0Hr; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p 1h FFST; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40758488	渗透压^在液体型禁食之后1小时:渗透压:时间点:尿液:定量型	4182948
40758489	Osmolality p 6h FFST Ur	4180186
40758489	After; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p 6h FFST; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40758489	渗透压^在液体型禁食之后6小时:渗透压:时间点:尿液:定量型	4182948
40758490	BS; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40758490	Osmolality BS Ur	4180186
40758490	渗透压^基线:渗透压:时间点:尿液:定量型	4182948
40758494	Blood; CD138 Cells; CD138+Kappa+ Cells; Cell; CELL MARKERS; Cellularity; Gated cells; Heparan sulfate proteoglycan; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Syndecan-1; WB; Whole blood	4180186
40758494	CD138+Kappa+ Cells NFr Bld	4180186
40758494	细胞.CD138+Kappa+/100 个细胞:计数型分数:时间点:全血:定量型	4182948
40758495	CD138+Lambda+ Cells NFr Bld	4180186
40758495	Blood; CD138 Cells; CD138+Lambda+ Cells; Cell; CELL MARKERS; Cellularity; Gated cells; Heparan sulfate proteoglycan; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Syndecan-1; WB; Whole blood	4180186
40758495	细胞.CD138+Lambda+/100 个细胞:计数型分数:时间点:全血:定量型	4182948
40758496	#/area; Artificial Intelligence; Automated detection; Chol; Choles; Cholest; Cholest Cry; Cholesterol total; Cholesterols; Comp Assist; Crys; Cryst; Crystal; Lipid; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urn	4180186
40758496	Cholest Cry #/area Ur Comp Assist	4180186
40758496	胆固醇结晶:单位面积数量或计数:时间点:尿液:定量型:计算机辅助法	4182948
40758497	#/area; AM; Amorph; Amorph Cry; Amorphic; Crys; Cryst; Crystal; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
40758497	Amorph Cry #/area UrnS HPF	4180186
40758497	结晶.无定形:单位面积数量或计数:时间点:尿沉渣:定量型:显微镜检查.光学.高倍视野	4182948
40758498	DENV Ab Titr Ser HAI	4180186
40758498	登革热病毒 抗体:滴定度:时间点:血清:定量型:红细胞凝集抑制试验法	4182948
40758498	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Breakbone fever; Denv; Dilution factor; Dilution Factor (Titer); Flavivirus; Hemagglutination inhibition; HI; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40758499	Hgb A2+C+E+O MFr Bld	4180186
40758499	Blood; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb A2; Hgb A2+C; Hgb A2+C+E+O; Mass Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
40758499	血红蛋白 A2+C+E+O/血红蛋白.总计:质量分数:时间点:全血:定量型	4182948
40758500	Blood; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb A2; Hgb A2+E; Hgb A2+E+O; Mass Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
40758500	Hgb A2+E+O MFr Bld	4180186
40758500	血红蛋白 A2+E+O/血红蛋白.总计:质量分数:时间点:全血:定量型	4182948
40758502	Blood; Dextro; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb D; Hgb D+G; Mass Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
40758502	Hgb D+G MFr Bld	4180186
40758502	血红蛋白 D+G/血红蛋白.总计:质量分数:时间点:全血:定量型	4182948
40758507	#/area; AM; Amorph; Amorph Cry; Amorph Phos Cry; Amorphic; Artificial Intelligence; Automated detection; Comp Assist; Crys; Cryst; Crystal; i Phos; Inorganic phosphate; Number areic; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urn	4180186
40758507	Amorph Phos Cry #/area Ur Comp Assist	4180186
40758507	磷酸盐结晶.无定形:单位面积数量或计数:时间点:尿液:定量型:计算机辅助法	4182948
40758508	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SSHV; SUDS	4180186
40758508	SSHV IgM Ser Ql IA	4180186
40758508	雪鞋野兔病毒 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40758509	WNV Ab Titr Ser HAI	4180186
40758509	西尼罗河病毒 抗体:滴定度:时间点:血清:定量型:红细胞凝集抑制试验法	4182948
40758509	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); HEMAGGLUTINATION INHIBITION; HI; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr; WNV	4180186
40758510	2.5h p 75 g Glc PO; 75Gm; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p 75 g Glc PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758510	Glucose 2.5h p 75 g Glc PO SerPl-sCnc	4180186
40758510	葡萄糖^在口服75 g葡萄糖之后2.5小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758513	Insulin 3M p chal SerPl-sCnc	4180186
40758513	3M p chal; After; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758513	胰岛素^在XXX刺激之后3分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758514	15M p chal; After; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758514	Insulin 15M p chal SerPl-sCnc	4180186
40758514	胰岛素^在XXX刺激之后15分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758520	4M p chal; After; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758520	Insulin 4M p chal SerPl-sCnc	4180186
40758520	胰岛素^在XXX刺激之后4分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758521	1M p chal; After; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758521	Insulin 1M p chal SerPl-sCnc	4180186
40758521	胰岛素^在XXX刺激之后1分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758525	APOH; Apolipoprotein H; B; B2 Glycoprot1; B2 glycoprot1 IgA+IgG Pnl; B2 glycoprotein 1; B2GPI; B2-GPI; COAGULATION; gG; Glycoprot; Glycoproteins; GP; Hematology; Heme; i; II; Immune globulin A; Immune globulin G; Immunoglobulin A; Immunoglobulin G; Pan; PANEL.COAGULATION; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40758525	B2 glycoprot1 IgA+IgG Pnl Ser	4180186
40758525	Beta 2 糖蛋白 1 抗体.IgA 与 IgG 组套:-:时间点:血清:定量型	4182948
40758526	Pan; PANEL.SEROLOGY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; Short myasthenia gravis Pnl; SR	4180186
40758526	Short myasthenia gravis Pnl Ser	4180186
40758526	简版重症肌无力组套:-:时间点:血清:定量型	4182948
40758528	Diabetes tracking Pnl	4180186
40758528	Diabetes tracking Pnl; Pan; Panl; PHR panels; Pnl; Point in time; Random	4180186
40758528	糖尿病跟踪组套:-:时间点:^患者:-	4182948
40758529	Date of last eye exam	4180186
40758529	CLIN; Past; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40758529	末次眼科检查日期:日期:时间点:^患者:定量型	4182948
40758530	4-Hydroxycoumarin; COAGULATION; Coumadin; Coumarin; Coumarins; Pan; PANEL.COAGULATION; Panl; Panwarfin; Plas; Platelet poor plasma; Pnl; Point in time; Random; Sofarin; Warfarin tracking Pnl	4180186
40758530	Warfarin tracking Pnl PPP	4180186
40758530	丙酮苄羟香豆素跟踪组套:-:时间点:贫血小板血浆:-	4182948
40758531	ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; WNV; WNV IgG+IgM Pnl	4180186
40758531	WNV IgG+IgM Pnl Ser	4180186
40758531	西尼罗河病毒抗体.IgG 与 IgM 组套:-:时间点:血清:定量型	4182948
40758532	Asthma tracking Pnl	4180186
40758532	Asthma tracking Pnl; Pan; Panl; PHR panels; Pnl; Point in time; Random	4180186
40758532	哮喘跟踪组套:-:时间点:^患者:-	4182948
40758533	1 week; Count/time; Lung; nRate; Number rate; Number Rate = Count/Time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory	4180186
40758533	Asthma spells 1W nRate	4180186
40758533	哮喘发作:计数型速率:1星期:^患者:定量型	4182948
40758536	Finding; Findings; H+P; H+P.PX; Lower extremity joint; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40758536	Pitting edema severity Ankle	4180186
40758536	凹陷性水肿严重程度:发现:时间点:踝关节:序数型	4182948
40758537	CLIN; EXCZ; Finding; Findings; Nominal; Point in time; Random	4180186
40758537	运动耐力:发现:时间点:^患者:名义型	4182948
40758538	EXCZ; Exercise tracking Pnl; Pan; Panl; PHR panels; Pnl; Point in time; Random	4180186
40758538	Exercise tracking Pnl	4180186
40758538	运动跟踪组套:-:时间点:^患者:-	4182948
40758539	CLIN; EXCZ; Nominal; Point in time; Random; Typ	4180186
40758540	Activity; CLIN; Durat; EXCZ; Exercise; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40758540	运动持续时间:时间:时间点:^患者:定量型	4182948
40758541	?Tm; Activity; CLIN; EXCZ; Exercise; Length; QNT; Quan; Quant; Quantitative	4180186
40758541	Exercise distance ?Tm	4180186
40758541	运动距离:长度:XXX:^患者:定量型	4182948
40758543	CLIN; Count/time; nRate; Number rate; Number Rate = Count/Time; Point in time; QNT; Quan; Quant; Quantitative; Random; Seizures/month	4180186
40758543	Seizures/month nRate	4180186
40758543	每月发作次数:计数型速率:时间点:^患者:定量型	4182948
40758544	氧饱和度与治疗组套:-:时间点:^患者:-	4182948
40758544	O2; Pan; Panl; PHR panels; Pnl; Point in time; Random; SaO2; SaO2 & therapy Pnl; SAT; Satn; SO2; tO2	4180186
40758544	SaO2 & therapy Pnl	4180186
40758547	Weight & Height tracking Pnl	4180186
40758547	Pan; Panl; PHR panels; Pnl; Point in time; Random; Weight & Height tracking Pnl; Wt	4180186
40758547	体重与身高跟踪组套:-:时间点:^患者:-	4182948
40758548	Home drug screen Pnl Ur	4180186
40758548	Asympt; Asymptomatic; DRUG/TOXICOLOGY; Drugs; Home drug screen Pnl; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; Scn; UA; UR; Urn	4180186
40758548	家庭毒品筛查组套:-:时间点:尿液:-	4182948
40758549	Hours p meal Time Patient	4180186
40758549	CHEMISTRY.CHALLENGE TESTING; Hours p meal; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40758549	餐后小时数:时间:时间点:^患者:定量型	4182948
40758550	CLIN; Energy/time; estimation; Point in time; Power; QNT; Quan; Quant; Quantitative; Random	4180186
40758550	Calories burned Machine est	4180186
40758550	已消耗的热量:功率:时间点:^患者:定量型:机器估计法	4182948
40758552	# steps ?Tm nRate Pedometer	4180186
40758552	# steps; ?Tm; CLIN; Count/time; No; nRate; Num; Number rate; Number Rate = Count/Time; QNT; Quan; Quant; Quantitative	4180186
40758552	步数:计数型速率:XXX:^患者:定量型:计步器	4182948
40758554	Heart rate ?Tm Mean Pedometer	4180186
40758554	?Tm; Art sys; Average; Avg; Count/time; Heart beat; HEART RATE.MOLEC; nRate; Number rate; Number Rate = Count/Time; Pulse; QNT; Quan; Quant; Quantitative	4180186
40758554	心率:计数型速率:XXX^平均值:动脉系统:定量型:计步器	4182948
40758556	Neuro; Neurology; Pan; Panl; PHR panels; Pnl; Point in time; Random; Seizure disorder tracking Pnl	4180186
40758556	Seizure disorder tracking Pnl	4180186
40758556	癫痫症跟踪组套:-:时间点:^患者:-	4182948
40758558	Blood; CBC; HEMATOLOGY/CELL COUNTS; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Short blood count Pnl; WB; Whole blood	4180186
40758558	Short blood count Pnl Bld	4180186
40758558	简版血细胞计数组套:-:时间点:全血:定量型	4182948
40758560	#; ABS; absolute; absolutes; Blood; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; HLA-B27 Cells; Human Leukocyte Antigen; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40758560	HLA-B27 Cells # Bld	4180186
40758560	细胞.HLA-B27:计数型浓度:时间点:全血:定量型	4182948
40758564	Immature mononuc # Bld Manual	4180186
40758564	#; ABS; absolute; absolutes; Blood; Cell; Cellularity; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Imm; Immat; Immature mononuc; Manl; Mononuc; Mononuc Cells; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40758564	单个核细胞.不成熟:计数型浓度:时间点:全血:定量型:手工计数方法	4182948
40758565	100WBC; Cerebral spinal fluid; Cerebrospinal Fl; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Myelo; Myeloblast; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WBC; WBCs; White blood cell; White blood cells	4180186
40758565	Myeloblasts/leuk NFr CSF Manual	4180186
40758565	原始粒细胞/100 个白细胞:计数型分数:时间点:脑脊液:定量型:手工计数方法	4182948
40758566	Neoplastic cells/leuk NFr CSF Manual	4180186
40758566	100WBC; Cell; Cellularity; Cerebral spinal fluid; Cerebrospinal Fl; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WBC; WBCs; White blood cell; White blood cells	4180186
40758566	新生细胞/100 个白细胞:计数型分数:时间点:脑脊液:定量型:手工计数方法	4182948
40758568	DOCUMENT.REGULATORY; FDA label; Narrative; Report	4180186
40758568	FDA label Medical device	4180186
40758568	医疗装置:-:-:^FDA 产品标签:叙述型	4182948
40758569	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; LDLc; LDL-C; LDLc-R; LDL-R; Level; Lipid; Low density lipoprotein cholesterol; Low density lipoprotein cholesterols; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Real LDL; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40758569	LDLc-R SerPl VAP-mCnc	4180186
40758569	胆固醇.LDL 之中的:质量浓度:时间点:血清/血浆:定量型:VAP 法	4182948
40758570	Anti thrombin; Antigen; Antigens; Antithrm; Antithrombin III; Antithrombn; AT; AT III; ATIII; Hematology; Heme; Heparin cofactor I; Lab orders; LimitedUseLabOrders; Plas; Platelet poor plasma; Point in time; Random; Thrombin inhibitor I	4180186
40758570	Deprecated AT III Ag PPP	4180186
40758571	Anti thrombin; Antithrm; Antithrombin III; Antithrombn; AT; AT III; ATIII; Heparin cofactor I; Lab orders; LimitedUseLabOrders; Plas; Platelet poor plasma; Point in time; Random; Thrombin inhibitor I	4180186
40758571	Deprecated AT III PPP	4180186
40758573	ABS; Aby; ACA; aCL; Antby; Anti; Antibodies; Antibody; Anticardiolipin; Autoantibodies; Autoantibody; Cardio; Cardiolip; Cardiolipn; Cardiolpn; CL; Hematology; Heme; Immune globulin A; Immunoglobulin A; Lab orders; LimitedUseLabOrders; Point in time; Random; Serum; SR	4180186
40758573	Deprecated Cardiolipin IgA Ser	4180186
40758574	ABS; Aby; ACA; aCL; Antby; Anti; Antibodies; Antibody; Anticardiolipin; Autoantibodies; Autoantibody; Cardio; Cardiolip; Cardiolipn; Cardiolpn; CL; Hematology; Heme; Immune globulin M; Immunoglobulin M; Lab orders; LimitedUseLabOrders; Point in time; Random; Serum; SR	4180186
40758574	Deprecated Cardiolipin IgM Ser	4180186
40758576	AHF; AHG; Antigen; Antigens; Antihemophilic factor; Antihemophilic globulin; Circulating anticoagulant; Coag; F8; Fac; Fact; Fact VIII; Factor 8; Factor VIII clotting activity; FVIII; Hematology; Heme; Lab orders; LimitedUseLabOrders; Plas; Platelet poor plasma; Point in time; Random; Thrombocyte cofactor A; VIII:C	4180186
40758576	Deprecated Fact VIII Ag PPP	4180186
40758577	Comp; Complement CH50; Complmt; Lab orders; LimitedUseLabOrders; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Total Hem Comp; Totl	4180186
40758577	Deprecated CH50 SerPl	4180186
40758580	Coagulation factor I; FDP; FgDP; FGN; Fibrin degradation products; Fibrin split products; Fibrinogen degradation products; Fibrinogen Frg; Fibrinogen related antigens; Frag; Fragment; FSP; Lab orders; LimitedUseLabOrders; Plas; Platelet poor plasma; Point in time; Random; TDP	4180186
40758580	Deprecated FSP PPP	4180186
40758581	Coagulation factor I; FGN; Lab orders; LimitedUseLabOrders; Plas; Platelet poor plasma; Point in time; Random	4180186
40758581	Deprecated Fibrinogen PPP	4180186
40758582	Haptoglob; HP; Hpt; Lab orders; LimitedUseLabOrders; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40758582	Deprecated Haptoglob SerPl	4180186
40758583	Blood; GHb; Glycated hemoglobin; Glycohaemogolobin; Glycohemogolobin; Glycosylated hemoglobin; HA1c; Haemoglobin; Hb; HbA1c; Hgb; Hgb A1c; Lab orders; LimitedUseLabOrders; Point in time; Random; WB; Whole blood	4180186
40758583	Deprecated Hgb A1c Bld	4180186
40758584	Fetal hemoglobin; Haemoglobin; Hb; HbF; Hgb; Hgb F; Lab orders; LimitedUseLabOrders; Misc; Miscellaneous; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified	4180186
40758584	Deprecated Hgb F XXX	4180186
40758589	Antigen; Antigens; Autoprothrombin II-a; Lab orders; LimitedUseLabOrders; PC; Plas; Platelet poor plasma; Point in time; PR; Prot; Prot C; Random; Rh; Rh Blood Group System	4180186
40758589	Deprecated Prot C Ag PPP	4180186
40758593	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV swine; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Pig; Point in time; Polymerase chain reaction; Pork; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40758593	FLUAV swine RNA Spec Ql NAA+probe	4180186
40758593	流感病毒 A 型猪源性 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40758594	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV H1; FLUAV H1 2009 pand; FLUV; Fowl plague; H1N1; H1N1v; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Influenza virus A hemagglutinin H1 swine origin; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; S-OIV; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40758594	FLUAV H1 2009 pand RNA Spec Ql NAA+probe	4180186
40758594	流感病毒 A 型血凝素 H1 型 2009 大流行 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40758596	11DC; BS; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Deoxycortisol; Desoxycortisol; Level; Metopirone; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758596	11DC BS SerPl-sCnc	4180186
40758596	11-脱氧皮质醇^基线:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758597	11DC 1h p ACTH SerPl-sCnc	4180186
40758597	1 hour; 1.0Hr; 11DC; 1h p ACTH; 60 min; 60 minutes; 60M; 60min; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Cortrosyn; Deoxycortisol; Desoxycortisol; Level; Metopirone; p ACTH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	4180186
40758597	11-脱氧皮质醇^在给予剂量促肾上腺皮质激素之后1小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758598	17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; 30M p ACTH; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Endocrine; Endocrinology; Genetics; Heredity; Heritable; Hydroxyproges; Hydroxyprogstron; Inherited; Level; p ACTH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	4180186
40758598	17OHP 30M p ACTH SerPl-sCnc	4180186
40758598	17-羟孕酮^在给予剂量促肾上腺皮质激素之后30分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758601	17-Hydroxycorticosterone; 2.5h p chal; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758601	Cortis 2.5h p chal SerPl-sCnc	4180186
40758601	皮质醇^在XXX刺激之后2.5小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758605	17-beta estradiol; BS; CHEMISTRY.CHALLENGE TESTING; E2; Gyn; Gynecology; Level; OB; ObGyn; Obstetrics; Oestradiol; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758605	Estradiol BS SerPl-sCnc	4180186
40758605	雌二醇^基线:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758610	10M pre Glc; Before; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; Pl; Plasma; Plsm; Point in time; pre Glc; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758610	Insulin 10M pre Glc SerPl-sCnc	4180186
40758610	胰岛素^在给予剂量葡萄糖之前10分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758611	Insulin 4h p Glc IV SerPl-sCnc	4180186
40758611	4h p Glc; 4h p Glc IV; After; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758611	胰岛素^在静脉注射剂量葡萄糖之后4小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758612	1 1/2 hours; 1 1/2 HR; 1.5h p Glc; 1.5h p Glc IV; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758612	Insulin 1.5h p Glc IV SerPl-sCnc	4180186
40758612	胰岛素^在静脉注射剂量葡萄糖之后1.5小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758614	1 hour; 1.0Hr; 1h p Glc; 1h p Glc IV; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758614	Insulin 1h p Glc IV SerPl-sCnc	4180186
40758614	胰岛素^在静脉注射剂量葡萄糖之后1小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758615	1M p Glc; 1M p Glc IV; After; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758615	Insulin 1M p Glc IV SerPl-sCnc	4180186
40758615	胰岛素^在静脉注射剂量葡萄糖之后1分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758616	2.5h p Glc; 2.5h p Glc IV; After; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758616	Insulin 2.5h p Glc IV SerPl-sCnc	4180186
40758616	胰岛素^在静脉注射剂量葡萄糖之后2.5小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758619	45M p Gc; After; CHEMISTRY.CHALLENGE TESTING; HGF; HUM; Humulin; Hyperglycemic factor; IH7; Insul; Lente; Level; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758619	Insulin 45M p Gc SerPl-sCnc	4180186
40758619	胰岛素^在给予剂量胰高血糖素之后45分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758622	3h p Glc; 3hp Glc IV; After; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758622	Insulin 3hp Glc IV SerPl-sCnc	4180186
40758622	胰岛素^在静脉注射剂量葡萄糖之后3小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758623	5M p dose; 5M p Glc; 5M p Glc IV; After; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758623	Insulin 5M p Glc IV SerPl-sCnc	4180186
40758623	胰岛素^在静脉注射剂量葡萄糖之后5分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758624	45M p Glc; 45M p Glc IV; After; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758624	Insulin 45M p Glc IV SerPl-sCnc	4180186
40758624	胰岛素^在静脉注射剂量葡萄糖之后45分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758628	15M p Glc; 15M p Glc IV; After; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40758628	Insulin 15M p Glc IV SerPl-sCnc	4180186
40758628	胰岛素^在静脉注射剂量葡萄糖之后15分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758632	Prolactin 40M p TRH IV SerPl-mCnc	4180186
40758632	40M p TRH IV; After; CHEMISTRY.CHALLENGE TESTING; Lactotropic hormone; Lactotropin; Level; Mammatropic hormone; Mammotropin; Mass concentration; p dose; p TRH; Pl; Plasma; Plsm; Point in time; PRL; Prol; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40758632	催乳素^在静脉注射剂量TRH之前40分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40758636	120 min; 120 minutes; 120min; 2 hours; 2h p Glc; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; Growth hormone; GTT; HGH; Human growth hormone; Level; Mass concentration; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40758636	GH 2h p Glc SerPl-mCnc	4180186
40758636	生长激素^在剂量葡萄糖之后2小时:质量浓度:时间点:血清/血浆:定量型	4182948
40758638	45M p CLN; After; Catapres; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40758638	GH 45M p CLN SerPl-mCnc	4180186
40758638	生长激素^在剂量可乐定之后45分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40758639	1 1/2 hours; 1 1/2 HR; 1.5h p Glc; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; Growth hormone; GTT; HGH; Human growth hormone; Level; Mass concentration; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40758639	GH 1.5h p Glc SerPl-mCnc	4180186
40758639	生长激素^在剂量葡萄糖之后1.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
40758643	20M p Exc; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; EXCZ; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p Exc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40758643	GH 20M p Exc SerPl-mCnc	4180186
40758643	生长激素^在运动之后20分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40758645	1 1/2 hours; 1 1/2 HR; 1.5h p Gc; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGF; HGH; Human growth hormone; Hyperglycemic factor; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40758645	GH 1.5h p Gc SerPl-mCnc	4180186
40758645	生长激素^在给予剂量胰高血糖素之后1.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
40758647	4h p GnRH; After; CHEMISTRY.CHALLENGE TESTING; GHR; GnRH; Horm; Level; LHRH; Luliberin; Luteinizing hormone releasing hormone; Lutropin release factor; p dose; p GnRH; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Testo; Testos; Testost	4180186
40758647	Testost 4h p GnRH SerPl-sCnc	4180186
40758647	睾酮^在剂量促性腺激素释放激素之后4小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758649	6 MAM; 6 mono acetyl morphine; 6-acetylmorphine; 6MAM; Acetylmorphine; Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Heroin metabolite; Illicit; Level; MAM; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40758649	6MAM Ur-sCnc	4180186
40758649	6-单乙酰吗啡:物质的量浓度:时间点:尿液:定量型	4182948
40758652	DRUG/TOXICOLOGY; Drugs; Leritine; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758652	Anileridine SerPl-sCnc	4180186
40758652	阿尼利定:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758654	BEC; BEG; Benz; Benzoylec; BZE; Cocaine degradation production; Cocaine metabolite; Crack metabolite; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758654	BZE SerPl-sCnc	4180186
40758654	苯甲酰芽子碱:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758655	Brompheniramine SerPl-sCnc	4180186
40758655	Antial; BPN; Bromarest; Bromfed; Bromfenex; Dimegan; Dimetane; Dimetapp; Dimotane; DRUG/TOXICOLOGY; Drugs; Gammistin; Ilvin; Level; Lodrane; Parabromdylamine maleate; Pl; Plasma; Plsm; Point in time; PROBAHIST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758655	溴苯那敏:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758656	buPROPion SerPl-sCnc	4180186
40758656	DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Wellbutrin; Zyban	4180186
40758656	丁氨苯丙酮:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758658	Ciatyl; Cisordinol; Clopixol; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Sedanxol; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sordinol; SR; Substance concentration; Zuclopenthixol	4180186
40758658	Clopenthixol SerPl-sCnc	4180186
40758658	氯哌噻吨:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758659	Cocaethylene SerPl-sCnc	4180186
40758659	Cocaine/Ethanol By-Product; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758659	古柯乙烯:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758661	Addiction; Amphepramone; Diethylprop; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tenuate	4180186
40758661	Diethylpropion SerPl-sCnc	4180186
40758661	二乙胺苯丙酮:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758663	Decapryn; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758663	Doxylamine SerPl-sCnc	4180186
40758663	苯吡拉明:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758664	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ectasule; Illicit; Level; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758664	Ephedrin SerPl-sCnc	4180186
40758664	麻黄碱:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758665	DRUG/TOXICOLOGY; Drugs; Level; Nalfon; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758665	Fenoprofen SerPl-sCnc	4180186
40758665	苯氧苯丙酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758667	Flupenthixol SerPl-sCnc	4180186
40758667	Depixol; DRUG/TOXICOLOGY; Drugs; Fluanxol; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758667	三氟噻吨:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758669	c210; DRUG/TOXICOLOGY; Drugs; Furj; LASIX; LASJ; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758669	Furosemide SerPl-sCnc	4180186
40758669	呋塞米:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758672	DRUG/TOXICOLOGY; Drugs; HCQ; Hydroxy chloroquine; Level; OH-Chloroquine; Oxichlorochin; Pl; Plaquenil; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Quensyl; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758672	OH-Chloroquine SerPl-sCnc	4180186
40758672	羟基氯喹:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758674	c282; C54; DRUG/TOXICOLOGY; Drugs; Indochron; Indocin; Indometacin; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758674	Indomethacin SerPl-sCnc	4180186
40758674	茚甲新:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758675	2-(meta-benzylphenyl) propionate; C16H14O3; c388; DRUG/TOXICOLOGY; Drugs; Level; Orudis; Oruvail; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758675	Ketoprofen SerPl-sCnc	4180186
40758675	酮洛芬:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758678	Methocarbamol SerPl-sCnc	4180186
40758678	Carbacot; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Robaxin; SerP; SerPl; SerPlas; Serum; Serum or plasma; Skelex; SR; Substance concentration	4180186
40758678	美索巴莫:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758679	Celontin; Desmeth; Desmethylmethsuximide; Dmms; DRUG/TOXICOLOGY; Drugs; Level; Mesuximide; Methsuximide metabolite; Petinutin; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Suximide metabolite	4180186
40758679	Methsuximide+Nor SerPl-sCnc	4180186
40758679	甲琥胺+去甲基甲琥胺:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758683	Avanza; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Reflex; Remeron; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Zispin	4180186
40758683	Mirtazapine SerPl-sCnc	4180186
40758683	米氮平:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758684	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mo; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
40758684	Molybdenum Bld-sCnc	4180186
40758684	钼:物质的量浓度:时间点:全血:定量型	4182948
40758685	Nadolol SerPl-sCnc	4180186
40758685	Corgard; Cotzide; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758685	纳多洛尔:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758686	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Habitrol; Illicit; Level; Nicoderm; Nictoine; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758686	Nicotine SerPl-sCnc	4180186
40758686	烟碱:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758687	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Habitrol; Illicit; Level; Nicoderm; Nictoine; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758687	Nicotine SerPl Scn-sCnc	4180186
40758687	烟碱:物质的量浓度:时间点:血清/血浆:定量型:毒理学筛查试验	4182948
40758688	DRUG/TOXICOLOGY; Drugs; Level; n-desmethylproproxyphene; Norpropoxyp; Pl; Plasma; Plsm; Point in time; Propoxyphene metabolite; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758688	Norpropoxyph SerPl-sCnc	4180186
40758688	去甲基丙氧氨酚:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758690	Apsolox; Corbeton; DRUG/TOXICOLOGY; Drugs; Level; Lo-tone; Ornel; Oxyprenolol; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Slow-pren; Slow-trasicor; SR; Substance concentration; Trasicor	4180186
40758690	Oxprenolol SerPl-sCnc	4180186
40758690	氧烯洛尔:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758692	Paraldehyde SerPl-sCnc	4180186
40758692	2,4,6-Trimethyl-1,3,4-trioxane; DRUG/TOXICOLOGY; Drugs; Level; Paracetaldehyde; Paral; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758692	三聚乙醛:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758694	Aceto-p-phenetidide; Addiction; Cratodin rectal; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Gripponyl; Hemagene tailleur; Illicit; Level; Nevral; Pl; Plasma; Plsm; Point in time; Polypirine; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758694	Phenac SerPl-sCnc	4180186
40758694	乙酰对氨苯乙醚:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758695	Phenelzine SerPl-sCnc	4180186
40758695	DRUG/TOXICOLOGY; Drugs; Level; Nardil; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758695	苯乙肼:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758696	Pheniramine SerPl-sCnc	4180186
40758696	Avil; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; Prophenpyridamine; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758696	非尼拉敏:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758701	c217; c284; c83; DRUG/TOXICOLOGY; Drugs; Level; Novocaine; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758701	Procaine SerPl-sCnc	4180186
40758701	普鲁卡因:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758707	Citric acid; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Revatio; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Viagra	4180186
40758707	Sildenafil cit SerPl-sCnc	4180186
40758707	枸橼酸西地那非:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758708	Sotalol SerPl-sCnc	4180186
40758708	Beta-cardone; Betapace; Betudes; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Solalex; Sotacor; SR; Substance concentration	4180186
40758708	索他洛尔:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758709	Sulfapyridine SerPl-sCnc	4180186
40758709	Dagenan; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758709	磺胺吡啶:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758711	Timolol SerPl-sCnc	4180186
40758711	DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Timoptic	4180186
40758711	噻吗洛尔:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758718	Budgie Feather IgE Ql	4180186
40758718	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Australian parrot; Autoantibodies; Autoantibody; Budgeriar; Budgie; Budgie Feather; e78; Feathers; Immune globulin E; Immunoglobulin E; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
40758718	虎皮鹦鹉羽毛 抗体.IgE:存在情况或阈值:时间点:血清:序数型	4182948
40758719	Canary Feather IgE Ql	4180186
40758719	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e201; Feathers; Immune globulin E; Immunoglobulin E; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
40758719	金丝雀羽毛 抗体.IgE:存在情况或阈值:时间点:血清:序数型	4182948
40758724	Finch Feather IgE Ql	4180186
40758724	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e214; Feathers; Immune globulin E; Immunoglobulin E; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Re214; Screen; Serum; SR	4180186
40758724	雀类羽毛 抗体.IgE:存在情况或阈值:时间点:血清:序数型	4182948
40758725	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e070; e70; f158; Feathers; Immune globulin E; Immunoglobulin E; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
40758725	Goose Feather IgE Ql	4180186
40758725	鹅羽毛 抗体.IgE:存在情况或阈值:时间点:血清:序数型	4182948
40758730	Cardio; Cardiology; CYTOLOGY; Cytology stain; Cytostain; Heart Disease; Identity or presence; Nominal; Pap Smear; Pap Stain; Papanicolaou smear; PCAR; Pericardial Fluid; Point in time; Random; St; Stains; Stn	4180186
40758730	Cyto Pcar	4180186
40758730	显微镜观察:存在与否或特征标识:时间点:心包液:名义型:细胞学染色法	4182948
40758731	Cyto Plr	4180186
40758731	CYTOLOGY; Cytology stain; Cytostain; Identity or presence; Nominal; Pap Smear; Pap Stain; Papanicolaou smear; Pleural; Pleural fluid; Point in time; Random; St; Stains; Stn; thoracentesis fluid	4180186
40758731	显微镜观察:存在与否或特征标识:时间点:胸膜液:名义型:细胞学染色法	4182948
40758732	CYTOLOGY; Cytology stain; Cytostain; Identity or presence; Joint aspirate; Joint fld; Joint flu; Joint fluid; Nominal; Pap Smear; Pap Stain; Papanicolaou smear; Point in time; Random; SF; SNV; St; Stains; Stn; Syn; Syn fl; Synov; Synovial fluid	4180186
40758732	Cyto Snv	4180186
40758732	显微镜观察:存在与否或特征标识:时间点:滑液:名义型:细胞学染色法	4182948
40758733	CYTOLOGY; Cytology stain; Cytostain; Endm; Endometr; Endometrium; Identity or presence; Nominal; Pap Smear; Pap Stain; Papanicolaou smear; Point in time; Random; St; Stains; Stn	4180186
40758733	Cyto Endometrium	4180186
40758733	显微镜观察:存在与否或特征标识:时间点:子宫内膜:名义型:细胞学染色法	4182948
40758734	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e196; Feathers; Immune globulin E; Immunoglobulin E; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
40758734	Parakeet Feather IgE Ql	4180186
40758734	长尾小鹦鹉羽毛 抗体.IgE:存在情况或阈值:时间点:血清:序数型	4182948
40758738	Urea ?Tm Ur-sCnc	4180186
40758738	?Tm; Chemistry; Level; QNT; Quan; Quant; Quantitative; Substance concentration; UA; UR; Urn	4180186
40758738	尿素:物质的量浓度:XXX:尿液:定量型	4182948
40758739	FSH sp2 p chal SerPl-aCnc	4180186
40758739	After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Convalescent; Follicle stimulating hormone; FSH; p chal; Pl; Plasma; Plsm; Point in time; Post immunization; PST; QNT; Quan; Quant; Quantitative; Random; Second; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp2; sp2 p chal; Spec; SR	4180186
40758739	促卵泡激素^在XXX刺激之后的第2个标本:任意型浓度:时间点:血清/血浆:定量型	4182948
40758742	#days to wean patient who is now independent from ventilator; CARE Survey; Cnt; Continuity assessment record and evaluation; Count; Dextro; No; Num; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; World Heatlth Organization	4180186
40758743	Amox; Amoxicilloyl; Amoxil; ANTIBIOTIC SUSCEPTIBILITIES; AST; Bristamox; c204; c6; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Larotid; Moxalin; Point in time; Polymox; Random; Sulb; Sulbact; Sumox; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Trimox; Wymox	4180186
40758743	Amoxicillin+Sulbactam Susc Islt	4180186
40758743	羟氨苄青霉素+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
40758744	Amox; Amoxicilloyl; Amoxil; ANTIBIOTIC SUSCEPTIBILITIES; AST; Bristamox; c204; c6; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Larotid; MIC; Minimum inhibitory concentration; Moxalin; Point in time; Polymox; Random; Sulb; Sulbact; Sumox; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Trimox; Wymox	4180186
40758744	Amoxicillin+Sulbactam Islt Grad strip	4180186
40758744	羟氨苄青霉素+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758746	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Other Antibiotic; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758746	Other Antibiotic Islt Grad strip	4180186
40758746	抗生素 XXX:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758748	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758748	Avilamycin Islt Grad strip	4180186
40758748	卑霉素:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758755	ANTIBIOTIC SUSCEPTIBILITIES; AST; cephacetrile; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758755	Cefacetrile Islt KB	4180186
40758755	头孢乙腈:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40758756	ANTIBIOTIC SUSCEPTIBILITIES; AST; cephacetrile; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758756	Cefacetrile Islt Grad strip	4180186
40758756	头孢乙腈:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758760	ANTIBIOTIC SUSCEPTIBILITIES; AST; Cefalotin; Cephalotin; Ceporacin; Cepovenin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Keflin; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758760	Cephalothin+Sulbactam Susc Islt	4180186
40758760	头孢金素+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
40758764	ANTIBIOTIC SUSCEPTIBILITIES; AST; C31; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Kefadol; Mandol; MANJ; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758764	Cefamandole+Sulbactam Susc Islt	4180186
40758764	头孢羟唑+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
40758766	ANTIBIOTIC SUSCEPTIBILITIES; AST; C31; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Kefadol; Mandol; MANJ; MIC; Minimum inhibitory concentration; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758766	Cefamandole+Sulbactam Islt Grad strip	4180186
40758766	头孢羟唑+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758768	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758768	Cefatrizine Islt Grad strip	4180186
40758768	头孢曲秦:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758772	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Precef; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758772	Ceforanide Islt Grad strip	4180186
40758772	头孢雷特:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758776	ANTIBIOTIC SUSCEPTIBILITIES; AST; Cefsulodine; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Monaspor; Point in time; Pseudocef; Pyocefal; Random; Sulcephalosporin; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Takesulin	4180186
40758776	Cefsulodin Islt Grad strip	4180186
40758776	磺吡下头孢霉素:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758780	ANTIBIOTIC SUSCEPTIBILITIES; AST; Ceftaz; Epsilometer; Estrip; E-strip; Forj; Fortaz; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tazicef; Tazj	4180186
40758780	cefTAZidime+Sulbactam Islt Grad strip	4180186
40758780	头孢他啶+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758781	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Naxcel; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vet; Veterinary	4180186
40758781	Ceftiofur Islt Grad strip	4180186
40758781	头孢噻呋:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758785	ANTIBIOTIC SUSCEPTIBILITIES; AST; Azolinic acid; Cinobac; Cinobactin; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Nofrin; Nossacin; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Uronorm; Uroxacin	4180186
40758785	Cinoxacin Islt Grad strip	4180186
40758785	西诺沙星:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758787	ANTIBIOTIC SUSCEPTIBILITIES; AST; c306; Cleocin; CLIJ; Dalacin; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sobelin; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Synergistic; Synergy; Topical	4180186
40758787	Clindamycin.high potency Islt Grad strip	4180186
40758787	氯洁霉素.高效:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758789	ANTIBIOTIC SUSCEPTIBILITIES; AST; c306; Cleocin; CLIJ; Dalacin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sobelin; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Synergistic; Synergy; Topical	4180186
40758789	Clindamycin.high potency Islt MIC	4180186
40758789	氯洁霉素.高效:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
40758790	ANTIBIOTIC SUSCEPTIBILITIES; AST; Clofazamine; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758790	Clofazamine Islt KB	4180186
40758790	氯法齐明:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40758792	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758792	Clotrimazole Islt Grad strip	4180186
40758792	克霉唑:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758794	ANTIBIOTIC SUSCEPTIBILITIES; AST; Colimicina; Colimycine; Colistin sulphomethate; Colomycin M; Coly-micin S; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758794	Colistimethate Islt Grad strip	4180186
40758794	多粘菌素E甲磺酸:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758795	ANTIBIOTIC SUSCEPTIBILITIES; AST; Calthor; Ciclacillin; Cyclapen-w; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Wypicil	4180186
40758795	Cyclacillin Islt Grad strip	4180186
40758795	氨环已青霉素:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758797	ANTIBIOTIC SUSCEPTIBILITIES; AST; Dynapen; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Pathocil; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Veracillin; Veracilline	4180186
40758797	Dicloxacillin Islt Grad strip	4180186
40758797	双氯青霉素:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758798	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758798	Dibekacin Islt MIC	4180186
40758798	地贝卡星:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
40758799	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758799	Dibekacin Susc Islt	4180186
40758799	地贝卡星:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
40758800	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758800	Dibekacin Islt KB	4180186
40758800	地贝卡星:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40758802	ANTIBIOTIC SUSCEPTIBILITIES; AST; Ecostatin; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Spectazole; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758802	Econazole Islt Grad strip	4180186
40758802	益康唑:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758803	2 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; Etambol; Ethamb; ID; Inagen; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myambutol; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Mycobutol; Olbutam; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis	4180186
40758803	Ethambutol 2 ug/mL Islt SlowMyco	4180186
40758803	乙胺丁醇 2.0 微克/毫升:抗生素敏感性:时间点:分离株:定量型或序数型:针对慢长型分枝杆菌的方法	4182948
40758805	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758805	Flumequine Susc Islt	4180186
40758805	氟甲喹:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
40758807	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758807	Flumequine Islt Grad strip	4180186
40758807	氟甲喹:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758810	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758810	Isoconazole Islt MIC	4180186
40758810	异康唑:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
40758811	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758811	Isoconazole Susc Islt	4180186
40758811	异康唑:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
40758812	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758812	Isoconazole Islt KB	4180186
40758812	异康唑:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40758814	10 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; Hyzyd; ID; Infectious Disease; InfectiousDisease; INH; Islt; Isol; Isoniaz; Isoniazide; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Nudrazod; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis	4180186
40758814	Isoniazid 10 ug/mL Islt SlowMyco	4180186
40758814	异烟肼 10.0 微克/毫升:抗生素敏感性:时间点:分离株:定量型或序数型:针对慢长型分枝杆菌的方法	4182948
40758815	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Micostadin; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758815	Miconazole Islt Grad strip	4180186
40758815	咪康唑:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758817	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758817	Nitroxoline Islt Grad strip	4180186
40758817	硝羟喹啉:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758819	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sigmamycine; Sigmanycine; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758819	Oleandomycin Islt Grad strip	4180186
40758819	竹桃霉素:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758820	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758820	Ornidazole Susc Islt	4180186
40758820	奥硝唑:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
40758821	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758821	Ornidazole Islt Grad strip	4180186
40758821	奥硝唑:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758825	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Oxolinic acid; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758825	Oxolinate Susc Islt	4180186
40758825	噁喹酸:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
40758826	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Oxolinic acid; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758826	Oxolinate Islt KB	4180186
40758826	噁喹酸:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40758829	Aminoglycosides; Aminosidine; ANTIBIOTIC SUSCEPTIBILITIES; AST; Humatin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Monomycin; Paramomycin; Paromycin; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758829	Deprecated Paramomycin Islt MIC	4180186
40758830	Aminoglycosides; Aminosidine; ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; Humatin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Monomycin; Paramomycin; Paromycin; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758830	Paromomycin Islt KB	4180186
40758830	巴龙霉素:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40758831	Aminoglycosides; Aminosidine; ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; Humatin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Monomycin; Paramomycin; Paromycin; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758831	Paromomycin Islt Grad strip	4180186
40758831	巴龙霉素:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758832	Acipern; ANTIBIOTIC SUSCEPTIBILITIES; AST; Biopim; Cistomid; Deblaston; Diperpen; Dokol; Epsilometer; Estrip; E-strip; Faremid; Filtrax; Galusan; Grad strip; ID; Impresial; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Nuril; Pipeacid; Pipedac; Pipedose; Pipefort; Pipemid; Pipemidic acid; Piperamic acid; Pipram; Pipurin; Point in time; Pro-uro; Random; Septidron; Solupemid; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tractur; Urisan; Urodene	4180186
40758832	Pipemidate Islt Grad strip	4180186
40758832	吡哌酸:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758833	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Piper; PIPJ; Pipracil; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758833	Piperacillin+Sulbac Islt Grad strip	4180186
40758833	氧哌嗪青霉素+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758834	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Piromidic acid; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758834	Piromidate Islt MIC	4180186
40758834	吡咯酸:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
40758837	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Piromidic acid; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758837	Piromidate Islt Grad strip	4180186
40758837	吡咯酸:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758838	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758838	Pristinamycin Islt Grad strip	4180186
40758838	原始霉素:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758839	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; PZA; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758839	PZA Islt Grad strip	4180186
40758839	吡嗪酰胺:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758843	ANTIBIOTIC SUSCEPTIBILITIES; AST; Bykomycetin; Dicorvin; Epsilometer; Estrip; E-strip; Extramycin; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Mensiso; MIC; Minimum inhibitory concentration; Point in time; Random; Rickamicin; Rovamycin; Rovamycine; Selectomycin; Sisobiotic; Sisolline; Sisomina; Sisomycin; Sissomicin; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758843	Sisomicin Islt Grad strip	4180186
40758843	西梭霉素:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758848	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Ticar; Timentin; TIMJ	4180186
40758848	Ticarcillin+Sulbactam Islt Grad strip	4180186
40758848	羧噻吩青霉素+舒巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758849	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tindamax	4180186
40758849	Tinidazole Islt MIC	4180186
40758849	替硝唑:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
40758850	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tindamax	4180186
40758850	Tinidazole Islt KB	4180186
40758850	替硝唑:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40758855	B burg; B burgdor; B burgdor IgA+IgG+IgM Pnl; B burgdorferi; Bb; Burgdorf; Cerebral spinal fluid; Cerebrospinal Fl; ID; Immune globulin A; Immune globulin G; Immune globulin M; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Neuro; Neurology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
40758855	B burgdor IgA+IgG+IgM Pnl CSF	4180186
40758855	伯氏疏螺旋体抗体.IgA 与 IgG 与 IgM 组套:-:时间点:脑脊液:-	4182948
40758859	Blood; Fetomaternal hemorrhage; FMH; HEMATOLOGY/CELL COUNTS; Point in time; QNT; Quan; Quant; Quantitative; Random; Volume; WB; Whole blood	4180186
40758859	Fetal blood Vol Bld	4180186
40758859	胎儿血液:体积型属性:时间点:全血:定量型	4182948
40758861	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Spizef; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758861	Cefotiam hexetil Islt MIC	4180186
40758861	头孢替安己酯:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
40758862	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Spizef; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758862	Cefotiam hexetil Susc Islt	4180186
40758862	头孢替安己酯:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
40758863	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Spizef; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758863	Cefotiam hexetil Islt KB	4180186
40758863	头孢替安己酯:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40758864	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Spizef; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40758864	Cefotiam hexetil Islt Grad strip	4180186
40758864	头孢替安己酯:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40758865	Pan; PANEL.SURVEY.R-OUTCOMES; Panl; Pnl; Point in time; R prime; Random; Right; Survey; SURVEY.R-OUTCOMES	4180186
40758866	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen; Survey; SURVEY.R-OUTCOMES	4180186
40758870	Point in time; QNT; Quan; Quant; Quantitative; R prime; Random; Right; Scale; Survey; SURVEY.R-OUTCOMES	4180186
40758873	AOEObservation; Finding; Findings; Narrative; Point in time; Public Health; PUBLICHEALTH; Random; Report	4180186
40758873	Clinical info	4180186
40758873	临床信息:发现:时间点:^患者:叙述型	4182948
40758874	Treatment info	4180186
40758874	Finding; Findings; Narrative; Point in time; Public Health; PUBLICHEALTH; Random; Report; Tx	4180186
40758874	治疗信息:发现:时间点:^患者:叙述型	4182948
40758875	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40758876	CARE Survey; Continuity assessment record and evaluation; Point in time; Random; Survey	4180186
40758877	CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
40758879	II; Patient Health Questionnaire; PHQ; PHQ 2; PHQ2; PHQ-2; PHQ-2 total score; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PHQ; Tot; Totl	4180186
40758880	CARE Survey; Point in time; Random; Survey	4180186
40758882	CARE Survey; Continuity assessment record and evaluation; Disch; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
40758883	CARE Survey; Point in time; Random; Survey	4180186
40758886	Arbitrary; Blood; EGFR c.2156G&gt;C+2155G&gt;A+2155G&gt;T; epidermal growth factor receptor; Epidermal growth factor receptor gene; ERBB; ERBB1; G2155A; G2155T; G2156C; G719X; Genetics; HER1; Heredity; Heritable; Inherited; mENA; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; NISBD2; Oncogene ERBB; Oncology; Ordinal; PCR; PIG61; Point in time; QL; Qual; Qualitative; Random; Screen; T prime; Tissue; Tissue, unspecified; V-ERB-B avian erythroblastic leukemia viral oncogene homolog; WB; Whole blood; Whole blood or Tissue	4180186
40758886	EGFR c.2156G>C+2155G>A+2155G>T Bld/T Ql	4180186
40758886	EGFR 基因.c.2156G>C+2155G>A+2155G>T:任意型:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40758887	Blood; EGFR c.2573T&gt;G; epidermal growth factor receptor; Epidermal growth factor receptor gene; ERBB; ERBB1; Genetics; HER1; Heredity; Heritable; Inherited; L858R; mENA; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; NISBD2; Oncogene ERBB; Oncology; Ordinal; PCR; PIG61; Point in time; PR; QL; Qual; Qualitative; Random; Screen; T2573G; Tissue; Tissue, unspecified; V-ERB-B avian erythroblastic leukemia viral oncogene homolog; WB; Whole blood; Whole blood or Tissue	4180186
40758887	EGFR c.2573T>G Bld/T Ql	4180186
40758887	EGFR 基因.c.2573T>G:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40758888	Blood; EGFR c.2582T&gt;A; epidermal growth factor receptor; Epidermal growth factor receptor gene; ERBB; ERBB1; Genetics; HER1; Heredity; Heritable; Inherited; L861Q; mENA; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; NISBD2; Oncogene ERBB; Oncology; Ordinal; PCR; PIG61; Point in time; PR; QL; Qual; Qualitative; Random; Screen; T2582A; Tissue; Tissue, unspecified; V-ERB-B avian erythroblastic leukemia viral oncogene homolog; WB; Whole blood; Whole blood or Tissue	4180186
40758888	EGFR c.2582T>A Bld/T Ql	4180186
40758888	EGFR 基因.c.2582T>A:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40758890	Blood; EGFR c.2369C&gt;T; epidermal growth factor receptor; Epidermal growth factor receptor gene; ERBB; ERBB1; Genetics; HER1; Heredity; Heritable; Inherited; mENA; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; NISBD2; Oncogene ERBB; Oncology; Ordinal; PCR; PIG61; Point in time; PR; QL; Qual; Qualitative; Random; rs121434569; Screen; T prime; T790M; Thr790Met; Tissue; Tissue, unspecified; V-ERB-B avian erythroblastic leukemia viral oncogene homolog; WB; Whole blood; Whole blood or Tissue	4180186
40758890	EGFR c.2369C>T Bld/T Ql	4180186
40758890	EGFR 基因.c.2369C>T:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40758896	Antiglob; BLOOD BANK; DAGT; DAT; DAT IgA-Sp Reag; DCT; Dir; Direct Coomb; Direct coombs test; Erythrocytes; Hematology; Heme; Immune globulin A; Immunoglobulin A; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen; Spec	4180186
40758896	DAT IgA-Sp Reag RBC Ql	4180186
40758896	直接抗球蛋白试验.IgA 特异性试剂:存在情况或阈值:时间点:红细胞:序数型	4182948
40758897	Antiglob; BLOOD BANK; DAGT; DAT; DAT IgG-Sp Reag; DCT; Dir; Direct Coomb; Direct coombs test; Erythrocytes; Hematology; Heme; Immune globulin G; Immunoglobulin G; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen; Spec	4180186
40758897	DAT IgG-Sp Reag RBC Ql	4180186
40758897	直接抗球蛋白试验.IgG 特异性试剂:存在情况或阈值:时间点:红细胞:序数型	4182948
40758898	Antiglob; BLOOD BANK; DAGT; DAT; DAT IgM-Sp Reag; DCT; Dir; Direct Coomb; Direct coombs test; Erythrocytes; Hematology; Heme; Immune globulin M; Immunoglobulin M; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen; Spec	4180186
40758898	DAT IgM-Sp Reag RBC Ql	4180186
40758898	直接抗球蛋白试验.IgM 特异性试剂:存在情况或阈值:时间点:红细胞:序数型	4182948
40758900	RBC # Amn	4180186
40758900	#; ABS; absolute; absolutes; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Cnt; Count; Count/volume; CT; Discocytes; Erthrocyte; Erythrocyte; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells	4180186
40758900	红细胞:计数型浓度:时间点:羊水:定量型	4182948
40758901	nRBC CSF Manual	4180186
40758901	Cerebral spinal fluid; Cerebrospinal Fl; Cnt; Count; Discocytes; Erthrocyte; Erythroblasts; Erythrocyte; HEMATOLOGY/CELL COUNTS; Manl; Normoblasts; nRBC; nRBCs; Nuc; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
40758901	红细胞.有核:数量(计数):时间点:脑脊液:定量型:手工计数方法	4182948
40758902	Hct VFr Mar	4180186
40758902	BM; BON; Bone marrow; Hct; HEMATOLOGY/CELL COUNTS; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; PCV; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
40758902	血细胞压积:体积分数:时间点:骨髓:定量型	4182948
40758904	Hgb Barts Bld Ql HPLC	4180186
40758904	Bart; Bart's; Blood; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb Barts; High performance liquid chromatography; High pressure liquid chromatography; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
40758904	血红蛋白 Barts:存在情况或阈值:时间点:全血:序数型:高效液相色谱分析法	4182948
40758905	#; ABS; absolute; absolutes; BM; BON; Bone marrow; Cnt; Count; Count/volume; CT; Discocytes; Erthrocyte; Erythrocyte; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; nRBC cor; Nuc; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; WBC; WBCs; White blood cell; White blood cells	4180186
40758905	WBC nRBC cor # Mar	4180186
40758905	白细胞^^经过针对有核红细胞而校正的:计数型浓度:时间点:骨髓:定量型	4182948
40758906	Anticoag; Anti-phospholipid antibody; Clot; Clottable; COAGULATION; Coagulation assay; Coagulation inhibiting antibody; dRVVT; Fac; Fact; Hematology; Heme; i; II; imm 1:2 saline; LA; LA Nt HPL; LAC; Lipid; Lupus inhibitor; Neut; Neutr; Phoslpd; Phospholipids; Pl; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Tilt tube	4180186
40758906	LA Nt HPL imm 1:2 saline PPP	4180186
40758906	狼疮抗凝物质中和作用.高磷脂.因子替换^紧接着在添加1:2盐水之后:时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
40758916	ABS; Aby; Antby; Anti; Antibodies; Antibody; aPS; Autoantibodies; Autoantibody; COAGULATION; Hematology; Heme; Immune globulin G; Immunoglobulin G; MoM; Multiple of the median; Phosphatidyl serine; Point in time; PS; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40758916	PS IgG MoM Ser	4180186
40758916	磷脂酰丝氨酸 抗体.IgG:中位数的倍数:时间点:血清:定量型	4182948
40758918	Adenosine 5'-Pyrophosphate; Adenosine Pyrophosphate; ADO; ADP; Agg; Aggr; ANED; Clopidogrel response assay; COAGULATION; Hematology; Heme; Left; Levo; Medication stress; Ordinal; P2Y12 Assay; P2Y12 inhibition; PA; PA ADP; Pl; Platelet rich plasma; Platelets; Platelt; Plavix response assay; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Thrombocyte; Thrombocytes	4180186
40758918	PA ADP 2.5 umol/L PRP Ql	4180186
40758918	血小板聚集.二磷酸腺苷诱导型^2.5 微摩尔/升:存在情况或阈值:时间点:富血小板血浆:序数型	4182948
40758924	Cerebral spinal fluid; Cerebrospinal Fl; Cnt; Count; HEMATOLOGY/CELL COUNTS; Manl; Number; Point in time; Pro myelos; Progranulocyte; Progranulocytes; Promyel; Promyelocyte; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
40758924	Promyelocytes CSF Manual	4180186
40758924	早幼粒细胞:数量(计数):时间点:脑脊液:定量型:手工计数方法	4182948
40758926	Blood; Ciclosporin; Ciclosporine; CsA; Cyclosporin a; Cyclosporins; DRUG/TOXICOLOGY; Drugs; Gengraf; Level; Mass concentration; Neoral; Point in time; QNT; Quan; Quant; Quantitative; Random; Restasis; Sandimmune; SangCya; WB; Whole blood	4180186
40758926	cycloSPORINE Bld LC/MS/MS-mCnc	4180186
40758926	环孢菌素:质量浓度:时间点:全血:定量型:LC/MS/MS	4182948
40758929	11DOC 24h Ur-sRate	4180186
40758929	1 day; 11DOC; 11-DOC; 21-Hydroxyprogesterone; 24 hours; 24HR; Chemistry; DOC; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
40758929	11-脱氧皮质酮:物质的量速率:24小时:尿液:定量型	4182948
40758932	18OH-Cortis 24h Ur-sRate	4180186
40758932	1 day; 18OH-Cortis; 24 hours; 24HR; Chemistry; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
40758932	18-羟基皮质醇:物质的量速率:24小时:尿液:定量型	4182948
40758934	2-aminobutanoic acid; 2-aminobutyrate; 2-aminobutyric acid; AA; A-Aminobutyr; AANB; A-ANB; Acd; Acid; Alfa; Alpha aminobutyric acid; Alpha amino-n-butyrate; Alpha amino-n-butyric acid; Amino acid; Amino acids.total; Aminobutric; Aminobutyric; Amino-n-butyrate; Chemistry; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance fraction; Tot; Totl	4180186
40758934	A-Aminobutyr SFr SerPl	4180186
40758934	Alpha 氨基丁酸/氨基酸类.总计:物质的量分数:时间点:血清/血浆:定量型	4182948
40758935	25(OH)D3; 25-hydroxycholecalciferol; 25-hydroxyvitamin D 3; 25-hydroxyvitamin D3; Blood - (umbilical) cord; Calciderol; Calcifediol; Chemistry; Cord (umbilical) blood; Cord bld; Cord blood; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Vitamin D 25 hydroxy	4180186
40758935	25(OH)D3 BldCo-sCnc	4180186
40758935	钙二醇:物质的量浓度:时间点:脐带全血:定量型	4182948
40758937	3,4-Dihydroxy phenylacetate; 3,4-Dihydroxy phenylacetic acid; 3,4-Dihydroxyphenylacetic acid; 3,4-DiOH-phenylacetate; DOPAC; Dopamine metabolite; DRUG/TOXICOLOGY; Drugs; III; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40758937	3,4-DiOH-phenylacetate Ur-sCnc	4180186
40758937	3,4-二羟基苯乙酸:物质的量浓度:时间点:尿液:定量型	4182948
40758939	Organic Acids Stl-sCnt	4180186
40758939	Acd; Acid; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal; Substance Content	4180186
40758939	有机酸类:物质的量含量:时间点:大便:定量型	4182948
40758943	Allo-TH-DC 24h Ur-mRate	4180186
40758943	1 day; 24 hours; 24HR; Allo TH-DC; Allo-TH-DC; Chemistry; Mass Rate; mRate; QNT; Quan; Quant; Quantitative; tetrahydro-11-deoxycortisol; TH-DC; UA; UR; Urn	4180186
40758943	别-四氢脱氧皮质醇:质量速率:24小时:尿液:定量型	4182948
40758949	Al Carb C14-C26 Ester Stl Ql	4180186
40758949	Al Carb C14-C26 Ester; Bowel movement; Chemistry; Ester; Faecal; Faeces; Fecal; Feces; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal	4180186
40758949	脂肪族羧酸 C14-C26.酯类:存在情况或阈值:时间点:大便:序数型	4182948
40758952	Catechols Fld-sCnc	4180186
40758952	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cate; Catec; Catech; Catechol; Catecholamine; Catecholamines.total; Catechols; Chemistry; Epinephrine+norepinephrine+dopamine; Fl; Fld; FLU; Fluid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40758952	儿茶酚胺类:物质的量浓度:时间点:体液:定量型	4182948
40758955	Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40758955	Cathepsin S SerPl-mCnc	4180186
40758955	组织蛋白酶 S:质量浓度:时间点:血清/血浆:定量型	4182948
40758956	Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Fiber; LM; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal	4180186
40758956	Vegetable Fibers Stl Ql Micro	4180186
40758956	蔬菜纤维:存在情况或阈值:时间点:大便:序数型:显微镜检查.光学	4182948
40758957	Chitotriosidase DBS-cCnc	4180186
40758957	Blood; Catalytic Concentration; Chemistry; DBS; Dried blood spot; Filter paper; FP; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40758957	壳三糖苷酶:催化浓度:时间点:全血.斑点:定量型	4182948
40758959	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; Lipid; Phoslpd; Phospholipids; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration ratio; Substance ratio	4180186
40758959	Cholest/Phospholipid SerPl-sRto	4180186
40758959	胆固醇/磷脂:物质的量比率:时间点:血清/血浆:定量型	4182948
40758960	Arbitrary concentration; CETP; Chemistry; Chol; Choles; Cholest; Cholest est trnsfr prot; Cholesterol total; Cholesterols; Esters; Lipid; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40758960	Cholest est trnsfr prot SerPl-aCnc	4180186
40758960	胆固醇酯转移蛋白:任意型浓度:时间点:血清/血浆:定量型	4182948
40758963	Corticoster 24h Ur-sRate	4180186
40758963	1 day; 24 hours; 24HR; B; Chemistry; Compound B; Cort; Corticoster; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
40758963	皮质酮:物质的量速率:24小时:尿液:定量型	4182948
40758966	Cortis F 24h Ur RIA-mCnc	4180186
40758966	1 day; 17-Hydroxycorticosterone; 24 hours; 24HR; Chemistry; Compound F; Coritsol; Cort; Cortis F; F; FR; hydrocortisone; Level; Mass concentration; Non-protein bound; QNT; Quan; Quant; Quantitative; RADIOIMMUNOASSAY; UA; UR; Urn	4180186
40758966	皮质醇.游离型:质量浓度:24小时:尿液:定量型:放射免疫分析法	4182948
40758968	Cryoglob IgG moncl Ser Ql	4180186
40758968	Cryo; Cryoglob IgG; Cryoglob IgG moncl; Cryoglobulins; Cryoprecipitate; Immune globulin G; Immunoglobulin G; M-IgG; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
40758968	冷球蛋白.IgG.单克隆型:存在情况或阈值:时间点:血清:序数型	4182948
40758969	Cryo; Cryoglob IgG; Cryoglobulins; Cryoprecipitate; Immune globulin G; Immunoglobulin G; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
40758969	Cryoglob IgG Ser Ql	4180186
40758969	冷球蛋白.IgG:存在情况或阈值:时间点:血清:序数型	4182948
40758970	Cryo; Cryoglob IgM; Cryoglob IgM moncl; Cryoglobulins; Cryoprecipitate; Immune globulin M; Immunoglobulin M; M-IgM; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
40758970	Cryoglob IgM moncl Ser Ql	4180186
40758970	冷球蛋白.IgM.单克隆型:存在情况或阈值:时间点:血清:序数型	4182948
40758971	Vit B12 Ur-mCnc	4180186
40758971	C721; Cbl; Chemistry; Cobalamin; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Vit B12; Vitamin B12	4180186
40758971	钴胺素类:质量浓度:时间点:尿液:定量型	4182948
40758973	C12DC; C12-DC; Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40758973	Dicarboxydodecanoylcarn/Creat Ur-sRto	4180186
40758973	二羧基十二烷酰肉碱 (C12-DC)/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40758975	Dicarboxydodecanoylcarn Amn-sCnc	4180186
40758975	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C12DC; C12-DC; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40758975	二羧基十二烷酰肉碱 (C12-DC):物质的量浓度:时间点:羊水:定量型	4182948
40758977	C12DC; C12-DC; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40758977	Dicarboxydodecanoylcarn Ur-sCnc	4180186
40758977	二羧基十二烷酰肉碱 (C12-DC):物质的量浓度:时间点:尿液:定量型	4182948
40758982	Glutamate Hair-sCnt	4180186
40758982	c707; Chemistry; Glu; Glutamic acid; Har; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance content	4180186
40758982	谷氨酸:物质的量含量:时间点:毛发:定量型	4182948
40758983	Chemistry; Gly; Har; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance content	4180186
40758983	Glycine Hair-sCnt	4180186
40758983	甘氨酸:物质的量含量:时间点:毛发:定量型	4182948
40758984	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Glycolic acid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40758984	Glycolate Fld-mCnc	4180186
40758984	羟乙酸:质量浓度:时间点:体液:定量型	4182948
40758986	Glycolate Ur-sCnc	4180186
40758986	Chemistry; Glycolic acid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40758986	羟乙酸:物质的量浓度:时间点:尿液:定量型	4182948
40758987	B-HCG Free CSF-mCnc	4180186
40758987	B; B HCG; Beta HCG; Beta human chorionic gonadotropin; B-HCG; B-HCG Free; Cerebral spinal fluid; Cerebrospinal Fl; CG; Chemistry; Choriogonadotropin beta chain; Choriogonadotropins total; Chorionic gonadotropin; FR; HCG; Human chorionic gonadotropin; Level; Mass concentration; Non-protein bound; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Tumor marker	4180186
40758987	绒毛膜促性腺激素.Beta 亚单位.游离型:质量浓度:时间点:脑脊液:定量型	4182948
40758989	B-HCG MoM SerPl	4180186
40758989	B; B HCG; Beta HCG; Beta human chorionic gonadotropin; B-HCG; CG; Chemistry; Choriogonadotropin beta chain; Choriogonadotropins total; Chorionic gonadotropin; HCG; Human chorionic gonadotropin; MoM; Multiple of the median; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker	4180186
40758989	绒毛膜促性腺激素.Beta 亚单位:中位数的倍数:时间点:血清/血浆:定量型	4182948
40758991	HCG BldCo-aCnc	4180186
40758991	Arbitrary concentration; Blood - (umbilical) cord; CG; Chemistry; Choriogonadotropins total; Chorionic gonadotropin; Cord (umbilical) blood; Cord bld; Cord blood; HCG; Human chorionic gonadotropin; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40758991	绒毛膜促性腺激素:任意型浓度:时间点:脐带全血:定量型	4182948
40758992	Heptanoylcarn SerPl-sCnc	4180186
40758992	C7; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758992	庚酰肉碱 (C7):物质的量浓度:时间点:血清/血浆:定量型	4182948
40758994	C12:0; C16:0; Chemistry; Dodecanoate; Dodecanoic acid; Hexadecanoate; Hexadecanoic acid; Lauric acid; Palmitic acid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration ratio; Substance ratio	4180186
40758994	Palmitate/Laurate SerPl-sRto	4180186
40758994	棕榈酸/月桂酸:物质的量比率:时间点:血清/血浆:定量型	4182948
40758996	Homocitrulline CSF-sCnc	4180186
40758996	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Hci; HOMCIT; Homocit; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
40758996	同型瓜氨酸:物质的量浓度:时间点:脑脊液:定量型	4182948
40758997	Chemistry; Hci; HOMCIT; Homocit; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40758997	Homocitrulline SerPl-sCnc	4180186
40758997	同型瓜氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
40758998	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cardio; Cardiology; Chemistry; Fl; Fld; FLU; Fluid; HCY; Hcys; Hcyst; Heart Disease; Homocyst(e)ine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40758998	Hcys Fld-sCnc	4180186
40758998	同型半胱氨酸:物质的量浓度:时间点:体液:定量型	4182948
40759000	(Hcys)2 Fld-sCnc	4180186
40759000	(Hcys)2; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Homocyst(e)ine; Homocystin; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40759000	同型胱氨酸:物质的量浓度:时间点:体液:定量型	4182948
40759001	HVA Ser-sCnc	4180186
40759001	3-methoxy-4-hydroxy-phenylacetic acid; Chemistry; Homovanilic; Homovanillic acid; HVA; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Substance concentration; Tumor marker	4180186
40759001	同型香子兰酸:物质的量浓度:时间点:血清:定量型	4182948
40759002	Vit B12b SerPl-sCnc	4180186
40759002	Chemistry; Hydroxycobalamin; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Vit B12b; Vitamin B12; Vitamin B12b	4180186
40759002	羟钴胺素:物质的量浓度:时间点:血清/血浆:定量型	4182948
40759004	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Hydroxycobalamin; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Vit B12b; Vitamin B12; Vitamin B12b	4180186
40759004	Vit B12b Fld-mCnc	4180186
40759004	羟钴胺素:质量浓度:时间点:体液:定量型	4182948
40759005	Vit B12b Ur-sCnc	4180186
40759005	Chemistry; Hydroxycobalamin; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn; Vit B12b; Vitamin B12; Vitamin B12b	4180186
40759005	羟钴胺素:物质的量浓度:时间点:尿液:定量型	4182948
40759007	3-Hydroxy anthranilate; 3-Hydroxyanthranilic acid; 3OH-anthranilate; Chemistry; CR; Crea; Creat; III; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40759007	3OH-anthranilate/Creat Ur-sRto	4180186
40759007	3-羟邻氨苯甲酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40759010	3-Hydroxy anthranilate; 3-Hydroxyanthranilic acid; 3OH-anthranilate; Chemistry; III; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40759010	3OH-anthranilate Ur-sCnc	4180186
40759010	3-羟邻氨苯甲酸:物质的量浓度:时间点:尿液:定量型	4182948
40759011	AA; Acd; Acid; Amino acid; Amino acids.total; Chemistry; Har; Hydroxy lysine; Hydroxyl; OH-Lysine; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance fraction; Tot; Totl	4180186
40759011	OH-Lysine SFr Hair	4180186
40759011	羟基赖氨酸/氨基酸类.总计:物质的量分数:时间点:毛发:定量型	4182948
40759013	Adenine transaminase; AF; Amn; Amn fl; Amnc; Amnio; Amniotic flu; Amniotic fluid; Amniotic fluid cells; APRT; B4 Hemosan; Catalytic Concentration Ratio; Catalytic Ratio; CCrto; Chemistry; Enzymatic activity ratio; HGPRT; HPRT; hypoxanthine-guanine phosphoribosyltransferase; Leuco-4; Point in time; QNT; Quan; Quant; Quantitative; Random; Vit B4; Vitamin B4	4180186
40759013	HPRT/APRT Amnc-cRto	4180186
40759013	次黄嘌呤-鸟嘌呤磷酸核糖转移酶/腺嘌呤磷酸核糖转移酶:催化比率:时间点:羊水细胞:定量型	4182948
40759014	HPRT/APRT RBC-cRto	4180186
40759014	Adenine transaminase; APRT; B4 Hemosan; Catalytic Concentration Ratio; Catalytic Ratio; CCrto; Chemistry; Enzymatic activity ratio; Erythrocytes; HGPRT; HPRT; hypoxanthine-guanine phosphoribosyltransferase; Leuco-4; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Vit B4; Vitamin B4	4180186
40759014	次黄嘌呤-鸟嘌呤磷酸核糖转移酶/腺嘌呤磷酸核糖转移酶:催化比率:时间点:红细胞:定量型	4182948
40759016	Adenine transaminase; APRT; B4 Hemosan; Catalytic Concentration Ratio; Catalytic Ratio; CCrto; Chemistry; Chorionic villi; Chorionic villus sample; Enzymatic activity ratio; HGPRT; HPRT; hypoxanthine-guanine phosphoribosyltransferase; Leuco-4; Point in time; QNT; Quan; Quant; Quantitative; Random; Vit B4; Vitamin B4	4180186
40759016	HPRT/APRT CVS-cRto	4180186
40759016	次黄嘌呤-鸟嘌呤磷酸核糖转移酶/腺嘌呤磷酸核糖转移酶:催化比率:时间点:绒毛膜绒毛样本:定量型	4182948
40759017	Catalytic Content; Chemistry; Chorionic villi; Chorionic villus sample; HGPRT; HPRT; hypoxanthine-guanine phosphoribosyltransferase; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40759017	HPRT CVS-cCnt	4180186
40759017	次黄嘌呤-鸟嘌呤磷酸核糖转移酶:催化含量:时间点:绒毛膜绒毛样本:定量型	4182948
40759018	Bence Jones protein; BJ Protein; BJ Protein Free; BJP; Chain; Chemistry; FLC; FR; Hematology; Heme; IEP; Imm elect; Immune globulin; Immuno; Immunoelect; Immunoglob; Immunoglobin; Imunoglbon; Imunoglobn; Non-protein bound; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SIE; SIEP; SR	4180186
40759018	BJ Protein Free Ser Ql IEP	4180186
40759018	免疫球蛋白轻链.游离型:存在情况或阈值:时间点:血清:序数型:免疫电泳	4182948
40759026	1 day; 24 hours; 24HR; A-Cortol; Alfa; Chemistry; Level; Mass concentration; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40759026	A-Cortol 24h Ur-mCnc	4180186
40759026	Alpha 皮五醇:质量浓度:24小时:尿液:定量型	4182948
40759029	A-Galactosidase A DBS-cCnc	4180186
40759029	A-Galactosidase A; Alfa; Alpha galactosidase; Alpha-D-galactosidase; Blood; Catalytic Concentration; Chemistry; DBS; Dried blood spot; Filter paper; FP; GM1-gangliosidosis; Morquio disease type B; MPS IV B; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40759029	Alpha 半乳糖苷酶:催化浓度:时间点:全血.斑点:定量型	4182948
40759031	Alfa; Alpha mannosidosis; A-Mannosidase; Blood; Catalytic Concentration; Chemistry; DBS; Dried blood spot; Filter paper; FP; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40759031	A-Mannosidase DBS-cCnc	4180186
40759031	Alpha 甘露糖苷酶:催化浓度:时间点:全血.斑点:定量型	4182948
40759032	Arg; Chemistry; Har; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance content	4180186
40759032	Arginine Hair-sCnt	4180186
40759032	精氨酸:物质的量含量:时间点:毛发:定量型	4182948
40759034	Aspartate Hair-sCnt	4180186
40759034	Asp; Aspartic acid; Chemistry; Har; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance content	4180186
40759034	天门冬氨酸:物质的量含量:时间点:毛发:定量型	4182948
40759036	B; B2 globulin; Beta2 Glob; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; II; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
40759036	Beta2 Glob CSF Elph-mCnc	4180186
40759036	Beta 2 球蛋白:质量浓度:时间点:脑脊液:定量型:电泳	4182948
40759041	1 day; 24 hours; 24HR; Chemistry; Connecting peptide of insulin; Endocrine; Endocrinology; Level; Mass concentration; Pept; Pro-insulin c peptide; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40759041	C peptide 24h Ur-mCnc	4180186
40759041	C 肽:质量浓度:24小时:尿液:定量型	4182948
40759042	M-IgG Ser Ql IEP	4180186
40759042	Chemistry; IEP; Imm elect; Immune globulin G; Immunoelect; Immunoglobulin G; M-IgG; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SIE; SIEP; SR	4180186
40759042	IgG.单克隆型:存在情况或阈值:时间点:血清:序数型:免疫电泳	4182948
40759043	IgG Ser Elph-mCnc	4180186
40759043	Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759043	IgG:质量浓度:时间点:血清:定量型:电泳	4182948
40759044	1 day; 24 hours; 24HR; Chemistry; Immune globulin G; Immunoglobulin G; Mass rate; mRate; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40759044	IgG 24h Ur-mRate	4180186
40759044	IgG:质量速率:24小时:尿液:定量型	4182948
40759046	IgM Ser Elph-mCnc	4180186
40759046	Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Immune globulin M; Immunoglobulin M; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759046	IgM:质量浓度:时间点:血清:定量型:电泳	4182948
40759048	Alfa; CG Antigen-Specific Helper Factor; Chains; Chemistry; Chn; Epidermal Cell Derived Thymocyte-Activating Factor; ETAF; i; IL; IL1; IL-1; Il2RecepA; Level; Lymphocyte-Activating Factor; Lymphocyte-Stimulating Hormone; Macrophage Cell Factor; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rec; Recept; Receptors; Recp; Recptr; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sol IL1RA; SR; T Helper Factor	4180186
40759048	Sol IL1RA SerPl-mCnc	4180186
40759048	白细胞介素 1 受体 alpha 链.可溶性:质量浓度:时间点:血清/血浆:定量型	4182948
40759051	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40759051	Isovalerylgly Plas-sCnc	4180186
40759051	异戊酰甘氨酸:物质的量浓度:时间点:血浆:定量型	4182948
40759052	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Chemistry; Diaf; Dialysate; Dialysis fluid; Lact; Lactic acid; Level; L-lactate; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40759052	Lactate Dial fld-sCnc	4180186
40759052	乳酸:物质的量浓度:时间点:透析液:定量型	4182948
40759054	Leucine Hair-sCnt	4180186
40759054	Chemistry; Har; Leu; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance content	4180186
40759054	亮氨酸:物质的量含量:时间点:毛发:定量型	4182948
40759055	Catalytic Concentration; Chemistry; Diaf; Dialysate; Dialysis fluid; LIPA; Lipase; LPS; Pancreatic lipase; Point in time; QNT; Quan; Quant; Quantitative; Random; Steapsin; Tributyrase; Tributyrinase	4180186
40759055	Lipase Dial fld-cCnc	4180186
40759055	三酰基甘油脂肪酶:催化浓度:时间点:透析液:定量型	4182948
40759057	Lysozyme CSF-mCnc	4180186
40759057	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; k208; Level; Lysozymes; Mass concentration; Muramidase; N-Acetylmuramide Glycanhydrolase; nGal d 4 Lysozyme, Egg; Point in time; QNT; Quan; Quant; Quantitative; Random; Rk208; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
40759057	溶菌酶:质量浓度:时间点:脑脊液:定量型	4182948
40759058	Magnesium p dialysis SerPl-sCnc	4180186
40759058	After; Chemistry; Dialy; Level; MAG; Magnes; Mg; p dialysis; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40759058	镁^在透析之后:物质的量浓度:时间点:血清/血浆:定量型	4182948
40759059	Chemistry; Level; MAG; Magnes; Mg; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Total parental nutrition	4180186
40759059	Magnesium TPN-sCnc	4180186
40759059	镁:物质的量浓度:时间点:全面父母营养:定量型	4182948
40759060	Chemistry; Erythrocytes; MDA; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Substance content	4180186
40759060	Malondialdehyde RBC-sCnt	4180186
40759060	丙二醛:物质的量含量:时间点:红细胞:定量型	4182948
40759064	Chemistry; Har; Met; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance content	4180186
40759064	Methionine Hair-sCnt	4180186
40759064	蛋氨酸:物质的量含量:时间点:毛发:定量型	4182948
40759065	Neopterin 24h Ur-sRate	4180186
40759065	1 day; 24 hours; 24HR; Chemistry; Neopterine; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
40759065	新喋呤:物质的量速率:24小时:尿液:定量型	4182948
40759066	Neopterin 24h Ur-sCnc	4180186
40759066	1 day; 24 hours; 24HR; Chemistry; Level; Neopterine; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn	4180186
40759066	新喋呤:物质的量浓度:24小时:尿液:定量型	4182948
40759067	Neopterin Ur-sCnc	4180186
40759067	Chemistry; Level; Neopterine; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40759067	新喋呤:物质的量浓度:时间点:尿液:定量型	4182948
40759068	Chemistry; Diaf; Dialysate; Dialysis fluid; Level; Mass concentration; NO2; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40759068	Nitrite Dial fld-mCnc	4180186
40759068	亚硝酸盐:质量浓度:时间点:透析液:定量型	4182948
40759072	C8:1; Chemistry; CR; Crea; Creat; i; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40759072	Octenoylcarn/Creat Ur-sRto	4180186
40759072	辛烯酰肉碱 (C8:1)/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40759073	Octenoylcarn CSF-sCnc	4180186
40759073	C8:1; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; i; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
40759073	辛烯酰肉碱 (C8:1):物质的量浓度:时间点:脑脊液:定量型	4182948
40759074	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C8:1; Chemistry; i; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40759074	Octenoylcarn Amn-sCnc	4180186
40759074	辛烯酰肉碱 (C8:1):物质的量浓度:时间点:羊水:定量型	4182948
40759075	Octenoylcarn Ur-sCnc	4180186
40759075	C8:1; Chemistry; i; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40759075	辛烯酰肉碱 (C8:1):物质的量浓度:时间点:尿液:定量型	4182948
40759076	C18:1; Chemistry; CR; Crea; Creat; i; Octadecenoyl carnitine; Octadecenoylcarnitine; Oleoyl carnitine; Oleyl carnitine; Oleylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40759076	Oleoylcarn/Creat Ur-sRto	4180186
40759076	油酰肉碱 (C18:1)/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40759077	Oleoylcarn CSF-sCnc	4180186
40759077	C18:1; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; i; Level; Octadecenoyl carnitine; Octadecenoylcarnitine; Oleoyl carnitine; Oleyl carnitine; Oleylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
40759077	油酰肉碱 (C18:1):物质的量浓度:时间点:脑脊液:定量型	4182948
40759079	Oleoylcarn Ur-sCnc	4180186
40759079	C18:1; Chemistry; i; Level; Octadecenoyl carnitine; Octadecenoylcarnitine; Oleoyl carnitine; Oleyl carnitine; Oleylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40759079	油酰肉碱 (C18:1):物质的量浓度:时间点:尿液:定量型	4182948
40759083	Blood - (umbilical) cord; Chemistry; Cord (umbilical) blood; Cord bld; Cord blood; ctO2; Level; O2; O2 Ct; O2CT; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; tO2	4180186
40759083	O2 Ct BldCo-sCnc	4180186
40759083	氧含量:物质的量浓度:时间点:脐带全血:定量型	4182948
40759088	C16; Chemistry; Hexadecanoylcarnitine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40759088	Palmitoylcarn Ur-sCnc	4180186
40759088	棕榈酰肉碱 (C16):物质的量浓度:时间点:尿液:定量型	4182948
40759089	pH TPN	4180186
40759089	pH:对数型物质的量浓度:时间点:全面父母营养:定量型	4182948
40759089	Chemistry; Log molar concentration; Point in time; Random; SmQn; Total parental nutrition	4180186
40759090	AA; Acd; Acid; Amino acid; Amino acids.total; Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Percent; Phe; PKU; Point in time; PPA; QNT; Quan; Quant; Quantitative; Random; Substance fraction; Tot; Totl; WB; Whole blood	4180186
40759090	Phe SFr DBS	4180186
40759090	苯丙氨酸/氨基酸类.总计:物质的量分数:时间点:全血.斑点:定量型	4182948
40759092	Alk; Alk phos; Alkaline phos; Alkaline phosphatase.total; ALKP; ALP; AP; Blood - (umbilical) cord; Catalytic Concentration; Chemistry; Cord (umbilical) blood; Cord bld; Cord blood; Gyn; Gynecology; OB; ObGyn; Obstetrics; Phos; Phosphtase; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40759092	ALP BldCo-cCnc	4180186
40759092	碱性磷酸酶:催化浓度:时间点:脐带全血:定量型	4182948
40759093	After; Chemistry; Dialy; i Phos; Inorganic phosphate; Level; p dialysis; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; Pl; Plasma; Plsm; PO4; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40759093	Phosphate p dialysis SerPl-sCnc	4180186
40759093	磷酸盐^在透析之后:物质的量浓度:时间点:血清/血浆:定量型	4182948
40759096	IgG Fld ID-mCnc	4180186
40759096	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; ID; Imm; Immune globulin G; Immunodiff; Immunodiffusion; Immunoglobulin G; Imun; Imune; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40759096	IgG:质量浓度:时间点:体液:定量型:免疫扩散法	4182948
40759097	pH Fld.NB	4180186
40759097	pH:对数型物质的量浓度:时间点:液体.非生物性:定量型	4182948
40759097	Chemistry; Fld.NB; Log molar concentration; Point in time; Random; SmQn	4180186
40759101	R corr lens SBM sphere far by LM	4180186
40759101	by LM; Corr lens; Distance; EYE; EYE.GLASSES; Focimeter; Inverse Length; Lensometer; LM; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R corr lens; Random; RT	4180186
40759101	SBM 球面距离:长度倒数:时间点:矫正镜片.右侧:定量型:透镜屈光度计法	4182948
40759109	棱镜基准方向:角度:时间点:眼睛.右侧:定量型:综合屈光检查仪	4182948
40759109	by Phoropter; Eye; EYE.REFRACTION; Eyeball; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
40759109	R eye Prism base dist Phoropter	4180186
40759110	Eye; EYE.VISUAL_FIELD; Eyeball; Finding; Findings; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; R; R eye; Random; RT; Vision; Visual	4180186
40759110	R eye Pressure border code Perimetry	4180186
40759110	压力边界代码:发现:时间点:眼睛.右侧:名义型:视野测定法	4182948
40759111	Eye; EYE.VISUAL_FIELD; Eyeball; Finding; Findings; L; L eye; LT; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; Random; Vision; Visual	4180186
40759111	L eye GF border code Perimetry	4180186
40759111	GF 边界代码:发现:时间点:眼睛.左侧:名义型:视野测定法	4182948
40759112	by Phoropter; cmmt; cmnt; Cmnt N; Com; Comm; Comments; Commt; Eye; EYE.REFRACTION; Eyeball; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; R; R eye; Random; Remarks; Report; RT; Vision; Visual	4180186
40759112	Phoropter R eye Cmnt near vision	4180186
40759112	注释 N:印象:时间点:眼睛.右侧:叙述型:综合屈光检查仪	4182948
40759114	Cont lens; EYE; EYE.CONTACT_LENS; Identity or presence; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; R; R cont lens Rx; Random; RT; Rx	4180186
40759114	R cont lens Rx Linsensitz	4180186
40759114	Linsensitz:存在与否或特征标识:时间点:隐形眼镜处方.右侧:名义型	4182948
40759115	Cont lens; EYE; EYE.CONTACT_LENS; Identity or presence; L; L cont lens; LT; Narrative; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Report	4180186
40759115	L cont lens Producer text	4180186
40759115	制造商文本:存在与否或特征标识:时间点:隐形眼镜.左侧:叙述型	4182948
40759123	Adenosine 5'-Pyrophosphate; Adenosine Pyrophosphate; ADO; ADP; Agg; Aggr; ANED; Blood; Clopidogrel response assay; COAGULATION; Hematology; Heme; Left; Levo; Medication stress; P2Y12 Assay; P2Y12 inhibition; PA; PA ADP; PA ADP ATP secr; Pl; Platelets; Platelt; Plavix response assay; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
40759123	PA ADP ATP secr 5 umol/L Bld	4180186
40759123	血小板聚集.二磷酸腺苷诱导型 ATP 分泌^5 微摩尔/升:相对任意型浓度:时间点:全血:定量型	4182948
40759125	Adenosine 5'-Pyrophosphate; Adenosine Pyrophosphate; ADO; ADP; Agg; Aggr; ANED; Blood; Clopidogrel response assay; COAGULATION; Hematology; Heme; Left; Levo; Medication stress; Ordinal; P2Y12 Assay; P2Y12 inhibition; PA; PA ADP; PA ADP ATP secr; Pl; Platelets; Platelt; Plavix response assay; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
40759125	PA ADP ATP secr 5 umol/L Bld Ql	4180186
40759125	血小板聚集.二磷酸腺苷诱导型 ATP 分泌^5 微摩尔/升:存在情况或阈值:时间点:全血:序数型	4182948
40759127	Adenosine 5'-Pyrophosphate; Adenosine Pyrophosphate; ADO; ADP; Agg; Aggr; ANED; Blood; Clopidogrel response assay; COAGULATION; Hematology; Heme; Left; Levo; Medication stress; P2Y12 Assay; P2Y12 inhibition; PA; PA ADP; Pl; Platelets; Platelt; Plavix response assay; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
40759127	PA ADP 10 umol/L Bld	4180186
40759127	血小板聚集.二磷酸腺苷诱导型^10 微摩尔/升:相对任意型浓度:时间点:全血:定量型	4182948
40759129	Agg; Aggr; Blood; COAGULATION; Hematology; Heme; i; mcg; PA; PA Coll; Pl; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
40759129	PA Coll 1 ug/mL Bld	4180186
40759129	血小板聚集.胶原诱导型^1 微克/毫升:相对任意型浓度:时间点:全血:定量型	4182948
40759130	Agg; Aggr; Blood; COAGULATION; Hematology; Heme; mcg; PA; PA Coll; Pl; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
40759130	PA Coll 5 ug/mL Bld	4180186
40759130	血小板聚集.胶原诱导型^5 微克/毫升:相对任意型浓度:时间点:全血:定量型	4182948
40759132	Adenosine 5'-Pyrophosphate; Adenosine Pyrophosphate; ADO; ADP; Agg; Aggr; ANED; Blood; Clopidogrel response assay; COAGULATION; Hematology; Heme; Left; Levo; Medication stress; P2Y12 Assay; P2Y12 inhibition; PA; PA ADP; PA ADP ATP secr; Pl; Platelets; Platelt; Plavix response assay; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
40759132	PA ADP ATP secr 10 umol/L Bld	4180186
40759132	血小板聚集.二磷酸腺苷诱导型 ATP 分泌^10 微摩尔/升:相对任意型浓度:时间点:全血:定量型	4182948
40759134	5,8,11,14 Eicosatetraenoic acid; AA; Agg; Aggr; Arachidonic acid; Arch acid; Aspirin Assay; Blood; C20:4w6; COAGULATION; Eicosatetraenoate; Hematology; Heme; Left; Levo; PA; PA AA; PA AA ATP secr; Pl; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
40759134	PA AA ATP secr 500 umol/L Bld	4180186
40759134	血小板聚集.花生四烯酸诱导型 ATP 分泌^500 微摩尔/升:相对任意型浓度:时间点:全血:定量型	4182948
40759135	Agg; Aggr; Blood; COAGULATION; Hematology; Heme; mcg; PA; PA Coll; PA Coll ATP secr; Pl; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
40759135	PA Coll ATP secr 5 ug/mL Bld	4180186
40759135	血小板聚集.胶原诱导型 ATP 分泌^5 微克/毫升:相对任意型浓度:时间点:全血:定量型	4182948
40759136	Agg; Aggr; Blood; COAGULATION; Hematology; Heme; i; mcg; PA; PA Coll; PA Coll ATP secr; Pl; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
40759136	PA Coll ATP secr 1 ug/mL Bld	4180186
40759136	血小板聚集.胶原诱导型 ATP 分泌^1 微克/毫升:相对任意型浓度:时间点:全血:定量型	4182948
40759137	Agg; Aggr; Blood; COAGULATION; Hematology; Heme; i; mcg; Ordinal; PA; PA Coll; PA Coll ATP secr; Pl; Platelets; Platelt; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
40759137	PA Coll ATP secr 1 ug/mL Bld Ql	4180186
40759137	血小板聚集.胶原诱导型 ATP 分泌^1 微克/毫升:存在情况或阈值:时间点:全血:序数型	4182948
40759138	Agg; Aggr; Blood; COAGULATION; Hematology; Heme; mcg; Ordinal; PA; PA Coll; PA Coll ATP secr; Pl; Platelets; Platelt; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
40759138	PA Coll ATP secr 5 ug/mL Bld Ql	4180186
40759138	血小板聚集.胶原诱导型 ATP 分泌^5 微克/毫升:存在情况或阈值:时间点:全血:序数型	4182948
40759139	Agg; Aggr; Blood; COAGULATION; Hematology; Heme; Ordinal; PA; PA Thromb ATP secr; PA Thrombin; Pl; Platelets; Platelt; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Throm; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
40759139	PA Thromb ATP secr 5 U/mL Bld Ql	4180186
40759139	血小板聚集.凝血酶诱导型 ATP 分泌^5 单位/毫升:存在情况或阈值:时间点:全血:序数型	4182948
40759142	Agg; Aggr; Blood; COAGULATION; Hematology; Heme; i; Ordinal; PA; PA Thromb ATP secr; PA Thrombin; Pl; Platelets; Platelt; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Throm; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
40759142	PA Thromb ATP secr 1 U/mL Bld Ql	4180186
40759142	血小板聚集.凝血酶诱导型 ATP 分泌^1 单位/毫升:存在情况或阈值:时间点:全血:序数型	4182948
40759143	ACE1; angiotensin I converting enzyme; Blood; CD143; DCP; DCP1; Genetics; Heredity; Heritable; ICH; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; MVCD3; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40759143	ACE gene Mut Anl Bld/T	4180186
40759143	ACE 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40759147	300 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; PZA; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis	4180186
40759147	PZA 300 ug/mL Islt SlowMyco	4180186
40759147	吡嗪酰胺 300.0 微克/毫升:抗生素敏感性:时间点:分离株:定量型或序数型:针对慢长型分枝杆菌的方法	4182948
40759148	Agg; Aggr; Blood; COAGULATION; Hematology; Heme; PA; PA Rist; Pl; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RIPA; RlACnc; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
40759148	PA Rist 1.0 mg/mL Bld	4180186
40759148	血小板聚集.瑞斯托菌素诱导型^1.0 毫克/毫升:相对任意型浓度:时间点:全血:定量型	4182948
40759149	BM; BON; Bone marrow; CD3 Cells; CD3+CD56+ Cells; CD3-CD56+ Cells; Cell; CELL MARKERS; Cellularity; Gated cells; Leu19; Leu-19; Leu4; Leu-4; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Natural killer cells; NCAM; Neural cell adhesion molecule; NKH1; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T3	4180186
40759149	CD3-CD56+ Cells NFr Mar	4180186
40759149	细胞.CD3-CD56+/100 个细胞:计数型分数:时间点:骨髓:定量型	4182948
40759152	ANTIBIOTIC SUSCEPTIBILITIES; AST; Doribax; Finibax; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40759152	Doripenem Islt MIC	4180186
40759152	多尼培南:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
40759153	锂:物质的量浓度:时间点:胃液:定量型	4182948
40759153	Lithium, Bld Gast-sCnc	4180186
40759153	DRUG/TOXICOLOGY; Drugs; Eskalith; GAST; Gastric contents; Gastric fluid; Level; Li; Lithane; Lithium, Bld; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40759156	APO; Apo A; Apo A-I; ApoA1; Apolipo; Apolipoprot; Apolipoprotein A1; Apolipoproteins; Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; HDLc; HDL-C; Heart Disease; High density lipoprotein cholesterols; Lipid; Mass concentration ratio; Mass ratio; MCRto; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TCHHDL	4180186
40759156	Apo A-I/HDLc SerPl	4180186
40759156	载脂蛋白 A-I/胆固醇.HDL 之中的:质量比率:时间点:血清/血浆:定量型	4182948
40759158	Protein phosphatase 3 WBC-cCnc	4180186
40759158	Catalytic Concentration; Chemistry; III; Leukocytes; Phos; Phosphtase; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells	4180186
40759158	蛋白磷酸酯酶 3:催化浓度:时间点:白细胞:定量型	4182948
40759159	1 day; 24 hours; 24HR; Arbitrary rate; Chemistry; k208; Lysozymes; Muramidase; N-Acetylmuramide Glycanhydrolase; nGal d 4 Lysozyme, Egg; QNT; Quan; Quant; Quantitative; Rk208; UA; UR; Urn	4180186
40759159	Lysozyme 24h Ur	4180186
40759159	溶菌酶:任意型速率:24小时:尿液:定量型	4182948
40759161	Blood; Chemistry; Hemiglobin; Hi; Level; Methaemoglobin; MetHb; Methgb; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
40759161	MetHgb Bld-sCnc	4180186
40759161	高铁血红蛋白:物质的量浓度:时间点:全血:定量型	4182948
40759162	B; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal	4180186
40759162	Beta defensin Stool.wet-mCnt	4180186
40759162	Beta 防御素:质量含量:时间点:大便.湿:定量型	4182948
40759163	B; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal	4180186
40759163	Beta defensin Stool.dried-mCnt	4180186
40759163	Beta 防御素:质量含量:时间点:大便.干:定量型	4182948
40759165	Adduction AROM; AROM; H+P; H+P.PX; Horizontal adduction AROM; MSK; Musculoskeletal; Ortho; Orthopedics; P prime; Point in time; QNT; Quan; Quant; Quantitative; R; Random; Rnge; RT; Should-R; Upper extremity joint	4180186
40759165	Should-R Horizontal adduction AROM Qn	4180186
40759165	水平内收.主动运动范围:角度:时间点:肩关节.右侧:定量型	4182948
40759171	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40759173	Ethnicity; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40759174	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Sex	4180186
40759176	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Wt	4180186
40759178	@ birth; Bdy weight; Bdy wt &gt; or &lt; 5.5 lbs; bod; Bodies; Finding; Findings; New born; Newborn; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Wt	4180186
40759178	Birth wt > or < 5.5 lbs Reported	4180186
40759178	小于 5.5磅 (2500 g) 的体重^出生时:发现:时间点:^患者:序数型:报告法	4182948
40759179	Girth; HC; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40759180	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Upper extremity	4180186
40759182	Length; Lower extremity joint; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40759182	膝关节高度:长度:时间点:^患者:定量型	4182948
40759189	Pan; Panel; PANEL.PHENX; Panl; PhenX; Pnl; Point in time; Random; Wt	4180186
40759189	自我报告的最大成年体重:-:时间点:^患者:-	4182948
40759190	Bdy weight; bod; Bodies; Largest; Maximal; Maximum; Peak; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random; Wt	4180186
40759190	Body weight.max Reported	4180186
40759190	体重.最大值:质量:时间点:^患者:定量型:报告法	4182948
40759191	Age at body weight.max	4180186
40759191	Bdy weight; bod; Bodies; Largest; Maximal; Maximum; Peak; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random; Wt	4180186
40759191	年龄^当体重.最大值:时间:时间点:^患者:定量型	4182948
40759193	Girth; Humerus; Length; Mid Upper arm-R; PhenX; Point in time; QNT; Quan; Quant; Quantitative; R; Random; RT; Up; Upper extremity	4180186
40759193	Circumf Mid Upper arm-R	4180186
40759193	周长:长度:时间点:上臂.中部.右侧:定量型	4182948
40759194	Girth; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40759196	Gestation; Gestations; Gravida; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Pregnancies; Random; Wt; Wt gain	4180186
40759201	Wt gain most recent preg	4180186
40759201	Gestation; Gestations; Gravida; PhenX; Point in time; Pregnancies; QNT; Quan; Quant; Quantitative; Random; Wt; Wt gain	4180186
40759201	体重增加^在最近妊娠过程中:质量:时间点:^患者:定量型	4182948
40759203	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Wt	4180186
40759208	Child Waist Circumf	4180186
40759208	Girth; Pan; Panel; PANEL.PHENX; Panl; PhenX; Pnl; Point in time; Random	4180186
40759208	儿童腰围方案:-:时间点:^患者:-	4182948
40759210	Gestation; Gestations; Gravida; Pan; Panel; PANEL.PHENX; Panl; PhenX; Pnl; Point in time; Pregnancies; Random; Wt; Wt gain	4180186
40759210	妊娠期体重增加.最近:-:时间点:^患者:-	4182948
40759211	ADMIN; ADMIN.PATIENT; ADMIN.PT.DEMOG; Nominal; Point in time; Random; Spanish origin; Typ	4180186
40759211	西班牙裔血统:类型:时间点:^患者:名义型	4182948
40759213	@ birth; Bdy weight; bod; Bodies; BODY WEIGHT.MOLEC; New born; Newborn; Point in time; QNT; Quan; Quant; Quantitative; Random; Wt	4180186
40759213	体重^出生时:质量:时间点:^患者:定量型:GNWCH	4182948
40759215	@ birth; Bdy weight; bod; Bodies; H+P; New born; Newborn; P prime; Pan; Panel; PANEL.H&P; Panl; Pnl; Point in time; Random; Wt	4180186
40759215	Birth weight NHANES	4180186
40759215	体重^出生时:-:时间点:^患者:-:NHANES	4182948
40759216	@ birth; Bdy weight; Bdy wt &gt; or &lt; 9 lbs; bod; Bodies; Finding; Findings; New born; Newborn; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Wt	4180186
40759216	Birth wt > or < 9 lbs Reported	4180186
40759216	小于 9.0磅 (4100 g) 的体重^出生时:发现:时间点:^患者:序数型:报告法	4182948
40759218	Finding; Findings; Hand dom- drawing; Nominal; PhenX; Point in time; Random; Upper extremity	4180186
40759218	Hand dom- drawing ALSPAC	4180186
40759218	手部优势 - 绘画:发现:时间点:^患者:名义型:ALSPAC	4182948
40759222	Hand dom- 12Y proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Upper extremity	4180186
40759222	Hand dom- 12Y proto EHI	4180186
40759222	PhenX - 手部优势 - 12 岁及其以上方案 020602:-:时间点:^患者:-:爱丁堡利手量表	4182948
40759223	Finding; Findings; Hand dom- write; Nominal; PhenX; Point in time; Random; Upper extremity	4180186
40759223	Hand dom- write EHI	4180186
40759223	手部优势 - 书写:发现:时间点:^患者:名义型:爱丁堡利手量表	4182948
40759224	Finding; Findings; Hand dom- draw; Nominal; PhenX; Point in time; Random; Upper extremity	4180186
40759224	Hand dom- draw EHI	4180186
40759224	手部优势 - 绘画:发现:时间点:^患者:名义型:爱丁堡利手量表	4182948
40759225	Hand dom- throw EHI	4180186
40759225	Finding; Findings; Hand dom- throw; Nominal; PhenX; Point in time; Random; Upper extremity	4180186
40759225	手部优势 - 投掷:发现:时间点:^患者:名义型:爱丁堡利手量表	4182948
40759226	Finding; Findings; Hand dom- hold a racquet; Nominal; PhenX; Point in time; Random; Upper extremity	4180186
40759226	Hand dom- hold a racquet EHI	4180186
40759226	手部优势 - 手持球拍:发现:时间点:^患者:名义型:爱丁堡利手量表	4182948
40759227	Finding; Findings; Hand dom- clean teeth; Nominal; PhenX; Point in time; Random; Upper extremity	4180186
40759227	Hand dom- clean teeth EHI	4180186
40759227	手部优势 - 清洁牙齿:发现:时间点:^患者:名义型:爱丁堡利手量表	4182948
40759228	Finding; Findings; Hand dom- hammer; Nominal; PhenX; Point in time; Random; Upper extremity	4180186
40759228	Hand dom- hammer EHI	4180186
40759228	手部优势 - 用锤子击打:发现:时间点:^患者:名义型:爱丁堡利手量表	4182948
40759229	Hand dom- strike a match EHI	4180186
40759229	Finding; Findings; Hand dom- strike a match; Nominal; PhenX; Point in time; Random; Upper extremity	4180186
40759229	手部优势 - 划火柴:发现:时间点:^患者:名义型:爱丁堡利手量表	4182948
40759230	Finding; Findings; Hand dom- use an eraser; Nominal; PhenX; Point in time; Random; Upper extremity	4180186
40759230	Hand dom- use an eraser EHI	4180186
40759230	手部优势 - 使用橡皮:发现:时间点:^患者:名义型:爱丁堡利手量表	4182948
40759231	Hand dom- deal cards EHI	4180186
40759231	Finding; Findings; Hand dom- deal cards; Nominal; PhenX; Point in time; Random; Upper extremity	4180186
40759231	手部优势 - 发牌:发现:时间点:^患者:名义型:爱丁堡利手量表	4182948
40759233	Finding; Findings; Hand dom- cut food with a knife; Nominal; PhenX; Point in time; Random; Upper extremity	4180186
40759233	Hand dom- cut food with a knife EHI	4180186
40759233	手部优势 - 用刀切割食物:发现:时间点:^患者:名义型:爱丁堡利手量表	4182948
40759234	Hand dom- Total score; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Tot; Totl; Upper extremity	4180186
40759234	Hand dom- Total score EHI	4180186
40759234	手部优势 - 总评分:评分:时间点:^患者:定量型:爱丁堡利手量表	4182948
40759237	H+P; H+P.PX; Length; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Upper extremity	4180186
40759237	宽度:长度:时间点:臂展:定量型	4182948
40759239	Nominal; Person name; PhenX; Point in time; Random	4180186
40759239	代理人姓名:人员姓名:时间点:^代理人:名义型	4182948
40759240	Calc; Calculi; Cell material; Est; estimation; Gastro; Gastroenterology; GI; Kidney; Mass Content; Nephrology; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; SPEC; Stn; Stone; Stones	4180186
40759240	Cell material Stone Est-mCnt	4180186
40759240	蜂窝材料:质量含量:时间点:结石:定量型:估计法	4182948
40759241	Addiction; Amph; Amphet; Amphet+Methamphet; Amphetam; Amphetamines; Ampht; Desoxyn; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Methamphet; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Speed; UA; UR; Urn	4180186
40759241	Amphet+Methamphet Ur-mCnc	4180186
40759241	苯丙胺+甲基苯丙胺:质量浓度:时间点:尿液:定量型	4182948
40759247	Copper Liver-mCnt	4180186
40759247	Chemistry; Cu; Hepar; Hepatic; Hepatic liver concentration; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40759247	铜:质量含量:时间点:肝脏:定量型	4182948
40759248	ADP-ribosyl cyclase; Antigen; Antigens; CELL MARKERS; Cyclic ADP-ribose hydrolase; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Leu17; Leu-17; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; T10; Tissue; Tissue, unspecified	4180186
40759248	CD38 Ag Tiss Ql ImStn	4180186
40759248	CD38 抗原:存在情况或阈值:时间点:组织与涂片:序数型:免疫染色法	4182948
40759250	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CHIKV; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Time Resolved Fluorescence; TRF	4180186
40759250	CHIKV IgG SerPl Ql IF	4180186
40759250	基孔肯亚病毒 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:免疫荧光法	4182948
40759251	CHIKV IgM Titr SerPl IF	4180186
40759251	基孔肯亚病毒 抗体.IgM:滴定度:时间点:血清/血浆:定量型:免疫荧光法	4182948
40759251	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CHIKV; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40759254	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; HDLc; HDL-C; HDLc 2b; Heart Disease; High density lipoprotein cholesterols; Level; Lipid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; TCHHDL	4180186
40759254	HDLc 2b SerPl-sCnc	4180186
40759254	胆固醇.HDL 2b 之中的:物质的量浓度:时间点:血清/血浆:定量型	4182948
40759255	Beta VLDL; Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; i; IDL1c; IDLc; Intermediate density lipoprotein cholesterols; Level; Lipid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40759255	IDL1c SerPl-sCnc	4180186
40759255	胆固醇.IDL 1 之中的:物质的量浓度:时间点:血清/血浆:定量型	4182948
40759256	Beta VLDL; Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; IDL2c; IDLc; II; Intermediate density lipoprotein cholesterols; Level; Lipid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40759256	IDL2c SerPl-sCnc	4180186
40759256	胆固醇.IDL 2 之中的:物质的量浓度:时间点:血清/血浆:定量型	4182948
40759263	Arbitrary; Blood; CD110; C-MPL; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; MPL p.W515L+W515K; MPL proto-oncogene, thrombopoietin receptor; MPLV; MYELOPROLIFERATIVE LEUKEMIA VIRUS ONCOGENE; Ordinal; P prime; PCR; Point in time; QL; Qual; Qualitative; Random; Screen; THCYT2; thrombopoietin receptor mutations; Tissue; Tissue, unspecified; TPOR; Trp515Leu; Trp515Lys; WB; Whole blood; Whole blood or Tissue	4180186
40759263	MPL p.W515L+W515K Bld/T Ql	4180186
40759263	MPL 基因.p.W515L+W515K:任意型:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40759267	Fungal Ab Pnl; ID; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Serum; SR; UniversalLabOrders	4180186
40759267	Fungal Ab Pnl Ser	4180186
40759267	真菌抗体组套:-:时间点:血清:-	4182948
40759269	ANA; ANF; Antinuclear antibody; ENA; ENA Ab Pnl; ENA RNP; ENA SM; ENA SM + RNP; ENA SM+RNP; NA; Nuc; Pan; PANEL.SEROLOGY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Ribonuclear protein; RNP; Ro; Serology; Serum; SM; SR	4180186
40759269	ENA SM + RNP Ser	4180186
40759269	Smith 可提取性核抗体与核糖核蛋白可提取性核抗体组套:-:时间点:血清:定量型	4182948
40759270	ACA; aCL; Anticardiolipin; Antiphospholipid panel; B; B2GPI+Cardiolipin Ab+PS Pnl; Cardio; Cardiolip; Cardiolipn; Cardiolpn; CL; COAGULATION; gG; Glycoprot; Glycoproteins; GP; II; Pan; PANEL.COAGULATION; Panl; Phosphatidyl serine; Pnl; Point in time; PS; Random; Serum; SR	4180186
40759270	B2GPI+Cardiolipin Ab+PS Pnl Ser	4180186
40759270	Beta 2 糖蛋白 与 心磷脂抗体 与 磷脂酰丝氨酸 组套:-:时间点:血清:-	4182948
40759271	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; C albicans; Cand; Candidiasis; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; m005; m5; Microbiology; Monilia; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Thrush	4180186
40759271	C albicans IgM Ser-aCnc	4180186
40759271	白色假丝酵母 抗体.IgM:任意型浓度:时间点:血清:定量型	4182948
40759272	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; C albicans; Cand; Candidiasis; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; m005; m5; Microbiology; Monilia; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Thrush	4180186
40759272	C albicans IgA Ser-aCnc	4180186
40759272	白色假丝酵母 抗体.IgA:任意型浓度:时间点:血清:定量型	4182948
40759273	APOH; Apolipoprotein H; B; B2 glycoprot 1 IgA+IgG+IgM Pnl; B2 Glycoprot1; B2 glycoprotein 1; B2GPI; B2-GPI; COAGULATION; gG; Glycoprot; Glycoproteins; GP; Hematology; Heme; i; II; Immune globulin A; Immune globulin G; Immune globulin M; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Pan; PANEL.COAGULATION; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759273	B2 glycoprot 1 IgA+IgG+IgM Pnl Ser	4180186
40759273	Beta 2 糖蛋白 1 抗体.IgA 与 IgG 与 IgM 组套:-:时间点:血清:定量型	4182948
40759274	Alb; Alb Prt; Alb Ser; albumin gradient; Albumin ser-prt fld; Ascites; Ascitic fluid; Ascitis; Chemistry; Periton fld+SerPl; Peritoneal fluid; Pl; Plasma; Plsm; Point in time; Protein.albumin; Prt; QNT; Quan; Quant; Quantitative; Random; Relative ratio; SAAG; Ser; SerP; SerPl; SerPlas; Serum; Serum or plasma; serum-ascites albumin gradient; SR	4180186
40759274	Albumin.Serum/Prt	4180186
40759274	白蛋白.血清/白蛋白.腹膜液:相对比率:时间点:腹膜液+血清/血浆:定量型	4182948
40759275	Abn Prot MFr SerPl Elph	4180186
40759275	abn; Abn Prot; abnorm; Bands; bnd; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Mass fraction; Percent; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEP; SR; Tot; Totl; TP	4180186
40759275	蛋白质.异常区带/蛋白质.总计:质量分数:时间点:血清/血浆:定量型:电泳	4182948
40759277	C albicans; C albicans IgA+IgG+IgM Pnl; Cand; Candidiasis; Gm5; ID; Immune globulin A; Immune globulin G; Immune globulin M; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; m005; m5; Microbiology; Monilia; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Thrush	4180186
40759277	C albicans IgA+IgG+IgM Pnl Ser	4180186
40759277	白色假丝酵母抗体.IgA 与 IgG 与 IgM 组套:-:时间点:血清:定量型	4182948
40759280	Blood; FH; FHC; Genetics; Heredity; Heritable; Identity or presence; Inherited; LDLCQ2; Low Density Lipoprotein Receptor; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40759280	LDLR gene Mut Anl Bld/T	4180186
40759280	LDLR 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40759281	4h p PD; After; Chemistry; Diaf; DiafP; Dialy; Dialysate; Dialysis fluid; Glu; Gluc; Glucoseur; Level; Mass concentration; Peritoneal Dialysis fluid; Point in time; PST; QNT; Quan; Quant; Quantitative; Random	4180186
40759281	Glucose 4h p PD DiafP-mCnc	4180186
40759281	葡萄糖^在腹膜透析之后4小时:质量浓度:时间点:腹膜透析液:定量型	4182948
40759285	Blood; CPC9; CYP2C; CYP2C10; CYP2C9 allele; CYP2C9 allele 2; CYPIIC9; Cytochrome P450 2C9 Genotyping; cytochrome P450, family 2, subfamily C, polypeptide 9; Genetics; Heredity; Heritable; Identity or presence; II; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Nominal; P450IIC9; PCR; Point in time; Random; WB; Whole blood	4180186
40759285	CYP2C9 allele 2 Bld	4180186
40759285	CYP2C9 基因 等位基因 2:存在与否或特征标识:时间点:全血:名义型:分子遗传学类实验室方法	4182948
40759291	A alternata; A tenuis; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Alternaria tenuis; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; m006; m6; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759291	A alternata IgG4-mCnc	4180186
40759291	链格孢 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759294	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Amer Roach; American cockroach; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; i100; i206; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Ri206; Serum; SR	4180186
40759294	Amer Roach IgG4-mCnc	4180186
40759294	美洲大蠊 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759296	Amer Sycamore IgG4-mCnc	4180186
40759296	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Amer Sycamore; American sycamore; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Eastern sycamore; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Sycamore; t061; t61	4180186
40759296	美国梧桐 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759297	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Apple; Autoantibodies; Autoantibody; f049; f49; Level; Mass concentration; Point in time; Pyrus malus; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759297	Apple IgG4-mCnc	4180186
40759297	苹果 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759299	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Artichoke; Autoantibodies; Autoantibody; f358; f361; Globe artichoke; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759299	Artichoke IgG4-mCnc	4180186
40759299	洋蓟 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759301	A fumigatus; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Asperg; Aspergil; Aspergilis; Aspergilla; Aspergillin; Aspergillosis; Aspergils; Aspergilus; Autoantibodies; Autoantibody; Farmers lung; Fum; Level; m003; m3; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759301	A fumigatus IgG4-mCnc	4180186
40759301	烟曲霉 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759302	A niger IgG4-mCnc	4180186
40759302	A niger; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Asperg; Aspergil; Aspergilis; Aspergilla; Aspergillin; Aspergillosis; Aspergils; Aspergilus; Autoantibodies; Autoantibody; Farmers lung; Level; m207; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759302	黑曲霉 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759303	A versicolor IgG4-mCnc	4180186
40759303	A versicolor; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Asperg; Aspergil; Aspergilis; Aspergilla; Aspergillin; Aspergillosis; Aspergils; Aspergilus; Autoantibodies; Autoantibody; Farmers lung; Level; m019; m19; m25; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759303	杂色曲霉 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759305	Avocado IgG4-mCnc	4180186
40759305	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Alligator pear; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avocado; f096; f96; Level; Mass concentration; Point in time; Prickly pear; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759305	美国鳄梨 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759307	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Banana; f092; f92; Level; Mass concentration; Musa sp; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759307	Banana IgG4-mCnc	4180186
40759307	芭蕉属多个未知种 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759311	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bermuda grass; g002; g2; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759311	Bermuda grass IgG4-mCnc	4180186
40759311	狗牙根 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759313	Bass IgG4-mCnc	4180186
40759313	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bass; Black bass; Chub; f368; Largemouth bass; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759313	鲈鱼 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759315	Blackberry IgG4-mCnc	4180186
40759315	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blackberry; f022; f211; f22; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf211; Serum; SR	4180186
40759315	黑莓 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759317	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blue berry; Blueberry; f288; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf288; Serum; SR	4180186
40759317	Blueberry IgG4-mCnc	4180186
40759317	蓝莓 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759318	Insulin Bovine IgG4-mCnc	4180186
40759318	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Beef; c071; c71; HUM; Humulin; IH7; Insul; Lente; Level; Mass concentration; NPH; Point in time; QNT; Quan; Quant; Quantitative; Random; Semilente; Serum; Sliding; SR; Ultralente	4180186
40759318	牛胰岛素 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759320	Brewer's yeast IgG4-mCnc	4180186
40759320	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Brewer's yeast; f155; Level; Mass concentration; MNSs Blood Group System; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; Saccharomyces carlsbergensis; Sacchromyces sp; Serum; SR	4180186
40759320	啤酒酵母 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759325	C albicans IgG4-mCnc	4180186
40759325	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C albicans; Cand; Candidiasis; Level; m005; m5; Mass concentration; Monilia; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Thrush	4180186
40759325	白色假丝酵母 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759326	Careless Weed IgG4-mCnc	4180186
40759326	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Careless weed; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; w082; w82	4180186
40759326	长芒苋 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759332	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Catfish; f369; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759332	Catfish IgG4-mCnc	4180186
40759332	鲶鱼 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759333	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cauliflower; f291; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf291; Serum; SR	4180186
40759333	Cauliflower IgG4-mCnc	4180186
40759333	花椰菜 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759338	Chick Pea IgG4-mCnc	4180186
40759338	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Besan; Chick pea; Chickpea; f309; Garbanzo bean; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf309; Serum; SR	4180186
40759338	鹰嘴豆 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759341	Chili Pepper IgG4-mCnc	4180186
40759341	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chili pepper; f279; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf279; Serum; SR	4180186
40759341	辣椒 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759342	Chinese Elm IgG4-mCnc	4180186
40759342	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chinese elm; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Siberian elm; SR; t038; t38	4180186
40759342	榔榆 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759347	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cocklebur; Common cocklebur; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; w013; w13	4180186
40759347	Cocklebur IgG4-mCnc	4180186
40759347	苍耳 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759348	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Coconut; f036; f36; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759348	Coconut IgG4-mCnc	4180186
40759348	椰子 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759351	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Common reed; Common reed grass; g007; g7; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759351	Common Reed IgG4-mCnc	4180186
40759351	芦苇 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759357	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cranberry; f177; f341; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf341; Serum; SR; Vaccinium oxycoccus	4180186
40759357	Cranberry IgG4-mCnc	4180186
40759357	酸果蔓 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759362	D farinae IgG4-mCnc	4180186
40759362	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; American house dust mite; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; D farinae; d002; d2; Dermatophagoides farianae; HDM; House dust mite; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759362	粉尘螨 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759363	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; D pteronyss; D pteronyssinus; d001; d1; European house dust mite; HDM; House dust mite; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759363	D pteronyss IgG4-mCnc	4180186
40759363	屋尘螨 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759364	Dandelion IgG4-mCnc	4180186
40759364	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dandelion; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; w008; w8	4180186
40759364	窄苞蒲公英 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759365	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Date; Dates; f289; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf289; Serum; SR	4180186
40759365	Dates IgG4-mCnc	4180186
40759365	海枣 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759369	Dog Dander IgG4-mCnc	4180186
40759369	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Canine; Dog hair; e005; e5; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759369	狗毛屑 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759373	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Eel; f264; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf264; Serum; SR	4180186
40759373	Eel IgG4-mCnc	4180186
40759373	鳗鲡 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759374	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f001; f1; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759374	Egg White IgG4-mCnc	4180186
40759374	蛋清 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759376	Whole Egg IgG4-mCnc	4180186
40759376	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f245; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Whole Egg; Yolk+White	4180186
40759376	全卵 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759378	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Buckhorn plantain; Engl plantain; English plantain; Level; Mass concentration; Plantain Buckhorn; Point in time; QNT; Quan; Quant; Quantitative; Random; Ribwort; Serum; SR; w009; w9	4180186
40759378	Engl plantain IgG4-mCnc	4180186
40759378	长叶车前 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759380	Epid Allerg Mix71 IgG4-mCnc	4180186
40759380	(鸡羽毛+鸭羽毛+鹅羽毛+吐绶鸡羽毛) 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759380	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dander; e070; e085; e086; e70; e85; e86; e89; EP71; Epid Allerg Mix A; Epid Allerg Mix71; ex71; f083; f158; f83; Feather mix; Feathers; Gallus spp; Level; Mass concentration; Meleagis gallopavo; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759385	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; d073; d73; G domesticus; Glycyphagus domesticus; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Storage mite	4180186
40759385	G domesticus IgG4-mCnc	4180186
40759385	家甜食螨 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759387	Roach IgG4-mCnc	4180186
40759387	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B germanica; Cockroach; German cockroach; i006; i6; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Roach; Serum; SR	4180186
40759387	德国小蠊 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759390	Goat Milk IgG4-mCnc	4180186
40759390	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f300; f409; f43; Goat's milk; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf300; Serum; SR	4180186
40759390	山羊奶 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759393	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e070; e70; f158; Feathers; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759393	Goose Feather IgG4-mCnc	4180186
40759393	鹅羽毛 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759394	Grape IgG4-mCnc	4180186
40759394	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f259; Grape; Grapes; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759394	葡萄 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759396	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Beans; f315; Green Bean; Level; Mass concentration; Phaseolus vulgaris; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf315; Serum; SR	4180186
40759396	Green Bean IgG4-mCnc	4180186
40759396	青豆 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759399	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f152; f263; f335; Green Pepper; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf263; Serum; SR	4180186
40759399	Green Pepper IgG4-mCnc	4180186
40759399	青辣椒 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759401	Haddock IgG4-mCnc	4180186
40759401	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f042; f42; Haddock; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759401	黑线鳕 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759407	Honey bee IgG4-mCnc	4180186
40759407	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Honey bee; Honeybee; i001; i1; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759407	意大利蜜蜂 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759410	Horseradish IgG4-mCnc	4180186
40759410	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cochlearia armoracia; f375; Horseradish; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759410	辣根 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759415	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; g010; g10; Johnson grass; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759415	Johnson grass IgG4-mCnc	4180186
40759415	石茅高梁 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759419	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chinese gooseberry; f084; f84; Kiwi fruit; Kiwifruit; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759419	Kiwifruit IgG4-mCnc	4180186
40759419	中华猕猴桃 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759421	L destructor IgG4-mCnc	4180186
40759421	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; d071; d71; L destructor; Level; Mass concentration; Mite; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Storage mite	4180186
40759421	害嗜鳞螨 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759426	Lenscale IgG4-mCnc	4180186
40759426	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Lenscale; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Serum; SR; w015; w15	4180186
40759426	大滨藜 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759430	Lime IgG4-mCnc	4180186
40759430	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f306; Level; Lime; Mass Concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf306; Serum; SR	4180186
40759430	来檬 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759431	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f080; f80; Level; Lobster; Mass Concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759431	Lobster IgG4-mCnc	4180186
40759431	大螯虾 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759433	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f090; f90; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759433	Malt IgG4-mCnc	4180186
40759433	麦芽 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759434	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f091; f91; Level; Mango; Mass Concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759434	Mango IgG4-mCnc	4180186
40759434	芒果 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759436	A negundo; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Box elder; Boxelder; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t001; t1	4180186
40759436	Boxelder IgG4-mCnc	4180186
40759436	羽叶槭 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759437	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; Marsh Elder; Mass Concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rough marsh elder; Rough marshelder; Serum; SR; w016; w16	4180186
40759437	Marsh Elder IgG4-mCnc	4180186
40759437	沼泽地松 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759439	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; g016; g16; Level; Mass concentration; Meadow Foxtail; Meadow foxtail grass; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759439	Meadow Foxtail IgG4-mCnc	4180186
40759439	草原看麦娘 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759441	Mesquite IgG4-mCnc	4180186
40759441	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Honey locust; Level; Mass concentration; Mesquite; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t020; t20	4180186
40759441	柔黄花牡豆树 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759446	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; Mass concentration; Mugwort; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; w006; w6	4180186
40759446	Mugwort IgG4-mCnc	4180186
40759446	北艾 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759447	Mushroom IgG4-mCnc	4180186
40759447	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Champignon; f212; Level; Mass concentration; Mushroom; Mushrooms; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf212; Serum; SR	4180186
40759447	香蕈 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759451	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; Mass concentration; Nettle; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; w20	4180186
40759451	Nettle IgG4-mCnc	4180186
40759451	异株荨麻 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759452	Food Allerg Mix46 IgG4-mCnc	4180186
40759452	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Carya pecan; Cashew; Cashew nut; Chestnut; European chestnut; f202; f203; f256; f299; Food Allerg Mix46; fx46; Green almond; Hickory; Juglans sp; Level; Mass concentration; Pecan; Pecan/Hick; Pistachio; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Sweet chestnut; Walnut; Walnuts	4180186
40759452	(腰果+美洲山核桃+欧洲板栗+胡桃+阿月浑子) 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759455	Oat Poln IgG4-mCnc	4180186
40759455	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cult; Cultivated oat; Cultivated oat grass; f007; f7; g014; g14; Level; Mass concentration; Oat; Oat Poln; Oats; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759455	栽培燕麦花粉 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759456	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; bamia; Bhindi; Bindi; f379; Gumbo; Hibiscus esculentus; lady's finger; Level; Mass concentration; Okra; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759456	Okra IgG4-mCnc	4180186
40759456	黄秋葵 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759459	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f033; f33; Level; Mass concentration; Orange; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759459	Orange IgG4-mCnc	4180186
40759459	甜橙 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759462	Ox-eye daisy IgG4-mCnc	4180186
40759462	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chrysanthemum laucanthemum; Level; Marguerite; Mass concentration; Ox-eye daisy; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; w007; w7	4180186
40759462	滨菊 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759463	Oyster IgG4-mCnc	4180186
40759463	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f290; Level; Mass concentration; Oyster; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759463	牡蛎 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759466	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f218; Level; Mass concentration; Paprika; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Sweet pepper	4180186
40759466	Paprika IgG4-mCnc	4180186
40759466	菜椒 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759467	Parmesan IgG4-mCnc	4180186
40759467	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f067; f67; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759467	巴尔马干酪 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759469	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f086; f86; Level; Mass concentration; Parsley; Petrosilenum crispum; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759469	Parsley IgG4-mCnc	4180186
40759469	皱叶欧芹 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759470	Parsnip IgG4-mCnc	4180186
40759470	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f380; Level; Mass concentration; Parsnip; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759470	美国防风 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759472	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f013; f13; Level; Mass concentration; Peanut; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759472	Peanut IgG4-mCnc	4180186
40759472	落花生 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759473	Pear IgG4-mCnc	4180186
40759473	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f094; f94; Level; Mass concentration; Pear; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759473	西洋梨 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759474	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Carya pecan; f201; Hickory; Level; Mass concentration; Nuts; Pecan; Pecan/Hick; Pecan/Hick Nut; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759474	Pecan/Hick Nut IgG4-mCnc	4180186
40759474	美洲山核桃 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759476	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; m001; m1; Mass concentration; P chrysogenum; P notatum; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759476	P notatum IgG4-mCnc	4180186
40759476	特异青霉 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759478	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; g005; g5; Italian Ryegrass; Level; Mass concentration; Per rye grass; Perennial ryegrass; Point in time; QNT; Quan; Quant; Quantitative; Random; Rye grass; Ryegrass; Serum; SR	4180186
40759478	Per rye grass IgG4-mCnc	4180186
40759478	多年生黑麦草 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759483	Poppy Seed IgG4-mCnc	4180186
40759483	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f224; Level; Mass concentration; Point in time; Poppy seed; QNT; Quan; Quant; Quantitative; Random; Rf224; Serum; SR	4180186
40759483	罂粟籽 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759484	Insulin Porcine IgG4-mCnc	4180186
40759484	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c070; c70; HUM; Humulin; IH7; Insul; Lente; Level; Mass concentration; NPH; Point in time; Pork; QNT; Quan; Quant; Quantitative; Random; Semilente; Serum; Sliding; SR; Swine; Ultralente	4180186
40759484	猪胰岛素 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759485	Povertyweed IgG4-mCnc	4180186
40759485	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; Mass concentration; Point in time; Poverty weed; Povertyweed; QNT; Quan; Quant; Quantitative; Random; Serum; SR; w042; w42	4180186
40759485	小花假苍耳 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759493	West Ragweed IgG4-mCnc	4180186
40759493	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; w002; w2; West Ragweed; Western ragweed	4180186
40759493	多年生豚草 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759494	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f343; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Raspberry; Rf343; Serum; SR	4180186
40759494	Raspberry IgG4-mCnc	4180186
40759494	欧洲覆盆子 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759496	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f136; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Red Beet; Serum; SR	4180186
40759496	Red Beet IgG4-mCnc	4180186
40759496	红甜菜 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759497	Red Snapper IgG4-mCnc	4180186
40759497	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f381; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Red snapper; Serum; SR	4180186
40759497	红鲷鱼 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759499	Rhubarb IgG4-mCnc	4180186
40759499	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f178; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rhubarb; Serum; SR	4180186
40759499	大黄属多个未知种 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759500	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f009; f9; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rice; Serum; SR	4180186
40759500	Rice IgG4-mCnc	4180186
40759500	水稻 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759501	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Russian thistle; Salosola kali; Salsola pestifer; Saltwort; Saltwort (prickly); Serum; SR; w011; w11	4180186
40759501	Saltwort IgG4-mCnc	4180186
40759501	猪毛菜 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759502	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cultivated rye; Cultivated rye grass; f005; f5; g012; g12; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rye; Serum; SR	4180186
40759502	Cultivated Rye IgG4-mCnc	4180186
40759502	黑麦花粉 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759504	Salmon IgG4-mCnc	4180186
40759504	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Atlantic salmon; Autoantibodies; Autoantibody; f041; f41; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Salmon; Serum; SR	4180186
40759504	大西洋鲑 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759505	Sardine (pilchard) IgG4-mCnc	4180186
40759505	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f308; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf308; Sardine; Sardine (pilchard); Sardine pilchard; Serum; SR	4180186
40759505	沙丁鱼 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759506	Scallop IgG4-mCnc	4180186
40759506	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f053; f338; f53; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf338; Scallop; Serum; SR	4180186
40759506	扇贝多个未知种 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759510	Sole IgG4-mCnc	4180186
40759510	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f129; f337; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf337; Serum; Sole; SR	4180186
40759510	欧洲鳎 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759512	Spinach IgG4-mCnc	4180186
40759512	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f214; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Spinach; SR	4180186
40759512	菠菜 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759513	Spiny Pigweed IgG4-mCnc	4180186
40759513	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Amaranth; Amaranthus sp; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Spiney pigweed; Spiny Pigweed; SR; w024; w24	4180186
40759513	刺苋 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759515	Sugar Cane IgG4-mCnc	4180186
40759515	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f021; f21; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Sugar cane; Sugarcane	4180186
40759515	甘蔗 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759518	Sweet potato IgG4-mCnc	4180186
40759518	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f054; f54; Ipomea batatas; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Sweet potato	4180186
40759518	甘薯 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759519	Sw Vernal grass IgG4-mCnc	4180186
40759519	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; g001; g1; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Sw Vernal grass; Sweet vernal grass	4180186
40759519	黄花茅 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759520	Swiss Cheese IgG4-mCnc	4180186
40759520	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f170; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Swiss Cheese	4180186
40759520	瑞士硬干酪 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759522	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f222; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf222; Serum; SR; Tea	4180186
40759522	Tea IgG4-mCnc	4180186
40759522	茶 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759524	Timothy IgG4-mCnc	4180186
40759524	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; g006; g6; Level; Mass concentration; Phleum pretense; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Timothy; Timothy grass	4180186
40759524	梯牧草 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759526	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f25; Level; Lycopersicon esculatum; Lycopersicon lycopersicon; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tomato	4180186
40759526	Tomato IgG4-mCnc	4180186
40759526	番茄 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759527	T viride IgG4-mCnc	4180186
40759527	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; m015; m15; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; T viridae; T viride; Trichoderma viridae	4180186
40759527	绿色木霉 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759528	Trout IgG4-mCnc	4180186
40759528	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f204; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Salmo gairdnieri; Serum; SR; Trout	4180186
40759528	虹鳟 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759529	Tuna IgG4-mCnc	4180186
40759529	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f040; f40; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tuna; Yellow fin	4180186
40759529	黄鳍金枪鱼 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759531	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f234; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf234; Serum; SR; Vanilla; Vanillin	4180186
40759531	Vanilla IgG4-mCnc	4180186
40759531	扁叶香子兰 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759532	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; g013; g13; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Velvet grass; Yorkshire fog	4180186
40759532	Velvet grass IgG4-mCnc	4180186
40759532	绒毛草 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759534	Virg Live Oak IgG4-mCnc	4180186
40759534	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; Live oak; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rt218; Serum; SR; t103; t218; Virg Live Oak; Virginia live oak; Virginia oak	4180186
40759534	弗吉尼亚栎 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759536	Watermelon IgG4-mCnc	4180186
40759536	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Citrullus vulgaris; f029; f29; f329; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf329; Serum; SR; Watermelon	4180186
40759536	西瓜 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759538	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f004; f4; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Triticum sativum; Wheat	4180186
40759538	Wheat IgG4-mCnc	4180186
40759538	小麦 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759539	Cultivated Wheat IgG4-mCnc	4180186
40759539	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cultivated wheat; Cultivated wheat grass; f004; f4; g015; g15; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Triticum sativum; Wheat	4180186
40759539	小麦花粉 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759542	White Bean IgG4-mCnc	4180186
40759542	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Beans; Cannellini bean; f015; f15; Level; Mass concentration; Navy bean; Phaseolus vulgaris; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; White Bean; White kidney bean	4180186
40759542	白豆 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759543	White Birch IgG4-mCnc	4180186
40759543	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Gray birch; Grey birch; Level; Mass concentration; Old Field birch; Point in time; Poplar birch; Poverty birch; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t030; t30; White birch	4180186
40759543	杨叶桦 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759544	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t041; t41; White Hickory	4180186
40759544	White Hickory IgG4-mCnc	4180186
40759544	柔毛山核桃 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759546	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; Mass concentration; Mulberry; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t070; t70; White mulberry	4180186
40759546	White mulberry IgG4-mCnc	4180186
40759546	白桑树 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759547	White Oak IgG4-mCnc	4180186
40759547	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; Mass concentration; Oak; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t007; t7; White oak	4180186
40759547	白栎 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759550	Potato IgG4-mCnc	4180186
40759550	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f035; f35; Level; Mass concentration; Point in time; Potato; QNT; Quan; Quant; Quantitative; Random; Serum; SR; White potato	4180186
40759550	马铃薯 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759551	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f384; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759551	Whitefish IgG4-mCnc	4180186
40759551	白鲑 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759552	Wine vinegar IgG4-mCnc	4180186
40759552	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f336; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759552	葡萄酒醋 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759553	A absinthium; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; w005; w5; Wormwood	4180186
40759553	Wormwood IgG4-mCnc	4180186
40759553	洋艾 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759554	ABS; Aby; Aerial yellow jacket; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; i005; i5; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Wasp; Yellow hornet; Yelow-faced hornet	4180186
40759554	Yellow Hornet IgG4-mCnc	4180186
40759554	长黄胡蜂 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759555	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Common wasp; i003; i3; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Vespula sp; Yellow jacket; Yellow wasp	4180186
40759555	Yellow Jacket IgG4-mCnc	4180186
40759555	黄胡蜂属多个未知种 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759556	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f360; Joghurt; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Yoghurt	4180186
40759556	Yogurt IgG4-mCnc	4180186
40759556	酸乳酪 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759557	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f118; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759557	Zucchini IgG4-mCnc	4180186
40759557	绿皮密生西葫芦 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759558	Chicken Feather IgG4-mCnc	4180186
40759558	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e085; e85; f083; f83; Feathers; Gallus spp; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759558	鸡羽毛 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759559	Beef IgG4-mCnc	4180186
40759559	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bos spp; f027; f27; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759559	牛肉 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759560	Chub Mackerel IgG4-mCnc	4180186
40759560	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chub mackerel; f050; f50; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Spanish mackerel; SR	4180186
40759560	太平洋鲭鱼 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759566	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
40759566	Medication summary Doc	4180186
40759566	药物摘要:发现:时间点:^患者:文档型	4182948
40759571	Black Pepper IgG4-mCnc	4180186
40759571	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Black pepper; f280; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759571	黑胡椒 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759573	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cottonseed oil; f109; Gossypium hirsutum; Gossypium spp; k83; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759573	Cottonseed IgG4-mCnc	4180186
40759573	棉籽 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759575	Cumin IgG4-mCnc	4180186
40759575	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cumin; Cummin; f265; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759575	莳萝 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759577	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e003; e3; Equus spp; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759577	Horse Dander IgG4-mCnc	4180186
40759577	马毛屑 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759578	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f088; f88; Level; Mass concentration; Mutton; Ovis spp; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759578	Lamb IgG4-mCnc	4180186
40759578	羊肉 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759579	Wattle IgG4-mCnc	4180186
40759579	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; Mass concentration; Point in time; Port jackson; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t019; t19; Wattle	4180186
40759579	金合欢树 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759580	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; m211; Mass concentration; Oat smut; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759580	Oat smut IgG4-mCnc	4180186
40759580	燕麦散黑穗病 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759582	Red Alder IgG4-mCnc	4180186
40759582	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Red alder; Serum; SR; t217	4180186
40759582	红桤木 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759584	Rough Pigweed IgG4-mCnc	4180186
40759584	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Amaranth; Amaranthus retroflexus; Amaranthus sp; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rough Pigweed; Serum; SR	4180186
40759584	西风古 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759586	Salt grass IgG4-mCnc	4180186
40759586	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; g203; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rg203; Salt grass; Serum; SR	4180186
40759586	盐草 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759589	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C. maxima; C. mixta; C. moschata; Cucumis pepo; f225; Level; Mass concentration; Point in time; Pumpkin; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759589	Pumpkin IgG4-mCnc	4180186
40759589	西葫芦 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40759590	CHD risk SerPl-Rto	4180186
40759590	CHD risk; Chemistry; Dis; Diseases; Dz; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759590	心脏疾病风险:比率:时间点:血清/血浆:定量型	4182948
40759593	nRBC Spec Manual	4180186
40759593	Cnt; Count; Discocytes; Erthrocyte; Erythroblasts; Erythrocyte; HEMATOLOGY/CELL COUNTS; Manl; Misc; Miscellaneous; Normoblasts; nRBC; nRBCs; Nuc; Number; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Spec; To be specified in another part of the message; Unspecified	4180186
40759593	红细胞.有核:数量(计数):时间点:XXX:定量型:手工计数方法	4182948
40759594	Cerebral spinal fluid; Cerebrospinal Fl; Cnt; Count; HEMATOLOGY/CELL COUNTS; Manl; Meta; Metamyelo; Metamyelocyte; Metamyelocyte%; Metas; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
40759594	Metamyelocytes CSF Manual	4180186
40759594	晚幼粒细胞:数量(计数):时间点:脑脊液:定量型:手工计数方法	4182948
40759595	C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Isolated; Microbiology; Nominal; Point in time; Random; Sal; Salmonel; Spec; species; spp	4180186
40759595	Deprecated Salmonell Islt Cult	4180186
40759596	Agg; Agglut; Agglutination; ID; Ident; Identifier; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Nominal; Point in time; Random; Sal; Salmonel; Salmonella sp Ag form; species; spp	4180186
40759596	Salmonella sp Ag form Islt Aggl	4180186
40759596	沙门菌属抗原结构公式:标识符:时间点:分离株:名义型:凝集试验法	4182948
40759597	Hgb S MFr DBS	4180186
40759597	Blood; DBS; Dried blood spot; Filter paper; FP; Haemoglobin; Hb; HBs; HEMATOLOGY/CELL COUNTS; Hgb; Hgb S; Mass Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; Sickle cell; Sickle cells; Tot; Totl; WB; Whole blood	4180186
40759597	血红蛋白 S/血红蛋白.总计:质量分数:时间点:全血.斑点:定量型	4182948
40759598	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Endocrine; Endocrinology; Enzyme immunoassay; IAA; Iodide peroxidase; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Thyroid Microsomal; Thyroid microsomes; Thyroid peroxidase; TPO	4180186
40759598	Thyroperoxidase Ab SerPl IA-aCnc	4180186
40759598	甲状腺过氧化物酶 抗体:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
40759602	Bence Jones protein; BJ Protein; BJP; Chain; Chemistry; FR; Hematology; Heme; IFE; Ifix; Immune globulin; Immuno; Immunofixation electrophoresis; Immunoglob; Immunoglobin; Imunoglbon; Imunoglobn; Lambda LC; Lambda LC Free; Non-protein bound; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40759602	Lambda LC Free Ur Ql IFE	4180186
40759602	免疫球蛋白轻链.Lambda 型.游离型:存在情况或阈值:时间点:尿液:序数型:免疫固定电泳分析法	4182948
40759604	Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Hematology; Heme; Mass Content; PBG; Point in time; Porph; Porphobili; Porphoblngn; Porpoblngn; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal	4180186
40759604	PBG Stl-mCnt	4180186
40759604	胆色素原:质量含量:时间点:大便:定量型	4182948
40759605	Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Hematology; Heme; Mass Content; Octacarboxyl porphyrin; Octacarboxylporphyrin; Octacarboxyphyrin; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal; Urophorph	4180186
40759605	Uropor Stl-mCnt	4180186
40759605	尿卟啉:质量含量:时间点:大便:定量型	4182948
40759607	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS; T sol; T solium; Tapeworm	4180186
40759607	T sol IgG Ser IA-aCnc	4180186
40759607	猪带绦虫 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40759609	Etiocholanolone 24h Ur-mCnc	4180186
40759609	1 day; 24 hours; 24HR; Aetiocholanolone; Chemistry; Etiochol; Level; Mass concentration; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40759609	本胆烷醇酮:质量浓度:24小时:尿液:定量型	4182948
40759610	1 day; 24 hours; 24HR; Chemistry; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; Titratable Acidity; UA; UR; Urn	4180186
40759610	Titratable Acidity 24h Ur-sRate	4180186
40759610	酸度.可滴定型:物质的量速率:24小时:尿液:定量型	4182948
40759611	Bowel movement; Chemistry; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; Faecal; Faeces; Fecal; Fecal occult blood; Feces; FIT; FOB; FOBT; Gastrocult; Gastrointest blood; GI; Guiac; Haemoglobin; Hb; Hemoccult; Hemocult; Hgb; IAA; iFOBT; Low; MEIA; Occult blood; Occult blood in stool; Ordinal; Point in time; Post immunization; PR; QL; Qual; Qualitative; Random; Screen; Second; sp2; Spec; Stl; Stool = Fecal; SUDS	4180186
40759611	Hemoccult sp2 Stl Ql IA	4180186
40759611	血红蛋白.胃肠道.下段^第2个标本:存在情况或阈值:时间点:大便:序数型:免疫测定法	4182948
40759614	10M p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; ICSH; Interstitial cell-stimulating hormone; Interstitual cell stimulating hormone; Leutinizing hormone; LH; Luteinizing hormone; Lutenin; Lutenizing hormone; Ovulation test; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759614	LH 10M p chal SerPl-aCnc	4180186
40759614	促黄体素^在XXX刺激之后10分钟:任意型浓度:时间点:血清/血浆:定量型	4182948
40759618	B-HCG 24h Ur	4180186
40759618	1 day; 24 hours; 24HR; Arbitrary rate; B; B HCG; Beta HCG; Beta human chorionic gonadotropin; B-HCG; CG; Chemistry; Choriogonadotropin beta chain; Choriogonadotropins total; Chorionic gonadotropin; HCG; Human chorionic gonadotropin; QNT; Quan; Quant; Quantitative; Tumor marker; UA; UR; Urn	4180186
40759618	绒毛膜促性腺激素.Beta 亚单位:任意型速率:24小时:尿液:定量型	4182948
40759620	45M p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40759620	GH 45M p chal SerPl-mCnc	4180186
40759620	生长激素^在XXX刺激之后45分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759622	6h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40759622	GH 6h p chal SerPl-mCnc	4180186
40759622	生长激素^在XXX刺激之后6小时:质量浓度:时间点:血清/血浆:定量型	4182948
40759623	7h p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40759623	GH 7h p chal SerPl-aCnc	4180186
40759623	生长激素^在XXX刺激之后7小时:任意型浓度:时间点:血清/血浆:定量型	4182948
40759625	ACTH 15M p chal Plas-mCnc	4180186
40759625	15M p chal; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Tumor marker	4180186
40759625	促肾上腺皮质激素^在XXX刺激之后15分钟:质量浓度:时间点:血浆:定量型	4182948
40759628	DHEA-S 30M p chal SerPl-mCnc	4180186
40759628	30M p chal; adrenal dysfunction; After; CHEMISTRY.CHALLENGE TESTING; DHEA; DHEAS; DHEA-S; DHEA-SO4; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Prasterone; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SO4; SO4-2; SR; Sulf	4180186
40759628	硫酸脱氢表雄甾酮^在XXX刺激之后30分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759635	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Malaria; Malarial; Microbiology; Ordinal; P falciparum; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Time Resolved Fluorescence; TRF	4180186
40759635	P falciparum IgG Ser Ql IF	4180186
40759635	恶性疟原虫 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40759636	C peptide 6M p chal SerPl-mCnc	4180186
40759636	6M p chal; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Mass concentration; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759636	C 肽^在XXX刺激之后6分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759640	11DC; 45M p chal; After; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Deoxycortisol; Desoxycortisol; Level; Mass concentration; Metopirone; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759640	11DC 45M p chal SerPl-mCnc	4180186
40759640	11-脱氧皮质醇^在XXX刺激之后45分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759643	15M p chal; After; CHEMISTRY.CHALLENGE TESTING; Fac; Fact; Factor 1; FI; HUM; Humulin; IGF; IGF1; IGF-1; IGF-I; IH7; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; Somatomedin C; SR; Ultralente	4180186
40759643	IGF-I 15M p chal SerPl-mCnc	4180186
40759643	胰岛素样生长因子-I^在XXX刺激之后15分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759644	IGF-I 45M p chal SerPl-mCnc	4180186
40759644	45M p chal; After; CHEMISTRY.CHALLENGE TESTING; Fac; Fact; Factor 1; FI; HUM; Humulin; IGF; IGF1; IGF-1; IGF-I; IH7; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; Somatomedin C; SR; Ultralente	4180186
40759644	胰岛素样生长因子-I^在XXX刺激之后45分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759647	1 hour; 1.0Hr; 1h p chal; 60 min; 60 minutes; 60M; 60min; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; VP	4180186
40759647	Vasopressin 1h p chal Plas-mCnc	4180186
40759647	后叶加压素^在XXX刺激之后1小时:质量浓度:时间点:血浆:定量型	4182948
40759648	Androst 20M p chal SerPl-mCnc	4180186
40759648	20M p chal; After; CHEMISTRY.CHALLENGE TESTING; gamma-4-Androstenedione; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759648	雄烯二酮^在XXX刺激之后20分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759650	CV2 Ab Titr CSF IF	4180186
40759650	CV2 抗体:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
40759650	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Collapsin response mediator protein 5; Collapsin response mediator protein 5 Ab; CRMP5; CRMP-5; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Neuro; Neurology; Point in time; POP66; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; ULIP	4180186
40759652	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; ASGPR; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Hepatology; IAA; Liver; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; Serum; SR; SUDS	4180186
40759652	ASGPR Ab Ser IA-aCnc	4180186
40759652	无唾液酸糖蛋白受体 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40759654	Calcit 15M p chal SerPl-mCnc	4180186
40759654	15M p chal; After; CHEMISTRY.CHALLENGE TESTING; CT; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyrocalcitonin; Tumor marker	4180186
40759654	降钙素^在XXX刺激之后15分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759655	8-DHC; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40759655	8-DHC SerPl-sCnc	4180186
40759655	8-脱氢胆固醇:物质的量浓度:时间点:血清/血浆:定量型	4182948
40759656	ABS; Aby; Antby; Anti; Antibodies; Antibody; Antithyroglob; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Endocrine; Endocrinology; Enzyme immunoassay; Hashimoto's thyroiditis; IAA; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Tg; TgAbs; Thyglobulin; Thyroglbn; Thyroglob; Tumor marker	4180186
40759656	Thyroglob Ab SerPl IA-aCnc	4180186
40759656	甲状腺球蛋白 抗体:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
40759657	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Celiac disease; EIA; ELFA; ELISA; Enzyme immunoassay; Fibrin stabilizing factor; Gastro; Gastroenterology; GI; IAA; Immune globulin G; Immunoglobulin G; MEIA; Point in time; Protein-glutamine gamma glutamyltransferase; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS; TG2; tTG; UniversalLabOrders	4180186
40759657	tTG IgG Ser IA-aCnc	4180186
40759657	组织谷氨酰胺转移酶 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40759658	ABS; Aby; Antby; Anti; Antibodies; Antibody; APOH; Apolipoprotein H; Arbitrary concentration; Autoantibodies; Autoantibody; B; B2 Glycoprot1; B2 glycoprotein 1; B2GPI; B2-GPI; COAGULATION; EIA; ELFA; ELISA; Enzyme immunoassay; gG; Glycoprot; Glycoproteins; GP; Hematology; Heme; i; IAA; II; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS	4180186
40759658	B2 Glycoprot1 Ab Ser IA-aCnc	4180186
40759658	Beta 2 糖蛋白 1 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40759660	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Autoimmune myelopathy; c707; EIA; ELFA; ELISA; Endocrine; Endocrinology; Enzyme immunoassay; GAD; GAD65; GAD-65; GADA; Glu; Glutamic acid; Glutamic acid decarboxylase-65; IAA; Insulin-Dependent Diabetes Mellitus; MEIA; Paraneoplastic neurological syndrome; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS; UniversalLabOrders	4180186
40759660	GAD65 Ab Ser IA-aCnc	4180186
40759660	谷氨酸脱羧酶-65 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40759661	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Disialolganglioside; Disialylganglioside; EIA; ELFA; ELISA; Enzyme immunoassay; GD1b; GD1b Gangl; IAA; Immune globulin G; Immunoglobulin G; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
40759661	GD1b Gangl IgG Ser IA-aCnc	4180186
40759661	神经节苷脂 GD1b 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40759663	GM2 Gangl IgG Ser IA-aCnc	4180186
40759663	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; GM2 Gangl; IAA; Immune globulin G; Immunoglobulin G; MEIA; Monosialoganglioside; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
40759663	神经节苷脂 GM2 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40759664	GM2 Gangl IgM Ser IA-aCnc	4180186
40759664	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; GM2 Gangl; IAA; Immune globulin M; Immunoglobulin M; MEIA; Monosialoganglioside; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
40759664	神经节苷脂 GM2 抗体.IgM:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40759668	ABS; Aby; ANA IgG; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Ribonuclear protein; RNP; Serology; Serum; snRNP; SR; SUDS; U1 RNP; U1 snRNP; U1RNP	4180186
40759668	U1 snRNP IgG Ser IA-aCnc	4180186
40759668	U1 小细胞核核糖核蛋白 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40759670	PCA-Tr Ab Titr Ser IF	4180186
40759670	浦肯雅细胞胞浆 Tr 型 抗体:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40759670	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cytopl; Cytoplas; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; Hodgkin's lymphoma; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Limbic encephalopathy; Neuro; Neurology; Paraneoplastic cerebellar degeneration; Paraneoplastic neurological syndrome; Paraneoplastic syndrome; PCD; PNS; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40759671	PCA-Tr Ab Titr CSF IF	4180186
40759671	浦肯雅细胞胞浆 Tr 型 抗体:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
40759671	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Cytopl; Cytoplas; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; Hodgkin's lymphoma; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Limbic encephalopathy; Neuro; Neurology; Paraneoplastic cerebellar degeneration; Paraneoplastic neurological syndrome; Paraneoplastic syndrome; PCD; PNS; Point in time; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40759672	DHEA-S BS SerPl-mCnc	4180186
40759672	adrenal dysfunction; BS; CHEMISTRY.CHALLENGE TESTING; DHEA; DHEAS; DHEA-S; DHEA-SO4; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Prasterone; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SO4; SO4-2; SR; Sulf	4180186
40759672	硫酸脱氢表雄甾酮^基线:质量浓度:时间点:血清/血浆:定量型	4182948
40759673	1/3 day; 8 hours; 8HR; Alb; Chemistry; DL=20 mg/L; Kidney; Left; Levo; MA; Malb; Mass rate; Micro albumin; Microalbumin; mRate; Nephrology; Protein.albumin; QNT; Quan; Quant; Quantitative; Renal; UA; UR; Urn	4180186
40759673	Microalbumin 8h Ur-mRate	4180186
40759673	白蛋白:质量速率:8小时:尿液:定量型:检测极限 <= 20 mg/L	4182948
40759674	3 days; 72 hours; 72HR; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Hematology; Heme; Mass Rate; mRate; Porph; Porphyrin; QNT; Quan; Quant; Quantitative; Stl; Stool = Fecal	4180186
40759674	Porphyrins 72h Stl-mRate	4180186
40759674	卟啉类:质量速率:72小时:大便:定量型	4182948
40759676	11DOC 30M p chal SerPl-mCnc	4180186
40759676	11DOC; 11-DOC; 21-Hydroxyprogesterone; 30M p chal; After; CHEMISTRY.CHALLENGE TESTING; DOC; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759676	11-脱氧皮质酮^在XXX刺激之后30分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759677	10M p chal; Active renin; After; Angiotensin forming enzyme; Angiotensinogenase; Cardio; Cardiology; Catalytic Concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Heart Disease; Kidney; Nephrology; p chal; Pl; Plasma; Plasma renin activity; Plsm; Point in time; PRA; PST; QNT; Quan; Quant; Quantitative; Random; Renal	4180186
40759677	Renin 10M p chal Plas-cCnc	4180186
40759677	肾素^在XXX刺激之后10分钟:催化浓度:时间点:血浆:定量型	4182948
40759680	270 min; 4 1/2 hours; 4.5h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40759680	GH 4.5h p chal SerPl-mCnc	4180186
40759680	生长激素^在XXX刺激之后4.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
40759683	7.5h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40759683	GH 7.5h p chal SerPl-mCnc	4180186
40759683	生长激素^在XXX刺激之后7.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
40759686	9.5h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40759686	GH 9.5h p chal SerPl-mCnc	4180186
40759686	生长激素^在XXX刺激之后9.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
40759689	11h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40759689	GH 11h p chal SerPl-mCnc	4180186
40759689	生长激素^在XXX刺激之后11小时:质量浓度:时间点:血清/血浆:定量型	4182948
40759691	After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; EXCZ; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p Exc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40759691	GH p Exc SerPl-mCnc	4180186
40759691	生长激素^在运动之后:质量浓度:时间点:血清/血浆:定量型	4182948
40759695	15M p chal; 17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Genetics; Heredity; Heritable; Hydroxyproges; Hydroxyprogstron; Inherited; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759695	17OHP 15M p chal SerPl-mCnc	4180186
40759695	17-羟孕酮^在XXX刺激之后15分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759698	1 1/2 hours; 1 1/2 HR; 1.5h p chal; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759698	Aldost 1.5h p chal SerPl-mCnc	4180186
40759698	醛固酮^在XXX刺激之后1.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
40759699	20M p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759699	Aldost 20M p chal SerPl-mCnc	4180186
40759699	醛固酮^在XXX刺激之后20分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759700	20M p chal; Active renin; After; Angiotensin forming enzyme; Angiotensinogenase; Cardio; Cardiology; Catalytic Concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Heart Disease; Kidney; Nephrology; p chal; Pl; Plasma; Plasma renin activity; Plsm; Point in time; PRA; PST; QNT; Quan; Quant; Quantitative; Random; Renal	4180186
40759700	Renin 20M p chal Plas-cCnc	4180186
40759700	肾素^在XXX刺激之后20分钟:催化浓度:时间点:血浆:定量型	4182948
40759702	10M p chal; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Mass concentration; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759702	C peptide 10M p chal SerPl-mCnc	4180186
40759702	C 肽^在XXX刺激之后10分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759703	C peptide 45M p chal SerPl-mCnc	4180186
40759703	45M p chal; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Mass concentration; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759703	C 肽^在XXX刺激之后45分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759705	Cortis 45M p chal SerPl-mCnc	4180186
40759705	17-Hydroxycorticosterone; 45M p chal; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759705	皮质醇^在XXX刺激之后45分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759707	DHEA 30M p chal SerPl-mCnc	4180186
40759707	30M p chal; After; CHEMISTRY.CHALLENGE TESTING; DHEA; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Prasterone; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759707	脱氢表雄酮^在XXX刺激之后30分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759715	Latex (rHev b) 3 IgE Qn	4180186
40759715	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Hevea braziliensis; III; Immune globulin E; Immunoglobulin E; k082; k217; k82; Latex (rHev b) 3; Ltx; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759715	乳胶 重组 (rHev b) 3 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40759716	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Hevea braziliensis; Immune globulin E; Immunoglobulin E; k082; k218; k82; Latex (rHev b) 5; Ltx; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759716	Latex (rHev b) 5 IgE Qn	4180186
40759716	乳胶 重组 (rHev b) 5 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40759717	Latex (rHev b) 8 IgE Qn	4180186
40759717	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Hevea braziliensis; Immune globulin E; Immunoglobulin E; k082; k221; k82; Latex (rHev b) 8; Ltx; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759717	乳胶 重组 (rHev b) 8 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40759718	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EA; EBV; EBV EA; EIA; ELFA; ELISA; Enzyme immunoassay; Epstn; HHV-4; human herpesvirus 4; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Mono; Mononucleosis; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS; UniversalLabOrders	4180186
40759718	EBV EA IgM Ser IA-aCnc	4180186
40759718	Epstein Barr 病毒早期 抗体.IgM:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40759719	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; CAP; Cerebral spinal fluid; Cerebrospinal Fl; EBV; EBV capsid Ab; EBV VCA; EIA; ELFA; ELISA; Enzyme immunoassay; Epstn; HHV-4; human herpesvirus 4; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Mono; Mononucleosis; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS; VCA; Viral capsid	4180186
40759719	EBV VCA IgM CSF IA-aCnc	4180186
40759719	Epstein Barr 病毒衣壳 抗体.IgM:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40759720	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; European hornet; i75; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759720	European Hornet IgG-mCnc	4180186
40759720	胡蜂 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40759727	11DOC 15M p chal SerPl-mCnc	4180186
40759727	11DOC; 11-DOC; 15M p chal; 21-Hydroxyprogesterone; After; CHEMISTRY.CHALLENGE TESTING; DOC; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759727	11-脱氧皮质酮^在XXX刺激之后15分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759728	11DOC; 11-DOC; 20M p chal; 21-Hydroxyprogesterone; After; CHEMISTRY.CHALLENGE TESTING; DOC; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759728	11DOC 20M p chal SerPl-mCnc	4180186
40759728	11-脱氧皮质酮^在XXX刺激之后20分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759730	1 1/2 hours; 1 1/2 HR; 1.5h p chal; 1.5Hr; 11DOC; 11-DOC; 21-Hydroxyprogesterone; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; DOC; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759730	11DOC 1.5h p chal SerPl-mCnc	4180186
40759730	11-脱氧皮质酮^在XXX刺激之后1.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
40759731	11DOC 2h p chal SerPl-mCnc	4180186
40759731	11DOC; 11-DOC; 120 min; 120 minutes; 120min; 2 hours; 21-Hydroxyprogesterone; 2h p chal; After; CHEMISTRY.CHALLENGE TESTING; DOC; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759731	11-脱氧皮质酮^在XXX刺激之后2小时:质量浓度:时间点:血清/血浆:定量型	4182948
40759732	11DOC; 11-DOC; 2.5h p chal; 21-Hydroxyprogesterone; After; CHEMISTRY.CHALLENGE TESTING; DOC; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759732	11DOC 2.5h p chal SerPl-mCnc	4180186
40759732	11-脱氧皮质酮^在XXX刺激之后2.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
40759733	10M p chal; 17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Genetics; Heredity; Heritable; Hydroxyproges; Hydroxyprogstron; Inherited; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759733	17OHP 10M p chal SerPl-mCnc	4180186
40759733	17-羟孕酮^在XXX刺激之后10分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759736	120 min; 120 minutes; 120min; 17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; 2 hours; 2h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Genetics; Heredity; Heritable; Hydroxyproges; Hydroxyprogstron; Inherited; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759736	17OHP 2h p chal SerPl-mCnc	4180186
40759736	17-羟孕酮^在XXX刺激之后2小时:质量浓度:时间点:血清/血浆:定量型	4182948
40759737	10M p chal; After; CHEMISTRY.CHALLENGE TESTING; Fac; Fact; Factor 1; FI; HUM; Humulin; IGF; IGF1; IGF-1; IGF-I; IH7; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; Somatomedin C; SR; Ultralente	4180186
40759737	IGF-I 10M p chal SerPl-mCnc	4180186
40759737	胰岛素样生长因子-I^在XXX刺激之后10分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759740	CV A9 IgG Titr CSF IF	4180186
40759740	柯萨奇病毒 A9 型 抗体.IgG:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
40759740	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CAV; Cerebral spinal fluid; Cerebrospinal Fl; Coxsackie; Coxsackie virus; CV; CV A9; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40759743	Chemistry; Level; Levulose; Point in time; QNT; Quan; Quant; Quantitative; Random; Revulose; Serum; SR; Substance concentration	4180186
40759743	Fructose Ser-sCnc	4180186
40759743	果糖:物质的量浓度:时间点:血清:定量型	4182948
40759744	Addiction; Blood; Cl; Cl-; DCM; Dichloromethane; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
40759744	DCM Bld-sCnc	4180186
40759744	二氯甲烷:物质的量浓度:时间点:全血:定量型	4182948
40759745	Blood; DRUG/TOXICOLOGY; Drugs; Level; Perchloroethylene; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Tetrachloroethene; TTCE; WB; Whole blood	4180186
40759745	TTCE Bld-sCnc	4180186
40759745	四氯乙烯:物质的量浓度:时间点:全血:定量型	4182948
40759747	Amikin; Aminoglycosides; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40759747	Amikacin SerPl-sCnc	4180186
40759747	丁胺卡那霉素:物质的量浓度:时间点:血清/血浆:定量型	4182948
40759748	Myelin Ab Titr Ser IF	4180186
40759748	髓磷脂 抗体:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40759748	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40759750	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Bruc; Brucellosis; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; species; spp; SR; SUDS	4180186
40759750	Brucella IgM Ser IA-aCnc	4180186
40759750	布鲁氏菌属单个未知种 抗体.IgM:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40759751	Mitochondria M2 IgG Titr Ser IF	4180186
40759751	线粒体 M2 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40759751	ABS; Aby; ACIF; AMA-M2; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; Hepatology; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Liver; Microtubule Associated Protein 2; Mito; Mitochon; Mitochond; Mitochondrial; Mitochondrial m2; Point in time; Pyruvate dehydrogenase ab; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40759755	B parapert IgM Titr Ser IF	4180186
40759755	副百日咳博德特菌 抗体.IgM:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40759755	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; B parapert; B parapertussis; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Whooping cough	4180186
40759759	1 day; 24 hours; 24HR; Asp; Aspartic acid; Chemistry; CR; Crea; Creat; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759759	Aspartate/Creat 24h Ur-Rto	4180186
40759759	天门冬氨酸/肌酐:比率:24小时:尿液:定量型	4182948
40759760	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; QNT; Quan; Quant; Quantitative; Ratios; Rto; Thr; UA; UCr; UR; Urn	4180186
40759760	Threonine/Creat 24h Ur-Rto	4180186
40759760	苏氨酸/肌酐:比率:24小时:尿液:定量型	4182948
40759761	Serine/Creat 24h Ur-Rto	4180186
40759761	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; QNT; Quan; Quant; Quantitative; Ratios; Rto; Ser; UA; UCr; UR; Urn	4180186
40759761	丝氨酸/肌酐:比率:24小时:尿液:定量型	4182948
40759768	1 day; 24 hours; 24HR; Benzyl alcohol metabolite; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Hipp; Hippramine; Hippuran; Hippuric acid; Hiprex; HIP-REX; QNT; Quan; Quant; Quantitative; Ratios; Rto; Toluene metabolite; UA; UCr; UR; Urex; Urn; Urotractan	4180186
40759768	Hippurate/Creat 24h Ur-Rto	4180186
40759768	马尿酸/肌酐:比率:24小时:尿液:定量型	4182948
40759770	Cadmium/Creat Ur-Rto	4180186
40759770	CD; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759770	镉/肌酐:比率:时间点:尿液:定量型	4182948
40759773	Nickel/Creat Ur-Rto	4180186
40759773	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; NI; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759773	镍/肌酐:比率:时间点:尿液:定量型	4182948
40759776	1 day; 24 hours; 24HR; DRUG/TOXICOLOGY; Drugs; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; THcortisone; UA; UR; Urn	4180186
40759776	THcortisone 24h Ur-sRate	4180186
40759776	四氢可的松:物质的量速率:24小时:尿液:定量型	4182948
40759777	5-ALA; 5-aminolevulinate; 5-aminolevulinic acid; ALA; Aminolevulinic acid; Amnolev; Amnolevuunc; Chemistry; CR; Crea; Creat; D-ALA; Delta-ala; Delta-aminolevulinic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759777	D-ALA/Creat Ur-Rto	4180186
40759777	Delta 氨基酮戊酸/肌酐:比率:时间点:尿液:定量型	4182948
40759781	1 day; 24 hours; 24HR; B; B2 Microglob; b2-M; Chemistry; Hematology; Heme; II; Microglob; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
40759781	B2 Microglob 24h Ur-sRate	4180186
40759781	Beta-2-微球蛋白:物质的量速率:24小时:尿液:定量型	4182948
40759782	5OH-Tryptophan 24h Ur-sRate	4180186
40759782	1 day; 24 hours; 24HR; 5-HTP; 5-Hydroxy tryptophan; 5OH-Tryptophan; DRUG/TOXICOLOGY; Drugs; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
40759782	5-羟色氨酸脱羧醇:物质的量速率:24小时:尿液:定量型	4182948
40759783	Methylmalonate/Creat Ur-Rto	4180186
40759783	Chemistry; CR; Crea; Creat; Methylmalonic acid; Methylmalonic Acidemia; MMA; Point in time; Propionic acidemia; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759783	甲基丙二酸/肌酐:比率:时间点:尿液:定量型	4182948
40759784	T sol IgG Titr Ser IF	4180186
40759784	猪带绦虫 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40759784	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; T sol; T solium; Tapeworm; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40759785	1Me-hist/Creat 24h Ur-Rto	4180186
40759785	1 day; 1Me-hist; 24 hours; 24HR; Chemistry; CR; Crea; Creat; i; methyl-histidine; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759785	1-甲基组氨酸/肌酐:比率:24小时:尿液:定量型	4182948
40759786	1 day; 24 hours; 24HR; 3Me-histidine; 3-MH; Ch3hist; Chemistry; CR; Crea; Creat; III; methyl-histidine; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759786	3Me-histidine/Creat 24h Ur-Rto	4180186
40759786	3-甲基组氨酸/肌酐:比率:24小时:尿液:定量型	4182948
40759787	AAA/Creat 24h Ur-Rto	4180186
40759787	1 day; 24 hours; 24HR; 2-aminoadipate; 2-aminoadipic acid; AAA; AAD; Alfa; Alpha aminoadipic acid; Aminoadipic acid; Chemistry; CR; Crea; Creat; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759787	Alpha 氨基己二酸/肌酐:比率:24小时:尿液:定量型	4182948
40759788	A-Carotene; Alfa; Beta carotene; Chemistry; Level; Mass concentration; Point in time; Pro vitamin A; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759788	A-Carotene Ser-mCnc	4180186
40759788	胡萝卜素.Alpha:质量浓度:时间点:血清:定量型	4182948
40759791	Arginine/Creat 24h Ur-Rto	4180186
40759791	1 day; 24 hours; 24HR; Arg; Chemistry; CR; Crea; Creat; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759791	精氨酸/肌酐:比率:24小时:尿液:定量型	4182948
40759793	1 day; 24 hours; 24HR; Ala; Alpha alanine; B; Bala; B-Ala; B-Alanine; Chemistry; CR; Crea; Creat; L-alanine; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759793	B-Alanine/Creat 24h Ur-Rto	4180186
40759793	Beta 丙氨酸/肌酐:比率:24小时:尿液:定量型	4182948
40759797	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; EA; Etn; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759797	Ethanolamine/Creat 24h Ur-Rto	4180186
40759797	乙醇胺/肌酐:比率:24小时:尿液:定量型	4182948
40759800	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Gly; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759800	Glycine/Creat 24h Ur-Rto	4180186
40759800	甘氨酸/肌酐:比率:24小时:尿液:定量型	4182948
40759804	Chemistry; FR; Hydroxylproline; Hydroxyprol; Hydroxy-proline; Hydrxprol; Hydrxproln; Hydrxyprln; Hyp; Level; Non-protein bound; Ohpro; OH-Proline; OH-Proline Free; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40759804	OH-Proline Free SerPl-sCnc	4180186
40759804	羟基脯氨酸.游离型:物质的量浓度:时间点:血清/血浆:定量型	4182948
40759805	OH-Proline Free/Creat 24h Ur-Rto	4180186
40759805	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; FR; Hydroxylproline; Hydroxyprol; Hydroxy-proline; Hydrxprol; Hydrxproln; Hydrxyprln; Hyp; Non-protein bound; Ohpro; OH-Proline; OH-Proline Free; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40759805	羟基脯氨酸.游离型/肌酐:比率:24小时:尿液:定量型	4182948
40759806	Panc Islet Cell IgG Titr Ser IF	4180186
40759806	胰岛细胞 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40759806	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); Endocrine; Endocrinology; FA; Fluorescent antibody; Fluoresent; ICA; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Panc Islet Cell; Pancr; Pancreatc; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; UniversalLabOrders	4180186
40759807	Arbitrary concentration; Chemistry; Immune globulin D; Immunoglobulin D; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759807	IgD Ser-aCnc	4180186
40759807	IgD:任意型浓度:时间点:血清:定量型	4182948
40759809	16h p chal; After; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
40759809	Insulin 16h p chal SerPl-mCnc	4180186
40759809	胰岛素^在XXX刺激之后16小时:质量浓度:时间点:血清/血浆:定量型	4182948
40759810	Insulin 20H p chal SerPl-mCnc	4180186
40759810	20H p chal; After; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
40759810	胰岛素^在XXX刺激之后20小时:质量浓度:时间点:血清/血浆:定量型	4182948
40759811	1D p chal; After; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
40759811	Insulin 1D p chal SerPl-mCnc	4180186
40759811	胰岛素^在XXX刺激之后1天:质量浓度:时间点:血清/血浆:定量型	4182948
40759812	ENA Scl70 Ab Ser Ql IB	4180186
40759812	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; anti-topo I; Autoantibodies; Autoantibody; Blt; DNA-Topoisomerase I; ENA; ENA Scl70; IMMUNE BLOT; Immunobl; Immunoblot; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Scleroderma; Scleroderma ab; Screen; Serology; Serum; SR; Topo I; Topoisomerase I; WB; WBLOT; West blot; West blt; Western blot	4180186
40759812	SCL-70 可提取性核 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40759813	Chicken Drop Ab Ql ID	4180186
40759813	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e218; f083; f83; Feces; Gallus spp; ID; Imm; Immunodiff; Immunodiffusion; Imun; Imune; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Re218; Screen; Serum; SR; stool	4180186
40759813	鸡粪便 抗体:存在情况或阈值:时间点:血清:序数型:免疫扩散法	4182948
40759815	Cloxacillin IgE Qn	4180186
40759815	ABS; Aby; Alclox; Allergen; Allergens; ALLERGY TESTING; Ampiclox; Amplium; Antby; Anti; Antibodies; Antibody; APO-CLOXI; Arbitrary concentration; Austrastaph; Autoantibodies; Autoantibody; Clocillin; Cloxin; Ekvacillin; Immune globulin E; Immunoglobulin E; Novo-cloxi; Nu-cloxi; Orbenin; Penstapho n; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tegopen	4180186
40759815	邻氯青霉素 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40759816	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Barbiturate; Immune globulin E; Immunoglobulin E; Pentothal; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759816	Thiopental IgE Qn	4180186
40759816	戊硫代巴比妥 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40759819	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Anaprox; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; c228; c283; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759819	Naproxen IgE Qn	4180186
40759819	甲氧萘丙酸 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40759820	Diclofenac IgE Qn	4180186
40759820	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; c215; c281; C52; Cambia; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Voltaren optha; Voltaren opthalmic	4180186
40759820	环氟拉嗪 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40759823	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; C22H22FN3O2; Immune globulin E; Immunoglobulin E; Inapsine; Marinol; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759823	Droperidol IgE Qn	4180186
40759823	氟哌利多 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40759825	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; c206; c216; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Vibramycin	4180186
40759825	Doxycycline IgE Qn	4180186
40759825	强力霉素 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40759826	Spiramycin IgE Qn	4180186
40759826	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Bykomycetin; c436; Immune globulin E; Immunoglobulin E; Leucomycin; Point in time; Provamicina; QNT; Quan; Quant; Quantitative; Random; Rovamicina; Rovamycin; Rovamycine; Selectomycin; Serum; SR	4180186
40759826	螺旋霉素 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40759827	metroNIDAZOLE IgE Qn	4180186
40759827	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; c237; c398; Flagyl; Immune globulin E; Immunoglobulin E; Metrogel; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759827	甲硝唑 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40759828	Tartrazine IgE Qn	4180186
40759828	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; c717; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759828	酒石黄 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40759829	Clarithro IgE Qn	4180186
40759829	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Biaxin; Claripen; Immune globulin E; Immunoglobulin E; Klacid; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759829	克拉霉素 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40759830	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Benzoic acid; C111; c703; E211; Immune globulin E; Immunoglobulin E; k05; Na; Na+; Na-benzoate; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759830	Sodium benzoate IgE Qn	4180186
40759830	苯甲酸钠 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40759831	Dexamethasone IgE Qn	4180186
40759831	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Decadron; Dexameth; Dexone; Hexadrol; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759831	地塞米松 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40759834	Bact; C&S; Cardio; Cardiology; Cult; Cultures; Heart Disease; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; PCAR; Pericardial Fluid; Point in time; Random	4180186
40759834	Bacteria Pcar Cult	4180186
40759834	细菌 已鉴定的:存在与否或特征标识:时间点:心包液:名义型:培养	4182948
40759841	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Cytokeratin; Hepatology; IMMUNE BLOT; Immunobl; Immunoblot; Liver; Liver-pancreas antigen; O-phosphoseryl-tRNA(Sec) selenium transferase; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SLA; Soluble liver antigen; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40759841	Soluble liver Ab Ser Ql IB	4180186
40759841	可溶性肝 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40759844	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; Blt; ENA; ENA SS-B; HA; Ha AB; Immune blot; Immunobl; Immunoblot; La AB; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; Sjogren; SR; SS; SSB; SS-B; WB; WBLOT; West blot; West blt; Western blot	4180186
40759844	ENA SS-B Ab Ser Ql IB	4180186
40759844	Sjogrens 综合征-b 可提取性核 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40759845	Per rye grass profilin IgE Qn	4180186
40759845	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; g005; g5; Immune globulin E; Immunoglobulin E; Italian Ryegrass; Per rye grass; Per rye grass profilin; Perennial ryegrass; Point in time; QNT; Quan; Quant; Quantitative; Random; Rye grass; Ryegrass; Serum; SR	4180186
40759845	多年生黑麦草重组抑制蛋白 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40759848	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; C cladosporioides; Cladorsporium cladosporiodes; Hormodendrum; Immune globulin E; Immunoglobulin E; m26; m32; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759848	C cladosporioides IgE Qn	4180186
40759848	枝状枝孢 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40759851	Ribosomal P Ab Ser Ql IB	4180186
40759851	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Immune blot; Immunobl; Immunoblot; Ordinal; P prime; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Ribosomal P Protein; Rib-P; RPP; Screen; Serology; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40759851	核糖体 P 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40759853	Centromere B Ab Ser Ql IB	4180186
40759853	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Cen; CENP B; CENPB; CENP-B; Centromere B; CRST syndrome; Immune blot; Immunobl; Immunoblot; Major centromere autoantigen B; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40759853	着丝点蛋白 B 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40759855	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Cell; Cellularity; Cerebral spinal fluid; Cerebrospinal Fl; Immune blot; Immunobl; Immunoblot; Neuro; Neurology; Ordinal; Paraneoplastic syndrome; PCA; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WB; WBLOT; West blot; West blt; Western blot; Yo autoantibody	4180186
40759855	Purkinje Cells Ab CSF Ql IB	4180186
40759855	浦肯雅细胞 抗体:存在情况或阈值:时间点:脑脊液:序数型:免疫印迹法	4182948
40759858	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Disialolganglioside; Disialylganglioside; GD1b; GD1b Gangl; IMMUNE BLOT; Immune globulin G; Immunobl; Immunoblot; Immunoglobulin G; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40759858	GD1b Gangl IgG Ser Ql IB	4180186
40759858	神经节苷脂 GD1b 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40759859	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Disialolganglioside; Disialylganglioside; GD1b; GD1b Gangl; IMMUNE BLOT; Immune globulin M; Immunobl; Immunoblot; Immunoglobulin M; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40759859	GD1b Gangl IgM Ser Ql IB	4180186
40759859	神经节苷脂 GD1b 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40759861	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; GQ1b; GQ1b Gangl; IMMUNE BLOT; Immune globulin M; Immunobl; Immunoblot; Immunoglobulin M; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SR; Tetrasialylganglioside; WB; WBLOT; West blot; West blt; Western blot	4180186
40759861	GQ1b Gangl IgM Ser Ql IB	4180186
40759861	神经节苷脂 GQ1b 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40759864	PL12 Ab Ser Ql IB	4180186
40759864	ABS; Aby; Alanyl tRNA Synthetase; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; CADM; Clinically amyopathic DM; ILD; Immune blot; Immunobl; Immunoblot; Interstitial Lung Disease; Ordinal; PL12; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40759864	Pl-12 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40759866	Azithromycin IgE Qn	4180186
40759866	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Zithromax	4180186
40759866	阿齐霉素 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40759869	1 hour; 1.0Hr; 17-beta estradiol; 1h p chal; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; E2; Level; Mass concentration; Oestradiol; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759869	Estradiol 1h p chal SerPl-mCnc	4180186
40759869	雌二醇^在XXX刺激之后1小时:质量浓度:时间点:血清/血浆:定量型	4182948
40759871	APOB+LDLR gene; apolipoprotein B; Apolipoprotein B gene; Blood; FH; FHC; FLDB; Genetics; Heredity; Heritable; Identity or presence; Inherited; LDLCQ2; LDLCQ4; Low Density Lipoprotein Receptor; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40759871	APOB+LDLR gene Mut Anl Bld/T	4180186
40759871	APOB 基因+LDLR 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40759874	100M p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759874	Aldost 100M p chal SerPl-mCnc	4180186
40759874	醛固酮^在XXX刺激之后100分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759875	70M p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759875	Aldost 70M p chal SerPl-mCnc	4180186
40759875	醛固酮^在XXX刺激之后70分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40759876	100M p chal; Active renin; After; Angiotensin forming enzyme; Angiotensinogenase; Cardio; Cardiology; Catalytic Concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Heart Disease; Kidney; Nephrology; p chal; Pl; Plasma; Plasma renin activity; Plsm; Point in time; PRA; PST; QNT; Quan; Quant; Quantitative; Random; Renal	4180186
40759876	Renin 100M p chal Plas-cCnc	4180186
40759876	肾素^在XXX刺激之后100分钟:催化浓度:时间点:血浆:定量型	4182948
40759878	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Catalytic Concentration; Chemistry; Dehydrog; Dehyrdogenase; Ejaculate; Genitourinary; GU; L to P; L.D.H; Lact; Lactic acid; Lactic acid dehydrogenase; LD; LDH; L-lactate; L-lactate dehydrogenase; Point in time; QNT; Quan; Quant; Quantitative; Random; React; Rxn; Sem; Seminal fluid; Smn; SMPLS; Tumor marker; URO; Urology	4180186
40759878	Deprecated LDH Smn L to P-cCnc	4180186
40759879	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Hepatology; IMMUNE BLOT; Immunobl; Immunoblot; Liver; Liver kidney microsome; LKM; Microsm; Microsom; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40759879	LKM Ab Ser Ql IB	4180186
40759879	肝肾微粒体 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40759880	Baker's yeast Ab Titr IF	4180186
40759880	酿酒酵母 抗体:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40759880	ABS; Aby; ACIF; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; ASCA; Autoantibodies; Autoantibody; Bakers yeast; Baker's yeast; Dilution factor; Dilution Factor (Titer); f045; f403; f45; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Point in time; Random; SCA; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Yeast	4180186
40759881	Oligoclonal Bands IgG SerPl Ql	4180186
40759881	Chemistry; Frac; Fract; Fraction; Fractionated; Fractionation; Immune globulin G; Immunoglobulin G; M-spikes; Oligoclonal Bands IgG; Ordinal; Pl; Plasma; Plsm; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759881	蛋白质成分.寡克隆区带.IgG:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40759882	Oligoclonal Bands IgM SerPl-Imp	4180186
40759882	Chemistry; Frac; Fract; Fraction; Fractionated; Fractionation; Immune globulin M; Immunoglobulin M; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; M-spikes; Nominal; Oligoclonal Bands IgM; Pl; Plasma; Plsm; Point in time; PR; Prot; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40759882	蛋白质成分.寡克隆区带.IgM:印象:时间点:血清/血浆:名义型	4182948
40759885	Bands; bnd; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; i; M Protein; M Protein 1; Mass Fraction; M-band; Monoclonal band; Monoclonal spike; M-protein; M-spike; Para protein; Paraprotein; Percent; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEP; SR; Tot; Totl; TP	4180186
40759885	M Protein 1 MFr SerPl Elph	4180186
40759885	蛋白质.单克隆型 区带 1/蛋白质.总计:质量分数:时间点:血清/血浆:定量型:电泳	4182948
40759888	100WBC; Bro; Dynamic; FC; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lung; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Number fraction; Percent; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; WBC; WBCs; White blood cell; White blood cells	4180186
40759888	Lymphocytes/leuk NFr Bronch FC	4180186
40759888	淋巴细胞/100 个白细胞:计数型分数:时间点:支气管来源的标本:定量型:流式细胞测量术	4182948
40759891	100WBC; Bro; Dynamic; FC; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Macrop; Macrophage; Macros; Macrphg; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
40759891	Macrophages/leuk NFr Bronch FC	4180186
40759891	巨噬细胞/100 个白细胞:计数型分数:时间点:支气管来源的标本:定量型:流式细胞测量术	4182948
40759894	#; ABS; absolute; absolutes; CD3 Cells; CD3+CD16+ Cells; CD3+CD16+CD56+ Cells; CD3-CD16+ Cells; CD3-CD16+CD56+ Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; FCGR3A; Leu11; Leu-11; Leu11b; Leu-11B; Leu19; Leu-19; Leu4; Leu-4; Natural killer cells; NCAM; Neural cell adhesion molecule; NKH1; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; T3; Tissue; Tissue, unspecified	4180186
40759894	CD3-CD16+CD56+ Cells # Tiss	4180186
40759894	细胞.CD3-CD16+CD56+:计数型浓度:时间点:组织与涂片:定量型	4182948
40759896	B; Before; Chemistry; LDL; Lip; Lipoprot; Lipoproteins; Low density lipoproteins; LP; Mass concentration ratio; Mass ratio; MCRto; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Very low density lipoproteins; VLDL	4180186
40759896	VLDL/LDL SerPl	4180186
40759896	脂蛋白.前 Beta/脂蛋白.beta:质量比率:时间点:血清/血浆:定量型	4182948
40759897	Articaine IgE Qn	4180186
40759897	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; c231; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759897	阿替卡因 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40759899	21 Hydroxylase Deficiency; Blood; CA21H; CAH1; Congenital adrenal hyperplasia; CPS1; CYP21; CYP21B; cytochrome P450, family 21, subfamily A, polypeptide 2; Gene mut tested; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Tested; Mutation; Muts; Nominal; P450c21B; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40759899	CYP21A2 Mut Tested Bld/T	4180186
40759899	CYP21A2 基因 已测试的突变:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40759901	Alpha amylase; Ams; Amyl; Amylase S4; Catalytic Fraction; Chemistry; Diastase; Gastro; Gastroenterology; GI; k87; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl	4180186
40759901	Amylase S4 CFr SerPl	4180186
40759901	淀粉酶.S4/淀粉酶.总计:催化分数:时间点:血清/血浆:定量型	4182948
40759902	TCE Bld-sCnc	4180186
40759902	1,1,1-TCE; Aerothene tt; Alpha trichloroethane; Blood; C2H3Cl3; Chlorothene; Chlorothene NU; Chlorothene VG; DRUG/TOXICOLOGY; Drugs; Level; Methyl chloroform; Methylchloroform; Methyltrichloromethane; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; TCE; Tri-ethane; WB; Whole blood	4180186
40759902	三氯乙烷:物质的量浓度:时间点:全血:定量型	4182948
40759905	B; B2 Microglob; B2 Microglob tumor marker; b2-M; Chemistry; Hematology; Heme; II; Level; Mark; Mass concentration; Microglob; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tumor marker	4180186
40759905	B2 Microglob tumor marker Ser-mCnc	4180186
40759905	Beta-2-微球蛋白.肿瘤标志物:质量浓度:时间点:血清:定量型	4182948
40759906	Arbitrary concentration; Autoimmune hepatitis; Chemistry; CK; CK 19; Cyfra 21-1; Keratin 19; Keratin, type I cytoskeletal 19; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40759906	CK 19 Ur-aCnc	4180186
40759906	细胞角蛋白 19:任意型浓度:时间点:尿液:定量型	4182948
40759910	ANTIBIOTIC SUSCEPTIBILITIES; AST; Baraclude; ETV; Genotype; Genotypic; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40759910	Entecavir Islt Genotyp	4180186
40759910	恩替卡韦:抗生素敏感性:时间点:分离株:序数型:基因分型	4182948
40759912	ANTIBIOTIC SUSCEPTIBILITIES; AST; Genotype; Genotypic; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40759912	Deprecated Tenefovir Islt Genotyp	4180186
40759913	ADMIN; ADMIN.PATIENT; ADMIN.PATIENT.ID; Ident; Identifier; Intradermal; Nominal; Point in time; Random	4180186
40759913	Internal ID	4180186
40759913	内部标识符:标识符:时间点:^患者:名义型	4182948
40759917	DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Nominal; Person name; Point in time; Random	4180186
40759917	别名:人员姓名:时间点:^患者:名义型	4182948
40759918	Address; ADMIN; ADMIN.PATIENT; Nominal; Point in time; Random	4180186
40759918	地址:地址:时间点:^患者:名义型	4182948
40759919	Date and time; Date+time; Date+time ED consult request initiated; DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
40759919	Date+time ED consult request initiated	4180186
40759919	急诊科会诊申请发出日期和时间:时间戳:时间点:^患者:定量型	4182948
40759923	ED nurse Provider	4180186
40759923	ADMIN; Emergency Department; Ident; Identifier; Intradermal; Nominal; nursing; Point in time; Random	4180186
40759923	急诊科护士:标识符:时间点:服务提供者:名义型	4182948
40759926	ED transferring facility	4180186
40759926	ADMIN; Emergency Department; Ident; Identifier; Nominal; Point in time; Random	4180186
40759926	急诊科移交设施:标识符:时间点:设施:名义型	4182948
40759929	ADMIN; Emergency Department; Ident; Identifier; Intradermal; Nominal; nursing; Point in time; Random	4180186
40759929	急诊科分诊护士:标识符:时间点:服务提供者:名义型	4182948
40759930	ADMIN; Ident; Identifier; Nominal; Point in time; Random	4180186
40759930	Primary care clinic or system Facility	4180186
40759930	初级保健服务门诊或体系:标识符:时间点:设施:名义型	4182948
40759931	ADMIN; Ident; Identifier; Intradermal; Nominal; Point in time; Provider who accepted pt in transfer; Random; World Heatlth Organization	4180186
40759931	Provider who accepted pt in transfer	4180186
40759931	在移交至另一设施过程中接收患者的服务提供者:标识符:时间点:服务提供者:名义型	4182948
40759936	DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Finding; Findings; Nominal; Point in time; Random	4180186
40759936	提出问题:发现:时间点:^患者:名义型	4182948
40759938	Assessment; DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Eval; Finding; Findings; H&P; History and physical; Nominal; Point in time; Random	4180186
40759938	问题既往评价:发现:时间点:^患者:名义型	4182948
40759939	DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Finding; Findings; Nominal; Point in time; Random	4180186
40759939	问题语境:发现:时间点:^患者:名义型	4182948
40759940	DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Finding; Findings; Nominal; Point in time; Random	4180186
40759940	问题加剧因素:发现:时间点:^患者:名义型	4182948
40759944	Date and time; DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
40759944	问题时间过程:时间戳:时间点:^患者:定量型	4182948
40759946	DEEDS; Durat; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Point in time; QNT; Quan; Quant; Quantitative; Random; Sx; Sym dur during occurrences or episodes	4180186
40759946	Sym dur during occurrences or episodes	4180186
40759946	发生期间或患病期间的症状持续时间:时间:时间点:^患者:定量型	4182948
40759951	DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Nominal; Point in time; Random; Subs; Typ	4180186
40759951	所滥用的物质:类型:时间点:^患者:名义型	4182948
40759952	Finding; Findings; Gestation; Gestations; Gravida; H+P; H+P.HX; Hx; Narrative; P prime; Point in time; Pregnancies; Random; Report	4180186
40759952	Pregnancy related history	4180186
40759952	妊娠相关病史:发现:时间点:^患者:叙述型	4182948
40759954	Viability of current pregnancy	4180186
40759954	Finding; Findings; Gestation; Gestations; Gravida; H+P; H+P.HX; Narrative; P prime; Point in time; Pregnancies; Random; Report	4180186
40759954	当前妊娠的成活性:发现:时间点:^患者:叙述型	4182948
40759957	Dis; Diseases; Dz; H+P; H+P.HX; History; Narrative; P prime; Point in time; Random; Report	4180186
40759957	Hx of Infectious disease	4180186
40759957	传染病:历史记录:时间点:^患者:叙述型	4182948
40759958	Finding; Findings; H+P; H+P.PX; Narrative; P prime; Point in time; Random; Report	4180186
40759958	Acuity assess	4180186
40759958	病情危急程度评估:发现:时间点:^患者:叙述型	4182948
40759961	Chronic pain assessment	4180186
40759961	Finding; Findings; H+P; H+P.PX; Narrative; P prime; Point in time; Random; Report	4180186
40759961	慢性疼痛评估:发现:时间点:^患者:叙述型	4182948
40759965	Cardio; Cardiology; Complex; DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Heart Disease	4180186
40759965	Cardiac biomarkers	4180186
40759965	心脏生物标志物:复合型属性:-:^患者:集合型	4182948
40759970	DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Identity or presence; Nominal; Point in time; Random	4180186
40759970	医疗护理过程或计划:存在与否或特征标识:时间点:^患者:名义型	4182948
40759971	Amount ED discharge meds to be dispensed; Cnt; Count; DEEDS; Disch; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Number; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40759971	Amount ED discharge meds to be dispensed	4180186
40759971	要配发的急诊科出院药物的数量:数量(计数):时间点:^患者:定量型	4182948
40759972	DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Finding; Findings; Nominal; Point in time; Random	4180186
40759972	急诊科结局:发现:时间点:^患者:名义型	4182948
40759974	Prov assuming resp for care	4180186
40759974	ADMIN; Emergency Department; Ident; Identifier; Intradermal; Nominal; Point in time; Prov assuming resp for care; Random	4180186
40759974	急诊科处置时担任患者医疗护理服务工作最终责任的服务提供者:标识符:时间点:服务提供者:名义型	4182948
40759975	ADMIN; Emergency Department; Ident; Identifier; Intradermal; Nominal; Point in time; Prov assuming care uponED dispon; Random	4180186
40759975	Prov assuming care uponED dispon	4180186
40759975	急诊科处置时担任患者医疗护理服务工作的服务提供者:标识符:时间点:服务提供者:名义型	4182948
40759976	Date and time; DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
40759976	入院或移交的接受时间:时间戳:时间点:^患者:定量型	4182948
40759978	Date+time of ED departure	4180186
40759978	Date and time; Date+time; Date+time of ED departure; DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
40759978	急诊科离开日期和时间:时间戳:时间点:^患者:定量型	4182948
40759981	Address; DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Nominal; Point in time; Random	4180186
40759981	地址:地址:时间点:^应急联系人:名义型	4182948
40759982	ADMIN; No; Nominal; Num; Phone #; Point in time; Random; Telecommunication number; Telephone number	4180186
40759982	Emergency contact Phone #	4180186
40759982	电话号码:电话号码:时间点:^应急联系人:名义型	4182948
40759984	DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Identity or presence; Nominal; Point in time; Random	4180186
40759984	问题诊断考虑事项:存在与否或特征标识:时间点:^患者:名义型	4182948
40759988	Continuous ST segment monitoring	4180186
40759988	Complex; DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS)	4180186
40759988	连续性 ST 段监测:复合型属性:-:^患者:集合型	4182948
40759990	Hx of Gynecologic system disorders	4180186
40759990	Gyn; H+P; H+P.HX; History; Narrative; P prime; Point in time; Random; Report; Sx; Symp + dis	4180186
40759990	症状与疾病:历史记录:时间点:妇科系统:叙述型	4182948
40759991	Constitutional symptoms	4180186
40759991	Finding; Findings; H+P; H+P.HX; Narrative; P prime; Point in time; Random; Report; Sx	4180186
40759991	全身症状:发现:时间点:^患者:叙述型	4182948
40759996	Mepivacaine IgE Qn	4180186
40759996	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Carbocaine; Immune globulin E; Immunoglobulin E; Isocaine; Point in time; Polocaine; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759996	甲哌卡因 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40759997	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Butacote; Butadion; Butadione; Butazolidin; Butazone; Butrex; c231; C57; Carudol; Cotylbutazone; Exiheudon N; Immune globulin E; Immunoglobulin E; Inflazone; Intrabutazone; Kadol; Novobutazone; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Spondyril; SR; Ticinil	4180186
40759997	Phenylbutazone IgE Qn	4180186
40759997	苯基保泰松 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40759998	Lactose IgE Qn	4180186
40759998	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40759998	乳糖 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40760002	Blood; butyrylcholinesterase; Butyrylcholinesterase gene; CHE1; CHE2; E1; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Pseudocholinesterase gene; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40760002	BCHE gene Mut Anl Bld/T	4180186
40760002	BCHE 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40760013	CD13+HLA-DR+ Cells NFr CSF	4180186
40760013	Aminopeptidase n; APN; CD13 Cells; CD13+HLA-DR+ Cells; Cell; CELL MARKERS; Cellularity; Cerebral spinal fluid; Cerebrospinal Fl; Gated cells; gp150; Human Leukocyte Antigen; I3; LeuM7; Leu-M7; My7; My-7; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
40760013	细胞.CD13+HLA-DR+/100 个细胞:计数型分数:时间点:脑脊液:定量型	4182948
40760015	CD33+CD34+ Cells NFr Mar	4180186
40760015	BM; BON; Bone marrow; CD33 Cells; CD33+CD34+ Cells; Cell; CELL MARKERS; Cellularity; Gated cells; gp105-120; gp67; Hematopoietic stem cell; HSC; LeuM9; Leu-M9; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; My10; My-10; My9; My-9; Number fraction; p67; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Stem cells	4180186
40760015	细胞.CD33+CD34+/100 个细胞:计数型分数:时间点:骨髓:定量型	4182948
40760016	CD3 Cells; CD3+CD56+ Cells; CD3-CD56+ Cells; Cell; CELL MARKERS; Cellularity; Cerebral spinal fluid; Cerebrospinal Fl; Gated cells; Leu19; Leu-19; Leu4; Leu-4; Natural killer cells; NCAM; Neural cell adhesion molecule; NKH1; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; T3	4180186
40760016	CD3-CD56+ Cells NFr CSF	4180186
40760016	细胞.CD3-CD56+/100 个细胞:计数型分数:时间点:脑脊液:定量型	4182948
40760017	CD5 Cells; CD5+FMC7+ Cells; Cell; CELL MARKERS; Cellularity; FMC-7; Gated cells; Leu1; Leu-1; Ly-1; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T1; Tissue; Tissue, unspecified; Tp67	4180186
40760017	CD5+FMC7+ Cells NFr Tiss	4180186
40760017	细胞.CD5+FMC7+/100 个细胞:计数型分数:时间点:组织与涂片:定量型	4182948
40760019	TdT Cells NFr CSF FC	4180186
40760019	Cell; CELL MARKERS; Cellularity; Cerebral spinal fluid; Cerebrospinal Fl; Dynamic; FC; Gated cells; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; TdT; TdT Cells	4180186
40760019	细胞.末端脱氧核苷酸转移酶/100 个细胞:计数型分数:时间点:脑脊液:定量型:流式细胞测量术	4182948
40760020	Acd; Acids; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random	4180186
40760020	Amino acid Pat Fld-Imp	4180186
40760020	氨基酸模式:印象:时间点:体液:名义型	4182948
40760021	1 day; 24 hours; 24HR; Alpha amylase; Ams; Amyl; Chemistry; CR; Crea; Creat; Diastase; Gastro; Gastroenterology; GI; k87; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40760021	Amylase/Creat 24h Ur-Rto	4180186
40760021	淀粉酶/肌酐:比率:24小时:尿液:定量型	4182948
40760024	Alb; Associated; Bc; Bili; Bili.delta; Bili-alb; Bilirub Conj; Bilirub Delta; Bilirub Direct; Bilirubin conjugated; Bilirubin direct; Bilirubin glucuronides; Bilirubins; Billirubin; bnd; Chemistry; DELB; Delta bilirubin; Deltab; Level; Mass concentration; Pleural; Pleural fluid; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; TBIL; TBIL-(Bu+Bc); TBIL-Bu; thoracentesis fluid	4180186
40760024	Bilirub Direct Plr-mCnc	4180186
40760024	胆红素.葡糖醛酸化+胆红素.白蛋白结合型:质量浓度:时间点:胸膜液:定量型	4182948
40760026	B220; Blood; CD3 Cells; CD3+CD45+ Cells; CD3-CD45+ cells; CD45R; CD45RA; CD45RB; CD45RC; CD45RO; Cell; CELL MARKERS; Cellularity; Gated cells; LCA; Leu4; Leu-4; Leukocyte common antigen; Ly5; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T200; T3; WB; Whole blood	4180186
40760026	CD3+CD45+ Cells NFr Bld	4180186
40760026	细胞.CD3+CD45+/100 个细胞:计数型分数:时间点:全血:定量型	4182948
40760028	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chlam; Chlamid; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; species; spp; SR; SUDS	4180186
40760028	Chlamydia IgG Ser Ql IA	4180186
40760028	衣原体属单个未知种 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40760030	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Chlam; Chlamid; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Post immunization; QNT; Quan; Quant; Quantitative; Random; Second; Serum; sp2; Spec; species; spp; SR; SUDS	4180186
40760030	Chlamydia IgG sp2 Ser IA-aCnc	4180186
40760030	衣原体属单个未知种 抗体.IgG^第2个标本:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40760031	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; Level; Lipid; Mass concentration; Pcar; Pericardial fluid; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760031	Cholest Pcar-mCnc	4180186
40760031	胆固醇:质量浓度:时间点:心包液:定量型	4182948
40760035	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Arbitrary concentration; Autoantibodies; Autoantibody; C burnet; C burnetii; Convalescent; Coxiella burnettii; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Post immunization; Q fev; Q fever; Qfever; QNT; Quan; Quant; Quantitative; Random; Second; Serum; sp2; Spec; SR; Time Resolved Fluorescence; TRF	4180186
40760035	C burnet IgM sp2 Ser IF-aCnc	4180186
40760035	贝氏柯克斯体 抗体.IgM^第2个标本:任意型浓度:时间点:血清:定量型:免疫荧光法	4182948
40760037	C burnet IgM sp1 Titr Ser IF	4180186
40760037	贝氏柯克斯体 抗体.IgM^第1个标本:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40760037	ABS; Aby; ACIF; Acute specimen; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; C burnet; C burnetii; Coxiella burnettii; Dilution factor; Dilution Factor (Titer); FA; First; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Pre immunization; Q fev; Q fever; Qfever; Random; Serum; SmQn; sp1; Spec; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40760038	C burnet IgG sp2 Titr Ser IF	4180186
40760038	贝氏柯克斯体 抗体.IgG^第2个标本:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40760038	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; C burnet; C burnetii; Convalescent; Coxiella burnettii; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Post immunization; Q fev; Q fever; Qfever; Random; Second; Serum; SmQn; sp2; Spec; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40760039	C burnet IgG sp1 Titr Ser IF	4180186
40760039	贝氏柯克斯体 抗体.IgG^第1个标本:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40760039	ABS; Aby; ACIF; Acute specimen; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; C burnet; C burnetii; Coxiella burnettii; Dilution factor; Dilution Factor (Titer); FA; First; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Pre immunization; Q fev; Q fever; Qfever; Random; Serum; SmQn; sp1; Spec; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40760041	ABS; Aby; Ameba; Amebiasis; Amebic; Amoeba; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; E histolyt; E histolytica; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
40760041	E histolyt IgG Ser Ql IA	4180186
40760041	溶组织内阿米巴 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40760043	F hepatica Ab Titr Ser HA	4180186
40760043	肝片吸虫 抗体:滴定度:时间点:血清:定量型:红细胞凝集试验法	4182948
40760043	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); F hepatica; Hemagglutination; ID; IHA; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40760045	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; HCV; HCV c1; Hep; Hep C; Hepatis; Hepatit; Hepatology; ID; IMMUNE BLOT; Immunobl; Immunoblot; Infectious Disease; InfectiousDisease; Liver; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40760045	HCV c1 Ab Ser Ql IB	4180186
40760045	丙型肝炎病毒 c1 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40760046	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; HCV; HCV c2; Hep; Hep C; Hepatis; Hepatit; Hepatology; ID; IMMUNE BLOT; Immunobl; Immunoblot; Infectious Disease; InfectiousDisease; Liver; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40760046	HCV c2 Ab Ser Ql IB	4180186
40760046	丙型肝炎病毒 c2 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40760047	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; HCV; HCV E2; Hep; Hep C; Hepatis; Hepatit; Hepatology; ID; IMMUNE BLOT; Immunobl; Immunoblot; Infectious Disease; InfectiousDisease; Liver; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40760047	HCV E2 Ab Ser Ql IB	4180186
40760047	丙型肝炎病毒 E2 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40760048	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; HCV; HCV NS3; Hep; Hep C; Hepatis; Hepatit; Hepatology; ID; IMMUNE BLOT; Immunobl; Immunoblot; Infectious Disease; InfectiousDisease; Liver; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40760048	HCV NS3 Ab Ser Ql IB	4180186
40760048	丙型肝炎病毒 NS3 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40760049	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; HCV; HCV NS4; Hep; Hep C; Hepatis; Hepatit; Hepatology; ID; IMMUNE BLOT; Immunobl; Immunoblot; Infectious Disease; InfectiousDisease; Liver; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40760049	HCV NS4 Ab Ser Ql IB	4180186
40760049	丙型肝炎病毒 NS4 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40760050	Breath H2 pre Lac	4180186
40760050	Before; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; Percent; Point in time; pre Lac; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
40760050	氢/已呼出的气体^在给予剂量乳果糖之前:体积分数:时间点:呼出的气体:定量型	4182948
40760052	Breath H2 2h p Lac	4180186
40760052	120 min; 120 minutes; 120min; 2 hours; 2h p Lac; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
40760052	氢/已呼出的气体^在给予剂量乳果糖之后2小时:体积分数:时间点:呼出的气体:定量型	4182948
40760053	2.5h p Lac; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
40760053	Breath H2 2.5h p Lac	4180186
40760053	氢/已呼出的气体^在给予剂量乳果糖之后2.5小时:体积分数:时间点:呼出的气体:定量型	4182948
40760054	3.5h p Lac; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; Gastro; Gastroenterology; GI; H2; Hyd; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
40760054	Breath H2 3.5h p Lac	4180186
40760054	氢/已呼出的气体^在给予剂量乳果糖之后3.5小时:体积分数:时间点:呼出的气体:定量型	4182948
40760056	Breath H2 30M p Glc	4180186
40760056	30M p Glc; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; H2; Hyd; p dose; p Glc; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
40760056	氢/已呼出的气体^在剂量葡萄糖之后30分钟:体积分数:时间点:呼出的气体:定量型	4182948
40760057	Breath H2 30M p Lac	4180186
40760057	30M p Lac; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
40760057	氢/已呼出的气体^在给予剂量乳果糖之后30分钟:体积分数:时间点:呼出的气体:定量型	4182948
40760059	Inhibin B SerPl IA-mCnc	4180186
40760059	Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Tumor marker	4180186
40760059	抑制素 B:质量浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
40760061	64h p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
40760061	Insulin 64h p chal SerPl-aCnc	4180186
40760061	胰岛素^在XXX刺激之后64小时:任意型浓度:时间点:血清/血浆:定量型	4182948
40760063	Insulin 3D p chal SerPl-aCnc	4180186
40760063	3D p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
40760063	胰岛素^在XXX刺激之后3天:任意型浓度:时间点:血清/血浆:定量型	4182948
40760065	Insulin 2D p chal SerPl-aCnc	4180186
40760065	2D p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
40760065	胰岛素^在XXX刺激之后2天:任意型浓度:时间点:血清/血浆:定量型	4182948
40760066	Insulin 60H p chal SerPl-aCnc	4180186
40760066	60H p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
40760066	胰岛素^在XXX刺激之后60小时:任意型浓度:时间点:血清/血浆:定量型	4182948
40760068	40H p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
40760068	Insulin 40H p chal SerPl-aCnc	4180186
40760068	胰岛素^在XXX刺激之后40小时:任意型浓度:时间点:血清/血浆:定量型	4182948
40760069	L pneumo IgG sp2 Titr Ser IF	4180186
40760069	嗜肺军团菌 抗体.IgG^第2个标本:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40760069	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Convalescent; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; L pneumo; L pneumonphila; Legion; Legionela; Microbiology; Pneu; pneum; Pneumophilia; Point in time; Post immunization; Random; Second; Serum; SmQn; sp2; Spec; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40760070	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Kala azar; Leishmaniasis; Leishmaniosis; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; species; spp; SR; Time Resolved Fluorescence; TRF; Visceral leishmaniasis	4180186
40760070	Leishmania IgG Ser Ql IF	4180186
40760070	利什曼原虫属单个未知种 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40760074	1 day; 2,6-diaminohexanoic acid; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Lys; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
40760074	Lysine/Creat 24h Ur-Rto	4180186
40760074	赖氨酸/肌酐:比率:24小时:尿液:定量型	4182948
40760075	Chemistry; CR; Crea; Creat; MAG; Magnes; Mg; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; UA; UCr; UR; Urn	4180186
40760075	Magnesium/Creat Ur-Rto	4180186
40760075	镁/肌酐:比率:时间点:尿液:定量型	4182948
40760077	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzootic pneumonia; Enzyme immunoassay; First; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; M pneumo; M pneumonia; M pneumoniae; MEIA; Microbiology; Myco; Myco pneu; Mycoplas; Mycoplasm; Mycoplasmoides pneumoniae; Mycoplasmosis; Mycoplsm; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Serum; sp1; Spec; SR; SUDS	4180186
40760077	M pneumo IgG sp1 Ser IA-aCnc	4180186
40760077	肺炎支原体 抗体.IgG^第1个标本:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40760078	ABS; Aby; ACIF; ANNA 2; ANNA-2; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; FA; FANA; Fluorescent antibody; Fluoresent; Hu; Hu2; IFA; II; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Neuro; Neurology; Neuronal nuclear type II; Nuc; Ordinal; Paraneoplastic syndrome; Point in time; PR; QL; Qual; Qualitative; Random; RI; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF	4180186
40760078	Hu2 Ab CSF Ql IF	4180186
40760078	神经元细胞核 2 型 抗体:存在情况或阈值:时间点:脑脊液:序数型:免疫荧光法	4182948
40760079	100WBC; BM; BON; Bone marrow; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Neut; Neutr; Neutrophil; Neuts Seg; N-Seg; Number fraction; Percent; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; Seg; Segs; WBC; WBCs; White blood cell; White blood cells	4180186
40760079	Neuts Seg/leuk NFr Mar Manual	4180186
40760079	嗜中性粒细胞.分叶型/100 个白细胞:计数型分数:时间点:骨髓:定量型:手工计数方法	4182948
40760081	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; AOA; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Ordinal; Ovarian; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF	4180186
40760081	Ovary IgG Ser Ql IF	4180186
40760081	卵巢 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40760083	Chemistry; CR; Crea; Creat; i Phos; Inorganic phosphate; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; UA; UCr; UR; Urn	4180186
40760083	Phosphate/Creat Ur-Rto	4180186
40760083	磷酸盐/肌酐:比率:时间点:尿液:定量型	4182948
40760100	30M p resting; After; Chemistry; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40760100	GH 30M p resting SerPl-mCnc	4180186
40760100	生长激素^在休息之后30分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40760101	90M p resting; After; Chemistry; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40760101	GH 90M p resting SerPl-mCnc	4180186
40760101	生长激素^在休息之后90分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40760102	1 hour; 1.0Hr; 1h p resting; 60 min; 60 minutes; 60M; 60min; After; Chemistry; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40760102	GH 1h p resting SerPl-mCnc	4180186
40760102	生长激素^在休息之后1小时:质量浓度:时间点:血清/血浆:定量型	4182948
40760103	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cysticercosis; Cysticercus; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; T sol; T sol lar; T solium; Tapeworm	4180186
40760103	T sol lar Ab Ser Ql IA	4180186
40760103	猪囊尾蚴 抗体:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40760104	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; QNT; Quan; Quant; Quantitative; Ratios; Rto; Tau; UA; UCr; UR; Urn	4180186
40760104	Taurine/Creat 24h Ur-Rto	4180186
40760104	牛磺酸/肌酐:比率:24小时:尿液:定量型	4182948
40760106	40M p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; FR; FreeT4; FT4; Level; Levothyroxine; Levo-thyroxine; L-thyroxine; Mass concentration; Non-protein bound; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T4; T-4; T4 Free; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T4; TT4	4180186
40760106	T4 Free 40M p chal SerPl-mCnc	4180186
40760106	甲状腺素.游离型^在XXX刺激之后40分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40760107	1 1/2 hours; 1 1/2 HR; 1.5h p chal; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; FR; FreeT4; FT4; Level; Levothyroxine; Levo-thyroxine; L-thyroxine; Mass concentration; Non-protein bound; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T4; T-4; T4 Free; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T4; TT4	4180186
40760107	T4 Free 1.5h p chal SerPl-mCnc	4180186
40760107	甲状腺素.游离型^在XXX刺激之后1.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
40760110	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; T gondii; Toxo; Toxoplasmosis	4180186
40760110	T gondii IgG Avidity SerPl Ql IA	4180186
40760110	刚地弓形虫 抗体.IgG 亲合力:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法	4182948
40760111	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; species; spp; SR; Time Resolved Fluorescence; TRF; Tric; Trich	4180186
40760111	Trichinella IgG Ser Ql IF	4180186
40760111	旋毛形线虫属单个未知种 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40760116	Chemistry; CR; Crea; Creat; Mass concentration ratio; Mass ratio; MCRto; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760116	Urea/Creat SerPl	4180186
40760116	尿素/肌酐:质量比率:时间点:血清/血浆:定量型	4182948
40760118	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; European hornet; i75; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40760118	European Hornet IgG4 Qn	4180186
40760118	胡蜂 抗体.IgG4:任意型浓度:时间点:血清:定量型	4182948
40760119	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Common wasp; i003; i3; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Vespula sp; Yellow jacket; Yellow wasp	4180186
40760119	Yellow Jacket IgG4 Qn	4180186
40760119	黄胡蜂属多个未知种 抗体.IgG4:任意型浓度:时间点:血清:定量型	4182948
40760121	11DC; 4D p chal; After; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Deoxycortisol; Desoxycortisol; Level; Mass concentration; Metopirone; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760121	11DC 4D p chal SerPl-mCnc	4180186
40760121	11-脱氧皮质醇^在XXX刺激之后4天:质量浓度:时间点:血清/血浆:定量型	4182948
40760123	Glucose/Creat 24h Ur	4180186
40760123	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Glu; Gluc; Glucoseur; Mass concentration ratio; Mass ratio; MCRto; QNT; Quan; Quant; Quantitative; UA; UCr; UR; Urn	4180186
40760123	葡萄糖/肌酐:质量比率:24小时:尿液:定量型	4182948
40760128	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzootic pneumonia; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; M pneumo; M pneumonia; M pneumoniae; MEIA; Microbiology; Myco; Myco pneu; Mycoplas; Mycoplasm; Mycoplasmoides pneumoniae; Mycoplasmosis; Mycoplsm; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Post immunization; QNT; Quan; Quant; Quantitative; Random; Second; Serum; sp2; Spec; SR; SUDS	4180186
40760128	M pneumo IgG sp2 Ser IA-aCnc	4180186
40760128	肺炎支原体 抗体.IgG^第2个标本:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40760133	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Fe; Mass concentration ratio; Mass ratio; MCRto; QNT; Quan; Quant; Quantitative; UA; UCr; UR; Urn	4180186
40760133	Iron/Creat 24h Ur	4180186
40760133	铁/肌酐:质量比率:24小时:尿液:定量型	4182948
40760143	Document; Finding; Findings; HQM document; Pan; Panel; PANEL.DOC; Panl; Pnl; Point in time; Random	4180186
40760143	HQM document	4180186
40760143	健康质量指标文档:发现:时间点:^患者:文档型	4182948
40760145	Population criteria	4180186
40760145	DOCUMENT QUALITY; Finding; Findings; Narrative; Point in time; Quality; Random; Report	4180186
40760145	样本总体准则:发现:时间点:^患者:叙述型	4182948
40760147	Chemistry; Fe; Hepar; Hepatic; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760147	Iron Liver-mCnt	4180186
40760147	铁:质量含量:时间点:肝脏:定量型	4182948
40760149	Chr 13+18+21+X+Y aneup Bld	4180186
40760149	Blood; Chr 13+18+21+X+Y aneup; Chromosom; Chromosomes; Finding; Findings; Molecular genetics; Molecular pathology; MOLPATH; Nominal; PCR; Point in time; Random; WB; Whole blood	4180186
40760149	染色体 13+18+21+X+Y 非整倍体性:发现:时间点:全血:名义型:分子遗传学类实验室方法	4182948
40760151	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; ID; IMMUNE BLOT; Immunobl; Immunoblot; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serum; SR; Syphilis; T pallidum; Treponemal; WB; WBLOT; West blot; West blt; Western blot	4180186
40760151	T pallidum Ab Ser Ql IB	4180186
40760151	梅毒螺旋体 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40760154	Cow Milk Ab Ql ID	4180186
40760154	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f002; f2; f43; ID; Imm; Immunodiff; Immunodiffusion; Imun; Imune; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
40760154	牛奶 抗体:存在情况或阈值:时间点:血清:序数型:免疫扩散法	4182948
40760156	Chr 13+18+21+X+Y aneup Amn	4180186
40760156	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chr 13+18+21+X+Y aneup; Chromosom; Chromosomes; Finding; Findings; Molecular genetics; Molecular pathology; MOLPATH; Nominal; PCR; Point in time; Random	4180186
40760156	染色体 13+18+21+X+Y 非整倍体性:发现:时间点:羊水:名义型:分子遗传学类实验室方法	4182948
40760161	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
40760168	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
40760172	DOC.ONT; Document; ED; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; nursing; Point in time; Random; Visit note	4180186
40760172	Nurse ED Note	4180186
40760172	记录:发现:时间点:急诊科:文档型:护士	4182948
40760173	Nurse ED Triage+care note	4180186
40760173	DOC.ONT; Document; ED; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; nursing; Point in time; Random; Visit note	4180186
40760173	分诊与护理记录:发现:时间点:急诊科:文档型:护士	4182948
40760176	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; L&D summary note; notes; Point in time; Random; Visit note	4180186
40760176	L&D summary note	4180186
40760176	临产和分娩摘要记录:发现:时间点:{环境}:文档型:{角色}	4182948
40760177	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Mat dischrg sum note; notes; Point in time; Random; Visit note	4180186
40760177	Deprecated Mat dischrg sum note	4180186
40760180	Antepartum flowsheet Pnl; CLIN; Finding; Findings; Narrative; Pan; Panl; Pnl; Point in time; Random; Report	4180186
40760180	Antepartum flowsheet Pnl	4180186
40760180	分娩前流程记录单组套:发现:时间点:^患者:叙述型	4182948
40760181	Cnt; Count; Gyn; Gynecology; Number; OB; ObGyn; OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760181	Births.stillborn	4180186
40760181	生产.死产:数量(计数):时间点:^患者:定量型:报告法	4182948
40760187	Ausc; Count/time; Fetal; Gyn; Gynecology; H+P; H+P.HX; Heart beat; nRate; Number rate; Number Rate = Count/Time; OB; ObGyn; Obstetrics; P prime; Point in time; Pulse; QNT; Quan; Quant; Quantitative; Random	4180186
40760187	Fet Heart rate Auscultation	4180186
40760187	心率:计数型速率:时间点:^胎儿:定量型:听诊法	4182948
40760189	H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760189	下次门诊就诊日期:日期:时间点:^患者:定量型	4182948
40760192	Document; Finding; Findings; H+P; H+P.PX; P prime; Point in time; Random	4180186
40760192	产前记录:发现:时间点:^患者:文档型	4182948
40760194	Document; Finding; Findings; H+P; H+P.PX; NB; NB delivery info; New born; P prime; Point in time; Random	4180186
40760194	NB delivery information	4180186
40760194	新生儿分娩信息:发现:时间点:^新生儿:文档型	4182948
40760197	Antenatal testing & surveillance; Finding; Findings; H+P; H+P.PX; Narrative; P prime; Point in time; Random; Report	4180186
40760197	Antenatal testing & surveillance	4180186
40760197	出生前测试与监测:发现:时间点:^患者:叙述型	4182948
40760198	Finding; Findings; H+P; H+P.PX; Narrative; P prime; Point in time; Random; Report	4180186
40760198	Birth plan	4180186
40760198	出生计划:发现:时间点:^患者:叙述型	4182948
40760199	Implanted medical device	4180186
40760199	Finding; Findings; H+P; H+P.PX; Narrative; P prime; Point in time; Random; Report	4180186
40760199	植入型医疗装置:发现:时间点:^患者:叙述型	4182948
40760201	Antepartum record Pnl; APR; Pan; PANEL.DOC; Panl; Pnl; Point in time; Random	4180186
40760201	Antepartum record Pnl	4180186
40760201	分娩前记录组套:-:时间点:^患者:-	4182948
40760202	Labor and Delivery record	4180186
40760202	LDR; Pan; PANEL.DOC; Panl; Pnl; Point in time; Random	4180186
40760202	临产和分娩记录组套:-:时间点:^患者:-	4182948
40760207	Fetal; Finding; Findings; Gyn; Gynecology; H+P; H+P.HX; OB; ObGyn; Obstetrics; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40760207	Fet Movement Reported	4180186
40760207	运动:发现:时间点:^胎儿:序数型:报告法	4182948
40760211	Arbitrary concentration; Chemistry; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760211	IgE Nasal fluid-aCnc	4180186
40760211	IgE:任意型浓度:时间点:鼻腔液体:定量型	4182948
40760214	ANTIBIOTIC SUSCEPTIBILITIES; AST; Ecalta; Eraxis; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LY303366; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40760214	Anidulafungin Susc Islt	4180186
40760214	阿尼芬净:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
40760215	HPA 1a/1a+HPA 3a-/3a Bld Ql	4180186
40760215	Blood; HPA 1a/1a+HPA 3a-/3a; HPA antigen; HPA-1a; Human Platelet Antigen; Ordinal; Pl-a1; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood; Zw-a	4180186
40760215	HPA 1a-1a+HPA 3a-3a:存在情况或阈值:时间点:全血:序数型	4182948
40760217	1 1/2 hours; 1 1/2 HR; 1.5h p GnRH; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Follicle stimulating hormone; FSH; GHR; GnRH; Horm; LHRH; Luliberin; Luteinizing hormone releasing hormone; Lutropin release factor; p dose; p GnRH; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760217	FSH 1.5h p GnRH SerPl-aCnc	4180186
40760217	促卵泡激素^在剂量促性腺激素释放激素之后1.5小时:任意型浓度:时间点:血清/血浆:定量型	4182948
40760218	FSH 1h p GnRH SerPl-aCnc	4180186
40760218	1 hour; 1.0Hr; 1h p GnRH; 60 min; 60 minutes; 60M; 60min; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Follicle stimulating hormone; FSH; GHR; GnRH; Horm; LHRH; Luliberin; Luteinizing hormone releasing hormone; Lutropin release factor; p dose; p GnRH; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760218	促卵泡激素^在剂量促性腺激素释放激素之后1小时:任意型浓度:时间点:血清/血浆:定量型	4182948
40760220	FSH 20M p GnRH SerPl-aCnc	4180186
40760220	20M p GnRH; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Follicle stimulating hormone; FSH; GHR; GnRH; Horm; LHRH; Luliberin; Luteinizing hormone releasing hormone; Lutropin release factor; p dose; p GnRH; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760220	促卵泡激素^在剂量促性腺激素释放激素之后20分钟:任意型浓度:时间点:血清/血浆:定量型	4182948
40760223	1 hour; 1.0Hr; 1h p GnRH; 60 min; 60 minutes; 60M; 60min; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GHR; GnRH; Horm; ICSH; Interstitial cell-stimulating hormone; Interstitual cell stimulating hormone; Leutinizing hormone; LH; LHRH; Luliberin; Luteinizing hormone; Luteinizing hormone releasing hormone; Lutenin; Lutenizing hormone; Lutropin release factor; Ovulation test; p dose; p GnRH; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760223	LH 1h p GnRH SerPl-aCnc	4180186
40760223	促黄体素^在剂量促性腺激素释放激素之后1小时:任意型浓度:时间点:血清/血浆:定量型	4182948
40760224	30M p GnRH; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GHR; GnRH; Horm; ICSH; Interstitial cell-stimulating hormone; Interstitual cell stimulating hormone; Leutinizing hormone; LH; LHRH; Luliberin; Luteinizing hormone; Luteinizing hormone releasing hormone; Lutenin; Lutenizing hormone; Lutropin release factor; Ovulation test; p dose; p GnRH; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760224	LH 30M p GnRH SerPl-aCnc	4180186
40760224	促黄体素^在剂量促性腺激素释放激素之后30分钟:任意型浓度:时间点:血清/血浆:定量型	4182948
40760226	10M pre GnRH; Arbitrary Concentration; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GHR; GnRH; Horm; ICSH; Interstitial cell-stimulating hormone; Interstitual cell stimulating hormone; Leutinizing hormone; LH; LHRH; Luliberin; Luteinizing hormone; Luteinizing hormone releasing hormone; Lutenin; Lutenizing hormone; Lutropin release factor; Ovulation test; Pl; Plasma; Plsm; Point in time; pre GnRH; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760226	LH 10M pre GnRH SerPl-aCnc	4180186
40760226	促黄体素^在给予剂量促性腺激素释放激素之前10分钟:任意型浓度:时间点:血清/血浆:定量型	4182948
40760228	Eye; EYE.OCT; Eyeball; Length; Macular grid.CS thickness; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Thick; Vision; Visual	4180186
40760228	Macular grid.CS thickness OCT	4180186
40760228	黄斑格栅.中心区厚度:长度:时间点:眼睛:定量型:光学相干断层扫描术	4182948
40760232	Eye; EYE.OCT; Eyeball; Length; Macular grid.ITS thickness; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Thick; Vision; Visual	4180186
40760232	Macular grid.ITS thickness OCT	4180186
40760232	黄斑格栅.内颞侧区厚度:长度:时间点:眼睛:定量型:光学相干断层扫描术	4182948
40760234	Eye; EYE.OCT; Eyeball; Length; Macular grid.ONS thickness; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Thick; Vision; Visual	4180186
40760234	Macular grid.ONS thickness OCT	4180186
40760234	黄斑格栅.外鼻侧区厚度:长度:时间点:眼睛:定量型:光学相干断层扫描术	4182948
40760236	Eye; EYE.OCT; Eyeball; Length; Macular grid.OTS thickness; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Thick; Vision; Visual	4180186
40760236	Macular grid.OTS thickness OCT	4180186
40760236	黄斑格栅.外颞侧区厚度:长度:时间点:眼睛:定量型:光学相干断层扫描术	4182948
40760237	Eye; EYE.OCT; Eyeball; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; Vision; Visual; Vol; Volume	4180186
40760237	Macular grid.total vol OCT	4180186
40760237	黄斑格栅.总体积:体积型属性:时间点:眼睛:定量型:光学相干断层扫描术	4182948
40760238	Eye; Eyeball; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Optical coherence tomo Pnl; Optical Coherence Tomography; Pan; PANEL.EYE; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
40760238	Optical coherence tomography Pnl	4180186
40760238	眼科光学相干断层扫描术组套:-:时间点:眼睛:定量型:光学相干断层扫描术	4182948
40760239	Nominal; Nursing Management Minimum Data Set; Point in time; Random; Survey; SURVEY.NMMDS; Typ	4180186
40760240	Nominal; Nursing Management Minimum Data Set; Point in time; Random; Survey; SURVEY.NMMDS; Typ	4180186
40760241	Nominal; Nursing Management Minimum Data Set; Point in time; Random; Survey; SURVEY.NMMDS; Typ	4180186
40760243	Cnt; Count; estimation; Number; Nursing Management Minimum Data Set; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.NMMDS	4180186
40760244	Cnt; Count; Number; Nursing Management Minimum Data Set; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.NMMDS	4180186
40760245	Nursing Management Minimum Data Set; Pan; PANEL.SURVEY.NMMDS; Panl; Pnl; Point in time; Random; Survey; SURVEY.NMMDS; Vol; Vol of nursing delivery unit or service pnl	4180186
40760249	NBS report - overall interp	4180186
40760249	Asympt; Asymptomatic; Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; NBS report - overall interp; New born; Nominal; Point in time; Random; Scn	4180186
40760249	新生儿筛查报告 - 总体解释:印象:时间点:^患者:名义型	4182948
40760252	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
40760252	转诊记录:发现:时间点:{环境}:文档型:{角色}	4182948
40760253	Dentist; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
40760253	转诊记录:发现:时间点:{环境}:文档型:牙科学	4182948
40760254	Derm; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
40760254	转诊记录:发现:时间点:{环境}:文档型:皮肤病学	4182948
40760256	DOC.ONT; Document; Encounter; Endocrine; Endocrinology; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
40760256	转诊记录:发现:时间点:{环境}:文档型:内分泌学	4182948
40760258	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
40760258	转诊记录:发现:时间点:{环境}:文档型:普通内科学	4182948
40760261	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
40760261	转诊记录:发现:时间点:{环境}:文档型:运动疗法	4182948
40760267	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
40760267	OT Referral note	4180186
40760267	转诊记录:发现:时间点:{环境}:文档型:职业疗法	4182948
40760268	Cancer; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Oncology; Point in time; Random; Visit note	4180186
40760268	转诊记录:发现:时间点:{环境}:文档型:肿瘤学	4182948
40760269	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Eye; Eye care; Finding; Findings; notes; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Visit note	4180186
40760269	Ophthalmol Referral note	4180186
40760269	转诊记录:发现:时间点:{环境}:文档型:眼科学	4182948
40760270	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Eye; Finding; Findings; notes; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Visit note	4180186
40760270	转诊记录:发现:时间点:{环境}:文档型:视力测定	4182948
40760273	PT Referral note	4180186
40760273	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; PT; Random; Visit note	4180186
40760273	转诊记录:发现:时间点:{环境}:文档型:物理疗法	4182948
40760274	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Surg; Visit note	4180186
40760274	转诊记录:发现:时间点:{环境}:文档型:成形外科学	4182948
40760275	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
40760275	转诊记录:发现:时间点:{环境}:文档型:足病学	4182948
40760276	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Mental health; MentalHealth; notes; Point in time; Psych; Psychiatric; Psychiatry; Random; Visit note	4180186
40760276	Psychiatric Referral note	4180186
40760276	转诊记录:发现:时间点:{环境}:文档型:精神病学	4182948
40760278	Cancer; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Oncology; Point in time; Random; Visit note	4180186
40760278	Radiation Onc Referral note	4180186
40760278	转诊记录:发现:时间点:{环境}:文档型:放射肿瘤学	4182948
40760280	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
40760283	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Social work; SW; Visit note	4180186
40760283	SW Referral note	4180186
40760283	转诊记录:发现:时间点:{环境}:文档型:社会工作者	4182948
40760284	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Path; Point in time; Random; Speech pathology; Speech therapy; Speech-lang path; Visit note	4180186
40760284	Speech-lang path Referral note	4180186
40760284	转诊记录:发现:时间点:{环境}:文档型:言语-语言病理学	4182948
40760286	Cardio; Cardiology; Cardiothor surg; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart Disease; notes; Point in time; Random; Surg; Visit note	4180186
40760286	Cardiothor surg Referral note	4180186
40760286	转诊记录:发现:时间点:{环境}:文档型:胸心外科学	4182948
40760287	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Genitourinary; GU; notes; Point in time; Random; URO; Urology; Visit note	4180186
40760287	转诊记录:发现:时间点:{环境}:文档型:泌尿外科学	4182948
40760293	OMS Referral note	4180186
40760293	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OMS; Point in time; Random; Surg; Visit note	4180186
40760293	转诊记录:发现:时间点:{环境}:文档型:口腔颌面外科学	4182948
40760294	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Orthopedic; Orthopedic surgery; Point in time; Random; Surg; Visit note	4180186
40760294	转诊记录:发现:时间点:{环境}:文档型:矫形外科学	4182948
40760295	DOC.ONT; Document; Ear Nose Throat; Encounter; ENT; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Oto; Otolaryngology; Otorhinolaryngology; Point in time; Random; Visit note	4180186
40760295	转诊记录:发现:时间点:{环境}:文档型:耳鼻喉科学	4182948
40760297	CCM Referral note	4180186
40760297	CCM; Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
40760297	转诊记录:发现:时间点:{环境}:文档型:危重病监护医学	4182948
40760302	Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.OASIS; Panl; Pnl; Point in time; Random; Survey; Survey.OASIS	4180186
40760304	No; Num; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.OASIS; Panl; Pnl; Point in time; Random; Survey; Survey.OASIS	4180186
40760305	No; Num; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.OASIS; Panl; Pnl; Point in time; Pressure ulcer; Pressure Ulcers; Random; Survey; Survey.OASIS	4180186
40760309	Form version; OASIS-C; OASIS-C - Start of care; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.OASIS; Panl; Pnl; Point in time; Random; Started; Survey; Survey.OASIS	4180186
40760310	Form version; OASIS-C; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.OASIS; Panl; Pnl; Point in time; Random; Survey; Survey.OASIS	4180186
40760311	Form version; OASIS-C; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.OASIS; Panl; Pnl; Point in time; Random; Survey; Survey.OASIS	4180186
40760313	Disch; Form version; OASIS-C; OASIS-C - Discharge from agency; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.OASIS; Panl; Pnl; Point in time; Random; Survey; Survey.OASIS	4180186
40760316	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
40760317	Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
40760318	Centers for Medicare and Medicaid Assessment; Financing and insurance; Nominal; Payers; Point in time; Random; Survey; Typ	4180186
40760320	Centers for Medicare and Medicaid Assessment; Point in time; QNT; Quan; Quant; Quantitative; Random; Started; Survey	4180186
40760321	Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40760322	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760324	Identity or presence; International Classification of Diseases; Nominal; Outcome and assessment information set; Past; Survey; Survey.OASIS	4180186
40760326	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Point in time; Random; Risk factors present or past affecting health status and or outcome; Survey	4180186
40760327	Centers for Medicare and Medicaid Assessment; Finding; Findings; FLUV; ID; Immunizations; Infectious Disease; InfectiousDisease; Influ; Influenza vacc received; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey; Vaccine	4180186
40760330	Finding; Findings; Gvn; Nominal; Outcome and assessment information set; Point in time; Random; Survey; Survey.OASIS	4180186
40760332	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Othr; Persons; Point in time; Random; Survey	4180186
40760333	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
40760339	Activ; Actvty; Centers for Medicare and Medicaid Assessment; Finding; Findings; Movements; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760342	#pressure ulcers - unstageable due to non-removable dressing or device; Cnt; Count; No; Num; Number; Outcome and assessment information set; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; Survey.OASIS	4180186
40760345	DIA; Diam; III; Length; Long diameter; Longitudinal diameter; Outcome and assessment information set; Point in time; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey; Survey.OASIS; Ulcer	4180186
40760346	Cnt; Count; Injury; Number; Outcome and assessment information set; Point in time; Pressure injuries; pressure injury; QNT; Quan; Quant; Quantitative; Random; Survey; Survey.OASIS	4180186
40760347	Centers for Medicare and Medicaid Assessment; Dpth; III; Length; Point in time; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey; Ulcer	4180186
40760348	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; pressure injury; Pressure ulcer; Pressure Ulcers; QL; Qual; Qualitative; Random; Screen; Survey; Ulcer	4180186
40760352	# stasis ulcers; Centers for Medicare and Medicaid Assessment; Cnt; Count; No; Num; Number; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760354	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Surg; Survey	4180186
40760358	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Sx	4180186
40760360	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760361	Asympt; Asymptomatic; Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Scn; Survey	4180186
40760366	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
40760369	Finding; Findings; Ordinal; Outcome and assessment information set; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Survey.OASIS	4180186
40760371	Finding; Findings; Ordinal; Outcome and assessment information set; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Survey.OASIS	4180186
40760372	Finding; Findings; Ordinal; Outcome and assessment information set; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Survey.OASIS	4180186
40760377	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760380	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760382	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Tx; Txs	4180186
40760383	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760384	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760385	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760386	Activities of Daily Living; ADL or IADL assistance from any caregiver; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760390	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760391	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760392	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760393	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; Pressure ulcer; Pressure Ulcers; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760394	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; pressure injury; Pressure ulcer; Pressure Ulcers; QL; Qual; Qualitative; Random; Screen; Survey; Tx; Ulcer	4180186
40760398	Centers for Medicare and Medicaid Assessment; Finding; Findings; Hospitalization hx; Nominal; Point in time; Random; Survey	4180186
40760399	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; Pressure ulcer; Pressure Ulcers; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760401	Drugs; Finding; Findings; Ordinal; Outcome and assessment information set; Patient/caregiver drug education intervention; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Survey.OASIS	4180186
40760403	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40760407	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C trac; C trach; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; LGV; Ligase chain reaction; Ligation-activated transcription; Lymphogranuloma venereum; Microbiology; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; SDA; Strand Displacement Amplification; TMA; Trachoma; Transcription mediated amplification	4180186
40760407	C trach rRNA Nph Ql NAA+probe	4180186
40760407	沙眼衣原体 rRNA:存在情况或阈值:时间点:鼻咽:序数型:探针法.基因扩增.靶向	4182948
40760408	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; GC; Gen-Probe; Gono; Gonorrhea; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; N gonorrhoea; N gonorrhoeae; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40760408	N gonorrhoea rRNA Nph Ql NAA+probe	4180186
40760408	淋病奈瑟菌 rRNA:存在情况或阈值:时间点:鼻咽:序数型:探针法.基因扩增.靶向	4182948
40760412	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
40760412	HLA-DRB1 High Res	4180186
40760412	HLA-DRB1:类型:时间点:全血/组织:名义型:高分辨率方法	4182948
40760413	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
40760413	HLA-DRB3 High Res	4180186
40760413	HLA-DRB3:类型:时间点:全血/组织:名义型:高分辨率方法	4182948
40760416	Blood; Continuous wave; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA-Cw; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
40760416	HLA-Cw High Res	4180186
40760416	HLA-Cw:类型:时间点:全血/组织:名义型:高分辨率方法	4182948
40760420	BEC; BEG; Benz; Benzoylec; BZE; Cocaine degradation production; Cocaine metabolite; Crack metabolite; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
40760420	BZE Sal-mCnc	4180186
40760420	苯甲酰芽子碱:质量浓度:时间点:唾液:定量型	4182948
40760421	Temazepam Sal-mCnc	4180186
40760421	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Normison; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Restoril; Sal	4180186
40760421	羟基安定:质量浓度:时间点:唾液:定量型	4182948
40760422	7Aminonitrazepam Sal-mCnc	4180186
40760422	7-amino nitrazepam; 7Aminonitrazepam; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Nitrazepam metabolite; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
40760422	7-氨基硝基安定:质量浓度:时间点:唾液:定量型	4182948
40760423	Addiction; c260; C300; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Methylmorphine; Morphine methyl ether; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
40760423	Codeine Sal-mCnc	4180186
40760423	可待因:质量浓度:时间点:唾液:定量型	4182948
40760424	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tm	4180186
40760424	Tropomyosin IgE-mCnc	4180186
40760424	原肌球蛋白 抗体.IgE:质量浓度:时间点:血清:定量型	4182948
40760425	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
40760427	Blood; CPN1; CYP11B; Cytochrome P450, family 11, subfamily B, polypeptide 1; FHI; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; P450C11; PCR; Point in time; Random; Steroid 11-beta-hydroxylase gene; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40760427	CYP11B1 gene Mut Anl Bld/T	4180186
40760427	CYP11B1 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40760429	Blood; Genetics; Gonadal Dysgenesis, 46, XY; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; Sex determining region Y; SRXX1; SRXY1; Swyer James Syndrome; TDF; TDY; Testis determining factor; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40760429	SRY gene Mut Anl Bld/T	4180186
40760429	SRY 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40760432	Pyrazole IgE Qn	4180186
40760432	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40760432	吡唑 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40760433	Blood; Gene mut tested; Genetics; Gonadal Dysgenesis, 46, XY; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Tested; Mutation; Muts; Nominal; PCR; Point in time; Random; Sex determining region Y; SRXX1; SRXY1; Swyer James Syndrome; TDF; TDY; Testis determining factor; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40760433	SRY gene Mut Tested Bld/T	4180186
40760433	SRY 基因 已测试的突变:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40760434	Sulphonamide IgE Qn	4180186
40760434	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40760434	硫酰胺 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40760435	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tm	4180186
40760435	Tropomyosin IgE Qn	4180186
40760435	原肌球蛋白 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40760436	AF; Amn; Amn fl; Amn/CVS; Amnio; Amniotic flu; Amniotic fluid; Chorionic villi; Chorionic villus sample; Chr 13+18+21+X+Y aneup; Chromosom; Chromosomes; Finding; Findings; Fluorescent in situ hybridization; Genetics; Gyn; Gynecology; Heredity; Heritable; Inherited; Molecular pathology; MOLPATH; Nominal; OB; ObGyn; Obstetrics; Point in time; Random	4180186
40760436	Chr 13+18+21+X+Y aneup Amn/CVS FISH	4180186
40760436	染色体 13+18+21+X+Y 非整倍体性:发现:时间点:羊水/绒毛膜绒毛样本:名义型:FISH	4182948
40760437	Blood; Chr 13+18+21+X+Y aneup; Chromosom; Chromosomes; Finding; Findings; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Inherited; Molecular pathology; MOLPATH; Nominal; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40760437	Chr 13+18+21+X+Y aneup Bld/T FISH	4180186
40760437	染色体 13+18+21+X+Y 非整倍体性:发现:时间点:全血/组织:名义型:FISH	4182948
40760438	Centers for Medicare and Medicaid Assessment; Finding; Findings; Hospitalization hx; Nominal; Point in time; Random; Survey	4180186
40760439	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chagas disease; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; T cruzi; Trypanosomiasis; Trypanosomosis	4180186
40760439	T cruzi Ab SerPl Ql IA	4180186
40760439	克氏锥虫 抗体:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法	4182948
40760440	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; Herp splx; Herpes simplex virus type 2; Herpes simplex virus type II; HSV; HSV2; IAA; ID; II; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Post immunization; QNT; Quan; Quant; Quantitative; Random; Second; Serum; sp2; Spec; SR; SUDS	4180186
40760440	HSV2 IgG sp2 Ser IA-aCnc	4180186
40760440	单纯疱疹病毒 2 型 抗体.IgG^第2个标本:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40760441	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Chicken pox; Chicken pox virus; Chickenpox; EIA; ELFA; ELISA; Enzyme immunoassay; First; Herpes zoster; HHV-3; Human herpesvirus 3; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Serum; Shingles; sp1; Spec; SR; SUDS; VZ; VZV; Zoster	4180186
40760441	VZV IgM sp1 Ser IA-aCnc	4180186
40760441	水痘带状疱疹病毒 抗体.IgM^第1个标本:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40760442	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Chicken pox; Chicken pox virus; Chickenpox; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; Herpes zoster; HHV-3; Human herpesvirus 3; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Post immunization; QNT; Quan; Quant; Quantitative; Random; Second; Serum; Shingles; sp2; Spec; SR; SUDS; VZ; VZV; Zoster	4180186
40760442	VZV IgM sp2 Ser IA-aCnc	4180186
40760442	水痘带状疱疹病毒 抗体.IgM^第2个标本:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40760444	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Avian influenza; Bird flu; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; FLUA; FLUAV; FLUV; Fowl plague; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; MEIA; Microbiology; Point in time; Post immunization; QNT; Quan; Quant; Quantitative; Random; Second; Serum; sp2; Spec; SR; SUDS	4180186
40760444	FLUAV IgG sp2 Ser IA-aCnc	4180186
40760444	流感病毒 A 型 抗体.IgG^第2个标本:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40760445	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Avian influenza; Bird flu; EIA; ELFA; ELISA; Enzyme immunoassay; First; FLUA; FLUAV; FLUV; Fowl plague; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; MEIA; Microbiology; Point in time; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Serum; sp1; Spec; SR; SUDS	4180186
40760445	FLUAV IgM sp1 Ser IA-aCnc	4180186
40760445	流感病毒 A 型 抗体.IgM^第1个标本:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40760446	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Avian influenza; Bird flu; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; FLUA; FLUAV; FLUV; Fowl plague; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; MEIA; Microbiology; Point in time; Post immunization; QNT; Quan; Quant; Quantitative; Random; Second; Serum; sp2; Spec; SR; SUDS	4180186
40760446	FLUAV IgM sp2 Ser IA-aCnc	4180186
40760446	流感病毒 A 型 抗体.IgM^第2个标本:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40760448	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; FLUB; FLUBV; FLUV; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; MEIA; Microbiology; Point in time; Post immunization; QNT; Quan; Quant; Quantitative; Random; Second; Serum; sp2; Spec; SR; SUDS	4180186
40760448	FLUBV IgM sp2 Ser IA-aCnc	4180186
40760448	流感病毒 B 型 抗体.IgM^第2个标本:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40760449	ACTH 40M p chal Plas-mCnc	4180186
40760449	40M p chal; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Tumor marker	4180186
40760449	促肾上腺皮质激素^在XXX刺激之后40分钟:质量浓度:时间点:血浆:定量型	4182948
40760450	12 hours; 12HR; Chemistry; Level; Mass concentration; QNT; Quan; Quant; Quantitative; UA; UR; Urates; Uric acid; Urn	4180186
40760450	Urate 12h Ur-mCnc	4180186
40760450	尿酸:质量浓度:12小时:尿液:定量型	4182948
40760451	adj; adj pH7.4; Ca; Ca-I; Cal; Calcium active; Calcium free; Chemistry; Coagulation factor I; ICA; Ion; Ion selective membrane electode; Ion selective membrane electrode; Ion-selective electrode; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760451	Ca-I adj pH7.4 SerPl ISE-mCnc	4180186
40760451	钙.离子型^^调整至pH 7.4的:质量浓度:时间点:血清/血浆:定量型:离子选择电极法	4182948
40760454	1 hour; 1.0Hr; 1h p chal; 3-hydroxybutyrate; 3-hydroxybutyric acid; 60 min; 60 minutes; 60M; 60min; After; B; Beta hydroxy butyrate; Beta hydroxybutyric acid; Betahydroxybutyrate; Betahydroxybutyric acid; BHB; BOHB; B-OH-Butyr; CHEMISTRY.CHALLENGE TESTING; Hydroxybutyric acid; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760454	B-OH-Butyr 1h p chal SerPl-mCnc	4180186
40760454	Beta 羟基丁酸^在XXX刺激之后1小时:质量浓度:时间点:血清/血浆:定量型	4182948
40760455	Citrate 12h Ur-mCnc	4180186
40760455	12 hours; 12HR; Chemistry; Citric acid; Level; Mass concentration; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760455	柠檬酸:质量浓度:12小时:尿液:定量型	4182948
40760456	Citrate 2h Ur-mCnc	4180186
40760456	120 min; 120 minutes; 120min; 2 hours; 2HR; Chemistry; Citric acid; Level; Mass concentration; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760456	柠檬酸:质量浓度:2小时:尿液:定量型	4182948
40760459	120 min; 120 minutes; 120min; 2 hours; 2HR; Chemistry; Cl; Cl-; Level; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn	4180186
40760459	Chloride 2h Ur-sCnc	4180186
40760459	氯:物质的量浓度:2小时:尿液:定量型	4182948
40760462	Chemistry; CR; Crea; Creat; Diaf; DiafP; Dialysate; Dialysis fluid; Kidney; Level; Mass concentration; Nephrology; Peritoneal Dialysis fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal	4180186
40760462	Creat Overnight DiafP-mCnc	4180186
40760462	肌酐^在前一夜:质量浓度:时间点:腹膜透析液:定量型	4182948
40760463	12 hours; 12HR; Chemistry; CR; Crea; Creat; Kidney; Level; Mass concentration; Nephrology; QNT; Quan; Quant; Quantitative; Renal; UA; UCr; UR; Urn	4180186
40760463	Creat 12h Ur-mCnc	4180186
40760463	肌酐:质量浓度:12小时:尿液:定量型	4182948
40760465	12 hours; 12HR; Chemistry; i Phos; Inorganic phosphate; Level; Mass concentration; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760465	Phosphate 12h Ur-mCnc	4180186
40760465	磷酸盐:质量浓度:12小时:尿液:定量型	4182948
40760466	120 min; 120 minutes; 120min; 2 hours; 2HR; Chemistry; i Phos; Inorganic phosphate; Level; Mass concentration; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760466	Phosphate 2h Ur-mCnc	4180186
40760466	磷酸盐:质量浓度:2小时:尿液:定量型	4182948
40760469	12 hours; 12HR; Chemistry; k; K+; Level; Potass; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn	4180186
40760469	Potassium 12h Ur-sCnc	4180186
40760469	钾:物质的量浓度:12小时:尿液:定量型	4182948
40760471	Lactate 10M p chal SerPl-mCnc	4180186
40760471	10M p chal; 2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; After; CHEMISTRY.CHALLENGE TESTING; Lact; Lactic acid; Level; L-lactate; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760471	乳酸^在XXX刺激之后10分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40760472	120 min; 120 minutes; 120min; 2 hours; 2h p chal; 2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; After; CHEMISTRY.CHALLENGE TESTING; Lact; Lactic acid; Level; L-lactate; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760472	Lactate 2h p chal SerPl-mCnc	4180186
40760472	乳酸^在XXX刺激之后2小时:质量浓度:时间点:血清/血浆:定量型	4182948
40760473	Lactate 3h p chal SerPl-mCnc	4180186
40760473	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; 3h p chal; After; CHEMISTRY.CHALLENGE TESTING; Lact; Lactic acid; Level; L-lactate; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760473	乳酸^在XXX刺激之后3小时:质量浓度:时间点:血清/血浆:定量型	4182948
40760476	Lactate 30M p chal SerPl-mCnc	4180186
40760476	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; 30M p chal; After; CHEMISTRY.CHALLENGE TESTING; Lact; Lactic acid; Level; L-lactate; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760476	乳酸^在XXX刺激之后30分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40760480	Lactate pre chal SerPl-mCnc	4180186
40760480	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Before; CHEMISTRY.CHALLENGE TESTING; Lact; Lactic acid; Level; L-lactate; Mass concentration; Pl; Plasma; Plsm; Point in time; pre chal; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760480	乳酸^在 XXX 刺激之前:质量浓度:时间点:血清/血浆:定量型	4182948
40760482	12 hours; 12HR; Chemistry; MAG; Magnes; Mass rate; Mg; mRate; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760482	Magnesium 12h Ur-mRate	4180186
40760482	镁:质量速率:12小时:尿液:定量型	4182948
40760483	12 hours; 12HR; Alb; Chemistry; DL=20 mg/L; Kidney; Left; Level; Levo; MA; Malb; Mass concentration; Micro albumin; Microalbumin; Nephrology; Protein.albumin; QNT; Quan; Quant; Quantitative; Renal; UA; UR; Urn	4180186
40760483	Microalbumin 12h Ur-mCnc	4180186
40760483	白蛋白:质量浓度:12小时:尿液:定量型:检测极限 <= 20 mg/L	4182948
40760485	Chemistry; EIA; ELFA; ELISA; ENO2; enolase 2; Enzyme immunoassay; Gamma-enolase; IAA; Level; Mass concentration; MEIA; NSE; Phosphopyruvate dehydratase; Phosphopyruvate hydratase.gamma subunit; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Spec; SR; SUDS; Tumor marker	4180186
40760485	NSE SerPl IA-mCnc	4180186
40760485	烯醇化酶.神经元特异性:质量浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
40760487	Oxalate 12h Ur-mCnc	4180186
40760487	12 hours; 12HR; Chemistry; Ethanedioate; Ethanedioic acid; Level; Mass concentration; Oxal; Oxalic acid; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760487	草酸:质量浓度:12小时:尿液:定量型	4182948
40760490	C peptide BS SerPl-mCnc	4180186
40760490	BS; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Mass concentration; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760490	C 肽^基线:质量浓度:时间点:血清/血浆:定量型	4182948
40760491	Pyruvate 5M p chal Bld-mCnc	4180186
40760491	5M p chal; After; Blood; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; p chal; Point in time; PST; Pyruvic acid; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40760491	丙酮酸^在XXX刺激之后5分钟:质量浓度:时间点:全血:定量型	4182948
40760492	Porphyrins/Creat Ur-sRto	4180186
40760492	Chemistry; CR; Crea; Creat; Point in time; Porph; Porphyrin; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40760492	卟啉类/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40760493	Potassium 2h Ur-sCnc	4180186
40760493	120 min; 120 minutes; 120min; 2 hours; 2HR; Chemistry; k; K+; Level; Potass; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn	4180186
40760493	钾:物质的量浓度:2小时:尿液:定量型	4182948
40760495	Sodium 2h Ur-sCnc	4180186
40760495	120 min; 120 minutes; 120min; 2 hours; 2HR; Chemistry; Level; Na; Na+; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn	4180186
40760495	钠:物质的量浓度:2小时:尿液:定量型	4182948
40760496	Tipranavir Ser-mCnc	4180186
40760496	Aptivus; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; TPV	4180186
40760496	替拉那韦:质量浓度:时间点:血清:定量型	4182948
40760497	12 hours; 12HR; Chemistry; Mass rate; mRate; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760497	Urea 12h Ur-mRate	4180186
40760497	尿素:质量速率:12小时:尿液:定量型	4182948
40760498	Urate 2h Ur-mCnc	4180186
40760498	120 min; 120 minutes; 120min; 2 hours; 2HR; Chemistry; Level; Mass concentration; QNT; Quan; Quant; Quantitative; UA; UR; Urates; Uric acid; Urn	4180186
40760498	尿酸:质量浓度:2小时:尿液:定量型	4182948
40760499	12 hours; 12HR; Chemistry; Mass Rate; mRate; QNT; Quan; Quant; Quantitative; UA; UR; Urates; Uric acid; Urn	4180186
40760499	Urate 12h Ur-mRate	4180186
40760499	尿酸:质量速率:12小时:尿液:定量型	4182948
40760501	Urea 12h Ur-mCnc	4180186
40760501	12 hours; 12HR; Chemistry; Level; Mass concentration; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760501	尿素:质量浓度:12小时:尿液:定量型	4182948
40760502	12 hours; 12HR; Flow; QNT; Quan; Quant; Quantitative; Spec; UA; UR; Urn; Vol; Volume rate; vRate	4180186
40760502	Specimen vol 12h Ur-vRate	4180186
40760502	标本体积:体积速率:12小时:尿液:定量型	4182948
40760503	Eosinophil/leuk NFr Snv Manual	4180186
40760503	100WBC; Eos; Eosin; Eosino; Eosinophil; Eosins; HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; WBC; WBCs; White blood cell; White blood cells	4180186
40760503	嗜酸性粒细胞/100 个白细胞:计数型分数:时间点:滑液:定量型:手工计数方法	4182948
40760506	CD19+CD34+ Cells NFr Fld	4180186
40760506	B cells expressing CD19 as a percent of total lymphocytes; B/F; B4; B-4; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD19 Cells; CD19+CD34+ Cells; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; gp105-120; HD-37; Hematopoietic stem cell; HSC; Leu12; Leu-12; My10; My-10; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Stem cells	4180186
40760506	细胞.CD19+CD34+/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760507	ADP-ribosyl cyclase; B cells expressing CD19 as a percent of total lymphocytes; B/F; B4; B-4; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD19 Cells; CD19+CD38+ Cells; Cell; CELL MARKERS; Cellularity; Cyclic ADP-ribose hydrolase; Fl; Fld; FLU; Fluid; Gated cells; HD-37; Leu12; Leu-12; Leu17; Leu-17; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T10	4180186
40760507	CD19+CD38+ Cells NFr Fld	4180186
40760507	细胞.CD19+CD38+/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760509	B cells expressing CD19 as a percent of total lymphocytes; B/F; B1; B-1; B4; B-4; BF; bod; Bodies; Body fluid; Body fluid, unsp; Bp35; CD19 Cells; CD19+CD20+ Cells; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; HD-37; Leu12; Leu-12; Leu16; Leu-16; Mature B cells; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760509	CD19+CD20+ Cells NFr Fld	4180186
40760509	细胞.CD19+CD20+/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760510	B/F; B3; B-3; B4; B-4; BF; BL-CAM; bod; Bodies; Body fluid; Body fluid, unsp; CD22 Cells; CD22+CD19+ Cells; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; HD-37; Leu12; Leu-12; Leu14; Leu-14; Lyb8; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; To-15	4180186
40760510	CD22+CD19+ Cells NFr Fld	4180186
40760510	细胞.CD22+CD19+/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760511	CD19+CD23+ Cells NFr Fld	4180186
40760511	B cells expressing CD19 as a percent of total lymphocytes; B/F; B4; B-4; B6; B-6; BF; BLAST-2; bod; Bodies; Body fluid; Body fluid, unsp; CD19 Cells; CD19+CD23+ Cells; Cell; CELL MARKERS; Cellularity; FceRII; Fl; Fld; FLU; Fluid; Gated cells; HD-37; Leu12; Leu-12; Leu20; Leu-20; Low affinity IgE receptor; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760511	细胞.CD19+CD23+/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760512	BM; BON; Bone marrow; CD34 Cells; Cell; CELL MARKERS; Cellularity; Gated cells; gp105-120; Hematopoietic stem cell; HSC; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; My10; My-10; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Stem cells	4180186
40760512	CD34 Cells NFr Mar	4180186
40760512	细胞.CD34/100 个细胞:计数型分数:时间点:骨髓:定量型	4182948
40760513	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD4 Cells; CD4+CD8+ Cells; CD4-CD8-; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; Helper T cells; Inducer T cells; L3T4; Leu2; Leu-2; Leu3; Leu-3; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Suppressor T cells; T4; T-4; T8; T-8; Tsuppressor; W3/25	4180186
40760513	CD4+CD8+ Cells NFr Fld	4180186
40760513	细胞.CD4+CD8+/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760514	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD42a Cells; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; GPIX; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760514	CD42a Cells NFr Fld	4180186
40760514	细胞.CD42A/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760517	CD8+CD56+ Cells NFr Fld	4180186
40760517	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD8 Cells; CD8+CD56+ Cells; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; Leu19; Leu-19; Leu2; Leu-2; NCAM; Neural cell adhesion molecule; NKH1; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Suppressor T cells; T8; T-8; Tsuppressor	4180186
40760517	细胞.CD8+CD56+/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760518	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD8 Cells; CD8+CD57+ Cells; CD8-CD57+ Cells; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; HNK1; Leu2; Leu-2; Leu7; Leu-7; Lyme disease; Natural killer cells; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Suppressor T cells; T8; T-8; Tsuppressor	4180186
40760518	CD8+CD57+ Cells NFr Fld	4180186
40760518	细胞.CD8+CD57+/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760519	CD8+CD45RA+ Cells NFr Fld	4180186
40760519	2H4; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD8 Cells; CD8+CD45RA+ Cells; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; Leu18; Leu-18; Leu2; Leu-2; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Suppressor T cells; T8; T-8; Tsuppressor	4180186
40760519	细胞.CD8+CD45RA+/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760520	CD8+CD45RO+ Cells NFr Fld	4180186
40760520	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD8 Cells; CD8+CD45RO+ Cells; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; Leu2; Leu-2; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Suppressor T cells; T8; T-8; Tsuppressor; UCHL-1	4180186
40760520	细胞.CD8+CD45RO+/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760522	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; F-actin; Filament; IAA; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
40760522	F-actin Ab SerPl IA-aCnc	4180186
40760522	纤丝状肌动蛋白 抗体:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
40760525	ABS; Aby; AMA; Antby; Anti; Antibodies; Antibodies to Microtubule Associated Protein 2; Antibody; Antimitochondrial antibodies; Autoantibodies; Autoantibody; Blt; Hepatology; IMMUNE BLOT; Immunobl; Immunoblot; Liver; M2; MA; Mito; Mitochon; Mitochond; Mitochondrial; Mitochondrial Ab; Ordinal; PBC; Point in time; PR; Primary Biliary Cirrhosis; QL; Qual; Qualitative; Random; RIBA; S; Screen; Serology; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40760525	Mitochondria Ab Ser Ql IB	4180186
40760525	线粒体 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40760526	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; Gastro; Gastroenterology; GI; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Reticuline; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF	4180186
40760526	Reticulin Ab Ser Ql IF	4180186
40760526	网硬蛋白 抗体:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40760527	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; ASCA; Autoantibodies; Autoantibody; Bakers yeast; Baker's yeast; EIA; ELFA; ELISA; Enzyme immunoassay; f045; f403; f45; IAA; Immune globulin A; Immunoglobulin A; MEIA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; SCA; Screen; Serum; SR; SUDS; Yeast	4180186
40760527	Baker's yeast IgA Ql IA	4180186
40760527	酿酒酵母 抗体.IgA:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40760531	CD21 Cells NFr Fld	4180186
40760531	B/F; B2; B-2; BF; bod; Bodies; Body fluid; Body fluid, unsp; C3d receptor; CD21 Cells; CD21- cells; Cell; CELL MARKERS; Cells.CD21+; Cellularity; CR2; EBV-R; Epstein Barr virus receptor; Fl; Fld; FLU; Fluid; Gated cells; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760531	细胞.CD21/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760532	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD27 Cells; CD27- cells; Cell; CELL MARKERS; Cells.CD27+; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; S152; T14	4180186
40760532	CD27 Cells NFr Fld	4180186
40760532	细胞.CD27/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760536	CD56 Cells NFr Fld	4180186
40760536	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD56 Cells; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; Leu19; Leu-19; NCAM; Neural cell adhesion molecule; NKH1; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760536	细胞.CD56/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760537	CD7 Cells NFr Fld	4180186
40760537	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD7 Cells; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; gp40; Leu9; Leu-9; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T-2; TP41	4180186
40760537	细胞.CD7/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760538	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD71 Cells; CD71Transferrin; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T9; Transferrin receptor	4180186
40760538	CD71 Cells NFr Fld	4180186
40760538	细胞.CD71/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760541	CD3+TCR G-D+ Cells NFr Fld	4180186
40760541	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD3 Cells; CD3+TCR Cells; CD3+TCR G-D+ Cells; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; Leu4; Leu-4; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T3; TCR G-D	4180186
40760541	细胞.CD3+TcR gamma delta+/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760542	CD235a Cells NFr Fld	4180186
40760542	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD235a Cells; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; Glycophorin A; GPA; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760542	细胞.CD235A/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760543	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; Blt; ENA; IMMUNE BLOT; Immunobl; Immunoblot; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40760543	ENA Ab Ser Ql IB	4180186
40760543	可提取性核 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40760544	B cells expressing CD19 as a percent of total lymphocytes; B/F; B4; B-4; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD19 Cells; CD19+Kappa+ Cells; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; HD-37; Leu12; Leu-12; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760544	CD19+Kappa+ Cells NFr Fld	4180186
40760544	细胞.CD19+κ+/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760545	B cells expressing CD19 as a percent of total lymphocytes; B/F; B4; B-4; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD19 Cells; CD19+Lambda+ Cells; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; HD-37; Leu12; Leu-12; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760545	CD19+Lambda+ Cells NFr Fld	4180186
40760545	细胞.CD19+λ+/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760546	LKM-1 Ab Titr Ser IF	4180186
40760546	肝肾微粒体 1 抗体:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40760546	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; Hepatology; i; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Liver; Liver kidney microsome; LKM; LKM1; LKM-1; Microsm; Microsom; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40760547	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; MPO; Myeloperoxidase Cells; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
40760547	Myeloperoxidase Cells Fld Ql	4180186
40760547	细胞.髓过氧化物酶:存在情况或阈值:时间点:体液:序数型	4182948
40760556	After; Ejaculate; FERTILITY TESTING; Genitourinary; GU; II; Number fraction; p conc; Percent; Point in time; post washing; PST; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; Sperm; Sperm Prog; Sperm Prog 2; URO; Urology	4180186
40760556	Sperm Prog 2 p conc NFr Smn	4180186
40760556	精子.前向运动型.2 级/100 个精子^在浓缩之后:计数型分数:时间点:精液:定量型	4182948
40760557	After; Ejaculate; FERTILITY TESTING; Genitourinary; GU; i; Number fraction; p conc; Percent; Point in time; post washing; PST; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; Sperm; Sperm Prog; Sperm Prog 1; URO; Urology	4180186
40760557	Sperm Prog 1 p conc NFr Smn	4180186
40760557	精子.前向运动型.1 级/100 个精子^在浓缩之后:计数型分数:时间点:精液:定量型	4182948
40760559	ABS; Aby; ACIF; ANA; ANF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Antinuclear antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Joint aspirate; Joint fld; Joint flu; Joint fluid; NA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Rheum; Rheumatology; Serology; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40760559	Deprecated ANA Titr Snv IF	4180186
40760560	ABS; Aby; ACIF; ANA; ANA Pat; ANF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Antinuclear antibody; Autoantibodies; Autoantibody; FA; FANA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Joint aspirate; Joint fld; Joint flu; Joint fluid; NA; Nominal; Nuc; Point in time; Random; Serology; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; Time Resolved Fluorescence; TRF	4180186
40760560	ANA Pat Snv IF-Imp	4180186
40760560	细胞核 抗体模式:印象:时间点:滑液:名义型:免疫荧光法	4182948
40760561	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Basem; Basemt; BM; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; TBM	4180186
40760561	TBM Ab Ser-aCnc	4180186
40760561	小管基底膜 抗体:任意型浓度:时间点:血清:定量型	4182948
40760564	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Cerebral spinal fluid; Cerebrospinal Fl; Immune blot; Immunobl; Immunoblot; MA1; MA-1; Ma2; MATA; Neuro; Neurology; Ordinal; Paraneoplastic Ag Ma 1; Paraneoplastic syndrome; PNMA1; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WB; WBLOT; West blot; West blt; Western blot	4180186
40760564	Ma+Ta Ab CSF Ql IB	4180186
40760564	Ma+Ta 抗体:存在情况或阈值:时间点:脑脊液:序数型:免疫印迹法	4182948
40760566	AF; Amn; Amn fl; Amn/CVS; Amnio; Amniotic flu; Amniotic fluid; Chorionic villi; Chorionic villus sample; Chr 13 aneup; Chromosom; Chromosomes; Finding; Findings; Fluorescent in situ hybridization; Genetics; Gyn; Gynecology; Heredity; Heritable; Inherited; Molecular pathology; MOLPATH; Nominal; OB; ObGyn; Obstetrics; Point in time; Random	4180186
40760566	Chr 13 aneup Amn/CVS FISH	4180186
40760566	染色体 13 非整倍体性:发现:时间点:羊水/绒毛膜绒毛样本:名义型:FISH	4182948
40760569	Interpretation 24h Ur IEP-Imp	4180186
40760569	1 day; 24 hours; 24HR; Chemistry; IEP; Imm elect; Immunoelect; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Nominal; UA; UR; Urn	4180186
40760569	解释:印象:24小时:尿液:名义型:免疫电泳	4182948
40760570	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Anus; DNA NUCLEIC ACID PROBE; DNA probe; GC; Gen-Probe; Gono; Gonorrhea; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; N gonorrhoea; N gonorrhoeae; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Rectal specimen; ribosomal RNA; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40760570	N gonorrhoea rRNA Anal Ql NAA+probe	4180186
40760570	淋病奈瑟菌 rRNA:存在情况或阈值:时间点:肛门:序数型:探针法.基因扩增.靶向	4182948
40760571	Form version; OASIS-C; OASIS-C - Death at home; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.OASIS; Panl; Pnl; Point in time; Random; Survey; Survey.OASIS	4180186
40760573	Activ; Activ T Lymphs; Bro; Cell; CELL MARKERS; Cellularity; Lung; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Number fraction; Percent; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; T prime	4180186
40760573	Activ T Lymphs NFr Bronch	4180186
40760573	淋巴细胞.活化型 T 细胞/100 个淋巴细胞.小:计数型分数:时间点:支气管来源的标本:定量型	4182948
40760574	Chemistry; FR; Level; Mass concentration; Non-protein bound; Normeta; Normetaneph; Normetaneph Free; Normetanephrn; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Unconjugated normetanephrine	4180186
40760574	Normetaneph Free SerPl-mCnc	4180186
40760574	去甲间肾上腺素.游离型:质量浓度:时间点:血清/血浆:定量型	4182948
40760575	Cortis sp12 SerPl-mCnc	4180186
40760575	17-Hydroxycorticosterone; Chemistry; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp12; Spec; SR	4180186
40760575	皮质醇^第12个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40760577	17-Hydroxycorticosterone; Chemistry; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp10; Spec; SR	4180186
40760577	Cortis sp10 SerPl-mCnc	4180186
40760577	皮质醇^第10个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40760581	1,25(OH)2D3; 1,25-Calcitriol; 1,25-Dihydroxycholecalciferol; 1,25-Dihydroxyvitamin D; 1,25-Dihydroxyvitamin D3; 120 min; 120 minutes; 120min; 2 hours; 2h p Ca; After; Ca; Cal; CHEMISTRY.CHALLENGE TESTING; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760581	1,25(OH)2D3 2h p Ca SerPl-sCnc	4180186
40760581	钙三醇^在给予剂量钙之后2小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760582	1,25(OH)2D3; 1,25-Calcitriol; 1,25-Dihydroxycholecalciferol; 1,25-Dihydroxyvitamin D; 1,25-Dihydroxyvitamin D3; 120 min; 120 minutes; 120min; 2 hours; 2h p Ca; After; Ca; Cal; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760582	1,25(OH)2D3 2h p Ca SerPl-mCnc	4180186
40760582	钙三醇^在给予剂量钙之后2小时:质量浓度:时间点:血清/血浆:定量型	4182948
40760586	1 hour; 1,25(OH)2D3; 1,25-Calcitriol; 1,25-Dihydroxycholecalciferol; 1,25-Dihydroxyvitamin D; 1,25-Dihydroxyvitamin D3; 1.0Hr; 1h p Ca; 60 min; 60 minutes; 60M; 60min; After; Ca; Cal; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760586	1,25(OH)2D3 1h p Ca SerPl-mCnc	4180186
40760586	钙三醇^在给予剂量钙之后1小时:质量浓度:时间点:血清/血浆:定量型	4182948
40760588	11Ketoandros pre hi Dex 24h Ur-mRate	4180186
40760588	1 day; 11Ketoandros; 24 hours; 24HR; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Ketoandrost; Mass rate; mRate; pre hi Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760588	11-酮雄酮^在给予高剂量地塞米松之前:质量速率:24小时:尿液:定量型	4182948
40760589	1 day; 11Ketoandros; 24 hours; 24HR; 2D p high Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Ketoandrost; Level; Mass concentration; p high Dex; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760589	11Ketoandros 2D p high Dex 24h Ur-mCnc	4180186
40760589	11-酮雄酮^在给予高剂量地塞米松之后2天:质量浓度:24小时:尿液:定量型	4182948
40760592	11Ketoandros Pre Dex 24h Ur-mRate	4180186
40760592	1 day; 11Ketoandros; 24 hours; 24HR; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Ketoandrost; Mass rate; mRate; Pre Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760592	11-酮雄酮^在给予地塞米松之前:质量速率:24小时:尿液:定量型	4182948
40760595	1 day; 11Ketoetioch; 24 hours; 24HR; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Ketoetiochol; Level; Mass concentration; pre hi Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760595	11Ketoetioch pre hi Dex 24h Ur-mCnc	4180186
40760595	11-酮本胆烷醇酮^在给予高剂量地塞米松之前:质量浓度:24小时:尿液:定量型	4182948
40760598	11Ketoetioch 2D p high Dex 24h Ur-mRate	4180186
40760598	1 day; 11Ketoetioch; 24 hours; 24HR; 2D p high Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Ketoetiochol; Mass rate; mRate; p high Dex; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760598	11-酮本胆烷醇酮^在给予高剂量地塞米松之后2天:质量速率:24小时:尿液:定量型	4182948
40760599	1 day; 11Ketoetioch; 24 hours; 24HR; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Ketoetiochol; Level; Mass concentration; Pre Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760599	11Ketoetioch Pre Dex 24h Ur-mCnc	4180186
40760599	11-酮本胆烷醇酮^在给予地塞米松之前:质量浓度:24小时:尿液:定量型	4182948
40760604	11DOC 30M p 250 ug ACTH SerPl-sCnc	4180186
40760604	11DOC; 11-DOC; 21-Hydroxyprogesterone; 30M p 250 ug ACTH; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; DOC; Level; mcg; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	4180186
40760604	11-脱氧皮质酮^在给予250 ug促肾上腺皮质激素之后30分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760606	11DC; Before; c350; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Decadron; Deoxycortisol; Desoxycortisol; Dexameth; Dexone; Hexadrol; Level; Metopirone; Pl; Plasma; Plsm; Point in time; Pre Dex; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760606	11DC Pre Dex SerPl-sCnc	4180186
40760606	11-脱氧皮质醇^在给予地塞米松之前:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760608	11DC; 1D p Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Decadron; Deoxycortisol; Desoxycortisol; Dexameth; Dexone; Hexadrol; Level; Metopirone; p Dex; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760608	11DC 1D p Dex SerPl-sCnc	4180186
40760608	11-脱氧皮质醇^在给予剂量地塞米松之后1天:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760609	11DC 1D p Dex SerPl-mCnc	4180186
40760609	11DC; 1D p Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Decadron; Deoxycortisol; Desoxycortisol; Dexameth; Dexone; Hexadrol; Level; Mass concentration; Metopirone; p Dex; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760609	11-脱氧皮质醇^在给予剂量地塞米松之后1天:质量浓度:时间点:血清/血浆:定量型	4182948
40760612	11DC pre MTP SerPl-sCnc	4180186
40760612	11DC; Before; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Deoxycortisol; Desoxycortisol; Level; Metopirone; Pl; Plasma; Plsm; Point in time; pre MTP; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760612	11-脱氧皮质醇^在给予剂量美替拉酮之前:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760613	11DC; Before; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Deoxycortisol; Desoxycortisol; Level; Mass concentration; Metopirone; Pl; Plasma; Plsm; Point in time; pre MTP; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760613	11DC pre MTP SerPl-mCnc	4180186
40760613	11-脱氧皮质醇^在给予剂量美替拉酮之前:质量浓度:时间点:血清/血浆:定量型	4182948
40760614	11DC; 1D p MTP; After; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Deoxycortisol; Desoxycortisol; Level; Metopirone; p dose; p metyraPONE; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760614	11DC 1D p MTP SerPl-sCnc	4180186
40760614	11-脱氧皮质醇^在给予剂量美替拉酮之后1天:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760618	11DC; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Cortrosyn; Deoxycortisol; Desoxycortisol; Level; Mass concentration; mcg; Metopirone; Pl; Plasma; Plsm; Point in time; pre 250 ug ACTH; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker	4180186
40760618	11DC pre 250 ug ACTH SerPl-mCnc	4180186
40760618	11-脱氧皮质醇^在给予250 ug促肾上腺皮质激素之前:质量浓度:时间点:血清/血浆:定量型	4182948
40760624	11OH-Androst Pre Dex 24h Ur-mCnc	4180186
40760624	1 day; 11-beta-hydroxyandrosterone; 11-Hydroxy androsterone; 11OH-Androst; 24 hours; 24HR; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Level; Mass concentration; Pre Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760624	11-羟雄酮^在给予地塞米松之前:质量浓度:24小时:尿液:定量型	4182948
40760629	1 day; 11 beta-hydroxyandrosterone; 11-Hydroxy etiocholanolone; 11OH-Etioch; 24 hours; 24HR; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Mass Rate; mRate; pre hi Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760629	11OH-Etioch pre hi Dex 24h Ur-mRate	4180186
40760629	11-羟本胆烷醇酮^在给予高剂量地塞米松之前:质量速率:24小时:尿液:定量型	4182948
40760630	1 day; 11 beta-hydroxyandrosterone; 11-Hydroxy etiocholanolone; 11OH-Etioch; 24 hours; 24HR; 2D p high Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Level; Mass concentration; p high Dex; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760630	11OH-Etioch 2D p high Dex 24h Ur-mCnc	4180186
40760630	11-羟本胆烷醇酮^在给予高剂量地塞米松之后2天:质量浓度:24小时:尿液:定量型	4182948
40760634	11OH-Etioch 2D p Dex 24h Ur-mCnc	4180186
40760634	1 day; 11 beta-hydroxyandrosterone; 11-Hydroxy etiocholanolone; 11OH-Etioch; 24 hours; 24HR; 2D p Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Level; Mass concentration; p Dex; p dose; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760634	11-羟本胆烷醇酮^在给予剂量地塞米松之后2天:质量浓度:24小时:尿液:定量型	4182948
40760635	11OH-Etioch 2D p Dex 24h Ur-mRate	4180186
40760635	1 day; 11 beta-hydroxyandrosterone; 11-Hydroxy etiocholanolone; 11OH-Etioch; 24 hours; 24HR; 2D p Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Mass rate; mRate; p Dex; p dose; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760635	11-羟本胆烷醇酮^在给予剂量地塞米松之后2天:质量速率:24小时:尿液:定量型	4182948
40760636	1 day; 17KGS; 17-KGS; 24 hours; 24HR; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Ketogen; Ketogenc; Ketognc; Level; Mass concentration; Pre Dex; QNT; Quan; Quant; Quantitative; Ste; Steriods; Steroid; UA; UR; Urn	4180186
40760636	17KGS Pre Dex 24h Ur-mCnc	4180186
40760636	17-羟基生酮类固醇^在给予地塞米松之前:质量浓度:24小时:尿液:定量型	4182948
40760638	17OHCS pre hi Dex 24h Ur-mCnc	4180186
40760638	1 day; 17-CS; 17-hydroxy corticosteroids; 17OHCS; 17-OHCS; 24 hours; 24HR; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Level; Mass concentration; pre hi Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760638	17-羟基皮质类固醇^在给予高剂量地塞米松之前:质量浓度:24小时:尿液:定量型	4182948
40760639	1 day; 17-CS; 17-hydroxy corticosteroids; 17OHCS; 17-OHCS; 24 hours; 24HR; 2D p high Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Level; Mass concentration; p high Dex; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760639	17OHCS 2D p high Dex 24h Ur-mCnc	4180186
40760639	17-羟基皮质类固醇^在给予高剂量地塞米松之后2天:质量浓度:24小时:尿液:定量型	4182948
40760642	17OH-Preg Pre Dex SerPl-sCnc	4180186
40760642	17 hydroxy pregnenolone; 17-alpha-Hydroxypregnenolone; 17OH-Preg; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Level; Pl; Plasma; Plsm; Point in time; Pre Dex; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760642	17-羟基孕烯醇酮^在给予地塞米松之前:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760644	17 hydroxy pregnenolone; 17-alpha-Hydroxypregnenolone; 17OH-Preg; 2D p Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Level; p Dex; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760644	17OH-Preg 2D p Dex SerPl-sCnc	4180186
40760644	17-羟基孕烯醇酮^在给予剂量地塞米松之后2天:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760645	17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Genetics; Heredity; Heritable; Hydroxyproges; Hydroxyprogstron; Inherited; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp10; sp10 p chal; Spec; SR	4180186
40760645	17OHP sp10 p chal SerPl-mCnc	4180186
40760645	17-羟孕酮^在XXX刺激之后的第10个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40760647	17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Genetics; Heredity; Heritable; Hydroxyproges; Hydroxyprogstron; Inherited; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp12; sp12 p chal; Spec; SR	4180186
40760647	17OHP sp12 p chal SerPl-mCnc	4180186
40760647	17-羟孕酮^在XXX刺激之后的第12个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40760649	17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Genetics; Heredity; Heritable; Hydroxyproges; Hydroxyprogstron; Inherited; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp9; sp9 p chal; Spec; SR	4180186
40760649	17OHP sp9 p chal SerPl-mCnc	4180186
40760649	17-羟孕酮^在XXX刺激之后的第9个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40760651	17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; After; CHEMISTRY.CHALLENGE TESTING; Convalescent; Endocrine; Endocrinology; Genetics; GHR; GnRH; Heredity; Heritable; Horm; Hydroxyproges; Hydroxyprogstron; Inherited; Level; LHRH; Luliberin; Luteinizing hormone releasing hormone; Lutropin release factor; Mass concentration; p dose; p GnRH; Pl; Plasma; Plsm; Point in time; Post immunization; PST; QNT; Quan; Quant; Quantitative; Random; Second; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp2; sp2 p GnRH; Spec; SR	4180186
40760651	17OHP sp2 p GnRH SerPl-mCnc	4180186
40760651	17-羟孕酮^在剂量促性腺激素释放激素之后的第2个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40760653	17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Genetics; GHR; GnRH; Heredity; Heritable; Horm; Hydroxyproges; Hydroxyprogstron; Inherited; Level; LHRH; Luliberin; Luteinizing hormone releasing hormone; Lutropin release factor; Mass concentration; p dose; p GnRH; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp4; sp4 p GnRH; Spec; SR	4180186
40760653	17OHP sp4 p GnRH SerPl-mCnc	4180186
40760653	17-羟孕酮^在剂量促性腺激素释放激素之后的第4个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40760655	17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Genetics; GHR; GnRH; Heredity; Heritable; Horm; Hydroxyproges; Hydroxyprogstron; Inherited; Level; LHRH; Luliberin; Luteinizing hormone releasing hormone; Lutropin release factor; Mass concentration; p dose; p GnRH; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp6; sp6 p GnRH; Spec; SR	4180186
40760655	17OHP sp6 p GnRH SerPl-mCnc	4180186
40760655	17-羟孕酮^在剂量促性腺激素释放激素之后的第6个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40760656	17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Genetics; GHR; GnRH; Heredity; Heritable; Horm; Hydroxyproges; Hydroxyprogstron; Inherited; Level; LHRH; Luliberin; Luteinizing hormone releasing hormone; Lutropin release factor; Mass concentration; p dose; p GnRH; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp7; sp7 p GnRH; Spec; SR	4180186
40760656	17OHP sp7 p GnRH SerPl-mCnc	4180186
40760656	17-羟孕酮^在剂量促性腺激素释放激素之后的第7个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40760657	17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Endocrine; Endocrinology; Genetics; Heredity; Heritable; Hexadrol; Hydroxyproges; Hydroxyprogstron; Inherited; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre Dex; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760657	17OHP Pre Dex SerPl-mCnc	4180186
40760657	17-羟孕酮^在给予地塞米松之前:质量浓度:时间点:血清/血浆:定量型	4182948
40760659	17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; 1D p Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Endocrine; Endocrinology; Genetics; Heredity; Heritable; Hexadrol; Hydroxyproges; Hydroxyprogstron; Inherited; Level; Mass concentration; p Dex; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760659	17OHP 1D p Dex SerPl-mCnc	4180186
40760659	17-羟孕酮^在给予剂量地塞米松之后1天:质量浓度:时间点:血清/血浆:定量型	4182948
40760661	17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; 2D p Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Endocrine; Endocrinology; Genetics; Heredity; Heritable; Hexadrol; Hydroxyproges; Hydroxyprogstron; Inherited; Level; Mass concentration; p Dex; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760661	17OHP 2D p Dex SerPl-mCnc	4180186
40760661	17-羟孕酮^在给予剂量地塞米松之后2天:质量浓度:时间点:血清/血浆:定量型	4182948
40760663	18-Hydroxy deoxycorticosterone; 18-OH-DOC; 18OH-DOC; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; Pl; Plasma; Plsm; Point in time; Pre ACTH; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	4180186
40760663	18OH-DOC Pre ACTH SerPl-sCnc	4180186
40760663	18-羟基脱氧皮质酮^在剂量促肾上腺皮质激素之前:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760665	18OH-DOC 1h p ACTH SerPl-sCnc	4180186
40760665	1 hour; 1.0Hr; 18-Hydroxy deoxycorticosterone; 18-OH-DOC; 18OH-DOC; 1h p ACTH; 60 min; 60 minutes; 60M; 60min; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; p ACTH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	4180186
40760665	18-羟基脱氧皮质酮^在给予剂量促肾上腺皮质激素之后1小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760669	18OH-Cortis; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; Pl; Plasma; Plsm; Point in time; Pre ACTH; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	4180186
40760669	18OH-Cortis Pre ACTH SerPl-sCnc	4180186
40760669	18-羟基皮质醇^在剂量促肾上腺皮质激素之前:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760670	18OH-Cortis; 30M p ACTH; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; p ACTH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	4180186
40760670	18OH-Cortis 30M p ACTH SerPl-sCnc	4180186
40760670	18-羟基皮质醇^在给予剂量促肾上腺皮质激素之后30分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760671	1 hour; 1.0Hr; 18OH-Cortis; 1h p ACTH; 60 min; 60 minutes; 60M; 60min; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; p ACTH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	4180186
40760671	18OH-Cortis 1h p ACTH SerPl-sCnc	4180186
40760671	18-羟基皮质醇^在给予剂量促肾上腺皮质激素之后1小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760672	21-DB; 21DOC; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; DOC; Level; Pl; Plasma; Plsm; Point in time; Pre ACTH; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	4180186
40760672	21DOC Pre ACTH SerPl-sCnc	4180186
40760672	21-脱氧皮质酮^在剂量促肾上腺皮质激素之前:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760673	21-DB; 21DOC; 30M p ACTH; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; DOC; Level; p ACTH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	4180186
40760673	21DOC 30M p ACTH SerPl-sCnc	4180186
40760673	21-脱氧皮质酮^在给予剂量促肾上腺皮质激素之后30分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760674	21DOC 1h p ACTH SerPl-sCnc	4180186
40760674	1 hour; 1.0Hr; 1h p ACTH; 21-DB; 21DOC; 60 min; 60 minutes; 60M; 60min; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; DOC; Level; p ACTH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	4180186
40760674	21-脱氧皮质酮^在给予剂量促肾上腺皮质激素之后1小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760675	21DC Pre Dex SerPl-sCnc	4180186
40760675	21DC; 21-DF; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Level; Pl; Plasma; Plsm; Point in time; Pre Dex; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760675	21-脱氧皮质醇^在给予地塞米松之前:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760676	21DC 1D p Dex SerPl-sCnc	4180186
40760676	1D p Dex; 21DC; 21-DF; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Level; p Dex; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760676	21-脱氧皮质醇^在给予剂量地塞米松之后1天:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760677	21DC 2D p Dex SerPl-sCnc	4180186
40760677	21DC; 21-DF; 2D p Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Level; p Dex; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760677	21-脱氧皮质醇^在给予剂量地塞米松之后2天:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760678	25(OH)D3; 25-hydroxycholecalciferol; 25-hydroxyvitamin D 3; 25-hydroxyvitamin D3; Before; Ca; Cal; Calciderol; Calcifediol; CHEMISTRY.CHALLENGE TESTING; Level; Pl; Plasma; Plsm; Point in time; pre Ca; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Vitamin D 25 hydroxy	4180186
40760678	25(OH)D3 pre Ca SerPl-sCnc	4180186
40760678	钙二醇^在给予剂量钙之前:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760679	120 min; 120 minutes; 120min; 2 hours; 25(OH)D3; 25-hydroxycholecalciferol; 25-hydroxyvitamin D 3; 25-hydroxyvitamin D3; 2h p Ca; After; Ca; Cal; Calciderol; Calcifediol; CHEMISTRY.CHALLENGE TESTING; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Vitamin D 25 hydroxy	4180186
40760679	25(OH)D3 2h p Ca SerPl-sCnc	4180186
40760679	钙二醇^在给予剂量钙之后2小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760680	25(OH)D3 3h p Ca SerPl-sCnc	4180186
40760680	25(OH)D3; 25-hydroxycholecalciferol; 25-hydroxyvitamin D 3; 25-hydroxyvitamin D3; 3h p Ca; After; Ca; Cal; Calciderol; Calcifediol; CHEMISTRY.CHALLENGE TESTING; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Vitamin D 25 hydroxy	4180186
40760680	钙二醇^在给予剂量钙之后3小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760682	3A-diol G; 3-alpha-diol G; Alfa; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Gluc; Glucouronide; Hexadrol; III; Level; Pl; Plasma; Plsm; Point in time; Pre Dex; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760682	3A-diol G Pre Dex SerPl-sCnc	4180186
40760682	Alpha-二氢雄酮葡糖苷酸^在给予地塞米松之前:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760685	3A-diol G Pre ACTH SerPl-sCnc	4180186
40760685	3A-diol G; 3-alpha-diol G; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Alfa; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Gluc; Glucouronide; III; Level; Pl; Plasma; Plsm; Point in time; Pre ACTH; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	4180186
40760685	Alpha-二氢雄酮葡糖苷酸^在剂量促肾上腺皮质激素之前:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760687	3A-diol G 1h p ACTH SerPl-sCnc	4180186
40760687	1 hour; 1.0Hr; 1h p ACTH; 3A-diol G; 3-alpha-diol G; 60 min; 60 minutes; 60M; 60min; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; Alfa; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Gluc; Glucouronide; III; Level; p ACTH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	4180186
40760687	Alpha-二氢雄酮葡糖苷酸^在给予剂量促肾上腺皮质激素之后1小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760689	Androstanolone 30M p ACTH SerPl-sCnc	4180186
40760689	30M p ACTH; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; DHT; Dihydrotestosterone; Level; p ACTH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	4180186
40760689	双氢睾酮^在给予剂量促肾上腺皮质激素之后30分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760694	Before; c246; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; pre 25 mg Cpl PO; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760694	Aldost pre 25 mg Cpl PO SerPl-mCnc	4180186
40760694	醛固酮^在口服25 mg卡托普利之前:质量浓度:时间点:血清/血浆:定量型	4182948
40760695	120 min; 120 minutes; 120min; 2 hours; 2h p 25 mg Cpl PO; After; c246; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; p 25 mg Cpl PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760695	Aldost 2h p 25 mg Cpl PO SerPl-sCnc	4180186
40760695	醛固酮^在口服25 mg卡托普利之后2小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760701	15M p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760701	Aldost 15M p chal SerPl-sCnc	4180186
40760701	醛固酮^在XXX刺激之后15分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760705	30M pre chal; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; pre chal; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760705	Aldost 30M pre chal SerPl-mCnc	4180186
40760705	醛固酮^在XXX刺激之前30分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40760706	30M pre chal; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Pl; Plasma; Plsm; Point in time; pre chal; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760706	Aldost 30M pre chal SerPl-sCnc	4180186
40760706	醛固酮^在XXX刺激之前30分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760708	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Endocrine; Endocrinology; Level; Mass concentration; mcg; Pl; Plasma; Plsm; Point in time; pre 250 ug ACTH; pre 250 ug ACTH IM; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker	4180186
40760708	Aldost pre 250 ug ACTH IM SerPl-mCnc	4180186
40760708	醛固酮^在肌肉注射250 ug促肾上腺皮质激素之前:质量浓度:时间点:血清/血浆:定量型	4182948
40760709	6A-OH-THS pre hi Dex 24h Ur-mCnc	4180186
40760709	1 day; 11DC; 24 hours; 24HR; 6A-OH-THS; Alfa; Before; c350; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Decadron; Deoxycortisol; Desoxycortisol; Dexameth; Dexone; Hexadrol; hi dose; Level; Mass concentration; Metopirone; pre hi Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760709	6-alpha 羟基四氢-11-脱氢皮质醇^在给予高剂量地塞米松之前:质量浓度:24小时:尿液:定量型	4182948
40760711	1 day; 11DC; 24 hours; 24HR; 2D p high Dex; 6A-OH-THS; After; Alfa; c350; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Decadron; Deoxycortisol; Desoxycortisol; Dexameth; Dexone; Hexadrol; hi dose; Level; Mass concentration; Metopirone; p high Dex; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760711	6A-OH-THS 2D p high Dex 24h Ur-mCnc	4180186
40760711	6-alpha 羟基四氢-11-脱氢皮质醇^在给予高剂量地塞米松之后2天:质量浓度:24小时:尿液:定量型	4182948
40760712	6A-OH-THS 2D p high Dex 24h Ur-mRate	4180186
40760712	1 day; 11DC; 24 hours; 24HR; 2D p high Dex; 6A-OH-THS; After; Alfa; c350; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Decadron; Deoxycortisol; Desoxycortisol; Dexameth; Dexone; Hexadrol; hi dose; Mass Rate; Metopirone; mRate; p high Dex; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760712	6-alpha 羟基四氢-11-脱氢皮质醇^在给予高剂量地塞米松之后2天:质量速率:24小时:尿液:定量型	4182948
40760716	1 day; 11DC; 24 hours; 24HR; 2D p Dex; 6A-OH-THS; After; Alfa; c350; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Decadron; Deoxycortisol; Desoxycortisol; Dexameth; Dexone; Hexadrol; Mass rate; Metopirone; mRate; p Dex; p dose; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760716	6A-OH-THS 2D p Dex 24h Ur-mRate	4180186
40760716	6-alpha 羟基四氢-11-脱氢皮质醇^在给予剂量地塞米松之后2天:质量速率:24小时:尿液:定量型	4182948
40760717	1 day; 24 hours; 24HR; 6A-OH-THA; Alfa; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Level; Mass concentration; pre hi Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760717	6A-OH-THA pre hi Dex 24h Ur-mCnc	4180186
40760717	6-alpha 羟基四氢-11-脱氢皮质酮^在给予高剂量地塞米松之前:质量浓度:24小时:尿液:定量型	4182948
40760719	1 day; 24 hours; 24HR; 2D p high Dex; 6A-OH-THA; After; Alfa; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Level; Mass concentration; p high Dex; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760719	6A-OH-THA 2D p high Dex 24h Ur-mCnc	4180186
40760719	6-alpha 羟基四氢-11-脱氢皮质酮^在给予高剂量地塞米松之后2天:质量浓度:24小时:尿液:定量型	4182948
40760720	6A-OH-THA 2D p high Dex 24h Ur-mRate	4180186
40760720	1 day; 24 hours; 24HR; 2D p high Dex; 6A-OH-THA; After; Alfa; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Mass Rate; mRate; p high Dex; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760720	6-alpha 羟基四氢-11-脱氢皮质酮^在给予高剂量地塞米松之后2天:质量速率:24小时:尿液:定量型	4182948
40760723	1 day; 24 hours; 24HR; 2D p Dex; 6A-OH-THA; After; Alfa; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Level; Mass concentration; p Dex; p dose; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760723	6A-OH-THA 2D p Dex 24h Ur-mCnc	4180186
40760723	6-alpha 羟基四氢-11-脱氢皮质酮^在给予剂量地塞米松之后2天:质量浓度:24小时:尿液:定量型	4182948
40760729	1 day; 24 hours; 24HR; 5-A THF; 5A-tetrahydrocortisol; Alfa; Before; c350; CHEMISTRY.CHALLENGE TESTING; Cortisol metabolite; Decadron; Dexameth; Dexone; Hexadrol; Level; Mass concentration; Pre Dex; QNT; Quan; Quant; Quantitative; THC; THF; UA; UR; Urn	4180186
40760729	5-A THF Pre Dex 24h Ur-mCnc	4180186
40760729	5-Alpha 四氢皮质醇^在给予地塞米松之前:质量浓度:24小时:尿液:定量型	4182948
40760731	1 day; 24 hours; 24HR; 2D p Dex; 5-A THF; 5A-tetrahydrocortisol; After; Alfa; c350; CHEMISTRY.CHALLENGE TESTING; Cortisol metabolite; Decadron; Dexameth; Dexone; Hexadrol; Level; Mass concentration; p Dex; p dose; PST; QNT; Quan; Quant; Quantitative; THC; THF; UA; UR; Urn	4180186
40760731	5-A THF 2D p Dex 24h Ur-mCnc	4180186
40760731	5-Alpha 四氢皮质醇^在给予剂量地塞米松之后2天:质量浓度:24小时:尿液:定量型	4182948
40760732	1 day; 24 hours; 24HR; 2D p Dex; 5-A THF; 5A-tetrahydrocortisol; After; Alfa; c350; CHEMISTRY.CHALLENGE TESTING; Cortisol metabolite; Decadron; Dexameth; Dexone; Hexadrol; Mass rate; mRate; p Dex; p dose; PST; QNT; Quan; Quant; Quantitative; THC; THF; UA; UR; Urn	4180186
40760732	5-A THF 2D p Dex 24h Ur-mRate	4180186
40760732	5-Alpha 四氢皮质醇^在给予剂量地塞米松之后2天:质量速率:24小时:尿液:定量型	4182948
40760734	A-Cortol pre hi Dex 24h Ur-mRate	4180186
40760734	1 day; 24 hours; 24HR; A-Cortol; Alfa; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Mass Rate; mRate; pre hi Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760734	Alpha 皮五醇^在给予高剂量地塞米松之前:质量速率:24小时:尿液:定量型	4182948
40760735	1 day; 24 hours; 24HR; 2D p high Dex; A-Cortol; After; Alfa; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Level; Mass concentration; p high Dex; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760735	A-Cortol 2D p high Dex 24h Ur-mCnc	4180186
40760735	Alpha 皮五醇^在给予高剂量地塞米松之后2天:质量浓度:24小时:尿液:定量型	4182948
40760736	1 day; 24 hours; 24HR; 2D p high Dex; A-Cortol; After; Alfa; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Mass Rate; mRate; p high Dex; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760736	A-Cortol 2D p high Dex 24h Ur-mRate	4180186
40760736	Alpha 皮五醇^在给予高剂量地塞米松之后2天:质量速率:24小时:尿液:定量型	4182948
40760737	A-Cortol Pre Dex 24h Ur-mCnc	4180186
40760737	1 day; 24 hours; 24HR; A-Cortol; Alfa; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Level; Mass concentration; Pre Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760737	Alpha 皮五醇^在给予地塞米松之前:质量浓度:24小时:尿液:定量型	4182948
40760738	1 day; 24 hours; 24HR; A-Cortol; Alfa; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Mass rate; mRate; Pre Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760738	A-Cortol Pre Dex 24h Ur-mRate	4180186
40760738	Alpha 皮五醇^在给予地塞米松之前:质量速率:24小时:尿液:定量型	4182948
40760739	1 day; 24 hours; 24HR; 2D p Dex; A-Cortol; After; Alfa; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Level; Mass concentration; p Dex; p dose; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760739	A-Cortol 2D p Dex 24h Ur-mCnc	4180186
40760739	Alpha 皮五醇^在给予剂量地塞米松之后2天:质量浓度:24小时:尿液:定量型	4182948
40760740	1 day; 24 hours; 24HR; 2D p Dex; A-Cortol; After; Alfa; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Mass rate; mRate; p Dex; p dose; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760740	A-Cortol 2D p Dex 24h Ur-mRate	4180186
40760740	Alpha 皮五醇^在给予剂量地塞米松之后2天:质量速率:24小时:尿液:定量型	4182948
40760741	A-cortolone pre hi Dex 24h Ur-mCnc	4180186
40760741	1 day; 24 hours; 24HR; A-cortolone; Alfa; Before; c350; CHEMISTRY.CHALLENGE TESTING; Cortisol metabolite; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Level; Mass concentration; pre hi Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760741	Alpha-皮酮四醇^在给予高剂量地塞米松之前:质量浓度:24小时:尿液:定量型	4182948
40760742	A-cortolone pre hi Dex 24h Ur-mRate	4180186
40760742	1 day; 24 hours; 24HR; A-cortolone; Alfa; Before; c350; CHEMISTRY.CHALLENGE TESTING; Cortisol metabolite; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Mass Rate; mRate; pre hi Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760742	Alpha-皮酮四醇^在给予高剂量地塞米松之前:质量速率:24小时:尿液:定量型	4182948
40760745	1 day; 24 hours; 24HR; A-cortolone; Alfa; Before; c350; CHEMISTRY.CHALLENGE TESTING; Cortisol metabolite; Decadron; Dexameth; Dexone; Hexadrol; Level; Mass concentration; Pre Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760745	A-cortolone Pre Dex 24h Ur-mCnc	4180186
40760745	Alpha-皮酮四醇^在给予地塞米松之前:质量浓度:24小时:尿液:定量型	4182948
40760746	1 day; 24 hours; 24HR; A-cortolone; Alfa; Before; c350; CHEMISTRY.CHALLENGE TESTING; Cortisol metabolite; Decadron; Dexameth; Dexone; Hexadrol; Mass rate; mRate; Pre Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760746	A-cortolone Pre Dex 24h Ur-mRate	4180186
40760746	Alpha-皮酮四醇^在给予地塞米松之前:质量速率:24小时:尿液:定量型	4182948
40760748	1 day; 24 hours; 24HR; 2D p Dex; A-cortolone; After; Alfa; c350; CHEMISTRY.CHALLENGE TESTING; Cortisol metabolite; Decadron; Dexameth; Dexone; Hexadrol; Mass rate; mRate; p Dex; p dose; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760748	A-cortolone 2D p Dex 24h Ur-mRate	4180186
40760748	Alpha-皮酮四醇^在给予剂量地塞米松之后2天:质量速率:24小时:尿液:定量型	4182948
40760751	1 day; 24 hours; 24HR; 2D p high Dex; After; Androster; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; hi dose; Level; Mass concentration; p high Dex; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760751	Androsterone 2D p high Dex 24h Ur-mCnc	4180186
40760751	雄酮^在给予高剂量地塞米松之后2天:质量浓度:24小时:尿液:定量型	4182948
40760754	Androsterone Pre Dex 24h Ur-mRate	4180186
40760754	1 day; 24 hours; 24HR; Androster; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Mass rate; mRate; Pre Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760754	雄酮^在给予地塞米松之前:质量速率:24小时:尿液:定量型	4182948
40760757	C peptide 10M pre chal SerPl-sCnc	4180186
40760757	10M pre chal; Before; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Pept; Pl; Plasma; Plsm; Point in time; pre chal; Pro-insulin c peptide; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760757	C 肽^在XXX刺激之前10分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760758	C peptide 190M p chal SerPl-sCnc	4180186
40760758	190M p chal; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760758	C 肽^在XXX刺激之后190分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760759	C peptide 3.3h p chal SerPl-sCnc	4180186
40760759	3.3h p chal; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760759	C 肽^在XXX刺激之后3.3小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760760	5M pre chal; Before; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Pept; Pl; Plasma; Plsm; Point in time; pre chal; Pro-insulin c peptide; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760760	C peptide 5M pre chal SerPl-sCnc	4180186
40760760	C 肽^在XXX刺激之前5分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760761	C peptide 1h pre chal SerPl-sCnc	4180186
40760761	1 hour; 1.0Hr; 1h pre chal; 60 min; 60 minutes; 60M; 60min; Before; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Pept; Pl; Plasma; Plsm; Point in time; pre chal; Pro-insulin c peptide; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760761	C 肽^在XXX刺激之前1小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760762	C peptide 70M pre chal SerPl-sCnc	4180186
40760762	70M pre chal; Before; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Pept; Pl; Plasma; Plsm; Point in time; pre chal; Pro-insulin c peptide; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760762	C 肽^在XXX刺激之前70分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760763	1.3h p chal; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40760763	C peptide 1.3h p chal SerPl-sCnc	4180186
40760763	C 肽^在XXX刺激之后1.3小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40760764	Diff; Differl; Differn; Humid wire TempDiff; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Temp; Temperature; Vent airway circuit; Vent away	4180186
40760764	Humid wire TempDiff Vent airway circuit	4180186
40760764	湿化器加热丝温度差别设置:温度:时间点:呼吸机气道线路:定量型	4182948
40760765	Lung; Minimal; minimum; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Spont VT; TV; Vent alarm; Vol; Volume; VT; VT.spontaneous min setting	4180186
40760765	VT.spontaneous min setting Vent alarm	4180186
40760765	潮气量.自主 最小值设置:体积型属性:时间点:呼吸机.警报:定量型	4182948
40760766	Largest; Lung; Maximal; Maximum; Peak; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; TV; Vent alarm; Vol; Volume; VT; VT.inspired; VT.inspired max setting	4180186
40760766	VT.inspired max setting Vent alarm	4180186
40760766	潮气量.吸入 最大值设置:体积型属性:时间点:呼吸机.警报:定量型	4182948
40760767	Largest; Lung; Maximal; Maximum; Peak; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; TV; Vent alarm; Vol; Volume; VT; VT.exhaled max	4180186
40760767	VT.exhaled max Vent alarm	4180186
40760767	潮气量.呼出 最大值设置:体积型属性:时间点:呼吸机.警报:定量型	4182948
40760771	GQ1b Gangl IgG Ser IA-aCnc	4180186
40760771	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; GQ1b; GQ1b Gangl; IAA; Immune globulin G; Immunoglobulin G; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS; Tetrasialylganglioside	4180186
40760771	神经节苷脂 GQ1b 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40760773	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Ribonuclear protein; RNP; Serology; Serum; snRNP; SR; SUDS; U1 RNP; U1 snRNP; U1RNP	4180186
40760773	U1 snRNP Ab Ser IA-aCnc	4180186
40760773	U1 小细胞核核糖核蛋白 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40760774	Norepineph p chal Plas-mCnc	4180186
40760774	After; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; NE; Noradrenalin; Norepi; Norepin; Norepineph; Norepinephr; Noreppi; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random	4180186
40760774	去甲肾上腺素^在 XXX 刺激之后:质量浓度:时间点:血浆:定量型	4182948
40760775	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Catalytic Concentration; Chemistry; Dehydrog; Dehyrdogenase; Ejaculate; Genitourinary; GU; L.D.H; Lact; Lactic acid; Lactic acid dehydrogenase; LD; LDH; L-lactate; L-lactate dehydrogenase; Point in time; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; Tumor marker; URO; Urology	4180186
40760775	LDH Smn-cCnc	4180186
40760775	乳酸脱氢酶:催化浓度:时间点:精液:定量型	4182948
40760776	Oligoclonal Bands IgG SerPl Ql IEF	4180186
40760776	Chemistry; Frac; Fract; Fraction; Fractionated; Fractionation; IEF; Immune globulin G; Immunoglobulin G; M-spikes; Oligoclonal Bands IgG; Ordinal; Pl; Plasma; Plsm; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760776	蛋白质成分.寡克隆区带.IgG:存在情况或阈值:时间点:血清/血浆:序数型:等电聚焦电泳	4182948
40760778	Deprecated M protein beta Ur Elph-mCnc	4180186
40760778	B; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Level; M Protein; M protein beta; Mass Concentration; M-band; Monoclonal band; Monoclonal spike; M-protein; M-spike; Para protein; Paraprotein; PEUR; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; UA; UPEP; UR; Urn	4180186
40760779	10M p chal; After; Bind; CHEMISTRY.CHALLENGE TESTING; Fac; Fact; HUM; Humulin; IGF; IGF BP; IGF BP3; IGFBP; IH7; III; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; PR; Prot; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
40760779	IGF BP3 10M p chal SerPl-mCnc	4180186
40760779	胰岛素样生长因子结合蛋白 3^在XXX刺激之后10分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40760780	20M p chal; After; Bind; CHEMISTRY.CHALLENGE TESTING; Fac; Fact; HUM; Humulin; IGF; IGF BP; IGF BP3; IGFBP; IH7; III; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; PR; Prot; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
40760780	IGF BP3 20M p chal SerPl-mCnc	4180186
40760780	胰岛素样生长因子结合蛋白 3^在XXX刺激之后20分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40760784	ABS; Aby; ACIF; Acute specimen; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; C burnet; C burnetii; Coxiella burnettii; FA; First; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; Pre immunization; Q fev; Q fever; Qfever; QL; Qual; Qualitative; Random; Screen; Serum; sp1; Spec; SR; Time Resolved Fluorescence; TRF	4180186
40760784	C burnet IgM sp1 Ser Ql IF	4180186
40760784	贝氏柯克斯体 抗体.IgM^第1个标本:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40760787	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Convalescent; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; L pneumo; L pneumonphila; Legion; Legionela; Microbiology; Ordinal; Pneu; pneum; Pneumophilia; Point in time; Post immunization; PR; QL; Qual; Qualitative; Random; Screen; Second; Serum; sp2; Spec; SR; Time Resolved Fluorescence; TRF	4180186
40760787	L pneumo IgG sp2 Ser Ql IF	4180186
40760787	嗜肺军团菌 抗体.IgG^第2个标本:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40760790	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chlam; Chlamid; EIA; ELFA; ELISA; Enzyme immunoassay; First; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; Pre immunization; QL; Qual; Qualitative; Random; Screen; Serum; sp1; Spec; species; spp; SR; SUDS	4180186
40760790	Chlamydia IgG sp1 Ser Ql IA	4180186
40760790	衣原体属单个未知种 抗体.IgG^第1个标本:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40760791	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chlam; Chlamid; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; Post immunization; PR; QL; Qual; Qualitative; Random; Screen; Second; Serum; sp2; Spec; species; spp; SR; SUDS	4180186
40760791	Chlamydia IgG sp2 Ser Ql IA	4180186
40760791	衣原体属单个未知种 抗体.IgG^第2个标本:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40760792	ABS; Aby; ACIF; Acute specimen; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; C burnet; C burnetii; Coxiella burnettii; FA; First; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; Pre immunization; Q fev; Q fever; Qfever; QL; Qual; Qualitative; Random; Screen; Serum; sp1; Spec; SR; Time Resolved Fluorescence; TRF	4180186
40760792	C burnet IgG sp1 Ser Ql IF	4180186
40760792	贝氏柯克斯体 抗体.IgG^第1个标本:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40760793	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; C burnet; C burnetii; Convalescent; Coxiella burnettii; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; Post immunization; PR; Q fev; Q fever; Qfever; QL; Qual; Qualitative; Random; Screen; Second; Serum; sp2; Spec; SR; Time Resolved Fluorescence; TRF	4180186
40760793	C burnet IgG sp2 Ser Ql IF	4180186
40760793	贝氏柯克斯体 抗体.IgG^第2个标本:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40760794	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Malaria; Malarial; MEIA; Microbiology; Ordinal; P falciparum; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
40760794	P falciparum IgM Ser Ql IA	4180186
40760794	恶性疟原虫 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40760796	17-Hydroxycorticosterone; Chemistry; Compound F; Convalescent; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Oral fluid; Point in time; Post immunization; QNT; Quan; Quant; Quantitative; Random; Sal; Second; sp2; Spec	4180186
40760796	Cortis sp2 Sal-mCnc	4180186
40760796	皮质醇^第2个标本:质量浓度:时间点:唾液:定量型	4182948
40760801	17-Hydroxycorticosterone; Chemistry; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; sp10; Spec	4180186
40760801	Cortis sp10 Sal-mCnc	4180186
40760801	皮质醇^第10个标本:质量浓度:时间点:唾液:定量型	4182948
40760803	Cortis sp5 Sal-mCnc	4180186
40760803	17-Hydroxycorticosterone; Chemistry; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; sp5; Spec	4180186
40760803	皮质醇^第5个标本:质量浓度:时间点:唾液:定量型	4182948
40760804	Cortis sp6 Sal-mCnc	4180186
40760804	17-Hydroxycorticosterone; Chemistry; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; sp6; Spec	4180186
40760804	皮质醇^第6个标本:质量浓度:时间点:唾液:定量型	4182948
40760805	17-Hydroxycorticosterone; Chemistry; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; sp7; Spec	4180186
40760805	Cortis sp7 Sal-mCnc	4180186
40760805	皮质醇^第7个标本:质量浓度:时间点:唾液:定量型	4182948
40760807	Faces Pain Scale - Revised; Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40760808	Protein Z Ag Plas IA-mCnc	4180186
40760808	Antigen; Antigens; Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Pl; Plasma; Plsm; Point in time; PR; Prot; PZ; QNT; Quan; Quant; Quantitative; Random; SUDS	4180186
40760808	蛋白 Z 抗原:质量浓度:时间点:血浆:定量型:免疫测定法	4182948
40760809	Chemistry; Dir; Lipid pnl with direct LDL; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders	4180186
40760809	Lipid pnl with direct LDL SerPl	4180186
40760809	带有直接低密度脂蛋白的脂类组套:-:时间点:血清/血浆:定量型	4182948
40760813	Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random; WB; Whole blood	4180186
40760813	Infectious diseases DBS-Imp	4180186
40760813	传染病类:印象:时间点:全血.斑点:名义型	4182948
40760815	Galactosemias NBS comment	4180186
40760815	Asympt; Asymptomatic; Blood; Chemistry; cmmt; cmnt; Com; Comm; Comments; Commt; DBS; Dried blood spot; Filter paper; FP; Galactosemias NBS comment; Narrative; NBS comment; New born; Point in time; Random; Remarks; Report; Scn; Text; WB; Whole blood	4180186
40760815	半乳糖血症 新生儿筛查注释-讨论:文本型属性:时间点:全血.斑点:叙述型	4182948
40760816	CH NBS comment	4180186
40760816	Asympt; Asymptomatic; Blood; CH; CH NBS comment; Chemistry; cmmt; cmnt; Com; Comm; Comments; Commt; DBS; Dried blood spot; Filter paper; FP; Narrative; NBS comment; New born; Point in time; Random; Remarks; Report; Scn; Text; WB; Whole blood	4180186
40760816	先天性甲状腺机能减退 新生儿筛查注释-讨论:文本型属性:时间点:全血.斑点:叙述型	4182948
40760820	Acd; Acids; Asympt; Asymptomatic; Blood; Chemistry; cmmt; cmnt; Com; Comm; Comments; Commt; DBS; Dried blood spot; FA Oxidation; FA oxidation defects NBS comment; FAO; FAODS; Filter paper; FOD; FP; Narrative; NBS comment; New born; Point in time; Random; Remarks; Report; Scn; Text; WB; Whole blood	4180186
40760820	FOD NBS comment	4180186
40760820	脂肪酸氧化过程缺陷 新生儿筛查注释-讨论:文本型属性:时间点:全血.斑点:叙述型	4182948
40760822	Ident; Identifier; No; Nominal; Num; Point in time; Random; SPEC; Unique bar code #	4180186
40760822	Unique bar code # Initial sample	4180186
40760822	唯一性条形码编号:标识符:时间点:初始样品:名义型	4182948
40760823	H+P; H+P.HX; History; Levels; Levl; LV; LVL; Mat; Maternal; Matnl; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH	4180186
40760823	文化程度:历史记录:时间点:^母亲:序数型	4182948
40760824	Asympt; Asymptomatic; Clinical events; Finding; Findings; H+P; H+P.HX; Inf factors affecting NBS imp; Interp; Interpret; Interpt; Intrp; New born; Nominal; P prime; Point in time; Random; Scn	4180186
40760824	Inf factors affecting NBS imp	4180186
40760824	影响新生儿筛查解释的婴儿因素:发现:时间点:^患者:名义型	4182948
40760826	Clock time; H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760826	出生时间:时钟时间:时间点:^患者:定量型	4182948
40760827	Chemistry; Ident; Identifier; Nominal; Point in time; Random; State printed on card	4180186
40760827	State printed on card NBS card	4180186
40760827	印刷在滤纸卡片上的州名:标识符:时间点:新生儿筛查卡:名义型	4182948
40760828	Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Gyn; Gynecology; NBS card data pnl; New born; OB; ObGyn; Obstetrics; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Scn; Scr; Scrn; WB; Whole blood	4180186
40760828	NBS card data pnl	4180186
40760828	新生儿筛查卡数据组套:-:时间点:全血.斑点:-	4182948
40760829	Sample quality of DBS	4180186
40760829	Blood; DBS; Dried blood spot; Filter paper; FP; Nominal; Point in time; Random; SPEC; Specimen quality; Typ; WB; Whole blood	4180186
40760829	标本状况:类型:时间点:全血.斑点:名义型	4182948
40760831	Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Identity or presence; NB conditions with equivocal markers; New born; Nominal; Point in time; Random; WB; Whole blood	4180186
40760831	NB conditions with equivocal markers	4180186
40760831	带有模糊标志的新生儿健康状况:存在与否或特征标识:时间点:全血.斑点:名义型	4182948
40760832	Blood; DBS; Dried blood spot; Filter paper; FP; MISC; Nominal; Point in time; Random; Typ; WB; Whole blood	4180186
40760832	Reason for lab test DBS	4180186
40760832	关于实验室检验项目的原因:类型:时间点:全血.斑点:名义型	4182948
40760835	NBS short summary	4180186
40760835	Asympt; Asymptomatic; Chemistry; Narrative; NBS short summary; New born; Point in time; Random; Report; Scn; Text	4180186
40760835	新生儿筛查简述摘要:文本型属性:时间点:^患者:叙述型	4182948
40760836	ACTH 20M p chal Plas-mCnc	4180186
40760836	20M p chal; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Tumor marker	4180186
40760836	促肾上腺皮质激素^在XXX刺激之后20分钟:质量浓度:时间点:血浆:定量型	4182948
40760839	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; 40M p chal; After; CHEMISTRY.CHALLENGE TESTING; Lact; Lactic acid; Level; L-lactate; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40760839	Lactate 40M p chal SerPl-mCnc	4180186
40760839	乳酸^在XXX刺激之后40分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40760841	Chemistry; Convalescent; Osmo; Osmol; Osmolality; osmolarity; Point in time; Post immunization; QNT; Quan; Quant; Quantitative; Random; Second; sp2; Spec; UA; UR; Urn	4180186
40760841	Osmolality sp2 Ur	4180186
40760841	渗透压^第2个标本:渗透压:时间点:尿液:定量型	4182948
40760842	Chemistry; Osmo; Osmol; Osmolality; osmolarity; Point in time; QNT; Quan; Quant; Quantitative; Random; sp3; Spec; UA; UR; Urn	4180186
40760842	Osmolality sp3 Ur	4180186
40760842	渗透压^第3个标本:渗透压:时间点:尿液:定量型	4182948
40760843	B; B/F; beta TP; BF; bod; Bodies; Body fluid; Body fluid, unsp; BTP; Cerebrin-28; Chemistry; Fl; Fld; FLU; Fluid; Glutathione-independent PGD synthase; Level; Lipocalin-type prostaglandin-D synthase; Mass concentration; PGD2 synthase; PGDS2; Point in time; PR; Prostaglandin-D2 synthase; Prostaglandin-H2 D-isomerase; Prot; QNT; Quan; Quant; Quantitative; Random	4180186
40760843	Beta-trace protein Fld-mCnc	4180186
40760843	Beta-微量蛋白:质量浓度:时间点:体液:定量型	4182948
40760844	Ketones Ur Ql Strip.auto	4180186
40760844	Acetest; Acetoacetate; Acetoacetates; Acetone bodies; Auto; Automated detection; Dip stick; Dipstick; Elec; Elect; Electr; Ketone; Ketone bodies; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; URINALYSIS; Urn	4180186
40760844	酮体:存在情况或阈值:时间点:尿液:序数型:试纸条.自动化法	4182948
40760845	Auto; Automated detection; Dip stick; Dipstick; Elec; Elect; Electr; Kidney; Nephrology; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Renal; Screen; UA; UR; URINALYSIS; Urn	4180186
40760845	Prot Ur Ql Strip.auto	4180186
40760845	蛋白质:存在情况或阈值:时间点:尿液:序数型:试纸条.自动化法	4182948
40760846	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD154 cells; CD40 ligand; CD40L; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; gp39; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T-BAM; TRAP; Tumor necrosis factor Related Activation Protein; X-linked hyper IgM	4180186
40760846	CD154 cells NFr Fld	4180186
40760846	细胞.CD154/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40760847	BM Ab Titr Ser IF	4180186
40760847	基底膜 抗体:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40760847	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Basem; Basemt; BM; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40760853	Blood; BLOOD BANK; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; GCMS; Hematology; Heme; Nominal; Point in time; Random; Typ; WB; Whole blood	4180186
40760853	ABO Group Bld Cfm	4180186
40760853	ABO 血型:类型:时间点:全血:名义型:毒理学确认试验	4182948
40760855	ABS; Aby; ACIF; Adrenal total antibodies; Adrnl; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Endocrine; Endocrinology; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Steroid cell antibodies; Time Resolved Fluorescence; TRF	4180186
40760855	Adrenal Ab Ser Ql IF	4180186
40760855	肾上腺 抗体:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40760860	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; breast cancer; Cerebral spinal fluid; Cerebrospinal Fl; Immune blot; Immunobl; Immunoblot; Neuro; Neurology; Ordinal; Paraneoplastic syndrome; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Stiff Man Syndrome; WB; WBLOT; West blot; West blt; Western blot	4180186
40760860	Amphiphysin Ab CSF Ql IB	4180186
40760860	双载蛋白 抗体:存在情况或阈值:时间点:脑脊液:序数型:免疫印迹法	4182948
40760861	Hgb Ur Ql Strip.auto	4180186
40760861	Auto; Automated detection; Blood; Dip stick; Dipstick; Elec; Elect; Electr; Haemoglobin; Hb; Hgb; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; URINALYSIS; Urn	4180186
40760861	血红蛋白:存在情况或阈值:时间点:尿液:序数型:试纸条.自动化法	4182948
40760862	Chemistry; Diaf; DiafP; Dialysate; Dialysis fluid; Level; Mass concentration; Peritoneal Dialysis fluid; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40760862	Urea Overnight DiafP-mCnc	4180186
40760862	尿素^在前一夜:质量浓度:时间点:腹膜透析液:定量型	4182948
40760864	BAFF; Blood; BLYS; CD267; CVID; CVID2; Gene mut tested; Genetics; Heredity; Heritable; Identity or presence; IGAD2; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Tested; Mutation; Muts; Nominal; PCR; Point in time; Random; RYZN; TACI; TALL1; THANK; Tissue; Tissue, unspecified; TNFRSF14B; TNFSF20; Tumor necrosis factor (ligand) superfamily, member 13b; tumor necrosis factor receptor superfamily, member 13B; WB; Whole blood; Whole blood or Tissue; ZTNF4	4180186
40760864	TNFRSF13B gene Mut Tested Bld/T	4180186
40760864	TNFRSF13B 基因 已测试的突变:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40760866	3; Arbitrary concentration; Chemistry; P3NP; PIIINP; Point in time; Procollagen III; Procollagen III.N-term propep; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40760866	Procollagen III.N-term propep Ser-aCnc	4180186
40760866	前胶原肽.III 型 N-末端:任意型浓度:时间点:血清:定量型	4182948
40760867	AMCBX1; Blood; FIP3; FIP-3; Fip3p; Gene mut tested; Genetics; Heredity; Heritable; Identity or presence; IKKAP1; IKKG; IKK-gamma; IMD33; Inherited; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; IP; IP1; IP2; IPD2; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Tested; Mutation; Muts; NEMO; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue; ZC2HC9	4180186
40760867	IKBKG gene Mut Tested Bld/T	4180186
40760867	IKBKG 基因 已测试的突变:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40760868	BAFF; Blood; BLYS; CD267; CVID; CVID2; Genetics; Heredity; Heritable; Identity or presence; IGAD2; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; RYZN; TACI; TALL1; THANK; Tissue; Tissue, unspecified; TNFRSF14B; TNFSF20; Tumor necrosis factor (ligand) superfamily, member 13b; tumor necrosis factor receptor superfamily, member 13B; WB; Whole blood; Whole blood or Tissue; ZTNF4	4180186
40760868	TNFRSF13B gene Mut Anl Bld/T	4180186
40760868	TNFRSF13B 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40760870	Clot; Clottable; Coag; Coagulation assay; Fac; Fact; Fact XIII; Fact XIII Inhib; Factor 13; Fibrin stabilizing factor; Fibrinase laki-lorand factor; Fibrinoligase; FXIII; Hematology; Heme; Inhib; Inhibit; Ordinal; Plas; Plasma transamidase; Plasma transglutaminase; Platelet poor plasma; Point in time; PR; Protransglutaminase; QL; Qual; Qualitative; Random; Screen; Tilt tube	4180186
40760870	Fact XIII Inhib PPP Ql	4180186
40760870	凝血因子 XIII 抑制剂:存在情况或阈值:时间点:贫血小板血浆:序数型:凝血功能分析	4182948
40760871	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Compx; EIA; ELFA; ELISA; Enzyme immunoassay; Fac; Fact; HAT; Hematology; Heme; Hep; Hepar; Heparin associated thrombycytopenia; Heparin dependent antibodies; Heparin induced thromocytopenia; Heparn; HIT; HITA; IAA; MEIA; Ordinal; PF; PF4; PF4 heparin cmplx; PF4-heparin Ab; PI-factor 4; Pl; Plasma; Platelet Ab.heparin induced; Platelet type heparin inactivator; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Thrombocyte; Thrombocytes	4180186
40760871	PF4 heparin cmplx Ab SerPl Ql IA	4180186
40760871	血小板因子 4 肝素复合物诱导型 抗体:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法	4182948
40760872	CD55+CD59 cells Bld Ql Aggl	4180186
40760872	Agg; Agglut; Agglutination; Blood; CD55 Cells; CD55+CD59 cells; Cell; CELL MARKERS; Cellularity; DAF; Decay accelerating factor; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
40760872	细胞.CD55+CD59:存在情况或阈值:时间点:全血:序数型:凝集试验法	4182948
40760874	Microscopic Mar-Imp	4180186
40760874	BM; BON; Bone marrow; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; MAR; Marrow (bone); Micro; minimal angle of resolution; Minimum angle of resolution; Nominal; Point in time; Random	4180186
40760874	显微镜检查:印象:时间点:骨髓:名义型:细胞学类实验室方法	4182948
40760878	Antigen; Antigens; Bowel movement; C coli; C jejuni; C jejuni+C coli; Campy; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal	4180186
40760878	C jejuni+C coli Ag Stl Ql	4180186
40760878	空肠弯曲菌+结肠弯曲菌 抗原:存在情况或阈值:时间点:大便:序数型	4182948
40760879	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; S typhi; S Typhi O; S Typhi O Vi; S typhosa; Sal; Salmonel; Screen; Serum; SR; Typh; Typhoid	4180186
40760879	S Typhi O Vi Ab Ser Ql	4180186
40760879	伤寒沙门菌 O Vi 抗体:存在情况或阈值:时间点:血清:序数型	4182948
40760880	ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; T gondii; T gondii IgG+IgM pnl; Toxo; Toxoplasmosis; UniversalLabOrders	4180186
40760880	T gondii IgG+IgM pnl Ser	4180186
40760880	刚地弓形虫抗体.IgG 与 IgM 组套:-:时间点:血清:定量型	4182948
40760883	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CTFV; ID; IgG+IgM; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; Microbiology; Narrative; Point in time; Random; Report; Serum; SR	4180186
40760883	CTFV IgG+IgM Ser-Imp	4180186
40760883	科洛拉多蜱传热病毒 抗体.IgG 与 IgM:印象:时间点:血清:叙述型	4182948
40760886	Gliadin peptide IgA & IgG pnl Ser	4180186
40760886	麦醇溶蛋白肽抗体.IgA 与 IgG 组套:-:时间点:血清:-	4182948
40760886	Agf98; Celiac; Celiac disease; Deamidated gliadin peptide; Deaminated gliadin; Dermatitis Herpetiformis; DGP; DH; F98; Gliadin peptide IgA & IgG pnl; Gliadin peptide IgA+IgG Ser Qn; Gliadine; Immune globulin A; Immune globulin G; Immunoglobulin A; Immunoglobulin G; Pan; PANEL.SEROLOGY; Panl; Pept; Pnl; Point in time; Random; Serology; Serum; SR	4180186
40760887	III; MPO; MPO - ANCA; MPO Ab + PR3 pnl; Myeloperoxidase ANCA; Pan; p-ANCA; PANEL.SEROLOGY; Panl; Pnl; Point in time; PR3; PR-3; PR3-ANCA; Proteinase3; PRTN3; QNT; Quan; Quant; Quantitative; Random; Serine protease 3; Serology; Serum; SR; Vasculitis	4180186
40760887	MPO Ab + PR3 pnl Ser	4180186
40760887	髓过氧物酶抗体与蛋白酶 3 组套:-:时间点:血清:定量型	4182948
40760889	Disaccharidases TSMI-Imp	4180186
40760889	Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Random; Report; Tissue small intestine	4180186
40760889	二糖酶:印象:时间点:小肠组织:叙述型	4182948
40760890	Antithyroglob; Chemistry; Hashimoto's thyroiditis; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tg; TgAbs; Thyglobulin; Thyroglbn; Thyroglob; Thyroglob + Thyroglob Ab pnl; Tumor marker	4180186
40760890	Thyroglob + Thyroglob Ab pnl SerPl	4180186
40760890	甲状腺球蛋白与甲状腺球蛋白抗体组套:-:时间点:血清/血浆:定量型	4182948
40760893	DHEA pre hi Dex 24h Ur-mCnc	4180186
40760893	1 day; 24 hours; 24HR; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; DHEA; Hexadrol; hi dose; Level; Mass concentration; Prasterone; pre hi Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760893	脱氢表雄酮^在给予高剂量地塞米松之前:质量浓度:24小时:尿液:定量型	4182948
40760894	1 day; 24 hours; 24HR; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; DHEA; Hexadrol; hi dose; Mass Rate; mRate; Prasterone; pre hi Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760894	DHEA pre hi Dex 24h Ur-mRate	4180186
40760894	脱氢表雄酮^在给予高剂量地塞米松之前:质量速率:24小时:尿液:定量型	4182948
40760898	DHEA Pre Dex 24h Ur-mRate	4180186
40760898	1 day; 24 hours; 24HR; Before; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; DHEA; Hexadrol; Mass rate; mRate; Prasterone; Pre Dex; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760898	脱氢表雄酮^在给予地塞米松之前:质量速率:24小时:尿液:定量型	4182948
40760900	1 day; 24 hours; 24HR; 2D p Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; DHEA; Hexadrol; Mass rate; mRate; p Dex; p dose; Prasterone; PST; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40760900	DHEA 2D p Dex 24h Ur-mRate	4180186
40760900	脱氢表雄酮^在给予剂量地塞米松之后2天:质量速率:24小时:尿液:定量型	4182948
40760902	Acd; Acids; Blood; Chemistry; DBS; Dried blood spot; FA Oxidation; FA oxidation conditions suspected; FAO; Filter paper; FP; Identity or presence; Nominal; Point in time; Random; WB; Whole blood	4180186
40760902	FA oxidation conditions suspected DBS	4180186
40760902	疑似脂肪酸氧化障碍:存在与否或特征标识:时间点:全血.斑点:名义型	4182948
40760903	Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Identity or presence; Nominal; Point in time; Random; WB; Whole blood	4180186
40760903	Amino acidemia disorder suspected DBS	4180186
40760903	疑似氨基酸血症:存在与否或特征标识:时间点:全血.斑点:名义型	4182948
40760909	Blood; Calc; Calculation; Chemistry; ctO2; Lung; O2; O2 Ct; O2CT; Percent; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; tO2; Volfr; Volume fraction; WB; Whole blood	4180186
40760909	O2 Ct VFr Bld Calc	4180186
40760909	氧含量:体积分数:时间点:全血:定量型:计算法	4182948
40760913	# Occ bld spec recommended Stl	4180186
40760913	# Occ bld spec recommended; Bowel movement; Chemistry; Cnt; Count; Faecal; Faeces; Fecal; Feces; No; Num; Number; Occ; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal	4180186
40760913	试剂盒方案所推荐的潜血标本的数量:数量(计数):时间点:大便:定量型	4182948
40760914	HEDIS 2010 PPC-C ABO+Rh	4180186
40760914	D phenotyping; D typing; HEDIS 2010 PPC-C ABO+Rh; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; Rh phenotyping; Rh typing	4180186
40760914	HEDIS 2010 早期产前护理当中所使用的试验 - ABO 与 Rh (PPC-C):-:时间点:^患者:-	4182948
40760915	HEDIS 2010-13 PPC-C RUBV; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
40760915	HEDIS 2010-13 PPC-C RUBV	4180186
40760915	HEDIS 2010-2013 早期产前护理当中所使用的试验 - 风疹 (PPC-C):-:时间点:^患者:-	4182948
40760916	HEDIS 2010 PPC-C; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
40760916	HEDIS 2010 PPC-C	4180186
40760916	HEDIS 2010 早期产前护理当中所使用的试验 (PPC-C):-:时间点:^患者:-	4182948
40760917	Carbamazapine; Carbamezapine; Carbazepine; CRBM; Epitol; HEDIS 2010-13 MPM-E carBAMazepine; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; Ser; SR; Tegretol; Teril	4180186
40760917	HEDIS 2010-13 MPM-E carBAMazepine	4180186
40760917	用于标识血清抗惊厥药物浓度监测试验的 HEDIS 2010-2013 代码 - 卡马西平 (MPM-E):-:时间点:^患者:-	4182948
40760918	HEDIS 2010-11 MPM-E	4180186
40760918	HEDIS 2010-11 MPM-E; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; Ser; SR	4180186
40760918	用于标识血清抗惊厥药物浓度监测试验的 HEDIS 2010, 2011 代码 (MPM-E):-:时间点:^患者:-	4182948
40760919	Blood urea nitrogen; HEDIS 2010-11 MPM-A BUN; N; N2; Nit; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; UN	4180186
40760919	HEDIS 2010-11 MPM-A BUN	4180186
40760919	用于标识生理监测试验的 HEDIS 2010, 2011 代码 - 血液尿素氮 (BUN) (MPM-A):-:时间点:^患者:-	4182948
40760921	HEDIS 2010 MPM-A	4180186
40760921	HEDIS 2010 MPM-A; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
40760921	用于标识生理监测试验的 HEDIS 2010 代码 (MPM-A):-:时间点:^患者:-	4182948
40760922	HEDIS 2010 CDC-K	4180186
40760922	HEDIS 2010 CDC-K; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
40760922	用于标识肾病证据的 HEDIS 2010 代码 (CDC-K):-:时间点:^患者:-	4182948
40760925	Asympt; Asymptomatic; Dextro; HEDIS 2010 CMC-D; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; Scn	4180186
40760925	HEDIS 2010 CMC-D	4180186
40760925	用于标识 LDLc 筛查的 HEDIS 2010 代码 (CMC-D):-:时间点:^患者:-	4182948
40760927	HEDIS 2010 CHL-B; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
40760927	HEDIS 2010 CHL-B	4180186
40760927	用于标识性活跃妇女的 HEDIS 2010 代码 (CHL-B):-:时间点:^患者:-	4182948
40760928	Asympt; Asymptomatic; HEDIS 2010 COL-A; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; Scn	4180186
40760928	HEDIS 2010 COL-A	4180186
40760928	用于标识结直肠癌筛查的 HEDIS 2010 代码 (COL-A):-:时间点:^患者:-	4182948
40760930	HEDIS 2010 MPM-A K	4180186
40760930	HEDIS 2010 MPM-A K; k; K+; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Potass; Random; Ser; SR	4180186
40760930	用于标识生理监测试验的 HEDIS 2010 代码 - 血清钾 (MPM-A):-:时间点:^患者:-	4182948
40760932	Document; Esophageal; Finding; Findings; Imaging; PET Scan; Point in time; Position Emmision Tomography; Positron Emission Tomography; Rad; RADIOLOGY; Radnuc.PET; Random; RN; RNC; Scan; Thorax; W RNC IV	4180186
40760932	PT Esophagus W RNC IV	4180186
40760932	多层^采用静脉注射放射性核素:发现:时间点:胸部>食管:文档型:PT	4182948
40760933	Cortis F AM peak SerPl-mCnc	4180186
40760933	17-Hydroxycorticosterone; 8 AM; 8AM; AM diurnal peak; Chemistry; circadian high; Compound F; Coritsol; Cort; Cortis F; F; FR; hydrocortisone; Level; Mass concentration; Morning; Non-protein bound; Pl; Plasma; Plsm; Point in time; Post; Postdose; Post-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Spec; SR	4180186
40760933	皮质醇.游离型^早晨峰值标本:质量浓度:时间点:血清/血浆:定量型	4182948
40760934	Cortis F PM SerPl-mCnc	4180186
40760934	12 AM; 12AM; 17-Hydroxycorticosterone; Chemistry; circadian low; Compound F; Coritsol; Cort; Cortis F; Evening; F; FR; hydrocortisone; late night specimen; Level; Mass concentration; Midnight; Non-protein bound; Pl; Plasma; Plsm; PM diurnal trough; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Spec; SR	4180186
40760934	皮质醇.游离型^晚上波谷标本:质量浓度:时间点:血清/血浆:定量型	4182948
40760935	DOC.MISC; Finding; Findings; MISC; Narrative; Point in time; Random; Report	4180186
40760935	Co-payment amount	4180186
40760935	共同支付金额:发现:时间点:^患者:叙述型	4182948
40760936	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
40760936	Reason for co-payment exemption Doc	4180186
40760936	关于豁免共同支付的原因:发现:时间点:^患者:文档型	4182948
40760940	DOC.ONT; Document; Finding; Findings; Point in time; Random; Rx; Rx for rehabilitation	4180186
40760940	Rx for rehabilitation	4180186
40760940	康复处方:发现:时间点:{环境}:文档型:{角色}	4182948
40760942	Rx for medication	4180186
40760942	DOC.ONT; Document; Finding; Findings; Point in time; Random; Rx; Rx for medication	4180186
40760942	药物处方:发现:时间点:{环境}:文档型:{角色}	4182948
40760944	Appear; Appearance; Appr; Diaf; Dialysate; Dialysis fluid; Nominal; Point in time; Random; SPEC	4180186
40760944	Appearance Dial fld	4180186
40760944	外观:外观:时间点:透析液:名义型	4182948
40760948	活化凝血时间.白陶土诱导型:时间:时间点:贫血小板血浆^对照:定量型:凝血功能分析	4182948
40760948	ACT; ACT Kaolin Ind; Activ; Activated coagulation time; Clot; Clottable; COAGULATION; Coagulation activated; Coagulation assay; Coagulation time; Contrl; Hematology; Heme; Normal; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Rate; R-time; Tilt tube	4180186
40760948	ACT Kaolin Ind Cont PPP	4180186
40760951	#; ABS; absolute; absolutes; Auto; Automated detection; Cardio; Cardiology; Cnt; Count; Count/volume; CT; Discocytes; Elec; Elect; Electr; Erthrocyte; Erythrocyte; Heart Disease; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Pcar; Pericardial fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells	4180186
40760951	RBC # Pcar Auto	4180186
40760951	红细胞:计数型浓度:时间点:心包液:定量型:自动化计数方法	4182948
40760952	RBC # Prt Auto	4180186
40760952	#; ABS; absolute; absolutes; Ascites; Ascitic fluid; Ascitis; Auto; Automated detection; Cnt; Count; Count/volume; CT; Discocytes; Elec; Elect; Electr; Erthrocyte; Erythrocyte; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells	4180186
40760952	红细胞:计数型浓度:时间点:腹膜液:定量型:自动化计数方法	4182948
40760955	#; ABS; absolute; absolutes; Auto; Automated detection; Cardio; Cardiology; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Heart Disease; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Number concentration; Number Concentration (count/vol); Pcar; Pericardial fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
40760955	WBC # Pcar Auto	4180186
40760955	白细胞:计数型浓度:时间点:心包液:定量型:自动化计数方法	4182948
40760956	#; ABS; absolute; absolutes; Cnt; Count; Count/volume; CT; Diaf; Dialysate; Dialysis fluid; HEMATOLOGY/CELL COUNTS; Kidney; Leuc; Leuk; Leukocyte; Lkcs; Manl; Nephrology; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; WBC; WBCs; White blood cell; White blood cells	4180186
40760956	WBC # Dial fld Manual	4180186
40760956	白细胞:计数型浓度:时间点:透析液:定量型:手工计数方法	4182948
40760957	Maltose Ur Ql	4180186
40760957	Chemistry; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40760957	麦芽糖:存在情况或阈值:时间点:尿液:序数型	4182948
40760958	Medication allergy Reported	4180186
40760958	H+P; H+P.HX; History; Narrative; P prime; Point in time; Random; Report	4180186
40760958	药物变态反应:历史记录:时间点:^患者:叙述型:报告法	4182948
40760959	Mesothl Cell/leuk NFr Snv Manual	4180186
40760959	100WBC; Cell; Cellularity; HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; Leuc; Leuk; Leukocyte; Lkcs; Manl; Mesothl; Mesothl Cell; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; WBC; WBCs; White blood cell; White blood cells	4180186
40760959	间皮细胞/100 个白细胞:计数型分数:时间点:滑液:定量型:手工计数方法	4182948
40760962	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SSHV; SUDS	4180186
40760962	SSHV IgG Ser Ql IA	4180186
40760962	雪鞋野兔病毒 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40760964	DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; Tenormin; To be specified in another part of the message; Unspecified	4180186
40760964	Atenolol Spec-sCnc	4180186
40760964	氨酰心安:物质的量浓度:时间点:XXX:定量型	4182948
40760966	Chlorphenir Spec-sCnc	4180186
40760966	CHL; Chlorphenamine; Chlorphenir; Chlortrimeton; Chlor-tripolon; DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Other; Piriton; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40760966	氯苯朴尔敏:物质的量浓度:时间点:XXX:定量型	4182948
40760968	D-methorphan Spec-sCnc	4180186
40760968	Dextro-methorphan; D-methorphan; DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40760968	右美沙芬:物质的量浓度:时间点:XXX:定量型	4182948
40760972	Addiction; Dihydromorphinone; Dilaudid; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Hydromorphinone; Illicit; Level; Misc; Miscellaneous; Other; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40760972	HYDROmorphone Spec-sCnc	4180186
40760972	二氢吗啡酮:物质的量浓度:时间点:XXX:定量型	4182948
40760975	Addiction; Barbiturate; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Misc; Miscellaneous; Nembutal; Other; Pentobarb; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40760975	Pentobarb Spec-sCnc	4180186
40760975	戊巴比妥:物质的量浓度:时间点:XXX:定量型	4182948
40760976	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Misc; Miscellaneous; Neulactil; Other; Periciazine; Point in time; PotentialForAbuse; Propericiazine; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40760976	Pericyazine Spec-sCnc	4180186
40760976	氰噻嗪:物质的量浓度:时间点:XXX:定量型	4182948
40760977	Perphenazine Spec-sCnc	4180186
40760977	DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Trilafon; Unspecified	4180186
40760977	奋乃静:物质的量浓度:时间点:XXX:定量型	4182948
40760978	Addiction; Angel dust; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Misc; Miscellaneous; Other; PCP; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sernylan; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40760978	PCP Spec-sCnc	4180186
40760978	苯环利定:物质的量浓度:时间点:XXX:定量型	4182948
40760979	Addiction; Dexatrim; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Misc; Miscellaneous; Norephedrine; Norephidrine; Other; Point in time; PotentialForAbuse; PPA; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40760979	PPA Spec-sCnc	4180186
40760979	去甲麻黄碱:物质的量浓度:时间点:XXX:定量型	4182948
40760980	quiNINE Spec-sCnc	4180186
40760980	DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40760980	奎宁:物质的量浓度:时间点:XXX:定量型	4182948
40760982	Thiothixene Spec-sCnc	4180186
40760982	DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Navane; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40760982	氨砜噻吨:物质的量浓度:时间点:XXX:定量型	4182948
40760985	Melon IgG4-mCnc	4180186
40760985	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f87; Honey dew; Honeydew; Level; Mass concentration; Melon; melons; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40760985	甜瓜多个未知种 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40760986	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cantalope; Cantaloup; Cantaloupe; f102; IgG RAST; Immune globulin G; Immunoglobulin G; Musk melon; Muskmelon; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rock melon; Screen; Serum; SR	4180186
40760986	罗马甜瓜 抗体.IgG.RAST 类:存在情况或阈值:时间点:血清:序数型	4182948
40760986	Deprecated Cantaloupe IgG RAST Ql	4180186
40760987	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f87; Honey dew; Honeydew; IgG RAST; Immune globulin G; Immunoglobulin G; Melon; melons; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
40760987	Deprecated Melon IgG RAST Ql	4180186
40760987	甜瓜多个未知种 抗体.IgG.RAST 类:存在情况或阈值:时间点:血清:序数型	4182948
40760991	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f87; Honey dew; Honeydew; IgE RAST; Immune globulin E; Immunoglobulin E; Melon; melons; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
40760991	Deprecated Melon IgE RAST Ql	4180186
40760991	甜瓜多个未知种 抗体.IgE.RAST 类:存在情况或阈值:时间点:血清:序数型	4182948
40760992	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cantalope; Cantaloup; Cantaloupe; f102; Immune globulin E; Immunoglobulin E; Musk melon; Muskmelon; Point in time; QNT; Quan; Quant; Quantitative; Random; Rock melon; Serum; SR	4180186
40760992	Cantaloupe IgE Qn	4180186
40760992	罗马甜瓜 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40760993	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f87; Honey dew; Honeydew; Immune globulin E; Immunoglobulin E; Melon; melons; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40760993	Melon IgE Qn	4180186
40760993	甜瓜多个未知种 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40761001	Pregnanediol 2D p Dex 24h Ur-mCnc	4180186
40761001	1 day; 24 hours; 24HR; 2D p Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Level; Mass concentration; p Dex; p dose; Pregnanedi; PST; PTL; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40761001	孕二醇^在给予剂量地塞米松之后2天:质量浓度:24小时:尿液:定量型	4182948
40761002	1 day; 24 hours; 24HR; 2D p Dex; After; c350; CHEMISTRY.CHALLENGE TESTING; Decadron; Dexameth; Dexone; Hexadrol; Mass rate; mRate; p Dex; p dose; Pregnanedi; PST; PTL; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40761002	Pregnanediol 2D p Dex 24h Ur-mRate	4180186
40761002	孕二醇^在给予剂量地塞米松之后2天:质量速率:24小时:尿液:定量型	4182948
40761004	ANTIBIOTIC SUSCEPTIBILITIES; AST; Avian influenza; Bird flu; FLUA; FLUAV; FLUAV H1; FLUAV H1 NI resis; FLUV; Fowl plague; Genotype; Genotypic; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Inhib; Inhibit; Misc; Miscellaneous; NA; Ordinal; Other; Point in time; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; To be specified in another part of the message; Unspecified	4180186
40761004	FLUAV H1 NI resis Spec Genotyp	4180186
40761004	流感病毒 A 型血凝素 H1 型.神经氨酸酶抑制剂抗性:抗生素敏感性:时间点:XXX:序数型:基因分型	4182948
40761005	ANTIBIOTIC SUSCEPTIBILITIES; AST; Avian influenza; Bird flu; FLUA; FLUAV; FLUAV 2009H1N1v NI resis; FLUV; Fowl plague; Genotype; Genotypic; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Inhib; Inhibit; Misc; Miscellaneous; NA; Ordinal; Other; Point in time; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; To be specified in another part of the message; Unspecified	4180186
40761005	FLUAV 2009H1N1v NI resis Spec Genotyp	4180186
40761005	流感病毒 A 型 2009 H1N1v.神经氨酸酶抑制剂抗性:抗生素敏感性:时间点:XXX:序数型:基因分型	4182948
40761006	A,B; ANTIBIOTIC SUSCEPTIBILITIES; AST; Avian influenza; Bird flu; FLUA; FLUAV; FLUAV + FLUBV; FLUAV+FLUBV; FLUAV+FLUBV NI resis; FLUV; Fowl plague; Genotype; Genotypic; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Inhib; Inhibit; Misc; Miscellaneous; NA; Ordinal; Other; Point in time; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; To be specified in another part of the message; Unspecified	4180186
40761006	FLUAV+FLUBV NI resis Spec Genotyp	4180186
40761006	流感病毒 A+B 型.神经氨酸酶抑制剂抗性:抗生素敏感性:时间点:XXX:序数型:基因分型	4182948
40761008	Chemistry; Endocrine; Endocrinology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; REV; Reverse T3; rT3; Rto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T3; T-3; T3Reverse; thyroid hormone; Total T3; Triodothyrne	4180186
40761008	T3/T3Reverse SerPl-Rto	4180186
40761008	三碘甲状腺原氨酸/三碘甲状腺原氨酸.反:比率:时间点:血清/血浆:定量型	4182948
40761009	Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified	4180186
40761009	标本年龄:时间:时间点:XXX:定量型	4182948
40761013	Antigen; Antigens; Bg sup(a); BLOOD BANK; Erythrocytes; Hematology; Heme; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
40761013	Bg sup(a) Ag RBC Ql	4180186
40761013	Bg^a 抗原:存在情况或阈值:时间点:红细胞:序数型	4182948
40761014	Hemoccult sp1 Stl Ql IA	4180186
40761014	Acute specimen; Bowel movement; Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; Faecal; Faeces; Fecal; Fecal occult blood; Feces; First; FIT; FOB; FOBT; Gastrocult; Gastrointest blood; GI; Guiac; Haemoglobin; Hb; Hemoccult; Hemocult; Hgb; IAA; iFOBT; Low; MEIA; Occult blood; Occult blood in stool; Ordinal; Point in time; PR; Pre immunization; QL; Qual; Qualitative; Random; Screen; sp1; Spec; Stl; Stool = Fecal; SUDS	4180186
40761014	血红蛋白.胃肠道.下段^第1个标本:存在情况或阈值:时间点:大便:序数型:免疫测定法	4182948
40761018	Autosomal dominant frontal lobe epilepsy; Blood; CHRNA2+CHRNA4+CHRNB2; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40761018	ADNFLE gene Mut Anl Bld/T	4180186
40761018	ADNFLE 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40761019	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B quintana; Cat Scratch Disease; Cat Scratch Fever; CSD; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; R quintana; Random; Rochalimae quintana; Rochalimaea quintana; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Trench fever; Unspecified	4180186
40761019	B quintana DNA Spec Ql NAA+probe	4180186
40761019	五日热巴通体 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40761020	BMZ BP230 Ab SerPl-aCnc	4180186
40761020	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Basem; Basemt; BM; BMZ; BMZ BP230; Pemphigoid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761020	基底膜带 BP230 抗体:任意型浓度:时间点:血清/血浆:定量型	4182948
40761022	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Beans; Cannellini bean; f015; f15; IgE total; Immune globulin E; Immunoglobulin E; Navy bean; Phaseolus vulgaris; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl; White Bean; White kidney bean	4180186
40761022	White Bean IgE/IgE total %	4180186
40761022	白豆 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40761024	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bumble bee; Bumblebee; Humblebee; i205; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Ri205; Serum; SR; Tot; Total IgE; Totl	4180186
40761024	Bumble Bee IgE/IgE total %	4180186
40761024	熊蜂 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40761025	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdor C6; B burgdorferi; Bb; Burgdorf; C6 Lyme Peptide; ID; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
40761025	B burgdor C6 Ab Ser Ql	4180186
40761025	伯氏疏螺旋体 C6 抗体:存在情况或阈值:时间点:血清:序数型	4182948
40761026	Budgie Drop IgG Qn	4180186
40761026	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Australian parrot; Autoantibodies; Autoantibody; Budgeriar; Budgie; Budgie Drop; e77; Feces; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; stool	4180186
40761026	虎皮鹦鹉粪便 抗体.IgG:任意型浓度:时间点:血清:定量型	4182948
40761027	Blood; Genetics; Heredity; Heritable; HOKPP2; HYKPP; HYPP; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Na(V)1.4; NAC1A; Nav1.4; Nominal; PCR; Point in time; Random; SkM1; sodium channel, voltage gated, type IV alpha subunit; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40761027	CACNA1S+SCN4A gene Mut Anl Bld/T	4180186
40761027	CACNA1S+SCN4A 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40761029	Bld mixed venous; Blood - mixed venous; Calc; Calculation; Carbonic anhydride; cCO2; Chemistry; CO2; CO2 TOTAL; CO2CT; ctCO2; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; tCO2	4180186
40761029	CO2 BldMV Calc-sCnc	4180186
40761029	二氧化碳:物质的量浓度:时间点:混合静脉全血:定量型:计算法	4182948
40761030	CO2 BldCoA Calc-sCnc	4180186
40761030	Bld cord; Calc; Calculation; Carbonic anhydride; cCO2; Chemistry; CO2; CO2 TOTAL; CO2CT; Cord arterial blood; Cord BldA; ctCO2; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; tCO2	4180186
40761030	二氧化碳:物质的量浓度:时间点:脐带动脉全血:定量型:计算法	4182948
40761032	CO2 BldCoV Calc-sCnc	4180186
40761032	Bld cord; Calc; Calculation; Carbonic anhydride; cCO2; Chemistry; CO2; CO2 TOTAL; CO2CT; Cord BldV; Cord venous blood; ctCO2; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; tCO2	4180186
40761032	二氧化碳:物质的量浓度:时间点:脐带静脉全血:定量型:计算法	4182948
40761033	11-nor-9-carboxy-delta-9-THC; 11-nor-9-carboxy-THC; 11-nor-delta-9-THC-9-COOH; 9-carboxy-11-nor-delta-9-tetrahydrocannabinol; Addiction; Carboxytetrahydrocannabinol; CarboxyTHC; Carboxy-THC-delta-9; Delta(9)-THC; Delta-9-tetrahydrocannabinol; Delta-9-tetrahydrocannabinol metabolite; Dronabinol; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Marijuana; Mec; Nabilone; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; THC; THCA; THCC; THCCOOH; THC-COOH	4180186
40761033	CarboxyTHC Mec Ql	4180186
40761033	羧基四氢大麻酚:存在情况或阈值:时间点:胎便:序数型	4182948
40761034	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chestnut; European chestnut; f299; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Sweet chestnut; Tot; Total IgE; Totl	4180186
40761034	Chestnut IgE/IgE total %	4180186
40761034	欧洲板栗 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40761035	Blood; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40761035	CDKN2A+CDK4 gene Mut Anl Bld/T	4180186
40761035	CDKN2A+CDK4 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40761041	Chocolate IgE/IgE total %	4180186
40761041	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f052; f52; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40761041	巧克力 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40761043	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; HDLc; HDL-C; HDLc 3a; Heart Disease; High density lipoprotein cholesterols; Level; Lipid; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TCHHDL	4180186
40761043	HDLc 3a SerPl-mCnc	4180186
40761043	胆固醇.HDL 3a 之中的:质量浓度:时间点:血清/血浆:定量型	4182948
40761046	Watermelon IgE/IgE total %	4180186
40761046	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Citrullus vulgaris; f029; f29; f329; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf329; Serum; SR; Tot; Total IgE; Totl; Watermelon	4180186
40761046	西瓜 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40761047	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f306; IgE total; Immune globulin E; Immunoglobulin E; Lime; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf306; Serum; SR; Tot; Total IgE; Totl	4180186
40761047	Lime IgE/IgE total %	4180186
40761047	来檬 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40761048	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Hormodendrum; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; species; spp; SR	4180186
40761048	Cladosporium IgG4-mCnc	4180186
40761048	枝孢属单个未知种 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40761051	Cocaine/Ethanol By-Product; DRUG/TOXICOLOGY; Drugs; Mec; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
40761051	Cocaethylene Mec Ql	4180186
40761051	古柯乙烯:存在情况或阈值:时间点:胎便:序数型	4182948
40761054	Collagen CTx 24h Ur-mCnc	4180186
40761054	1 day; 24 hours; 24HR; Beta crosslaps; Carboxyterminal cross-linking telopeptide of bone collagen; Chemistry; Collagen CTx; CrossLaps; C-Telopeptide of Type I Collagen; CTx; Level; Mass concentration; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40761054	胶原交联 C-末端肽:质量浓度:24小时:尿液:定量型	4182948
40761057	Blood; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40761057	CPVT1 gene Mut Anl Bld/T	4180186
40761057	CPVT1 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40761058	Melon IgE/IgE total %	4180186
40761058	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f87; Honey dew; Honeydew; IgE total; Immune globulin E; Immunoglobulin E; Melon; melons; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40761058	甜瓜多个未知种 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40761059	Ethisterone Ur Ql	4180186
40761059	Danazol ethisterone metabolite; Danazol metabolite; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40761059	伦理学小节:存在情况或阈值:时间点:尿液:序数型	4182948
40761063	Difenacoum SerPl-mCnc	4180186
40761063	4-Hydroxycoumarin; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rodenticide; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761063	鼠得克:质量浓度:时间点:血清/血浆:定量型	4182948
40761064	Arbitrary; Blood; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40761064	DPYD2A gene Mut Anl Bld/T Ql	4180186
40761064	DPYD2A 基因 突变分析:任意型:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40761065	Drostanolone Ur Ql	4180186
40761065	DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40761065	羟甲雄酮:存在情况或阈值:时间点:尿液:序数型	4182948
40761066	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Discocytes; Erthrocyte; Erythrocyte; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Morphology; Nominal; Point in time; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells	4180186
40761066	RBC Fld Micro	4180186
40761066	红细胞:形态学属性:时间点:体液:名义型:显微镜检查.光学	4182948
40761068	Blood; EPP; FCE; ferrochelatase; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40761068	FECH gene Mut Anl Bld/T	4180186
40761068	FECH 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40761069	BHD; BHD skin lesion fibrofolliculoma protein; Birt-Hogg-Dube syndrome protein; Blood; DKFZp547A118; FLCL; FLJ45004; FLJ99377; Folliculin; Genetics; Heredity; Heritable; Identity or presence; Inherited; MGC17998; MGC23445; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40761069	FLCN gene Mut Anl Bld/T	4180186
40761069	FLCN 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40761070	Formebolone metab Ur Ql	4180186
40761070	DRUG/TOXICOLOGY; Drugs; Metab; Metabolites; Metb; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40761070	甲酰勃龙代谢产物:存在情况或阈值:时间点:尿液:序数型	4182948
40761071	908; ANTIBIOTIC SUSCEPTIBILITIES; AST; FPV; GW433908; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Lexiva; Norvir; Pheno; Phenotype; Phenotypic; Point in time; Random; RTV; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Telzir; Virtual Phenotype	4180186
40761071	Fosamprenavir+Ritonavir Islt Phenotyp	4180186
40761071	夫沙那韦+利托那韦:抗生素敏感性:时间点:分离株:定量型或序数型:表现型分型	4182948
40761072	Furazabol metab Ur Ql	4180186
40761072	Androfurazanol; DRUG/TOXICOLOGY; Drugs; Metab; Metabolites; Metb; Methyl hydroxy nandrolone; Methylhydroxynandrolone; MHN; Miotolan; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40761072	夫拉扎勃代谢产物:存在情况或阈值:时间点:尿液:序数型	4182948
40761073	Galactitol Ur Ql	4180186
40761073	Chemistry; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40761073	半乳糖醇:存在情况或阈值:时间点:尿液:序数型	4182948
40761074	GD1a Gangl IgG Ser Ql	4180186
40761074	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Disialolganglioside; GD1a; GD1a Gangl; Immune globulin G; Immunoglobulin G; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
40761074	神经节苷脂 GD1a 抗体.IgG:存在情况或阈值:时间点:血清:序数型	4182948
40761082	ABS; Aby; AIDS; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; HIV type 2; HIV type II; Human immunodeficiency virus; ID; II; Immune blot; Immunobl; Immunoblot; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40761082	HIV 2 gp140 Ab Ser Ql IB	4180186
40761082	HIV 2 gp140 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40761084	ABS; Aby; AIDS; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; HIV type 2; HIV type II; Human immunodeficiency virus; ID; II; Immune blot; Immunobl; Immunoblot; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40761084	HIV 2 p34 Ab Ser Ql IB	4180186
40761084	HIV 2 p34 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40761085	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40761085	HLA-B*15:02 Ql	4180186
40761085	HLA-B*15:02:存在情况或阈值:时间点:全血/组织:序数型	4182948
40761087	Addiction; Anexsia; Dihydrocodeinone; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Mec; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Vicodin	4180186
40761087	HYDROcodone Mec Ql	4180186
40761087	氢可酮:存在情况或阈值:时间点:胎便:序数型	4182948
40761088	HYDROmorphone Mec Ql	4180186
40761088	Addiction; Dihydromorphinone; Dilaudid; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Hydromorphinone; Illicit; Mec; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen	4180186
40761088	二氢吗啡酮:存在情况或阈值:时间点:胎便:序数型	4182948
40761091	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV H2; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40761091	FLUAV H2 RNA Spec Ql NAA+probe	4180186
40761091	流感病毒 A 型血凝素 H2 型 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40761092	IGF sp1 p chal SerPl-mCnc	4180186
40761092	Acute specimen; After; CHEMISTRY.CHALLENGE TESTING; Fac; Fact; First; HUM; Humulin; IGF; IH7; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; Pre immunization; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; sp1; sp1 p chal; Spec; SR; Ultralente	4180186
40761092	胰岛素样生长因子^在XXX刺激之后的第1个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761095	Blood; CAM; CCM1; Genetics; Heredity; Heritable; Identity or presence; Inherited; KRIT1, ankyrin repeat containing; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40761095	KRIT1 gene Mut Anl Bld/T	4180186
40761095	KRIT1 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40761096	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40761096	Lactalb IgE/IgE total %	4180186
40761096	乳白蛋白 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40761097	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; i; ID; III; Infectious Disease; InfectiousDisease; L pneumo; L pneumo 1+3+4+5+6+8; L pneumo1; L pneumonphila; Legion; Legionela; Legionella pneumophila serogroup 1; Microbiology; Ordinal; Philadelphia 1; Pneu; pneum; Pneumophilia; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
40761097	L pneumo 1+3+4+5+6+8 Ab Ser Ql	4180186
40761097	嗜肺军团菌 1+3+4+5+6+8 型 抗体:存在情况或阈值:时间点:血清:序数型	4182948
40761098	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; d071; d71; IgE total; Immune globulin E; Immunoglobulin E; L destructor; Mite; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Storage mite; Tot; Total IgE; Totl	4180186
40761098	L destructor IgE/IgE total %	4180186
40761098	害嗜鳞螨 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40761099	2-aminopropanoic acid; ALA; Alpha alanine; Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; L-alanine; Leu; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40761099	Leucine/Alanine DBS	4180186
40761099	亮氨酸/丙氨酸:质量比率:时间点:全血.斑点:定量型	4182948
40761100	Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Leu; Mass concentration ratio; Mass ratio; MCRto; Phe; PKU; Point in time; PPA; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40761100	Leucine/Phe DBS	4180186
40761100	亮氨酸/苯丙氨酸:质量比率:时间点:全血.斑点:定量型	4182948
40761101	Leu+Ile DBS-mCnc	4180186
40761101	Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Ile; Leu; Leu+Ile; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40761101	亮氨酸+异亮氨酸:质量浓度:时间点:全血.斑点:定量型	4182948
40761102	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Kaletra; LPV; LPV/r; Norvir; Pheno; Phenotype; Phenotypic; Point in time; Random; RTV; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Virtual Phenotype	4180186
40761102	Lopinavir+Ritonavir Islt Phenotyp	4180186
40761102	洛匹那韦+利托那韦:抗生素敏感性:时间点:分离株:定量型或序数型:表现型分型	4182948
40761103	Chemistry; Fld.NB; Level; MAG; Magnes; Mass concentration; Mg; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40761103	Magnesium Fld.NB-mCnc	4180186
40761103	镁:质量浓度:时间点:液体.非生物性:定量型	4182948
40761108	DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40761108	Methylandrostenediol Ur Ql	4180186
40761108	甲基雄烯二醇:存在情况或阈值:时间点:尿液:序数型	4182948
40761111	DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40761111	Mibolerone Ur Ql	4180186
40761111	米勃龙:存在情况或阈值:时间点:尿液:序数型	4182948
40761113	Blood; CD110; C-MPL; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; MPL p.W515; MPL proto-oncogene, thrombopoietin receptor; MPLV; MYELOPROLIFERATIVE LEUKEMIA VIRUS ONCOGENE; Ordinal; P prime; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; THCYT2; thrombopoietin receptor mutations; Tissue; Tissue, unspecified; TPOR; Trp515Leu; Trp515Lys; WB; Whole blood; Whole blood or Tissue	4180186
40761113	MPL p.W515 Bld/T Ql	4180186
40761113	MPL 基因.p.W515:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40761114	BAT-26; Blood; COCA1; COCA2; Colon cancer nonpolyposis type 1; FCC1; FCC2; G/T mismatch-binding protein gene; Genetics; GTBP; GTMBP; Hereditary Nonpolyposis Colorectal Cancer; Heredity; Heritable; hMLH1; HNPCC; HNPCC1; HNPCC2; HNPCC5; HSAP; Identity or presence; Inherited; LCFS2; Lynch syndrome; MGC5172; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; MSH2+MLH1 gene; MSH2+MLH1+MSH6 gene; Mut; Mut Anl; Mutations; mutL homolog 1; MutL homolog 1, colon cancer, nonpolyposis type 2; mutS homolog 2; mutS homolog 6; Nominal; p160; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40761114	MSH2+MLH1+MSH6 gene Mut Anl Bld/T	4180186
40761114	MSH2 基因+MLH1 基因+MSH6 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40761115	Myelin IgG Ser Ql IF	4180186
40761115	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF	4180186
40761115	髓磷脂 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40761116	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Tysabri	4180186
40761116	Natalizumab Ab Ser Ql	4180186
40761116	那他珠单抗 抗体:存在情况或阈值:时间点:血清:序数型	4182948
40761120	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761120	Octreotide SerPl-mCnc	4180186
40761120	奥曲肽:质量浓度:时间点:血清/血浆:定量型	4182948
40761124	APKD2; Blood; Document; Finding; Findings; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; PC2; Pc-2; PCR; PKD4; Point in time; Polycystic kidney disease 2; polycystic kidney disease 2 (autosomal dominant); Random; Tissue; Tissue, unspecified; TRPP2; WB; Whole blood; Whole blood or Tissue	4180186
40761124	PKD2 gene Mut Anl Bld/T	4180186
40761124	PKD2 基因 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
40761127	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Lyssavirus; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Rabies; RABV; Random; Serum; SR	4180186
40761127	RABV IgG Ser-aCnc	4180186
40761127	狂犬病病毒 抗体.IgG:任意型浓度:时间点:血清:定量型	4182948
40761128	ANTIBIOTIC SUSCEPTIBILITIES; AST; Fortovase; ID; Infectious Disease; InfectiousDisease; Invirase; Islt; Isol; Norvir; Pheno; Phenotype; Phenotypic; Point in time; Random; RTV; SQV; SQV/r; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Virtual Phenotype	4180186
40761128	Saquinavir+Ritonavir Islt Phenotyp	4180186
40761128	沙奎那韦+利托那韦:抗生素敏感性:时间点:分离株:定量型或序数型:表现型分型	4182948
40761131	DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40761131	Testolactone Ur Ql	4180186
40761131	睾内酯:存在情况或阈值:时间点:尿液:序数型	4182948
40761132	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40761132	Tetrahydrogestrinone Ur Ql	4180186
40761132	四氢孕三烯酮:存在情况或阈值:时间点:尿液:序数型	4182948
40761139	Blueberry IgG-mCnc	4180186
40761139	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blue berry; Blueberry; f288; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf288; Serum; SR	4180186
40761139	蓝莓 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40761142	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40761142	Gestrinone Ur Ql	4180186
40761142	孕三烯酮:存在情况或阈值:时间点:尿液:序数型	4182948
40761143	BM; BON; Bone marrow; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Nominal; Point in time; Random; Sequence based typing; Typ	4180186
40761143	HLA-B SBT Mar High Res	4180186
40761143	HLA-B 基于序列的分型:类型:时间点:骨髓:名义型:高分辨率方法	4182948
40761144	DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40761144	Norclostebol Ur Ql	4180186
40761144	诺司替勃:存在情况或阈值:时间点:尿液:序数型	4182948
40761145	Addiction; Angel dust; Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Ordinal; PCP; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Sernylan; WB; Whole blood	4180186
40761145	PCP Bld Ql Cfm	4180186
40761145	苯环利定:存在情况或阈值:时间点:全血:序数型:毒理学确认试验	4182948
40761149	S stercoralis Ab Titr Ser	4180186
40761149	粪类圆线虫 抗体:滴定度:时间点:血清:定量型	4182948
40761149	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; S stercoralis; Serum; SmQn; SR; Strongyloidiasis; Titer; Titered; Titre; Ttr	4180186
40761153	Centers for Medicare and Medicaid Assessment; II; Isolated; Point in time; pressure injury; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey; Ulcer	4180186
40761155	Ch sup(a) Ab SerPl Ql	4180186
40761155	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; C (little h)(little a); Ch sup(a); Ch^a; Ch1; Chido; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761155	Ch^a 抗体:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40761157	Antigen; Antigens; BLOOD BANK; Co sup(b); Co^b; Colton Blood Group System; Erythrocytes; Hematology; Heme; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
40761157	Co sup(b) Ag RBC Ql	4180186
40761157	Co^b 抗原:存在情况或阈值:时间点:红细胞:序数型	4182948
40761158	Cs sup(a) Ab SerPl Ql	4180186
40761158	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Cs sup(a); Cs^a; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; s; S prime; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761158	Cs^a 抗体:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40761160	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Dextro; Do sup(b); Do^b; Dombrock; Dombrock Blood Group System; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761160	Do sup(b) Ab SerPl Ql	4180186
40761160	Do^b 抗体:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40761163	Antigen; Antigens; BLOOD BANK; Erythrocytes; Hematology; Heme; In sup (b); In^b; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
40761163	In sup (b) Ag RBC Ql	4180186
40761163	In^b 抗原:存在情况或阈值:时间点:红细胞:序数型	4182948
40761166	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Jr sup(a); Jr^a; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; R prime; Random; Right; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761166	Jr sup(a) Ab SerPl Ql	4180186
40761166	Jr^a 抗体:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40761169	Kn sup (b) Ab SerPl Ql	4180186
40761169	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Kell Blood Group System; Kn sup (b); Kn^b; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761169	Kn^b 抗体:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40761170	Antigen; Antigens; BLOOD BANK; Erythrocytes; Hematology; Heme; Kn sup (b); Kn^b; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
40761170	Kn sup (b) Ag RBC Ql	4180186
40761170	Kn^b 抗原:存在情况或阈值:时间点:红细胞:序数型	4182948
40761171	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; c; McC sup(a); McC^a; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761171	McC sup(a) Ab SerPl Ql	4180186
40761171	McC^a 抗体:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40761172	Antigen; Antigens; BLOOD BANK; Erythrocytes; Hematology; Heme; Ordinal; Point in time; PR; QL; Qual; Qualitative; R prime; Random; Red blood cells; Red blood corpusles; Rg; Rg sup(a); Rg^a; Rh1; Right; Rodgers; Rogers; Screen	4180186
40761172	Rg sup(a) Ag RBC Ql	4180186
40761172	Rg^a 抗原:存在情况或阈值:时间点:红细胞:序数型	4182948
40761173	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; R prime; Random; Rg; Rg sup(a); Rg^a; Rh1; Right; Rodgers; Rogers; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761173	Rg sup(a) Ab SerPl Ql	4180186
40761173	Rg^a 抗体:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40761174	Antigen; Antigens; BLOOD BANK; Erythrocytes; Hematology; Heme; Ordinal; Point in time; PR; QL; Qual; Qualitative; R prime; Random; Red blood cells; Red blood corpusles; Right; Screen; Wr sup(a); Wr^a	4180186
40761174	Wr sup(a) Ag RBC Ql	4180186
40761174	Wr^a 抗原:存在情况或阈值:时间点:红细胞:序数型	4182948
40761175	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; R prime; Random; Right; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Wr sup(a); Wr^a	4180186
40761175	Wr sup(a) Ab SerPl Ql	4180186
40761175	Wr^a 抗体:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40761179	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761179	IH Ab SerPl Ql	4180186
40761179	IH 抗体:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40761183	Antigen; Antigens; BLOOD BANK; Erythrocytes; Hematology; Heme; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
40761183	Vel Ag RBC Ql	4180186
40761183	Vel 抗原:存在情况或阈值:时间点:红细胞:序数型	4182948
40761184	Antigen; Antigens; BLOOD BANK; Erythrocytes; Hematology; Heme; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
40761184	Vw Ag RBC Ql	4180186
40761184	Vw 抗原:存在情况或阈值:时间点:红细胞:序数型	4182948
40761185	Vw Ab SerPl Ql	4180186
40761185	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761185	Vw 抗体:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40761186	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; PCN; Pen; Penicillin Parenteral; Penicilloyl; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Wycillin	4180186
40761186	Penicillin Parenteral Susc Islt	4180186
40761186	青霉素.胃肠外:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
40761187	Deprecated Other Ab SerPl Ql Warm Abs	4180186
40761187	ABS; Absorp; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Ordinal; Other; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761190	Blood; Chemistry; DBS; Dehydrog; Dehyrdogenase; Dried blood spot; Filter paper; FP; G6PD; G-6-PD; G6PDH; Glu; Gluc; Glucose-6-PD; Glucose-6-PDH; Glucoseur; GPD; Hematology; Heme; i Phos; Impression; Impression/interpretation of study; Impressions; Inorganic phosphate; Interp; Interpretation; Narrative; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; Random; Report; WB; Whole blood	4180186
40761190	G6PD DBS-Imp	4180186
40761190	葡萄糖-6-磷酸脱氢酶:印象:时间点:全血.斑点:叙述型	4182948
40761193	Acyl carnitine; Acylcarni; Acylcarnitine NBS pnl; Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Gyn; Gynecology; New born; OB; ObGyn; Obstetrics; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Scn; Scr; Scrn; WB; Whole blood	4180186
40761193	Acylcarnitine NBS pnl DBS	4180186
40761193	酰基肉碱新生儿筛查组套:-:时间点:全血.斑点:-	4182948
40761194	Acyl carnitine; Acylcarni; Acylcarnitine NBS comment; Asympt; Asymptomatic; Blood; Chemistry; cmmt; cmnt; Com; Comm; Comments; Commt; DBS; Dried blood spot; Filter paper; FP; Narrative; NBS comment; New born; Point in time; Random; Remarks; Report; Scn; Text; WB; Whole blood	4180186
40761194	Acylcarnitine NBS comment	4180186
40761194	酰基肉碱 新生儿筛查注释-讨论:文本型属性:时间点:全血.斑点:叙述型	4182948
40761197	# pressure ulcers present upon admission/reentry - stage 2; Cnt; Count; II; No; Num; Number; Outcome and assessment information set; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; Survey.OASIS	4180186
40761198	# pressure ulcers present upon admission/reentry - stage 3; Cnt; Count; III; No; Num; Number; Outcome and assessment information set; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; Survey.OASIS	4180186
40761199	# pressure ulcers present upon admission/reentry - stage 4; Cnt; Count; No; Num; Number; Outcome and assessment information set; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; Survey.OASIS	4180186
40761200	# pressure ulcers present upon admission/reentry - unstageable due to non-removable dressing; Cnt; Count; No; Num; Number; Outcome and assessment information set; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; Survey.OASIS	4180186
40761201	# pressure ulcers present upon admission/reentry - unstageable due to coverage of wound bed by slough/eschar; Cnt; Count; No; Num; Number; Outcome and assessment information set; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; Survey.OASIS	4180186
40761202	# pressure ulcers present upon admission/reentry - unstageable with suspected deep tissue injury in evolution; Cnt; Count; No; Num; Number; Outcome and assessment information set; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; Survey.OASIS; Ulcer	4180186
40761206	Financing and insurance; Finding; Findings; Nominal; Othr; Outcome and assessment information set; Payers; Point in time; Random; Survey; Survey.OASIS	4180186
40761207	Disch; Nominal; Othr; Outcome and assessment information set; Point in time; Random; Survey; Survey.OASIS; Typ	4180186
40761209	Centers for Medicare and Medicaid Assessment; Disch; Entry/discharge reporting; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
40761211	Finding; Findings; Lower extremity; MDS version 3; Ordinal; Othr; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40761212	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40761214	Dis; Diseases; Dz; Finding; Findings; Huntington's disease Multiple sclerosis in last 7D; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.MDS	4180186
40761217	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40761220	Finding; Findings; MDS version 3; Oral/dent status; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761222	Activities of Daily Living; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Prior Functioning ADL/IADL; Random; Survey	4180186
40761223	Finding; Findings; i; MDS version 3; Ordinal; Point in time; Pressure ulcer; Pressure Ulcers; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761226	Finding; Findings; Lower extremity; MDS version 3; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.MDS	4180186
40761227	#days injection of any type were received in last 5D or since admission &or reentry if less than 7D; Cnt; Count; Dextro; Inj; MDS version 3; No; Num; Number; Past; QNT; Quan; Quant; Quantitative; Survey; SURVEY.MDS	4180186
40761229	#days the physician changed the resident's insulin orders in last 7D or since admission &or reentry if less than 7D; Centers for Medicare and Medicaid Assessment; Count/time; Dextro; HUM; Humulin; IH7; Insul; Lente; No; NPH; nRate; Num; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; S prime; Semilente; Sliding; Survey; Ultralente	4180186
40761231	Finding; Findings; MDS version 3; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.MDS	4180186
40761232	Flu vaccine date	4180186
40761232	CLIN; Flu vaccine date; Immunizations; Point in time; QNT; Quan; Quant; Quantitative; Random; Vaccine	4180186
40761232	流行性感冒疫苗接种日期:日期:时间点:^患者:定量型	4182948
40761233	MDS version 3; Pan; Panel; Panl; Path; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40761235	Centers for Medicare and Medicaid Assessment; Past; Path; QNT; Quan; Quant; Quantitative; Survey	4180186
40761237	Centers for Medicare and Medicaid Assessment; OT; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
40761238	Centers for Medicare and Medicaid Assessment; OT; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
40761239	MDS version 3; Pan; Panel; Panl; Pnl; Point in time; PT; Random; Survey; SURVEY.MDS	4180186
40761240	Centers for Medicare and Medicaid Assessment; Past; PT; QNT; Quan; Quant; Quantitative; Survey	4180186
40761245	Finding; Findings; MDS version 3; Nominal; Point in time; Random; S prime; Survey; SURVEY.MDS	4180186
40761247	Centers for Medicare and Medicaid Assessment; Disch; Discharge planning in place for return to community; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40761248	Disch; Finding; Findings; MDS version 3; Nominal; Point in time; Random; Survey; SURVEY.MDS	4180186
40761249	Finding; Findings; MDS version 3; Nominal; Point in time; Random; Survey; SURVEY.MDS	4180186
40761251	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
40761252	BIMS; BIMS summary score; MDS version 3; Point in time; Prior assessment BIMS summary score; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MDS	4180186
40761253	MDS version 3; Mental health; MentalHealth; Patient Health Questionnaire; PHQ9; Point in time; Psych; Psychiatry; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MDS; Tot; Totl	4180186
40761256	MDS version 3; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40761257	MDS version 3; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40761259	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761262	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761263	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761264	Activities of Daily Living; Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761265	Activities of Daily Living; Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761266	Cath; Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761271	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761272	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS; Sx	4180186
40761273	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS; Sx	4180186
40761274	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761275	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761278	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761280	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761281	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761283	Finding; Findings; Fld; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761284	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761285	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761286	Finding; Findings; MDS version 3; Ordinal; Point in time; pressure injury; Pressure ulcer; Pressure Ulcers; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS; Ulcer	4180186
40761290	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761292	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761298	Correctn; MDS version 3; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40761303	MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS; Typ	4180186
40761304	MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS; Typ	4180186
40761306	MDS version 3; Nominal; Othr; Point in time; Random; Survey; SURVEY.MDS; Typ	4180186
40761307	MDS version 3; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40761309	Finding; Findings; MDS version 3; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761311	Centers for Medicare and Medicaid Assessment; Nominal; Point in time; Random; Survey; Typ	4180186
40761314	Centers for Medicare and Medicaid Assessment; Nominal; Point in time; Random; Resource Utilization Groups; Survey; Typ	4180186
40761316	i; MDS version 3; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40761317	Dpth; III; Injury; Length; MDS version 3; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.MDS	4180186
40761320	Centers for Medicare and Medicaid Assessment; OT; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
40761323	Disch; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.MDS	4180186
40761326	FCN; Finding; Findings; Func; Funct; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761327	FCN; Finding; Findings; Func; Funct; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761329	Finding; Findings; Lower extremity; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MDS	4180186
40761330	Weight when spec taken Measured	4180186
40761330	Bdy weight; bod; Bodies; CLIN; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; when spec taken; Wt	4180186
40761330	体重^采集标本时:质量:时间点:^患者:定量型:测量法	4182948
40761331	Acer; Asympt; Asymptomatic; Blood; Chemistry; cmmt; cmnt; Com; Comm; Comments; Commt; DBS; Dis; Diseases; Dried blood spot; Dz; f377; Filter paper; FP; Gyn; Gynecology; MSUD; MSUD NBS comment; Narrative; NBS comment; New born; OB; ObGyn; Obstetrics; Point in time; Random; Remarks; Report; Scn; Text; WB; Whole blood	4180186
40761331	MSUD NBS comment	4180186
40761331	槭糖浆尿病 新生儿筛查注释-讨论:文本型属性:时间点:全血.斑点:叙述型	4182948
40761335	PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40761335	创伤或操作的日期:日期:时间点:^患者:定量型	4182948
40761336	Nominal; PhenX; Point in time; Random; Typ	4180186
40761336	创伤或操作的类型:类型:时间点:^患者:名义型	4182948
40761340	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Prof; Random	4180186
40761345	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40761348	Abd; Abdo; Abdomen; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40761349	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40761350	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40761353	Non-cardiac origin discomfort/pain dx	4180186
40761353	Arterial Stenosis; Finding; Findings; Non-cardiac origin discomfort/pain dx; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761353	被诊断具有非心脏源性的不适或疼痛:发现:时间点:^患者:序数型	4182948
40761357	Dis; Diseases; Dz; Evid hem disease during hospit; Finding; Findings; Hospitalization hx; Nominal; PhenX; Point in time; Random	4180186
40761357	Evid hem disease during hospit	4180186
40761357	关于此次住院治疗过程中溶血性疾病的证据:发现:时间点:^患者:名义型	4182948
40761358	Enz; Enzyme; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Surg; Trauma/surgical proc/rhabdomyolysis	4180186
40761358	Trauma/surgical proc/rhabdomyolysis	4180186
40761358	提及在心肌酶测定前1个星期之内参与者存在创伤、外科手术操作或者横纹肌溶解:发现:时间点:^患者:序数型	4182948
40761360	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761360	胸痛:发现:时间点:^患者:序数型	4182948
40761361	Enz; Enzyme; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761361	心肌酶类:发现:时间点:^患者:序数型	4182948
40761363	Claudication or PAD	4180186
40761363	Claudication or PAD; Dis; Diseases; Dz; Finding; Findings; Ordinal; Periph; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761363	医生曾经告诉您患有跛行或外周动脉疾病:发现:时间点:^患者:序数型	4182948
40761364	Angiography for claudication or PAF	4180186
40761364	Angiography for claudication or PAF; Dis; Diseases; Dz; Finding; Findings; Ordinal; Periph; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761364	曾经因为跛行或外周动脉疾病而接受过血管造影术:发现:时间点:^患者:序数型	4182948
40761365	Angioplasty for claudication or PAD	4180186
40761365	Angioplasty for claudication or PAD; Dis; Diseases; Dz; Finding; Findings; Ordinal; Periph; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761365	曾经因为跛行或外周动脉疾病而接受过血管成形术:发现:时间点:^患者:序数型	4182948
40761366	Bld flow; Dis; Diseases; Dynamic; Dz; Finding; Findings; Ordinal; Periph; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Surg; Surgery to improve blood flow legs	4180186
40761366	Surgery to improve blood flow legs	4180186
40761366	曾经因为跛行或外周动脉疾病而接受过旨在改善腿部血流的外科手术:发现:时间点:^患者:序数型	4182948
40761371	ER visit/hospital/saw doctor for AF	4180186
40761371	ER visit/hospital/saw doctor for AF; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761371	因心房颤动而急诊室就诊或住院治疗或看医生:发现:时间点:^患者:序数型	4182948
40761373	Y perm pacemaker inserted	4180186
40761373	PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random; Y perm pacemaker inserted	4180186
40761373	永久性起搏器插入年份:日期:时间点:^患者:定量型	4182948
40761374	Anticoagulants for treatment of AF	4180186
40761374	Anticoagulants for treatment of AF; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Tx	4180186
40761374	服用任何旨在治疗心房颤动的抗凝血剂:发现:时间点:^患者:序数型	4182948
40761381	Source of evidence DVT Dx	4180186
40761381	DVT; DVT Dx; Dx; Finding; Findings; Nominal; PhenX; Point in time; Random; Source of evidence DVT Dx; Srce; Ven; Venous	4180186
40761381	深部静脉血栓形成诊断基于:发现:时间点:^患者:名义型	4182948
40761382	DVT Dx reporting source	4180186
40761382	DVT; DVT Dx; DVT Dx reporting source; Dx; Finding; Findings; Nominal; PhenX; Point in time; Random; Srce; Ven; Venous	4180186
40761382	深部静脉血栓形成诊断报告来源:发现:时间点:^患者:名义型	4182948
40761384	PE requiring hospitalization	4180186
40761384	Finding; Findings; Hospitalization hx; Nominal; PE requiring hospitalization; PhenX; Point in time; Pulm; Random	4180186
40761384	需要住院治疗的肺栓塞:发现:时间点:^患者:名义型	4182948
40761385	Date of pulmonary embolus Dx	4180186
40761385	Date of pulmonary embolus Dx; Dx; PE; PhenX; Point in time; Pulm; QNT; Quan; Quant; Quantitative; Random	4180186
40761385	肺栓塞诊断日期:日期:时间点:^患者:定量型	4182948
40761386	DVT Dx category	4180186
40761386	DVT; DVT Dx; DVT Dx category; Dx; Finding; Findings; Nominal; PhenX; Point in time; Random; Ven; Venous	4180186
40761386	深部静脉血栓形成诊断类别:发现:时间点:^患者:名义型	4182948
40761388	Rheumatic fever	4180186
40761388	Finding; Findings; Nominal; PhenX; Point in time; Random	4180186
40761388	医生曾经告诉您患有风湿热:发现:时间点:^患者:名义型	4182948
40761392	Family ever have a heart attack/MI; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761392	Family ever have a heart attack/MI	4180186
40761392	母亲、父亲、亲姐妹、亲兄弟、女儿或儿子曾经患有心脏病发作或者心肌梗死:发现:时间点:^患者:序数型	4182948
40761393	Chol; Choles; Cholest; Cholesterol total; Cholesterols; Finding; Findings; Hgh blood cholesterol; Lipid; nursing; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761393	Hgh blood cholesterol	4180186
40761393	医生或护士曾经告诉您患有高胆固醇血症:发现:时间点:^患者:序数型	4182948
40761394	Chol; Choles; Cholest; Cholesterol total; Cholesterols; Finding; Findings; High cholest med; Lipid; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761394	High cholest med	4180186
40761394	服用过针对高血胆固醇的药物:发现:时间点:^患者:序数型	4182948
40761398	BP; Dx; Dx high BP- pregnancy only; Finding; Findings; Gestation; Gestations; Gravida; Ordinal; PhenX; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen	4180186
40761398	Dx high BP- pregnancy only	4180186
40761398	仅发生在妊娠期间的高血压诊断:发现:时间点:^患者:序数型	4182948
40761402	High BP WO toxemia during pregnancy	4180186
40761402	BP; Finding; Findings; Gestation; Gestations; Gravida; High BP WO toxemia during pregnancy; Ordinal; PhenX; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen	4180186
40761402	在此次妊娠期间不伴随毒血症的血压高:发现:时间点:^患者:序数型	4182948
40761403	Rheumatic heart or heart valve problems	4180186
40761403	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761403	医生曾经告诉您患有风湿性心脏或心脏瓣膜问题:发现:时间点:^患者:序数型	4182948
40761406	Chest discomf W exertion/excitement	4180186
40761406	Chest discomf W exertion/excitement; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761406	用力或兴奋时胸部不适:发现:时间点:^患者:序数型	4182948
40761407	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761407	安静或静息时胸部不适:发现:时间点:^患者:序数型	4182948
40761408	PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40761408	胸部不适发作日期:日期:时间点:^患者:定量型	4182948
40761410	Durat; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40761410	胸部不适的最长持续时间:时间:时间点:^患者:定量型	4182948
40761412	Anatomy; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761412	胸部不适的放射:解剖学:时间点:^患者:序数型	4182948
40761413	Count/time; Freq (past Mo) of chest discomf; Last; month; No; nRate; Num; Number rate; Number Rate = Count/Time; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40761413	Freq (past Mo) of chest discomf	4180186
40761413	胸部不适的频率 (上个月当中的次数):计数型速率:时间点:^患者:定量型	4182948
40761415	Nominal; PhenX; Point in time; Random; Typ	4180186
40761415	胸部不适类型:类型:时间点:^患者:名义型	4182948
40761416	Chest discomfort relief by NTG	4180186
40761416	Chest discomfort relief by NTG; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761416	在少于15分钟的时间内采用硝酸甘油缓解胸部不适:发现:时间点:^患者:序数型	4182948
40761418	Chest discomfort relief spontaneous; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761418	Chest discomfort relief spontaneous	4180186
40761418	在少于15分钟的时间内自发地缓解胸部不适:发现:时间点:^患者:序数型	4182948
40761425	Provid familiar W death events	4180186
40761425	Finding; Findings; Nominal; PhenX; Point in time; Provid familiar W death events; Random; S prime	4180186
40761425	服务提供者熟悉与死者死亡密切相关的那些事件:发现:时间点:^患者:名义型	4182948
40761427	Chest/L-arm/shoulder/jaw pain&lt;3D death; Finding; Findings; L; LT; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Upper extremity; Upper extremity joint	4180186
40761427	Chest/L-arm/shoulder/jaw pain<3D death	4180186
40761427	在死亡前的72小时之内胸部、左臂或肩部或者下颌部位的疼痛:发现:时间点:^患者:序数型	4182948
40761431	Time onset acute symptoms to death	4180186
40761431	Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Sx; Time onset acute symptoms to death	4180186
40761431	急性症状发作到死亡之间的时间:时间:时间点:^患者:序数型	4182948
40761433	Location; Nominal; PhenX; Point in time; Random	4180186
40761433	死亡地点:位置:时间点:^患者:名义型	4182948
40761434	Finding; Findings; Nominal; PhenX; Point in time; Random	4180186
40761434	有目击证人的死亡:发现:时间点:^患者:名义型	4182948
40761438	Death due to CV causes	4180186
40761438	Death due to CV causes; Nominal; PhenX; Point in time; Random; S prime; Typ	4180186
40761438	死于心血管原因的患者的死亡机制:类型:时间点:^患者:名义型	4182948
40761443	Age 1st heart attack occurred Sister	4180186
40761443	Age 1st heart attack occurred; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761443	首次出现心脏病发作时的年龄:发现:时间点:^姐妹:序数型	4182948
40761444	Domain - Cardiovascular	4180186
40761444	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40761444	PhenX 领域 - 心血管:-:时间点:^患者:-:PhenX	4182948
40761445	Age 1st heart attack occurred Daughter	4180186
40761445	Age 1st heart attack occurred; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761445	首次出现心脏病发作时的年龄:发现:时间点:^女儿:序数型	4182948
40761446	Age 1st heart attack occurred; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761446	Age 1st heart attack occurred Son	4180186
40761446	首次出现心脏病发作时的年龄:发现:时间点:^儿子:序数型	4182948
40761448	Age 1st heart attack occurred Mother	4180186
40761448	Age 1st heart attack occurred; Finding; Findings; Mat; Maternal; Matnl; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40761448	首次出现心脏病发作时的年龄:发现:时间点:^母亲:序数型	4182948
40761453	Connective tissue GF Ur-sCnc	4180186
40761453	Chemistry; Conn tiss; Connective tissue GF; CTGF; Fac; Fact; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40761453	结缔组织生长因子:物质的量浓度:时间点:尿液:定量型	4182948
40761458	Amphet/Creat Ur	4180186
40761458	Amph; Amphet; Amphetam; Amphetamines; Ampht; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; Speed; UA; UCr; UR; Urn	4180186
40761458	苯丙胺/肌酐:质量比率:时间点:尿液:定量型	4182948
40761460	Buprenorphine+Nor Ur Ql Scn	4180186
40761460	BU; BUP; Bupe; Buprenex; buprenorphine HCI; Buprenorphine metabolite; Buprex; Butrans; DRUG/TOXICOLOGY; Drugs; Finobrin; NBU; norBUP; Norspan; Ordinal; Point in time; PR; Prefin; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Suboxone; Subutex; Temgesic; UA; UR; Urn	4180186
40761460	丁丙诺啡+去甲基丁丙诺啡:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
40761462	Buprenorphine metabolite; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; NBU; norBUP; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40761462	Norbuprenorphine/Creat Ur	4180186
40761462	去甲基丁丙诺啡/肌酐:质量比率:时间点:尿液:定量型	4182948
40761464	A-OH Alpraz/Creat Ur	4180186
40761464	Alfa; Alpha hydroxy alprazolam; Alprozolam metabolite; A-OH Alpraz; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Hydroxy alprazolam; Hydroxyalpraz; Mass concentration ratio; Mass ratio; MCRto; OH-Alpraz; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40761464	Alpha-羟基阿普唑仑/肌酐:质量比率:时间点:尿液:定量型	4182948
40761465	7-amino clonazepam; 7Aminoclonazepam; Clonazepam metabolite; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40761465	7Aminoclonazepam/Creat Ur	4180186
40761465	7-氨基氯硝安定/肌酐:质量比率:时间点:尿液:定量型	4182948
40761466	7-amino clonazepam; 7Aminoclonazepam; Addiction; Cfm; Clonazepam metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40761466	7Aminoclonazepam Ur Ql Cfm	4180186
40761466	7-氨基氯硝安定:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
40761467	LORazepam/Creat Ur	4180186
40761467	Ativan; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40761467	氯羟安定/肌酐:质量比率:时间点:尿液:定量型	4182948
40761470	Temazepam/Creat Ur	4180186
40761470	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Normison; Point in time; QNT; Quan; Quant; Quantitative; Random; Restoril; UA; UCr; UR; Urn	4180186
40761470	羟基安定/肌酐:质量比率:时间点:尿液:定量型	4182948
40761471	Addiction; Carisoma; Carisoprodol metabolite; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Equanil; Flexartal; Illicit; Isopropylmeprobamate; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Rela; Sanoma; Scn; Scr; Screen; Scrn; Soma; Somadril; Somalgit; UA; UR; Urn	4180186
40761471	Carisoprodol+Meprob Ur Ql Scn	4180186
40761471	异丙基甲丁双脲+氨甲丙二酯:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
40761474	Addiction; Carisoprodol metabolite; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Equanil; GCMS; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40761474	Meprobamate Ur Ql Cfm	4180186
40761474	氨甲丙二酯:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
40761476	DRUG/TOXICOLOGY; Drugs; EtG; Ethanol metabolite; Gluc; Glucouronide; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UniversalLabOrders; UR; Urn	4180186
40761476	Ethyl glucuronide Ur Ql Scn	4180186
40761476	乙基葡糖苷酸:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
40761488	Normeperidine/Creat Ur	4180186
40761488	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Meperidine metabolite; Norpethidine; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40761488	去甲基哌替啶/肌酐:质量比率:时间点:尿液:定量型	4182948
40761489	Normeperidine Ur Ql Cfm	4180186
40761489	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Meperidine metabolite; Norpethidine; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40761489	去甲基哌替啶:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
40761491	EDDP/Creat Ur	4180186
40761491	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; EDDP; i; II; III; Mass concentration ratio; Mass ratio; MCRto; Methadone metabolite; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40761491	2-亚乙基-1,5-二甲基-3,3-四氢吡咯/肌酐:质量比率:时间点:尿液:定量型	4182948
40761493	c260; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Morphine sulfate; MS; MSO4; OMPH; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40761493	Morphine/Creat Ur	4180186
40761493	吗啡/肌酐:质量比率:时间点:尿液:定量型	4182948
40761497	oxyMORphone/Creat Ur	4180186
40761497	14-Hydroxydihydromorphinone; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Numorphan; Numorphone; Opana; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40761497	羟吗啡酮/肌酐:质量比率:时间点:尿液:定量型	4182948
40761499	Algaphan; Cosalgesic; Cotonal-65; CR; Crea; Creat; Darvon; Depronal; Dextrogesic; Dextropropoxyphene; Distalgesic; Dolasan; Doloxene; D-propoxyphene; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Napsalgesic; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40761499	Propoxyph/Creat Ur	4180186
40761499	丙氧氨酚/肌酐:质量比率:时间点:尿液:定量型	4182948
40761500	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; n-desmethylproproxyphene; Norpropoxyp; Point in time; Propoxyphene metabolite; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40761500	Norpropoxyph/Creat Ur	4180186
40761500	去甲基丙氧氨酚/肌酐:质量比率:时间点:尿液:定量型	4182948
40761501	Accept; Arbitrary; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Spec; UA; UR; Urn	4180186
40761501	Specimen pH acceptable Ur	4180186
40761501	标本 pH 可接受:任意型:时间点:尿液:序数型	4182948
40761507	Platelet morphology pnl Bld	4180186
40761507	Blood; HEMATOLOGY/CELL COUNTS; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pl; Platelet morphology pnl; Platelets; Platelt; Plt; Pnl; Point in time; Random; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
40761507	血小板形态学组套:-:时间点:全血:-	4182948
40761509	Blood; Discocyte; Erc; Erythrocytes; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; Random; RBC; RBC morph; RBC morphology pnl; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; WB; Whole blood	4180186
40761509	RBC morphology pnl Bld	4180186
40761509	红细胞形态学组套:-:时间点:全血:-	4182948
40761510	100WBC; Auto; Automated detection; Blood; Cell; Cellularity; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Number fraction; Othr; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
40761510	Other cells/leuk NFr Bld Auto	4180186
40761510	其他细胞/100 个白细胞:计数型分数:时间点:全血:定量型:自动化计数方法	4182948
40761512	Clinical research drug Plas-mCnc	4180186
40761512	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40761512	临床研究药物 XXX:质量浓度:时间点:血浆:定量型	4182948
40761513	ANTIBIOTIC SUSCEPTIBILITIES; AST; Cefipime; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Islt.mening; Isol; KB; Kirby-bauer; Maxipime; Mening; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40761513	Cefepime Islt.mening KB	4180186
40761513	头孢吡肟:抗生素敏感性:时间点:分离株.脑膜炎:定量型或序数型:琼脂扩散法	4182948
40761514	nRBC/100 WBC Bld Auto-Rto	4180186
40761514	100WBC; Auto; Automated detection; Blood; Discocytes; Elec; Elect; Electr; Erthrocyte; Erythroblasts; Erythrocyte; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Normoblasts; nRBC; nRBCs; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Rto; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
40761514	红细胞.有核/100 个白细胞:比率:时间点:全血:定量型:自动化计数方法	4182948
40761517	MLH1 基因甲基化:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40761517	Blood; COCA2; DNA methylation; FCC2; hMLH1; HNPCC; HNPCC2; Lynch syndrome; MGC5172; Molecular genetics; Molecular pathology; MOLPATH; mutL homolog 1; MutL homolog 1, colon cancer, nonpolyposis type 2; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40761517	MLH1 gene methylation Bld/T Ql	4180186
40761518	Cardizem; Cartia; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tiamate; Tiazac; UA; UR; Urn	4180186
40761518	dilTIAZem Ur Ql	4180186
40761518	硫氮卓酮:存在情况或阈值:时间点:尿液:序数型	4182948
40761519	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; mycafungin; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761519	Micafungin SerPl-mCnc	4180186
40761519	米卡芬净:质量浓度:时间点:血清/血浆:定量型	4182948
40761520	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761520	Caspofungin SerPl-mCnc	4180186
40761520	卡泊芬净:质量浓度:时间点:血清/血浆:定量型	4182948
40761521	DRUG/TOXICOLOGY; Drugs; Ecalta; Eraxis; Level; LY303366; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761521	Anidulafungin SerPl-mCnc	4180186
40761521	阿尼芬净:质量浓度:时间点:血清/血浆:定量型	4182948
40761526	Ethyl sulfate Ur Cfm-mCnc	4180186
40761526	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Ethanol metabolite; ethyl hydrogen sulfate; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; SO4; SO4-2; Sulf; Sulfovinate; Sulfovinic acid; UA; UR; Urn	4180186
40761526	硫酸乙酯:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
40761527	Carisoprodol Ur Ql Cfm	4180186
40761527	Carisoma; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Flexartal; GCMS; Isopropylmeprobamate; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rela; Sanoma; Screen; Soma; Somadril; Somalgit; UA; UR; Urn	4180186
40761527	异丙基甲丁双脲:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
40761528	Carisoma; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Flexartal; GCMS; Isopropylmeprobamate; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rela; Sanoma; Soma; Somadril; Somalgit; UA; UR; Urn	4180186
40761528	Carisoprodol Ur Cfm-mCnc	4180186
40761528	异丙基甲丁双脲:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
40761530	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; EDDP; GCMS; i; II; III; Illicit; Level; Mass concentration; Methadone metabolite; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40761530	EDDP Ur Cfm-mCnc	4180186
40761530	2-亚乙基-1,5-二甲基-3,3-四氢吡咯:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
40761531	14-Hydroxydihydromorphinone; Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Lortab; Numorphan; Numorphone; Opana; Ordinal; OxyContin; Percocet; Percodan; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn; Vicodin	4180186
40761531	oxyCODONE+oxyMORphone Ur Ql Scn	4180186
40761531	羟考酮+羟吗啡酮:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
40761532	1 day; 24 hours; 24HR; Chemistry; Kidney; Nephrology; Pan; PANEL.CHEMISTRY; Panl; Pnl; Renal; UA; UniversalLabOrders; UR; Urn	4180186
40761532	Microalbumin panel 24h Ur	4180186
40761532	微量白蛋白组套:-:24小时:尿液:-	4182948
40761533	Cast; Casts Pnl; Pan; PANEL.URINALYSIS; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
40761533	Casts Pnl UrnS	4180186
40761533	管型组套:-:时间点:尿沉渣:定量型	4182948
40761535	Cells Pnl UrnS	4180186
40761535	Cell; Cells Pnl; Cellularity; Pan; PANEL.URINALYSIS; Panl; Pnl; Point in time; Random; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
40761535	细胞组套:-:时间点:尿沉渣:-	4182948
40761536	Microrganisms Pnl UrnS	4180186
40761536	Microrganisms Pnl; Pan; PANEL.URINALYSIS; Panl; Pnl; Point in time; Random; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
40761536	微生物组套:-:时间点:尿沉渣:-	4182948
40761538	Kidney; LM; Micro; Micros; Microscopic; Nephrology; Nominal; Point in time; Random; Renal; Typ; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
40761538	Microorganisms UrnS Micro	4180186
40761538	所观察到的微生物:类型:时间点:尿沉渣:名义型:显微镜检查.光学	4182948
40761540	Clinical research drug Ur-mCnc	4180186
40761540	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40761540	临床研究药物 XXX:质量浓度:时间点:尿液:定量型	4182948
40761541	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Classical swine fever; CSFV; CSFV E2; EIA; ELFA; ELISA; Enzyme immunoassay; Hog cholera; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Pestivirus; Pig; Point in time; Pork; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS; Vet; Veterinary	4180186
40761541	CSFV E2 Ab Ser IA-aCnc	4180186
40761541	猪瘟病毒 E2 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40761542	Other elements UrnS	4180186
40761542	Othr; Pan; Panel; PANEL.URINALYSIS; Panl; Pnl; Point in time; Random; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
40761542	其他成分:-:时间点:尿沉渣:-	4182948
40761545	D Cells; DE; Discocytes; Dysmorphic RBC; Erthrocyte; Erythrocyte; Glomerular erythrocytes; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Renal; Screen; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
40761545	Dysmorphic RBC UrnS Ql Micro	4180186
40761545	红细胞.形态不均一性:存在情况或阈值:时间点:尿沉渣:序数型:显微镜检查.光学	4182948
40761546	手工分类注释:印象:时间点:全血:叙述型	4182948
40761546	Manual dif comment Bld-Imp	4180186
40761546	Blood; cmmt; cmnt; Com; Comm; Comments; Commt; Diff; Differl; Differn; HEMATOLOGY/CELL COUNTS; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Manual dif comment; Narrative; Point in time; Random; Remarks; Report; WB; Whole blood	4180186
40761551	Bili; Bilirubins; Billirubin; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; GCMS; Ictotest; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; TBIL; UA; UR; URINALYSIS; Urn	4180186
40761551	Bilirub Ur Ql Cfm	4180186
40761551	胆红素:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
40761552	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Autoimmune myelopathy; c707; Endocrine; Endocrinology; GAD; GAD65; GAD-65; GADA; Glu; Glutamic acid; Glutamic acid decarboxylase-65; Insulin-Dependent Diabetes Mellitus; Level; Mass concentration; Paraneoplastic neurological syndrome; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR	4180186
40761552	GAD65 Ab Ser-mCnc	4180186
40761552	谷氨酸脱羧酶-65 抗体:质量浓度:时间点:血清:定量型	4182948
40761555	Subtelomere analysis Bld/T	4180186
40761555	Blood; Identity or presence; Molecular genetics; Molecular pathology; MOLPATH; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40761555	亚端粒分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40761556	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS; T sol; T solium; Tapeworm	4180186
40761556	T sol Ab CSF Ql IA	4180186
40761556	猪带绦虫 抗体:存在情况或阈值:时间点:脑脊液:序数型:免疫测定法	4182948
40761558	亚硫酸盐:存在情况或阈值:时间点:尿液:序数型:试纸条	4182948
40761558	Sulfites Ur Strip	4180186
40761558	Chemistry; Dip stick; Dipstick; Point in time; PR; Random; SmQn; Sulfite; UA; UR; Urn	4180186
40761559	ABS; Aby; ACIF; AMA; Antby; Anti; Antibodies; Antibodies to Microtubule Associated Protein 2; Antibody; Anticomplement Immunofluorescence; Antimitochondrial antibodies; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; Hepatology; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Liver; M2; MA; Mito; Mitochon; Mitochond; Mitochondrial; Mitochondrial Ab; Nominal; PBC; Point in time; Primary Biliary Cirrhosis; Random; S; Serology; Serum; SR; Time Resolved Fluorescence; TRF	4180186
40761559	Mitochondria Ab pattern Ser IF-Imp	4180186
40761559	线粒体 抗体模式:印象:时间点:血清:名义型:免疫荧光法	4182948
40761560	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; GT1b Ganlg; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF; Trisialoganglioside	4180186
40761560	GT1b Ganlg Ab Ser Ql IF	4180186
40761560	神经节苷脂 GT1b 抗体:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40761566	dsDNA IgG Ser Ql IA	4180186
40761566	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Deoxyribonucleic acid; DNA binding ab; ds; dsDNA; dsnda; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; Native DNA; N-DNA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Stranded; Strnd; SUDS	4180186
40761566	双链 DNA 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40761567	dsDNA IgG Titr Ser CLIF	4180186
40761567	双链 DNA 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光 - 短膜虫底物法	4182948
40761567	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CLIF; Deoxyribonucleic acid; Dilution factor; Dilution Factor (Titer); DNA binding ab; ds; dsDNA; dsnda; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Native DNA; N-DNA; Point in time; Random; Serology; Serum; SmQn; SR; Stranded; Strnd; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40761570	#; ABS; absolute; absolutes; Cell; Cellularity; Cerebral spinal fluid; Cerebrospinal Fl; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Nuc; Nuc cell; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
40761570	Nuc cell # CSF	4180186
40761570	有核细胞类:计数型浓度:时间点:脑脊液:定量型	4182948
40761571	RBC.pitted/RBC.total NFr RBC	4180186
40761571	Discocytes; Erthrocyte; Erythrocyte; Erythrocytes; HEMATOLOGY/CELL COUNTS; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBC.pitted; RBC.total; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Tot; Totl	4180186
40761571	红细胞.痘痕/红细胞.总计:计数型分数:时间点:红细胞:定量型	4182948
40761572	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; Cellularity; Cnt; Count; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Manl; Number; Othr; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40761572	Other cells Fld Manual	4180186
40761572	其他细胞:数量(计数):时间点:体液:定量型:手工计数方法	4182948
40761573	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; H flu; H influenza; H influenzae; Haem influ; Haem influ serotyp; Haemoph; ID; Identity or presence; Infectious Disease; InfectiousDisease; Influ; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40761573	Haem influ serotyp DNA Spec NAA+probe	4180186
40761573	流感嗜血杆菌血清型 DNA:存在与否或特征标识:时间点:XXX:名义型:探针法.基因扩增.靶向	4182948
40761575	DOCUMENT.REGULATORY; FDA label; Narrative; Report	4180186
40761575	FDA label Medical food	4180186
40761575	医疗食品:-:-:^FDA 产品标签:叙述型	4182948
40761578	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; species; spp; SR	4180186
40761578	Bombus sp IgG-mCnc	4180186
40761578	熊蜂属单个未知种 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40761579	NEFA sp7 p fast SerPl-sCnc	4180186
40761579	Acd; Acid; After; Aliphatic carboxylate C10-C26; Calorie Fast; CHEMISTRY.CHALLENGE TESTING; Fast; Fasting; Fatty acid; FFA; Free Fatty Acids; Level; Lipid; NEFA; p fast; PC; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp7; sp7 p fast; Spec; SR; Substance concentration	4180186
40761579	脂肪酸类.非酯化型^在热量型禁食之后的第7个标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
40761581	Antigen; Antigens; Antihemophilic factor B; Autoprothrombin II-a; Christmas factor; Coag; EIA; ELFA; ELISA; Enzyme immunoassay; Fac; Fact; Fact IX; Factor 9; FIX; Hematology; Heme; IAA; Mass concentration ratio; Mass ratio; MCRto; MEIA; PC; Plas; Plasma thromboplastin component; Platelet poor plasma; Point in time; PR; Prot; Prot C; PTC; QNT; Quan; Quant; Quantitative; Random; Rh; Rh Blood Group System; SUDS; Thrombocyte cofactor II	4180186
40761581	Prot C Ag/Fact IX Ag PPP IA	4180186
40761581	蛋白 C 抗原/凝血因子 IX 抗原:质量比率:时间点:贫血小板血浆:定量型:免疫测定法	4182948
40761582	Antigen; Antigens; Antihemophilic factor B; Christmas factor; Coag; EIA; ELFA; ELISA; Enzyme immunoassay; Fac; Fact; Fact IX; Factor 9; FIX; Hematology; Heme; IAA; Mass concentration ratio; Mass ratio; MCRto; MEIA; MNSs Blood Group System; Plas; Plasma thromboplastin component; Platelet poor plasma; Point in time; PR; Prot; Prot S; PS; PTC; QNT; Quan; Quant; Quantitative; Random; S prime; SUDS; Thrombocyte cofactor II	4180186
40761582	Prot S Ag/Fact IX Ag PPP IA	4180186
40761582	蛋白 S 抗原/凝血因子 IX 抗原:质量比率:时间点:贫血小板血浆:定量型:免疫测定法	4182948
40761583	Blood; B-Raf proto-oncogene, serine/threonine kinase; BRAF1; B-RAF1; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; NS7; PCR; Point in time; RAFB1; Random; Tissue; Tissue, unspecified; v-raf; WB; Whole blood; Whole blood or Tissue	4180186
40761583	BRAF gene Mut Anl Bld/T	4180186
40761583	BRAF 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40761584	17-beta estradiol; After; CHEMISTRY.CHALLENGE TESTING; E2; HS; Level; Mass concentration; Oestradiol; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp8; sp8 p chal; Spec; SR	4180186
40761584	Estradiol sp8 p chal SerPl HS-mCnc	4180186
40761584	雌二醇^在XXX刺激之后的第8个标本:质量浓度:时间点:血清/血浆:定量型:高灵敏度方法	4182948
40761585	17-beta estradiol; BS; CHEMISTRY.CHALLENGE TESTING; E2; Gyn; Gynecology; HS; Level; Mass concentration; OB; ObGyn; Obstetrics; Oestradiol; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761585	Estradiol BS SerPl HS-mCnc	4180186
40761585	雌二醇^基线:质量浓度:时间点:血清/血浆:定量型:高灵敏度方法	4182948
40761587	Estradiol sp6 p chal SerPl HS-mCnc	4180186
40761587	17-beta estradiol; After; CHEMISTRY.CHALLENGE TESTING; E2; HS; Level; Mass concentration; Oestradiol; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp6; sp6 p chal; Spec; SR	4180186
40761587	雌二醇^在XXX刺激之后的第6个标本:质量浓度:时间点:血清/血浆:定量型:高灵敏度方法	4182948
40761589	Estradiol sp4 p chal SerPl HS-mCnc	4180186
40761589	17-beta estradiol; After; CHEMISTRY.CHALLENGE TESTING; E2; HS; Level; Mass concentration; Oestradiol; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp4; sp4 p chal; Spec; SR	4180186
40761589	雌二醇^在XXX刺激之后的第4个标本:质量浓度:时间点:血清/血浆:定量型:高灵敏度方法	4182948
40761591	Estradiol sp2 p chal SerPl HS-mCnc	4180186
40761591	17-beta estradiol; After; CHEMISTRY.CHALLENGE TESTING; Convalescent; E2; HS; Level; Mass concentration; Oestradiol; p chal; Pl; Plasma; Plsm; Point in time; Post immunization; PST; QNT; Quan; Quant; Quantitative; Random; Second; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp2; sp2 p chal; Spec; SR	4180186
40761591	雌二醇^在XXX刺激之后的第2个标本:质量浓度:时间点:血清/血浆:定量型:高灵敏度方法	4182948
40761593	ABS; Aby; AHF; AHG; Antby; Anti; Antibodies; Antibody; Antihemophilic factor; Antihemophilic globulin; Autoantibodies; Autoantibody; Circulating anticoagulant; Coag; EIA; ELFA; ELISA; Enzyme immunoassay; F8; Fac; Fact; Fact VIII; Factor 8; Factor VIII clotting activity; FVIII; Hematology; Heme; IAA; MEIA; Ordinal; Plas; Platelet poor plasma; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SUDS; Thrombocyte cofactor A; VIII:C	4180186
40761593	Fact VIII Ab PPP Ql IA	4180186
40761593	凝血因子 VIII 抗体:存在情况或阈值:时间点:贫血小板血浆:序数型:免疫测定法	4182948
40761594	1 1/2 hours; 1 1/2 HR; 1.5h p Glc; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p dose; p Glc; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761594	C peptide 1.5h p Glc SerPl-mCnc	4180186
40761594	C 肽^在剂量葡萄糖之后1.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
40761595	10M p 1 mg Gc IV; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; HGF; Hyperglycemic factor; i; Level; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40761595	C peptide 10M p 1 mg Gc IV SerPl-sCnc	4180186
40761595	C 肽^在静脉注射1mg胰高血糖素之后10分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40761599	15M p 1 mg Gc PO; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; HGF; Hyperglycemic factor; i; Level; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40761599	C peptide 15M p 1 mg Gc PO SerPl-sCnc	4180186
40761599	C 肽^在静脉注射1mg胰高血糖素之后15分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40761600	15M p Glc; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p dose; p Glc; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761600	C peptide 15M p Glc SerPl-mCnc	4180186
40761600	C 肽^在剂量葡萄糖之后15分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40761602	15M pre chal; Before; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Pept; Pl; Plasma; Plsm; Point in time; pre chal; Pro-insulin c peptide; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40761602	C peptide 15M pre chal SerPl-sCnc	4180186
40761602	C 肽^在XXX刺激之前15分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40761603	C peptide 1h p Glc SerPl-mCnc	4180186
40761603	1 hour; 1.0Hr; 1h p Glc; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p dose; p Glc; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761603	C 肽^在剂量葡萄糖之后1小时:质量浓度:时间点:血清/血浆:定量型	4182948
40761604	C peptide sp1 p chal SerPl-mCnc	4180186
40761604	Acute specimen; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; First; Level; Mass concentration; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pre immunization; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp1; sp1 p chal; Spec; SR	4180186
40761604	C 肽^在XXX刺激之后的第1个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761607	2M p 1 mg Glc IV; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; HGF; Hyperglycemic factor; i; Level; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40761607	C peptide 2M p 1 mg Glc IV SerPl-sCnc	4180186
40761607	C 肽^在静脉注射1mg胰高血糖素之后2分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40761608	3.5h p Glc; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p dose; p Glc; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761608	C peptide 3.5h p Glc SerPl-mCnc	4180186
40761608	C 肽^在剂量葡萄糖之后3.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
40761609	3.5h p Glc; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p dose; p Glc; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40761609	C peptide 3.5h p Glc SerPl-sCnc	4180186
40761609	C 肽^在剂量葡萄糖之后3.5小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40761614	C peptide 45M p Glc SerPl-mCnc	4180186
40761614	45M p Glc; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p dose; p Glc; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761614	C 肽^在剂量葡萄糖之后45分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40761616	4h p Glc; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p dose; p Glc; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761616	C peptide 4h p Glc SerPl-mCnc	4180186
40761616	C 肽^在剂量葡萄糖之后4小时:质量浓度:时间点:血清/血浆:定量型	4182948
40761617	4h p Glc; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p dose; p Glc; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40761617	C peptide 4h p Glc SerPl-sCnc	4180186
40761617	C 肽^在剂量葡萄糖之后4小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40761619	5h p Glc; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p dose; p Glc; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40761619	C peptide 5h p Glc SerPl-sCnc	4180186
40761619	C 肽^在剂量葡萄糖之后5小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40761620	C peptide 5M p 1 mg Gc IV SerPl-sCnc	4180186
40761620	5M p 1 mg Gc IV; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; HGF; Hyperglycemic factor; i; Level; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40761620	C 肽^在静脉注射1mg胰高血糖素之后5分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40761623	30M p 250 ug ACTH; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; B; c206; c74; CHEMISTRY.CHALLENGE TESTING; Compound B; Cort; Corticoster; Cortrosyn; Level; mcg; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	4180186
40761623	Corticoster 30M p 250 ug ACTH SerPl-sCnc	4180186
40761623	皮质酮^在给予250 ug促肾上腺皮质激素之后30分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40761624	Corticoster 1h p 250 ug ACTH SerPl-sCnc	4180186
40761624	1 hour; 1.0Hr; 1h p 250 ug ACTH; 60 min; 60 minutes; 60M; 60min; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; B; c206; c74; CHEMISTRY.CHALLENGE TESTING; Compound B; Cort; Corticoster; Cortrosyn; Level; mcg; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	4180186
40761624	皮质酮^在给予250 ug促肾上腺皮质激素之后1小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40761625	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; B; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Compound B; Cort; Corticoster; Cortrosyn; Level; mcg; Pl; Plasma; Plsm; Point in time; pre 250 ug ACTH; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	4180186
40761625	Corticoster pre 250 ug ACTH SerPl-sCnc	4180186
40761625	皮质酮^在给予250 ug促肾上腺皮质激素之前:物质的量浓度:时间点:血清/血浆:定量型	4182948
40761630	ACTH 1.5h p 1 ug/kg CRH IV Plas-sCnc	4180186
40761630	1 1/2 hours; 1 1/2 HR; 1.5h p 1 ug/kg CRH IV; 1.5Hr; 90 min; 90 minutes; 90M; 90min; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; i; Level; mcg; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761630	促肾上腺皮质激素^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之后1.5小时:物质的量浓度:时间点:血浆:定量型	4182948
40761631	1 1/2 hours; 1 1/2 HR; 1.5h p Ins IV; 1.5Hr; 90 min; 90 minutes; 90M; 90min; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Semilente; Sliding; Substance concentration; Tumor marker; Ultralente	4180186
40761631	ACTH 1.5h p Ins IV Plas-sCnc	4180186
40761631	促肾上腺皮质激素^在静脉注射剂量胰岛素之后1.5小时:物质的量浓度:时间点:血浆:定量型	4182948
40761633	ACTH 10 AM Plas-sCnc	4180186
40761633	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; Morning; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rc206; Spec; Substance concentration; Tumor marker	4180186
40761633	促肾上腺皮质激素^上午10点标本:物质的量浓度:时间点:血浆:定量型	4182948
40761634	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Evening; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rc206; Spec; Tumor marker	4180186
40761634	ACTH 10 PM Plas-mCnc	4180186
40761634	促肾上腺皮质激素^晚上10点标本:质量浓度:时间点:血浆:定量型	4182948
40761635	ACTH 10 PM Plas-sCnc	4180186
40761635	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Evening; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rc206; Spec; Substance concentration; Tumor marker	4180186
40761635	促肾上腺皮质激素^晚上10点标本:物质的量浓度:时间点:血浆:定量型	4182948
40761638	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; sp10; sp10 p chal; Spec; Tumor marker	4180186
40761638	ACTH sp10 p chal Plas-mCnc	4180186
40761638	促肾上腺皮质激素^在XXX刺激之后的第10个标本:质量浓度:时间点:血浆:定量型	4182948
40761642	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; Midnight; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rc206; Spec; Substance concentration; Tumor marker	4180186
40761642	ACTH 12 AM Plas-sCnc	4180186
40761642	促肾上腺皮质激素^晚上12点标本:物质的量浓度:时间点:血浆:定量型	4182948
40761645	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; sp12; sp12 p chal; Spec; Substance concentration; Tumor marker	4180186
40761645	ACTH sp12 p chal Plas-sCnc	4180186
40761645	促肾上腺皮质激素^在XXX刺激之后的第12个标本:物质的量浓度:时间点:血浆:定量型	4182948
40761646	ACTH 15M p 1 ug/kg CRH IV Plas-sCnc	4180186
40761646	15M p 1 ug/kg CRH IV; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; i; Level; mcg; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761646	促肾上腺皮质激素^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之后15分钟:物质的量浓度:时间点:血浆:定量型	4182948
40761647	ACTH 15M p Ins IV Plas-mCnc	4180186
40761647	15M p Ins IV; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HUM; Humulin; IH7; Insul; Lente; Level; Mass concentration; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Semilente; Sliding; Tumor marker; Ultralente	4180186
40761647	促肾上腺皮质激素^在静脉注射剂量胰岛素之后15分钟:质量浓度:时间点:血浆:定量型	4182948
40761650	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; i; Level; mcg; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761650	ACTH 15M pre 1 ug/kg CRH IV Plas-sCnc	4180186
40761650	促肾上腺皮质激素^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之前15分钟:物质的量浓度:时间点:血浆:定量型	4182948
40761654	1 hour; 1.0Hr; 1h p Gc; 60 min; 60 minutes; 60M; 60min; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HGF; Hyperglycemic factor; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Tumor marker	4180186
40761654	ACTH 1h p Gc Plas-mCnc	4180186
40761654	促肾上腺皮质激素^在给予剂量胰高血糖素之后1小时:质量浓度:时间点:血浆:定量型	4182948
40761658	1 hour; 1.0Hr; 1h p Ins IV; 60 min; 60 minutes; 60M; 60min; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Semilente; Sliding; Substance concentration; Tumor marker; Ultralente	4180186
40761658	ACTH 1h p Ins IV Plas-sCnc	4180186
40761658	促肾上腺皮质激素^在静脉注射剂量胰岛素之后1小时:物质的量浓度:时间点:血浆:定量型	4182948
40761660	ACTH sp1 p chal Plas-sCnc	4180186
40761660	ACTH; Acute specimen; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; First; Level; p chal; Pl; Plasma; Plsm; Point in time; Pre immunization; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; sp1; sp1 p chal; Spec; Substance concentration; Tumor marker	4180186
40761660	促肾上腺皮质激素^在XXX刺激之后的第1个标本:物质的量浓度:时间点:血浆:定量型	4182948
40761664	2.5h p Gc; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HGF; Hyperglycemic factor; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761664	ACTH 2.5h p Gc Plas-sCnc	4180186
40761664	促肾上腺皮质激素^在给予剂量胰高血糖素之后2.5小时:物质的量浓度:时间点:血浆:定量型	4182948
40761673	120 min; 120 minutes; 120min; 2 hours; 2h p Gc; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HGF; Hyperglycemic factor; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761673	ACTH 2h p Gc Plas-sCnc	4180186
40761673	促肾上腺皮质激素^在给予剂量胰高血糖素之后2小时:物质的量浓度:时间点:血浆:定量型	4182948
40761675	120 min; 120 minutes; 120min; 2 hours; 2h p Glc; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761675	ACTH 2h p Glc Plas-sCnc	4180186
40761675	促肾上腺皮质激素^在剂量葡萄糖之后2小时:物质的量浓度:时间点:血浆:定量型	4182948
40761682	ACTH 30M p Gc Plas-sCnc	4180186
40761682	30M p Gc; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HGF; Hyperglycemic factor; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761682	促肾上腺皮质激素^在给予剂量胰高血糖素之后30分钟:物质的量浓度:时间点:血浆:定量型	4182948
40761683	ACTH 30M p Glc Plas-mCnc	4180186
40761683	30M p Glc; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Tumor marker	4180186
40761683	促肾上腺皮质激素^在剂量葡萄糖之后30分钟:质量浓度:时间点:血浆:定量型	4182948
40761685	30M p Ins IV; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Semilente; Sliding; Substance concentration; Tumor marker; Ultralente	4180186
40761685	ACTH 30M p Ins IV Plas-sCnc	4180186
40761685	促肾上腺皮质激素^在静脉注射剂量胰岛素之后30分钟:物质的量浓度:时间点:血浆:定量型	4182948
40761689	30M pre Gc; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HGF; Hyperglycemic factor; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; pre Gc; QNT; Quan; Quant; Quantitative; Random; Rc206; Tumor marker	4180186
40761689	ACTH 30M pre Gc Plas-mCnc	4180186
40761689	促肾上腺皮质激素^在给予剂量胰高血糖素之前30分钟:质量浓度:时间点:血浆:定量型	4182948
40761691	ACTH 30M pre Ins IV Plas-sCnc	4180186
40761691	30M pre Ins IV; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HUM; Humulin; IH7; Insul; Lente; Level; NPH; Pl; Plasma; Plsm; Point in time; pre Ins IV; QNT; Quan; Quant; Quantitative; Random; Rc206; Semilente; Sliding; Substance concentration; Tumor marker; Ultralente	4180186
40761691	促肾上腺皮质激素^在静脉注射剂量胰岛素之前30分钟:物质的量浓度:时间点:血浆:定量型	4182948
40761695	3h p Gc; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HGF; Hyperglycemic factor; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761695	ACTH 3h p Gc Plas-sCnc	4180186
40761695	促肾上腺皮质激素^在给予剂量胰高血糖素之后3小时:物质的量浓度:时间点:血浆:定量型	4182948
40761696	3h p Glc; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Tumor marker	4180186
40761696	ACTH 3h p Glc Plas-mCnc	4180186
40761696	促肾上腺皮质激素^在剂量葡萄糖之后3小时:质量浓度:时间点:血浆:定量型	4182948
40761699	ACTH 3h p Ins IV Plas-sCnc	4180186
40761699	3h p Ins IV; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Semilente; Sliding; Substance concentration; Tumor marker; Ultralente	4180186
40761699	促肾上腺皮质激素^在静脉注射剂量胰岛素之后3小时:物质的量浓度:时间点:血浆:定量型	4182948
40761700	ACTH 3h p chal Plas-mCnc	4180186
40761700	3h p chal; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Tumor marker	4180186
40761700	促肾上腺皮质激素^在XXX刺激之后3小时:质量浓度:时间点:血浆:定量型	4182948
40761701	ACTH 3h p chal Plas-sCnc	4180186
40761701	3h p chal; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761701	促肾上腺皮质激素^在XXX刺激之后3小时:物质的量浓度:时间点:血浆:定量型	4182948
40761703	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; Morning; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rc206; Spec; Substance concentration; Tumor marker	4180186
40761703	ACTH 4 AM specimen Plas-sCnc	4180186
40761703	促肾上腺皮质激素^上午4点标本:物质的量浓度:时间点:血浆:定量型	4182948
40761704	ACTH 4 PM Plas-sCnc	4180186
40761704	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Evening; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rc206; Spec; Substance concentration; Tumor marker	4180186
40761704	促肾上腺皮质激素^下午4点标本:物质的量浓度:时间点:血浆:定量型	4182948
40761706	ACTH 45M p Ins IV Plas-sCnc	4180186
40761706	45M p Ins IV; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Semilente; Sliding; Substance concentration; Tumor marker; Ultralente	4180186
40761706	促肾上腺皮质激素^在静脉注射剂量胰岛素之后45分钟:物质的量浓度:时间点:血浆:定量型	4182948
40761707	ACTH 2D p MTP Plas-sCnc	4180186
40761707	2D p MTP; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; p dose; p metyraPONE; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761707	促肾上腺皮质激素^在给予剂量美替拉酮之后2天:物质的量浓度:时间点:血浆:定量型	4182948
40761708	ACTH sp4 p chal Plas-sCnc	4180186
40761708	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; sp4; sp4 p chal; Spec; Substance concentration; Tumor marker	4180186
40761708	促肾上腺皮质激素^在XXX刺激之后的第4个标本:物质的量浓度:时间点:血浆:定量型	4182948
40761709	ACTH sp5 p chal Plas-sCnc	4180186
40761709	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; sp5; sp5 p chal; Spec; Substance concentration; Tumor marker	4180186
40761709	促肾上腺皮质激素^在XXX刺激之后的第5个标本:物质的量浓度:时间点:血浆:定量型	4182948
40761710	ACTH 6 PM Plas-sCnc	4180186
40761710	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Evening; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rc206; Spec; Substance concentration; Tumor marker	4180186
40761710	促肾上腺皮质激素^下午 6点 标本:物质的量浓度:时间点:血浆:定量型	4182948
40761712	ACTH 75M p Ins IV Plas-mCnc	4180186
40761712	75M p Ins IV; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HUM; Humulin; IH7; Insul; Lente; Level; Mass concentration; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Semilente; Sliding; Tumor marker; Ultralente	4180186
40761712	促肾上腺皮质激素^在静脉注射剂量胰岛素之后75分钟:质量浓度:时间点:血浆:定量型	4182948
40761713	75M p Ins IV; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Semilente; Sliding; Substance concentration; Tumor marker; Ultralente	4180186
40761713	ACTH 75M p Ins IV Plas-sCnc	4180186
40761713	促肾上腺皮质激素^在静脉注射剂量胰岛素之后75分钟:物质的量浓度:时间点:血浆:定量型	4182948
40761715	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; Morning; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rc206; Spec; Substance concentration; Tumor marker	4180186
40761715	ACTH 8 AM Plas-sCnc	4180186
40761715	促肾上腺皮质激素^上午8点标本:物质的量浓度:时间点:血浆:定量型	4182948
40761716	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Evening; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rc206; Spec; Substance concentration; Tumor marker	4180186
40761716	ACTH 8 PM Plas-sCnc	4180186
40761716	促肾上腺皮质激素^晚上8点标本:物质的量浓度:时间点:血浆:定量型	4182948
40761718	ACTH p Dex Plas-sCnc	4180186
40761718	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c350; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Decadron; Dexameth; Dexone; Hexadrol; Level; p Dex; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761718	促肾上腺皮质激素^在给予地塞米松之后:物质的量浓度:时间点:血浆:定量型	4182948
40761719	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; i; Level; mcg; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761719	ACTH pre 1 ug/kg CRH IV Plas-sCnc	4180186
40761719	促肾上腺皮质激素^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之前:物质的量浓度:时间点:血浆:定量型	4182948
40761720	ACTH Pre Dex Plas-mCnc	4180186
40761720	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Before; c206; c350; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Decadron; Dexameth; Dexone; Hexadrol; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre Dex; QNT; Quan; Quant; Quantitative; Random; Rc206; Tumor marker	4180186
40761720	促肾上腺皮质激素^在给予地塞米松之前:质量浓度:时间点:血浆:定量型	4182948
40761723	ACTH pre Gc Plas-sCnc	4180186
40761723	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HGF; Hyperglycemic factor; Level; Pl; Plasma; Plsm; Point in time; pre Gc; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761723	促肾上腺皮质激素^在给予剂量胰高血糖素之前:物质的量浓度:时间点:血浆:定量型	4182948
40761725	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Pl; Plasma; Plsm; Point in time; pre Glc; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761725	ACTH pre Glc Plas-sCnc	4180186
40761725	促肾上腺皮质激素^在给予剂量葡萄糖之前:物质的量浓度:时间点:血浆:定量型	4182948
40761726	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HUM; Humulin; IH7; Insul; Lente; Level; NPH; Pl; Plasma; Plsm; Point in time; pre Ins IV; QNT; Quan; Quant; Quantitative; Random; Rc206; Semilente; Sliding; Substance concentration; Tumor marker; Ultralente	4180186
40761726	ACTH pre Ins IV Plas-sCnc	4180186
40761726	促肾上腺皮质激素^在静脉注射剂量胰岛素之前:物质的量浓度:时间点:血浆:定量型	4182948
40761729	ACTH pre chal Plas-mCnc	4180186
40761729	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; pre chal; QNT; Quan; Quant; Quantitative; Random; Rc206; Tumor marker	4180186
40761729	促肾上腺皮质激素^在 XXX 刺激之前:质量浓度:时间点:血浆:定量型	4182948
40761731	Cortis 1.5h p 1 ug/kg CRH IV Sal-mCnc	4180186
40761731	1 1/2 hours; 1 1/2 HR; 1.5h p 1 ug/kg CRH IV; 1.5Hr; 17-Hydroxycorticosterone; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; Mass concentration; mcg; Oral fluid; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
40761731	皮质醇^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之后1.5小时:质量浓度:时间点:唾液:定量型	4182948
40761739	Cortis sp10 p chal SerPl-sCnc	4180186
40761739	17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp10; sp10 p chal; Spec; SR; Substance concentration	4180186
40761739	皮质醇^在XXX刺激之后的第10个标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
40761740	17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Oral fluid; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sal; sp11; sp11 p chal; Spec	4180186
40761740	Cortis sp11 p chal Sal-mCnc	4180186
40761740	皮质醇^在XXX刺激之后的第11个标本:质量浓度:时间点:唾液:定量型	4182948
40761743	Cortis 12 AM Sal-sCnc	4180186
40761743	17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Midnight; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Spec; Substance concentration	4180186
40761743	皮质醇^晚上12点标本:物质的量浓度:时间点:唾液:定量型	4182948
40761744	Cortis 12 PM Sal-mCnc	4180186
40761744	17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Evening; F; hydrocortisone; Level; Mass concentration; Noon; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Spec	4180186
40761744	皮质醇^中午12点标本:质量浓度:时间点:唾液:定量型	4182948
40761745	17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Evening; F; hydrocortisone; Level; Noon; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Spec; Substance concentration	4180186
40761745	Cortis 12 PM Sal-sCnc	4180186
40761745	皮质醇^中午12点标本:物质的量浓度:时间点:唾液:定量型	4182948
40761746	17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Oral fluid; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sal; sp12; sp12 p chal; Spec	4180186
40761746	Cortis sp12 p chal Sal-mCnc	4180186
40761746	皮质醇^在XXX刺激之后的第12个标本:质量浓度:时间点:唾液:定量型	4182948
40761747	Cortis sp12 p chal Sal-sCnc	4180186
40761747	17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Oral fluid; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sal; sp12; sp12 p chal; Spec; Substance concentration	4180186
40761747	皮质醇^在XXX刺激之后的第12个标本:物质的量浓度:时间点:唾液:定量型	4182948
40761750	17-Hydroxycorticosterone; Before; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; Mass concentration; mcg; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
40761750	Cortis 15M pre 1 ug/kg CRH IV Sal-mCnc	4180186
40761750	皮质醇^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之前15分钟:质量浓度:时间点:唾液:定量型	4182948
40761751	Cortis 15M pre 1 ug/kg CRH IV Sal-sCnc	4180186
40761751	17-Hydroxycorticosterone; Before; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; mcg; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Substance concentration	4180186
40761751	皮质醇^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之前15分钟:物质的量浓度:时间点:唾液:定量型	4182948
40761752	1 hour; 1.0Hr; 17-Hydroxycorticosterone; 1h p 1 ug/kg CRH IV; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; Mass concentration; mcg; Oral fluid; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
40761752	Cortis 1h p 1 ug/kg CRH IV Sal-mCnc	4180186
40761752	皮质醇^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之后1小时:质量浓度:时间点:唾液:定量型	4182948
40761755	Cortis 2 PM SerPl-mCnc	4180186
40761755	17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Evening; F; hydrocortisone; II; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Spec; SR	4180186
40761755	皮质醇^下午2点标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761759	Cortis 2h p 1 ug/kg CRH IV SerPl-sCnc	4180186
40761759	120 min; 120 minutes; 120min; 17-Hydroxycorticosterone; 2 hours; 2h p 1 ug/kg CRH IV; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; mcg; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40761759	皮质醇^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之后2小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40761760	17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Convalescent; Coritsol; Cort; F; hydrocortisone; Level; Oral fluid; p chal; Point in time; Post immunization; PST; QNT; Quan; Quant; Quantitative; Random; Sal; Second; sp2; sp2 p chal; Spec; Substance concentration	4180186
40761760	Cortis sp2 p chal Sal-sCnc	4180186
40761760	皮质醇^在XXX刺激之后的第2个标本:物质的量浓度:时间点:唾液:定量型	4182948
40761762	Cortis 30M pre 1 ug/kg CRH IV Sal-sCnc	4180186
40761762	17-Hydroxycorticosterone; Before; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; mcg; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Substance concentration	4180186
40761762	皮质醇^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之前30分钟:物质的量浓度:时间点:唾液:定量型	4182948
40761764	Cortis 30M pre 1 ug/kg CRH IV SerPl-sCnc	4180186
40761764	17-Hydroxycorticosterone; Before; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; mcg; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40761764	皮质醇^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之前30分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40761765	Cortis sp3 p chal Sal-sCnc	4180186
40761765	17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Oral fluid; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sal; sp3; sp3 p chal; Spec; Substance concentration	4180186
40761765	皮质醇^在XXX刺激之后的第3个标本:物质的量浓度:时间点:唾液:定量型	4182948
40761766	Cortis 4 AM specimen Sal-mCnc	4180186
40761766	17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Morning; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Spec	4180186
40761766	皮质醇^上午4点标本:质量浓度:时间点:唾液:定量型	4182948
40761767	Cortis 4 AM specimen Sal-sCnc	4180186
40761767	17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Morning; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Spec; Substance concentration	4180186
40761767	皮质醇^上午4点标本:物质的量浓度:时间点:唾液:定量型	4182948
40761769	17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Evening; F; hydrocortisone; Level; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Spec; Substance concentration	4180186
40761769	Cortis 4 PM Sal-sCnc	4180186
40761769	皮质醇^下午4点标本:物质的量浓度:时间点:唾液:定量型	4182948
40761770	Cortis 45M p 1 ug/kg CRH IV Sal-mCnc	4180186
40761770	17-Hydroxycorticosterone; 45M p 1 ug/kg CRH IV; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; Mass concentration; mcg; Oral fluid; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
40761770	皮质醇^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之后45分钟:质量浓度:时间点:唾液:定量型	4182948
40761772	Cortis 45M p 1 ug/kg CRH IV SerPl-sCnc	4180186
40761772	17-Hydroxycorticosterone; 45M p 1 ug/kg CRH IV; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; mcg; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40761772	皮质醇^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之后45分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40761774	17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Morning; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Spec	4180186
40761774	Cortis 8 AM Sal-mCnc	4180186
40761774	皮质醇^上午8点标本:质量浓度:时间点:唾液:定量型	4182948
40761775	17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Morning; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Spec; Substance concentration	4180186
40761775	Cortis 8 AM Sal-sCnc	4180186
40761775	皮质醇^上午8点标本:物质的量浓度:时间点:唾液:定量型	4182948
40761776	17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Evening; F; hydrocortisone; Level; Mass concentration; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Spec	4180186
40761776	Cortis 8 PM Sal-mCnc	4180186
40761776	皮质醇^晚上8点标本:质量浓度:时间点:唾液:定量型	4182948
40761779	17-Hydroxycorticosterone; Before; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; mcg; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Substance concentration	4180186
40761779	Cortis pre 1 ug/kg CRH IV Sal-sCnc	4180186
40761779	皮质醇^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之前:物质的量浓度:时间点:唾液:定量型	4182948
40761783	Beta 1 F-globulin; Comp; Complmt; HEMATOLOGY/CELL COUNTS; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761783	C5 SerPl Ql	4180186
40761783	补体 C5:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40761786	120 min; 120 minutes; 120min; 2 hours; 2h p Glc; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p dose; p Glc; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761786	C peptide 2h p Glc SerPl-mCnc	4180186
40761786	C 肽^在剂量葡萄糖之后2小时:质量浓度:时间点:血清/血浆:定量型	4182948
40761788	17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp11; sp11 p chal; Spec; SR	4180186
40761788	Cortis sp11 p chal SerPl-mCnc	4180186
40761788	皮质醇^在XXX刺激之后的第11个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761789	17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp11; sp11 p chal; Spec; SR; Substance concentration	4180186
40761789	Cortis sp11 p chal SerPl-sCnc	4180186
40761789	皮质醇^在XXX刺激之后的第11个标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
40761791	Cortis sp12 p chal SerPl-sCnc	4180186
40761791	17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp12; sp12 p chal; Spec; SR; Substance concentration	4180186
40761791	皮质醇^在XXX刺激之后的第12个标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
40761792	17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Oral fluid; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sal; sp5; sp5 p chal; Spec; Substance concentration	4180186
40761792	Cortis sp5 p chal Sal-sCnc	4180186
40761792	皮质醇^在XXX刺激之后的第5个标本:物质的量浓度:时间点:唾液:定量型	4182948
40761793	Cortis sp6 p chal Sal-sCnc	4180186
40761793	17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Oral fluid; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sal; sp6; sp6 p chal; Spec; Substance concentration	4180186
40761793	皮质醇^在XXX刺激之后的第6个标本:物质的量浓度:时间点:唾液:定量型	4182948
40761794	^7th spec pst XXX chal; 17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Oral fluid; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sal; sp7; sp7 p chal; Spec; Substance concentration	4180186
40761794	Cortis sp7 p chal Sal-sCnc	4180186
40761794	皮质醇^在XXX刺激之后的第7个标本:物质的量浓度:时间点:唾液:定量型	4182948
40761795	Cortis sp8 p chal Sal-mCnc	4180186
40761795	17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Oral fluid; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sal; sp8; sp8 p chal; Spec	4180186
40761795	皮质醇^在XXX刺激之后的第8个标本:质量浓度:时间点:唾液:定量型	4182948
40761804	ABS; Aby; Agf98; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Celiac; Celiac disease; Deamidated gliadin peptide; Deaminated gliadin; Dermatitis Herpetiformis; DGP; DH; F98; Gastro; Gastroenterology; GI; Gliadine; Immune globulin G; Immunoglobulin G; Pept; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR	4180186
40761804	Gliadin peptide IgG Ser-aCnc	4180186
40761804	麦醇溶蛋白肽 抗体.IgG:任意型浓度:时间点:血清:定量型	4182948
40761806	AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Synercid; TB; Tuberculosis	4180186
40761806	Quinupristin+Dalfoprist Islt SlowMyco	4180186
40761806	奎奴普丁+达福普汀:抗生素敏感性:时间点:分离株:定量型或序数型:针对慢长型分枝杆菌的方法	4182948
40761810	Testost free+WB + Total pnl SerPl	4180186
40761810	Associated; bnd; Chemistry; FR; Non-protein bound; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Testo; Testos; Testost; Testost Free; Testost free+WB + Total pnl; Testosterone free+weakly bound; Testosterone.bioavailable; Testosterone.free+WB; Testosterone.unconjugated; Tot; Totl; Tumor marker	4180186
40761810	睾酮.游离型+微弱结合型与总睾酮组套:-:时间点:血清/血浆:-	4182948
40761811	LPT CA Bld-Imp	4180186
40761811	Blood; conconavalin; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; LPA; LPT; LPT CA; LST; Lymphocyte antigen proliferation; Lymphocyte antigen stimulation; Nominal; PHA; Point in time; Random; Serology; Stim; WB; Whole blood	4180186
40761811	淋巴细胞增殖.伴刀豆球蛋白 A 丝裂原刺激:印象:时间点:全血:名义型	4182948
40761812	Act/Nor; Blood; conconavalin; Control; LPA; LPT; LPT 10 ug CA; LST; Lymphocyte antigen proliferation; Lymphocyte antigen stimulation; mcg; PHA; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serology; Stim; WB; Whole blood	4180186
40761812	LPT 10 ug CA Act/Nor Bld	4180186
40761812	淋巴细胞增殖. 10 ug 伴刀豆球蛋白 A 刺激 实际的/正常的:相对比率:时间点:全血:定量型	4182948
40761814	Act/Nor; Blood; conconavalin; Control; LPA; LPT; LPT 2 ug CA; LST; Lymphocyte antigen proliferation; Lymphocyte antigen stimulation; mcg; PHA; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serology; Stim; WB; Whole blood	4180186
40761814	LPT 2 ug CA Act/Nor Bld	4180186
40761814	淋巴细胞增殖. 2.0 ug 伴刀豆球蛋白 A 刺激 实际的/正常的:相对比率:时间点:全血:定量型	4182948
40761818	LPT 5 ug PW Act/Nor Bld	4180186
40761818	Act/Nor; Blood; Control; LPA; LPT; LPT 5 ug PW; LST; Lymphocyte antigen proliferation; Lymphocyte antigen stimulation; mcg; PHA; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serology; Stim; WB; Whole blood	4180186
40761818	淋巴细胞增殖. 5.0 ug 美洲商陆丝裂原刺激 实际的/正常的:相对比率:时间点:全血:定量型	4182948
40761821	LPT PHA Bld-Imp	4180186
40761821	Blood; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; LPA; LPT; LPT PHA; LST; Lymphocyte antigen proliferation; Lymphocyte antigen stimulation; Narrative; PHA; PHA mitogen stimulation; Point in time; Random; Report; Serology; Stim; WB; Whole blood	4180186
40761821	淋巴细胞增殖.植物血凝素刺激:印象:时间点:全血:叙述型	4182948
40761824	Act/Nor; Blood; Control; LPA; LPT; LPT 1.0 ug PHA; LST; Lymphocyte antigen proliferation; Lymphocyte antigen stimulation; mcg; PHA; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serology; Stim; WB; Whole blood	4180186
40761824	LPT 1.0 ug PHA Act/Nor Bld	4180186
40761824	淋巴细胞增殖. 1.0 ug 植物血凝素刺激 实际的/正常的:相对比率:时间点:全血:定量型	4182948
40761825	Act/Nor; Blood; Control; LPA; LPT; LPT 0.5 ug PHA; LST; Lymphocyte antigen proliferation; Lymphocyte antigen stimulation; mcg; PHA; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serology; Stim; WB; Whole blood	4180186
40761825	LPT 0.5 ug PHA Act/Nor Bld	4180186
40761825	淋巴细胞增殖. 0.50 ug 植物血凝素刺激 实际的/正常的:相对比率:时间点:全血:定量型	4182948
40761826	Porphyrin Fract Pnl SerPl-mCnc	4180186
40761826	Chemistry; Frac; Fract; Fraction; Fractionated; Fractionation; Level; Mass concentration; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Porphyrin Fract Pnl; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761826	卟啉类成分组套:质量浓度:时间点:血清/血浆:-	4182948
40761829	A1; AF; AFAFP; AFP; AFP Pnl; Alfa; Alpha fetoprotein; Alphafetoprotein; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chemistry; Feto; Gyn; Gynecology; i; Maternal screen; Maternal screen 1; Maternal screen for neural tube defect; msAFP; OB; ObGyn; Obstetrics; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Single marker screen; Tumor marker	4180186
40761829	AFP Pnl Amn	4180186
40761829	Alpha-1-胎蛋白组套:-:时间点:羊水:-	4182948
40761830	Manganese pnl Ur	4180186
40761830	DRUG/TOXICOLOGY; Drugs; Manganese pnl; MN; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; UA; UR; Urn	4180186
40761830	锰组套:-:时间点:尿液:-	4182948
40761831	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B19 virus; B19V; Fifth Disease; ID; IgG+IgM; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; Microbiology; Nominal; Parvo; Parvo virus; Parvov; Point in time; Random; Serum; SR	4180186
40761831	B19V IgG+IgM Ser-Imp	4180186
40761831	细小病毒 B19 抗体.IgG 与 IgM:印象:时间点:血清:名义型	4182948
40761832	Addiction; DAU; Drug; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Mec; Nominal; Point in time; PotentialForAbuse; Random	4180186
40761832	Drugs of abuse Mec-Imp	4180186
40761832	滥用药物:印象:时间点:胎便:名义型	4182948
40761838	Cardiac; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Hrt; Imaging; Point in time; Rad; RADIOLOGY; Random; Thorax	4180186
40761838	CT Hrt	4180186
40761838	多层:发现:时间点:胸部>心脏:文档型:CT	4182948
40761844	Cardiac; Cardio; Cardiology; Document; Exercise; Finding; Findings; Heart Disease; Hrt; Imaging; Mitral regurgitation maximum velocity; MRI; Point in time; Rad; RADIOLOGY; Random; Thorax	4180186
40761844	MR Hrt W Stress	4180186
40761844	多层^采用应激:发现:时间点:胸部>心脏:文档型:MR	4182948
40761845	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; FA; Fluorescent antibody; Fluorescent treponemal antibody; Fluoresent; FTA-ABS; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Syphilis; T pallidum; Time Resolved Fluorescence; Treponemal; TRF	4180186
40761845	T pallidum IgG CSF Ql IF	4180186
40761845	梅毒螺旋体 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:免疫荧光法	4182948
40761848	a482; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Black olive; f342; i; Immune globulin E; Immunoglobulin E; Olive; Olive (nOle e) 1; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t224	4180186
40761848	Olive (nOle e) 1 IgE Qn	4180186
40761848	油橄榄 原生 (nOle e) 1 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40761849	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Chicken pox; Chicken pox virus; Chickenpox; EIA; ELFA; ELISA; Enzyme immunoassay; Herpes zoster; HHV-3; Human herpesvirus 3; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Shingles; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS; VZ; VZV; Zoster	4180186
40761849	VZV IgG CSF IA-aCnc	4180186
40761849	水痘带状疱疹病毒 抗体.IgG:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40761852	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; C pneum; C pneumo; C pneumoniae; Cerebral spinal fluid; Cerebrospinal Fl; Chlamydia; Chlamydia pneumoniae; CPN; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Neuro; Neurology; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS; Twar agent	4180186
40761852	C pneum IgG CSF IA-aCnc	4180186
40761852	肺炎嗜性衣原体 抗体.IgG:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40761854	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; CAP; Cerebral spinal fluid; Cerebrospinal Fl; EBV; EBV capsid Ab; EBV VCA; EIA; ELFA; ELISA; Enzyme immunoassay; Epstn; HHV-4; human herpesvirus 4; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Mono; Mononucleosis; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS; VCA; Viral capsid	4180186
40761854	EBV VCA IgG CSF IA-aCnc	4180186
40761854	Epstein Barr 病毒衣壳 抗体.IgG:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40761857	IgA 24h Ur-mRate	4180186
40761857	1 day; 24 hours; 24HR; Chemistry; Immune globulin A; Immunoglobulin A; Mass rate; mRate; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40761857	IgA:质量速率:24小时:尿液:定量型	4182948
40761859	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; SUDS	4180186
40761859	Histone Ab Ser Ql IA	4180186
40761859	组蛋白 抗体:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40761860	#/area; Cell; Cellularity; Ejaculate; Epi; Epi Cells; Epith; Epithelia; FERTILITY TESTING; Genitourinary; GU; LM; Micro; Micros; Microscopic; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; URO; Urology	4180186
40761860	Epi Cells #/area Smn HPF	4180186
40761860	上皮细胞:单位面积数量或计数:时间点:精液:定量型:显微镜检查.光学.高倍视野	4182948
40761861	#/area; Discocytes; Ejaculate; Erthrocyte; Erythrocyte; FERTILITY TESTING; Genitourinary; GU; LM; Micro; Micros; Microscopic; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Sem; Seminal fluid; Smn; SMPLS; URO; Urology	4180186
40761861	RBC #/area Smn HPF	4180186
40761861	红细胞:单位面积数量或计数:时间点:精液:定量型:显微镜检查.光学.高倍视野	4182948
40761862	1 day; 24 hours; 24HR; Catalytic Rate; Chemistry; cRate; Gamma glutamyl transpeptidase; Gamma-GTP; GGT; GGTP; GT; Hepatology; Liver; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40761862	GGT 24h Ur-cRate	4180186
40761862	Gamma 谷氨酰转移酶:催化速率:24小时:尿液:定量型	4182948
40761865	BPI Ab Ser-aCnc	4180186
40761865	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; BPI; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR	4180186
40761865	杀菌/通透性增加蛋白 抗体:任意型浓度:时间点:血清:定量型	4182948
40761866	Dog (rCan f) 2 IgE Qn	4180186
40761866	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Canine; Dog (rCan f) 2; e102; II; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40761866	狗 重组 (rCan f) 2 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40761867	a174; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Canine; Dog (rCan f) 1; e101; i; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40761867	Dog (rCan f) 1 IgE Qn	4180186
40761867	狗 重组 (rCan f) 1 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40761869	Peach (rPru p) 4 IgE Qn	4180186
40761869	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f095; f421; f95; Immune globulin E; Immunoglobulin E; P prime; Peach; Peach (rPru p) 4; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40761869	桃子 重组 (rPru p) 4 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40761871	Peanut (rAra h) 3 IgE Qn	4180186
40761871	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f013; f13; f424; III; Immune globulin E; Immunoglobulin E; NR1B1; Peanut; Peanut (rAra h) 3; Point in time; QNT; Quan; Quant; Quantitative; Random; RAR alpha form; RARalpha; Retinoic acid receptor alpha; Serum; SR	4180186
40761871	落花生 重组 (rAra h) 3 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40761872	Peanut (rAra h) 2 IgE Qn	4180186
40761872	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f013; f13; f423; II; Immune globulin E; Immunoglobulin E; NR1B1; Peanut; Peanut (rAra h) 2; Point in time; QNT; Quan; Quant; Quantitative; Random; RAR alpha form; RARalpha; Retinoic acid receptor alpha; Serum; SR	4180186
40761872	落花生 重组 (rAra h) 2 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40761873	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f013; f13; f422; i; Immune globulin E; Immunoglobulin E; NR1B1; Peanut; Peanut (rAra h) 1; Point in time; QNT; Quan; Quant; Quantitative; Random; RAR alpha form; RARalpha; Retinoic acid receptor alpha; Serum; SR	4180186
40761873	Peanut (rAra h) 1 IgE Qn	4180186
40761873	落花生 重组 (rAra h) 1 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40761875	Ca; Cal; Chemistry; Diaf; DiafP; Dialysate; Dialysis fluid; Kidney; Level; Mass concentration; Nephrology; Peritoneal Dialysis fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal	4180186
40761875	Calcium DiafP-mCnc	4180186
40761875	钙:质量浓度:时间点:腹膜透析液:定量型	4182948
40761876	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzootic pneumonia; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; M pneumo; M pneumonia; M pneumoniae; MEIA; Microbiology; Myco; Myco pneu; Mycoplas; Mycoplasm; Mycoplasmoides pneumoniae; Mycoplasmosis; Mycoplsm; Neuro; Neurology; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
40761876	M pneumo IgM CSF IA-aCnc	4180186
40761876	肺炎支原体 抗体.IgM:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40761877	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; Herp splx; Herpes simplex virus type 2; Herpes simplex virus type II; HSV; HSV2; IAA; ID; II; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
40761877	HSV2 IgM CSF IA-aCnc	4180186
40761877	单纯疱疹病毒 2 型 抗体.IgM:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40761884	CV B IgM Titr Ser IF	4180186
40761884	柯萨奇病毒 B 型 抗体.IgM:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40761884	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CAV; CBV; Coxsackie; Coxsackie virus; CV; CV B; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40761887	Phytonadione SerPl-sCnc	4180186
40761887	Chemistry; Level; Phylloquinone; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Vit K1; Vitamin K1	4180186
40761887	植物甲萘醌:物质的量浓度:时间点:血清/血浆:定量型	4182948
40761890	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Basem; Basemt; BM; FA; Fluorescent antibody; Fluoresent; GBM; Glom; Goodpastures; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Kidney; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF	4180186
40761890	GBM IgG Ser Ql IF	4180186
40761890	肾小球基底膜 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40761893	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; i; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; L pneumo; L pneumo1; L pneumonphila; Legion; Legionela; Legionella pneumophila serogroup 1; MEIA; Microbiology; Philadelphia 1; Pneu; pneum; Pneumophilia; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS	4180186
40761893	L pneumo1 IgG Ser IA-aCnc	4180186
40761893	嗜肺军团菌 1 型 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40761896	100WBC; Cell; Cellularity; Diaf; DiafP; Dialysate; Dialysis fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Mononuc; Mononuc Cells; Number Fraction; Percent; Peritoneal Dialysis fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
40761896	Mononuc Cells/leuk NFr DiafP	4180186
40761896	单个核细胞/100 个白细胞:计数型分数:时间点:腹膜透析液:定量型	4182948
40761897	2-propanone; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Ketone bodies; Mass concentration ratio; Mass ratio; MCRto; Me2CO; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40761897	Acetone/Creat Ur	4180186
40761897	丙酮/肌酐:质量比率:时间点:尿液:定量型	4182948
40761899	WBC # Ur Strip.auto	4180186
40761899	白细胞:计数型浓度:时间点:尿液:定量型:试纸条.自动化法	4182948
40761899	#; ABS; absolute; absolutes; Auto; Automated detection; Cnt; Count; Count/volume; CT; Dip stick; Dipstick; Elec; Elect; Electr; Leuc; Leuk; Leukocyte; Lkcs; Number concentration; Number Concentration (count/vol); Point in time; Random; SmQn; UA; UR; URINALYSIS; Urn; WBC; WBCs; White blood cell; White blood cells	4180186
40761902	Aspergillus Ab Titr Ser HA	4180186
40761902	ABS; Aby; Antby; Anti; Antibodies; Antibody; Asperg; Aspergil; Aspergilis; Aspergilla; Aspergillin; Aspergillosis; Aspergils; Aspergilus; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); Farmers lung; Hemagglutination; ID; IHA; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; species; spp; SR; Titer; Titered; Titre; Ttr	4180186
40761902	曲霉属单个未知种 抗体:滴定度:时间点:血清:定量型:红细胞凝集试验法	4182948
40761903	R conorii IgG Titr CSF IF	4180186
40761903	康氏立克次体 抗体.IgG:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
40761903	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Boutonneuse fever; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Mediterranean spotted fever; Microbiology; Neuro; Neurology; Point in time; R conorii; Random; Ricket; Rickettsial; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Spotted fever; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40761906	Angiotensin forming enzyme; Angiotensinogenase; Cardio; Cardiology; CHEMISTRY.CHALLENGE TESTING; Direct renin; DRC; Endocrine; Endocrinology; Heart Disease; Kidney; Level; Mass concentration; Nephrology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; sp3; Spec	4180186
40761906	Renin sp3 Plas-mCnc	4180186
40761906	肾素^第3个标本:质量浓度:时间点:血浆:定量型	4182948
40761907	Angiotensin forming enzyme; Angiotensinogenase; Cardio; Cardiology; CHEMISTRY.CHALLENGE TESTING; Convalescent; Direct renin; DRC; Endocrine; Endocrinology; Heart Disease; Kidney; Level; Mass concentration; Nephrology; Pl; Plasma; Plsm; Point in time; Post immunization; QNT; Quan; Quant; Quantitative; Random; Renal; Second; sp2; Spec	4180186
40761907	Renin sp2 Plas-mCnc	4180186
40761907	肾素^第2个标本:质量浓度:时间点:血浆:定量型	4182948
40761909	17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; CHEMISTRY.CHALLENGE TESTING; Convalescent; Endocrine; Endocrinology; Genetics; Heredity; Heritable; Hydroxyproges; Hydroxyprogstron; Inherited; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Post immunization; QNT; Quan; Quant; Quantitative; Random; Second; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp2; Spec; SR	4180186
40761909	17OHP sp2 SerPl-mCnc	4180186
40761909	17-羟孕酮^第2个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761911	17-beta estradiol; CHEMISTRY.CHALLENGE TESTING; E2; Gyn; Gynecology; Level; Mass concentration; OB; ObGyn; Obstetrics; Oestradiol; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp3; Spec; SR	4180186
40761911	Estradiol sp3 SerPl-mCnc	4180186
40761911	雌二醇^第3个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761913	17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp21; Spec; SR	4180186
40761913	Cortis sp21 SerPl-mCnc	4180186
40761913	皮质醇^第21个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761914	17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp24; Spec; SR	4180186
40761914	Cortis sp24 SerPl-mCnc	4180186
40761914	皮质醇^第24个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761915	Cortis sp23 SerPl-mCnc	4180186
40761915	17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp23; Spec; SR	4180186
40761915	皮质醇^第23个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761919	17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp18; Spec; SR	4180186
40761919	Cortis sp18 SerPl-mCnc	4180186
40761919	皮质醇^第18个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761920	17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp17; Spec; SR	4180186
40761920	Cortis sp17 SerPl-mCnc	4180186
40761920	皮质醇^第17个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761923	17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp15; Spec; SR	4180186
40761923	Cortis sp15 SerPl-mCnc	4180186
40761923	皮质醇^第15个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761924	17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp13; Spec; SR	4180186
40761924	Cortis sp13 SerPl-mCnc	4180186
40761924	皮质醇^第13个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761929	BS; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Testo; Testos; Testost	4180186
40761929	Testost BS SerPl-mCnc	4180186
40761929	睾酮^基线:质量浓度:时间点:血清/血浆:定量型	4182948
40761932	BS; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; FR; FreeT4; FT4; Level; Levothyroxine; Levo-thyroxine; L-thyroxine; Mass concentration; Non-protein bound; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T4; T-4; T4 Free; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T4; TT4	4180186
40761932	T4 Free BS SerPl-mCnc	4180186
40761932	甲状腺素.游离型^基线:质量浓度:时间点:血清/血浆:定量型	4182948
40761934	BS; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; FR; Free T3; FT3; Level; Mass concentration; Non-protein bound; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T3; T-3; T3Free; thyroid hormone; Total T3; Triodothyrne	4180186
40761934	T3Free BS SerPl-mCnc	4180186
40761934	三碘甲状腺原氨酸.游离型^基线:质量浓度:时间点:血清/血浆:定量型	4182948
40761936	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp25; Spec; SR; STH	4180186
40761936	GH sp25 SerPl-mCnc	4180186
40761936	生长激素^第25个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761937	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp24; Spec; SR; STH	4180186
40761937	GH sp24 SerPl-mCnc	4180186
40761937	生长激素^第24个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761938	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp20; Spec; SR; STH	4180186
40761938	GH sp20 SerPl-mCnc	4180186
40761938	生长激素^第20个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761940	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp18; Spec; SR; STH	4180186
40761940	GH sp18 SerPl-mCnc	4180186
40761940	生长激素^第18个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761941	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp17; Spec; SR; STH	4180186
40761941	GH sp17 SerPl-mCnc	4180186
40761941	生长激素^第17个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761944	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp14; Spec; SR; STH	4180186
40761944	GH sp14 SerPl-mCnc	4180186
40761944	生长激素^第14个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761945	Testost 3D p chal SerPl-mCnc	4180186
40761945	3D p chal; After; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Testo; Testos; Testost	4180186
40761945	睾酮^在XXX刺激之后3天:质量浓度:时间点:血清/血浆:定量型	4182948
40761946	Osmolality p 1.5h FFST Ur	4180186
40761946	1 1/2 hours; 1 1/2 HR; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p 1.5h FFST; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40761946	渗透压^在液体型禁食之后1.5小时:渗透压:时间点:尿液:定量型	4182948
40761947	After; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p 30M FFST; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40761947	Osmolality p 30M FFST Ur	4180186
40761947	渗透压^在液体型禁食之后30分钟:渗透压:时间点:尿液:定量型	4182948
40761948	Estradiol 4D p chal SerPl-mCnc	4180186
40761948	17-beta estradiol; 4D p chal; After; CHEMISTRY.CHALLENGE TESTING; E2; Level; Mass concentration; Oestradiol; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761948	雌二醇^在XXX刺激之后4天:质量浓度:时间点:血清/血浆:定量型	4182948
40761949	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp13; Spec; SR; STH	4180186
40761949	GH sp13 SerPl-mCnc	4180186
40761949	生长激素^第13个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761950	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp10; Spec; SR; STH	4180186
40761950	GH sp10 SerPl-mCnc	4180186
40761950	生长激素^第10个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761951	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp9; Spec; SR; STH	4180186
40761951	GH sp9 SerPl-mCnc	4180186
40761951	生长激素^第9个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761952	After; CHEMISTRY.CHALLENGE TESTING; Intact Parathormone; intact parathyroid hormone; iPTH; Level; Mass concentration; p chal; Parathormone; Parathyroid hormone; Pl; Plasma; Plsm; Point in time; PST; PTH; PTH-Intact; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker	4180186
40761952	PTH-Intact p chal SerPl-mCnc	4180186
40761952	甲状旁腺素.完整型^在 XXX 刺激之后:质量浓度:时间点:血清/血浆:定量型	4182948
40761954	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp48; Spec; SR; STH	4180186
40761954	GH sp48 SerPl-mCnc	4180186
40761954	生长激素^第48个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761957	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp45; Spec; SR; STH	4180186
40761957	GH sp45 SerPl-mCnc	4180186
40761957	生长激素^第45个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761959	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp43; Spec; SR; STH	4180186
40761959	GH sp43 SerPl-mCnc	4180186
40761959	生长激素^第43个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761964	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp38; Spec; SR; STH	4180186
40761964	GH sp38 SerPl-mCnc	4180186
40761964	生长激素^第38个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761967	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp35; Spec; SR; STH	4180186
40761967	GH sp35 SerPl-mCnc	4180186
40761967	生长激素^第35个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761969	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp32; Spec; SR; STH	4180186
40761969	GH sp32 SerPl-mCnc	4180186
40761969	生长激素^第32个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761971	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp30; Spec; SR; STH	4180186
40761971	GH sp30 SerPl-mCnc	4180186
40761971	生长激素^第30个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761973	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp28; Spec; SR; STH	4180186
40761973	GH sp28 SerPl-mCnc	4180186
40761973	生长激素^第28个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761974	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp27; Spec; SR; STH	4180186
40761974	GH sp27 SerPl-mCnc	4180186
40761974	生长激素^第27个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761975	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp26; Spec; SR; STH	4180186
40761975	GH sp26 SerPl-mCnc	4180186
40761975	生长激素^第26个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761976	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp23; Spec; SR; STH	4180186
40761976	GH sp23 SerPl-mCnc	4180186
40761976	生长激素^第23个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761977	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp22; Spec; SR; STH	4180186
40761977	GH sp22 SerPl-mCnc	4180186
40761977	生长激素^第22个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761980	30M p chal; After; Blood; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; p chal; Point in time; PST; Pyruvic acid; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40761980	Pyruvate 30M p chal Bld-mCnc	4180186
40761980	丙酮酸^在XXX刺激之后30分钟:质量浓度:时间点:全血:定量型	4182948
40761981	Pyruvate 15M p chal Bld-mCnc	4180186
40761981	15M p chal; After; Blood; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; p chal; Point in time; PST; Pyruvic acid; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40761981	丙酮酸^在XXX刺激之后15分钟:质量浓度:时间点:全血:定量型	4182948
40761982	Pyruvate 10M p chal Bld-mCnc	4180186
40761982	10M p chal; After; Blood; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; p chal; Point in time; PST; Pyruvic acid; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40761982	丙酮酸^在XXX刺激之后10分钟:质量浓度:时间点:全血:定量型	4182948
40761983	Pyruvate 3M p chal Bld-mCnc	4180186
40761983	3M p chal; After; Blood; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; p chal; Point in time; PST; Pyruvic acid; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40761983	丙酮酸^在XXX刺激之后3分钟:质量浓度:时间点:全血:定量型	4182948
40761984	Pyruvate 1M p chal Bld-mCnc	4180186
40761984	1M p chal; After; Blood; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; p chal; Point in time; PST; Pyruvic acid; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40761984	丙酮酸^在XXX刺激之后1分钟:质量浓度:时间点:全血:定量型	4182948
40761985	Calcit 1M p chal SerPl-mCnc	4180186
40761985	1M p chal; After; CHEMISTRY.CHALLENGE TESTING; CT; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyrocalcitonin; Tumor marker	4180186
40761985	降钙素^在XXX刺激之后1分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40761990	C peptide p chal SerPl-mCnc	4180186
40761990	After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Mass concentration; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761990	C 肽^在 XXX 刺激之后:质量浓度:时间点:血清/血浆:定量型	4182948
40761994	AIDS; Antigen; Antigens; Arbitrary concentration; EIA; ELFA; ELISA; Enzyme immunoassay; HIV 1 & 2; HIV 1 and 2 Ab; HIV 1+2 Ab+HIV1p24; HIV type 1; HIV type I; HIV1; HIV1+2; HIV1+2 Ab+HIV1p24Ag; Human immunodeficiency virus; i; IAA; ID; II; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
40761994	HIV 1+2 Ab+HIV1 p24 Ag SerPl IA-aCnc	4180186
40761994	HIV 1 型+2 型抗体+HIV 1 型 p24 抗原:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
40761996	beta-factor XIIa part 1; Blood; coagulation factor XII; coagulation factor XII (Hageman factor); coagulation factor XIIa heavy chain; coagulation factor XIIa light chain; EC 3.4.21.38; Gene mut tested; Genetics; HAE3; HAEX; HAF; Hageman factor; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Tested; Mutation; Muts; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40761996	F12 gene Mut Tested Bld/T	4180186
40761996	F12 基因 已测试的突变:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40761997	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Aminoglycosides; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Neosporin; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40761997	Neomycin IgE Qn	4180186
40761997	新链丝菌素 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40762001	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; Hepatology; i; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Liver; Liver kidney microsome; LKM; LKM1; LKM-1; Microsm; Microsom; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF	4180186
40762001	LKM-1 Ab Ser Ql IF	4180186
40762001	肝肾微粒体 1 抗体:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40762002	11DC 40M p chal SerPl-mCnc	4180186
40762002	11DC; 40M p chal; After; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Deoxycortisol; Desoxycortisol; Level; Mass concentration; Metopirone; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762002	11-脱氧皮质醇^在XXX刺激之后40分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40762006	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e215; Feathers; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Re215; Serum; SR	4180186
40762006	Pigeon Feather IgG-mCnc	4180186
40762006	鸽子羽毛 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40762007	ABS; Aby; African Gray Parrot; African Grey Parrot; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e213; e91; Feathers; Immune globulin G; Immunoglobulin G; Level; Macaw; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40762007	Parrot Feather IgG-mCnc	4180186
40762007	鹦鹉羽毛 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40762009	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e196; Feathers; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40762009	Parakeet Feather IgG-mCnc	4180186
40762009	长尾小鹦鹉羽毛 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40762012	Androstanolone 30M p chal SerPl-mCnc	4180186
40762012	30M p chal; After; CHEMISTRY.CHALLENGE TESTING; DHT; Dihydrotestosterone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762012	双氢睾酮^在XXX刺激之后30分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40762013	1 1/2 hours; 1 1/2 HR; 1.5h p chal; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; gamma-4-Androstenedione; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762013	Androst 1.5h p chal SerPl-mCnc	4180186
40762013	雄烯二酮^在XXX刺激之后1.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
40762014	Blood; CD3 Cells; CD3+CD4+ Cells; CD3-CD4+; CD4 Cells; CD4+ T cells; CD4+CD45RO+ Cells; Cell; CELL MARKERS; Cellularity; Helper T cells; Inducer T cells; L3T4; Leu3; Leu-3; Leu4; Leu-4; Number ratio; Point in time; QNT; Quan; Quant; Quantitative; Random; T3; T4; T-4; T4 helper/inducer cells; UCHL-1; W3/25; WB; Whole blood	4180186
40762014	CD4+CD45RO+ Cells/CD3+CD4+ Cells Bld	4180186
40762014	细胞.CD4+CD45RO+/细胞.CD3+CD4+:计数型比率:时间点:全血:定量型	4182948
40762015	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Formiminoglutamic Acidemia; Gln; His; Histidinemia; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
40762015	Glutamine+Histidine CSF-sCnc	4180186
40762015	谷氨酰胺+组氨酸:物质的量浓度:时间点:脑脊液:定量型	4182948
40762016	120 min; 120 minutes; 120min; 2 hours; 2h p chal; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; VP	4180186
40762016	Vasopressin 2h p chal Plas-mCnc	4180186
40762016	后叶加压素^在XXX刺激之后2小时:质量浓度:时间点:血浆:定量型	4182948
40762018	Blood; Gene mut tested; Genetics; Heredity; Heritable; Identity or presence; Inherited; LAC; Lactase; lactase-glycosylceramidase; Lactase-Phlorizin Hydrolase; lactase-phlorizin hydrolase-1; LPH; LPH1; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Tested; Mutation; Muts; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40762018	LCT gene Mut Tested Bld/T	4180186
40762018	LCT 基因 已测试的突变:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40762019	Addiction; Dextro-methamphetamine; D-methamphet; D-methamphetamine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40762019	D-methamphet Ur Ql	4180186
40762019	右旋甲基苯丙胺:存在情况或阈值:时间点:尿液:序数型	4182948
40762021	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40762021	HLA-DQA1*03:01 Ql	4180186
40762021	HLA-DQA1*03:01:存在情况或阈值:时间点:全血/组织:序数型	4182948
40762022	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40762022	HLA-DQB1*03:02 Ql	4180186
40762022	HLA-DQB1*03:02:存在情况或阈值:时间点:全血/组织:序数型	4182948
40762023	Glutamine+Histidine SerPl-sCnc	4180186
40762023	Chemistry; Formiminoglutamic Acidemia; Gln; His; Histidinemia; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40762023	谷氨酰胺+组氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
40762027	Fat 72h Stl-mCnt	4180186
40762027	3 days; 72 hours; 72HR; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Mass content; QNT; Quan; Quant; Quantitative; Stl; Stool = Fecal	4180186
40762027	脂肪:质量含量:72小时:大便:定量型	4182948
40762028	ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Y pseudoTB; Y pseudotuberculosis	4180186
40762028	Y pseudoTB Ab Ser Ql Aggl	4180186
40762028	假结核耶尔森氏菌 抗体:存在情况或阈值:时间点:血清:序数型:凝集试验法	4182948
40762032	#; ABS; absolute; absolutes; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD34 Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Fl; Fld; FLU; Fluid; gp105-120; Hematopoietic stem cell; HSC; My10; My-10; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Stem cells	4180186
40762032	CD34 Cells # Fld	4180186
40762032	细胞.CD34:计数型浓度:时间点:体液:定量型	4182948
40762034	Bili; Bilirubins; Billirubin; Chemistry; Dermatologic; Epidermis; Integument; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Skn; TBIL; TcB	4180186
40762034	Bilirub Skin-mCnc	4180186
40762034	胆红素:质量浓度:时间点:皮肤:定量型:经皮测定仪	4182948
40762035	Acd; Acid fast Stn; Acids; AFB stain; Identity or presence; Lung; Microbiology; Nominal; Pleural; Pleural fluid; Point in time; Pulmonary; Pulmonology; Random; Respiratory; St; Stains; Stn; thoracentesis fluid; ZN Stn	4180186
40762035	ZN Stn Plr	4180186
40762035	显微镜观察:存在与否或特征标识:时间点:胸膜液:名义型:抗酸染色法.Ziehl-Neelsen	4182948
40762036	Acd; Acid fast Stn; Acids; AFB stain; Cerebral spinal fluid; Cerebrospinal Fl; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Nominal; Point in time; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; St; Stains; Stn; ZN Stn	4180186
40762036	ZN Stn CSF	4180186
40762036	显微镜观察:存在与否或特征标识:时间点:脑脊液:名义型:抗酸染色法.Ziehl-Neelsen	4182948
40762038	Acd; Acid fast Stn; Acids; AFB stain; Ascites; Ascitic fluid; Ascitis; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Peritoneal fluid; Point in time; Prt; Random; St; Stains; Stn; ZN Stn	4180186
40762038	ZN Stn Prt	4180186
40762038	显微镜观察:存在与否或特征标识:时间点:腹膜液:名义型:抗酸染色法.Ziehl-Neelsen	4182948
40762039	Arbitrary concentration; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; ICSH; Interstitial cell-stimulating hormone; Interstitual cell stimulating hormone; Leutinizing hormone; LH; Luteinizing hormone; Lutenin; Lutenizing hormone; Ovulation test; Pl; Plasma; Plsm; Point in time; pre chal; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762039	LH pre chal SerPl-aCnc	4180186
40762039	促黄体素^在 XXX 刺激之前:任意型浓度:时间点:血清/血浆:定量型	4182948
40762040	Arbitrary concentration; Before; CHEMISTRY.CHALLENGE TESTING; Follicle stimulating hormone; FSH; Pl; Plasma; Plsm; Point in time; pre chal; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762040	FSH pre chal SerPl-aCnc	4180186
40762040	促卵泡激素^在 XXX 刺激之前:任意型浓度:时间点:血清/血浆:定量型	4182948
40762041	Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; pre chal; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40762041	GH pre chal SerPl-mCnc	4180186
40762041	生长激素^在 XXX 刺激之前:质量浓度:时间点:血清/血浆:定量型	4182948
40762042	Chemistry; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp12; Spec; SR; STH	4180186
40762042	GH sp12 SerPl-mCnc	4180186
40762042	生长激素^第12个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40762045	Testost free+total panel SerPl-mCnc	4180186
40762045	Chemistry; FR; Level; Mass concentration; Non-protein bound; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Testo; Testos; Testost; Testost Free; Testost free+total panel; Testosterone.unconjugated; Tot; Totl	4180186
40762045	游离型睾酮与总睾酮组套:质量浓度:时间点:血清/血浆:定量型	4182948
40762046	Meperidine + Normeperidine Pnl Ur	4180186
40762046	Algil; Alodan; Centralgine; Demerol; Dispadol; Dolantin; Dolosal; DRUG/TOXICOLOGY; Drugs; Meperidine + Normeperidine Pnl; Meperidine metabolite; Meperidine+Nor; Norpethidine; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pethidine; Pnl; Point in time; Random; UA; UR; Urn	4180186
40762046	哌替啶与去甲哌替啶:-:时间点:尿液:-	4182948
40762048	Pyridinoline + Deoxypyridinoline Ur-Imp	4180186
40762048	Chemistry; DPD; Dpyr; Free lysly-pyridinoline; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Lysylpyridinoline; Nominal; Point in time; PYD; PYD+DPD; Pyr; Pyradinium collagen crosslinks; Pyridinium collagen crosslinks; Pyridinoline + Deoxypyridinoline; Random; UA; UR; Urn	4180186
40762048	吡啶啉与脱氧吡啶啉:印象:时间点:尿液:名义型	4182948
40762053	BIPAP; BPAP; Lung; Point in time; Pos; Pressure; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
40762053	BPAP Vent	4180186
40762053	压力.气道内双水平正向:压力或压强:时间点:呼吸机:定量型	4182948
40762054	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; GT1b Ganlg; IAA; Immune globulin M; Immunoglobulin M; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS; Trisialoganglioside	4180186
40762054	GT1b Ganlg IgM Ser IA-aCnc	4180186
40762054	神经节苷脂 GT1b 抗体.IgM:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40762055	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; GT1b Ganlg; IAA; Immune globulin G; Immunoglobulin G; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS; Trisialoganglioside	4180186
40762055	GT1b Ganlg IgG Ser IA-aCnc	4180186
40762055	神经节苷脂 GT1b 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40762056	GT1a Gangl IgM Ser IA-aCnc	4180186
40762056	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; GT1a Gangl; IAA; Immune globulin M; Immunoglobulin M; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS; Trisialoganglioside	4180186
40762056	神经节苷脂 GT1a 抗体.IgM:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40762057	GT1a Gangl IgG Ser IA-aCnc	4180186
40762057	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; GT1a Gangl; IAA; Immune globulin G; Immunoglobulin G; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS; Trisialoganglioside	4180186
40762057	神经节苷脂 GT1a 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40762058	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin M; Immunoglobulin M; MEIA; Monosialoganglioside; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
40762058	GM4 IgM Ser IA-aCnc	4180186
40762058	神经节苷脂 GM4 抗体.IgM:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40762059	GM4 IgG Ser IA-aCnc	4180186
40762059	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; Monosialoganglioside; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
40762059	神经节苷脂 GM4 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40762061	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Asialo Gm1; AsialoGM1; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; Ganglioside asialo; GM1 Asialo; IAA; Immune globulin G; Immunoglobulin G; MEIA; Monoasialoganglioside; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
40762061	GM1 Asialo IgG CSF IA-aCnc	4180186
40762061	无唾液酸基神经节苷脂 Gm1 抗体.IgG:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40762062	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Disialolganglioside; EIA; ELFA; ELISA; Enzyme immunoassay; GD1a; GD1a Gangl; IAA; Immune globulin G; Immunoglobulin G; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
40762062	GD1a Gangl IgG CSF IA-aCnc	4180186
40762062	神经节苷脂 GD1a 抗体.IgG:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40762063	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Disialolganglioside; EIA; ELFA; ELISA; Enzyme immunoassay; GD1a; GD1a Gangl; IAA; Immune globulin M; Immunoglobulin M; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
40762063	GD1a Gangl IgM CSF IA-aCnc	4180186
40762063	神经节苷脂 GD1a 抗体.IgM:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40762064	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Disialolganglioside; Disialylganglioside; EIA; ELFA; ELISA; Enzyme immunoassay; GD1b; GD1b Gangl; IAA; Immune globulin G; Immunoglobulin G; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
40762064	GD1b Gangl IgG CSF IA-aCnc	4180186
40762064	神经节苷脂 GD1b 抗体.IgG:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40762065	GM1 Gangl IgG CSF IA-aCnc	4180186
40762065	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; Ganglioside monosialo; GM1 Gangl; IAA; Immune globulin G; Immunoglobulin G; MEIA; Monosialoganglioside; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
40762065	神经节苷脂 GM1 抗体.IgG:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40762067	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; GM2 Gangl; IAA; Immune globulin M; Immunoglobulin M; MEIA; Monosialoganglioside; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
40762067	GM2 Gangl IgM CSF IA-aCnc	4180186
40762067	神经节苷脂 GM2 抗体.IgM:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40762068	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; GQ1b; GQ1b Gangl; IAA; Immune globulin G; Immunoglobulin G; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS; Tetrasialylganglioside	4180186
40762068	GQ1b Gangl IgG CSF IA-aCnc	4180186
40762068	神经节苷脂 GQ1b 抗体.IgG:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40762070	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Disialolganglioside; Disialylganglioside; EIA; ELFA; ELISA; Enzyme immunoassay; GD1b; GD1b Gangl; IAA; Immune globulin M; Immunoglobulin M; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
40762070	GD1b Gangl IgM Ser IA-aCnc	4180186
40762070	神经节苷脂 GD1b 抗体.IgM:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40762071	GD3 Gangl IgM Ser IA-aCnc	4180186
40762071	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Disialolganglioside; EIA; ELFA; ELISA; Enzyme immunoassay; GD3 Gangl; IAA; Immune globulin M; Immunoglobulin M; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
40762071	神经节苷脂 GD3 抗体.IgM:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40762073	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Disialolganglioside; EIA; ELFA; ELISA; Enzyme immunoassay; GD2 Gangl; IAA; Immune globulin M; Immunoglobulin M; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
40762073	GD2 Gangl IgM Ser IA-aCnc	4180186
40762073	神经节苷脂 GD2 抗体.IgM:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40762082	Specimen vol 18h Ur	4180186
40762082	18 hours; 18HR; QNT; Quan; Quant; Quantitative; Spec; UA; UR; Urn; Vol; Volume	4180186
40762082	标本体积:体积型属性:18小时:尿液:定量型	4182948
40762084	18 hours; 18HR; Chemistry; Mass rate; mRate; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40762084	Urea 18h Ur-mRate	4180186
40762084	尿素:质量速率:18小时:尿液:定量型	4182948
40762085	18 hours; 18HR; Chemistry; Kidney; Mass Rate; mRate; Nephrology; PR; Prot; QNT; Quan; Quant; Quantitative; Renal; UA; UR; Urn	4180186
40762085	Prot 18h Ur-mRate	4180186
40762085	蛋白质:质量速率:18小时:尿液:定量型	4182948
40762089	Potassium 18h Ur-sRate	4180186
40762089	18 hours; 18HR; Chemistry; k; K+; Potass; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
40762089	钾:物质的量速率:18小时:尿液:定量型	4182948
40762090	18 hours; 18HR; Chemistry; Glu; Gluc; Glucoseur; Mass rate; mRate; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40762090	Glucose 18h Ur-mRate	4180186
40762090	葡萄糖:质量速率:18小时:尿液:定量型	4182948
40762091	18 hours; 18HR; Chemistry; CR; Crea; Creat; Kidney; Mass Rate; mRate; Nephrology; QNT; Quan; Quant; Quantitative; Renal; UA; UCr; UR; Urn	4180186
40762091	Creat 18h Ur-mRate	4180186
40762091	肌酐:质量速率:18小时:尿液:定量型	4182948
40762092	Chloride 18h Ur-sRate	4180186
40762092	18 hours; 18HR; Chemistry; Cl; Cl-; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
40762092	氯:物质的量速率:18小时:尿液:定量型	4182948
40762093	Calcium 18h Ur-mRate	4180186
40762093	18 hours; 18HR; Ca; Cal; Chemistry; Mass Rate; mRate; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40762093	钙:质量速率:18小时:尿液:定量型	4182948
40762095	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762095	Deprecated Paliperidone SerPl-mCnc	4180186
40762096	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Lf; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
40762096	Lactoferrin Ab Ser IA-aCnc	4180186
40762096	乳铁蛋白 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40762097	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; BS; CHEMISTRY.CHALLENGE TESTING; Lact; Lactic acid; Level; L-lactate; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40762097	Lactate BS SerPl-sCnc	4180186
40762097	乳酸^基线:物质的量浓度:时间点:血清/血浆:定量型	4182948
40762098	Lactate 1M p chal SerPl-sCnc	4180186
40762098	1M p chal; 2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; After; CHEMISTRY.CHALLENGE TESTING; Lact; Lactic acid; Level; L-lactate; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40762098	乳酸^在XXX刺激之后1分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40762099	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; 3M p chal; After; CHEMISTRY.CHALLENGE TESTING; Lact; Lactic acid; Level; L-lactate; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40762099	Lactate 3M p chal SerPl-sCnc	4180186
40762099	乳酸^在XXX刺激之后3分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40762100	Lactate 5M p chal SerPl-sCnc	4180186
40762100	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; 5M p chal; After; CHEMISTRY.CHALLENGE TESTING; Lact; Lactic acid; Level; L-lactate; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40762100	乳酸^在XXX刺激之后5分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40762103	?Tm; Chemistry; Fract excret K; k; K+; Pl; Plasma; Plsm; Potass; QNT; Quan; Quant; Quantitative; Ratios; Rto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UA; UR; Ur+SerPl; Urn	4180186
40762103	Fract excret K ?Tm Ur+SerPl-Rto	4180186
40762103	钾排泄分数:比率:XXX:尿液+血清/血浆:定量型	4182948
40762104	Lactate 10M p chal SerPl-sCnc	4180186
40762104	10M p chal; 2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; After; CHEMISTRY.CHALLENGE TESTING; Lact; Lactic acid; Level; L-lactate; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40762104	乳酸^在XXX刺激之后10分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40762106	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; 30M p chal; After; CHEMISTRY.CHALLENGE TESTING; Lact; Lactic acid; Level; L-lactate; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40762106	Lactate 30M p chal SerPl-sCnc	4180186
40762106	乳酸^在XXX刺激之后30分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40762108	Carbohydrates Stl IR-mCnt	4180186
40762108	Bowel movement; Carbohydrate; Chemistry; Faecal; Faeces; Fecal; Feces; Infared spectoscopy; IR; Mass Content; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal	4180186
40762108	碳水化合物:质量含量:时间点:大便:定量型:红外光谱分析法	4182948
40762110	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
40762110	HLA-DPB1 High Res	4180186
40762110	HLA-DPB1:类型:时间点:全血/组织:名义型:高分辨率方法	4182948
40762111	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
40762111	HLA-DPA1 High Res	4180186
40762111	HLA-DPA1:类型:时间点:全血/组织:名义型:高分辨率方法	4182948
40762113	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
40762113	HLA-DRB5	4180186
40762113	HLA-DRB5:类型:时间点:全血/组织:名义型	4182948
40762114	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
40762114	HLA-DRB4	4180186
40762114	HLA-DRB4:类型:时间点:全血/组织:名义型	4182948
40762116	Adenosine deaminase DiafP-cCnc	4180186
40762116	ADA; ADO; ANED; Catalytic Concentration; Chemistry; Diaf; DiafP; Dialysate; Dialysis fluid; Medication stress; Peritoneal Dialysis fluid; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40762116	腺苷脱氨酶:催化浓度:时间点:腹膜透析液:定量型	4182948
40762117	30M p chal; Active renin; After; Angiotensin forming enzyme; Angiotensinogenase; Cardio; Cardiology; Catalytic Concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Heart Disease; Kidney; Lying; Nephrology; p chal; Pl; Plasma; Plasma renin activity; Plsm; Point in time; PRA; PST; QNT; Quan; Quant; Quantitative; Random; Renal; sup+30M p chal	4180186
40762117	Renin sup+30M p chal Plas-cCnc	4180186
40762117	肾素^仰卧位+在XXX刺激之后30分钟:催化浓度:时间点:血浆:定量型	4182948
40762120	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Asialo Gm1; AsialoGM1; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; Ganglioside asialo; GM1 Asialo; IAA; Immune globulin M; Immunoglobulin M; MEIA; Monoasialoganglioside; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
40762120	GM1 Asialo IgM CSF IA-aCnc	4180186
40762120	无唾液酸基神经节苷脂 Gm1 抗体.IgM:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40762122	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40762122	HLA-DRB1*15:01 Ql	4180186
40762122	HLA-DRB1*15:01:存在情况或阈值:时间点:全血/组织:序数型	4182948
40762123	B220; CD45 Cells; CD45+CD103+ Cells; CD45R; CD45RA; CD45RB; CD45RC; CD45RO; Cell; CELL MARKERS; Cellularity; Gated cells; HML-1; Human mucosal lymphocyte antigen 1; integrin alphaE chain; ITGAE; LCA; Leukocyte common antigen; Ly5; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T200; Tissue; Tissue, unspecified	4180186
40762123	CD45+CD103+ Cells NFr Tiss	4180186
40762123	细胞.CD45+CD103+/100 个细胞:计数型分数:时间点:组织与涂片:定量型	4182948
40762124	CD25+C69+ Cells NFr Bld	4180186
40762124	Blood; CD25 Cells; CD25+C69+ Cells; Cell; CELL MARKERS; Cellularity; Gated cells; IL-2 receptor alpha chain; IL-2R; IL-2R Tac antigen; ILR2; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tac antigen; WB; Whole blood	4180186
40762124	细胞.CD25+C69+/100 个细胞:计数型分数:时间点:全血:定量型	4182948
40762127	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Disialolganglioside; EIA; ELFA; ELISA; Enzyme immunoassay; GD2 Gangl; IAA; Immune globulin G; Immunoglobulin G; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
40762127	GD2 Gangl IgG Ser IA-aCnc	4180186
40762127	神经节苷脂 GD2 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40762130	Phosphate DiafP-mCnc	4180186
40762130	Chemistry; Diaf; DiafP; Dialysate; Dialysis fluid; i Phos; Inorganic phosphate; Level; Mass concentration; Peritoneal Dialysis fluid; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40762130	磷酸盐:质量浓度:时间点:腹膜透析液:定量型	4182948
40762131	Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Diaf; DiafP; Dialysate; Dialysis fluid; Kidney; Level; Lipid; Mass concentration; Nephrology; Peritoneal Dialysis fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal	4180186
40762131	Cholest DiafP-mCnc	4180186
40762131	胆固醇:质量浓度:时间点:腹膜透析液:定量型	4182948
40762133	Arbitrary concentration; CA; CA 125; Cancer Ag125; Cancer antigen 125; Carbohydrate antigen; Carbohydrate antigen 125; Chemistry; Diaf; DiafP; Dialysate; Dialysis fluid; Gyn; Gynecology; OB; ObGyn; Obstetrics; OC125; Peritoneal Dialysis fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Tumor marker	4180186
40762133	Cancer Ag125 DiafP-aCnc	4180186
40762133	癌抗原 125:任意型浓度:时间点:腹膜透析液:定量型	4182948
40762136	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp34; Spec; SR; STH	4180186
40762136	GH sp34 SerPl-mCnc	4180186
40762136	生长激素^第34个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40762138	BDPLT16; BDPLT2; Blood; CD61; Gene mut tested; Genetics; GP3A; GPIIIa; GT; Heredity; Heritable; Identity or presence; Inherited; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Tested; Mutation; Muts; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40762138	ITGB3 Mut Tested Bld/T	4180186
40762138	ITGB3 基因 已测试的突变:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40762139	Blood; Fibrinogen beta chain; Gene mut tested; Genetics; HEL-S-78p; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Tested; Mutation; Muts; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40762139	FGB Mut Tested Bld/T	4180186
40762139	FGB 基因 已测试的突变:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40762142	Coccidiodes; Coccidioides Ab.IgG + IgM Pnl; ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Other; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; San Joaquin Valley fever; Spec; species; spp; To be specified in another part of the message; Unspecified; Valley fever	4180186
40762142	Coccidioides Ab.IgG + IgM Pnl Spec	4180186
40762142	球孢子菌属抗体.IgG 与 IgM 组套:-:时间点:XXX:-	4182948
40762144	Anaero; Anaerobe; Anaerobe Cult; Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random; Tissue; Tissue, unspecified	4180186
40762144	Bacteria Tiss Anaerobe Cult org #4	4180186
40762144	细菌 已鉴定的^^^4:存在与否或特征标识:时间点:组织与涂片:名义型:厌氧微生物培养	4182948
40762146	Glucagon sp5 p fast SerPl-mCnc	4180186
40762146	After; Calorie Fast; CHEMISTRY.CHALLENGE TESTING; Fast; Fasting; HGF; Hyperglycemic factor; Level; Mass concentration; p fast; PC; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp5; sp5 p fast; Spec; SR	4180186
40762146	胰高血糖素^在热量型禁食之后的第5个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40762149	Glucagon sp2 p fast SerPl-mCnc	4180186
40762149	After; Calorie Fast; CHEMISTRY.CHALLENGE TESTING; Convalescent; Fast; Fasting; HGF; Hyperglycemic factor; Level; Mass concentration; p fast; PC; Pl; Plasma; Plsm; Point in time; Post immunization; PST; QNT; Quan; Quant; Quantitative; Random; Second; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp2; sp2 p fast; Spec; SR	4180186
40762149	胰高血糖素^在热量型禁食之后的第2个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40762150	Glucagon sp1 p fast SerPl-mCnc	4180186
40762150	Acute specimen; After; Calorie Fast; CHEMISTRY.CHALLENGE TESTING; Fast; Fasting; First; HGF; Hyperglycemic factor; Level; Mass concentration; p fast; PC; Pl; Plasma; Plsm; Point in time; Pre immunization; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp1; sp1 p fast; Spec; SR	4180186
40762150	胰高血糖素^在热量型禁食之后的第1个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40762152	Dis; Diseases; Dz; IBD; IBD Ab 7; IBD Ab 7 pnl; Pan; PANEL.SEROLOGY; Panl; Pnl; Point in time; Random; Serology; Serum; SR	4180186
40762152	IBD Ab 7 pnl Ser	4180186
40762152	炎症性肠病抗体 7 组套:-:时间点:血清:-	4182948
40762154	Adulterants Ur-Imp	4180186
40762154	Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random; UA; UR; Urn	4180186
40762154	混伪品:印象:时间点:尿液:名义型	4182948
40762158	Avian chlamydiosis; Bro; Bro Brush; C psittaci; C&S; Chlamydia; Chlamydia psittaci; Chlamydial abortion; CPS; Cult; Cultures; Enzootic abortion of ewes; ID; Infectious Disease; InfectiousDisease; Lung; Microbiology; Ordinal; Ornithosis; Ovine chlamydiosis; Point in time; PR; Psittacosis; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen; Spec	4180186
40762158	C psittaci Bro Brush Ql Cult	4180186
40762158	鹦鹉热嗜性衣原体:存在情况或阈值:时间点:支气管刷:序数型:微生物特异性培养	4182948
40762159	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Hepatology; IAA; Liver; MEIA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; SUDS	4180186
40762159	sp100 Ab Ser Ql IA	4180186
40762159	sp100 抗体:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40762160	5-aminolevulinate synthase 2; 5-aminolevulinate synthase, erythroid-specific, mitochondrial; 5-aminolevulinic acid synthase ALASE; ALASE; ALAS-E; aminolevulinate, delta-, synthase 2; aminolevulinate, delta-, synthase 2 (sideroblastic/hypochromic anemia); ANH1; ASB; Blood; Delta-ALA synthetase2; EC 2.3.1.37; FLJ93603; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue; XLDPP; XLEPP; XLSA	4180186
40762160	ALAS2 gene Mut Anl Bld/T	4180186
40762160	ALAS2 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40762163	Paraquat SerPl Ql	4180186
40762163	DRUG/TOXICOLOGY; Drugs; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762163	对草快:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40762165	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Hepatology; i; Immune blot; Immunobl; Immunoblot; Liver; Liver kidney microsome; LKM; LKM1; LKM-1; Microsm; Microsom; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40762165	LKM-1 Ab Ser Ql IB	4180186
40762165	肝肾微粒体 1 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40762166	CARD.US; Cardiac; Cardio; Cardiology; Circumf.transverse; Echography; Girth; Heart Disease; Hrt; Length; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound	4180186
40762166	Hrt Circumf.transverse US	4180186
40762166	周长.横断面:长度:时间点:心脏:定量型:超声	4182948
40762168	CARD.US; Cardiac; Cardio; Cardiology; Echography; Heart Disease; Hrt; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Xsection; Xsection.transverse	4180186
40762168	Hrt Xsection.transverse Area US	4180186
40762168	横截面.横向:面积:时间点:心脏:定量型:超声	4182948
40762171	CARD.US; Cardiac; Cardio; Cardiology; DIA; Diam; Echography; Heart Disease; Hrt; L; Length Ratio; LT; LV diam; Point in time; QNT; Quan; Quant; Quantitative; R; Random; RT; RV diam; Sonogram; Sonograph; Sonography; ULS; Ultrasound	4180186
40762171	Hrt LV diam/RV diam US	4180186
40762171	直径.左心室/直径.右心室:长度比率:时间点:心脏:定量型:超声	4182948
40762172	Bld flow; CARD.US; Cardio; Cardiology; Dynamic; Echography; Heart Disease; Largest; Max V; Maximal; Maximum; Peak; Peak reversal velocity; Point in time; PRV; Pulm v; QNT; Quan; Quant; Quantitative; Random; REV; Sonogram; Sonograph; Sonography; ULS; Ultrasound; V max; VEL max; Velocity; Ven; Venous; Vmax	4180186
40762172	Pulm v PRV AC US	4180186
40762172	血流.反向.最大值^在心房收缩过程中:速度:时间点:肺静脉:定量型:超声	4182948
40762173	Blood flow.diastolic.early wave.max; CARD.US; Cardiac; Cardio; Cardiology; Early wave; Echography; E-wave; Heart Disease; Hrt; Largest; Max V; Maximal; Maximum; Misc; Miscellaneous; Other; Peak; Peak E-wave; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Spec; To be specified in another part of the message; ULS; Ultrasound; Unspecified; V max; Velocity; Vmax	4180186
40762173	Valve Peak E-wave US	4180186
40762173	E 波.最大值:速度:时间点:心脏.瓣膜.XXX:定量型:超声	4182948
40762175	CARD.US; Cardiac; Cardio; Cardiology; Echography; Heart Disease; Hrt; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Spec; To be specified in another part of the message; ULS; Ultrasound; Unspecified	4180186
40762175	Valve Closure to opening Time US	4180186
40762175	关闭至打开:时间:时间点:心脏.瓣膜.XXX:定量型:超声	4182948
40762176	CARD.US; Cardiac; Cardio; Cardiology; Echography; Heart Disease; Hrt; IVRT; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound	4180186
40762176	Hrt Isovolumic relaxation time US	4180186
40762176	等容弛缓时间:时间:时间点:心脏:定量型:超声	4182948
40762182	CARD.US; Cardio; Cardiology; Echography; Heart Disease; Length; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; ROI; Sonogram; Sonograph; Sonography; Spec; Thick; To be specified in another part of the message; ULS; Ultrasound; Unspecified	4180186
40762182	ROI Thickness US	4180186
40762182	厚度:长度:时间点:兴趣区域.XXX:定量型:超声	4182948
40762183	CARD.US; Cardio; Cardiology; Echography; Heart Disease; Length; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; ROI; Sonogram; Sonograph; Sonography; Spec; To be specified in another part of the message; ULS; Ultrasound; Unspecified	4180186
40762183	ROI Internal dim US	4180186
40762183	内部尺寸:长度:时间点:兴趣区域.XXX:定量型:超声	4182948
40762186	CARD.US; Cardiac; Cardio; Cardiology; Echography; Heart Disease; Hrt; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound	4180186
40762186	Epicardial area US	4180186
40762186	心外膜面积:面积:时间点:心脏:定量型:超声	4182948
40762187	CARD.US; Cardiac; Cardio; Cardiology; Echography; Heart Disease; Hrt; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound	4180186
40762187	Endocardial area US	4180186
40762187	心内膜面积:面积:时间点:心脏:定量型:超声	4182948
40762188	CARD.US; Cardiac; Cardio; Cardiology; Echography; Heart Disease; Hrt; Hrt ventr; Largest; Maximal; Maximum; Peak; Point in time; QNT; QRS to S wave peak; Quan; Quant; Quantitative; Random; S prime; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ventricular	4180186
40762188	Hrt ventr QRS to S wave peak Time US	4180186
40762188	QRS 至 S 波.最大值:时间:时间点:心脏.心室:定量型:超声	4182948
40762189	Blood flow.diastolic.early wave.max; CARD.US; Cardiac; Cardio; Cardiology; Early wave; Echography; E-wave; Heart Disease; Hrt; Hrt ventr; Largest; Maximal; Maximum; Peak; Peak E-wave; Point in time; QNT; QRS to E wave peak; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ventricular	4180186
40762189	Hrt ventr QRS to E wave peak Time US	4180186
40762189	QRS 至 E 波.最大值:时间:时间点:心脏.心室:定量型:超声	4182948
40762190	CARD.US; Cardiac; Cardio; Cardiology; Echography; Heart Disease; Hrt; Hrt ventr; L; LT; LV; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ventricular	4180186
40762190	LV Meridional wall stress US	4180186
40762190	经线室壁应力:压力或压强:时间点:心脏.心室.左侧:定量型:超声	4182948
40762192	CARD.US; Cardiac; Cardio; Cardiology; Echography; Heart Disease; Hrt; Hrt ventr; Misc; Miscellaneous; MPI; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Spec; Tei; Time ratio; To be specified in another part of the message; ULS; Ultrasound; Unspecified; Ventricular	4180186
40762192	Hrt ventr MPI US	4180186
40762192	心肌性能指数:时间比率:时间点:心脏.心室.XXX:定量型:超声	4182948
40762193	Atrial wave; A-wave; a-wave amp; CARD.US; Cardiac; Cardio; Cardiology; Echography; Heart Disease; Hrt; Length; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Spec; To be specified in another part of the message; ULS; Ultrasound; Unspecified	4180186
40762193	Valve A-wave amp US	4180186
40762193	A 波振幅:长度:时间点:心脏.瓣膜.XXX:定量型:超声	4182948
40762197	Atrial wave; A-wave; Blood flow.diastolic.atrial wave.max; Blood flow.diastolic.early wave.max; CARD.US; Cardiac; Cardio; Cardiology; Early wave; Echography; E-wave; Heart Disease; Hrt; Largest; Maximal; Maximum; Misc; Miscellaneous; Other; Peak; Peak A wave; Peak A-wave; Peak E-wave; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Spec; To be specified in another part of the message; ULS; Ultrasound; Unspecified; Velocity ratio	4180186
40762197	Valve Peak E-wave/Peak A wave US	4180186
40762197	E 波.最大值/A 波.最大值:速度比率:时间点:心脏.瓣膜.XXX:定量型:超声	4182948
40762199	@ stenosis; CARD.US; Cardio; Cardiology; Circ; Circ sys; Echography; Grad; Heart Disease; Largest; Maximal; Maximum; Misc; Miscellaneous; Other; Peak; Peak press grad; Point in time; Press grad; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Spec; sten; To be specified in another part of the message; ULS; Ultrasound; Unspecified	4180186
40762199	Peak press grad @ stenosis US	4180186
40762199	压力梯度.最大值^在狭窄处:压差:时间点:循环系统.XXX:定量型:超声	4182948
40762200	@ stenosis; CARD.US; Cardio; Cardiology; Circ; Circ sys; Echography; Heart Disease; Largest; Max V; Maximal; Maximum; Misc; Miscellaneous; Other; Peak; Peak velocity; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Spec; sten; To be specified in another part of the message; ULS; Ultrasound; Unspecified; V max; Vel; Velocity; Vmax	4180186
40762200	Peak velocity @ stenosis US	4180186
40762200	速度.最大值^在狭窄处:速度:时间点:循环系统.XXX:定量型:超声	4182948
40762202	CARD.US; Cardiac; Cardio; Cardiology; Echography; Heart Disease; Hrt; Length; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Spec; To be specified in another part of the message; ULS; Ultrasound; Unspecified	4180186
40762202	Valve Leaflet separation US	4180186
40762202	瓣叶分离:长度:时间点:心脏.瓣膜.XXX:定量型:超声	4182948
40762208	CARD.US; Cardiac; Cardio; Cardiology; Dynamic; Echography; Heart Disease; Hrt; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Spec; To be specified in another part of the message; ULS; Ultrasound; Unspecified; Vel; Velocity	4180186
40762208	Valve Flow propagation velocity US	4180186
40762208	血流传播速度:速度:时间点:心脏.瓣膜.XXX:定量型:超声	4182948
40762209	AO; Aortic; CARD.US; Cardio; Cardiology; DIA; Diam; Diam AO root; Diam AO STJ; Echography; Heart Disease; Length Ratio; OA root; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound	4180186
40762209	Diam AO STJ/OA root US	4180186
40762209	直径.主动脉窦管结合部/直径.主动脉根部:长度比率:时间点:主动脉:定量型:超声	4182948
40762211	Average; Avg; CARD.US; Cardiac; Cardio; Cardiology; Echography; Fibers; Heart beat; Heart Disease; HR cor; Hrt; Hrt ventr; L; LT; LV; Mean VcFv; Point in time; Pulse; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; V mean; VcF; VcFv; Velocity; Ventricular; Vmean	4180186
40762211	LV Mean VcFv HR cor US	4180186
40762211	周径纤维缩短.平均值^^经过针对心率而校正的:速度:时间点:心脏.心室.左侧:定量型:超声	4182948
40762215	CARD.US; Cardiac; Cardio; Cardiology; C-E distance; Echography; Heart Disease; Hrt; Length; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Spec; To be specified in another part of the message; ULS; Ultrasound; Unspecified	4180186
40762215	Valve C-E distance US	4180186
40762215	C-E 位移:长度:时间点:心脏.瓣膜.XXX:定量型:超声	4182948
40762218	Atrial wave; A-wave; Bld vel; CARD.US; Cardiac; Cardio; Cardiology; Echography; Heart Disease; Hrt; Hrt ventr; L; Length; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; TVI; ULS; Ultrasound; Vel; Ventricular; VTI; VTI A-wave	4180186
40762218	LV VTI A-wave US	4180186
40762218	血液速度-时间积分.A 波:长度:时间点:心脏.心室.左侧:定量型:超声	4182948
40762219	CARD.US; Cardio; Cardiology; Echography; Heart Disease; Point in time; PV; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Velocity	4180186
40762219	PV B-C slope US	4180186
40762219	B-C 斜率:速度:时间点:肺动脉瓣:定量型:超声	4182948
40762220	CARD.US; Cardiac; Cardio; Cardiology; Dextro; Echography; Heart Disease; Hrt; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Spec; To be specified in another part of the message; ULS; Ultrasound; Unspecified; Velocity	4180186
40762220	Valve D-E slope US	4180186
40762220	D-E 斜率:速度:时间点:心脏.瓣膜.XXX:定量型:超声	4182948
40762224	Atrial; CARD.US; Cardiac; Cardio; Cardiology; Echography; Heart Disease; Hrt; Hrt.atria; L; LA vol; LT; Point in time; QNT; Quan; Quant; Quantitative; R; RA vol; Random; RT; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Vol; Volume ratio	4180186
40762224	Hrt.atria LA vol/RA vol US	4180186
40762224	容积.心房.左侧/容积.心房.右侧:体积比率:时间点:心脏.心房:定量型:超声	4182948
40762226	CARD.US; Cardiac; Cardio; Cardiology; Echography; Heart Disease; Hrt; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Spec; To be specified in another part of the message; ULS; Ultrasound; Unspecified; Vel; Velocity	4180186
40762226	Heart.XXX Tissue velocity US	4180186
40762226	组织速度:速度:时间点:心脏.XXX:定量型:超声	4182948
40762227	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ectasule; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40762227	Ephedrin Ur Cfm-mCnc	4180186
40762227	麻黄碱:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
40762228	Addiction; BZP; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; N-Benzylpiperazine; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40762228	Benzylpiperazine Ur Cfm-mCnc	4180186
40762228	苄基哌嗪:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
40762230	B6; B-6; BLAST-2; BM; BON; Bone marrow; CD5 Cells; CD5+CD23+ Cells; Cell; CELL MARKERS; Cellularity; FceRII; Gated cells; Leu1; Leu-1; Leu20; Leu-20; Low affinity IgE receptor; Ly-1; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T1; Tp67	4180186
40762230	CD5+CD23+ Cells NFr Mar	4180186
40762230	细胞.CD5+CD23+/100 个细胞:计数型分数:时间点:骨髓:定量型	4182948
40762232	B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; BM; BON; Bone marrow; CD19 Cells; CD19+CD34+ Cells; Cell; CELL MARKERS; Cellularity; Gated cells; gp105-120; HD-37; Hematopoietic stem cell; HSC; Leu12; Leu-12; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; My10; My-10; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Stem cells	4180186
40762232	CD19+CD34+ Cells NFr Mar	4180186
40762232	细胞.CD19+CD34+/100 个细胞:计数型分数:时间点:骨髓:定量型	4182948
40762233	CD13+CD34+ Cells NFr Mar	4180186
40762233	Aminopeptidase n; APN; BM; BON; Bone marrow; CD13 Cells; CD13+CD34+ Cells; Cell; CELL MARKERS; Cellularity; Gated cells; gp105-120; gp150; Hematopoietic stem cell; HSC; LeuM7; Leu-M7; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; My10; My-10; My7; My-7; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Stem cells	4180186
40762233	细胞.CD13+CD34+/100 个细胞:计数型分数:时间点:骨髓:定量型	4182948
40762234	CD11c-CD103+ Cells NFr Bld	4180186
40762234	AlphaX integrin chain; Axb2; Blood; CD11c Cells; CD11c+CD103+ Cells; CD11c-CD103+ Cells; Cell; CELL MARKERS; Cellularity; CR4; Gated cells; HML-1; Human mucosal lymphocyte antigen 1; integrin alphaE chain; ITGAE; leukocyte surface antigen p150,95; LeuM5; Leu-M5; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762234	细胞.CD11c-CD103+/100 个细胞:计数型分数:时间点:全血:定量型	4182948
40762237	B6; B-6; BLAST-2; Blood; CD5 Cells; CD5+CD23+ Cells; Cell; CELL MARKERS; Cellularity; FceRII; Gated cells; Leu1; Leu-1; Leu20; Leu-20; Low affinity IgE receptor; Ly-1; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T1; Tp67; WB; Whole blood	4180186
40762237	CD5+CD23+ Cells NFr Bld	4180186
40762237	细胞.CD5+CD23+/100 个细胞:计数型分数:时间点:全血:定量型	4182948
40762241	After; Ca; Cal; Chemistry; Dialy; Kidney; Level; Nephrology; p dialysis; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Renal; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40762241	Calcium p dialysis SerPl-sCnc	4180186
40762241	钙^在透析之后:物质的量浓度:时间点:血清/血浆:定量型	4182948
40762248	17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; 20M p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Genetics; Heredity; Heritable; Hydroxyproges; Hydroxyprogstron; Inherited; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40762248	17OHP 20M p chal SerPl-sCnc	4180186
40762248	17-羟孕酮^在XXX刺激之后20分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40762249	Glucose Ur Strip.auto-sCnc	4180186
40762249	葡萄糖:物质的量浓度:时间点:尿液:定量型:试纸条.自动化法	4182948
40762249	Auto; Automated detection; Dip stick; Dipstick; Elec; Elect; Electr; Glu; Gluc; Glucoseur; Level; Point in time; Random; SmQn; Substance Concentration; UA; UR; URINALYSIS; Urn	4180186
40762250	Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; LTT; Pl; Plasma; Plsm; Point in time; pre Lac PO; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40762250	Glucose pre Lac PO SerPl-sCnc	4180186
40762250	葡萄糖^在口服剂量乳糖之前:物质的量浓度:时间点:血清/血浆:定量型	4182948
40762257	Alk; Alk phos; Alkaline phos; Alkaline phosphatase.total; ALKP; ALP; AP; Catalytic Concentration; Chemistry; Diaf; Dialysate; Dialysis fluid; Kidney; Nephrology; Phos; Phosphtase; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal	4180186
40762257	ALP Dial fld-cCnc	4180186
40762257	碱性磷酸酶:催化浓度:时间点:透析液:定量型	4182948
40762258	Carbonic anhydride; Chemistry; CO2; Diaf; Dialysate; Dialysis fluid; Kidney; Nephrology; Partial pressure; PCO2; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal	4180186
40762258	pCO2 Dial fld	4180186
40762258	二氧化碳:分压:时间点:透析液:定量型	4182948
40762259	Bilirub 24h Stl-sRate	4180186
40762259	1 day; 24 hours; 24HR; Bili; Bilirubins; Billirubin; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; QNT; Quan; Quant; Quantitative; sRate; Stl; Stool = Fecal; Substance Rate; TBIL	4180186
40762259	胆红素:物质的量速率:24小时:大便:定量型	4182948
40762260	1 day; 24 hours; 24HR; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; i Phos; Inorganic phosphate; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; QNT; Quan; Quant; Quantitative; sRate; Stl; Stool = Fecal; Substance Rate	4180186
40762260	Phosphate 24h Stl-sRate	4180186
40762260	磷酸盐:物质的量速率:24小时:大便:定量型	4182948
40762262	buPROPion Ur Ql	4180186
40762262	DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn; Wellbutrin; Zyban	4180186
40762262	丁氨苯丙酮:存在情况或阈值:时间点:尿液:序数型	4182948
40762264	Clozapine metabolite; Desmethylclozapine; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40762264	Norclozapine Ur Ql	4180186
40762264	去甲基氯氮平:存在情况或阈值:时间点:尿液:序数型	4182948
40762266	DRUG/TOXICOLOGY; Drugs; Ketipinor; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Seroquel; UA; UR; Urn; Xeroquel	4180186
40762266	QUEtiapine Ur Ql	4180186
40762266	喹硫平:存在情况或阈值:时间点:尿液:序数型	4182948
40762273	IFN-B Gvn	4180186
40762273	B; Betaferon; B-IFN 1A+1B; DRUG DOSES; Gvn; IFN; IFN-B; INF-B; Nominal; Point in time; Random; Typ	4180186
40762273	干扰素.beta 给予的:类型:时间点:^患者:名义型	4182948
40762275	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EA; EA-D; EBV; EBV EA; EBV EA-D; Epstn; HHV-4; human herpesvirus 4; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Mono; Mononucleosis; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
40762275	EBV EA-D IgG Ser Ql	4180186
40762275	Epstein Barr 病毒早期扩散型 抗体.IgG:存在情况或阈值:时间点:血清:序数型	4182948
40762278	Urea Cl/1.73 sq M 24h Ur+SerPl-ArVRat	4180186
40762278	1 day; 24 hours; 24HR; BSA; Chemistry; Cl; Clear; Clearanc; Clearances; Clr; Kidney; Pl; Plasma; Plsm; QNT; Quan; Quant; Quantitative; SerP; SerPl; SerPlas; Serum; Serum or plasma; Square Meter; SR; UA; UR; Ur+SerPl; Urn; Volume rate/area; Volume Rate/Ratio	4180186
40762278	尿素 肾脏清除率/1.73 平方米:单位面积体积速率:24小时:尿液+血清/血浆:定量型	4182948
40762279	ALP Plac CSF-cCnc	4180186
40762279	Alk; Alk phos; Alkaline phos; Alkaline phosphatase.total; ALKP; ALP; ALP Plac; AP; Catalytic Concentration; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Phos; Phosphtase; Placent; Placenta; Placntl; PLAP; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
40762279	碱性磷酸酶.胎盘型:催化浓度:时间点:脑脊液:定量型	4182948
40762282	2-Ketobutyric acid; 2-Oxobutanoate; 2-Oxobutanoic acid; Chemistry; CR; Crea; Creat; II; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40762282	2-Ketobutyrate/Creat Ur-sRto	4180186
40762282	2-酮丁酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40762285	Tdecenoylcarn/C12:1 SerPl-sRto	4180186
40762285	C12:1; C14:1; Chemistry; i; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration ratio; Substance ratio; Tdecenoylcarn	4180186
40762285	十四烯酰肉碱 (C14:1)/十二烯酰肉碱 (C12:1):物质的量比率:时间点:血清/血浆:定量型	4182948
40762286	3-OH-dodecenoylcarn SerPl-sCnc	4180186
40762286	3-Hydroxy dodecenoylcarnitine; 3-OH-dodecenoylcarn; C12:1OH; C12:1-OH; Chemistry; i; III; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40762286	3-羟基十二烯酸基肉碱 (C12:1-OH):物质的量浓度:时间点:血清/血浆:定量型	4182948
40762290	Deoxyadenosine/Creat Ur-sRto	4180186
40762290	Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40762290	脱氧腺嘌呤核苷/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40762292	Deoxyguanosine/Creat Ur-sRto	4180186
40762292	Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40762292	脱氧鸟嘌呤核苷/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40762293	Deoxyinosine/Creat Ur-sRto	4180186
40762293	Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40762293	脱氧肌苷/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40762295	C16; C18:1; C2; Chemistry; Hexadecanoylcarnitine; i; Octadecenoyl carnitine; Octadecenoylcarnitine; Oleoyl carnitine; Oleyl carnitine; Oleylcarnitine; Palmitoyl+Oleoylcarn; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration ratio; Substance ratio	4180186
40762295	Palmitoyl+Oleoylcarn/C2 SerPl-sRto	4180186
40762295	棕榈酰肉碱 (C16)+油酰肉碱 (C18:1)/乙酰肉碱 (C2):物质的量比率:时间点:血清/血浆:定量型	4182948
40762301	Chemistry; CR; Crea; Creat; Hypoxanthosine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40762301	Inosine/Creat Ur-sRto	4180186
40762301	次黄嘌呤核苷/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40762302	Transcobalamin I+III Ser-sCnc	4180186
40762302	3; Chemistry; Haptocorrin; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Substance concentration; TC; TC-1; TC-3; TCI; TC-I; TCIII; TC-III; Transcobalamin 1; Transcobalamin 3; Transcobalamin I+III	4180186
40762302	运钴胺素蛋白 I+运钴胺素蛋白 III:物质的量浓度:时间点:血清:定量型	4182948
40762303	aIle; alloIle; Allo-isoleucine; Chemistry; Level; MSUD; MSUD (Maple Syrup Urine Disease); Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40762303	Alloisoleucine Ur-sCnc	4180186
40762303	别异亮氨酸:物质的量浓度:时间点:尿液:定量型	4182948
40762305	Succinyladenosine/Creat Ur-sRto	4180186
40762305	Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; S-Ado; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40762305	琥珀酰腺苷/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40762308	Ascites; Ascitic fluid; Ascitis; B; B2 Microglob; b2-M; Chemistry; Hematology; Heme; II; Level; Mass concentration; Microglob; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random	4180186
40762308	B2 Microglob Prt-mCnc	4180186
40762308	Beta-2-微球蛋白:质量浓度:时间点:腹膜液:定量型	4182948
40762312	PSA Plr-mCnc	4180186
40762312	Antigen; Antigens; Chemistry; Kallikrein 3; Level; Mass concentration; P-30 antigen; Pleural; Pleural fluid; Point in time; PS; PSA; QNT; Quan; Quant; Quantitative; Random; Seminin; Spec; thoracentesis fluid; Tumor marker	4180186
40762312	前列腺特异性 抗原:质量浓度:时间点:胸膜液:定量型	4182948
40762314	PSA Prt-mCnc	4180186
40762314	Antigen; Antigens; Ascites; Ascitic fluid; Ascitis; Chemistry; Kallikrein 3; Level; Mass concentration; P-30 antigen; Peritoneal fluid; Point in time; Prt; PS; PSA; QNT; Quan; Quant; Quantitative; Random; Seminin; Spec; Tumor marker	4180186
40762314	前列腺特异性 抗原:质量浓度:时间点:腹膜液:定量型	4182948
40762315	Ascites; Ascitic fluid; Ascitis; Chemistry; fPSA; FR; Kallikrein 3; Level; Mass concentration; Non-protein bound; P-30 antigen; Peritoneal fluid; Point in time; Prt; PS; PSA; PSA Free; QNT; Quan; Quant; Quantitative; Random; Seminin; Spec; Tumor marker	4180186
40762315	PSA Free Prt-mCnc	4180186
40762315	前列腺特异性抗原.游离型:质量浓度:时间点:腹膜液:定量型	4182948
40762316	Antigen; Antigens; Ascites; Ascitic fluid; Ascitis; Chemistry; Level; Mass concentration; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; SCC; Sq; Squamous cell associated; Tumor marker	4180186
40762316	SCC Ag Prt-mCnc	4180186
40762316	鳞状上皮细胞癌 抗原:质量浓度:时间点:腹膜液:定量型	4182948
40762322	PSA Free CSF-mCnc	4180186
40762322	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; fPSA; FR; Kallikrein 3; Level; Mass concentration; Non-protein bound; P-30 antigen; Point in time; PS; PSA; PSA Free; QNT; Quan; Quant; Quantitative; Random; Seminin; Spec; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Tumor marker	4180186
40762322	前列腺特异性抗原.游离型:质量浓度:时间点:脑脊液:定量型	4182948
40762323	Chemistry; fPSA; FR; Kallikrein 3; Level; Mass concentration; Non-protein bound; P-30 antigen; Pleural; Pleural fluid; Point in time; PS; PSA; PSA Free; QNT; Quan; Quant; Quantitative; Random; Seminin; Spec; thoracentesis fluid; Tumor marker	4180186
40762323	PSA Free Plr-mCnc	4180186
40762323	前列腺特异性抗原.游离型:质量浓度:时间点:胸膜液:定量型	4182948
40762325	Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Reduc; Reduc subs; Reducing substance; Substance concentration; UA; UR; Urn	4180186
40762325	Reducing Subs Ur-sCnc	4180186
40762325	还原性物质:物质的量浓度:时间点:尿液:定量型	4182948
40762327	Ascites; Ascitic fluid; Ascitis; Chemistry; fPSA; FR; Kallikrein 3; Mass fraction; Non-protein bound; P-30 antigen; Percent; Peritoneal fluid; Point in time; Prt; PS; PSA; PSA Free; QNT; Quan; Quant; Quantitative; Random; Seminin; Spec; Tot; Totl; Tumor marker	4180186
40762327	PSA Free MFr Prt	4180186
40762327	前列腺特异性抗原.游离型/前列腺特异性抗原.总计:质量分数:时间点:腹膜液:定量型	4182948
40762328	PSA Free MFr Plr	4180186
40762328	Chemistry; fPSA; FR; Kallikrein 3; Mass fraction; Non-protein bound; P-30 antigen; Percent; Pleural; Pleural fluid; Point in time; PS; PSA; PSA Free; QNT; Quan; Quant; Quantitative; Random; Seminin; Spec; thoracentesis fluid; Tot; Totl; Tumor marker	4180186
40762328	前列腺特异性抗原.游离型/前列腺特异性抗原.总计:质量分数:时间点:胸膜液:定量型	4182948
40762330	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; fPSA; FR; Kallikrein 3; Level; Mass concentration; Non-protein bound; P-30 antigen; Point in time; PS; PSA; PSA Free; QNT; Quan; Quant; Quantitative; Random; Seminin; Spec; Tumor marker	4180186
40762330	PSA Free Fld-mCnc	4180186
40762330	前列腺特异性抗原.游离型:质量浓度:时间点:体液:定量型	4182948
40762331	Testost Fld-sCnc	4180186
40762331	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Testo; Testos; Testost	4180186
40762331	睾酮:物质的量浓度:时间点:体液:定量型	4182948
40762332	CgA Fld-aCnc	4180186
40762332	Arbitrary concentration; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cg; CgA; Chemistry; Fl; Fld; FLU; Fluid; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40762332	嗜铬粒蛋白 A:任意型浓度:时间点:体液:定量型	4182948
40762334	Blood; C16; C18:1; C2; Chemistry; DBS; Dried blood spot; Filter paper; FP; Hexadecanoylcarnitine; i; Octadecenoyl carnitine; Octadecenoylcarnitine; Oleoyl carnitine; Oleyl carnitine; Oleylcarnitine; Palmitoyl+Oleoylcarn; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; WB; Whole blood	4180186
40762334	Palmitoyl+Oleoylcarn/C2 DBS-sRto	4180186
40762334	棕榈酰肉碱 (C16)+油酰肉碱 (C18:1)/乙酰肉碱 (C2):物质的量比率:时间点:全血.斑点:定量型	4182948
40762335	Arylsulfatase.total; Catalytic Content; Chemistry; Leukocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells	4180186
40762335	Arylsulfatase C WBC-cCnt	4180186
40762335	芳基硫酸酯酶 C:催化含量:时间点:白细胞:定量型	4182948
40762337	PPT DBS-cCnc	4180186
40762337	Blood; Catalytic Concentration; Chemistry; DBS; Dried blood spot; Filter paper; FP; Point in time; PPT; PR; Prot; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762337	棕榈酰蛋白硫酯酶:催化浓度:时间点:全血.斑点:定量型	4182948
40762338	BH4; BH4 deficiency; Biopterin deficiency; Biopterin H4; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Hyperphenylalaninaemia; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
40762338	Biopterin H4 CSF-sCnc	4180186
40762338	四氢生物蝶呤:物质的量浓度:时间点:脑脊液:定量型	4182948
40762339	Cholest Est Tiss-cCnt	4180186
40762339	Acid lipase; Catalytic Content; CE; Chemistry; Chol; Choles; Cholest; Cholest Est; Cholesterol total; Cholesterols; Lipid; lysosomal acid lipase; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; Wolman/cholesterol ester storage disease	4180186
40762339	胆固醇酯酶:催化含量:时间点:组织与涂片:定量型	4182948
40762340	Acyl carnitine; Acyl+C0; Acylcarni; Blood; C0; Carnitine.total; Chemistry; DBS; Dried blood spot; FC; Filter paper; FP; FR; Non-protein bound; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; WB; Whole blood	4180186
40762340	Acylcarnitine/Acyl+C0 DBS-sRto	4180186
40762340	酰基肉碱/酰基肉碱+游离型肉碱 (C0):物质的量比率:时间点:全血.斑点:定量型	4182948
40762341	Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Lipid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration ratio; Substance ratio; Vit E; Vitamin E	4180186
40762341	Tocopherols/Cholest SerPl-sRto	4180186
40762341	生育酚/胆固醇:物质的量比率:时间点:血清/血浆:定量型	4182948
40762342	Ala; Alpha alanine; B; Bala; B-Ala; B-Alanine; Chemistry; CR; Crea; Creat; L-alanine; N-carbamoyl B-alanine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40762342	N-carbamoyl B-alanine/Creat Ur-sRto	4180186
40762342	N-氨甲酰基 beta 丙氨酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40762343	Hycs-Cys diS CSF-sCnc	4180186
40762343	2-amino-4-[(2-amino-2-carboxyethyl)disulfanyl]butanoic acid; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Cys; Cys-homo-Cys-mixed disulfide; Cysteine-homocysteine mixed disulfide; Cysteinylhomocysteine mixed disulfide; HCY; Hcys; Hcyst; Homocyst(e)ine; Homocysteine-cysteine mixed disulfide; Hycs-Cys diS; Hycs-Cys Disulfide; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
40762343	同型半胱氨酸-半胱氨酸二硫化物:物质的量浓度:时间点:脑脊液:定量型	4182948
40762344	Hycs-Cys diS Ur-sCnc	4180186
40762344	2-amino-4-[(2-amino-2-carboxyethyl)disulfanyl]butanoic acid; Chemistry; Cys; Cys-homo-Cys-mixed disulfide; Cysteine-homocysteine mixed disulfide; Cysteinylhomocysteine mixed disulfide; HCY; Hcys; Hcyst; Homocyst(e)ine; Homocysteine-cysteine mixed disulfide; Hycs-Cys diS; Hycs-Cys Disulfide; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40762344	同型半胱氨酸-半胱氨酸二硫化物:物质的量浓度:时间点:尿液:定量型	4182948
40762349	D/C sum; Disch; Discharge summary; DOC.ONT; Document; ED; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
40762349	ED D/C sum	4180186
40762349	出院摘要记录:发现:时间点:急诊科:文档型:{角色}	4182948
40762351	Blood; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
40762351	Hgb Bld-sCnc	4180186
40762351	血红蛋白:物质的量浓度:时间点:全血:定量型	4182948
40762354	Amplif; Amplification; Amplified; bDNA; Bdn-A; Branched Chain DNA; Cervix; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Genital warts; Gyn; Gynecology; HC; HPA; HPV; HPV16; Human papillomavirus; Hybidization Protection Assay; Hybrid Capture; Hybrid Capture nucleic acid hybridization; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Papilloma virus high risk; Point in time; PR; Probe amp; Probe with ampification; Probe with signal amplification; Probe+sig amp; Ql; Qual; Qualitative; Random; Screen	4180186
40762354	HPV16 DNA Cvx Ql Probe+sig amp	4180186
40762354	人乳头瘤病毒 16 型 DNA:存在情况或阈值:时间点:子宫颈:序数型:探针法.基因扩增.信号	4182948
40762356	8OH-deoxyguanosine/Creat Ur	4180186
40762356	8-Hydroxy-deoxyguanosine; 8OH-deoxyguanosine; 8-OHdG; Chemistry; CR; Crea; Creat; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40762356	8-羟基脱氧鸟嘌呤核苷/肌酐:质量比率:时间点:尿液:定量型	4182948
40762359	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
40762359	新生儿照护报告:发现:时间点:^患者:文档型	4182948
40762361	Surgical operative note pnl	4180186
40762361	Encounter; Evaluation and management; Evaluation and management note; notes; Pan; PANEL.DOC; Panl; Pnl; Point in time; Random; Surg; Surgical operative note pnl; Visit note	4180186
40762361	外科手术记录组套:-:时间点:^患者:-	4182948
40762363	Arbitrary; Lung; Ordinal; Point in time; PULMONARY; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen	4180186
40762363	Power setting Vent	4180186
40762363	功率设定:任意型:时间点:呼吸机:序数型	4182948
40762366	O2 Cap VFr BldA	4180186
40762366	ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Chemistry; O2; O2 Cap; O2Cap; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; tO2; Volfr; Volume fraction	4180186
40762366	氧容量:体积分数:时间点:动脉全血:定量型	4182948
40762367	Brushite; Ca; Ca H2 Phos dihyd; Ca H2 Phos dihyd Cry; Cal; Calc; Calculi; Chemistry; CHPD; Crys; Cryst; Crystal; Gastro; Gastroenterology; GI; H2; Hyd; i Phos; Inorganic phosphate; Kidney; Nephrology; Ordinal; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; Plain Films; PO4; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; Stn; Stone; Stones; Xray; X-ray	4180186
40762367	Ca H2 Phos dihyd Cry Stone Ql XR diff	4180186
40762367	磷酸氢钙二水合物结晶:存在情况或阈值:时间点:结石:序数型:X射线衍射分析	4182948
40762368	Calc; Calculi; Chemistry; Crys; Cryst; Crystal; Cys-Cys; Dicysteine; Gastro; Gastroenterology; GI; Kidney; Nephrology; Ordinal; Plain Films; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; Stn; Stone; Stones; Xray; X-ray	4180186
40762368	Cystine Cry Stone Ql XR diff	4180186
40762368	胱氨酸结晶:存在情况或阈值:时间点:结石:序数型:X射线衍射分析	4182948
40762369	Ca; CaC2O4; CaC2O4.2H2O; Cal; Calc; Calculi; CaOx; Chemistry; COD Cry; Crys; Cryst; Crystal; Ethanedioate; Ethanedioic acid; Gastro; Gastroenterology; GI; Kidney; Nephrology; Ordinal; Oxal; Oxalic acid; Plain Films; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; Stn; Stone; Stones; Weddellite; Xray; X-ray	4180186
40762369	COD Cry Stone Ql XR diff	4180186
40762369	草酸钙二水合物结晶:存在情况或阈值:时间点:结石:序数型:X射线衍射分析	4182948
40762370	Calc; Calculi; Chemistry; Crys; Cryst; Crystal; Gastro; Gastroenterology; GI; Kidney; Nephrology; Ordinal; Plain Films; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; Stn; Stone; Stones; UA; Urates; Uric acid; Xray; X-ray	4180186
40762370	Urate Cry Stone Ql XR diff	4180186
40762370	尿酸结晶:存在情况或阈值:时间点:结石:序数型:X射线衍射分析	4182948
40762372	CARD.US; Cardiac; Cardio; Cardiology; Document; Echography; Finding; Findings; Heart Disease; Hrt; Point in time; Random; Sonogram; Sonograph; Sonography; Thorax; ULS; Ultrasound	4180186
40762372	经胸多层:发现:时间点:胸部>心脏:文档型:超声	4182948
40762373	心脏负荷超声检查:发现:时间点:心脏:文档型:超声	4182948
40762373	Stress cardiac echo study	4180186
40762373	CARD.US; Cardiac; Cardio; Cardiology; Document; Echography; Finding; Findings; Heart Disease; Hrt; Point in time; Random; Sonogram; Sonograph; Sonography; Study report; ULS; Ultrasound	4180186
40762376	Addiction; Blood; BZP; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; N-Benzylpiperazine; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762376	Benzylpiperazine Bld-mCnc	4180186
40762376	苄基哌嗪:质量浓度:时间点:全血:定量型	4182948
40762380	Iloperidone Bld-mCnc	4180186
40762380	Blood; DRUG/TOXICOLOGY; Drugs; Fanapt; Fanapta; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood; Zomaril	4180186
40762380	伊潘立酮:质量浓度:时间点:全血:定量型	4182948
40762381	DRUG/TOXICOLOGY; Drugs; Fanapt; Fanapta; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Zomaril	4180186
40762381	Iloperidone SerPl-mCnc	4180186
40762381	伊潘立酮:质量浓度:时间点:血清/血浆:定量型	4182948
40762382	Blood; Cocaine cutting agent; DRUG/TOXICOLOGY; Drugs; Ergamisole; Levasole; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762382	Levamisole Bld-mCnc	4180186
40762382	左旋咪唑:质量浓度:时间点:全血:定量型	4182948
40762384	Levamisole SerPl-mCnc	4180186
40762384	Cocaine cutting agent; DRUG/TOXICOLOGY; Drugs; Ergamisole; Levasole; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762384	左旋咪唑:质量浓度:时间点:血清/血浆:定量型	4182948
40762390	Blood; Claramax; Clarinex; Delot; Descarboethoxyloratadine; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; NeoClarinex; NeoClarityn; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762390	Desloratadine Bld-mCnc	4180186
40762390	地氯雷他定:质量浓度:时间点:全血:定量型	4182948
40762391	Desloratadine SerPl-mCnc	4180186
40762391	Claramax; Clarinex; Delot; Descarboethoxyloratadine; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; NeoClarinex; NeoClarityn; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762391	地氯雷他定:质量浓度:时间点:血清/血浆:定量型	4182948
40762392	Desloratadine Ur-mCnc	4180186
40762392	Claramax; Clarinex; Delot; Descarboethoxyloratadine; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; NeoClarinex; NeoClarityn; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40762392	地氯雷他定:质量浓度:时间点:尿液:定量型	4182948
40762394	Abixa; Akatinol; Axura; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Ebixa; Fl; Fld; FLU; Fluid; Level; Mass concentration; Memox; Namenda; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40762394	Memantine Fld-mCnc	4180186
40762394	美金刚胺:质量浓度:时间点:体液:定量型	4182948
40762395	Memantine SerPl-mCnc	4180186
40762395	Abixa; Akatinol; Axura; DRUG/TOXICOLOGY; Drugs; Ebixa; Level; Mass concentration; Memox; Namenda; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762395	美金刚胺:质量浓度:时间点:血清/血浆:定量型	4182948
40762397	Memantine Ur-mCnc	4180186
40762397	Abixa; Akatinol; Axura; DRUG/TOXICOLOGY; Drugs; Ebixa; Level; Mass concentration; Memox; Namenda; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40762397	美金刚胺:质量浓度:时间点:尿液:定量型	4182948
40762400	Metaxalone Ur-mCnc	4180186
40762400	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Skelaxin; UA; UR; Urn	4180186
40762400	美他沙酮:质量浓度:时间点:尿液:定量型	4182948
40762401	Blood; DRUG/TOXICOLOGY; Drugs; Ixel; Level; Mass concentration; Mildalcipran; Point in time; QNT; Quan; Quant; Quantitative; Random; Salvella; Toledomin; WB; Whole blood	4180186
40762401	Milnacipran Bld-mCnc	4180186
40762401	米那普仑:质量浓度:时间点:全血:定量型	4182948
40762402	Milnacipran SerPl-mCnc	4180186
40762402	DRUG/TOXICOLOGY; Drugs; Ixel; Level; Mass concentration; Mildalcipran; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Salvella; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Toledomin	4180186
40762402	米那普仑:质量浓度:时间点:血清/血浆:定量型	4182948
40762403	Milnacipran Ur-mCnc	4180186
40762403	DRUG/TOXICOLOGY; Drugs; Ixel; Level; Mass concentration; Mildalcipran; Point in time; QNT; Quan; Quant; Quantitative; Random; Salvella; Toledomin; UA; UR; Urn	4180186
40762403	米那普仑:质量浓度:时间点:尿液:定量型	4182948
40762404	2; Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Ramelton metabolite; Random; Rozerem; WB; Whole blood	4180186
40762404	Ramelteon M-II Bld-mCnc	4180186
40762404	雷美替胺 M-II:质量浓度:时间点:全血:定量型	4182948
40762405	Ramelteon Bld-mCnc	4180186
40762405	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rozerem; WB; Whole blood	4180186
40762405	雷美替胺:质量浓度:时间点:全血:定量型	4182948
40762406	2; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Ramelton metabolite; Random; Rozerem	4180186
40762406	Ramelteon M-II Fld-mCnc	4180186
40762406	雷美替胺 M-II:质量浓度:时间点:体液:定量型	4182948
40762408	2; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Ramelton metabolite; Random; Rozerem; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762408	Ramelteon M-II SerPl-mCnc	4180186
40762408	雷美替胺 M-II:质量浓度:时间点:血清/血浆:定量型	4182948
40762410	2; DRUG/TOXICOLOGY; Drugs; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Ramelton metabolite; Random; Rozerem; Tissue; Tissue, unspecified	4180186
40762410	Ramelteon M-II Tiss-mCnt	4180186
40762410	雷美替胺 M-II:质量含量:时间点:组织与涂片:定量型	4182948
40762411	Ramelteon Tiss-mCnt	4180186
40762411	DRUG/TOXICOLOGY; Drugs; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Rozerem; Tissue; Tissue, unspecified	4180186
40762411	雷美替胺:质量含量:时间点:组织与涂片:定量型	4182948
40762412	Ramelteon M-II Ur-mCnc	4180186
40762412	2; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Ramelton metabolite; Random; Rozerem; UA; UR; Urn	4180186
40762412	雷美替胺 M-II:质量浓度:时间点:尿液:定量型	4182948
40762415	Salvinorin A Bld-mCnc	4180186
40762415	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Salvia; WB; Whole blood	4180186
40762415	沙维林 A:质量浓度:时间点:全血:定量型	4182948
40762417	Salvinorin A SerPl-mCnc	4180186
40762417	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Salvia; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762417	沙维林 A:质量浓度:时间点:血清/血浆:定量型	4182948
40762418	2-Methoxymethyl Salvinorin B; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Salvia; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762418	Salvinorin B SerPl-mCnc	4180186
40762418	沙维林 B:质量浓度:时间点:血清/血浆:定量型	4182948
40762420	Salvinorin B Ur-mCnc	4180186
40762420	2-Methoxymethyl Salvinorin B; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Salvia; UA; UR; Urn	4180186
40762420	沙维林 B:质量浓度:时间点:尿液:定量型	4182948
40762424	Norsibutramine SerPl-mCnc	4180186
40762424	Desmethylsibutramine; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sibutramine metabolite; SR	4180186
40762424	去甲基西布曲明:质量浓度:时间点:血清/血浆:定量型	4182948
40762425	Didesmethylsibutramine; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sibutramine metabolite; SR	4180186
40762425	Dinorsibutramine SerPl-mCnc	4180186
40762425	二去甲基西布曲明:质量浓度:时间点:血清/血浆:定量型	4182948
40762426	Sibutramine SerPl-mCnc	4180186
40762426	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Meridia; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Reductil; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762426	西布曲明:质量浓度:时间点:血清/血浆:定量型	4182948
40762427	Desmethylsibutramine; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Sibutramine metabolite; UA; UR; Urn	4180186
40762427	Norsibutramine Ur-mCnc	4180186
40762427	去甲基西布曲明:质量浓度:时间点:尿液:定量型	4182948
40762428	Dinorsibutramine Ur-mCnc	4180186
40762428	Didesmethylsibutramine; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Sibutramine metabolite; UA; UR; Urn	4180186
40762428	二去甲基西布曲明:质量浓度:时间点:尿液:定量型	4182948
40762430	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762430	Stiripentol Bld-mCnc	4180186
40762430	斯利潘托:质量浓度:时间点:全血:定量型	4182948
40762433	Tadalafil Bld-mCnc	4180186
40762433	Blood; Cialis; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762433	他达那非:质量浓度:时间点:全血:定量型	4182948
40762439	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; N-desmethyltamoxifen; Point in time; QNT; Quan; Quant; Quantitative; Random; Tamoxifen metabolite; WB; Whole blood	4180186
40762439	Nortamoxifen Bld-mCnc	4180186
40762439	去甲基他莫西芬:质量浓度:时间点:全血:定量型	4182948
40762442	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; N-desmethyltamoxifen; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tamoxifen metabolite	4180186
40762442	Nortamoxifen SerPl-mCnc	4180186
40762442	去甲基他莫西芬:质量浓度:时间点:血清/血浆:定量型	4182948
40762446	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Mass Content; Nucynta; Palexia; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tapal; Tissue; Tissue, unspecified	4180186
40762446	Tapentadol Tiss-mCnt	4180186
40762446	他喷他多:质量含量:时间点:组织与涂片:定量型	4182948
40762450	Vardenafil SerPl-mCnc	4180186
40762450	DRUG/TOXICOLOGY; Drugs; Level; Levitra; Mass concentration; Phosphodiesterase #5 inhibitor; Phosphodiesterase 5 inhibitor; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762450	伐地那非:质量浓度:时间点:血清/血浆:定量型	4182948
40762451	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Phosphodiesterase #5 inhibitor; Phosphodiesterase 5 inhibitor; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Vardenafil metabolite	4180186
40762451	Desethylvardenafil Ur-mCnc	4180186
40762451	去乙基伐地那非:质量浓度:时间点:尿液:定量型	4182948
40762453	CLIN; Ethnicity; Nominal; Point in time; Random; Typ	4180186
40762453	种族或民族:类型:时间点:^患者:名义型:OMB.1997	4182948
40762454	L inter Manhao Ab Titr Ser Aggl	4180186
40762454	致病性钩端螺旋体 Manhao 血清型变种 抗体:滴定度:时间点:血清:定量型:凝集试验法	4182948
40762454	ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; L inter; L inter Manhao; L interrogans; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40762456	L inter Mini Ab Titr Ser Aggl	4180186
40762456	致病性钩端螺旋体 Mini 血清型变种 抗体:滴定度:时间点:血清:定量型:凝集试验法	4182948
40762456	ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; L inter; L inter Mini; L interrogans; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40762458	L inter Tarassovi Ab Titr Ser Aggl	4180186
40762458	致病性钩端螺旋体 Tarassovi 血清型变种 抗体:滴定度:时间点:血清:定量型:凝集试验法	4182948
40762458	ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; L inter; L inter Tarassovi; L interrogans; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40762462	L inter Autum Ab Titr Ser Aggl	4180186
40762462	致病性钩端螺旋体秋季血清型变种 抗体:滴定度:时间点:血清:定量型:凝集试验法	4182948
40762462	ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; L inter; L inter Autum; L interrogans; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40762463	L inter Ballum Ab Titr Ser Aggl	4180186
40762463	致病性钩端螺旋体 Ballum 血清型变种 抗体:滴定度:时间点:血清:定量型:凝集试验法	4182948
40762463	ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; L inter; L inter Ballum; L interrogans; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40762471	After; Aminoglycosides; Dialy; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; NEBCIN; NEBDIN; p dialysis; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TOBJ; TOBRA	4180186
40762471	Tobramycin p dialysis SerPl-mCnc	4180186
40762471	妥布霉素^在透析之后:质量浓度:时间点:血清/血浆:定量型	4182948
40762472	After; c162; Dialy; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; p dialysis; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; VANC; Vancocin; Vancor	4180186
40762472	Vancomycin p dialysis SerPl-mCnc	4180186
40762472	万古霉素^在透析之后:质量浓度:时间点:血清/血浆:定量型	4182948
40762474	120 min; 120 minutes; 120min; 2 hours; 2HR; Chemistry; CR; Crea; Creat; Hydroxylproline; Hydroxyprol; Hydroxy-proline; Hydrxprol; Hydrxproln; Hydrxyprln; Hyp; Mass concentration ratio; Mass ratio; MCRto; Ohpro; OH-Proline; QNT; Quan; Quant; Quantitative; UA; UCr; UR; Urn	4180186
40762474	OH-Proline/Creat 2h Ur	4180186
40762474	羟基脯氨酸/肌酐:质量比率:2小时:尿液:定量型	4182948
40762477	Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Infared spectoscopy; IR; Mass Content; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal	4180186
40762477	Starch Stl IR-mCnt	4180186
40762477	淀粉:质量含量:时间点:大便:定量型:红外光谱分析法	4182948
40762479	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Cysticercosis; Cysticercus; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; T sol; T sol lar; T solium; Tapeworm; TMA; Transcription mediated amplification	4180186
40762479	T sol lar DNA CSF Ql NAA+probe	4180186
40762479	猪囊尾蚴 DNA:存在情况或阈值:时间点:脑脊液:序数型:探针法.基因扩增.靶向	4182948
40762482	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f095; f420; f95; III; Immune globulin E; Immunoglobulin E; P prime; Peach; Peach (rPru p) 3; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40762482	Peach (rPru p) 3 IgE Qn	4180186
40762482	桃子 重组 (rPru p) 3 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40762484	T cruzi IgG Titr Ser IF	4180186
40762484	克氏锥虫 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40762484	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Chagas disease; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; T cruzi; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Trypanosomiasis; Trypanosomosis; Ttr	4180186
40762485	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Basem; Basemt; BM; EIA; ELFA; ELISA; Enzyme immunoassay; GBM; Glom; Goodpastures; IAA; Kidney; MEIA; Nephrology; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Serology; Serum; SR; SUDS	4180186
40762485	GBM Ab Ser IA-aCnc	4180186
40762485	肾小球基底膜 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40762487	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Echo; Echo virus; ECV; EIA; ELFA; ELISA; Enzyme immunoassay; EV; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
40762487	ECV IgM CSF IA-aCnc	4180186
40762487	艾柯病毒 抗体.IgM:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40762490	PM1 Ab Titr Ser IF	4180186
40762490	Pm-1 抗体:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40762490	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); Evening; FA; Fluorescent antibody; Fluoresent; i; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; PM1; Point in time; Polymyositis associated ab; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40762494	Ku Ab Titr Ser IF	4180186
40762494	Ku 抗体:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40762494	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40762496	1/3 day; 8 hours; 8HR; ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Lung; Mass Fraction; Maximum; O2; Percent; PULMONARY; Pulmonology; PulseOx; QNT; Quan; Quant; Quantitative; Respiratory; SaO2; SAT; Satn; SO2; SpO2; tO2	4180186
40762496	SaO2 8h Max % BldA PulseOx	4180186
40762496	氧饱和度:质量分数:8小时^最大值:动脉全血:定量型:脉搏血氧定量法	4182948
40762497	1/3 day; 8 hours; 8HR; ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Lung; Mass Fraction; Minimal; minimum; O2; Percent; PULMONARY; Pulmonology; PulseOx; QNT; Quan; Quant; Quantitative; Respiratory; SaO2; SAT; Satn; SO2; SpO2; tO2	4180186
40762497	SaO2 8h Min % BldA PulseOx	4180186
40762497	氧饱和度:质量分数:8小时^最小值:动脉全血:定量型:脉搏血氧定量法	4182948
40762498	Bld Preductal; Bld.right hand; BldA.right hand; Blood; Lung; Mass Fraction; O2; Percent; Point in time; Preductal blood; PULMONARY; Pulmonology; PulseOx; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; SpO2; tO2; WB; Whole blood	4180186
40762498	SaO2 % Bld Preductal PulseOx	4180186
40762498	氧饱和度:质量分数:时间点:全血.导管前:定量型:脉搏血氧定量法	4182948
40762499	ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Lung; Mass Fraction; O2; Percent; Point in time; PULMONARY; Pulmonology; PulseOx; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; SpO2; tO2	4180186
40762499	SaO2 % BldA PulseOx	4180186
40762499	氧饱和度:质量分数:时间点:动脉全血:定量型:脉搏血氧定量法	4182948
40762500	ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; during Tx; Lung; Mass Fraction; O2; Percent; Point in time; Pulmonary; Pulmonology; PulseOx; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; SpO2; tO2; Tx	4180186
40762500	SaO2 during Tx % BldA PulseOx	4180186
40762500	氧饱和度^在治疗过程中:质量分数:时间点:动脉全血:定量型:脉搏血氧定量法	4182948
40762507	ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Before; Blood arterial; Lung; Mass Fraction; O2; Percent; Point in time; pre Tx; Pulmonary; Pulmonology; PulseOx; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; SpO2; tO2; Tx	4180186
40762507	SaO2 pre Tx % BldA PulseOx	4180186
40762507	氧饱和度^在治疗之前:质量分数:时间点:动脉全血:定量型:脉搏血氧定量法	4182948
40762508	ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Lung; Mass Fraction; O2; Percent; Point in time; PULMONARY; Pulmonology; PulseOx; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; SpO2; tO2	4180186
40762508	SaO2 Resting % BldA PulseOx	4180186
40762508	氧饱和度^静息:质量分数:时间点:动脉全血:定量型:脉搏血氧定量法	4182948
40762511	Amplif; Amplification; Amplified; bDNA; Bdn-A; Branched Chain DNA; Cervix; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Genital warts; Gyn; Gynecology; HC; HPA; HPV; HPV I/H Risk 4; HPV16; HPV16 and 18; HPV16+18; HPV16+18+H Risk 12; HPV16+18+HRisk12DNA; Human papillomavirus; Hybidization Protection Assay; Hybrid Capture; Hybrid Capture nucleic acid hybridization; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Papilloma virus high risk; Point in time; PR; Probe amp; Probe with ampification; Probe with signal amplification; Probe+sig amp; Ql; Qual; Qualitative; Random; Screen	4180186
40762511	HPV I/H Risk 4 DNA Cvx Ql Probe+sig amp	4180186
40762511	人乳头瘤病毒 16+18+31+33+35+39+45+51+52+56+58+59+66+68 型 DNA:存在情况或阈值:时间点:子宫颈:序数型:探针法.基因扩增.信号	4182948
40762512	A,B; Antigen; Antigens; Cerebral spinal fluid; Cerebrospinal Fl; ID; Infectious Disease; InfectiousDisease; LAT; Latex agglutination; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; N men; N men sg A+B+C+W135+Y; N menigitidis; N meningitidis; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
40762512	N men sg A+B+C+W135+Y Ag CSF Ql LA	4180186
40762512	脑膜炎奈瑟菌 A+B+C+w135+Y 血清群 抗原:存在情况或阈值:时间点:脑脊液:序数型:胶乳凝集试验法	4182948
40762515	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV HA; FLUV; Fowl plague; HA; ID; Ident; Identifier; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Ribonucleic acid; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40762515	FLUAV HA RNA Islt NAA+probe	4180186
40762515	流感病毒 A 型血凝素类型 RNA:标识符:时间点:分离株:名义型:探针法.基因扩增.靶向	4182948
40762516	Finding; Findings; MFS; Morse Fall Score; Ordinal; Pan; PANEL.SURVEY.MFS; Panl; Pnl; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MFS	4180186
40762517	Finding; Findings; H/O; Hx; MFS; Morse Fall Score; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MFS	4180186
40762520	Finding; Findings; MFS; Morse Fall Score; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MFS	4180186
40762522	Finding; Findings; MFS; Morse Fall Score; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MFS	4180186
40762523	MFS; Morse fall risk total; Morse Fall Score; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MFS; Tot; Totl	4180186
40762526	100WBC; Diaf; Dialysate; Dialysis fluid; HEMATOLOGY/CELL COUNTS; Kidney; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Nephrology; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; WBC; WBCs; White blood cell; White blood cells	4180186
40762526	Lymphocytes/leuk NFr Dial fld	4180186
40762526	淋巴细胞/100 个白细胞:计数型分数:时间点:透析液:定量型	4182948
40762528	Path Rev	4180186
40762528	Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Narrative; Other; Path; Path Rev; PATHOLOGY; Point in time; Random; Report; Spec; To be specified in another part of the message; Unspecified	4180186
40762528	病理学家审核:印象:时间点:XXX:叙述型	4182948
40762529	Hematologist review	4180186
40762529	HEMATOLOGY/CELL COUNTS; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Narrative; Other; Point in time; Random; Report; Spec; To be specified in another part of the message; Unspecified	4180186
40762529	血液学家审核:印象:时间点:XXX:叙述型	4182948
40762530	Average; Avg; Discocyte; Erc; Erythrocytes; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Level; MCH; MCHC; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Substance concentration	4180186
40762530	MCHC RBC-sCnc	4180186
40762530	红细胞平均颗粒血红蛋白浓度:物质的量浓度:时间点:红细胞:定量型	4182948
40762531	Average; Avg; Discocyte; Entitic substance; Erc; Erythrocytes; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; MCH; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells	4180186
40762531	MCH EntSub RBC	4180186
40762531	红细胞平均颗粒血红蛋白:实体物质的量:时间点:红细胞:定量型	4182948
40762534	Ca-I adj pH7.4 BldA ISE-mCnc	4180186
40762534	ABG; adj; adj pH7.4; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Ca; Ca-I; Cal; Calcium active; Calcium free; Chemistry; Coagulation factor I; ICA; Ion; Ion selective membrane electode; Ion selective membrane electrode; Ion-selective electrode; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40762534	钙.离子型^^调整至pH 7.4的:质量浓度:时间点:动脉全血:定量型:离子选择电极法	4182948
40762535	adj; adj pH7.4; Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Ca; Ca-I; Cal; Calcium active; Calcium free; Chemistry; Coagulation factor I; ICA; Ion; Ion selective membrane electode; Ion selective membrane electrode; Ion-selective electrode; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Venous	4180186
40762535	Ca-I adj pH7.4 BldV ISE-mCnc	4180186
40762535	钙.离子型^^调整至pH 7.4的:质量浓度:时间点:静脉全血:定量型:离子选择电极法	4182948
40762536	AO; AO Stn; Cerebral spinal fluid; Cerebrospinal Fl; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Nominal; Point in time; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; St; Stains; Stn	4180186
40762536	AO Stn CSF	4180186
40762536	显微镜观察:存在与否或特征标识:时间点:脑脊液:名义型:吖啶橙染色法	4182948
40762537	CA; CS; CS mets at Dx; CS mets at Dx - bone; Dx; Identity or presence; Metastases; Mets; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762537	CS mets at Dx - bone Cancer	4180186
40762537	协作分期 诊断时转移 - 骨累及:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762538	CA; CS; CS mets at Dx; CS mets at Dx - brain; Dx; Identity or presence; Metastases; Mets; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762538	CS mets at Dx - brain Cancer	4180186
40762538	协作分期 诊断时转移 - 脑累及:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762539	CA; CS; CS mets at Dx; CS mets at Dx - liver; Dx; Identity or presence; Metastases; Mets; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762539	CS mets at Dx - liver Cancer	4180186
40762539	协作分期 诊断时转移 - 肝累及:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762543	After; CA; CS; CS post Rx mets at Dx; Dx; Identity or presence; Metastases; Mets; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; PST; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified	4180186
40762543	CS post Rx mets at Dx Cancer	4180186
40762543	协作分期 诊断时治疗后转移:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762544	After; CA; CS; CS post Rx tumor size; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; PST; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified	4180186
40762544	CS post Rx tumor size Cancer	4180186
40762544	协作分期 治疗后肿瘤大小:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762547	Assessment; Before; CA; CS; CS pre Rx mets eval; Eval; H&P; History and physical; Identity or presence; Metastases; Mets; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified	4180186
40762547	CS pre Rx mets eval Cancer	4180186
40762547	协作分期 治疗前转移评价:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762548	Assessment; Before; CA; CS; CS pre Rx reg nodes eval; Eval; H&P; History and physical; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified	4180186
40762548	CS pre Rx reg nodes eval Cancer	4180186
40762548	协作分期 治疗前区域淋巴结评价:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762549	Assessment; Before; CA; CS; CS pre Rx tumor size; CS pre Rx tumor size/ext eval; Eval; EXT; H&P; History and physical; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified	4180186
40762549	CS pre Rx tumor size/ext eval Cancer	4180186
40762549	协作分期 治疗前肿瘤大小和蔓延评价:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762550	Before; CA; CS; CS pre Rx tumor size; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified	4180186
40762550	CS pre Rx tumor size Cancer	4180186
40762550	协作分期 治疗前肿瘤大小:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762551	CA; CS; CS site-specific factor 7; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762551	CS site-specific factor 7 Cancer	4180186
40762551	协作分期 部位特异性因素 7:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762556	CA; CS; CS site-specific factor 12; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762556	CS site-specific factor 12 Cancer	4180186
40762556	协作分期 部位特异性因素 12:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762559	CA; CS; CS site-specific factor 15; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762559	CS site-specific factor 15 Cancer	4180186
40762559	协作分期 部位特异性因素 15:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762560	CA; CS; CS site-specific factor 16; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762560	CS site-specific factor 16 Cancer	4180186
40762560	协作分期 部位特异性因素 16:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762562	CA; CS; CS site-specific factor 18; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762562	CS site-specific factor 18 Cancer	4180186
40762562	协作分期 部位特异性因素 18:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762563	CA; CS; CS site-specific factor 19; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762563	CS site-specific factor 19 Cancer	4180186
40762563	协作分期 部位特异性因素 19:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762564	CA; CS; CS site-specific factor 20; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762564	CS site-specific factor 20 Cancer	4180186
40762564	协作分期 部位特异性因素 2:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762565	CA; CS; CS site-specific factor 21; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762565	CS site-specific factor 21 Cancer	4180186
40762565	协作分期 部位特异性因素 21:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762566	CA; CS; CS site-specific factor 22; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762566	CS site-specific factor 22 Cancer	4180186
40762566	协作分期 部位特异性因素 22:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762569	CA; CS; CS site-specific factor 25; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762569	CS site-specific factor 25 Cancer	4180186
40762569	协作分期 部位特异性因素 25:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762570	CA; CS; CS version current; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762570	CS version current Cancer	4180186
40762570	协作分期版本.现行:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762571	CA; Commission on Cancer; Misc; Miscellaneous; Oncology; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762571	案例完成日期.COC:日期:时间点:癌症病例.XXX:定量型	4182948
40762572	CA; Misc; Miscellaneous; Oncology; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762572	案例起始日期:日期:时间点:癌症病例.XXX:定量型	4182948
40762573	CA; Date of conclusive Dx; Dx; Flag for Date of conclusive Dx; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762573	Flag for Date of conclusive Dx Cancer	4180186
40762573	决定性诊断日期未填写标志:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762574	CA; Flag for 1st contact; Hosp; Hosp adm 1st contact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762574	Flag for 1st contact Cancer	4180186
40762574	医院入院.第一联系人未填写标志:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762575	CA; Commission on Cancer; First; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; Treatment; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762575	Flag for Date 1st cancer Rx (any).COC	4180186
40762575	第 1 次癌症治疗方案 (任何) 日期标志.COC 未填写:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762576	CA; Identity or presence; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762576	Flag for Date of birth	4180186
40762576	出生日期未填写标志:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762578	CA; Diagnosis; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762578	Flag for Date first Dx Cancer	4180186
40762578	第 1 次诊断日期未填写标志:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762579	CA; First; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; Treatment; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762579	Flag for Date 1st cancer Rx (any).SEERS	4180186
40762579	第 1 次癌症治疗方案 (任何) 日期标志.SEERS 未填写:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762580	CA; Date of inpt adm; Flag for Date of inpt adm; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762580	Flag for Date of inpt adm Cancer	4180186
40762580	住院患者入院日期未填写标志:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762587	AJCC; CA; Derived AJCC-7 N; Derived AJCC-7 N descript; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762587	Derived AJCC-7 N descript Cancer	4180186
40762587	派生型美国癌症联合委员会-7 N 描述符:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762589	AJCC; CA; Derived AJCC-7 T; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; T prime; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762589	Derived AJCC-7 T Cancer	4180186
40762589	派生型美国癌症联合委员会-7 T:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762590	AJCC; CA; Derived AJCC-7 T; Derived AJCC-7 T descript; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; T prime; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762590	Derived AJCC-7 T descript Cancer	4180186
40762590	派生型美国癌症联合委员会-7 T 描述符:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762592	After; CA; Derived post Rx-7 M; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; PST; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified	4180186
40762592	Derived post Rx-7 M Cancer	4180186
40762592	派生型治疗后-7 M:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762593	After; CA; Derived post Rx-7 N; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; PST; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified	4180186
40762593	Derived post Rx-7 N Cancer	4180186
40762593	派生型治疗后-7 N:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762596	Before; CA; Derived pre Rx-7 M; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified	4180186
40762596	Derived pre Rx-7 M Cancer	4180186
40762596	派生型治疗前-7 M:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762598	Before; CA; Derived pre Rx-7 N; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified	4180186
40762598	Derived pre Rx-7 N Cancer	4180186
40762598	派生型治疗前-7 N:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762600	Before; CA; Derived pre Rx-7 stg grp; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified	4180186
40762600	Derived pre Rx-7 stg grp Cancer	4180186
40762600	派生型治疗前-7 期别组合:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762601	Before; CA; Derived pre Rx-7 T; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; T prime; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified	4180186
40762601	Derived pre Rx-7 T Cancer	4180186
40762601	派生型治疗前-7 T:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762602	Before; CA; Derived pre Rx-7 T; Derived pre Rx-7 T descript; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; T prime; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified	4180186
40762602	Derived pre Rx-7 T descript Cancer	4180186
40762602	派生型治疗前-7 T 描述符:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762603	CA; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Path; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762603	分级病理学系统:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762604	CA; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Path; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762604	分级病理学取值:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762605	CA; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762605	住院患者状态:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762606	CA; Ca spec; Identity or presence; Nominal; Oncology; Point in time; Random; Spec; TUMOR REGISTRY(NAACCR)	4180186
40762606	Lymph-vascular invasion Ca spec	4180186
40762606	淋巴-血管侵袭:存在与否或特征标识:时间点:癌标本:名义型	4182948
40762608	CA; Date 1st most defn srg; First; Flag for Date 1st mst defn srg; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; Surg; To be specified in another part of the message; Treatment; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762608	Flag for Date 1st mst defn srg Cancer	4180186
40762608	第 1 次最确定性外科手术治疗方案日期未填写标志:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762609	CA; Date rad ended; Flag for Date rad ended; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762609	Flag for Date rad ended Cancer	4180186
40762609	放射治疗结束日期未填写标志:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762610	CA; Date of surg disch; Disch; Flag for Date of surg disch; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; Surg; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762610	Flag for Date of surg disch Cancer	4180186
40762610	外科手术出院日期未填写标志:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762614	Arterial Stenosis; CA; Date non CDS Rx as part of 1st cancer; First; Flag for Date Dx/Stg proc; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; Surg; To be specified in another part of the message; Treatment; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762614	Flag for Date Dx/Stg proc	4180186
40762614	作为第 1 次癌症过程组成部分的非癌症外科手术治疗方案日期未填写标志:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762617	CA; First; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified	4180186
40762617	Flag for Date 1st radiation Cancer	4180186
40762617	第 1 次放射治疗日期未填写标志:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762618	CA; First; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; Surg; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified	4180186
40762618	Flag for Date 1st surgery Cancer	4180186
40762618	第 1 次外科手术治疗日期未填写标志:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762620	2nd course Tx; 2nd crs Tx start date; CA; Flag for 2nd crs Tx start date; Identity or presence; Nominal; Oncology; Point in time; Random; Second; Started; Treatment; TUMOR REGISTRY(NAACCR); Tx	4180186
40762620	Flag for 2nd crs Tx start date Cancer Rx	4180186
40762620	第 2 疗程治疗起始日期未填写标志:存在与否或特征标识:时间点:后续的癌症治疗方案:名义型	4182948
40762621	Before; CA; CS; CS pre Rx ex; EXT; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified	4180186
40762621	CS pre Rx ex Cancer	4180186
40762621	协作分期 治疗前蔓延:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762622	CA; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; Surg; Surg app at facility 2010; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762622	Surg app at facility 2010 Cancer	4180186
40762622	外科手术入路 在设施.YYY 2010:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762623	CPRO; Diprivan; Diprivan metabolite; Disoprivan; DRUG/TOXICOLOGY; Drugs; Gluc; Glucouronide; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rapinovet; UA; UR; Urn	4180186
40762623	Propofol glucuronide Ur-mCnc	4180186
40762623	异丙酚葡萄糖苷酸:质量浓度:时间点:尿液:定量型	4182948
40762625	Bands; bnd; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Kidney; Level; M Protein; M Protein 4; Mass Concentration; M-band; Monoclonal band; Monoclonal spike; M-protein; M-spike; Nephrology; Para protein; Paraprotein; PEUR; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UPEP; UR; Urn	4180186
40762625	M Protein 4 Ur Elph-mCnc	4180186
40762625	蛋白质.单克隆型 区带 4:质量浓度:时间点:尿液:定量型:电泳	4182948
40762628	DRUG/TOXICOLOGY; Drugs; Level; Netilimicin; Netromycin; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40762628	Netilmicin SerPl-sCnc	4180186
40762628	乙基西梭霉素:物质的量浓度:时间点:血清/血浆:定量型	4182948
40762629	DRUG/TOXICOLOGY; Drugs; ID; Infectious Disease; InfectiousDisease; Level; Netilimicin; Netromycin; Pl; Plasma; Plsm; Point in time; Post; Postdose; Post-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40762629	Netilmicin Peak SerPl-sCnc	4180186
40762629	乙基西梭霉素^波峰:物质的量浓度:时间点:血清/血浆:定量型	4182948
40762630	Orotate 24h Ur-sRate	4180186
40762630	1 day; 24 hours; 24HR; Chemistry; Orotic acid; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
40762630	乳清酸:物质的量速率:24小时:尿液:定量型	4182948
40762633	1 day; 24 hours; 24HR; Chemistry; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; Tg; Trig; Trigly; Triglycerides; Triglycrides; UA; UR; Urn	4180186
40762633	Trigl 24h Ur-sRate	4180186
40762633	甘油三酯:物质的量速率:24小时:尿液:定量型	4182948
40762636	BMI Prctl	4180186
40762636	BMI; bod; Bodies; BODY WEIGHT.MOLEC; Percentile; Point in time; QNT; Quan; Quant; Quantitative; Quetelet index; Random	4180186
40762636	体质指数:百分位数:时间点:^患者:定量型	4182948
40762638	BMI Prctl Per age+sex	4180186
40762638	BMI; bod; Bodies; BODY WEIGHT.MOLEC; Gender; Per age+sex; Percentile; Point in time; QNT; Quan; Quant; Quantitative; Quetelet index; Random	4180186
40762638	体质指数:百分位数:时间点:^患者:定量型:按照年龄和性别	4182948
40762641	CV A24 IgM Titr Ser IF	4180186
40762641	柯萨奇病毒 A24 型 抗体.IgM:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40762641	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CAV; Coxsackie; Coxsackie virus; CV; CV A24; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40762642	CV A16 IgM Titr Ser IF	4180186
40762642	柯萨奇病毒 A16 型 抗体.IgM:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40762642	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CAV; Coxsackie; Coxsackie virus; CV; CV A16; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40762644	CV A24 IgG Titr Ser IF	4180186
40762644	柯萨奇病毒 A24 型 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40762644	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CAV; Coxsackie; Coxsackie virus; CV; CV A24; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40762646	CV A7 IgG Titr Ser IF	4180186
40762646	柯萨奇病毒 A7 型 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40762646	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CAV; Coxsackie; Coxsackie virus; CV; CV A7; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40762647	GSTP1+APC gene methylation Tiss Ql	4180186
40762647	Adenomatosis polyposis coli; adenomatous polyposis coli; Adenomatous polyposis of the colon; Arbitrary; BTPS2; DNA methylation; DP2; DP2.5; DP3; Familial adenomatous polyposis; FAP; FPC; GS; GSTP1+APC gene methylation; Molecular genetics; Molecular pathology; MOLPATH; Ordinal; PCR; Point in time; PPP1R46; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified	4180186
40762647	GSTP1 基因+APC 基因甲基化:任意型:时间点:组织与涂片:序数型:分子遗传学类实验室方法	4182948
40762649	HVA ?Tm Ur-mCnc	4180186
40762649	?Tm; 3-methoxy-4-hydroxy-phenylacetic acid; Chemistry; Homovanilic; Homovanillic acid; HVA; Level; Mass concentration; QNT; Quan; Quant; Quantitative; Tumor marker; UA; UR; Urn	4180186
40762649	同型香子兰酸:质量浓度:XXX:尿液:定量型	4182948
40762650	1OH-midazolam Mec-mCnt	4180186
40762650	1-Hydroxy midazolam; 1OH-midazolam; Alpha hydroxymidazolam; Alpha-hydroxymidazolam; Chlonazepam metabolite; DRUG/TOXICOLOGY; Drugs; i; Mass content; Mec; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40762650	1-羟基咪达唑仑:质量含量:时间点:胎便:定量型	4182948
40762651	1-Hydroxy midazolam; 1OH-midazolam; Alpha hydroxymidazolam; Alpha-hydroxymidazolam; Chlonazepam metabolite; DRUG/TOXICOLOGY; Drugs; i; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40762651	1OH-midazolam Ur-mCnc	4180186
40762651	1-羟基咪达唑仑:质量浓度:时间点:尿液:定量型	4182948
40762652	1OH-midazolam Ur Cfm-mCnc	4180186
40762652	1-Hydroxy midazolam; 1OH-midazolam; Alpha hydroxymidazolam; Alpha-hydroxymidazolam; Cfm; Chlonazepam metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; i; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40762652	1-羟基咪达唑仑:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
40762653	7-amino clonazepam; 7Aminoclonazepam; Addiction; Blood; Clonazepam metabolite; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762653	7Aminoclonazepam Bld-mCnc	4180186
40762653	7-氨基氯硝安定:质量浓度:时间点:全血:定量型	4182948
40762654	7-amino clonazepam; 7Aminoclonazepam; Addiction; Blood; Cfm; Clonazepam metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762654	7Aminoclonazepam Bld Cfm-mCnc	4180186
40762654	7-氨基氯硝安定:质量浓度:时间点:全血:定量型:毒理学确认试验	4182948
40762655	7-amino clonazepam; 7Aminoclonazepam; Addiction; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Clonazepam metabolite; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random	4180186
40762655	7Aminoclonazepam Fld-mCnc	4180186
40762655	7-氨基氯硝安定:质量浓度:时间点:体液:定量型	4182948
40762656	7-amino clonazepam; 7Aminoclonazepam; Addiction; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cfm; Clonazepam metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random	4180186
40762656	7Aminoclonazepam Fld Cfm-mCnc	4180186
40762656	7-氨基氯硝安定:质量浓度:时间点:体液:定量型:毒理学确认试验	4182948
40762660	acetaZOLAMIDE Bld-mCnc	4180186
40762660	Acetadiazol; Acetazolam; AK-Zol; Blood; Diamox; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762660	乙酰唑胺:质量浓度:时间点:全血:定量型	4182948
40762661	A-OH Alpraz Bld-mCnc	4180186
40762661	Alfa; Alpha hydroxy alprazolam; Alprozolam metabolite; A-OH Alpraz; Blood; DRUG/TOXICOLOGY; Drugs; Hydroxy alprazolam; Hydroxyalpraz; Level; Mass concentration; OH-Alpraz; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762661	Alpha-羟基阿普唑仑:质量浓度:时间点:全血:定量型	4182948
40762662	Alfa; Alpha hydroxy alprazolam; Alprozolam metabolite; A-OH Alpraz; Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Hydroxy alprazolam; Hydroxyalpraz; Level; Mass concentration; OH-Alpraz; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762662	A-OH Alpraz Bld Cfm-mCnc	4180186
40762662	Alpha-羟基阿普唑仑:质量浓度:时间点:全血:定量型:毒理学确认试验	4182948
40762663	Alfa; Alpha hydroxy alprazolam; Alprozolam metabolite; A-OH Alpraz; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Hydroxy alprazolam; Hydroxyalpraz; Level; Mass concentration; OH-Alpraz; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40762663	A-OH Alpraz Fld-mCnc	4180186
40762663	Alpha-羟基阿普唑仑:质量浓度:时间点:体液:定量型	4182948
40762666	Alfa; Alpha hydroxy alprazolam; Alprozolam metabolite; A-OH Alpraz; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Hydroxy alprazolam; Hydroxyalpraz; Level; Mass concentration; OH-Alpraz; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762666	A-OH Alpraz SerPl Cfm-mCnc	4180186
40762666	Alpha-羟基阿普唑仑:质量浓度:时间点:血清/血浆:定量型:毒理学确认试验	4182948
40762669	Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Niravam; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood; Xanax	4180186
40762669	Alpraz Bld Cfm-mCnc	4180186
40762669	阿普唑仑:质量浓度:时间点:全血:定量型:毒理学确认试验	4182948
40762670	Alpraz Fld-mCnc	4180186
40762670	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Mass concentration; Niravam; Point in time; QNT; Quan; Quant; Quantitative; Random; Xanax	4180186
40762670	阿普唑仑:质量浓度:时间点:体液:定量型	4182948
40762671	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; GCMS; Level; Mass concentration; Niravam; Point in time; QNT; Quan; Quant; Quantitative; Random; Xanax	4180186
40762671	Alpraz Fld Cfm-mCnc	4180186
40762671	阿普唑仑:质量浓度:时间点:体液:定量型:毒理学确认试验	4182948
40762672	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Mass content; Mec; Niravam; Point in time; QNT; Quan; Quant; Quantitative; Random; Xanax	4180186
40762672	Alpraz Mec Cfm-mCnt	4180186
40762672	阿普唑仑:质量含量:时间点:胎便:定量型:毒理学确认试验	4182948
40762674	Alpraz Stl Cfm-mCnt	4180186
40762674	Bowel movement; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Faecal; Faeces; Fecal; Feces; GCMS; Mass content; Niravam; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal; Xanax	4180186
40762674	阿普唑仑:质量含量:时间点:大便:定量型:毒理学确认试验	4182948
40762678	BZE SerPl Cfm-mCnc	4180186
40762678	BEC; BEG; Benz; Benzoylec; BZE; Cfm; CNFR; CNFRM; Cocaine degradation production; Cocaine metabolite; Conf; Confirmation; Confirmatory; Crack metabolite; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762678	苯甲酰芽子碱:质量浓度:时间点:血清/血浆:定量型:毒理学确认试验	4182948
40762683	Chlordiazep Mec Cfm-mCnt	4180186
40762683	Cfm; Chlordiaz; Chlordiaze; Chlordiazep; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Librium; Mass content; Mec; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40762683	甲氨二氮卓:质量含量:时间点:胎便:定量型:毒理学确认试验	4182948
40762686	Chlordiazep Tiss-mCnt	4180186
40762686	Chlordiaz; Chlordiaze; Chlordiazep; DRUG/TOXICOLOGY; Drugs; Librium; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40762686	甲氨二氮卓:质量含量:时间点:组织与涂片:定量型	4182948
40762687	Chlordiazep Tiss Cfm-mCnt	4180186
40762687	Cfm; Chlordiaz; Chlordiaze; Chlordiazep; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Librium; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40762687	甲氨二氮卓:质量含量:时间点:组织与涂片:定量型:毒理学确认试验	4182948
40762688	cloBAZam Bld-mCnc	4180186
40762688	Blood; Clarmyl; Clopax; DRUG/TOXICOLOGY; Drugs; Frisium; Level; Mass concentration; Noiafren; Point in time; QNT; Quan; Quant; Quantitative; Random; Sederlona; Urbadan; Urbanol; Urbanyl; WB; Whole blood	4180186
40762688	氯巴詹:质量浓度:时间点:全血:定量型	4182948
40762691	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cfm; Clarmyl; Clopax; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Frisium; GCMS; Level; Mass concentration; Noiafren; Point in time; QNT; Quan; Quant; Quantitative; Random; Sederlona; Urbadan; Urbanol; Urbanyl	4180186
40762691	cloBAZam Fld Cfm-mCnc	4180186
40762691	氯巴詹:质量浓度:时间点:体液:定量型:毒理学确认试验	4182948
40762693	Cfm; Clarmyl; Clopax; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Frisium; GCMS; Mass content; Mec; Noiafren; Point in time; QNT; Quan; Quant; Quantitative; Random; Sederlona; Urbadan; Urbanol; Urbanyl	4180186
40762693	cloBAZam Mec Cfm-mCnt	4180186
40762693	氯巴詹:质量含量:时间点:胎便:定量型:毒理学确认试验	4182948
40762695	cloBAZam Tiss-mCnt	4180186
40762695	Clarmyl; Clopax; DRUG/TOXICOLOGY; Drugs; Frisium; Mass content; Noiafren; Point in time; QNT; Quan; Quant; Quantitative; Random; Sederlona; Tissue; Tissue, unspecified; Urbadan; Urbanol; Urbanyl	4180186
40762695	氯巴詹:质量含量:时间点:组织与涂片:定量型	4182948
40762698	Blood; DRUG/TOXICOLOGY; Drugs; Klonopin; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762698	clonazePAM Bld-mCnc	4180186
40762698	氯硝安定:质量浓度:时间点:全血:定量型	4182948
40762699	clonazePAM Bld Cfm-mCnc	4180186
40762699	Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Klonopin; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762699	氯硝安定:质量浓度:时间点:全血:定量型:毒理学确认试验	4182948
40762701	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; GCMS; Klonopin; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40762701	clonazePAM Fld Cfm-mCnc	4180186
40762701	氯硝安定:质量浓度:时间点:体液:定量型:毒理学确认试验	4182948
40762703	DRUG/TOXICOLOGY; Drugs; Klonopin; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40762703	clonazePAM Tiss-mCnt	4180186
40762703	氯硝安定:质量含量:时间点:组织与涂片:定量型	4182948
40762704	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Klonopin; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40762704	clonazePAM Tiss Cfm-mCnt	4180186
40762704	氯硝安定:质量含量:时间点:组织与涂片:定量型:毒理学确认试验	4182948
40762705	Cfm; CNFR; CNFRM; Cocaine/Ethanol By-Product; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762705	Cocaethylene SerPl Cfm-mCnc	4180186
40762705	古柯乙烯:质量浓度:时间点:血清/血浆:定量型:毒理学确认试验	4182948
40762707	DRUG/TOXICOLOGY; Drugs; Nicotine metabolite; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762707	Cotinine SerPl Ql Scn	4180186
40762707	可铁宁:存在情况或阈值:时间点:血清/血浆:序数型:毒理学筛查试验	4182948
40762708	DRUG/TOXICOLOGY; Drugs; Nicotine metabolite; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
40762708	Cotinine Ur Ql Scn	4180186
40762708	可铁宁:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
40762711	Desalkylfluraz Fld Cfm-mCnc	4180186
40762711	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desalkyfluraz; Desalkylfluraz; Desalkylflurazepam; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Flurazepam metabolite; GCMS; Level; Mass concentration; norfludiazepam; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40762711	N-去烷基氟胺安定:质量浓度:时间点:体液:定量型:毒理学确认试验	4182948
40762712	Desalkylfluraz Mec Cfm-mCnt	4180186
40762712	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desalkyfluraz; Desalkylfluraz; Desalkylflurazepam; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; GCMS; Mass content; Mec; norfludiazepam; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40762712	N-去烷基氟胺安定:质量含量:时间点:胎便:定量型:毒理学确认试验	4182948
40762713	Desalkylfluraz Stl Cfm-mCnt	4180186
40762713	Bowel movement; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desalkyfluraz; Desalkylfluraz; Desalkylflurazepam; DRUG/TOXICOLOGY; Drugs; Faecal; Faeces; Fecal; Feces; Flurazepam metabolite; GCMS; Mass content; norfludiazepam; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal	4180186
40762713	N-去烷基氟胺安定:质量含量:时间点:大便:定量型:毒理学确认试验	4182948
40762715	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desalkyfluraz; Desalkylfluraz; Desalkylflurazepam; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; GCMS; Mass content; norfludiazepam; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40762715	Desalkylfluraz Tiss Cfm-mCnt	4180186
40762715	N-去烷基氟胺安定:质量含量:时间点:组织与涂片:定量型:毒理学确认试验	4182948
40762722	Addiction; c311; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Mass Content; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Stesolid; Tissue; Tissue, unspecified; Valium	4180186
40762722	diazePAM Tiss-mCnt	4180186
40762722	安定:质量含量:时间点:组织与涂片:定量型	4182948
40762725	c215; c281; C52; Cambia; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Voltaren optha; Voltaren opthalmic	4180186
40762725	Diclofenac Ur-mCnc	4180186
40762725	环氟拉嗪:质量浓度:时间点:尿液:定量型	4182948
40762726	Blood; DRUG/TOXICOLOGY; Drugs; Esilgan; Eurodin; Level; Mass concentration; Nuctalon; Point in time; Prosom; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762726	Estazolam Bld-mCnc	4180186
40762726	艾司唑仑:质量浓度:时间点:全血:定量型	4182948
40762728	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Esilgan; Eurodin; Fl; Fld; FLU; Fluid; Level; Mass concentration; Nuctalon; Point in time; Prosom; QNT; Quan; Quant; Quantitative; Random	4180186
40762728	Estazolam Fld-mCnc	4180186
40762728	艾司唑仑:质量浓度:时间点:体液:定量型	4182948
40762729	Estazolam Fld Cfm-mCnc	4180186
40762729	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Esilgan; Eurodin; Fl; Fld; FLU; Fluid; GCMS; Level; Mass concentration; Nuctalon; Point in time; Prosom; QNT; Quan; Quant; Quantitative; Random	4180186
40762729	艾司唑仑:质量浓度:时间点:体液:定量型:毒理学确认试验	4182948
40762735	Actiq; Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Duragesic; Durogesic; Fenpat; fentanil; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Sublimaze; UA; UR; Urn	4180186
40762735	fentaNYL Ur Ql Scn	4180186
40762735	芬太尼:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
40762738	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Dalmane; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40762738	Flurazepam Fld-mCnc	4180186
40762738	氟胺安定:质量浓度:时间点:体液:定量型	4182948
40762739	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dalmane; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40762739	Flurazepam Fld Cfm-mCnc	4180186
40762739	氟胺安定:质量浓度:时间点:体液:定量型:毒理学确认试验	4182948
40762740	Flurazepam Tiss-mCnt	4180186
40762740	Dalmane; DRUG/TOXICOLOGY; Drugs; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40762740	氟胺安定:质量含量:时间点:组织与涂片:定量型	4182948
40762742	DRUG/TOXICOLOGY; Drugs; Horizant; Level; Mass concentration; Neurontin; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40762742	Gabapentin Ur-mCnc	4180186
40762742	加巴喷丁:质量浓度:时间点:尿液:定量型	4182948
40762745	Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; GCMS; Hydroxy ethylflurazepam; Level; Mass concentration; OH-Ethylfluraz; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762745	OH-Ethylfluraz Bld Cfm-mCnc	4180186
40762745	羟乙基氟胺安定:质量浓度:时间点:全血:定量型:毒理学确认试验	4182948
40762747	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Flurazepam metabolite; GCMS; Hydroxy ethylflurazepam; Level; Mass concentration; OH-Ethylfluraz; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40762747	OH-Ethylfluraz Fld Cfm-mCnc	4180186
40762747	羟乙基氟胺安定:质量浓度:时间点:体液:定量型:毒理学确认试验	4182948
40762749	Bowel movement; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Faecal; Faeces; Fecal; Feces; Flurazepam metabolite; GCMS; Hydroxy ethylflurazepam; Mass content; OH-Ethylfluraz; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal	4180186
40762749	OH-Ethylfluraz Stl Cfm-mCnt	4180186
40762749	羟乙基氟胺安定:质量含量:时间点:大便:定量型:毒理学确认试验	4182948
40762755	Addiction; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; GCMS; Hydroxy triazolam; Illicit; Level; Mass concentration; OH-Triazolam; OHTRZ; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Triazolam metabolite	4180186
40762755	OH-Triazolam Fld Cfm-mCnc	4180186
40762755	羟基三唑仑:质量浓度:时间点:体液:定量型:毒理学确认试验	4182948
40762757	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Hydroxy triazolam; Illicit; Mass Content; OH-Triazolam; OHTRZ; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; Triazolam metabolite	4180186
40762757	OH-Triazolam Tiss-mCnt	4180186
40762757	羟基三唑仑:质量含量:时间点:组织与涂片:定量型	4182948
40762758	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Hydroxy triazolam; Illicit; Mass Content; OH-Triazolam; OHTRZ; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; Triazolam metabolite	4180186
40762758	OH-Triazolam Tiss Cfm-mCnt	4180186
40762758	羟基三唑仑:质量含量:时间点:组织与涂片:定量型:毒理学确认试验	4182948
40762760	Addiction; Ativan; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762760	LORazepam Bld-mCnc	4180186
40762760	氯羟安定:质量浓度:时间点:全血:定量型	4182948
40762763	Addiction; Ativan; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random	4180186
40762763	LORazepam Fld Cfm-mCnc	4180186
40762763	氯羟安定:质量浓度:时间点:体液:定量型:毒理学确认试验	4182948
40762765	Addiction; Ativan; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Mass Content; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40762765	LORazepam Tiss-mCnt	4180186
40762765	氯羟安定:质量含量:时间点:组织与涂片:定量型	4182948
40762766	Addiction; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; METD; Methadose; MTD; Ordinal; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762766	Methadone SerPl Ql Scn	4180186
40762766	美沙酮:存在情况或阈值:时间点:血清/血浆:序数型:毒理学筛查试验	4182948
40762767	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ivilco; Level; Mass concentration; Me-ePHEDrine; Pholcomed; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tossamine plus	4180186
40762767	Me-ePHEDrine SerPl-mCnc	4180186
40762767	甲基麻黄碱:质量浓度:时间点:血清/血浆:定量型	4182948
40762769	Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Versed; WB; Whole blood	4180186
40762769	Midazolam Bld Cfm-mCnc	4180186
40762769	咪达唑仑:质量浓度:时间点:全血:定量型:毒理学确认试验	4182948
40762771	Midazolam Fld Cfm-mCnc	4180186
40762771	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Versed	4180186
40762771	咪达唑仑:质量浓度:时间点:体液:定量型:毒理学确认试验	4182948
40762772	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Versed	4180186
40762772	Midazolam SerPl Cfm-mCnc	4180186
40762772	咪达唑仑:质量浓度:时间点:血清/血浆:定量型:毒理学确认试验	4182948
40762773	DRUG/TOXICOLOGY; Drugs; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; Versed	4180186
40762773	Midazolam Tiss-mCnt	4180186
40762773	咪达唑仑:质量含量:时间点:组织与涂片:定量型	4182948
40762774	Midazolam Tiss Cfm-mCnt	4180186
40762774	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; Versed	4180186
40762774	咪达唑仑:质量含量:时间点:组织与涂片:定量型:毒理学确认试验	4182948
40762783	Bowel movement; Calmday; Cfm; Chlordiazepoxide metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desmethyldiazepam; Diazepam metabolite; Dimethyldiazepam; DRUG/TOXICOLOGY; Drugs; Faecal; Faeces; Fecal; Feces; GCMS; Madar; Mass content; n-dimethyldiazepam; Nordaz; Nordazepam; Nordiaze; Point in time; Praxadium; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Stilny; Stl; Stool = Fecal; Tranxilium N; Vegesan	4180186
40762783	Nordiazepam Stl Cfm-mCnt	4180186
40762783	去甲基安定:质量含量:时间点:大便:定量型:毒理学确认试验	4182948
40762784	Nordiazepam Tiss-mCnt	4180186
40762784	Calmday; Chlordiazepoxide metabolite; Desmethyldiazepam; Diazepam metabolite; Dimethyldiazepam; DRUG/TOXICOLOGY; Drugs; Madar; Mass content; n-dimethyldiazepam; Nordaz; Nordazepam; Nordiaze; Point in time; Praxadium; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Stilny; Tissue; Tissue, unspecified; Tranxilium N; Vegesan	4180186
40762784	去甲基安定:质量含量:时间点:组织与涂片:定量型	4182948
40762785	Addiction; d-Norpseudoephedrine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Norpseudoephedrine; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762785	Cathine SerPl-mCnc	4180186
40762785	去甲伪麻黄碱:质量浓度:时间点:血清/血浆:定量型	4182948
40762789	Alepam; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cfm; Chlordiazepoxide metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; GCMS; Level; Mass concentration; Point in time; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Serax; Temazepam metabolite	4180186
40762789	Oxazepam Fld Cfm-mCnc	4180186
40762789	去甲羟安定:质量浓度:时间点:体液:定量型:毒理学确认试验	4182948
40762795	Addiction; Algaphan; Cosalgesic; Cotonal-65; Darvon; Depronal; Dextrogesic; Dextropropoxyphene; Distalgesic; Dolasan; Doloxene; D-propoxyphene; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Napsalgesic; Ordinal; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762795	Propoxyph SerPl Ql Scn	4180186
40762795	丙氧氨酚:存在情况或阈值:时间点:血清/血浆:序数型:毒理学筛查试验	4182948
40762796	Blood; DRUG/TOXICOLOGY; Drugs; Level; Lobac; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Salicylamid; Sinedol; Triaprin-DC; Utrosal; WB; Whole blood	4180186
40762796	Salicylamide Bld-mCnc	4180186
40762796	水杨酰胺:质量浓度:时间点:全血:定量型	4182948
40762797	DRUG/TOXICOLOGY; Drugs; Level; Lobac; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Salicylamid; Sinedol; Triaprin-DC; UA; UR; Urn; Utrosal	4180186
40762797	Salicylamide Ur-mCnc	4180186
40762797	水杨酰胺:质量浓度:时间点:尿液:定量型	4182948
40762798	DRUG/TOXICOLOGY; Drugs; Mass content; Nails; Point in time; QNT; Quan; Quant; Quantitative; Random; SE; Ungal nail	4180186
40762798	Selenium Nail-mCnt	4180186
40762798	硒:质量含量:时间点:甲:定量型	4182948
40762800	Ag; DRUG/TOXICOLOGY; Drugs; Mass content; Nails; Point in time; QNT; Quan; Quant; Quantitative; Random; Silv; Ungal nail	4180186
40762800	Silver Nail-mCnt	4180186
40762800	银:质量含量:时间点:甲:定量型	4182948
40762802	Silver Tiss-mCnt	4180186
40762802	Ag; DRUG/TOXICOLOGY; Drugs; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Silv; Tissue; Tissue, unspecified	4180186
40762802	银:质量含量:时间点:组织与涂片:定量型	4182948
40762803	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Microsulfon; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762803	sulfADIAZINE Bld-mCnc	4180186
40762803	磺胺嘧啶:质量浓度:时间点:全血:定量型	4182948
40762805	SUMAtriptan Ur-mCnc	4180186
40762805	DRUG/TOXICOLOGY; Drugs; Imitrex; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40762805	舒马曲坦:质量浓度:时间点:尿液:定量型	4182948
40762807	Temazepam Bld Cfm-mCnc	4180186
40762807	Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Normison; Point in time; QNT; Quan; Quant; Quantitative; Random; Restoril; WB; Whole blood	4180186
40762807	羟基安定:质量浓度:时间点:全血:定量型:毒理学确认试验	4182948
40762809	Temazepam Fld Cfm-mCnc	4180186
40762809	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; GCMS; Level; Mass concentration; Normison; Point in time; QNT; Quan; Quant; Quantitative; Random; Restoril	4180186
40762809	羟基安定:质量浓度:时间点:体液:定量型:毒理学确认试验	4182948
40762811	Temazepam SerPl Cfm-mCnc	4180186
40762811	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Normison; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Restoril; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762811	羟基安定:质量浓度:时间点:血清/血浆:定量型:毒理学确认试验	4182948
40762812	Bowel movement; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Faecal; Faeces; Fecal; Feces; GCMS; Mass content; Normison; Point in time; QNT; Quan; Quant; Quantitative; Random; Restoril; Stl; Stool = Fecal	4180186
40762812	Temazepam Stl Cfm-mCnt	4180186
40762812	羟基安定:质量含量:时间点:大便:定量型:毒理学确认试验	4182948
40762813	Temazepam Tiss-mCnt	4180186
40762813	DRUG/TOXICOLOGY; Drugs; Mass content; Normison; Point in time; QNT; Quan; Quant; Quantitative; Random; Restoril; Tissue; Tissue, unspecified	4180186
40762813	羟基安定:质量含量:时间点:组织与涂片:定量型	4182948
40762814	Titanium Bld-mCnc	4180186
40762814	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; TI; WB; Whole blood	4180186
40762814	钛:质量浓度:时间点:全血:定量型	4182948
40762818	tiZANidine Bld-mCnc	4180186
40762818	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood; Zanaflex	4180186
40762818	替扎尼定:质量浓度:时间点:全血:定量型	4182948
40762819	Triazolam Bld-mCnc	4180186
40762819	APO-TRIAZO; Blood; DRUG/TOXICOLOGY; Drugs; Halcion; Level; Mass concentration; Novo-triolam; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762819	三唑苯二氮:质量浓度:时间点:全血:定量型	4182948
40762821	Triazolam Fld-mCnc	4180186
40762821	APO-TRIAZO; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Halcion; Level; Mass concentration; Novo-triolam; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40762821	三唑苯二氮:质量浓度:时间点:体液:定量型	4182948
40762825	APO-TRIAZO; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Halcion; Mass content; Novo-triolam; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40762825	Triazolam Tiss Cfm-mCnt	4180186
40762825	三唑苯二氮:质量含量:时间点:组织与涂片:定量型:毒理学确认试验	4182948
40762827	DRUG/TOXICOLOGY; Drugs; Erythrocytes; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; W	4180186
40762827	Tungsten RBC-mCnc	4180186
40762827	钨:质量浓度:时间点:红细胞:定量型	4182948
40762829	Procedure indications Imp	4180186
40762829	DOC.MISC; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; MISC; Narrative; Point in time; Random; Report	4180186
40762829	操作适应症:印象:时间点:^患者:叙述型	4182948
40762832	Implants	4180186
40762832	DOC.MISC; Finding; Findings; MISC; Narrative; Point in time; Random; Report	4180186
40762832	操作植入物:发现:时间点:^患者:叙述型	4182948
40762835	Anesthesia	4180186
40762835	DOC.MISC; Finding; Findings; MISC; Narrative; Point in time; Random; Report	4180186
40762835	操作麻醉:发现:时间点:^患者:叙述型	4182948
40762837	DOC.MISC; Finding; Findings; MISC; Narrative; Point in time; Random; Report	4180186
40762837	Findings	4180186
40762837	操作发现:发现:时间点:^患者:叙述型	4182948
40762838	Immunization status; Point in time; QNT; Quan; Quant; Quantitative; Random; Vaccination; Vaccinations; Vaccine	4180186
40762838	要给予疫苗接种的最新日期:日期:时间点:^患者:定量型	4182948
40762842	Finding; Findings; Nominal; Point in time; Random; VACCINE	4180186
40762842	剂量有效性:发现:时间点:^患者:名义型	4182948
40762844	Finding; Findings; Immunization status; Nominal; Point in time; Random; Vaccination; Vaccinations; Vaccine	4180186
40762844	疫苗接种系列之中的状态:发现:时间点:^患者:名义型	4182948
40762845	Dis; Diseases; Dz; Finding; Findings; Nominal; Point in time; Random; VACCINE	4180186
40762845	具有假定免疫力的疾病:发现:时间点:^患者:名义型	4182948
40762846	Finding; Findings; Immunization status; Nominal; Point in time; Random; Vaccination; Vaccinations; Vaccine	4180186
40762846	疫苗接种适应症:发现:时间点:^患者:名义型	4182948
40762847	Urea/Creat Ur-sRto	4180186
40762847	Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40762847	尿素/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40762850	120 min; 120 minutes; 120min; 2 hours; 2h NP; 2h p Inc; After; Clot; Clottable; Coag; Coagulation assay; Control; DDRVTVT; Dil; Dil Russell Vip Ven; Dilut; dRVV; dRVVT; Fac; Fact; Hematology; Heme; Plas; Platelet poor plasma; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rus; RVV; Screening test for lupus anticoagulant; Tilt tube	4180186
40762850	dRVVT 2h NP PPP	4180186
40762850	稀释蝰蛇毒诱导型凝血过程.因子替换^在添加正常血浆后孵育之后2小时:时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
40762852	30M p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SCDiff; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762852	Glucose 30M p chal SerPl-SCDiff	4180186
40762852	葡萄糖^在XXX刺激之后30分钟:物质的量浓度差:时间点:血清/血浆:定量型	4182948
40762853	1 hour; 1.0Hr; 1h p chal; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SCDiff; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762853	Glucose 1h p chal SerPl-SCDiff	4180186
40762853	葡萄糖^在XXX刺激之后1小时:物质的量浓度差:时间点:血清/血浆:定量型	4182948
40762854	1 1/2 hours; 1 1/2 HR; 1.5h p chal; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SCDiff; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762854	Glucose 1.5h p chal SerPl-SCDiff	4180186
40762854	葡萄糖^在XXX刺激之后1.5小时:物质的量浓度差:时间点:血清/血浆:定量型	4182948
40762855	120 min; 120 minutes; 120min; 2 hours; 2h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SCDiff; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762855	Glucose 2h p chal SerPl-SCDiff	4180186
40762855	葡萄糖^在XXX刺激之后2小时:物质的量浓度差:时间点:血清/血浆:定量型	4182948
40762858	5h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SCDiff; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762858	Glucose 5h p chal SerPl-SCDiff	4180186
40762858	葡萄糖^在XXX刺激之后5小时:物质的量浓度差:时间点:血清/血浆:定量型	4182948
40762860	Ganciclovir Trough Plas-mCnc	4180186
40762860	Cytovene; DRUG/TOXICOLOGY; Drugs; GCV; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; Valcyte; Valganciclovir	4180186
40762860	更昔洛韦^波谷:质量浓度:时间点:血浆:定量型	4182948
40762863	Bands; bnd; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Kidney; M Protein; M Protein 4; Mass Fraction; M-band; Monoclonal band; Monoclonal spike; M-protein; M-spike; Nephrology; Para protein; Paraprotein; Percent; PEUR; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Renal; Tot; Totl; TP; UA; UPEP; UR; Urn	4180186
40762863	M Protein 4 MFr Ur Elph	4180186
40762863	蛋白质.单克隆型 区带 4/蛋白质.总计:质量分数:时间点:尿液:定量型:电泳	4182948
40762864	Cortis 30M p chal SerPl-SCDiff	4180186
40762864	17-Hydroxycorticosterone; 30M p chal; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SCDiff; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762864	皮质醇^在XXX刺激之后30分钟:物质的量浓度差:时间点:血清/血浆:定量型	4182948
40762868	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chemistry; Fetal lung maturity; Level; PG; Phosphatidyl Glycerol; Phosphotidylglycerol; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762868	PG Amn-sCnc	4180186
40762868	磷脂酰甘油:物质的量浓度:时间点:羊水:定量型	4182948
40762870	Blood; Cell; Cellularity; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
40762870	Lymphoma Cells Bld Ql	4180186
40762870	淋巴瘤细胞:存在情况或阈值:时间点:全血:序数型	4182948
40762871	Caffeine Trough Ser-sCnc	4180186
40762871	CAFFN; DRUG/TOXICOLOGY; Drugs; Level; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Substance concentration	4180186
40762871	咖啡因^波谷:物质的量浓度:时间点:血清:定量型	4182948
40762874	Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Finger stick; Glu; Glu tol; Gluc; Glucomtr; Glucose tolerance; Glucoseur; GTT; Level; Morning; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance concentration	4180186
40762874	Glucose 7 AM BldC Glucomtr-sCnc	4180186
40762874	葡萄糖^上午7点标本:物质的量浓度:时间点:毛细血管全血:定量型:葡萄糖测定仪	4182948
40762875	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Morning; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Spec; SR; Substance concentration	4180186
40762875	Glucose 7 AM SerPl-sCnc	4180186
40762875	葡萄糖^上午7点标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
40762876	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Evening; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; III; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Spec; SR; Substance concentration	4180186
40762876	Glucose 3 PM SerPl-sCnc	4180186
40762876	葡萄糖^下午3点标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
40762878	Uropor1/Creat 24h Ur-sRto	4180186
40762878	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; i; Isom; Octacarboxyl porphyrin; Octacarboxylporphyrin; Octacarboxyphyrin; Porphyria; Porphyria cutanea tarda; QNT; Quan; Quant; Quantitative; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn; Urophorph; Uropor1; Uroporphyrin I	4180186
40762878	尿卟啉 I 同分异构体/肌酐:物质的量比率:24小时:尿液:定量型	4182948
40762879	Uropor3/Creat 24h Ur-sRto	4180186
40762879	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; III; Isom; Octacarboxyl porphyrin; Octacarboxylporphyrin; Octacarboxyphyrin; Porphyria; Porphyria cutanea tarda; QNT; Quan; Quant; Quantitative; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn; Urophorph; Uropor3; Uroporphyrin III	4180186
40762879	尿卟啉 III 同分异构体/肌酐:物质的量比率:24小时:尿液:定量型	4182948
40762880	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Pentacarboxyl porphyrins; Pentacarboxyporhyrin; Penta-CP; Pentaporphyrins; QNT; Quan; Quant; Quantitative; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40762880	Penta-CP/Creat 24h Ur-sRto	4180186
40762880	五羧基卟啉/肌酐:物质的量比率:24小时:尿液:定量型	4182948
40762881	1 day; 24 hours; 24HR; Chemistry; Copro; Copro1; Coproporph; Coproporphyrin I; Coproporphyrins; CR; Crea; Creat; i; QNT; Quan; Quant; Quantitative; Scrto; Substance concentration ratio; Substance ratio; Tetracarboxyl porphyrin; Tetracarboxylporphyrin; Tetracarboxylporphyrins; Tetracarboxyporphyrin; UA; UCr; UR; Urn	4180186
40762881	Copro1/Creat 24h Ur-sRto	4180186
40762881	粪卟啉 I/肌酐:物质的量比率:24小时:尿液:定量型	4182948
40762883	After; DRUG/TOXICOLOGY; Drugs; FK506; FK-506; Fujimycin; Hecoria; L04AD02; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; Prograf; Protopic; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762883	Tacrolimus 4h p SerPl-mCnc	4180186
40762883	他克莫司^在剂量之后4小时:质量浓度:时间点:血清/血浆:定量型	4182948
40762884	120 min; 120 minutes; 120min; 2 hours; After; DRUG/TOXICOLOGY; Drugs; FK506; FK-506; Fujimycin; Hecoria; L04AD02; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; Prograf; Protopic; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762884	Tacrolimus 2h p SerPl-mCnc	4180186
40762884	他克莫司^在剂量药物之后2小时:质量浓度:时间点:血清/血浆:定量型	4182948
40762888	Bilirub BldA-mCnc	4180186
40762888	ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Bili; Bilirubins; Billirubin; Blood arterial; Chemistry; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; TBIL	4180186
40762888	胆红素:质量浓度:时间点:动脉全血:定量型	4182948
40762889	Bilirub BldV-mCnc	4180186
40762889	Bili; Bilirubins; Billirubin; Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Chemistry; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; TBIL; Venous	4180186
40762889	胆红素:质量浓度:时间点:静脉全血:定量型	4182948
40762890	180 minutes; 180min; 3 hours; 3.0Hr; 3HR; Addis count; Count/time; Kidney; Leuc; Leuk; Leukocyte; Lkcs; LM; Micro; Micros; Microscopic; Nephrology; nRate; Number rate; Number Rate = Count/Time; QNT; Quan; Quant; Quantitative; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS; WBC; WBCs; White blood cell; White blood cells	4180186
40762890	WBC 3h UrnS Micro-nRate	4180186
40762890	白细胞:计数型速率:3小时:尿沉渣:定量型:显微镜检查.光学	4182948
40762891	180 minutes; 180min; 3 hours; 3.0Hr; 3HR; Addis count; Count/time; Discocytes; Erthrocyte; Erythrocyte; Kidney; LM; Micro; Micros; Microscopic; Nephrology; nRate; Number rate; Number Rate = Count/Time; QNT; Quan; Quant; Quantitative; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
40762891	RBC 3h UrnS Micro-nRate	4180186
40762891	红细胞:计数型速率:3小时:尿沉渣:定量型:显微镜检查.光学	4182948
40762893	Gastrin sp1 p chal SerPl-mCnc	4180186
40762893	Acute specimen; After; CHEMISTRY.CHALLENGE TESTING; First; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Pre immunization; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp1; sp1 p chal; Spec; SR; Total gastrins; Zollinger-Ellison syndrome	4180186
40762893	胃泌素^在XXX刺激之后的第1个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40762896	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Intact Parathormone; intact parathyroid hormone; iPTH; Level; Mass concentration; Parathormone; Parathyroid hormone; Point in time; PTH; PTH-Intact; QNT; Quan; Quant; Quantitative; Random; Tumor marker	4180186
40762896	PTH-Intact Fld-mCnc	4180186
40762896	甲状旁腺素.完整型:质量浓度:时间点:体液:定量型	4182948
40762897	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; Myco; Mycoplas; Mycoplas+U urealyt; Mycoplas+U urealyticum DNA; Mycoplasm; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; species; spp; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; U urealyticum; Unspecified	4180186
40762897	Mycoplas+U urealyt DNA Spec Ql NAA+probe	4180186
40762897	支原体属+解脲支原体 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40762899	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CMV; Cytomegalo virus; Cytomgal; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; LAT; Latex agglutination; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762899	CMV Ab SerPl Ql LA	4180186
40762899	巨细胞病毒 抗体:存在情况或阈值:时间点:血清/血浆:序数型:胶乳凝集试验法	4182948
40762900	Urate Cry Tiss Ql Micro	4180186
40762900	Crys; Cryst; Crystal; LM; Micro; Micros; Microscopic; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; UA; Urates; Uric acid	4180186
40762900	尿酸结晶:存在情况或阈值:时间点:组织与涂片:序数型:显微镜检查.光学	4182948
40762901	DHEA sp8 p chal SerPl-mCnc	4180186
40762901	After; CHEMISTRY.CHALLENGE TESTING; DHEA; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Prasterone; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp8; sp8 p chal; Spec; SR	4180186
40762901	脱氢表雄酮^在XXX刺激之后的第8个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40762903	Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Vent alarm	4180186
40762903	Apnea interval Vent alarm	4180186
40762903	呼吸暂停间隔:时间:时间点:呼吸机.警报:定量型	4182948
40762904	Congenital dyserythropoietic anaemia; Encounter; Evaluation and management; Evaluation and management note; notes; Pan; Panel; PANEL.DOC; Panl; Pnl; Point in time; Proced Nte C-CDA R1.1 Sections; Random; Visit note	4180186
40762904	Proced Nte C-CDA R1.1 Sections	4180186
40762904	操作记录 - 推荐 CDA 小节:-:时间点:{环境}:-	4182948
40762905	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; MDEA; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
40762905	MDEA Ur Ql Scn	4180186
40762905	亚甲基二乙氧基苯丙胺:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
40762907	ID; Infectious Disease; InfectiousDisease; Islt; Isol; Isolated; Microbiology; Nominal; Point in time; Random; Sal; Salmonel; species; spp; Typ	4180186
40762907	Salmonella Islt	4180186
40762907	沙门菌属单个未知种 已鉴定的:类型:时间点:分离株:名义型	4182948
40762908	CA; Identity or presence; III; International Classification of Diseases; International Classification of Diseases for Oncology; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762908	组织学与行为 ICD-O-3:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762909	CA; Identity or presence; III; International Classification of Diseases; International Classification of Diseases for Oncology; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762909	形态学.ICD-O-3:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762910	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; After; CHEMISTRY.CHALLENGE TESTING; EXCZ; Lact; Lactic acid; Level; L-lactate; p Exc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40762910	Lactate p Exc SerPl-sCnc	4180186
40762910	乳酸^在运动之后:物质的量浓度:时间点:血清/血浆:定量型	4182948
40762912	NAACCR v 12 Pnl	4180186
40762912	NAACCR v 12 Pnl; North American Association of Central Cancer Registries; Pan; Panl; Pnl; Point in time; Random; TUMOR REGISTRY(NAACCR)	4180186
40762912	NAACCR 12 版组套:-:时间点:^患者:-	4182948
40762914	CA; Coll; Collect; Collect Date; Collected; Date and time; II; Misc; Miscellaneous; Oncology; Other; Path; Path spec coll date 2; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Time stamp; Timestamp; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762914	Path spec coll date 2 Cancer	4180186
40762914	病理标本采集日期 2:时间戳:时间点:癌.XXX:定量型	4182948
40762918	CA; i; Ident; Identifier; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; Surveillance Epidemiology and End Result; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762918	SEER site-specific fact 1 Cancer	4180186
40762918	SEER 部位特异性事实 1:标识符:时间点:癌.XXX:名义型	4182948
40762920	CA; Ident; Identifier; III; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; Surveillance Epidemiology and End Result; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762920	SEER site-specific fact 3 Cancer	4180186
40762920	SEER 部位特异性事实 3:标识符:时间点:癌.XXX:名义型	4182948
40762921	CA; Ident; Identifier; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; Surveillance Epidemiology and End Result; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762921	SEER site-specific fact 4 Cancer	4180186
40762921	SEER 部位特异性事实 4:标识符:时间点:癌.XXX:名义型	4182948
40762922	CA; Ident; Identifier; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; Surveillance Epidemiology and End Result; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762922	SEER site-specific fact 5 Cancer	4180186
40762922	SEER 部位特异性事实 5:标识符:时间点:癌.XXX:名义型	4182948
40762923	CA; Ident; Identifier; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; Surveillance Epidemiology and End Result; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762923	SEER site-specific fact 6 Cancer	4180186
40762923	SEER 部位特异性事实 6:标识符:时间点:癌.XXX:名义型	4182948
40762929	Cogentin; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40762929	Benztropine SerPl-sCnc	4180186
40762929	苯扎托品:物质的量浓度:时间点:血清/血浆:定量型	4182948
40762930	Benztropine Ur-sCnc	4180186
40762930	Cogentin; DRUG/TOXICOLOGY; Drugs; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40762930	苯扎托品:物质的量浓度:时间点:尿液:定量型	4182948
40762931	Cogentin; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762931	Benztropine Gast-sCnc	4180186
40762931	苯扎托品:物质的量浓度:时间点:胃液:定量型	4182948
40762932	Bromazepam Ur-sCnc	4180186
40762932	Bromazanil; Brozam; Calmepam; Compendium; Creosedin; DRUG/TOXICOLOGY; Drugs; Durazanil; Gityl; Lectopam; Level; Lexatin; Lexaurin; Lexonil; Lexotan; Lexotanil; Neo-opt; Normoc; Point in time; QNT; Quan; Quant; Quantitative; Random; Somalium; Substance concentration; UA; UR; Urn	4180186
40762932	溴吡二氮卓:物质的量浓度:时间点:尿液:定量型	4182948
40762934	Antial; BPN; Bromarest; Bromfed; Bromfenex; Dimegan; Dimetane; Dimetapp; Dimotane; DRUG/TOXICOLOGY; Drugs; Gammistin; Ilvin; Level; Lodrane; Parabromdylamine maleate; Point in time; PROBAHIST; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40762934	Brompheniramine Ur-sCnc	4180186
40762934	溴苯那敏:物质的量浓度:时间点:尿液:定量型	4182948
40762935	Antial; BPN; Bromarest; Bromfed; Bromfenex; Dimegan; Dimetane; Dimetapp; Dimotane; DRUG/TOXICOLOGY; Drugs; Gammistin; GAST; Gastric contents; Gastric fluid; Ilvin; Level; Lodrane; Parabromdylamine maleate; Point in time; PROBAHIST; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762935	Brompheniramine Gast-sCnc	4180186
40762935	溴苯那敏:物质的量浓度:时间点:胃液:定量型	4182948
40762936	Carbamazapine; Carbamezapine; Carbazepine; CRBM; DRUG/TOXICOLOGY; Drugs; Epitol; GAST; Gastric contents; Gastric fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tegretol; Teril	4180186
40762936	carBAMazepine Gast Ql	4180186
40762936	卡马西平:存在情况或阈值:时间点:胃液:序数型	4182948
40762937	Chloraldurat; Chloralix; Dormel; DRUG/TOXICOLOGY; Drugs; Elix-node; Level; Medianox; Noctec; Pediatric chloral elixir; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Trichloroethanol; Trichloroethyl alcohol; Trichloroethylalcohol; UA; UR; Urn; Welldorm	4180186
40762937	Chloral Hydrate Ur-sCnc	4180186
40762937	水合氯醛:物质的量浓度:时间点:尿液:定量型	4182948
40762939	Chlordiaz; Chlordiaze; Chlordiazep; DRUG/TOXICOLOGY; Drugs; Level; Librium; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40762939	Chlordiazep Ur-sCnc	4180186
40762939	甲氨二氮卓:物质的量浓度:时间点:尿液:定量型	4182948
40762942	CHL; Chlorphenamine; Chlorphenir; Chlortrimeton; Chlor-tripolon; DRUG/TOXICOLOGY; Drugs; Level; Piriton; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40762942	Chlorphenir Ur-sCnc	4180186
40762942	氯苯朴尔敏:物质的量浓度:时间点:尿液:定量型	4182948
40762943	CHL; Chlorphenamine; Chlorphenir; Chlortrimeton; Chlor-tripolon; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Piriton; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762943	Chlorphenir Gast-sCnc	4180186
40762943	氯苯朴尔敏:物质的量浓度:时间点:胃液:定量型	4182948
40762944	Chlopromazine; Chlorpromaz; DRUG/TOXICOLOGY; Drugs; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Thorazine; UA; UR; Urn	4180186
40762944	chlorproMAZINE Ur-sCnc	4180186
40762944	氯丙嗪:物质的量浓度:时间点:尿液:定量型	4182948
40762948	cloBAZam Ur-sCnc	4180186
40762948	Clarmyl; Clopax; DRUG/TOXICOLOGY; Drugs; Frisium; Level; Noiafren; Point in time; QNT; Quan; Quant; Quantitative; Random; Sederlona; Substance concentration; UA; UR; Urbadan; Urbanol; Urbanyl; Urn	4180186
40762948	氯巴詹:物质的量浓度:时间点:尿液:定量型	4182948
40762950	cloZAPine Gast-sCnc	4180186
40762950	Clozaril; DRUG/TOXICOLOGY; Drugs; FazaClo; GAST; Gastric contents; Gastric fluid; Leponex; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762950	氯氮平:物质的量浓度:时间点:胃液:定量型	4182948
40762952	DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Nicotine metabolite; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762952	Cotinine Gast-sCnc	4180186
40762952	可铁宁:物质的量浓度:时间点:胃液:定量型	4182948
40762953	Desipramine Gast-sCnc	4180186
40762953	Desi; Desip; Desipra; Desmethylimipramine; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Imipramine metabolite; Level; Norpramin; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762953	去甲丙咪嗪:物质的量浓度:时间点:胃液:定量型	4182948
40762955	Dextro-methorphan; D-methorphan; DRUG/TOXICOLOGY; Drugs; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40762955	D-methorphan Ur-sCnc	4180186
40762955	右美沙芬:物质的量浓度:时间点:尿液:定量型	4182948
40762957	Diso durules; DRUG/TOXICOLOGY; Drugs; Level; Norpace; Point in time; Pyramide; QNT; Quan; Quant; Quantitative; Random; Rythmodan; Substance concentration; UA; UR; Urn	4180186
40762957	Disopyramide Ur-sCnc	4180186
40762957	丙吡胺:物质的量浓度:时间点:尿液:定量型	4182948
40762958	Disopyramide Gast-sCnc	4180186
40762958	Diso durules; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Norpace; Point in time; Pyramide; QNT; Quan; Quant; Quantitative; Random; Rythmodan; Substance concentration	4180186
40762958	丙吡胺:物质的量浓度:时间点:胃液:定量型	4182948
40762968	Atarax; DRUG/TOXICOLOGY; Drugs; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn; Vistaril	4180186
40762968	hydrOXYzine Ur-sCnc	4180186
40762968	羟嗪:物质的量浓度:时间点:尿液:定量型	4182948
40762969	hydrOXYzine Gast-sCnc	4180186
40762969	Atarax; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Vistaril	4180186
40762969	羟嗪:物质的量浓度:时间点:胃液:定量型	4182948
40762972	DRUG/TOXICOLOGY; Drugs; Imipra; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Tofranil; UA; UR; Urn	4180186
40762972	Imipramine Ur-sCnc	4180186
40762972	丙咪嗪:物质的量浓度:时间点:尿液:定量型	4182948
40762974	Indomethacin Ur-sCnc	4180186
40762974	c282; C54; DRUG/TOXICOLOGY; Drugs; Indochron; Indocin; Indometacin; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40762974	茚甲新:物质的量浓度:时间点:尿液:定量型	4182948
40762976	Isopropanol Gast-sCnc	4180186
40762976	2-propanol; c615; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Isopropyl alcohol; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762976	异丙醇:物质的量浓度:时间点:胃液:定量型	4182948
40762978	2-(meta-benzylphenyl) propionate; C16H14O3; c388; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Orudis; Oruvail; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762978	Ketoprofen Gast-sCnc	4180186
40762978	酮洛芬:物质的量浓度:时间点:胃液:定量型	4182948
40762980	DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Lamictal; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762980	lamoTRIgine Gast-sCnc	4180186
40762980	拉莫三嗪:物质的量浓度:时间点:胃液:定量型	4182948
40762981	Mefenamate SerPl-sCnc	4180186
40762981	C15H15NO2; C56; DRUG/TOXICOLOGY; Drugs; Du-diclo; Forte mefenamic acid; Level; Mefenamic acid; Mefic; N-(2,3-xylyl)anthranilic acid; Pl; Plasma; Plsm; Point in time; Ponstan; Ponstel; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40762981	甲灭酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
40762982	Mefenamate Ur-sCnc	4180186
40762982	C15H15NO2; C56; DRUG/TOXICOLOGY; Drugs; Du-diclo; Forte mefenamic acid; Level; Mefenamic acid; Mefic; N-(2,3-xylyl)anthranilic acid; Point in time; Ponstan; Ponstel; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40762982	甲灭酸:物质的量浓度:时间点:尿液:定量型	4182948
40762986	DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Mesoridazine besylate; Point in time; QNT; Quan; Quant; Quantitative; Random; Serentil; Substance concentration	4180186
40762986	Mesoridazine Gast-sCnc	4180186
40762986	美索达嗪:物质的量浓度:时间点:胃液:定量型	4182948
40762988	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Methaqualon; Point in time; PotentialForAbuse; QNT; Quaalude; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40762988	Methaqualone Ur-sCnc	4180186
40762988	甲喹酮:物质的量浓度:时间点:尿液:定量型	4182948
40762989	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GAST; Gastric contents; Gastric fluid; Illicit; Level; Methaqualon; Point in time; PotentialForAbuse; QNT; Quaalude; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762989	Methaqualone Gast-sCnc	4180186
40762989	甲喹酮:物质的量浓度:时间点:胃液:定量型	4182948
40762990	Methotrimeprazine Ur-sCnc	4180186
40762990	DRUG/TOXICOLOGY; Drugs; Hirnamin; Lepurin; Lerium; Levamin; Level; Levohalte; Levomazine; Levomeprazine; Levomeproma; Levomepromazin; Levomepromazina; Levomepromazine; Levomezine; Levonormal; Levopromazine; Levoprome; Levotomin; Levozan; Levozin; Methotrimeprazine; Milezin; Minozinan; Neozine; Neuractil; Neurocil; Neurozil; Novo-Meprazine; Nozinan; Point in time; Procrazine; QNT; Quan; Quant; Quantitative; Random; Ronexine; Sinogan; Sofmin; Specia 246; Substance concentration; Tisercin; Tisercine; Tisercinetta; Tisercinettes; UA; UR; Urn; Veractil	4180186
40762990	甲氧异丁嗪:物质的量浓度:时间点:尿液:定量型	4182948
40762991	Methotrimeprazine Gast-sCnc	4180186
40762991	DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Hirnamin; Lepurin; Lerium; Levamin; Level; Levohalte; Levomazine; Levomeprazine; Levomeproma; Levomepromazin; Levomepromazina; Levomepromazine; Levomezine; Levonormal; Levopromazine; Levoprome; Levotomin; Levozan; Levozin; Methotrimeprazine; Milezin; Minozinan; Neozine; Neuractil; Neurocil; Neurozil; Novo-Meprazine; Nozinan; Point in time; Procrazine; QNT; Quan; Quant; Quantitative; Random; Ronexine; Sinogan; Sofmin; Specia 246; Substance concentration; Tisercin; Tisercine; Tisercinetta; Tisercinettes; Veractil	4180186
40762991	甲氧异丁嗪:物质的量浓度:时间点:胃液:定量型	4182948
40762992	Mexiletine Ur-sCnc	4180186
40762992	DRUG/TOXICOLOGY; Drugs; Level; Mexiletene; Mexitil; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40762992	美西律:物质的量浓度:时间点:尿液:定量型	4182948
40762999	Clobazam metabolite; Desmeth; Desmethylclobazam; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; N-desmethylclobazam; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762999	Norclobazam Gast-sCnc	4180186
40762999	去甲基氯巴詹:物质的量浓度:时间点:胃液:定量型	4182948
40763003	Nordoxepin Gast-sCnc	4180186
40763003	Desdoxepin; Desdoxepine; Desmeth; Desmethyl; Desmethyldox; Desmethyldoxepin; Doxepin metabolite; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; N-desmethyldoxepin; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40763003	去甲基多虑平:物质的量浓度:时间点:胃液:定量型	4182948
40763005	Amitriptyline metabolite; Aventyl; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Nortrip; Nortriptylene; Nortriptyln; Pamelor; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40763005	Nortrip Gast-sCnc	4180186
40763005	去甲阿米替林:物质的量浓度:时间点:胃液:定量型	4182948
40763006	OLANZapine Gast-sCnc	4180186
40763006	DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Lanzek; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Zypadhera; Zyprexa	4180186
40763006	奥氮平:物质的量浓度:时间点:胃液:定量型	4182948
40763007	OXcarbazepine Ur-sCnc	4180186
40763007	DRUG/TOXICOLOGY; Drugs; Level; OXC; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Trileptal; UA; UR; Urn	4180186
40763007	奥卡西平:物质的量浓度:时间点:尿液:定量型	4182948
40763009	DRUG/TOXICOLOGY; Drugs; Level; Paxil; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40763009	PARoxetine Ur-sCnc	4180186
40763009	帕罗西汀:物质的量浓度:时间点:尿液:定量型	4182948
40763011	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Talwin; UA; UR; Urn	4180186
40763011	Pentazocine Ur-sCnc	4180186
40763011	戊唑星:物质的量浓度:时间点:尿液:定量型	4182948
40763013	DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Trilafon	4180186
40763013	Perphenazine SerPl-sCnc	4180186
40763013	奋乃静:物质的量浓度:时间点:血清/血浆:定量型	4182948
40763014	DRUG/TOXICOLOGY; Drugs; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Trilafon; UA; UR; Urn	4180186
40763014	Perphenazine Ur-sCnc	4180186
40763014	奋乃静:物质的量浓度:时间点:尿液:定量型	4182948
40763016	Addiction; Angel dust; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; PCP; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sernylan; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40763016	PCP SerPl-sCnc	4180186
40763016	苯环利定:物质的量浓度:时间点:血清/血浆:定量型	4182948
40763017	DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sparine; SR; Substance concentration; Tranquazine	4180186
40763017	Promazine SerPl-sCnc	4180186
40763017	丙嗪:物质的量浓度:时间点:血清/血浆:定量型	4182948
40763018	Promazine Ur-sCnc	4180186
40763018	DRUG/TOXICOLOGY; Drugs; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Sparine; Substance concentration; Tranquazine; UA; UR; Urn	4180186
40763018	丙嗪:物质的量浓度:时间点:尿液:定量型	4182948
40763019	Promazine Gast-sCnc	4180186
40763019	DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Sparine; Substance concentration; Tranquazine	4180186
40763019	丙嗪:物质的量浓度:时间点:胃液:定量型	4182948
40763020	Addiction; Algaphan; Cosalgesic; Cotonal-65; Darvon; Depronal; Dextrogesic; Dextropropoxyphene; Distalgesic; Dolasan; Doloxene; D-propoxyphene; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Napsalgesic; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40763020	Propoxyph Ur-sCnc	4180186
40763020	丙氧氨酚:物质的量浓度:时间点:尿液:定量型	4182948
40763021	Addiction; Algaphan; Cosalgesic; Cotonal-65; Darvon; Depronal; Dextrogesic; Dextropropoxyphene; Distalgesic; Dolasan; Doloxene; D-propoxyphene; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GAST; Gastric contents; Gastric fluid; Illicit; Level; Napsalgesic; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40763021	Propoxyph Gast-sCnc	4180186
40763021	丙氧氨酚:物质的量浓度:时间点:胃液:定量型	4182948
40763022	Propranolol Gast-sCnc	4180186
40763022	DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Inderal; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40763022	普萘洛尔:物质的量浓度:时间点:胃液:定量型	4182948
40763024	QUEtiapine Gast-sCnc	4180186
40763024	DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Ketipinor; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Seroquel; Substance concentration; Xeroquel	4180186
40763024	喹硫平:物质的量浓度:时间点:胃液:定量型	4182948
40763026	quiNINE Ur-sCnc	4180186
40763026	DRUG/TOXICOLOGY; Drugs; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40763026	奎宁:物质的量浓度:时间点:尿液:定量型	4182948
40763029	DRUG/TOXICOLOGY; Drugs; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40763029	Strychnine Ur-sCnc	4180186
40763029	番木鳖碱:物质的量浓度:时间点:尿液:定量型	4182948
40763030	DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40763030	Strychnine Gast-sCnc	4180186
40763030	番木鳖碱:物质的量浓度:时间点:胃液:定量型	4182948
40763036	Desyrel; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Trazon; Trialodine	4180186
40763036	traZODone Gast-sCnc	4180186
40763036	曲唑酮:物质的量浓度:时间点:胃液:定量型	4182948
40763037	DRUG/TOXICOLOGY; Drugs; Efexor; Effexor; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn; Venlafaxin	4180186
40763037	Venlafaxine Ur-sCnc	4180186
40763037	文拉法辛:物质的量浓度:时间点:尿液:定量型	4182948
40763038	Venlafaxine Gast-sCnc	4180186
40763038	DRUG/TOXICOLOGY; Drugs; Efexor; Effexor; GAST; Gastric contents; Gastric fluid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Venlafaxin	4180186
40763038	文拉法辛:物质的量浓度:时间点:胃液:定量型	4182948
40763041	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Imovane; Level; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn; Zopliclone	4180186
40763041	Zopiclone Ur-sCnc	4180186
40763041	佐匹克隆:物质的量浓度:时间点:尿液:定量型	4182948
40763042	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GAST; Gastric contents; Gastric fluid; Illicit; Imovane; Level; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Zopliclone	4180186
40763042	Zopiclone Gast-sCnc	4180186
40763042	佐匹克隆:物质的量浓度:时间点:胃液:定量型	4182948
40763044	11DOC sp8 p chal SerPl-mCnc	4180186
40763044	11DOC; 11-DOC; 21-Hydroxyprogesterone; After; CHEMISTRY.CHALLENGE TESTING; DOC; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp8; sp8 p chal; Spec; SR	4180186
40763044	11-脱氧皮质酮^在XXX刺激之后的第8个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763045	^7th spec pst XXX chal; 11DOC; 11-DOC; 21-Hydroxyprogesterone; After; CHEMISTRY.CHALLENGE TESTING; DOC; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp7; sp7 p chal; Spec; SR	4180186
40763045	11DOC sp7 p chal SerPl-mCnc	4180186
40763045	11-脱氧皮质酮^在XXX刺激之后的第7个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763046	11DOC sp6 p chal SerPl-mCnc	4180186
40763046	11DOC; 11-DOC; 21-Hydroxyprogesterone; After; CHEMISTRY.CHALLENGE TESTING; DOC; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp6; sp6 p chal; Spec; SR	4180186
40763046	11-脱氧皮质酮^在XXX刺激之后的第6个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763051	Testost sp5 p chal SerPl-mCnc	4180186
40763051	After; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp5; sp5 p chal; Spec; SR; Testo; Testos; Testost	4180186
40763051	睾酮^在XXX刺激之后的第5个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763053	After; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp3; sp3 p chal; Spec; SR; Testo; Testos; Testost	4180186
40763053	Testost sp3 p chal SerPl-mCnc	4180186
40763053	睾酮^在XXX刺激之后的第3个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763054	After; CHEMISTRY.CHALLENGE TESTING; Convalescent; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Post immunization; PST; QNT; Quan; Quant; Quantitative; Random; Second; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp2; sp2 p chal; Spec; SR; Testo; Testos; Testost	4180186
40763054	Testost sp2 p chal SerPl-mCnc	4180186
40763054	睾酮^在XXX刺激之后的第2个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763055	Testost sp1 p chal SerPl-mCnc	4180186
40763055	Acute specimen; After; CHEMISTRY.CHALLENGE TESTING; First; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Pre immunization; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp1; sp1 p chal; Spec; SR; Testo; Testos; Testost	4180186
40763055	睾酮^在XXX刺激之后的第1个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763058	IGF BP3 sp6 p chal SerPl-mCnc	4180186
40763058	After; Bind; CHEMISTRY.CHALLENGE TESTING; Fac; Fact; HUM; Humulin; IGF; IGF BP; IGF BP3; IGFBP; IH7; III; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; PR; Prot; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; sp6; sp6 p chal; Spec; SR; Ultralente	4180186
40763058	胰岛素样生长因子结合蛋白 3^在XXX刺激之后的第6个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763059	After; Bind; CHEMISTRY.CHALLENGE TESTING; Fac; Fact; HUM; Humulin; IGF; IGF BP; IGF BP3; IGFBP; IH7; III; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; PR; Prot; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; sp5; sp5 p chal; Spec; SR; Ultralente	4180186
40763059	IGF BP3 sp5 p chal SerPl-mCnc	4180186
40763059	胰岛素样生长因子结合蛋白 3^在XXX刺激之后的第5个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763060	After; Bind; CHEMISTRY.CHALLENGE TESTING; Fac; Fact; HUM; Humulin; IGF; IGF BP; IGF BP3; IGFBP; IH7; III; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; PR; Prot; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; sp4; sp4 p chal; Spec; SR; Ultralente	4180186
40763060	IGF BP3 sp4 p chal SerPl-mCnc	4180186
40763060	胰岛素样生长因子结合蛋白 3^在XXX刺激之后的第4个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763061	IGF BP3 sp3 p chal SerPl-mCnc	4180186
40763061	After; Bind; CHEMISTRY.CHALLENGE TESTING; Fac; Fact; HUM; Humulin; IGF; IGF BP; IGF BP3; IGFBP; IH7; III; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; PR; Prot; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; sp3; sp3 p chal; Spec; SR; Ultralente	4180186
40763061	胰岛素样生长因子结合蛋白 3^在XXX刺激之后的第3个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763066	^7th spec pst XXX chal; After; CHEMISTRY.CHALLENGE TESTING; Fac; Fact; Factor 1; FI; HUM; Humulin; IGF; IGF1; IGF-1; IGF-I; IH7; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; Somatomedin C; sp7; sp7 p chal; Spec; SR; Ultralente	4180186
40763066	IGF-I sp7 p chal SerPl-mCnc	4180186
40763066	胰岛素样生长因子-I^在XXX刺激之后的第7个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763068	IGF-I sp5 p chal SerPl-mCnc	4180186
40763068	After; CHEMISTRY.CHALLENGE TESTING; Fac; Fact; Factor 1; FI; HUM; Humulin; IGF; IGF1; IGF-1; IGF-I; IH7; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; Somatomedin C; sp5; sp5 p chal; Spec; SR; Ultralente	4180186
40763068	胰岛素样生长因子-I^在XXX刺激之后的第5个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763069	IGF-I sp4 p chal SerPl-mCnc	4180186
40763069	After; CHEMISTRY.CHALLENGE TESTING; Fac; Fact; Factor 1; FI; HUM; Humulin; IGF; IGF1; IGF-1; IGF-I; IH7; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; Somatomedin C; sp4; sp4 p chal; Spec; SR; Ultralente	4180186
40763069	胰岛素样生长因子-I^在XXX刺激之后的第4个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763070	IGF-I sp3 p chal SerPl-mCnc	4180186
40763070	After; CHEMISTRY.CHALLENGE TESTING; Fac; Fact; Factor 1; FI; HUM; Humulin; IGF; IGF1; IGF-1; IGF-I; IH7; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; Somatomedin C; sp3; sp3 p chal; Spec; SR; Ultralente	4180186
40763070	胰岛素样生长因子-I^在XXX刺激之后的第3个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763072	Acute specimen; After; CHEMISTRY.CHALLENGE TESTING; Fac; Fact; Factor 1; FI; First; HUM; Humulin; IGF; IGF1; IGF-1; IGF-I; IH7; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; Pre immunization; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; Somatomedin C; sp1; sp1 p chal; Spec; SR; Ultralente	4180186
40763072	IGF-I sp1 p chal SerPl-mCnc	4180186
40763072	胰岛素样生长因子-I^在XXX刺激之后的第1个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763073	17-Hydroxycorticosterone; 40M p chal; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40763073	Cortis 40M p chal SerPl-sCnc	4180186
40763073	皮质醇^在XXX刺激之后40分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40763076	1 1/2 hours; 1 1/2 HR; 1.5h p chal; 1.5Hr; 90 min; 90 minutes; 90M; 90min; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40763076	ACTH 1.5h p chal Plas-sCnc	4180186
40763076	促肾上腺皮质激素^在XXX刺激之后1.5小时:物质的量浓度:时间点:血浆:定量型	4182948
40763079	LDH Pcar L to P-cCnc	4180186
40763079	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Catalytic Concentration; Chemistry; Dehydrog; Dehyrdogenase; L to P; L.D.H; Lact; Lactic acid; Lactic acid dehydrogenase; LD; LDH; L-lactate; L-lactate dehydrogenase; PCAR; Pericardial Fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; React; Rxn; Tumor marker	4180186
40763079	乳酸脱氢酶:催化浓度:时间点:心包液:定量型:反应: 乳酸至丙酮酸	4182948
40763080	LDH Prt P to L-cCnc	4180186
40763080	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Ascites; Ascitic fluid; Ascitis; Catalytic Concentration; Chemistry; Dehydrog; Dehyrdogenase; L.D.H; Lact; Lactic acid; Lactic acid dehydrogenase; LD; LDH; L-lactate; L-lactate dehydrogenase; P to L; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; React; Rxn; Tumor marker	4180186
40763080	乳酸脱氢酶:催化浓度:时间点:腹膜液:定量型:反应: 丙酮酸至乳酸	4182948
40763082	LDH Plr L to P-cCnc	4180186
40763082	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Catalytic Concentration; Chemistry; Dehydrog; Dehyrdogenase; L to P; L.D.H; Lact; Lactic acid; Lactic acid dehydrogenase; LD; LDH; L-lactate; L-lactate dehydrogenase; Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; React; Rxn; thoracentesis fluid; Tumor marker	4180186
40763082	乳酸脱氢酶:催化浓度:时间点:胸膜液:定量型:反应: 乳酸至丙酮酸	4182948
40763083	LDH CSF P to L-cCnc	4180186
40763083	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Catalytic Concentration; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Dehydrog; Dehyrdogenase; L.D.H; Lact; Lactic acid; Lactic acid dehydrogenase; LD; LDH; L-lactate; L-lactate dehydrogenase; P to L; Point in time; QNT; Quan; Quant; Quantitative; Random; React; Rxn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Tumor marker	4180186
40763083	乳酸脱氢酶:催化浓度:时间点:脑脊液:定量型:反应: 丙酮酸至乳酸	4182948
40763084	LDH CSF L to P-cCnc	4180186
40763084	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Catalytic Concentration; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Dehydrog; Dehyrdogenase; L to P; L.D.H; Lact; Lactic acid; Lactic acid dehydrogenase; LD; LDH; L-lactate; L-lactate dehydrogenase; Point in time; QNT; Quan; Quant; Quantitative; Random; React; Rxn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Tumor marker	4180186
40763084	乳酸脱氢酶:催化浓度:时间点:脑脊液:定量型:反应: 乳酸至丙酮酸	4182948
40763086	Leukocyte esterase Ur Ql Strip.auto	4180186
40763086	Auto; Automated detection; Dip stick; Dipstick; Elec; Elect; Electr; Leuc; Leuk; Leukocytes; Lkcs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; URINALYSIS; Urn; WBC; WBCs; White blood cell; White blood cells	4180186
40763086	白细胞酯酶:存在情况或阈值:时间点:尿液:序数型:试纸条.自动化法	4182948
40763089	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Time Resolved Fluorescence; TRF; WNV	4180186
40763089	WNV IgG Avidity Ser Ql IF	4180186
40763089	西尼罗河病毒 抗体.IgG 亲合力:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40763090	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Time Resolved Fluorescence; TRF; WNV	4180186
40763090	WNV IgG Ser Ql IF	4180186
40763090	西尼罗河病毒 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40763091	Bact; C&S; Cult; Cultures; Diaf; DiafP; Dialysate; Dialysis fluid; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Kidney; Microbiology; Nephrology; Nominal; Peritoneal Dialysis fluid; Point in time; Random; Renal	4180186
40763091	Bacteria DiafP Cult	4180186
40763091	细菌 已鉴定的:存在与否或特征标识:时间点:腹膜透析液:名义型:培养	4182948
40763092	Blood; CLOVE; CWS5; E542K; E545D; E545K; Genetics; H1047R; Heredity; Heritable; Identity or presence; Inherited; MCAP; MCM; MCMTC; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; p110-alpha; P13K; PCR; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha; PI3K; PIK3CA Oncogene; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40763092	PIK3CA gene Mut Anl Bld/T	4180186
40763092	PIK3CA 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40763093	Blood; CLOVE; CWS5; Document; E542K; E545D; E545K; Finding; Findings; Genetics; H1047R; Heredity; Heritable; Inherited; MCAP; MCM; MCMTC; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; p110-alpha; P13K; PCR; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha; PI3K; PIK3CA Oncogene; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40763093	PIK3CA gene Mut Anl Bld/T	4180186
40763093	PIK3CA 基因 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
40763096	1Naphthol; alpha-naphthol; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Carbaryl metabolite; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; i; Level; Mass concentration; Naphthalene metabolite; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40763096	1Naphthol Fld-mCnc	4180186
40763096	1-萘酚:质量浓度:时间点:体液:定量型	4182948
40763099	Acebutolol SerPl-mCnc	4180186
40763099	Acecor; ALOL; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Monitan; Neptal; Pl; Plasma; Plsm; Point in time; Prent; QNT; Quan; Quant; Quantitative; Random; Rhotral; Sectral; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40763099	醋丁洛尔:质量浓度:时间点:血清/血浆:定量型	4182948
40763101	NAPA Bld-mCnc	4180186
40763101	Acecainide; Acetylprocanam; Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; NAPA; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763101	N-乙酰普鲁卡因胺:质量浓度:时间点:全血:定量型	4182948
40763102	ACE; Acetylpromazine; AcP; Atravet; Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Notensil; Plegicil; Point in time; QNT; Quan; Quant; Quantitative; Random; Vet; Veterinary; WB; Whole blood	4180186
40763102	Acepromazine Bld-mCnc	4180186
40763102	乙酰丙嗪:质量浓度:时间点:全血:定量型	4182948
40763103	ACE; Acetylpromazine; AcP; Atravet; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Notensil; Plegicil; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Vet; Veterinary	4180186
40763103	Acepromazine Ur-mCnc	4180186
40763103	乙酰丙嗪:质量浓度:时间点:尿液:定量型	4182948
40763104	Addiction; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ethanal; Fl; Fld; FLU; Fluid; Illicit; Level; Mass concentration; Paraldehyde metabolite; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random	4180186
40763104	Acetaldehyde Fld-mCnc	4180186
40763104	乙醛:质量浓度:时间点:体液:定量型	4182948
40763105	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Erythrocytes; Ethanal; Illicit; Level; Mass concentration; Paraldehyde metabolite; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
40763105	Acetaldehyde RBC-mCnc	4180186
40763105	乙醛:质量浓度:时间点:红细胞:定量型	4182948
40763106	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ethanal; Illicit; Mass Content; Paraldehyde metabolite; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40763106	Acetaldehyde Tiss-mCnt	4180186
40763106	乙醛:质量含量:时间点:组织与涂片:定量型	4182948
40763108	ACET; Acetamidophenol; Acetaminoph; Acetominophen; Addiction; APAP; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; c209; C55; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; Hepatology; Hydroxyacetanilide; Illicit; Level; Liver; Mass Concentration; N-(4-Hydroxyphenyl)acetanilide; N-Acetyl-p-aminophenol; p-Acetamidophenol; Paracetamol; p-Hydroxyacetanilide; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tylenol; u209	4180186
40763108	APAP Fld-mCnc	4180186
40763108	对乙酰氨基酚:质量浓度:时间点:体液:定量型	4182948
40763110	Acetophenazine Bld-mCnc	4180186
40763110	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Tindal; WB; Whole blood	4180186
40763110	乙酰非那嗪:质量浓度:时间点:全血:定量型	4182948
40763112	Amikal; Amilospare; Amipramizide; Blood; DRUG/TOXICOLOGY; Drugs; Kaluril; Level; Mass concentration; Midamor; Modamide; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763112	aMILoride Bld-mCnc	4180186
40763112	阿米洛利:质量浓度:时间点:全血:定量型	4182948
40763115	DRUG/TOXICOLOGY; Drugs; Hismana; Hismanal; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40763115	Astemizole Tiss-mCnt	4180186
40763115	阿司咪唑:质量含量:时间点:组织与涂片:定量型	4182948
40763116	Bismuth Hair-mCnt	4180186
40763116	BI; DRUG/TOXICOLOGY; Drugs; Har; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40763116	铋:质量含量:时间点:毛发:定量型	4182948
40763119	B; DRUG/TOXICOLOGY; Drugs; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40763119	Boron Tiss-mCnt	4180186
40763119	硼:质量含量:时间点:组织与涂片:定量型	4182948
40763120	buPROPion Bld-mCnc	4180186
40763120	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Wellbutrin; Whole blood; Zyban	4180186
40763120	丁氨苯丙酮:质量浓度:时间点:全血:定量型	4182948
40763121	buPROPion Fld-mCnc	4180186
40763121	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Wellbutrin; Zyban	4180186
40763121	丁氨苯丙酮:质量浓度:时间点:体液:定量型	4182948
40763122	DRUG/TOXICOLOGY; Drugs; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; Wellbutrin; Zyban	4180186
40763122	buPROPion Tiss-mCnt	4180186
40763122	丁氨苯丙酮:质量含量:时间点:组织与涂片:定量型	4182948
40763123	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Wellbutrin; Zyban	4180186
40763123	buPROPion Ur-mCnc	4180186
40763123	丁氨苯丙酮:质量浓度:时间点:尿液:定量型	4182948
40763124	Cobalt Nail-mCnt	4180186
40763124	c617; CO; DRUG/TOXICOLOGY; Drugs; Mass content; Nails; Point in time; QNT; Quan; Quant; Quantitative; Random; Ungal nail	4180186
40763124	钴:质量含量:时间点:甲:定量型	4182948
40763126	Cobalt Tiss-mCnt	4180186
40763126	c617; CO; DRUG/TOXICOLOGY; Drugs; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40763126	钴:质量含量:时间点:组织与涂片:定量型	4182948
40763127	Colchicine Bld-mCnc	4180186
40763127	Blood; C22H25NO6; Colchiceine methyl ether; Colchineos; Colchisol; Colcin; Colgout; Colsaloid; Condylon; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; n-acetyltrimethylcolchicinic acid methyl ether; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763127	秋水仙碱:质量浓度:时间点:全血:定量型	4182948
40763129	2,2-Dichlorobinyldimethyl phosphate; Blood; C4H7Cl2O4P; DDVP; Dichlorophos; Dichlorovos; DRUG/TOXICOLOGY; Drugs; Equigand; Level; Mass concentration; Organophosphate pesticide; Point in time; QNT; Quan; Quant; Quantitative; Random; SD1750; Tetravos; Vapona; WB; Whole blood	4180186
40763129	Dichlorvos Bld-mCnc	4180186
40763129	敌敌畏:质量浓度:时间点:全血:定量型	4182948
40763130	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; EDDP; i; II; III; Illicit; Level; Mass concentration; Methadone metabolite; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40763130	EDDP SerPl-mCnc	4180186
40763130	2-亚乙基-1,5-二甲基-3,3-四氢吡咯:质量浓度:时间点:血清/血浆:定量型	4182948
40763135	Gallium RBC-mCnc	4180186
40763135	DRUG/TOXICOLOGY; Drugs; Erythrocytes; GA; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
40763135	镓:质量浓度:时间点:红细胞:定量型	4182948
40763136	Ganciclovir Bld-mCnc	4180186
40763136	Blood; Cytovene; DRUG/TOXICOLOGY; Drugs; GCV; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Valcyte; Valganciclovir; WB; Whole blood	4180186
40763136	更昔洛韦:质量浓度:时间点:全血:定量型	4182948
40763139	Germanium RBC-mCnc	4180186
40763139	DRUG/TOXICOLOGY; Drugs; Erythrocytes; GE; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
40763139	锗:质量浓度:时间点:红细胞:定量型	4182948
40763142	6-hydroxybupropion; Blood; Bupropion metabolite; BW 306U; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; OH-bupropion; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763142	OH-bupropion Bld-mCnc	4180186
40763142	羟基丁氨苯丙酮:质量浓度:时间点:全血:定量型	4182948
40763145	6-hydroxybupropion; Bupropion metabolite; BW 306U; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; OH-bupropion; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40763145	OH-bupropion Ur-mCnc	4180186
40763145	羟基丁氨苯丙酮:质量浓度:时间点:尿液:定量型	4182948
40763146	Hyoscyamine Bld-mCnc	4180186
40763146	Anaspaz; Blood; Cystospaz; DRUG/TOXICOLOGY; Drugs; Levbid; Level; Levsin; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763146	天仙子胺:质量浓度:时间点:全血:定量型	4182948
40763147	Hyoscyamine Ur-mCnc	4180186
40763147	Anaspaz; Cystospaz; DRUG/TOXICOLOGY; Drugs; Levbid; Level; Levsin; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40763147	天仙子胺:质量浓度:时间点:尿液:定量型	4182948
40763148	Indium RBC-mCnc	4180186
40763148	DRUG/TOXICOLOGY; Drugs; Erythrocytes; In; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
40763148	铟:质量浓度:时间点:红细胞:定量型	4182948
40763153	Ketoprofen Ur-mCnc	4180186
40763153	2-(meta-benzylphenyl) propionate; C16H14O3; c388; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Orudis; Oruvail; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40763153	酮洛芬:质量浓度:时间点:尿液:定量型	4182948
40763155	Loperamide Ur-mCnc	4180186
40763155	C29H33ClN2O2; DRUG/TOXICOLOGY; Drugs; Immodium; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40763155	洛哌丁胺:质量浓度:时间点:尿液:定量型	4182948
40763156	Alavert; Blood; Claritin; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763156	Loratadine Bld-mCnc	4180186
40763156	氯雷他定:质量浓度:时间点:全血:定量型	4182948
40763160	Molybdenum Nail-mCnt	4180186
40763160	DRUG/TOXICOLOGY; Drugs; Mass content; Mo; Nails; Point in time; QNT; Quan; Quant; Quantitative; Random; Ungal nail	4180186
40763160	钼:质量含量:时间点:甲:定量型	4182948
40763162	O-去甲基文拉法新:质量浓度:时间点:体液:定量型	4182948
40763162	ODV Fld-mCnc	4180186
40763162	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Desmeth; Desvenlafaxine; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Mass concentration; Norvenlafaxin; Norvenlafaxine; O-desmethylvenlafaxine; ODV; Point in time; Pristiq; QNT; Quan; Quant; Quantitative; Random; Venlafaxine metabolite	4180186
40763164	Blood; DRUG/TOXICOLOGY; Drugs; Lanzek; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood; Zypadhera; Zyprexa	4180186
40763164	OLANZapine Bld-mCnc	4180186
40763164	奥氮平:质量浓度:时间点:全血:定量型	4182948
40763165	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Lanzek; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Zypadhera; Zyprexa	4180186
40763165	OLANZapine Fld-mCnc	4180186
40763165	奥氮平:质量浓度:时间点:体液:定量型	4182948
40763166	OLANZapine Tiss-mCnt	4180186
40763166	DRUG/TOXICOLOGY; Drugs; Lanzek; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; Zypadhera; Zyprexa	4180186
40763166	奥氮平:质量含量:时间点:组织与涂片:定量型	4182948
40763174	9-Hydroxy risperidone; 9-Hydroxy-risperidone; 9-OH-Risperidone; 9OH-risperidone; Blood; DRUG/TOXICOLOGY; Drugs; Invega; Level; Mass concentration; Paliperidone; Point in time; QNT; Quan; Quant; Quantitative; Random; Risperidone metabolite; WB; Whole blood	4180186
40763174	9OH-risperidone Bld-mCnc	4180186
40763174	9-羟基利培酮:质量浓度:时间点:全血:定量型	4182948
40763175	9-Hydroxy risperidone; 9-Hydroxy-risperidone; 9-OH-Risperidone; 9OH-risperidone; DRUG/TOXICOLOGY; Drugs; Invega; Level; Mass concentration; Paliperidone; Point in time; QNT; Quan; Quant; Quantitative; Random; Risperidone metabolite; UA; UR; Urn	4180186
40763175	9OH-risperidone Ur-mCnc	4180186
40763175	9-羟基利培酮:质量浓度:时间点:尿液:定量型	4182948
40763178	c629; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pd; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40763178	Palladium SerPl-mCnc	4180186
40763178	钯:质量浓度:时间点:血清/血浆:定量型	4182948
40763180	Pancuronium Bld-mCnc	4180186
40763180	Blood; CPAN; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Mioblock; Pavulon; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763180	泮库溴铵:质量浓度:时间点:全血:定量型	4182948
40763181	CPAN; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Mioblock; Pavulon; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40763181	Pancuronium SerPl-mCnc	4180186
40763181	泮库溴铵:质量浓度:时间点:血清/血浆:定量型	4182948
40763183	CPAN; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Mioblock; Pavulon; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40763183	Pancuronium Ur-mCnc	4180186
40763183	泮库溴铵:质量浓度:时间点:尿液:定量型	4182948
40763184	Papaverine Bld-mCnc	4180186
40763184	Blood; CereSer; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pavobid; Plasan; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763184	罂粟碱:质量浓度:时间点:全血:定量型	4182948
40763186	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; PMO; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763186	PMO Bld-mCnc	4180186
40763186	甲乙双酮:质量浓度:时间点:全血:定量型	4182948
40763189	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Mass concentration; Parathion metabolite; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40763189	Paraoxon Fld-mCnc	4180186
40763189	对氧磷:质量浓度:时间点:体液:定量型	4182948
40763190	Paraoxon Tiss-mCnt	4180186
40763190	DRUG/TOXICOLOGY; Drugs; Mass content; Parathion metabolite; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40763190	对氧磷:质量含量:时间点:组织与涂片:定量型	4182948
40763194	Pargyline SerPl-mCnc	4180186
40763194	DRUG/TOXICOLOGY; Drugs; Eutonyl; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40763194	优降宁:质量浓度:时间点:血清/血浆:定量型	4182948
40763198	Pemoline Bld-mCnc	4180186
40763198	Blood; Cylert; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763198	苯异妥英:质量浓度:时间点:全血:定量型	4182948
40763200	Denavir; DRUG/TOXICOLOGY; Drugs; Famciclovir metabolite; Famvir metabolite; Level; Mass concentration; PCV; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40763200	Penciclovir SerPl-mCnc	4180186
40763200	喷昔洛韦:质量浓度:时间点:血清/血浆:定量型	4182948
40763202	Pendimethalin SerPl-mCnc	4180186
40763202	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40763202	二甲戊乐灵:质量浓度:时间点:血清/血浆:定量型	4182948
40763203	Pendimethalin Ur-mCnc	4180186
40763203	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40763203	二甲戊乐灵:质量浓度:时间点:尿液:定量型	4182948
40763204	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40763204	Pentane Fld-mCnc	4180186
40763204	戊烷:质量浓度:时间点:体液:定量型	4182948
40763206	Pentane Tiss-mCnt	4180186
40763206	DRUG/TOXICOLOGY; Drugs; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40763206	戊烷:质量含量:时间点:组织与涂片:定量型	4182948
40763207	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40763207	Pentane Ur-mCnc	4180186
40763207	戊烷:质量浓度:时间点:尿液:定量型	4182948
40763208	Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Talwin; WB; Whole blood	4180186
40763208	Pentazocine Bld-mCnc	4180186
40763208	戊唑星:质量浓度:时间点:全血:定量型	4182948
40763210	Addiction; Barbiturate; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Nembutal; Pentobarb; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763210	Pentobarb Bld-mCnc	4180186
40763210	戊巴比妥:质量浓度:时间点:全血:定量型	4182948
40763215	Perfluorooctanoate Bld-mCnc	4180186
40763215	Blood; DRUG/TOXICOLOGY; Drugs; FC-143 component; Level; Mass concentration; Pentadecafluorooctanoic acid; PFOA; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763215	全氟辛酸:质量浓度:时间点:全血:定量型	4182948
40763217	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Permax; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763217	Pergolide Bld-mCnc	4180186
40763217	培高利特:质量浓度:时间点:全血:定量型	4182948
40763218	Pergolide Ur-mCnc	4180186
40763218	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Permax; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40763218	培高利特:质量浓度:时间点:尿液:定量型	4182948
40763220	Phenacemide Bld-mCnc	4180186
40763220	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Phenurone; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763220	苯乙酰脲:质量浓度:时间点:全血:定量型	4182948
40763223	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Milontin; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763223	Phensuximide Bld-mCnc	4180186
40763223	苯琥胺:质量浓度:时间点:全血:定量型	4182948
40763228	DRUG/TOXICOLOGY; Drugs; Erythrocytes; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; RB; Red blood cells; Red blood corpusles	4180186
40763228	Rubidium RBC-mCnc	4180186
40763228	铷:质量浓度:时间点:红细胞:定量型	4182948
40763229	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; SI	4180186
40763229	Silicon Fld-mCnc	4180186
40763229	硅:质量浓度:时间点:体液:定量型	4182948
40763230	DRUG/TOXICOLOGY; Drugs; Erythrocytes; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; SI	4180186
40763230	Silicon RBC-mCnc	4180186
40763230	硅:质量浓度:时间点:红细胞:定量型	4182948
40763233	DRUG/TOXICOLOGY; Drugs; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; SR; Tissue; Tissue, unspecified	4180186
40763233	Strontium Tiss-mCnt	4180186
40763233	锶:质量含量:时间点:组织与涂片:定量型	4182948
40763234	Sulfamethizole Bld-mCnc	4180186
40763234	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763234	磺胺甲二唑:质量浓度:时间点:全血:定量型	4182948
40763235	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40763235	Sulfamethizole SerPl-mCnc	4180186
40763235	磺胺甲二唑:质量浓度:时间点:血清/血浆:定量型	4182948
40763238	Tellurium Nail-mCnt	4180186
40763238	DRUG/TOXICOLOGY; Drugs; Mass content; Nails; Point in time; QNT; Quan; Quant; Quantitative; Random; TE; Ungal nail	4180186
40763238	碲:质量含量:时间点:甲:定量型	4182948
40763239	DRUG/TOXICOLOGY; Drugs; Erythrocytes; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; TE	4180186
40763239	Tellurium RBC-mCnc	4180186
40763239	碲:质量浓度:时间点:红细胞:定量型	4182948
40763241	Temephos Ur-mCnc	4180186
40763241	Abate; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40763241	双硫磷:质量浓度:时间点:尿液:定量型	4182948
40763242	Terazosin Bld-mCnc	4180186
40763242	Blood; DRUG/TOXICOLOGY; Drugs; Hytrin; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763242	特拉唑嗪:质量浓度:时间点:全血:定量型	4182948
40763243	DRUG/TOXICOLOGY; Drugs; Hytrin; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40763243	Terazosin SerPl-mCnc	4180186
40763243	特拉唑嗪:质量浓度:时间点:血清/血浆:定量型	4182948
40763244	Thallium RBC-mCnc	4180186
40763244	DRUG/TOXICOLOGY; Drugs; Erythrocytes; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; TL	4180186
40763244	铊:质量浓度:时间点:红细胞:定量型	4182948
40763246	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Torecan	4180186
40763246	Thiethylperazine SerPl-mCnc	4180186
40763246	乙巯拉嗪:质量浓度:时间点:血清/血浆:定量型	4182948
40763248	DRUG/TOXICOLOGY; Drugs; Mass content; Nails; Point in time; QNT; Quan; Quant; Quantitative; Random; SN; Ungal nail	4180186
40763248	Tin Nail-mCnt	4180186
40763248	锡:质量含量:时间点:甲:定量型	4182948
40763249	Tin RBC-mCnc	4180186
40763249	DRUG/TOXICOLOGY; Drugs; Erythrocytes; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; SN	4180186
40763249	锡:质量浓度:时间点:红细胞:定量型	4182948
40763250	Tin Tiss-mCnt	4180186
40763250	DRUG/TOXICOLOGY; Drugs; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; SN; Tissue; Tissue, unspecified	4180186
40763250	锡:质量含量:时间点:组织与涂片:定量型	4182948
40763253	Blood; DRUG/TOXICOLOGY; Drugs; Dyrenium; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763253	Triamterene Bld-mCnc	4180186
40763253	氨苯蝶啶:质量浓度:时间点:全血:定量型	4182948
40763255	TCM SerPl-mCnc	4180186
40763255	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TCM; Triflumen	4180186
40763255	三氯甲噻嗪:质量浓度:时间点:血清/血浆:定量型	4182948
40763256	Triclopyr SerPl-mCnc	4180186
40763256	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40763256	绿草定:质量浓度:时间点:血清/血浆:定量型	4182948
40763258	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Triflurali	4180186
40763258	Trifluralin SerPl-mCnc	4180186
40763258	氟乐灵:质量浓度:时间点:血清/血浆:定量型	4182948
40763263	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; Pyribenzamine; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763263	Tripelennamine Bld-mCnc	4180186
40763263	苄吡二胺:质量浓度:时间点:全血:定量型	4182948
40763266	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Efexor; Effexor; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Venlafaxin	4180186
40763266	Venlafaxine Fld-mCnc	4180186
40763266	文拉法辛:质量浓度:时间点:体液:定量型	4182948
40763268	Blood; DRUG/TOXICOLOGY; Drugs; Flupyrazapon; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Vet; Veterinary; WB; Whole blood	4180186
40763268	Zolazepam Bld-mCnc	4180186
40763268	唑拉西泮:质量浓度:时间点:全血:定量型	4182948
40763269	DRUG/TOXICOLOGY; Drugs; Flupyrazapon; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Vet; Veterinary	4180186
40763269	Zolazepam SerPl-mCnc	4180186
40763269	唑拉西泮:质量浓度:时间点:血清/血浆:定量型	4182948
40763274	Chemistry; Cl; Cl-; Level; Mother Milk; Mother's milk; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40763274	Chloride Mother Milk-sCnc	4180186
40763274	氯:物质的量浓度:时间点:母乳:定量型	4182948
40763275	Chemistry; k; K+; Level; Mother Milk; Mother's milk; Point in time; Potass; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40763275	Potassium Mother Milk-sCnc	4180186
40763275	钾:物质的量浓度:时间点:母乳:定量型	4182948
40763277	Chemistry; Level; Mother Milk; Mother's milk; Na; Na+; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40763277	Sodium Mother Milk-sCnc	4180186
40763277	钠:物质的量浓度:时间点:母乳:定量型	4182948
40763278	ABS; Absorbing intrinsic; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Fac; Fact; Hematology; Heme; IF; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR	4180186
40763278	IF IgG Ser-aCnc	4180186
40763278	内因子 抗体.IgG:任意型浓度:时间点:血清:定量型	4182948
40763280	Breath H2 3h p fructose PO	4180186
40763280	3h p fructose PO; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; Levulose; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Revulose; Volfr; Volume fraction	4180186
40763280	氢/已呼出的气体^在口服剂量果糖之后3小时:体积分数:时间点:呼出的气体:定量型	4182948
40763281	2.5h p fructose PO; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; Levulose; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Revulose; Volfr; Volume fraction	4180186
40763281	Breath H2 2.5h p fructose PO	4180186
40763281	氢/已呼出的气体^在口服剂量果糖之后2.5小时:体积分数:时间点:呼出的气体:定量型	4182948
40763282	120 min; 120 minutes; 120min; 2 hours; 2h p fructose PO; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; Levulose; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Revulose; Volfr; Volume fraction	4180186
40763282	Breath H2 2h p fructose PO	4180186
40763282	氢/已呼出的气体^在口服剂量果糖之后2小时:体积分数:时间点:呼出的气体:定量型	4182948
40763283	Breath H2 1.5h p fructose PO	4180186
40763283	1 1/2 hours; 1 1/2 HR; 1.5h p fructose PO; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; Levulose; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Revulose; Volfr; Volume fraction	4180186
40763283	氢/已呼出的气体^在口服剂量果糖之后1.5小时:体积分数:时间点:呼出的气体:定量型	4182948
40763285	Breath H2 30M p fructose PO	4180186
40763285	30M p fructose PO; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; Levulose; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Revulose; Volfr; Volume fraction	4180186
40763285	氢/已呼出的气体^在口服剂量果糖之后30分钟:体积分数:时间点:呼出的气体:定量型	4182948
40763293	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; European ash; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t25	4180186
40763293	European Ash IgE Qn	4180186
40763293	欧洲梣木 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40763295	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Common wasp; Common wasp (rVes v) 5; i209; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763295	Common wasp (rVes v) 5 IgE Qn	4180186
40763295	常见黄胡蜂 重组 (rVes v) 5 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40763296	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Honey bee; Honeybee; i; i001; i1; i208; IgE RAST; Immune globulin E; Immunoglobulin E; k203; nApi m 1 Phospholipase A2, Bee; Ordinal; PLA2 rApi m 1; Point in time; PR; QL; Qual; Qualitative; Random; Rk203; Screen; Serum; SR	4180186
40763296	意大利蜜蜂磷脂酶 A2 重组 (rApi m) 1 抗体.IgE.RAST 类:存在情况或阈值:时间点:血清:序数型	4182948
40763296	Deprecated PLA2 rApi m 1 IgE RAST Ql	4180186
40763300	^7th spec pst XXX chal; After; CHEMISTRY.CHALLENGE TESTING; DHT; Dihydrotestosterone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp7; sp7 p chal; Spec; SR	4180186
40763300	Androstanolone sp7 p chal SerPl-mCnc	4180186
40763300	双氢睾酮^在XXX刺激之后的第7个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763301	Androstanolone sp6 p chal SerPl-mCnc	4180186
40763301	After; CHEMISTRY.CHALLENGE TESTING; DHT; Dihydrotestosterone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp6; sp6 p chal; Spec; SR	4180186
40763301	双氢睾酮^在XXX刺激之后的第6个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763302	After; CHEMISTRY.CHALLENGE TESTING; DHT; Dihydrotestosterone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp5; sp5 p chal; Spec; SR	4180186
40763302	Androstanolone sp5 p chal SerPl-mCnc	4180186
40763302	双氢睾酮^在XXX刺激之后的第5个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763304	Androstanolone sp3 p chal SerPl-mCnc	4180186
40763304	After; CHEMISTRY.CHALLENGE TESTING; DHT; Dihydrotestosterone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp3; sp3 p chal; Spec; SR	4180186
40763304	双氢睾酮^在XXX刺激之后的第3个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763307	Arbitrary; DNA methylation; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified	4180186
40763307	MGMT gene methylation Tiss Ql	4180186
40763307	MGMT 基因甲基化:任意型:时间点:组织与涂片:序数型:分子遗传学类实验室方法	4182948
40763308	Arbitrary concentration; Deoxyribonucleic acid; DI; DNA Index 4th peak; DNA score; Dynamic; FC; Misc; Miscellaneous; Molecular pathology; MOLPATH; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified	4180186
40763308	DNA index 4 Spec FC-aCnc	4180186
40763308	DNA 指数 4:任意型浓度:时间点:XXX:定量型:流式细胞测量术	4182948
40763310	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; GC; Gen-Probe; Gono; Gonorrhea; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; N gonorrhoea; N gonorrhoeae; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; SDA; Strand Displacement Amplification; Throat; TMA; Transcription mediated amplification; Upper respiratory	4180186
40763310	N gonorrhoea rRNA Throat Ql NAA+probe	4180186
40763310	淋病奈瑟菌 rRNA:存在情况或阈值:时间点:咽喉:序数型:探针法.基因扩增.靶向	4182948
40763313	Bact; BM; BON; Bone marrow; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; MAR; Marrow (bone); Microbiology; minimal angle of resolution; Minimum angle of resolution; Nominal; Point in time; Random	4180186
40763313	Bacteria Mar Cult	4180186
40763313	细菌 已鉴定的:存在与否或特征标识:时间点:骨髓:名义型:培养	4182948
40763314	3 Self-Sustaining Sequence Replication; 3SR SR; Adeno virus; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HAdV; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40763314	HAdV DNA Islt Ql NAA+probe	4180186
40763314	腺病毒 DNA:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
40763315	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; CHIKV; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40763315	CHIKV RNA SerPl Ql NAA+probe	4180186
40763315	基孔肯亚病毒 RNA:存在情况或阈值:时间点:血清/血浆:序数型:探针法.基因扩增.靶向	4182948
40763316	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C burnet; C burnetii; Coxiella burnettii; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Q fev; Q fever; QBR; Qfever; QL; Qual; Qualitative; Random; Screen; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40763316	C burnet DNA SerPl Ql NAA+probe	4180186
40763316	贝氏柯克斯体 DNA:存在情况或阈值:时间点:血清/血浆:序数型:探针法.基因扩增.靶向	4182948
40763317	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breakbone fever; Dengue type I; Denv; DENV RNA; DENV1; DNA NUCLEIC ACID PROBE; DNA probe; Flavivirus; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Serum; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40763317	DENV1 RNA Ser Ql NAA+probe	4180186
40763317	登革热病毒 1 型 RNA:存在情况或阈值:时间点:血清:序数型:探针法.基因扩增.靶向	4182948
40763319	Hantavirus Ab Titr Ser	4180186
40763319	汉坦病毒 抗体:滴定度:时间点:血清:定量型	4182948
40763319	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; ID; Infectious Disease; InfectiousDisease; Microbiology; Orthohantavirus; Point in time; Random; Serum; SmQn; SNV; SR; Titer; Titered; Titre; Ttr	4180186
40763320	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40763320	HCoV RNA SerPl Ql NAA+probe	4180186
40763320	人类冠状病毒 RNA:存在情况或阈值:时间点:血清/血浆:序数型:探针法.基因扩增.靶向	4182948
40763321	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; hMPV; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40763321	hMPV RNA Islt Ql NAA+probe	4180186
40763321	人类偏肺病毒 RNA:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
40763322	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; FLUC; FLUCV; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Influenza C; Influenza C virus; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40763322	FLUCV RNA Islt Ql NAA+probe	4180186
40763322	流感病毒 C 型 RNA:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
40763326	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HRSV; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; RSV; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40763326	RSV RNA Islt Ql NAA+probe	4180186
40763326	呼吸道合胞病毒 RNA:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
40763327	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Rick Typhus; Ricket; Rickettsial; Screen; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; Typh; Typhus	4180186
40763327	Rick Typhus DNA SerPl Ql NAA+probe	4180186
40763327	立克次体斑疹伤寒群 DNA:存在情况或阈值:时间点:血清/血浆:序数型:探针法.基因扩增.靶向	4182948
40763328	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40763328	RV RNA Islt Ql NAA+probe	4180186
40763328	轮状病毒 RNA:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
40763330	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; Screen; SDA; Severe Acute Respiratory Syndrome; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40763330	SARS-CoV RNA Islt Ql NAA+probe	4180186
40763330	SARS 冠状病毒 RNA:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
40763333	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; COAGULATION; Coagulation factor I; DFA; FA; FGN; Fluorescent antibody; Fluoresent; Hematology; Heme; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; Tissue; Tissue, unspecified; TRF	4180186
40763333	Fibrinogen Ag Tiss Ql IF	4180186
40763333	纤维蛋白原 抗原:存在情况或阈值:时间点:组织与涂片:序数型:免疫荧光法	4182948
40763334	Assoc; Blood; Chromosome 19q13 polymorphism; Genetics; HCV genotype 1; Hep C; Hepatitis C virus; Heredity; Heritable; IFNL3; IFN-lambda-3; IL 28; IL28B; IL-28B; IL28B Hepatitis C treatment predicting variant; IL28B rs12979860; IL28C; Inherited; interferon, lambda 3; Interleukin 28b; interleukin 28B (interferon, lambda 3; Interleukin-28b; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40763334	IL28B rs12979860 Bld/T Ql	4180186
40763334	IL28B 基因相关变体 rs12979860:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40763335	ED Discharge instruct	4180186
40763335	Disch; DOC.ONT; Document; ED; Finding; Findings; Point in time; Random	4180186
40763335	出院指导:发现:时间点:急诊科:文档型:{角色}	4182948
40763336	Deprecated IP hospital Discharge instruc	4180186
40763336	Disch; DOC.ONT; Document; Finding; Findings; Hosp; Inpatient; IP; IP hospital; Point in time; Random	4180186
40763339	Addiction; Amobarb; Amylobarbitone; Amytal; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Misc; Miscellaneous; Other; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763339	Amobarbital Spec-sCnc	4180186
40763339	异戊巴比妥:物质的量浓度:时间点:XXX:定量型	4182948
40763340	Amox; Asendin; Defanyl; Demolox; DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Moxadil; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763340	Amoxapine Spec-sCnc	4180186
40763340	阿莫沙平:物质的量浓度:时间点:XXX:定量型	4182948
40763341	Vit C Spec-sCnc	4180186
40763341	Ascorbic acid; c702; DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified; Vit C; Vitamin C	4180186
40763341	抗坏血酸:物质的量浓度:时间点:XXX:定量型	4182948
40763342	Benztropine Spec-sCnc	4180186
40763342	Cogentin; DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763342	苯扎托品:物质的量浓度:时间点:XXX:定量型	4182948
40763344	Antial; BPN; Bromarest; Bromfed; Bromfenex; Dimegan; Dimetane; Dimetapp; Dimotane; DRUG/TOXICOLOGY; Drugs; Gammistin; Ilvin; Level; Lodrane; Misc; Miscellaneous; Other; Parabromdylamine maleate; Point in time; PROBAHIST; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763344	Brompheniramine Spec-sCnc	4180186
40763344	溴苯那敏:物质的量浓度:时间点:XXX:定量型	4182948
40763345	CAFFN; DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763345	Caffeine Spec-sCnc	4180186
40763345	咖啡因:物质的量浓度:时间点:XXX:定量型	4182948
40763346	Carbamazapine; Carbamezapine; Carbazepine; CRBM; DRUG/TOXICOLOGY; Drugs; Epitol; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Tegretol; Teril; To be specified in another part of the message; Unspecified	4180186
40763346	carBAMazepine Spec Ql	4180186
40763346	卡马西平:存在情况或阈值:时间点:XXX:序数型	4182948
40763347	Chloraldurat; Chloralix; Dormel; DRUG/TOXICOLOGY; Drugs; Elix-node; Level; Medianox; Misc; Miscellaneous; Noctec; Other; Pediatric chloral elixir; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Trichloroethanol; Trichloroethyl alcohol; Trichloroethylalcohol; Unspecified; Welldorm	4180186
40763347	Chloral Hydrate Spec-sCnc	4180186
40763347	水合氯醛:物质的量浓度:时间点:XXX:定量型	4182948
40763349	Chlopromazine; Chlorpromaz; DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; Thorazine; To be specified in another part of the message; Unspecified	4180186
40763349	chlorproMAZINE Spec-sCnc	4180186
40763349	氯丙嗪:物质的量浓度:时间点:XXX:定量型	4182948
40763351	cloBAZam Spec-sCnc	4180186
40763351	Clarmyl; Clopax; DRUG/TOXICOLOGY; Drugs; Frisium; Level; Misc; Miscellaneous; Noiafren; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Sederlona; Spec; Substance Concentration; To be specified in another part of the message; Unspecified; Urbadan; Urbanol; Urbanyl	4180186
40763351	氯巴詹:物质的量浓度:时间点:XXX:定量型	4182948
40763354	Cotinine Spec-sCnc	4180186
40763354	DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Nicotine metabolite; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763354	可铁宁:物质的量浓度:时间点:XXX:定量型	4182948
40763356	Diso durules; DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Norpace; Other; Point in time; Pyramide; QNT; Quan; Quant; Quantitative; Random; Rythmodan; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763356	Disopyramide Spec-sCnc	4180186
40763356	丙吡胺:物质的量浓度:时间点:XXX:定量型	4182948
40763357	Adapin; Aponal; Dox; Doxpin; DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Sinequan; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763357	Doxepin Spec-sCnc	4180186
40763357	多虑平:物质的量浓度:时间点:XXX:定量型	4182948
40763359	FLUoxetine Spec-sCnc	4180186
40763359	DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Other; Point in time; Prozac; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763359	氟西汀:物质的量浓度:时间点:XXX:定量型	4182948
40763360	fluPHENAZine Spec-sCnc	4180186
40763360	DRUG/TOXICOLOGY; Drugs; Fluphenazine Hydrochloride; Level; Misc; Miscellaneous; Other; Point in time; Prolixin; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763360	氟奋乃静:物质的量浓度:时间点:XXX:定量型	4182948
40763362	Atarax; DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified; Vistaril	4180186
40763362	hydrOXYzine Spec-sCnc	4180186
40763362	羟嗪:物质的量浓度:时间点:XXX:定量型	4182948
40763363	Advil; c20; c235; c286; C53; DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Motrin; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763363	Ibuprofen Spec-sCnc	4180186
40763363	对异丁基苯异丙酸:物质的量浓度:时间点:XXX:定量型	4182948
40763368	Maprotiline Spec-sCnc	4180186
40763368	DRUG/TOXICOLOGY; Drugs; Level; Ludiomil; Misc; Miscellaneous; Novartis; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763368	马普替林:物质的量浓度:时间点:XXX:定量型	4182948
40763369	Mefenamate Spec-sCnc	4180186
40763369	C15H15NO2; C56; DRUG/TOXICOLOGY; Drugs; Du-diclo; Forte mefenamic acid; Level; Mefenamic acid; Mefic; Misc; Miscellaneous; N-(2,3-xylyl)anthranilic acid; Other; Point in time; Ponstan; Ponstel; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763369	甲灭酸:物质的量浓度:时间点:XXX:定量型	4182948
40763376	Clobazam metabolite; Desmeth; Desmethylclobazam; DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; N-desmethylclobazam; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763376	Norclobazam Spec-sCnc	4180186
40763376	去甲基氯巴詹:物质的量浓度:时间点:XXX:定量型	4182948
40763382	PARoxetine Spec-sCnc	4180186
40763382	DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Other; Paxil; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763382	帕罗西汀:物质的量浓度:时间点:XXX:定量型	4182948
40763383	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Misc; Miscellaneous; Other; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; Talwin; To be specified in another part of the message; Unspecified	4180186
40763383	Pentazocine Spec-sCnc	4180186
40763383	戊唑星:物质的量浓度:时间点:XXX:定量型	4182948
40763384	Promazine Spec-sCnc	4180186
40763384	DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Sparine; Spec; Substance Concentration; To be specified in another part of the message; Tranquazine; Unspecified	4180186
40763384	丙嗪:物质的量浓度:时间点:XXX:定量型	4182948
40763388	Acetylsulfamethoxazole; c203; c223; C61; DRUG/TOXICOLOGY; Drugs; Gantanol; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; SMX; Spec; Substance Concentration; Sulfa; Sulfamethox; To be specified in another part of the message; Unspecified	4180186
40763388	Sulfamethoxazole Spec-sCnc	4180186
40763388	磺胺甲噁唑:物质的量浓度:时间点:XXX:定量型	4182948
40763389	Thiocyanate Spec-sCnc	4180186
40763389	DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763389	硫氰化物:物质的量浓度:时间点:XXX:定量型	4182948
40763392	Venlafaxine Spec-sCnc	4180186
40763392	DRUG/TOXICOLOGY; Drugs; Efexor; Effexor; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified; Venlafaxin	4180186
40763392	文拉法辛:物质的量浓度:时间点:XXX:定量型	4182948
40763396	Arbitrary concentration; Crys; Cryst; Crystal; LM; Micro; Micros; Microscopic; Monosodium Urate; Na; Na Urate; Na Urate Cry; Na+; NaU; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; UA; UR; Urates; Uric acid; URINALYSIS; Urine sediment; Urn; UrnS	4180186
40763396	Deprecated Na Urate Cry UrnS Ql Micro	4180186
40763399	LPa MFr SerPl	4180186
40763399	Chemistry; Lip; Lipoprot; Lipoproteins; LP; Lp(a); LPa; Mass Fraction; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl	4180186
40763399	脂蛋白 (a)/脂蛋白.总计:质量分数:时间点:血清/血浆:定量型	4182948
40763401	Viable CD34 cells/100 CD34 NFr Fld	4180186
40763401	100 CD34; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; gp105-120; Hematopoietic stem cell; HSC; My10; My-10; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Stem cells	4180186
40763401	活细胞.CD34/100 个细胞.CD34:计数型分数:时间点:体液:定量型	4182948
40763402	Viable CD34 cells # Fld	4180186
40763402	#; ABS; absolute; absolutes; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Fl; Fld; FLU; Fluid; gp105-120; Hematopoietic stem cell; HSC; My10; My-10; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Stem cells	4180186
40763402	活细胞.CD34:计数型浓度:时间点:体液:定量型	4182948
40763403	Almond IgG-mCnc	4180186
40763403	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Almond; Amygdalus communis; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f020; f20; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; Prunus amygdalus; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763403	杏树 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763405	Apricot IgG-mCnc	4180186
40763405	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Apricot; Autoantibodies; Autoantibody; f237; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; Prunus armeciaca; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763405	杏 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763406	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Artichoke; Autoantibodies; Autoantibody; f358; f361; Globe artichoke; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763406	Artichoke IgG-mCnc	4180186
40763406	洋蓟 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763408	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Beans; f315; Green Bean; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Phaseolus vulgaris; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf315; Serum; SR	4180186
40763408	Green Bean IgG-mCnc	4180186
40763408	青豆 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763410	Pinto Bean IgG-mCnc	4180186
40763410	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Beans; f121; f300; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Phaseolus vulgaris; Pinto Bean; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763410	斑豆 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763411	Broccoli IgG-mCnc	4180186
40763411	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Brassica oleracea cymosa; Brassica oleracea var italics; Broccoli; f260; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763411	花茎甘蓝 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763412	Brussel Sprouts IgG-mCnc	4180186
40763412	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Brassica oleracea gemmifera; Brussel sprouts; Brussels sprouts; f217; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf217; Serum; SR	4180186
40763412	抱子甘蓝 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763414	Cantaloupe IgG-mCnc	4180186
40763414	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cantalope; Cantaloup; Cantaloupe; f102; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Musk melon; Muskmelon; Point in time; QNT; Quan; Quant; Quantitative; Random; Rock melon; Serum; SR	4180186
40763414	罗马甜瓜 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763415	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Carrot; f031; f31; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763415	Carrot IgG-mCnc	4180186
40763415	胡萝卜 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763416	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cauliflower; f291; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf291; Serum; SR	4180186
40763416	Cauliflower IgG-mCnc	4180186
40763416	花椰菜 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763419	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f082; f82; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Mould; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763419	Cheese Mold IgG-mCnc	4180186
40763419	长霉干酪 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763420	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bing cherry; Cherry; f242; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763420	Cherry IgG-mCnc	4180186
40763420	甜樱桃 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763421	Chili Pepper IgG-mCnc	4180186
40763421	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chili pepper; f279; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf279; Serum; SR	4180186
40763421	辣椒 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763422	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cinnamate; Cinnamon; f220; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf220; Serum; SR	4180186
40763422	Cinnamon IgG-mCnc	4180186
40763422	樟属多个未知种 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763424	Clove IgG-mCnc	4180186
40763424	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Clove; Cloves; f268; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf268; Serum; SR	4180186
40763424	丁香树 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763425	Crab IgG-mCnc	4180186
40763425	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Crab; f023; f23; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763425	食用黄道蟹 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763426	Cucumber IgG-mCnc	4180186
40763426	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cucumber; f244; Gherkin; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763426	黄瓜 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763427	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Aubergine; Autoantibodies; Autoantibody; Eggplant; f262; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf262; Serum; SR	4180186
40763427	Eggplant IgG-mCnc	4180186
40763427	茄子 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763428	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f147; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763428	Flounder IgG-mCnc	4180186
40763428	鲆 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763429	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f047; f47; Garlic; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763429	Garlic IgG-mCnc	4180186
40763429	大蒜 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763432	Grapefruit IgG-mCnc	4180186
40763432	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f209; Grapefruit; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763432	葡萄柚 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763434	Halibut IgG-mCnc	4180186
40763434	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f303; Halibut; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf303; Serum; SR	4180186
40763434	庸鲽 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763435	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f088; f88; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Mutton; Ovis spp; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763435	Lamb IgG-mCnc	4180186
40763435	羊肉 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763439	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Brassica/Sinapis spp; f089; f89; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763439	Mustard IgG-mCnc	4180186
40763439	芥菜 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763440	Nutmeg IgG-mCnc	4180186
40763440	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f282; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Myristica fragrans; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf282; Serum; SR	4180186
40763440	肉豆蔻 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763441	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f223; Green Olive; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763441	Deprecated Green Olive IgG-mCnc	4180186
40763442	Oregano IgG-mCnc	4180186
40763442	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f283; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Oregano; Oreganum; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf283; Serum; SR	4180186
40763442	牛至 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763443	Oyster IgG-mCnc	4180186
40763443	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f290; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Oyster; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763443	牡蛎 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763445	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f095; f95; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Peach; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763445	Peach IgG-mCnc	4180186
40763445	桃子 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763446	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f094; f94; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Pear; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763446	Pear IgG-mCnc	4180186
40763446	西洋梨 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763448	Green Pepper IgG-mCnc	4180186
40763448	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f152; f263; f335; Green Pepper; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf263; Serum; SR	4180186
40763448	青辣椒 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763450	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f255; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Plum; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763450	Plum IgG-mCnc	4180186
40763450	欧洲李 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763451	Sweet potato IgG-mCnc	4180186
40763451	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f054; f54; Immune globulin G; Immunoglobulin G; Ipomea batatas; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Sweet potato	4180186
40763451	甘薯 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763452	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f119; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Radish; Random; Serum; SR	4180186
40763452	Radish IgG-mCnc	4180186
40763452	萝卜 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763453	Avocado IgG-mCnc	4180186
40763453	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Alligator pear; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avocado; f096; f96; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; Prickly pear; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763453	美国鳄梨 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763454	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f219; f344; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf344; Sage; Serum; SR	4180186
40763454	Sage IgG-mCnc	4180186
40763454	鼠尾草 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763457	Sesame Seed IgG-mCnc	4180186
40763457	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f010; f10; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Sesame Seed; Sesamum orientale; SR	4180186
40763457	胡麻 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763458	Shrimp IgG-mCnc	4180186
40763458	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f024; f24; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; Prawns; QNT; Quan; Quant; Quantitative; Random; Serum; Shrimp; SR	4180186
40763458	长额虾 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763459	Red Snapper IgG-mCnc	4180186
40763459	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f381; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Red snapper; Serum; SR	4180186
40763459	红鲷鱼 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763460	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f129; f337; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf337; Serum; Sole; SR	4180186
40763460	Sole IgG-mCnc	4180186
40763460	欧洲鳎 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763461	Spinach IgG-mCnc	4180186
40763461	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f214; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Spinach; SR	4180186
40763461	菠菜 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763462	Sunflower Seed IgG-mCnc	4180186
40763462	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f183; Immune globulin G; Immunoglobulin G; k84; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Seeds; Serum; SR; Sunflower; Sunflower pip; Sunflower Seed	4180186
40763462	向日葵种子 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763463	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C reticula; Clementine; f302; Immune globulin G; Immunoglobulin G; Level; Mandarin; Mandarine; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf302; satsumas; Serum; SR; tangerine	4180186
40763463	Mandarin IgG-mCnc	4180186
40763463	柑橘 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763465	Tuna IgG-mCnc	4180186
40763465	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f040; f40; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tuna; Yellow fin	4180186
40763465	黄鳍金枪鱼 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763467	Vanilla IgG-mCnc	4180186
40763467	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f234; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf234; Serum; SR; Vanilla; Vanillin	4180186
40763467	扁叶香子兰 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763470	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV4; Human rubulavirus 4; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Para; Parainflu; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40763470	HPIV4 RNA Islt Ql NAA+probe	4180186
40763470	副流感病毒 4 型 RNA:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
40763473	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breakbone fever; Dengue type IV; Denv; DENV4; DNA NUCLEIC ACID PROBE; DNA probe; Flavivirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Serum; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40763473	DENV4 RNA Ser Ql NAA+probe	4180186
40763473	登革热病毒 4 型 RNA:存在情况或阈值:时间点:血清:序数型:探针法.基因扩增.靶向	4182948
40763475	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breakbone fever; Dengue type II; Denv; DENV2; DNA NUCLEIC ACID PROBE; DNA probe; Flavivirus; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Serum; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40763475	DENV2 RNA Ser Ql NAA+probe	4180186
40763475	登革热病毒 2 型 RNA:存在情况或阈值:时间点:血清:序数型:探针法.基因扩增.靶向	4182948
40763476	PLA2 rApi m 1 IgE Qn	4180186
40763476	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Honey bee; Honeybee; i; i001; i1; i208; Immune globulin E; Immunoglobulin E; k203; nApi m 1 Phospholipase A2, Bee; PLA2 rApi m 1; Point in time; QNT; Quan; Quant; Quantitative; Random; Rk203; Serum; SR	4180186
40763476	意大利蜜蜂磷脂酶 A2 重组 (rApi m) 1 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40763477	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Gentyp; ID; Identity or presence; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; MeV; Microbiology; Misc; Miscellaneous; Msls; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Rubeola; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40763477	MeV Gentyp Spec NAA+probe	4180186
40763477	麻疹病毒 基因型:存在与否或特征标识:时间点:XXX:名义型:探针法.基因扩增.靶向	4182948
40763478	C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; MeV; Microbiology; Misc; Miscellaneous; Msls; Nominal; Other; Point in time; Random; Rubeola; Spec; To be specified in another part of the message; Unspecified	4180186
40763478	Deprecated MeV XXX Cult	4180186
40763480	Antigen; Antigens; hMPV; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
40763480	hMPV Ag Spec Ql	4180186
40763480	人类偏肺病毒 抗原:存在情况或阈值:时间点:XXX:序数型	4182948
40763482	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Human Calcivirus; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Norwalk virus; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40763482	Norovirus RNA Islt Ql NAA+probe	4180186
40763482	诺如病毒 RNA:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
40763483	T gondii IgA Titr Ser	4180186
40763483	刚地弓形虫 抗体.IgA:滴定度:时间点:血清:定量型	4182948
40763483	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; T gondii; Titer; Titered; Titre; Toxo; Toxoplasmosis; Ttr	4180186
40763487	Date of previous PAP	4180186
40763487	H+P; H+P.HX; P prime; Point in time; Prev; QNT; Quan; Quant; Quantitative; Random; smears	4180186
40763487	上次 PAP 涂片日期:日期:时间点:^患者:定量型	4182948
40763489	CD19+CD103+ Cells # Bld	4180186
40763489	#; ABS; absolute; absolutes; B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; Blood; CD19 Cells; CD19+CD103+ Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; HD-37; HML-1; Human mucosal lymphocyte antigen 1; integrin alphaE chain; ITGAE; Leu12; Leu-12; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763489	细胞.CD19+CD103:计数型浓度:时间点:全血:定量型	4182948
40763490	CD10+CD19+ Cells # Bld	4180186
40763490	#; ABS; absolute; absolutes; B4; B-4; Blood; CALLA; CD10 Cells; CD10+CD19+ Cells; Cell; CELL MARKERS; Cellularity; Cnt; Common acute lymphoblastic leukemia; Common acute lymphoblastic leukemia antigen; Count; Count/volume; CT; Enkephalinase; gp100; HD-37; J5; Leu12; Leu-12; NEP; Neprilysin; Neutral endopeptidase metalloendopeptidase; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763490	细胞.CD10+CD19+:计数型浓度:时间点:全血:定量型	4182948
40763492	#; ABS; absolute; absolutes; B6; B-6; BLAST-2; Blood; CD5 Cells; CD5+CD23+ Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; FceRII; Leu1; Leu-1; Leu20; Leu-20; Low affinity IgE receptor; Ly-1; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; T1; Tp67; WB; Whole blood	4180186
40763492	CD5+CD23+ Cells # Bld	4180186
40763492	细胞.CD5+CD23+:计数型浓度:时间点:全血:定量型	4182948
40763497	Pan; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
40763497	HEDIS 2011 组套:-:时间点:^患者:-	4182948
40763498	HEDIS 2011 COL-A	4180186
40763498	Asympt; Asymptomatic; HEDIS 2011 COL-A; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; Scn	4180186
40763498	用于标识结直肠癌筛查的 HEDIS 2011 代码 (COL-A):-:时间点:^患者:-	4182948
40763499	HEDIS 2011 CHL-B	4180186
40763499	HEDIS 2011 CHL-B; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
40763499	用于标识性活跃妇女的 HEDIS 2011 代码 (CHL-B):-:时间点:^患者:-	4182948
40763500	Dextro; HEDIS 2011 CHL-D; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
40763500	HEDIS 2011 CHL-D	4180186
40763500	用于标识排除项目的 HEDIS 2011 代码 (CHL-D):-:时间点:^患者:-	4182948
40763501	HEDIS 2011 CDC-J	4180186
40763501	Asympt; Asymptomatic; HEDIS 2011 CDC-J; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; Scn	4180186
40763501	用于标识肾病筛查试验的 HEDIS 2011 代码 (CDC-J):-:时间点:^患者:-	4182948
40763503	HEDIS 2011 MPM-A	4180186
40763503	HEDIS 2011 MPM-A; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
40763503	用于标识生理监测试验的 HEDIS 2011 代码 (MPM-A):-:时间点:^患者:-	4182948
40763504	HEDIS 2011-12 MPM-A K; k; K+; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Potass; Random; Ser; SR	4180186
40763504	HEDIS 2011-12 MPM-A K	4180186
40763504	用于标识生理监测试验的 HEDIS 2011-2013 代码 - 血清钾 (MPM-A):-:时间点:^患者:-	4182948
40763505	HEDIS 2011 PPC-C; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
40763505	HEDIS 2011 PPC-C	4180186
40763505	HEDIS 2011 早期产前护理当中所使用的试验 (PPC-C):-:时间点:^患者:-	4182948
40763506	HEDIS 2011-12 PPC-C HSV	4180186
40763506	HEDIS 2011-12 PPC-C HSV; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
40763506	HEDIS 2011-2013 早期产前护理当中所使用的试验 - 单纯疱疹 (PPC-C):-:时间点:^患者:-	4182948
40763508	HEDIS 2011 PPC-C ABO+Rh	4180186
40763508	D phenotyping; D typing; HEDIS 2011 PPC-C ABO+Rh; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; Rh phenotyping; Rh typing	4180186
40763508	HEDIS 2011 早期产前护理当中所使用的试验 - ABO 与 Rh (PPC-C):-:时间点:^患者:-	4182948
40763509	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Annatto seed; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; IgE RAST; Immune globulin E; Immunoglobulin E; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Seeds; Serum; SR	4180186
40763509	胭脂树种子 抗体.IgE.RAST 类:存在情况或阈值:时间点:血清:序数型	4182948
40763509	Deprecated Annatto seed IgE RAST Ql	4180186
40763510	Bizarre platelets Bld Ql Smear	4180186
40763510	Blood; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Ordinal; Platelet; Platelet adequacy; Platelet estimate; Platelt; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Thrb; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
40763510	异形血小板:存在情况或阈值:时间点:全血:序数型:显微镜检查.光学	4182948
40763512	#; ABS; absolute; absolutes; ADA-binding protein; Adenosine deaminase-binding protein; Blood; CD4 Cells; CD4+CD26- Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Dipeptidylpeptidase IV; DPP IV; Ectoenzyme; Helper T cells; Inducer T cells; L3T4; Leu3; Leu-3; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; T4; T-4; W3/25; WB; Whole blood	4180186
40763512	CD4+CD26- Cells # Bld	4180186
40763512	细胞.CD4+CD26-:计数型浓度:时间点:全血:定量型	4182948
40763515	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 1; HSV; HSV1; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Viral load	4180186
40763515	HSV1 DNA # Spec NAA+probe	4180186
40763515	单纯疱疹病毒 1 型 DNA:计数型浓度:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
40763517	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Endocrine; Endocrinology; HUM; Humulin; IH7; Insul; Lente; Level; NPH; Point in time; QNT; Quan; Quant; Quantitative; Random; Semilente; Serology; Serum; Sliding; SR; Substance concentration; Ultralente	4180186
40763517	Insulin Ab Ser-sCnc	4180186
40763517	胰岛素 抗体:物质的量浓度:时间点:血清:定量型	4182948
40763518	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c707; Glu; Glutamic acid; IgE RAST; Immune globulin E; Immunoglobulin E; MSG; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
40763518	谷氨酸单钠 抗体.IgE.RAST 类:存在情况或阈值:时间点:血清:序数型	4182948
40763518	Deprecated MSG IgE RAST Ql	4180186
40763519	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; N men; N men serogroup; N men sg W135; N men sg w135 Ab; N men sg w135 IgG; N menigitidis; N meningitidis; Neisseria meningitidis group w135; Neisseria meningitidis type w135; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS	4180186
40763519	N men sg W135 IgG Ser IA-mCnc	4180186
40763519	脑膜炎奈瑟菌 w135 血清群 抗体.IgG:质量浓度:时间点:血清:定量型:免疫测定法	4182948
40763521	14-Hydroxydihydromorphinone; Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Numorphan; Numorphone; Opana; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40763521	oxyMORphone SerPl-mCnc	4180186
40763521	羟吗啡酮:质量浓度:时间点:血清/血浆:定量型	4182948
40763523	Urate Plr-mCnc	4180186
40763523	Chemistry; Level; Mass concentration; Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; thoracentesis fluid; UA; Urates; Uric acid	4180186
40763523	尿酸:质量浓度:时间点:胸膜液:定量型	4182948
40763525	Buspar; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40763525	busPIRone Ur-mCnc	4180186
40763525	丁螺旋酮:质量浓度:时间点:尿液:定量型	4182948
40763527	Lymphs Vac Bld Ql Smear	4180186
40763527	Blood; HEMATOLOGY/CELL COUNTS; LM; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs Vac; Lymphs%; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Vaculated; WB; Whole blood	4180186
40763527	淋巴细胞.空泡化:存在情况或阈值:时间点:全血:序数型:显微镜检查.光学	4182948
40763529	5-HT; 5-hydroxytryptamine; 5-hydroxytryptophane; Arbitrary concentration; C10H12N2O; Clexane; Enoxaparin; Enteramine; Hep; Hepar; Heparin dependent platelet antibody; Heparn; LMWH; Lovenox; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serotonin release assay; Serum; SR; SRA; SRA .2 IU; SRA .2 IU/mL LMWH; Wt	4180186
40763529	SRA .2 IU/mL LMW heparin Ser-aCnc	4180186
40763529	5-羟色胺释放分析 0.2 IU/mL 肝素.低分子量:任意型浓度:时间点:血清:定量型	4182948
40763533	Asympt; Asymptomatic; Dextro; HEDIS 2011-12 CMC-D; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; Scn	4180186
40763533	HEDIS 2011-12 CMC-D	4180186
40763533	用于标识 LDLc 筛查的 HEDIS 2011-2013 代码 (CMC-D):-:时间点:^患者:-	4182948
40763538	CDC Immunization pnl	4180186
40763538	CDC Immunization pnl; Immunization status; Pan; PANEL.VACCIN; Panl; Pnl; Point in time; Random; Vaccination; Vaccinations; Vaccine	4180186
40763538	CDC 疫苗接种组套:-:时间点:^患者:-	4182948
40763541	Blood; Document; Finding; Findings; Genetics; Heredity; Heritable; Inherited; JBTS4; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nephronophthisis 1 (juvenile); NPH1; PCR; Point in time; Random; SLSN1; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40763541	NPHP1 gene Mut Anl Bld/T	4180186
40763541	NPHP1 基因 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
40763543	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; GAS; Group A Strep; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S pyogenes; Screen; SDA; Steptococcus Group A; Strand Displacement Amplification; Strep; Strept; Streptococci group A; Streptococcus group A; Throat; TMA; Transcription mediated amplification; Upper respiratory	4180186
40763543	S pyo DNA Throat Ql NAA+probe	4180186
40763543	化脓性链球菌 DNA:存在情况或阈值:时间点:咽喉:序数型:探针法.基因扩增.靶向	4182948
40763544	ADMCKD2; Blood; Document; Finding; Findings; FJHN; Genetics; Heredity; Heritable; HNFJ; HNFJ1; Inherited; MCKD2; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; PCR; Point in time; Random; THGP; THP; Tissue; Tissue, unspecified; uromodulin; WB; Whole blood; Whole blood or Tissue	4180186
40763544	UMOD gene Mut Anl Bld/T	4180186
40763544	UMOD 基因 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
40763545	B220; Blood; CD45; CD45R; Document; Finding; Findings; Genetics; GP180; Heredity; Heritable; Inherited; LCA; L-CA; Leber congenital amaurosis; LY5; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; PCR; Point in time; protein tyrosine phosphatase, receptor type, C; Random; T200; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40763545	LCA gene Mut Anl Bld/T	4180186
40763545	LCA 基因 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
40763546	Blood; Document; Finding; Findings; Genetics; HCM; HCM gene; Heredity; Heritable; Hypertrophic cardiomyopathy; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40763546	HCM Mut Anl Bld/T	4180186
40763546	HCM 基因 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
40763550	Blood; CFC4; Document; Finding; Findings; Genetics; Heredity; Heritable; Inherited; MAPKK2; MEK2; Mitogen-Activated Protein Kinase Kinase 2; MKK2; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; PCR; Point in time; PRKMK2; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40763550	MAP2K2 gene Mut Anl Bld/T	4180186
40763550	MAP2K2 基因 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
40763553	North American Association of Central Cancer Registries; Oncology; Point in time; Random; TUMOR REGISTRY(NAACCR)	4180186
40763553	Demographic section NAACCR v.12	4180186
40763553	人口统计学小节:-:时间点:^患者:集合型:NAACCR v.12	4182948
40763554	Edit ovrds/Conv Hx/Sys admin; Hx; North American Association of Central Cancer Registries; Oncology; Point in time; Random; TUMOR REGISTRY(NAACCR)	4180186
40763554	Edit ovrds/Conv Hx/Sys admin NAACCR v.12	4180186
40763554	编辑重写和或转换历史和或系统管理小节:-:时间点:^患者:集合型:NAACCR v.12	4182948
40763557	Hosp; Hosp-specific section; North American Association of Central Cancer Registries; Oncology; Point in time; Random; Spec; TUMOR REGISTRY(NAACCR)	4180186
40763557	Hosp-specific section NAACCR v.12	4180186
40763557	医院特异性小节:-:时间点:^患者:集合型:NAACCR v.12	4182948
40763561	North American Association of Central Cancer Registries; Oncology; Point in time; Random; TUMOR REGISTRY(NAACCR)	4180186
40763561	Special use section NAACCR v.12	4180186
40763561	特殊用途小节:-:时间点:^患者:集合型:NAACCR v.12	4182948
40763564	North American Association of Central Cancer Registries; Oncology; Point in time; Random; TUMOR REGISTRY(NAACCR)	4180186
40763564	Text-miscellaneous section NAACCR v.12	4180186
40763564	文本-杂项小节:-:时间点:^患者:集合型:NAACCR v.12	4182948
40763567	North American Association of Central Cancer Registries; Oncology; Othr; Point in time; Random; TUMOR REGISTRY(NAACCR); Tx; Tx-subseq + other section	4180186
40763567	Tx-subseq + other section NAACCR v.12	4180186
40763567	后续或其他治疗小节:-:时间点:^患者:集合型:NAACCR v.12	4182948
40763570	Hormone Rx	4180186
40763570	CLIN; Horm; Nominal; Point in time; Random; Treatment; Typ	4180186
40763570	激素治疗方案:类型:时间点:^患者:名义型	4182948
40763571	Iron/Transferrin SerPl-Rto	4180186
40763571	Chemistry; Fe; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; SerP; SerPl; SerPlas; Serum; Serum or plasma; Siderophilin; SR; Tf; Trf; TRFRN	4180186
40763571	铁/转铁蛋白:比率:时间点:血清/血浆:定量型	4182948
40763572	1 day; 24 hours; 24HR; Bowel movement; Chemistry; CR; Crea; Creat; Faecal; Faeces; Fecal; Feces; Kidney; Nephrology; QNT; Quan; Quant; Quantitative; Renal; sRate; Stl; Stool = Fecal; Substance Rate	4180186
40763572	Creat 24h Stl-sRate	4180186
40763572	肌酐:物质的量速率:24小时:大便:定量型	4182948
40763577	Carbromal SerPl-mCnc	4180186
40763577	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40763577	阿大林:质量浓度:时间点:血清/血浆:定量型	4182948
40763582	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Entero virus; EV; EV subtype; EV-PCR; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Typ; Unspecified	4180186
40763582	EV subtype Spec NAA+probe	4180186
40763582	肠道病毒亚型:类型:时间点:XXX:名义型:探针法.基因扩增.靶向	4182948
40763583	FLUAV H1 2009 pand Ab Titr Ser	4180186
40763583	流感病毒 A 型血凝素 H1 型 2009 大流行 抗体:滴定度:时间点:血清:定量型	4182948
40763583	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avian influenza; Bird flu; Dilution factor; Dilution Factor (Titer); FLUA; FLUAV; FLUAV H1; FLUAV H1 2009 pand; FLUV; Fowl plague; H1N1; H1N1v; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Influenza virus A hemagglutinin H1 swine origin; Microbiology; Point in time; Random; Serum; SmQn; S-OIV; SR; Titer; Titered; Titre; Ttr	4180186
40763584	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV H9; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40763584	FLUAV H9 RNA Islt Ql NAA+probe	4180186
40763584	流感病毒 A 型血凝素 H9 型 RNA:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
40763585	JEV IgM Titr Ser	4180186
40763585	日本脑炎病毒 抗体.IgM:滴定度:时间点:血清:定量型	4182948
40763585	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); Enc; Enceph; Encephalomyelitis; Flavivirus; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Japanese B encephalitis; Japanese encephalitis; JBE; JE virus; JEV; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40763588	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; Screen; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; Severe Acute Respiratory Syndrome; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40763588	SARS-CoV RNA SerPl Ql NAA+probe	4180186
40763588	SARS 冠状病毒 RNA:存在情况或阈值:时间点:血清/血浆:序数型:探针法.基因扩增.靶向	4182948
40763589	ANTIBIOTIC SUSCEPTIBILITIES; AST; Doribax; Finibax; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40763589	Doripenem Susc Islt	4180186
40763589	多尼培南:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
40763590	B; Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
40763590	HLA-DQ beta	4180186
40763590	HLA-DQ beta:类型:时间点:全血/组织:名义型	4182948
40763596	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; mcg; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40763596	Mupirocin 5 ug Islt KB	4180186
40763596	莫匹罗星 5 微克:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40763597	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; mcg; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40763597	Mupirocin 200 ug Islt KB	4180186
40763597	莫匹罗星 200 微克:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
40763602	11oxoEtioch; Aetiocholanolone; Chemistry; CR; Crea; Creat; Etiochol; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40763602	11oxoEtioch/Creat Ur	4180186
40763602	11-氧代-本胆烷醇酮/肌酐:质量比率:时间点:尿液:定量型	4182948
40763603	Deprecated 8-Estriol Ur-mCnc	4180186
40763603	Chemistry; E3; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40763604	Fascin Tiss Ql ImStn	4180186
40763604	IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified	4180186
40763604	肌成束蛋白:存在情况或阈值:时间点:组织与涂片:序数型:免疫染色法	4182948
40763605	INF-B1a Ab Titr SerPl	4180186
40763605	干扰素.beta 1a 抗体:滴定度:时间点:血清/血浆:定量型	4182948
40763605	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avonex; B; Betaferon; B-IFN 1A+1B; Dilution factor; Dilution Factor (Titer); IFN; IFN-B; INF-B; INF-B1a; Pl; Plasma; Plsm; Point in time; Random; Rebif; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40763606	INF-B1b Ab Titr SerPl	4180186
40763606	干扰素.beta 1b 抗体:滴定度:时间点:血清/血浆:定量型	4182948
40763606	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B; Betaferon; Betaseron; B-IFN 1A+1B; Dilution factor; Dilution Factor (Titer); Extavia; IFN; IFN-B; INF-B; INF-B1b; Pl; Plasma; Plsm; Point in time; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40763608	1F-5Ag; Blood; CD59 deficient Monocytes; CD59 Monocytes; CD59.deficient; Cell; CELL MARKERS; Cellularity; Gated cells; H19; HRF20; MACIF; Membrane Inhibitor of Reactive Lysis; MIRL; Mono; Monocyte; Monos; Number fraction; P-18; Percent; Point in time; Protectin; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763608	CD59 deficient Monocytes NFr Bld	4180186
40763608	单核细胞.CD59 缺乏型/100 个细胞:计数型分数:时间点:全血:定量型	4182948
40763609	DOCUMENT.REF; FDA insert; Narrative; Report; SPL; Structured Product Labelling	4180186
40763609	FDA insert Accessories	4180186
40763609	配件:-:-:^FDA 包装说明书:叙述型	4182948
40763610	FDA insert Assembly/install inst	4180186
40763610	Assembly/install inst; DOCUMENT.REF; FDA insert; Narrative; Report; SPL; Structured Product Labelling	4180186
40763610	组装或安装说明:-:-:^FDA 包装说明书:叙述型	4182948
40763611	DOCUMENT.REF; FDA insert; Narrative; Report; SPL; Structured Product Labelling	4180186
40763611	FDA insert Calibration instructions	4180186
40763611	校准说明:-:-:^FDA 包装说明书:叙述型	4182948
40763612	Clean/disinfect/ster inst; DOCUMENT.REF; FDA insert; Narrative; Report; SPL; Structured Product Labelling	4180186
40763612	FDA insert Clean/disinfect/ster inst	4180186
40763612	清洁、消毒及灭菌说明:-:-:^FDA 包装说明书:叙述型	4182948
40763615	FDA insert Other safety info	4180186
40763615	DOCUMENT.REF; FDA insert; Narrative; Othr; Report; SPL; Structured Product Labelling	4180186
40763615	其他的安全信息:-:-:^FDA 包装说明书:叙述型	4182948
40763616	DOCUMENT.REGULATORY; FDA insert; Meth; Method of; Narrative; Report; Route/method/freq; SPL; Structured Product Labelling	4180186
40763616	FDA insert Route/method/freq	4180186
40763616	施用途径、方法及频率:-:-:^FDA 包装说明书:叙述型	4182948
40763618	1 ug/mL; AFB; Amikin; Aminoglycosides; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis	4180186
40763618	Amikacin 1 ug/mL Islt SlowMyco	4180186
40763618	丁胺卡那霉素 1.0 微克/毫升:抗生素敏感性:时间点:分离株:定量型或序数型:针对慢长型分枝杆菌的方法	4182948
40763620	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; Random; Resp path 12b Pnl; Resp path DNA+; Resp path DNA+RNA; Resp pathogens; Respiratory; Respiratory bacteria & viruses; Respiratory bacteria & viruses DNA & RNA; Respiratory virus panel; Respiratory viruses panel; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40763620	Resp path 12b Pnl Spec NAA+probe	4180186
40763620	呼吸道病原体类 DNA 与 RNA 12b 项组套:-:时间点:XXX:-:探针法.基因扩增.靶向	4182948
40763621	Comprehensive path report pnl; Pan; PANEL.DOC; Panl; Path; Pnl; Point in time; Random	4180186
40763621	Comprehensive path report pnl	4180186
40763621	综合性病理学报告组套:-:时间点:^患者:-	4182948
40763622	提纲式报告:发现:时间点:^患者:文档型:病理学	4182948
40763622	Finding; Findings; Narrative; Path; Pathology; Point in time; Random; Report	4180186
40763627	DOCUMENT.REF; Ident; Identifier; Nominal; Point in time; Random; Srce	4180186
40763627	报告模板来源:标识符:时间点:报告:名义型	4182948
40763628	DOC.MISC; Ident; Identifier; Intradermal; MISC; Nominal; Point in time; Random	4180186
40763628	报告模板版本标识符:标识符:时间点:报告:名义型	4182948
40763631	Blood; Document; Endothelial plasminogen activator inhibitor; Finding; Findings; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; PAI; PAI 1; PAI1; PAI-1; PCR; PLANH1; Point in time; Random; SERBP; Serine (or cysteine) proteinase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1; Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40763631	SERPINE1 gene Mut Anl Bld/T	4180186
40763631	SERPINE1 基因 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
40763633	Arbitrary; Cerebral spinal fluid; Cerebrospinal Fl; Clonality; Genetics; Heredity; Heritable; Inherited; Leukemia; Lymphoma; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; Neuro; Neurology; Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; Rearr; Rearrangement; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; T-cell rearranging gene gamma; TRG	4180186
40763633	TCRG gene Rear CSF Ql	4180186
40763633	TCRG 基因重排:任意型:时间点:脑脊液:序数型:分子遗传学类实验室方法	4182948
40763634	Arbitrary; BM; BON; Bone marrow; Clonality; Genetics; Heredity; Heritable; Inherited; Leukemia; Lymphoma; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; Rearr; Rearrangement; Screen; T-cell rearranging gene gamma; TRG	4180186
40763634	TCRG gene Rear Mar Ql	4180186
40763634	TCRG 基因重排:任意型:时间点:骨髓:序数型:分子遗传学类实验室方法	4182948
40763635	Arbitrary; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Clonality; Fl; Fld; FLU; Fluid; Genetics; Heredity; Heritable; Inherited; Leukemia; Lymphoma; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; Rearr; Rearrangement; Screen; T cell receptor beta chain	4180186
40763635	TCRB gene Rear Fld Ql	4180186
40763635	TCRB 基因重排:任意型:时间点:体液:序数型:分子遗传学类实验室方法	4182948
40763637	Arbitrary; BM; BON; Bone marrow; Clonality; Genetics; Heredity; Heritable; Inherited; Leukemia; Lymphoma; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; Rearr; Rearrangement; Screen; T cell receptor beta chain	4180186
40763637	TCRB gene Rear Mar Ql	4180186
40763637	TCRB 基因重排:任意型:时间点:骨髓:序数型:分子遗传学类实验室方法	4182948
40763638	Arbitrary; B-cell leukemia/lymphoma 2; B-cell NHL; B-cell non-hodgkin lymphoma; BCL-2; breakpoint; Cerebral spinal fluid; Cerebrospinal Fl; DNA; Follicular B cell lymphoma; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; Mcr; Minor Cluster Region; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; Neuro; Neurology; Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; RNA; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; T prime; t(14,18)(IGH,BCL2) gene translocation; t(14,18)(IGH,BCL2) gene translocation minor break points; t(14;18)(IGH,BCL2); translocation	4180186
40763638	t(14;18)(IGH,BCL2) Minor CSF Ql	4180186
40763638	t(14;18)(q32;q21.3)(IGH,BCL2) 融合转录物次要断裂点:任意型:时间点:脑脊液:序数型:分子遗传学类实验室方法	4182948
40763639	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; GT1b Ganlg; IMMUNE BLOT; Immune globulin G; Immunobl; Immunoblot; Immunoglobulin G; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SR; Trisialoganglioside; WB; WBLOT; West blot; West blt; Western blot	4180186
40763639	Deprecated GT1b Ganlg IgG Ser Ql IB	4180186
40763640	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Immune blot; Immune globulin G; Immunobl; Immunoblot; Immunoglobulin G; Monosialoganglioside; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40763640	Deprecated GM3 IgG Ser Ql IB	4180186
40763641	Cell Cnt + Diff Pnl DiafP	4180186
40763641	Cell Cnt + Diff Pnl; Diaf; DiafP; Dialysate; Dialysis fluid; Diff; Diff Pnl; Differl; Differn; HEMATOLOGY/CELL COUNTS; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Peritoneal Dialysis fluid; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40763641	细胞计数与分类组套:-:时间点:腹膜透析液:定量型	4182948
40763643	Acute promyelocytic leukemia; APL; Arbitrary; Blood; breakpoint cluster region 1; DNA; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; long form; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; Myelogenous; MYL; NR1B1; Ordinal; PCR; PML-1; PML-2; PML-3; PML-3B; PML-X; Point in time; Promyelocytic leukemia; QL; Qual; Qualitative; Random; RAR alpha form; RARalpha; Retinoic acid receptor alpha; RNA; Screen; T prime; t(15,17) (PML,RARA) gene translocation; t(15,17)(PML,RARA) gene translocation breakpoint cluster region 1; t(15,17)(q22,q11.2-q12); t(15;17) BCR1; t(15;17)(PML,RARA); Tissue; Tissue, unspecified; translocation; WB; Whole blood; Whole blood or Tissue	4180186
40763643	t(15;17) BCR1 Bld/T Ql	4180186
40763643	t(15;17)(q24.1;q21.1)(PML,RARA) bcr1 融合转录物:任意型:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40763644	Medication dispensed.brief Doc	4180186
40763644	DOC.EPSOS; Document; Finding; Findings; Point in time; Random	4180186
40763644	已配发的药物.简要:发现:时间点:^患者:文档型	4182948
40763645	Patient summary Doc	4180186
40763645	DOC.EPSOS; Document; Finding; Findings; Point in time; Random	4180186
40763645	患者摘要:发现:时间点:^患者:文档型	4182948
40763647	Medication dispensed.extended Doc	4180186
40763647	DOC.EPSOS; Document; Finding; Findings; Point in time; Random	4180186
40763647	已配发的药物.扩充:发现:时间点:^患者:文档型	4182948
40763648	Cranial; Cranium; Dental; Dentistry; Head; Length Ratio; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; SN-ME'; Xray; X-ray	4180186
40763648	Sn-Me'/Face all Skull XR	4180186
40763648	面部下部/整个面部:长度比率:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763649	Cranial; Cranium; Dental; Dentistry; Gl'-Sn; Head; Length Ratio; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763649	Gl'-Sn/Face all Skull XR	4180186
40763649	面部中部/整个面部:长度比率:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763650	Cranial; Cranium; Dental; Dentistry; Face L1 to chin; Gl'-Sn; Head; Length Ratio; Low; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763650	Face L1 to chin/Face mid Skull XR	4180186
40763650	面部 下切牙至颏部/面部中部:长度比率:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763654	Cranial; Cranium; Dental; Dentistry; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Up; Xray; X-ray	4180186
40763654	Face upper Skull XR	4180186
40763654	面部上部:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763657	Cranial; Cranium; Dental; Dentistry; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763657	Molar rel Skull XR	4180186
40763657	磨牙关系:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763658	1L-NB; Cranial; Cranium; Dental; Dentistry; Head; Length; Low; NB; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Supramentale; Xray; X-ray	4180186
40763658	1L-NB Skull XR	4180186
40763658	垂直于鼻根点-下齿槽座点连线的下切缘:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763659	Cranial; Cranium; Dental; Dentistry; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763659	Overjet Skull XR	4180186
40763659	覆盖:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763661	Cranial; Cranium; Dental; Dentistry; Go-Gn; gonion to gnathion; Head; IMPA; IMPA (1L-GoMe) (constructed); Mand; Me-Goi; menton to reconstructed gonion; MP; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763661	IMPA (1L-GoMe) (constructed) Skull XR	4180186
40763661	采用已构建下颌角点的切牙下颌平面角:角度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763662	1L-NB; Cranial; Cranium; Dental; Dentistry; Head; Low; NB; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Supramentale; Xray; X-ray	4180186
40763662	1L-NB Angle Skull XR	4180186
40763662	下切牙至鼻根点-下齿槽座点连线:角度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763664	1U-ANSPNS; Cranial; Cranium; Dental; Dentistry; Head; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Up; Xray; X-ray	4180186
40763664	1U-ANSPNS Angle Skull XR	4180186
40763664	上切牙至腭平面:角度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763665	1U-SENA; Cranial; Cranium; Dental; Dentistry; Head; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Up; Xray; X-ray	4180186
40763665	1U-SeNa Angle Skull XR	4180186
40763665	上中切牙至蝶鞍点-鼻根点连线:角度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763666	Cranial; Cranium; Dental; Dentistry; Go-Gn; gonion to gnathion; Head; IMPA; IMPA (1L-GoGn); Mand; Me-Goi; menton to reconstructed gonion; MP; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763666	IMPA (1L-GoGn) Skull XR	4180186
40763666	采用颌下点的切牙下颌平面角:角度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763667	Cranial; Cranium; Dental; Dentistry; Head; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; U1-L1; Xray; X-ray	4180186
40763667	U1-L1 Skull XR	4180186
40763667	切牙间夹角:角度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763668	CD-GN; Cranial; Cranium; Dental; Dentistry; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763668	Cd-Gn Skull XR	4180186
40763668	髁顶点至颌下点:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763670	CD-A; Cranial; Cranium; Dental; Dentistry; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; SS; Subspinale; Xray; X-ray	4180186
40763670	Cd-A Skull XR	4180186
40763670	髁顶点至上齿槽座点:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763671	Cranial; Cranium; Dental; Dentistry; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; SS; Subspinale; UIE-A FH; Xray; X-ray	4180186
40763671	UIE-A FH Skull XR	4180186
40763671	下齿槽点至上齿槽座点:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763672	Cranial; Cranium; Dental; Dentistry; Go-Gn-A; Head; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763672	Go-Gn-A Angle Skull XR	4180186
40763672	面部锥形:角度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763673	Cranial; Cranium; Dental; Dentistry; Head; NAP; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763673	NAP Skull XR	4180186
40763673	颌凸角:角度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763674	1U-ST; Cranial; Cranium; Dental; Dentistry; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Up; Xray; X-ray	4180186
40763674	1U-St Skull XR	4180186
40763674	上中切牙至口点:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763675	Cranial; Cranium; Dental; Dentistry; Head; Length; PG-PG'; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Thick; Xray; X-ray	4180186
40763675	Pg-Pg' Skull XR	4180186
40763675	颏部厚度:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763676	Cranial; Cranium; Dental; Dentistry; Head; Length; PG'LS-SLS; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763676	Pg'Ls-Sls Skull XR	4180186
40763676	H-线至鼻中隔下点:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763683	Cranial; Cranium; Dental; Dentistry; FH; FH-SEGN; FH-SeGn (constructed); Head; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763683	FH-SeGn (constructed) Skull XR	4180186
40763683	采用已构建颌下点的 Y 轴至眼耳平面:角度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763685	Cranial; Cranium; Dental; Dentistry; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; SE-GO; Xray; X-ray	4180186
40763685	Se-Go Skull XR	4180186
40763685	后面高度:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763686	AR-GO; Cranial; Cranium; Dental; Dentistry; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763686	Ar-Go Skull XR	4180186
40763686	岔枝高度:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763687	AR-GO; Ar-Go (constructed); Cranial; Cranium; Dental; Dentistry; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763687	Ar-Go (constructed) Skull XR	4180186
40763687	采用已构建下颌角点的岔枝高度:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763691	Cranial; Cranium; Dental; Dentistry; FH; FMA; FMA (constructed); Go-Gn; gonion to gnathion; Head; Mand; Me-Goi; menton to reconstructed gonion; MP; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763691	FMA (constructed) Angle Skull XR	4180186
40763691	眼耳平面至使用已构建下颌角点的下颌平面:角度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763694	Cranial; Cranium; Dental; Dentistry; Head; Length; LI-PG'; Low; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763694	Li-Pg' Skull XR	4180186
40763694	下唇至颏前点:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763695	Cranial; Cranium; Dental; Dentistry; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; STI-ME'; Xray; X-ray	4180186
40763695	Sti-Me' Skull XR	4180186
40763695	口点至颏下点:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763696	Cranial; Cranium; Dental; Dentistry; Head; Length; LS-PG'; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Up; Xray; X-ray	4180186
40763696	Ls-Pg' Skull XR	4180186
40763696	上唇至颏前点:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763697	Cranial; Cranium; Dental; Dentistry; Head; Length; NA-ME; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763697	Na-Me Skull XR	4180186
40763697	前面高:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763698	Cranial; Cranium; Dental; Dentistry; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; SN-PG'; Xray; X-ray	4180186
40763698	Sn-Pg' Skull XR	4180186
40763698	鼻中隔下点至颏前点:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763700	Cranial; Cranium; Dental; Dentistry; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; ST-SN; Xray; X-ray	4180186
40763700	St-Sn Skull XR	4180186
40763700	鼻中隔下点至口点:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763703	Cranial; Cranium; Dental; Dentistry; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763703	Tonsil Skull XR	4180186
40763703	扁桃体宽度:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763704	AO-BO; Cranial; Cranium; Dental; Dentistry; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763704	AO-BO Skull XR	4180186
40763704	威氏分析:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763705	CD-XI-PM; Cranial; Cranium; Dental; Dentistry; Head; Mand; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763705	Cd-Xi-Pm Angle Skull XR	4180186
40763705	下颌弓:角度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763706	ANS-XI-PM; Cranial; Cranium; Dental; Dentistry; Head; Low; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763706	ANS-Xi-Pm Skull XR	4180186
40763706	下面高角:角度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763709	CC-NA; Cranial; Cranium; Dental; Dentistry; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763709	CC-Na Skull XR	4180186
40763709	前颅:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763710	CD-GO; Cranial; Cranium; Dental; Dentistry; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763710	Cd-Go Skull XR	4180186
40763710	髁顶点至下颌角点:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763713	Cranial; Cranium; Dental; Dentistry; Gl'-Sn; Head; Length Ratio; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; SN-ME'; Xray; X-ray	4180186
40763713	GL'-SN/Face low Skull XR	4180186
40763713	面部中部/面部下部:长度比率:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763716	ANSPNS-GoMe; ANSPNS-GoMe (constructed); Cranial; Cranium; Dental; Dentistry; Head; Mand; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763716	ANSPNS-GoMe (constructed) Skull XR	4180186
40763716	采用颏下点和已构建下颌角点的上下颌平面角:角度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763718	Cranial; Cranium; Dental; Dentistry; Go-Gn; gonion to gnathion; Head; Mand; Me-Goi; menton to reconstructed gonion; MP; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Se-Na; SENA-GOME; SENA-GoMe (constructed); S-N; Xray; X-ray	4180186
40763718	SENA-GoMe (constructed) Angle Skull XR	4180186
40763718	采用颏下点和已构建下颌角点的蝶鞍点-鼻根点平面至下颌平面:角度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763720	Cranial; Cranium; Dental; Dentistry; Head; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Se-Na; SENA-ANSPNS; S-N; Xray; X-ray	4180186
